Citrus Sinensis ID: 046703
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 635 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.6 | 0.486 | 0.458 | 1e-103 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.609 | 0.455 | 0.428 | 3e-94 | |
| P07761 | 436 | S-locus-specific glycopro | N/A | no | 0.625 | 0.910 | 0.422 | 8e-88 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.606 | 0.456 | 0.412 | 8e-87 | |
| P17840 | 435 | S-locus-specific glycopro | N/A | no | 0.625 | 0.912 | 0.419 | 1e-86 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.6 | 0.449 | 0.412 | 3e-85 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.595 | 0.441 | 0.407 | 5e-82 | |
| P22553 | 435 | S-locus-specific glycopro | N/A | no | 0.612 | 0.894 | 0.412 | 2e-81 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.595 | 0.443 | 0.411 | 3e-81 | |
| P0DH87 | 546 | Putative inactive G-type | no | no | 0.595 | 0.692 | 0.411 | 1e-80 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 376 bits (966), Expect = e-103, Method: Compositional matrix adjust.
Identities = 188/410 (45%), Positives = 270/410 (65%), Gaps = 29/410 (7%)
Query: 22 APDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNL 81
A DI+ ++QTL DG T++S+ GSFE+GFFSPG S+NRY+GIWYK I ++TVVWVANR +
Sbjct: 23 ATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSP 82
Query: 82 INDSSGFLMINKTGNLVLTSKSNIVVWSAYL-----SKEVRTPVVLQLLDSGNLVLRGEQ 136
+ D SG L +++ G+L L + N ++WS+ +R P+V Q+LD+GNLV+R
Sbjct: 83 LYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILDTGNLVVR--N 139
Query: 137 DGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDN 196
GD + Y WQS DYP D LPGMK G + TGL R +TSW++ DDPS G++ ++
Sbjct: 140 SGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGV 199
Query: 197 PEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYYTFNITNKAVISR 255
P+ + K S +RTGPWNGLRF+ P+L+PNP++ + +V + E+YYT+ + N +V++R
Sbjct: 200 PQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTR 259
Query: 256 IIMNQ----------------TLYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLKGFKH 299
+ +N Y D CD Y LCG+YG C I++SP C+CLKGF
Sbjct: 260 MQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVA 319
Query: 300 KS-GGYV--DWSKGCVRNKPLNYSR-QDGFMKFTELKLPDATPSWVSKSMNLKESREGCL 355
K+ +V DWS+GCVR L+ + +DGF+K ++LKLPD SW K+M+L E ++ CL
Sbjct: 320 KTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCL 379
Query: 356 ENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELD 405
N C AY+ DIR GG GC +WFGDLID+R + + GQDLY+R+++SE++
Sbjct: 380 RNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIE 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 346 bits (888), Expect = 3e-94, Method: Compositional matrix adjust.
Identities = 178/415 (42%), Positives = 258/415 (62%), Gaps = 28/415 (6%)
Query: 19 FSFAPDIITSSQ--TLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVA 76
+S + + +++S+ T++ T++S FELGFF PG Y+GIWYK I +T VWVA
Sbjct: 25 YSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVA 84
Query: 77 NRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSK-EVRTPVVLQLLDSGNLVLRGE 135
NR ++ S G L I+ + NLV+ +S+ VWS L+ +VR+P+V +LLD+GN VLR
Sbjct: 85 NRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDS 143
Query: 136 QDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQD 195
++ + WQSFD+P+DTLLP MKLGWD +TG R + SWKS DDPS GDF + +E +
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 196 NPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYYTFNITNKAVIS 254
PE+ +W + YR+GPWNG+RFS P ++P F+F ++ E+ Y+F IT V S
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 255 RIIM------------------NQTLYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLKG 296
R+ + NQ Y+ P+DQCD Y CG YG C + SPVC C+KG
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYA--PKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321
Query: 297 FKHKSG---GYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREG 353
FK ++ G D S GCVR L+ DGF++ ++KLPD T + V + + +KE +
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381
Query: 354 CLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQER 408
CL + C A+ N+DIRG GSGC W G+L D+R++ GGQDLY+R++A++L+ +R
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKR 436
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P07761|SLSG6_BRAOL S-locus-specific glycoprotein S6 OS=Brassica oleracea GN=SLSG PE=2 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 178/421 (42%), Positives = 250/421 (59%), Gaps = 24/421 (5%)
Query: 6 LLCTQQLPFFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYK 65
LL L F FS T S ++ RTL+S +FELGFF SS Y+GIWYK
Sbjct: 17 LLVFFVLILFCPAFSINTLSSTESLRISSNRTLVSPGNNFELGFFRTNSSSRWYLGIWYK 76
Query: 66 NIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSK-EVRTPVVLQL 124
+ +T VWVANR N ++++ G L I+ NLVL +N VWS L++ R PVV +L
Sbjct: 77 KLLDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLGHTNKSVWSTNLTRGNERLPVVAEL 135
Query: 125 LDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSP 184
L +GN V+R + D+ Y WQSFDYP+DTLLP MKLG+DL+TGL R +TSW+S DDPS
Sbjct: 136 LSNGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYDLKTGLNRFLTSWRSSDDPSS 195
Query: 185 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYY 243
GDF + +E + PE +W G +R+GPWNG+RFS P + ++F N E+ Y
Sbjct: 196 GDFSYKLETRSLPEFYLWHGIFPMHRSGPWNGVRFSGIPEDQKLSYMVYNFTENSEEVAY 255
Query: 244 TFNITNKAVISRIIMNQTLYSD----------------VPRD-QCDTYGLCGAYGICIIS 286
TF +TN ++ SR+ ++ Y P D QCDTY +CG Y C ++
Sbjct: 256 TFRMTNNSIYSRLTLSSEGYFQRLTWNPSIGIWNRFWSSPVDPQCDTYIMCGPYAYCGVN 315
Query: 287 QSPVCQCLKGFKHKSGGYVD---WSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSK 343
SPVC C++GF ++ D W+ GC+R L+ S DGF + +KLP+ T + V +
Sbjct: 316 TSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTRLSCS-GDGFTRMKNMKLPETTMAIVDR 374
Query: 344 SMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASE 403
S+ +KE + CL + C A+ N+DIR GG+GC +W G L DMR++ GQDLY+R++ ++
Sbjct: 375 SIGVKECEKRCLSDCNCTAFANADIRNGGTGCVIWTGRLDDMRNYVAHGQDLYVRLAVAD 434
Query: 404 L 404
L
Sbjct: 435 L 435
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization). Brassica oleracea (taxid: 3712) |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (824), Expect = 8e-87, Method: Compositional matrix adjust.
Identities = 172/417 (41%), Positives = 251/417 (60%), Gaps = 32/417 (7%)
Query: 19 FSFAPDII--TSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVA 76
FS +P+ + T S T++ +T+IS FELGFF+P SS Y+GIWYK IP++T VWVA
Sbjct: 23 FSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVA 82
Query: 77 NRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSK-EVRTPVVLQLLDSGNLVLRGE 135
NR N ++ S+G L I+ NLV+ +S+ VWS ++ +VR+PV +LLD+GN +LR
Sbjct: 83 NRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDS 141
Query: 136 QDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQD 195
+ WQSFD+P+DTLL MKLGWD +TG R + SWK+ DDPS G+F +E +
Sbjct: 142 NN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSE 197
Query: 196 NPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYYTFNITNKAVIS 254
PE + YR+GPWNG+RFS+ P ++F ++ E+ Y++ I + S
Sbjct: 198 FPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYS 257
Query: 255 RIIMN------------------QTLYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLKG 296
R+ +N Q YS P+D CD Y +CG +G C + P C C+KG
Sbjct: 258 RLYLNSAGLLQRLTWFETTQSWKQLWYS--PKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315
Query: 297 FK---HKSGGYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREG 353
FK ++ D S GC+R L+ +DGF + +KLPD T + V + + LK +E
Sbjct: 316 FKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKER 375
Query: 354 CLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQERCK 410
CLE+ C A+ N+DIR GGSGC +W +++DMR++ GGQDLY+R++A+EL+ +R K
Sbjct: 376 CLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIK 432
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17840|SLSG3_BRAOL S-locus-specific glycoprotein S13 OS=Brassica oleracea GN=SLSG PE=2 SV=2 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 176/420 (41%), Positives = 248/420 (59%), Gaps = 23/420 (5%)
Query: 6 LLCTQQLPFFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYK 65
LL L F FS T S T++ RTL+S FELGFF SS Y+GIWYK
Sbjct: 17 LLVFFVLILFRPAFSINTLSSTESLTISSNRTLVSPGNVFELGFFKTTSSSRWYLGIWYK 76
Query: 66 NIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSK-EVRTPVVLQL 124
P +T VWVANR N +++ G L I+ NLVL SN VWS +++ R+PVV +L
Sbjct: 77 KFPYRTYVWVANRDNPLSNDIGTLKISG-NNLVLLDHSNKSVWSTNVTRGNERSPVVAEL 135
Query: 125 LDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSP 184
LD+GN V+R ++ + WQSFDYP+DTLLP MKLG+DL+TGL R +TSW+S DDPS
Sbjct: 136 LDNGNFVMRDSNSNNASQFLWQSFDYPTDTLLPEMKLGYDLKTGLNRFLTSWRSSDDPSS 195
Query: 185 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYY 243
GD+ + +E + PE + GS + +R+GPWNG R S P + ++F N E Y
Sbjct: 196 GDYSYKLELRRLPEFYLSSGSFRLHRSGPWNGFRISGIPEDQKLSYMVYNFTENSEEAAY 255
Query: 244 TFNITNKAVISRIIMNQTLYSD----------------VPRDQCDTYGLCGAYGICIISQ 287
TF +TN + SR+ ++ T Y + P QCD Y +CG Y C ++
Sbjct: 256 TFLMTNNSFYSRLTISSTGYFERLTWAPSSVVWNVFWSSPNHQCDMYRMCGPYSYCDVNT 315
Query: 288 SPVCQCLKGFKHKSGGYVDW---SKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKS 344
SPVC C++GF+ K+ D + GC+R L+ S DGF + +KLP+ T + V +S
Sbjct: 316 SPVCNCIQGFRPKNRQQWDLRIPTSGCIRRTRLSCS-GDGFTRMKNMKLPETTMAIVHRS 374
Query: 345 MNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASEL 404
+ LKE + CL + C A+ N+DIR G+GC +W G+L D+R++ GQDLY+R++A++L
Sbjct: 375 IGLKECEKRCLSDCNCTAFANADIRNRGTGCVIWTGELEDIRTYFADGQDLYVRLAAADL 434
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization). Brassica oleracea (taxid: 3712) |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 168/407 (41%), Positives = 244/407 (59%), Gaps = 26/407 (6%)
Query: 27 TSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSS 86
T S T++ +T+IS FELGFF+P SS Y+GIWYK IP++T VWVANR N ++ S+
Sbjct: 33 TESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSN 92
Query: 87 GFLMINKTGNLVLTSKSNIVVWSAYLSK-EVRTPVVLQLLDSGNLVLRGEQDGDSETYFW 145
G L I+ NLV+ +S+ VWS ++ +VR+PV +LLD GN VLR ++ + W
Sbjct: 93 GTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLW 151
Query: 146 QSFDYPSDTLLPGMKLGWDLET-GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKG 204
QSFD+P+DTLL MK+GWD ++ G R + SWK+ DDPS GDF + PE ++
Sbjct: 152 QSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNK 211
Query: 205 SRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMNQT-- 261
YR+GPW G RFS+ P ++P SF N+ ++ Y++ + + S + ++ T
Sbjct: 212 ESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGL 271
Query: 262 ----------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLKGFK--HKSGG 303
YS P+D CD Y CG YG C + SP+C C+KGF+ ++
Sbjct: 272 LQRLTWMEAAQSWKQLWYS--PKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQAA 329
Query: 304 YVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAY 363
D S GCVR L+ +DGF++ +++LPD T + V K + LKE E CL+ C A+
Sbjct: 330 LRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAF 389
Query: 364 TNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQERCK 410
N+DIR GGSGC +W G L D+R++ GGQDLY+R++A +L+ +R K
Sbjct: 390 ANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIK 436
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 166/407 (40%), Positives = 250/407 (61%), Gaps = 29/407 (7%)
Query: 27 TSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSS 86
T S T++ +TL+S FE+GFF S Y+G+WYK + +T VWVANR N ++++
Sbjct: 39 TESLTISSNKTLVSPGSIFEVGFFRTNS--RWYLGMWYKKVSDRTYVWVANRDNPLSNAI 96
Query: 87 GFLMINKTGNLVLTSKSNIVVWSAYLSK-EVRTPVVLQLLDSGNLVLRGEQDGDSETYFW 145
G L I+ NLVL SN VW L++ R+PVV +LL +GN V+R + D+ Y W
Sbjct: 97 GTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYLW 155
Query: 146 QSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGS 205
QSFDYP+DTLLP MKLG++L+TGL R +TSW+S DDPS G+F + +E Q PE + + +
Sbjct: 156 QSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSREN 215
Query: 206 RKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIM------ 258
+R+GPWNG+RFS P + ++F+ N+ E+ YTF +TN + SR+ +
Sbjct: 216 FPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYF 275
Query: 259 -NQTLYSDV---------PRD-QCDTYGLCGAYGICIISQSPVCQCLKGFKHKSGGYVD- 306
T Y + P D QCDTY +CG Y C ++ SPVC C++GF ++ D
Sbjct: 276 QRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQ 335
Query: 307 --WSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYT 364
W+ GC+R L+ S DGF + ++KLP+ T + V +S+ +KE ++ C+ + C A+
Sbjct: 336 RVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFA 394
Query: 365 NSDIRGGGSGCAMWFGDLIDMRSFPD---GGQDLYIRMSASELDQER 408
N+DIR GGSGC +W L D+R++ GQDLY+R++A+++ ++R
Sbjct: 395 NADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKR 441
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P22553|SLSG2_BRAOA S-locus-specific glycoprotein BS29-2 OS=Brassica oleracea var. alboglabra GN=SLSG PE=2 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 172/417 (41%), Positives = 249/417 (59%), Gaps = 28/417 (6%)
Query: 14 FFLSEFS--FAPDIITSSQTL--NDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPV 69
F L+ FS F+ + ++S ++L ++ RTL+S ELGFF SS Y+G+WYK +
Sbjct: 20 FVLTLFSPAFSINTLSSIESLKISNSRTLVSPGNVLELGFFRTPSSSRWYLGMWYKKLSE 79
Query: 70 KTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSK-EVRTPVVLQLLDSG 128
+T VWVANR N ++ S G L I+ NLVL SN +WS ++ R+PVV +LL +G
Sbjct: 80 RTYVWVANRDNPLSCSIGTLKISNM-NLVLLDHSNKSLWSTNHTRGNERSPVVAELLANG 138
Query: 129 NLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFI 188
N VLR D + WQSFDYP+DTLLP MKLG+DL TGL R +TSW+S DDPS GDF
Sbjct: 139 NFVLRDSNKNDRSGFLWQSFDYPTDTLLPEMKLGYDLRTGLNRFLTSWRSSDDPSSGDFS 198
Query: 189 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYYTFNI 247
+ ++ + PE ++K +R+GPWNG+ FS P + ++F N E+ YTF +
Sbjct: 199 YKLQTRRLPEFYLFKDDFLVHRSGPWNGVGFSGMPEDQKLSYMVYNFTQNSEEVAYTFLM 258
Query: 248 TNKAVISRIIMNQTLYSD----------------VPRD-QCDTYGLCGAYGICIISQSPV 290
TN ++ SR+ ++ + Y + P D QCD Y +CGAY C ++ SPV
Sbjct: 259 TNNSIYSRLTISSSGYFERLTWTPSSGMWNVFWSSPEDFQCDVYKICGAYSYCDVNTSPV 318
Query: 291 CQCLKGF---KHKSGGYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNL 347
C C++ F + G WS GC R L+ S DGF + ++KLP+ T + V +S+ L
Sbjct: 319 CNCIQRFDPSNVQEWGLRAWSGGCRRRTRLSCS-GDGFTRMKKMKLPETTMAIVDRSIGL 377
Query: 348 KESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASEL 404
KE + CL + C A+ N+DIR GG+GC +W G L D+R++ GQDLY+R++ ++L
Sbjct: 378 KECEKRCLSDCNCTAFANADIRNGGTGCVIWTGQLEDIRTYFANGQDLYVRLAPADL 434
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization). Brassica oleracea var. alboglabra (taxid: 3714) |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (776), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 166/403 (41%), Positives = 234/403 (58%), Gaps = 25/403 (6%)
Query: 27 TSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSS 86
T S T++ +T++S G FELGFF + Y+GIWYK I +T VWVANR +++
Sbjct: 38 TESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVANRDTPLSNPI 96
Query: 87 GFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQ 146
G L I+ NLV+ S+ VWS L+ VR+ VV +LLD+GN VLRG + +S+ + WQ
Sbjct: 97 GILKIS-NANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKINESDEFLWQ 155
Query: 147 SFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSR 206
SFD+P+DTLLP MKLG D + GL R VTSWKS DPS G F++ +E PE +
Sbjct: 156 SFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLPEFFGFTSFL 215
Query: 207 KFYRTGPWNGLRFSAP-SLRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMNQT---- 261
+ YR+GPW+GLRFS ++ ++F N E+ YTF +T+ SR+ +N
Sbjct: 216 EVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYSRLTINTVGRLE 275
Query: 262 ------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLKGFKHKSGGYVDWSK 309
++ +P+D CD YG+CG Y C +S SP C C+KGF+ S DW+
Sbjct: 276 GFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQPLSPQ--DWAS 333
Query: 310 GCV----RNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTN 365
G V R K +D F + +K+P T + V K + LKE E C + C AY N
Sbjct: 334 GDVTGRCRRKTQLTCGEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKTHCNCTAYAN 393
Query: 366 SDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQER 408
SDIR GGSGC +W G+ D+R++ GQDL++R++A+E + R
Sbjct: 394 SDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERR 436
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH87|PSRK_ARATH Putative inactive G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=PSEUDOSRKA PE=5 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (771), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 166/403 (41%), Positives = 234/403 (58%), Gaps = 25/403 (6%)
Query: 27 TSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSS 86
T S T++ +T++S G FELGFF + Y+GIWYK I +T VWVANR +++
Sbjct: 38 TESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVANRDTPLSNPI 96
Query: 87 GFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQ 146
G L I+ NLV+ S+ VWS L+ VR+ VV +LLD+GN VLRG + +S+ + WQ
Sbjct: 97 GILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKINESDEFLWQ 155
Query: 147 SFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSR 206
SFD+P+DTLLP MKLG D + GL R VTSWKS DPS G F++ +E PE +
Sbjct: 156 SFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLPEFFGFTSFL 215
Query: 207 KFYRTGPWNGLRFSAP-SLRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMNQT---- 261
+ YR+GPW+GLRFS ++ ++F N E+ YTF +T+ SR+ +N
Sbjct: 216 EVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYSRLTINTVGRLE 275
Query: 262 ------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLKGFKHKSGGYVDWSK 309
++ +P+D CD YG+CG Y C +S SP C C+KGF+ S DW+
Sbjct: 276 GFTWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQPLSPQ--DWAS 333
Query: 310 GCV----RNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTN 365
G V R K +D F + +K+P T + V K + LKE E C + C AY N
Sbjct: 334 GDVTGRCRRKTQLTCGEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKTHCNCTAYAN 393
Query: 366 SDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQER 408
SDIR GGSGC +W G+ D+R++ GQDL++R++A+E + R
Sbjct: 394 SDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERR 436
|
Truncated and inactivated form of SRK, the female specificity determinant of self-incompatibility when active. Most A.thaliana cultivars contain such an inactive form and thus, are self-fertiles. Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 635 | ||||||
| 25956274 | 686 | hypothetical protein [Lotus japonicus] | 0.948 | 0.877 | 0.433 | 1e-152 | |
| 164605525 | 685 | CM0216.570.nc [Lotus japonicus] | 0.946 | 0.877 | 0.433 | 1e-150 | |
| 33945884 | 685 | S-receptor kinase-like protein 1 [Lotus | 0.946 | 0.877 | 0.431 | 1e-150 | |
| 302143131 | 1901 | unnamed protein product [Vitis vinifera] | 0.937 | 0.312 | 0.434 | 1e-145 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.607 | 0.461 | 0.619 | 1e-142 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.628 | 0.507 | 0.584 | 1e-142 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.607 | 0.470 | 0.621 | 1e-141 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.642 | 0.519 | 0.579 | 1e-141 | |
| 224151394 | 439 | predicted protein [Populus trichocarpa] | 0.607 | 0.879 | 0.621 | 1e-141 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.607 | 0.470 | 0.616 | 1e-140 |
| >gi|25956274|dbj|BAC41328.1| hypothetical protein [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1405), Expect = e-152, Method: Compositional matrix adjust.
Identities = 296/683 (43%), Positives = 405/683 (59%), Gaps = 81/683 (11%)
Query: 26 ITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDS 85
+T +Q++ D TL+S +G+FE GFF G+S+ +Y GIWYK+I +T+VWVANR + +S
Sbjct: 12 VTQNQSIQDDETLVSAEGTFEAGFFGLGNSQRQYFGIWYKSISPRTIVWVANRDAPVQNS 71
Query: 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFW 145
+ + + GNL++ S ++WS+ S+ P +QLLDSGNLV++ + + W
Sbjct: 72 TATIKLTDKGNLLILDGSKGIIWSSNGSRAAEKP-YMQLLDSGNLVVK-DGGKRKKNLIW 129
Query: 146 QSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGS 205
+SFDYP DTLL GMK+ +L G +TSW++ +DP+ G+F + I+ + P++V+ + +
Sbjct: 130 ESFDYPGDTLLAGMKIKSNLVKGPTSYLTSWRNTEDPASGEFSYLIDTRGFPQLVITRNA 189
Query: 206 RKFYRTGPWNGLRFSAPS---LRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMN--- 259
+YR GPW G FS S LR FS F S ++ L Y N+++I+R ++N
Sbjct: 190 TAYYRAGPWTGKLFSGSSWLRLRKILTFSMQFTSQEISLEY--ETANRSIITRAVINPSG 247
Query: 260 ---QTLYSDV----------PRDQCDTYGLCGAYGICIISQSPVCQCLKGFKHKSGGY-- 304
+ L+SD P DQC YGLCGA +C IS +P+C CL+GF+ K
Sbjct: 248 TTQRLLWSDRSQSWEIISTHPTDQCTYYGLCGANSMCDISNNPICHCLEGFRPKFQAKWN 307
Query: 305 -VDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAY 363
DW GCV K L+ DGF+K T +KLPD + SW K+ +L E CL+N C +Y
Sbjct: 308 SFDWPGGCVPMKNLSCQNGDGFLKHTGVKLPDTSSSWYGKNKSLDECGTLCLQNCSCTSY 367
Query: 364 TNSDIRGGGSGCAMWFGDLIDM--RSFPDGGQDLYIRMSASELDQE-------------- 407
D GGS C +WFGD++D+ PD GQ++YI++ ASELD
Sbjct: 368 AYLDNDIGGSACLIWFGDILDLSIHPNPDQGQEIYIKVVASELDHRRNKKSFMTKKLAGS 427
Query: 408 -----------------------------------RCKLLDWSKRFRIICGTGRGLLYLH 432
R KLLDW+KR +II G RGLLYLH
Sbjct: 428 LAGIVALVICIIILGLATSTCIQRKKNERGDGDSTRSKLLDWNKRLQIIDGIARGLLYLH 487
Query: 433 QDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA 492
QDSRLRIIHRDLK N+LLD +MNPKISDFGLAR F GD+ E T RV+GTYGYM PEYA
Sbjct: 488 QDSRLRIIHRDLKTSNILLDNEMNPKISDFGLARIFIGDQVEARTKRVMGTYGYMPPEYA 547
Query: 493 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCY 552
G FS+KSDVFSFG+++LEI+SGKK R FY + LNL+ HAW+LW +G P E++D +
Sbjct: 548 VHGSFSIKSDVFSFGVIVLEIISGKKIRKFYDPHHHLNLLSHAWRLWIEGSPLELVDKLF 607
Query: 553 QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPKQPGFLADRKSIGP 612
++S TE++R IH++LLCVQ+ P+ RP M S++LML E LP+P P F +
Sbjct: 608 EDSIIPTEILRYIHVALLCVQRRPETRPDMLSIVLMLNGEKELPKPSLPAFYTGKHD--- 664
Query: 613 DSLLSIPESSSSNSITISELEAR 635
LL P S S+TIS LEAR
Sbjct: 665 PILLESPSRRCSTSVTIS-LEAR 686
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|164605525|dbj|BAF98591.1| CM0216.570.nc [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1391), Expect = e-150, Method: Compositional matrix adjust.
Identities = 296/683 (43%), Positives = 405/683 (59%), Gaps = 82/683 (12%)
Query: 26 ITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDS 85
+T +Q++ D TL+S +G+FE GFFS G+S+ +Y GIWYK+I +T+VWVANR + +S
Sbjct: 12 VTQNQSIQDDETLVSAEGTFEAGFFSLGNSQRQYFGIWYKSISPRTIVWVANRDAPVQNS 71
Query: 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFW 145
+ + + GNL++ S ++WS+ S+ P +QLLDSGNLV++ + + W
Sbjct: 72 TATIKLTDKGNLLILDGSKGIIWSSNGSRAAEKP-YMQLLDSGNLVVK-DGGKRKKNLIW 129
Query: 146 QSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGS 205
+SFDYP DTLL GMK+ +L G +TSW++ +DP+ G+F + I+ + P++V+ + +
Sbjct: 130 ESFDYPGDTLLAGMKIKSNLVKGPTSYLTSWRNTEDPASGEFSYLIDTRGFPQLVITRNA 189
Query: 206 RKFYRTGPWNGLRFSAPS---LRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMN--- 259
+YR GPW G FS S LR FS F S ++ L Y N+++I+R ++N
Sbjct: 190 TAYYRAGPWTGKLFSGSSWLRLRKILTFSMQFTSQEISLEY--ETANRSIITRAVINPSG 247
Query: 260 ---QTLYSDV----------PRDQCDTYGLCGAYGICIISQSPVCQCLKGFKHKSGGY-- 304
+ L+SD P DQC YGLCGA +C IS +P+C CL+GF+ K
Sbjct: 248 TTQRLLWSDRSQSWEIISTHPTDQCTYYGLCGANSMCDISNNPICHCLEGFRPKFQAKWN 307
Query: 305 -VDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAY 363
DW GCV K L+ DGF+K T +KLPD + SW K+ +L E CL+N C +Y
Sbjct: 308 SFDWPGGCVPMKNLSCQNGDGFLKHTGVKLPDTSSSWYGKNKSLDECGTLCLQNCSCTSY 367
Query: 364 TNSDIRGGGSGCAMWFGDLIDM--RSFPDGGQDLYIRMSASELDQE-------------- 407
D GGS C +WFGD++D+ PD GQ++YI++ ASELD
Sbjct: 368 AYLDNDIGGSACLIWFGDILDLSIHPNPDQGQEIYIKVVASELDHRRNKKSFMTKKLAGS 427
Query: 408 -----------------------------------RCKLLDWSKRFRIICGTGRGLLYLH 432
R KLLDW+KR +II G RGLLYLH
Sbjct: 428 LAGIVALVICIIILGLATSTCIQRKKNERGDGDSTRSKLLDWNKRLQIIDGIARGLLYLH 487
Query: 433 QDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA 492
QDSRLRIIHRDLK N+LLD +MNPKISDFGLAR F GD+ E T RV+GT GYM PEYA
Sbjct: 488 QDSRLRIIHRDLKTSNILLDNEMNPKISDFGLARIFIGDQVEARTKRVMGT-GYMPPEYA 546
Query: 493 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCY 552
G FS+KSDVFSFG+++LEI+SGKK R FY + LNL+ HAW+LW +G P E++D +
Sbjct: 547 VHGSFSIKSDVFSFGVIVLEIISGKKIRKFYDPHHHLNLLSHAWRLWIEGSPLELVDKLF 606
Query: 553 QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPKQPGFLADRKSIGP 612
++S TE++R IH++LLCVQ+ P+ RP M S++LML E LP+P P F +
Sbjct: 607 EDSIIPTEILRYIHVALLCVQRRPETRPDMLSIVLMLNGEKELPKPSLPAFYTGKHD--- 663
Query: 613 DSLLSIPESSSSNSITISELEAR 635
LL P S S+TIS LEAR
Sbjct: 664 PILLESPSRRCSTSVTIS-LEAR 685
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|33945884|emb|CAE45594.1| S-receptor kinase-like protein 1 [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1385), Expect = e-150, Method: Compositional matrix adjust.
Identities = 295/683 (43%), Positives = 404/683 (59%), Gaps = 82/683 (12%)
Query: 26 ITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDS 85
+T +Q++ D TL+S +G+FE GFF G+S+ +Y GIWYK+I +T+VWVANR + +S
Sbjct: 12 VTQNQSIQDDETLVSAEGTFEAGFFGLGNSQRQYFGIWYKSISPRTIVWVANRDAPVQNS 71
Query: 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFW 145
+ + + GNL++ S ++WS+ S+ P +QLLDSGNLV++ + + W
Sbjct: 72 TATIKLTDKGNLLILDGSKGIIWSSNGSRAAEKP-YMQLLDSGNLVVK-DGGKRKKNLIW 129
Query: 146 QSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGS 205
+SFDYP DTLL GMK+ +L G +TSW++ +DP+ G+F + I+ + P++V+ + +
Sbjct: 130 ESFDYPGDTLLAGMKIKSNLVKGPTSYLTSWRNTEDPASGEFSYLIDTRGFPQLVITRNA 189
Query: 206 RKFYRTGPWNGLRFSAPS---LRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMN--- 259
+YR GPW G FS S LR FS F S ++ L Y N+++I+R ++N
Sbjct: 190 TAYYRAGPWTGKLFSGSSWLRLRKILTFSMQFTSQEISLEY--ETANRSIITRAVINPSG 247
Query: 260 ---QTLYSDV----------PRDQCDTYGLCGAYGICIISQSPVCQCLKGFKHKSGGY-- 304
+ L+SD P DQC YGLCGA +C IS +P+C CL+GF+ K
Sbjct: 248 TTQRLLWSDRSQSWEIISTHPTDQCTYYGLCGANSMCDISNNPICHCLEGFRPKFQAKWN 307
Query: 305 -VDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAY 363
DW GCV K L+ DGF+K T +KLPD + SW K+ +L E CL+N C +Y
Sbjct: 308 SFDWPGGCVPMKNLSCQNGDGFLKHTGVKLPDTSSSWYGKNKSLDECGTLCLQNCSCTSY 367
Query: 364 TNSDIRGGGSGCAMWFGDLIDM--RSFPDGGQDLYIRMSASELDQE-------------- 407
D GGS C +WFGD++D+ PD GQ++YI++ ASELD
Sbjct: 368 AYLDNDIGGSACLIWFGDILDLSIHPNPDQGQEIYIKVVASELDHRRNKKSFMTKKLAGS 427
Query: 408 -----------------------------------RCKLLDWSKRFRIICGTGRGLLYLH 432
R KLLDW+KR +II G RGLLYLH
Sbjct: 428 LAGIVALVICIIILGLATSTCIQRKKNERGDGDSTRSKLLDWNKRLQIIDGIARGLLYLH 487
Query: 433 QDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA 492
QDSRLRIIHRDLK N+LLD +MNPKISDFGLAR F GD+ E T RV+GT GYM PEYA
Sbjct: 488 QDSRLRIIHRDLKTSNILLDNEMNPKISDFGLARIFIGDQVEARTKRVMGT-GYMPPEYA 546
Query: 493 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCY 552
G FS+KSDVFSFG+++LEI+SGKK R FY + LNL+ HAW+LW +G P E++D +
Sbjct: 547 VHGSFSIKSDVFSFGVIVLEIISGKKIRKFYDPHHHLNLLSHAWRLWIEGSPLELVDKLF 606
Query: 553 QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPKQPGFLADRKSIGP 612
++S TE++R IH++LLCVQ+ P+ RP M S++LML E LP+P P F +
Sbjct: 607 EDSIIPTEILRYIHVALLCVQRRPETRPDMLSIVLMLNGEKELPKPSLPAFYTGKHD--- 663
Query: 613 DSLLSIPESSSSNSITISELEAR 635
LL P S S+TIS LEAR
Sbjct: 664 PILLESPSRRCSTSVTIS-LEAR 685
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143131|emb|CBI20426.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 293/675 (43%), Positives = 405/675 (60%), Gaps = 80/675 (11%)
Query: 1 MADLVLLCTQQLPFFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYV 60
+A LV++ + L F+ S A D IT +Q + G T+IS GSFELGF++P +SKN+Y+
Sbjct: 4 LARLVIIFSSVL--FIVPISIAVDTITVNQPIRYGETIISAGGSFELGFYTPENSKNQYL 61
Query: 61 GIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPV 120
GIWYK + +TVVWVAN + DS G L + G LV+ + +N ++WS+ S+ + P
Sbjct: 62 GIWYKKVTPRTVVWVANGDFPLTDSLGVLKVTDQGTLVILNGTNSIIWSSNASRSAQNPT 121
Query: 121 VLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFD 180
QLL+SGNLVL+ D D E + WQSFD+P TLLP MKLG + TG E ++S KS D
Sbjct: 122 A-QLLESGNLVLKNGNDDDPENFLWQSFDHPCSTLLPNMKLGRNKSTGQEWYLSSSKSTD 180
Query: 181 DPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDV 239
DPS G+ + ++ P+++ G + +GPWNGLRFS +L ++ F N+
Sbjct: 181 DPSKGNLTYRLDPHGYPQLLKRNGLILTFCSGPWNGLRFSGFRALAGKSIYKHVFTFNEK 240
Query: 240 ELYYTFNITNKAVISRIIMNQ---------------TLYSDVPRDQCDTYGLCGAYGICI 284
E+YYT+ + + +V+SR+++N T YS +P D CD Y CG +G C
Sbjct: 241 EMYYTYELLDSSVVSRLVLNSNGDVQRLTWTDVTGWTEYSTMPMDDCDGYAFCGVHGFCN 300
Query: 285 ISQSPVCQCLKGFKHKSGGYVD---WSKGCVRNKPLNYSRQDGFMKFT------ELKLP- 334
I+Q P C CL GF+ + WS GC R++PL+ R + F K++ +L+LP
Sbjct: 301 INQVPKCGCLDGFQPNFPNNWEMGVWSNGCFRSRPLDCQRGEWFKKYSGKIPPFDLELPL 360
Query: 335 -------DATPSW------------------------VSKSMNLKESREGCLE-NSFCMA 362
+AT ++ V+ K+SR+G +E + +
Sbjct: 361 FDLATILNATNNFSIENKLGEGGFGPVYKGLLQQGQEVAVKRLSKDSRQGLIEFKTEVIH 420
Query: 363 YTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQD---LYIRMSASEL-----DQERCKLLDW 414
N R +L+ + GQ+ +Y MS L D+ R K LDW
Sbjct: 421 IANLQHR-----------NLVKLLGCCIHGQEKMLIYEYMSNKSLESFIFDKRRSKELDW 469
Query: 415 SKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE 474
KRF II G RGLLYLHQDSRLRIIHRDLKA N+LLD +M PKISDFG+AR+FGG+ETE
Sbjct: 470 PKRFLIINGIARGLLYLHQDSRLRIIHRDLKADNILLDSEMGPKISDFGIARSFGGNETE 529
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGH 534
NTT+VVGT GY++PEYAS+G +SVKSDVFSFG+++LEIVSGK+NRGF H D++LNL+GH
Sbjct: 530 ANTTKVVGTLGYISPEYASEGLYSVKSDVFSFGVMVLEIVSGKRNRGFSHPDHRLNLLGH 589
Query: 535 AWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594
AW L+ +G E++D ++ +EV+R IH+ LLCVQ DDRP M SV+LML SE+
Sbjct: 590 AWTLYTEGRYLELMDAMVGDTFQPSEVLRSIHVGLLCVQHCADDRPSMSSVVLMLSSEVA 649
Query: 595 LPQPKQPGFLADRKS 609
LPQP++PGF D S
Sbjct: 650 LPQPREPGFFCDWNS 664
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 512 bits (1319), Expect = e-142, Method: Compositional matrix adjust.
Identities = 256/413 (61%), Positives = 314/413 (76%), Gaps = 27/413 (6%)
Query: 16 LSEFSFAPDIITSSQTLNDG--RTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVV 73
S F + +T SQ++ DG RTL+SKDGSFELGFFSPGSS+NRYVGIWYKNIPV+TVV
Sbjct: 12 FSRFCNTANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVV 71
Query: 74 WVANRLNLINDSSGFLMINKTGNLVLTSKSN-IVVWSAYLSKEVRTPVVLQLLDSGNLVL 132
WVANR N INDSSGFLM++ TGNLVL S +N VVWS+ SK+ + +LLDSGNLVL
Sbjct: 72 WVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSN-SKKAAQSAMGELLDSGNLVL 130
Query: 133 RGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIE 192
R E+D +S +Y WQSFDYPSDT+LPGMKLGWDL GL+RR+++WKS DDPS GDF W +
Sbjct: 131 RDEKDVNSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQ 190
Query: 193 RQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVELYYTFNITNKA 251
Q NPE+V+WKGS K++R+GPWNG+ FS +LR NPVF F FV N E+YYT+N+ NK+
Sbjct: 191 LQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVYYTYNLKNKS 250
Query: 252 VISRIIMNQT------------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQC 293
+I+R++MNQT LY+ VPRD CD Y LCGAYG CIISQSPVC+C
Sbjct: 251 LITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCEC 310
Query: 294 LKGFKHKSG---GYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKES 350
L+ F KS ++WS+GCVRNKPL+ + DGF+K+ LKLPDAT SWV+K+MNLKE
Sbjct: 311 LEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKEC 370
Query: 351 REGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASE 403
R CL+N CMAYT +DI+ SGCA+WFGDLID+R FPDGGQ++YIRM+ASE
Sbjct: 371 RSKCLQNCSCMAYTATDIK-ERSGCAIWFGDLIDIRQFPDGGQEIYIRMNASE 422
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1315), Expect = e-142, Method: Compositional matrix adjust.
Identities = 248/424 (58%), Positives = 315/424 (74%), Gaps = 25/424 (5%)
Query: 14 FFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVV 73
F +FS A D I SQ+L DG+TL+S++GSFELGFFSPG SKNRY+GIWYKNIPV+TV+
Sbjct: 24 IFQLKFSTALDTIAPSQSLIDGKTLVSREGSFELGFFSPGISKNRYLGIWYKNIPVRTVL 83
Query: 74 WVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLR 133
WVANR N I DSSGFL I+ T NL+L S N+VVWS+ + ++P+VLQLLDSGNLVLR
Sbjct: 84 WVANRRNPIEDSSGFLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQLLDSGNLVLR 143
Query: 134 GEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIER 193
E+ DS Y WQSFD+PSDTL+PGMKLGWDL TGLERR++SW+S DDPSPGD W I+
Sbjct: 144 DEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSPGDLTWGIKL 202
Query: 194 QDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPVFSFSFVSNDVELYYTFNITNKAV 252
Q+NPE ++W+GS++++R+GPW G+ F+ AP L NPVF +FVS++ E+Y ++N+ N +
Sbjct: 203 QNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYLSYNLKNISA 262
Query: 253 ISRIIMNQT-----------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLK 295
SRI++NQT LY+ VPRD CD Y CGA G CII+ P+C+CLK
Sbjct: 263 FSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIINDLPICRCLK 322
Query: 296 GFKHKSG---GYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESRE 352
FK KS +DWS GCVRNKPLN + DGF+K+ LK PDAT SW++KSMNL E R
Sbjct: 323 KFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNKSMNLNECRA 382
Query: 353 GCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSAS---ELDQERC 409
CL+N CMAY+NSD+RGGGSGC +W+GDLID+R FP GGQ+LYIRM+ S E+DQ+
Sbjct: 383 KCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIRQFPAGGQELYIRMNPSESAEMDQQND 442
Query: 410 KLLD 413
++ D
Sbjct: 443 QITD 446
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1312), Expect = e-141, Method: Compositional matrix adjust.
Identities = 256/412 (62%), Positives = 312/412 (75%), Gaps = 26/412 (6%)
Query: 16 LSEFSFAPDIITSSQTLNDG--RTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVV 73
S F + +T SQ++ DG RTL+SKDGSFELGFFSPGSS+NRYVGIWYKNIPV+TVV
Sbjct: 12 FSRFCNTANTLTLSQSVCDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVV 71
Query: 74 WVANRLNLINDSSGFLMINKTGNLVLTSKSN-IVVWSAYLSKEVRTPVVLQLLDSGNLVL 132
WVANR N INDSSGFLM++ TGNLVL S +N VVWS+ SK+ + +LLDSGNLVL
Sbjct: 72 WVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSN-SKKAAQSAMGELLDSGNLVL 130
Query: 133 RGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIE 192
R E+D +S Y WQSFDYPSDTLLPGMKLGWDL GL+RR+++WKS DDPS GDF W +
Sbjct: 131 RDEKDANSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQ 190
Query: 193 RQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPVFSFSFVSNDVELYYTFNITNKA 251
Q NPE+VMWKGS+++YR+GPWNG+ FS P LR NPVF F FV + E+YYT+N+ NK+
Sbjct: 191 LQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVYYTYNLKNKS 250
Query: 252 VISRIIMNQT-----------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCL 294
+I+RI+MNQ+ LY++VPRD CDTY LCGAYG CIISQSPVC+CL
Sbjct: 251 LITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCIISQSPVCECL 310
Query: 295 KGFKHKSG---GYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESR 351
+ F KS +DWS+GCVRNKPL+ + DGF+K+ LKLPDAT SWV+K+MNLKE R
Sbjct: 311 EKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECR 370
Query: 352 EGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASE 403
CLEN CMAYT ++I+ SGCA+WFGDLID+ P GQ++YIRM+ASE
Sbjct: 371 SICLENCSCMAYTATNIK-ERSGCAIWFGDLIDITQLPAAGQEIYIRMNASE 421
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1309), Expect = e-141, Method: Compositional matrix adjust.
Identities = 251/433 (57%), Positives = 319/433 (73%), Gaps = 25/433 (5%)
Query: 4 LVLLCTQQLPFFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIW 63
L L T L F L +FS A D I SQ+L+DG+TL+S++GSFELGFFSPG SKNRY+GIW
Sbjct: 15 LTLFNTSFLIFQL-KFSTALDTIAPSQSLSDGKTLVSREGSFELGFFSPGISKNRYLGIW 73
Query: 64 YKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQ 123
YKNIP++TV+WVANR N I DSSG L I+ T NL+L S N+VVWS+ + ++P+VLQ
Sbjct: 74 YKNIPLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQ 133
Query: 124 LLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPS 183
LLDSGNLVLR E+ DS Y WQSFD+PSDTL+PGMKLGWDL TGLERR++SW+S DDPS
Sbjct: 134 LLDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPS 192
Query: 184 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPVFSFSFVSNDVELY 242
PGD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NPVF +FVS++ E+Y
Sbjct: 193 PGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVY 252
Query: 243 YTFNITNKAVISRIIMNQT-----------------LYSDVPRDQCDTYGLCGAYGICII 285
++N+ N + SRI++NQT LY+ VPRD CD Y CGA G CII
Sbjct: 253 LSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCII 312
Query: 286 SQSPVCQCLKGFKHKSG---GYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVS 342
+ P+C+CLK FK KS +DWS GCVRNKPLN + DGF+K+ LK PDAT SW++
Sbjct: 313 NDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLN 372
Query: 343 KSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRM--S 400
KSMNL E R CL+N CMAY+NSD+RGGGSGC +W+G LID+R FP GGQ+LYIRM S
Sbjct: 373 KSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPAGGQELYIRMNPS 432
Query: 401 ASELDQERCKLLD 413
SE+DQ+ ++ D
Sbjct: 433 ESEMDQQNDQITD 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224151394|ref|XP_002337099.1| predicted protein [Populus trichocarpa] gi|222838019|gb|EEE76384.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1307), Expect = e-141, Method: Compositional matrix adjust.
Identities = 256/412 (62%), Positives = 311/412 (75%), Gaps = 26/412 (6%)
Query: 16 LSEFSFAPDIITSSQTLNDG--RTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVV 73
S F + +T SQ++ DG RTL+SKDGSFELGFFSPGSS+NRYVGIWYKNIPV+TVV
Sbjct: 18 FSRFCNTANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVV 77
Query: 74 WVANRLNLINDSSGFLMINKTGNLVLTSKSN-IVVWSAYLSKEVRTPVVLQLLDSGNLVL 132
WVANR N INDSSGFLM++ TGN VL S +N VVWS+ SK+ + +L DSGNLVL
Sbjct: 78 WVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSN-SKKAAQSAMGELQDSGNLVL 136
Query: 133 RGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIE 192
R E+D +S Y WQSFDYPSDTLLPGMKLGWDL GL+RR+++WKS DDPS GDF W +
Sbjct: 137 RDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQ 196
Query: 193 RQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPVFSFSFVSNDVELYYTFNITNKA 251
Q NPE+VMWKGS+K+YR+GPWNG+ FS +LR NPVF F FV + E+YYT+N+ NK+
Sbjct: 197 LQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKS 256
Query: 252 VISRIIMNQT-----------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCL 294
+I+RI+MNQT LY+ VPRD CDTY LCGAYG CI+SQSPVCQCL
Sbjct: 257 LITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCL 316
Query: 295 KGFKHK---SGGYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESR 351
+ F + S +DWSKGCVRNKPL+ + DGF+K+ LKLPDAT SWV+K+MNLKE R
Sbjct: 317 EKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECR 376
Query: 352 EGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASE 403
CL+N CMAYT ++I+ SGCA+WFGDLID+R FP GQ++YIRM+ASE
Sbjct: 377 SKCLQNCSCMAYTATNIK-ERSGCAVWFGDLIDIRQFPAAGQEIYIRMNASE 427
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 254/412 (61%), Positives = 310/412 (75%), Gaps = 26/412 (6%)
Query: 16 LSEFSFAPDIITSSQTLNDG--RTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVV 73
S F + +T SQ++ DG RTL+SKDGSFELGFFSPGSS+NRYVGIWYKNIPV+TVV
Sbjct: 18 FSRFCNTANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVV 77
Query: 74 WVANRLNLINDSSGFLMINKTGNLVLTSKSN-IVVWSAYLSKEVRTPVVLQLLDSGNLVL 132
WVANR N INDSSGFLM++ TGN VL S +N VVWS+ SK+ + +L DSGNLVL
Sbjct: 78 WVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSN-SKKAAQSAMGELQDSGNLVL 136
Query: 133 RGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIE 192
R E+D +S Y WQSFDYPSDTLLPGMKLGWDL GL+RR+++WKS DDPS GDF W +
Sbjct: 137 RDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQ 196
Query: 193 RQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPVFSFSFVSNDVELYYTFNITNKA 251
Q NPE+VMWKGS+K+YR+GPWNG+ FS +LR NPVF F FV + E+YYT+N+ NK+
Sbjct: 197 LQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKS 256
Query: 252 VISRIIMNQT-----------------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCL 294
+I+RI+MNQT LY+ VPRD CDTY LCGAYG CI+SQSPVCQCL
Sbjct: 257 LITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCL 316
Query: 295 KGFKHKSG---GYVDWSKGCVRNKPLNYSRQDGFMKFTELKLPDATPSWVSKSMNLKESR 351
+ F +S +DWSKGCVRNKPL+ + DGF+K+ LKLPDAT SWV+K+MNLKE R
Sbjct: 317 EKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECR 376
Query: 352 EGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASE 403
CL+N CMAYT ++I+ SGCA+WFGDLID+R F GQ++YIR++ASE
Sbjct: 377 SKCLQNCSCMAYTATNIK-ERSGCAVWFGDLIDIRQFSAAGQEIYIRLNASE 427
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 635 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.329 | 0.266 | 0.652 | 3.9e-175 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.329 | 0.246 | 0.612 | 8.7e-157 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.329 | 0.247 | 0.612 | 8.7e-157 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.319 | 0.249 | 0.651 | 1.4e-152 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.329 | 0.251 | 0.585 | 9.3e-129 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.329 | 0.245 | 0.605 | 8.2e-123 | |
| TAIR|locus:2197724 | 806 | AT1G61430 [Arabidopsis thalian | 0.611 | 0.481 | 0.350 | 7.9e-112 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.609 | 0.478 | 0.360 | 1.5e-108 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.609 | 0.488 | 0.353 | 3.1e-108 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.300 | 0.237 | 0.564 | 8.3e-108 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 3.9e-175, Sum P(3) = 3.9e-175
Identities = 137/210 (65%), Positives = 165/210 (78%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
D+ER + LDW KR II G RG+LYLH+DSRLRIIHRDLKA NVLLD DMN KISDFGL
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
ART GGDETE NTTRVVGTYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRGF +
Sbjct: 612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESC-NLTEVIRCIHISLLCVQQHPDDRPCMP 583
++KLNL+GHAW+ + + E+ID ESC +++EV+R IHI LLCVQQ P DRP M
Sbjct: 672 EEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMS 731
Query: 584 SVILMLGSEIVLPQPKQPGFLADRKSIGPD 613
V+LML SE++L P+QPGF +R + D
Sbjct: 732 VVVLMLSSEMLLLDPRQPGFFNERNLLFSD 761
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 8.7e-157, Sum P(3) = 8.7e-157
Identities = 131/214 (61%), Positives = 161/214 (75%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
DQ R L+W KRF II G RGLLYLHQDSR RIIHRDLKA NVLLD++M PKISDFG+
Sbjct: 610 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 669
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
AR FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY+
Sbjct: 670 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 729
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT----EVIRCIHISLLCVQQHPDDRP 580
+ LNL+G W+ W +G E++DP ++ + E++RCI I LLCVQ+ +DRP
Sbjct: 730 SNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRP 789
Query: 581 CMPSVILMLGSEIV-LPQPKQPGFLADRKSIGPD 613
M SV++MLGSE +PQPK+PGF R S+ D
Sbjct: 790 VMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVD 823
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 678 (243.7 bits), Expect = 8.7e-157, Sum P(3) = 8.7e-157
Identities = 131/214 (61%), Positives = 160/214 (74%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
DQ R L+W KRF II G RGLLYLHQDSR RIIHRDLKA NVLLD++M PKISDFG+
Sbjct: 606 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 665
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
AR FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY+
Sbjct: 666 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 725
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT----EVIRCIHISLLCVQQHPDDRP 580
+ LNL+G W+ W +G E++DP +S + E++RCI I LLCVQ+ +DRP
Sbjct: 726 SNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRP 785
Query: 581 CMPSVILMLGSEIV-LPQPKQPGFLADRKSIGPD 613
M SV++MLGSE +PQPK+PGF R + D
Sbjct: 786 VMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEAD 819
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 1.4e-152, Sum P(3) = 1.4e-152
Identities = 133/204 (65%), Positives = 161/204 (78%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
D+ R LDW KR II G RG+LYLHQDSRLRIIHRDLKAGNVLLD DMNPKISDFGL
Sbjct: 587 DERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGL 646
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
A++FGGD++E +T RVVGTYGYM PEYA DG FSVKSDVFSFG+L+LEI++GK NRGF H
Sbjct: 647 AKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRH 706
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCY-QESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583
D+ LNL+GH WK+W + E+ + + +E+ + EV+RCIH++LLCVQQ P+DRP M
Sbjct: 707 ADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMA 766
Query: 584 SVILMLGSEIVLPQPKQPGFLADR 607
SV+LM GS+ LP P QPGF +R
Sbjct: 767 SVVLMFGSDSSLPHPTQPGFFTNR 790
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 637 (229.3 bits), Expect = 9.3e-129, Sum P(3) = 9.3e-129
Identities = 123/210 (58%), Positives = 151/210 (71%)
Query: 399 MSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPK 458
+ A D + +LLDW RF II G RGL+YLH+DSRL+IIHRDLKA N+LLD+++NPK
Sbjct: 593 LDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPK 652
Query: 459 ISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 518
ISDFGLAR F G+E E +T RVVGTYGYMAPEYA G FS KSDVFS G++LLEIVSG++
Sbjct: 653 ISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRR 712
Query: 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD 578
N FY+ NL +AWKLWN G ++DP E C E+ RC+H+ LLCVQ H +D
Sbjct: 713 NSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHAND 772
Query: 579 RPCMPSVILMLGSEIV-LPQPKQPGFLADR 607
RP + +VI ML SE LP+PKQP F+ R
Sbjct: 773 RPSVATVIWMLSSENSNLPEPKQPAFIPRR 802
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 8.2e-123, Sum P(2) = 8.2e-123
Identities = 129/213 (60%), Positives = 156/213 (73%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
D+ R L+W RF II G RGLLYLHQDSR RIIHRDLKA N+LLD+ M PKISDFG+
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
AR FG DETE NT +VVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+S K+N+GFY+
Sbjct: 673 ARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYN 732
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT---EVIRCIHISLLCVQQHPDDRPC 581
D LNL+G W+ W +G E+IDP +S + E++RCI I LLCVQ+ +DRP
Sbjct: 733 SDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPT 792
Query: 582 MPSVILMLGSE-IVLPQPKQPGFLADRKSIGPD 613
M VILMLGSE +PQPK PG+ +R + D
Sbjct: 793 MSLVILMLGSESTTIPQPKAPGYCLERSLLDTD 825
|
|
| TAIR|locus:2197724 AT1G61430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 7.9e-112, Sum P(2) = 7.9e-112
Identities = 149/425 (35%), Positives = 229/425 (53%)
Query: 12 LPFFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKT 71
LPFF SF+ IT + G+TL S +G +ELGFFS +S+N+Y+GIW+K+I +
Sbjct: 12 LPFFTIFMSFSFAGITKESPFSIGQTLSSSNGVYELGFFSLNNSQNQYLGIWFKSIIPQV 71
Query: 72 VVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSA---YLSKEVRTPVVLQLLDSG 128
VVWVANR + DS+ L I+ G+L+L++ + VVWS + S R +L D G
Sbjct: 72 VVWVANREKPVTDSAANLGISSNGSLLLSNGKHGVVWSTGDIFASNGSRA----ELTDHG 127
Query: 129 NLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFI 188
NLV + G + WQSF++ +TLLP + ++L G +R +T+WKS+ DPSPG+F+
Sbjct: 128 NLVFIDKVSGRT---LWQSFEHLGNTLLPTSIMMYNLVAGEKRGLTAWKSYTDPSPGEFV 184
Query: 189 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPVFSFSFVSNDVEL--YYTF 245
I Q + ++ +GS ++YRTGPW RF+ +P + + F ++ DV Y++F
Sbjct: 185 ALITPQVPSQGIIMRGSTRYYRTGPWAKTRFTGSPQMDESYTSPF-ILTQDVNGSGYFSF 243
Query: 246 N---------ITNKAVISRIIMN----QTLYSDVPRDQCDTYGLCGAYGICIISQSPVCQ 292
+T++ + ++ N ++ Y P + CD YG+CG +G+C++S P C+
Sbjct: 244 VERGKPSRMILTSEGTMKVLVHNGMDWESTYEG-PANSCDIYGVCGPFGLCVVSIPPKCK 302
Query: 293 CLKGF--KH-KSGGYVDWSKGCVRNKPLN-YSRQDGFMKFTELKLPDATPSWVSKSMNLK 348
C KGF K K +W+ GCVR L+ G +P+ P + N +
Sbjct: 303 CFKGFVPKFAKEWKKGNWTSGCVRRTELHCQGNSSGKDANVFYTVPNIKPPDFYEYANSQ 362
Query: 349 ESREGCLENSF--CMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQ 406
+ E C +N C S I G GC MW DL+D R F G+ L IR++ SELD
Sbjct: 363 NAEE-CHQNCLHNCSCLAFSYIPG--IGCLMWSKDLMDTRQFSAAGELLSIRLARSELDV 419
Query: 407 ERCKL 411
+ K+
Sbjct: 420 NKRKM 424
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 1.5e-108, Sum P(2) = 1.5e-108
Identities = 154/427 (36%), Positives = 231/427 (54%)
Query: 12 LPFFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKT 71
+ FLS FS+A IT L+ G+TL S +G +ELGFFS +S+N+YVGIW+K I +
Sbjct: 15 ITIFLS-FSYAG--ITRESPLSIGKTLSSSNGVYELGFFSFNNSQNQYVGIWFKGIIPRV 71
Query: 72 VVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWS---AYLSKEVRTPVVLQLLDSG 128
VVWVANR + DS+ L I+ G+L+L ++++ VVWS + S R +L D+G
Sbjct: 72 VVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIGETFASNGSRA----ELTDNG 127
Query: 129 NLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFI 188
NLV+ D +S W+SF++ DT+LP L ++L TG +R +TSWKS DPSPGDF
Sbjct: 128 NLVVI---DNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPGDFT 184
Query: 189 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS----------AP-SLRP--NPVFSFSFV 235
I Q + +GS+ ++R+GPW RF+ +P SL+ N SF++
Sbjct: 185 VQITPQVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFSLQQDTNGSGSFTYF 244
Query: 236 SNDVELYYTFNITNKA---VISRIIMNQTLYSDVPRDQCDTYGLCGAYGICIISQSPVCQ 292
+ +L Y IT++ + M+ L + P + CD YG CG +GIC++S P C+
Sbjct: 245 ERNFKLSYIM-ITSEGSLKIFQHNGMDWELNFEAPENSCDIYGFCGPFGICVMSVPPKCK 303
Query: 293 CLKGFKHKS---GGYVDWSKGCVRNKPLN-YSRQDGFMKFTELKLPDATPSWVSKSMNLK 348
C KGF KS +W+ GCVR+ L+ +G + + P + +
Sbjct: 304 CFKGFVPKSIEEWKRGNWTDGCVRHTELHCQGNTNGKTVNGFYHVANIKPPDFYEFASFV 363
Query: 349 ESREGCLENSF--CMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELD- 405
++ EGC + C + I G GC MW DL+D F GG+ L IR+++SEL
Sbjct: 364 DA-EGCYQICLHNCSCLAFAYING--IGCLMWNQDLMDAVQFSAGGEILSIRLASSELGG 420
Query: 406 QERCKLL 412
+R K++
Sbjct: 421 NKRNKII 427
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
Identities = 150/424 (35%), Positives = 228/424 (53%)
Query: 12 LPFFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKT 71
L F+S FS+A IT L+ G+TL S +G +ELGFFS +S+N+YVGIW+K I +
Sbjct: 8 LLLFIS-FSYAE--ITKESPLSIGQTLSSSNGVYELGFFSFNNSQNQYVGIWFKGIIPRV 64
Query: 72 VVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSA-YLSKEVRTPVVLQLLDSGNL 130
VVWVANR + DS+ L+I+ +G+L+L + + VVWS +S + +L D GNL
Sbjct: 65 VVWVANREKPVTDSAANLVISSSGSLLLINGKHDVVWSTGEISASKGSHA--ELSDYGNL 122
Query: 131 VLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWA 190
+++ G + W+SF++ +TLLP + ++L TG +R ++SWKS+ DPSPGDF
Sbjct: 123 MVKDNVTGRT---LWESFEHLGNTLLPLSTMMYNLVTGEKRGLSSWKSYTDPSPGDFWVQ 179
Query: 191 IERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPVFSFSFVSNDVEL--YYTFNI 247
I Q + + +GS +YRTGPW R++ P + + FS + DV Y+++
Sbjct: 180 ITPQVPSQGFVMRGSTPYYRTGPWAKTRYTGIPQMDESYTSPFS-LHQDVNGSGYFSY-F 237
Query: 248 TNKAVISRIIMN-----QTL-YSDV--------PRDQCDTYGLCGAYGICIISQSPVCQC 293
+SRI++ + L Y+ + P + CD YG+CG +G C+IS P C+C
Sbjct: 238 ERDYKLSRIMLTSEGSMKVLRYNGLDWKSSYEGPANSCDIYGVCGPFGFCVISDPPKCKC 297
Query: 294 LKGFKHKS---GGYVDWSKGCVRNKPLN-YSRQDGFMKFTELKLPDATPSWVSKSMNLKE 349
KGF KS +W+ GC R L+ G +P+ P + N +
Sbjct: 298 FKGFVPKSIEEWKRGNWTSGCARRTELHCQGNSTGKDANVFHTVPNIKPPDFYEYANSVD 357
Query: 350 SREGCLENSF--CMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQE 407
+ EGC ++ C + I G GC MW DL+D F GG+ L IR++ SELD
Sbjct: 358 A-EGCYQSCLHNCSCLAFAYIPG--IGCLMWSKDLMDTMQFSAGGEILSIRLAHSELDVH 414
Query: 408 RCKL 411
+ K+
Sbjct: 415 KRKM 418
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 8.3e-108, Sum P(2) = 8.3e-108
Identities = 109/193 (56%), Positives = 137/193 (70%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
+DW KRF II G RGLLYLH DSRLR+IHRDLK N+LLD+ MNPKISDFGLAR + G
Sbjct: 585 IDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGT 644
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHLDNKLN 530
E + NT RVVGT GYM+PEYA G FS KSD++SFG+L+LEI+SG+K +R Y ++ K
Sbjct: 645 EYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGK-T 703
Query: 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590
LI +AW+ W++ +++D +SC+ EV RCI I LLCVQ P DRP ++ ML
Sbjct: 704 LIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLT 763
Query: 591 SEIVLPQPKQPGF 603
+ LP PKQP F
Sbjct: 764 TTSDLPSPKQPTF 776
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XIII.2650.1 | hypothetical protein (833 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 635 | |||
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-34 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-34 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 5e-31 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 9e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-27 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-26 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-21 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 5e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-10 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 3e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 58/115 (50%), Positives = 72/115 (62%), Gaps = 6/115 (5%)
Query: 69 VKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSG 128
+TVVWVANRLN + DSS L++ GNLVL + VVWS+ S + + V L D G
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKG-SGCVAVLQDDG 59
Query: 129 NLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPS 183
NLVL +S WQSFD+P+DTLLPG K G ++ G RR+TSWKS DPS
Sbjct: 60 NLVLY----DNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 55/123 (44%), Positives = 65/123 (52%), Gaps = 7/123 (5%)
Query: 29 SQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGF 88
S L+ G+TL+S FELGFF Y I YK +TVVWVANR N + SS
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCT 58
Query: 89 LMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSF 148
L + GNLV+ S VVWS+ + V VL LLD GNLVL + WQSF
Sbjct: 59 LTLQSDGNLVIYDGSGTVVWSS-NTTRVNGNYVLVLLDDGNLVLY----DSDGNFLWQSF 113
Query: 149 DYP 151
DYP
Sbjct: 114 DYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 54/122 (44%), Positives = 68/122 (55%), Gaps = 8/122 (6%)
Query: 29 SQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGF 88
S TL+ G+TL+S + FELGFF+ N Y I YK+ +TVVWVANR N ++D S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCT 57
Query: 89 LMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSF 148
L + GNLVL VVWS+ + VL LLD GNLV+ + WQSF
Sbjct: 58 LTLQSDGNLVLYDGDGRVVWSS-NTTGANGNYVLVLLDDGNLVIY----DSDGNFLWQSF 112
Query: 149 DY 150
DY
Sbjct: 113 DY 114
|
Length = 114 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-31
Identities = 41/110 (37%), Positives = 64/110 (58%), Gaps = 17/110 (15%)
Query: 209 YRTGPWNGLRFS-APSLRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMNQT------ 261
+R+GPWNG+RFS P ++ + ++F N+ E+YYT+ +TN ++ SR+ ++
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 262 ----------LYSDVPRDQCDTYGLCGAYGICIISQSPVCQCLKGFKHKS 301
L+ P+DQCD YG CG YG C ++ SP C C+KGF K+
Sbjct: 61 TWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
+ L YLH I+HRDLK N+LLD+D + K++DFGLAR E T
Sbjct: 101 FYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LT 154
Query: 479 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKL 538
VGT YMAPE + D++S G++L E+++GK F D++L +
Sbjct: 155 TFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK--PPFPG-DDQLLELFKKIGK 211
Query: 539 WNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
P D E+ +L IR + + P+ R
Sbjct: 212 PKPPFPPPEWD-ISPEAKDL---IRK------LLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 45/110 (40%), Positives = 62/110 (56%), Gaps = 7/110 (6%)
Query: 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD-MNPKISDFGL 464
+E L + RI+ GL YLH IIHRDLK N+LLD D K++DFGL
Sbjct: 83 KENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGL 139
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEI 513
++ D++ T +VGT YMAPE G +S KSD++S G++L E+
Sbjct: 140 SKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 44/109 (40%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469
L + +I RGL YLH IIHRDLK N+LLD++ KI+DFGLA+
Sbjct: 93 GPLSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLL 149
Query: 470 GDETEGNTTRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
+ + T VGT YMAPE + K DV+S G++L E+++GK
Sbjct: 150 K--SSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/221 (28%), Positives = 89/221 (40%), Gaps = 45/221 (20%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
M GDL+D Y+R S L +G+ YL
Sbjct: 78 MEGGDLLD-----------YLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--- 123
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLAR-TFGGDETEGNTTRVVGTYGYMAPEYASDG 495
+ +HRDL A N L+ +D+ KISDFGL+R + D T + +MAPE DG
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDG 182
Query: 496 QFSVKSDVFSFGILLLEIVS-------GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMI 548
F+ KSDV+SFG+LL EI + G N + L + KG
Sbjct: 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYL-------RKGYRLPKP 229
Query: 549 DPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
+ C E L E++ C Q P+DRP ++ L
Sbjct: 230 EYCPDE---LYELMLS------CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 17/155 (10%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
GL YLH I+HRD+K N+L+D D K++DFG A+ G ET T V GT
Sbjct: 112 EGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS 545
+MAPE ++ +D++S G ++E+ +GK + L N + + +K+ + G P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGK--PPWSELGNPMAAL---YKIGSSGEPP 223
Query: 546 EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
E+ P + S + +R C+++ P RP
Sbjct: 224 EI--PEHL-SEEAKDFLRK------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 56/183 (30%), Positives = 81/183 (44%), Gaps = 35/183 (19%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467
R K L S RG+ YL IHRDL A N L+ +++ KISDFGL+R
Sbjct: 96 RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR- 151
Query: 468 FGGDETEGNTTRVVGT---YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG--- 521
D + + +V G +MAPE +G+F+ KSDV+SFG+LL EI + G
Sbjct: 152 ---DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT----LGEEP 204
Query: 522 FYHLDNK--LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579
+ + N L + ++L P Y+ + L C + P+DR
Sbjct: 205 YPGMSNAEVLEYLKKGYRLP---KPPNCPPELYK-------------LMLQCWAEDPEDR 248
Query: 580 PCM 582
P
Sbjct: 249 PTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 53/172 (30%), Positives = 81/172 (47%), Gaps = 35/172 (20%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT-- 483
RG+ YL IHRDL A N L+ +++ KISDFGL+R D + + R G
Sbjct: 113 RGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKL 165
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG---FYHLDNK--LNLIGHAWK 537
+MAPE +G+F+ KSDV+SFG+LL EI + G + + N+ L + + ++
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLEYLKNGYR 221
Query: 538 LWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
L P Y + L C + P+DRP ++ +L
Sbjct: 222 LP---QPPNCPPELYD-------------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 43/126 (34%), Positives = 64/126 (50%), Gaps = 17/126 (13%)
Query: 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453
++R +L + LL + + I +G+ YL +HRDL A N L+ +
Sbjct: 89 LDFLRKHGEKLTLKD--LLQMALQ---IA---KGMEYLE---SKNFVHRDLAARNCLVTE 137
Query: 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYG---YMAPEYASDGQFSVKSDVFSFGILL 510
++ KISDFGL+R D+ G +MAPE DG+F+ KSDV+SFG+LL
Sbjct: 138 NLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194
Query: 511 LEIVSG 516
EI +
Sbjct: 195 WEIFTL 200
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL YLH IIHRD+KA N+LL D K+ DFGL+ +VGT +
Sbjct: 110 GLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYW 163
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
MAPE + + K+D++S GI +E+ GK
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 44/132 (33%), Positives = 69/132 (52%), Gaps = 17/132 (12%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRF--RIICGTGRGLLYLHQDSRLRIIHRDLK 445
+ GG +L+ +S +E + ++ + I+ L YLH L II+RDLK
Sbjct: 74 YAPGG-ELFSHLS-----KEGRFSEERARFYAAEIVLA----LEYLH---SLGIIYRDLK 120
Query: 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFS 505
N+LLD D + K++DFGLA+ + + NT GT Y+APE + D +S
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWS 178
Query: 506 FGILLLEIVSGK 517
G+LL E+++GK
Sbjct: 179 LGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 47/161 (29%), Positives = 68/161 (42%), Gaps = 28/161 (17%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL YLH IIHRD+K N+L++ KI+DFG+++ + T VGT
Sbjct: 110 KGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVT 165
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK------KNRGFYHLDNKLNLIGHAWKLW 539
YM+PE +S +D++S G+ LLE GK F+ L + G L
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPPPSLP 224
Query: 540 NKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+ E D I C+Q+ P RP
Sbjct: 225 AEEFSPEFRD-----------FISA------CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 33/196 (16%)
Query: 390 DGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445
DGG DL ++ + + E ++LDW F +C L YLH SR +I+HRD+K
Sbjct: 82 DGG-DLSQKIKKQKKEGKPFPEE-QILDW---FVQLC---LALKYLH--SR-KILHRDIK 130
Query: 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFS 505
N+ L + K+ DFG+++ T VVGT Y++PE + ++ KSD++S
Sbjct: 131 PQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDIWS 188
Query: 506 FGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCI 565
G +L E+ + K F +N L L K+ P I Y S L ++
Sbjct: 189 LGCVLYELCTLK--HPFEG-ENLLELA---LKILKGQYP--PIPSQY--SSELRNLVS-- 236
Query: 566 HISLLCVQQHPDDRPC 581
SLL Q+ P++RP
Sbjct: 237 --SLL--QKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-19
Identities = 32/65 (49%), Positives = 43/65 (66%), Gaps = 1/65 (1%)
Query: 321 RQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFG 380
DGF++ +KLPD T + V +S+ LKE + CL N C AY +DIR GGSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTG 61
Query: 381 DLIDM 385
+L+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 46/131 (35%), Positives = 74/131 (56%), Gaps = 11/131 (8%)
Query: 393 QDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446
DL+I M S S++ + K L + I+ T +GL YLH + IHRD+KA
Sbjct: 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKA 127
Query: 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSF 506
GN+LL+++ K++DFG++ + NT V+GT +MAPE + ++ K+D++S
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSL 185
Query: 507 GILLLEIVSGK 517
GI +E+ GK
Sbjct: 186 GITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 42/106 (39%), Positives = 61/106 (57%), Gaps = 5/106 (4%)
Query: 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469
++L + + C G+ YL + IHRDL A N+L+ +D+ K++DFGLAR
Sbjct: 99 QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155
Query: 470 GDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
D + ++ Y + APE AS G FS KSDV+SFGILL E+ +
Sbjct: 156 EDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 22/107 (20%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG--------LARTFGG 470
+I +GL YLH + +IIHRD+K N+L++ K+ DFG LA+TF
Sbjct: 104 KIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-- 159
Query: 471 DETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
VGT YMAPE +SVKSD++S G+ L+E+ +G+
Sbjct: 160 ----------VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 40/94 (42%), Positives = 58/94 (61%), Gaps = 6/94 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF--GGDETEGNTTRVVGTY 484
GL YLH + + IHRD+KAGN+LL +D + KI+DFG++ + GGD T VGT
Sbjct: 114 GLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 485 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGK 517
+MAPE + K+D++SFGI +E+ +G
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 10/99 (10%)
Query: 421 ICG-TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
+C +GL YLH +IHRD+K+ N+LL +D + K++DFG F T+ + R
Sbjct: 121 VCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKR 173
Query: 480 --VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
VVGT +MAPE + K D++S GI+ +E+ G
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 41/98 (41%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
IICG L +LHQ RI++RDLK NVLLD N +ISD GLA G +
Sbjct: 104 IICG----LEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG 153
Query: 480 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
GT GYMAPE + D F+ G L E+++G+
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL YLH+ +IHRD+KA N+L +D K++DFG+A + + VVGT
Sbjct: 110 QGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPY 164
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE S SD++S G ++E+++G
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 43/92 (46%), Positives = 57/92 (61%), Gaps = 10/92 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDE---TEGNTTRVVGT 483
G+ YL IHRDL A N+L+ +++ KI+DFGLAR DE EG + T
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
APE A+ G+F++KSDV+SFGILL EIV+
Sbjct: 172 ----APEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-17
Identities = 34/86 (39%), Positives = 48/86 (55%), Gaps = 8/86 (9%)
Query: 316 PLNYSR---QDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGG 372
PLN DGF+K ++KLPD + +++L+E RE CL N C AY ++ G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNN---GS 56
Query: 373 SGCAMWFGDLIDMRSFPDGGQDLYIR 398
GC +W G L ++RS GG LY+R
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 46/136 (33%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 393 QDLYIRM---SASELDQ--ERCK----LLDWSKRFRIICGTGRGLLYLH--QDSRLRIIH 441
Q LYI M +L Q ++CK ++ +RI+ L H D ++H
Sbjct: 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133
Query: 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKS 501
RDLK N+ LD + N K+ DFGLA+ G D + T VGT YM+PE + + KS
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNHMSYDEKS 191
Query: 502 DVFSFGILLLEIVSGK 517
D++S G L+ E+ +
Sbjct: 192 DIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 21/109 (19%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV------ 480
L YLH IIHRDLK N+LLD+DM+ KI+DFG A+ + + +
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 481 ------------VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
VGT Y++PE ++ SD+++ G ++ ++++GK
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 45/135 (33%), Positives = 61/135 (45%), Gaps = 13/135 (9%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
IC L YLH IIHRD+K N+LLD+ + I+DF +A D TT
Sbjct: 105 WICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158
Query: 480 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL-NLIGHAWK- 537
GT GYMAPE +SV D +S G+ E + GK R + + + I +
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRAKQET 216
Query: 538 ---LWNKGMPSEMID 549
L+ +E ID
Sbjct: 217 ADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 55/162 (33%), Positives = 76/162 (46%), Gaps = 35/162 (21%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT--- 483
G+ YL + IHRDL A NVL+ ++ K++DFGLAR D E G
Sbjct: 115 GMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFP 167
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKG 542
+ APE A +FS+KSDV+SFGILL EIV+ G+ + + G
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR--------------MPYP------G 207
Query: 543 MPS----EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
M + + +D Y+ C I L C ++ PDDRP
Sbjct: 208 MTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 48/138 (34%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 387 SFPDGGQDLYIRMSASE-------LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439
SF D G+ L I M +E L +R + L + +R GL +LH +I
Sbjct: 67 SFLDKGK-LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KI 122
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
+HRD+K+ N+ LD N KI D G+A+ + NT +VGT Y++PE D ++
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNE 180
Query: 500 KSDVFSFGILLLEIVSGK 517
KSDV++ G++L E +GK
Sbjct: 181 KSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 430 YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAP 489
Y+H+ I+HRD+K N+ L + K+ DFG+++ G E T VVGT YM+P
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSP 170
Query: 490 EYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMID 549
E +++ KSD+++ G +L E+++ K+ + N LNL+ K+ +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRT---FDATNPLNLV---VKIVQGNY--TPVV 222
Query: 550 PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
Y S L ++ +QQ P+ RP V+
Sbjct: 223 SVY--SSELISLVHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 40/128 (31%), Positives = 60/128 (46%), Gaps = 16/128 (12%)
Query: 393 QDLY--IRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450
DLY I+ L + K + +GL + H I+HRDLK N+L
Sbjct: 82 TDLYKLIKDRQRGLPESLIKSYLYQ--------LLQGLAFCHSH---GILHRDLKPENLL 130
Query: 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE-YASDGQFSVKSDVFSFGIL 509
++ + K++DFGLAR+FG T V T Y APE D +S D++S G +
Sbjct: 131 INTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCI 188
Query: 510 LLEIVSGK 517
E++S +
Sbjct: 189 FAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 14/136 (10%)
Query: 382 LIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441
+ M P G Y++ +++ +LL +S + IC +G+ YL R IH
Sbjct: 84 RLIMEYLPSGSLRDYLQRHRDQIN--LKRLLLFSSQ---IC---KGMDYLGS---QRYIH 132
Query: 442 RDLKAGNVLLDQDMNPKISDFGLAR--TFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
RDL A N+L++ + KISDFGLA+ D + Y APE +FS
Sbjct: 133 RDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSS 191
Query: 500 KSDVFSFGILLLEIVS 515
SDV+SFG+ L E+ +
Sbjct: 192 ASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 79.4 bits (194), Expect = 8e-16
Identities = 59/234 (25%), Positives = 86/234 (36%), Gaps = 19/234 (8%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN-PKISDFGLAR 466
R L S+ I+ L YLH IIHRD+K N+LLD+D K+ DFGLA+
Sbjct: 94 RKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAK 150
Query: 467 TFGGDETEGN----TTRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKN 519
+ + + VGT GYMAPE S S SD++S GI L E+++G
Sbjct: 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
Query: 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579
+ + + K+ + + P S + + + P +R
Sbjct: 211 ---FEGEKNSSATSQTLKIILELPTPSLASP-LSPSNPELISKAASDLLKKLLAKDPKNR 266
Query: 580 PCMPSVILMLGSEIVLPQPKQPGFLADRKSIGPDSLLSIPESSSSNSITISELE 633
S + S +L K DS S IS L
Sbjct: 267 LSSSSDL----SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 39/107 (36%), Positives = 52/107 (48%), Gaps = 23/107 (21%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG--------LARTFGG 470
+I +GL YLH +IIHRD+K N+LL + K+ DFG LA TF
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF-- 163
Query: 471 DETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
GT YMAPE +S+ SDV+S G+ LLE+ +
Sbjct: 164 ----------TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL YLH + I+HRD+K N+L++ D K++DFGLAR + + T RV+ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 487 MAPEY---ASDGQFSVKSDVFSFGILLLEIVSGK 517
PE A+ ++ + D++S G +L E+ GK
Sbjct: 168 RPPELLLGAT--RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 38/90 (42%), Positives = 52/90 (57%), Gaps = 3/90 (3%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ +L + IHRDL A NVL+ +D KI+DFGLAR + TT
Sbjct: 143 RGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 200 WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 39/107 (36%), Positives = 57/107 (53%), Gaps = 22/107 (20%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG--------LARTFGG 470
+I GL YL+ + RI+HRD+K N+L++ K+ DFG +A TF
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF-- 162
Query: 471 DETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
VGT YM+PE G+++VKSDV+S GI ++E+ GK
Sbjct: 163 ----------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 39/91 (42%), Positives = 53/91 (58%), Gaps = 12/91 (13%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY-- 484
G+ YL + +HRDL A NVL+ +D+ K+SDFGLA+ E + + G
Sbjct: 114 GMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPV 163
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE + +FS KSDV+SFGILL EI S
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 9/96 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN--TTRVVGTY 484
GL YLH I+HRDLKA N+L+D D KISDFG+++ D+ N + G+
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSV 174
Query: 485 GYMAPEY-ASDGQ-FSVKSDVFSFGILLLEIVSGKK 518
+MAPE S Q +S K D++S G ++LE+ +G++
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 43/109 (39%), Positives = 62/109 (56%), Gaps = 16/109 (14%)
Query: 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469
KL+D + + G+ ++ R IHRDL+A N+L+ + + KI+DFGLAR
Sbjct: 103 KLIDMAAQ------IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153
Query: 470 GDE---TEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+E EG + T APE + G F++KSDV+SFGILL EIV+
Sbjct: 154 DNEYTAREGAKFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 11/93 (11%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT--- 483
G+ YL + +HRDL A N ++ +D+ KI DFG+ R D E + R G
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE DG F+ KSDV+SFG++L E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 20/155 (12%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
GL YLH++ IHRD+KA N+LL ++ + K++DFG++ ++ NT VGT
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPF 163
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS 545
+MAPE + K+D++S GI +E+ G+ H L LI K P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------PKNNPP 216
Query: 546 EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+ + S + + C+ + P +RP
Sbjct: 217 SLEGNKF--SKPFKDFVSL------CLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA------RTFGGDETEGNTTRV 480
L YLH IIHRDLK N+L+D + + K++DFGL+ R ++ E R+
Sbjct: 105 ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 481 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
VGT Y+APE S D +S G +L E + G
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 42/101 (41%), Positives = 57/101 (56%), Gaps = 13/101 (12%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF--GGDETEGN 476
+II G L +LHQ RII+RDLK NVLLD D N +ISD GLA G +T+G
Sbjct: 105 QIISG----LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG- 156
Query: 477 TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
GT G+MAPE ++ D F+ G+ L E+++ +
Sbjct: 157 ---YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 28/163 (17%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLD---QDMNPKISDFGLARTF-----GGDETEGNT 477
RGL YLH++ +IIHRD+K N+L+D Q + +I+DFG A G E +G
Sbjct: 114 RGLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG-- 166
Query: 478 TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWK 537
+++GT +MAPE Q+ DV+S G +++E+ + K N L LI +K
Sbjct: 167 -QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FK 222
Query: 538 LWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+ + P E L+ +R ++L C++ P+DRP
Sbjct: 223 IASATTA-----PSIPEH--LSPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 52/155 (33%), Positives = 77/155 (49%), Gaps = 18/155 (11%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ YL + ++++HRDL A NVL+ + KISDFGL+R +++ ++
Sbjct: 138 RGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS 545
+MA E D ++ +SDV+SFG+LL EIV+ N Y L + L G
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPERL----FNLLKTGYRM 248
Query: 546 EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
E + C +E NL L C +Q PD RP
Sbjct: 249 ERPENCSEEMYNLM---------LTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 32/90 (35%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L Y+H+ +IHRD+KA N+L+ N K+ DFG+A ++ + VGT +M
Sbjct: 114 LKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWM 168
Query: 488 APEYASDGQ-FSVKSDVFSFGILLLEIVSG 516
APE ++G+ + K+D++S GI + E+ +G
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 23/156 (14%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY-- 484
G+ Y+ R+ IHRDL++ N+L+ + KI+DFGLAR +E T R +
Sbjct: 114 GMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPI 167
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMP 544
+ APE A G+F++KSDV+SFGILL E+V+ K R Y N ++
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVT--KGRVPYPGMNNREVL------------ 213
Query: 545 SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
E ++ Y+ C I + L C ++ P++RP
Sbjct: 214 -EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 389 PDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448
P G Y+R + + LL+W + +G+ YL + R++HRDL A N
Sbjct: 91 PLGCLLDYVRNHKDNIGSQ--YLLNWCVQI------AKGMSYLEEK---RLVHRDLAARN 139
Query: 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGI 508
VL+ + KI+DFGLA+ DE E + +MA E ++ KSDV+S+G+
Sbjct: 140 VLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGV 199
Query: 509 LLLEIVS-GKK 518
+ E+++ G K
Sbjct: 200 TVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 45/108 (41%), Positives = 63/108 (58%), Gaps = 14/108 (12%)
Query: 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469
KL+D+S + G+ Y+ R IHRDL+A NVL+ + + KI+DFGLAR
Sbjct: 104 KLIDFSAQI------AEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154
Query: 470 GDETEGNTTRVVGTY--GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+E T R + + APE + G F++KSDV+SFGILL EIV+
Sbjct: 155 DNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 28/151 (18%)
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY--GYMAPEYAS 493
R+ IHRDL+A N+L+ ++ KI+DFGLAR +E T R + + APE A
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176
Query: 494 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LNLIGHAWKLWNKGMPSEMIDPC 551
G+F++KSDV+SFGILL E+V+ K + + N+ L + +++ PC
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT-KGRVPYPGMVNREVLEQVERGYRM-----------PC 224
Query: 552 YQESC--NLTEVIRCIHISLLCVQQHPDDRP 580
Q C +L E+++ LC ++ PD+RP
Sbjct: 225 PQ-GCPESLHELMK------LCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 410 KLLDWSKRFR------IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG 463
L KR + I+ T RGL YLH++ ++IHRD+K N+LL ++ K+ DFG
Sbjct: 102 GLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158
Query: 464 LARTFGGDETEGNTTRVVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 517
++ D T G +GT +MAPE D + +SDV+S GI +E+ GK
Sbjct: 159 VSAQL--DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 52/170 (30%), Positives = 69/170 (40%), Gaps = 29/170 (17%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ YL +HRDL A NVLL KISDFG++R G T T G
Sbjct: 106 MGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAG 158
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLW 539
+ APE + G+FS KSDV+S+G+ L E S G K G + ++ +L
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL- 217
Query: 540 NKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
P E Y I L C + P+DRP +
Sbjct: 218 --PRPEECPQEIYS-------------IMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (177), Expect = 1e-13
Identities = 40/99 (40%), Positives = 56/99 (56%), Gaps = 18/99 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y H RI+HRDLK N+L+++D K++DFGLAR FG T VV T
Sbjct: 109 RGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLW 163
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE Y++ +V D++S G + E+++GK
Sbjct: 164 YRAPEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 29/173 (16%)
Query: 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469
KL+D+S + G+ ++ Q + IHRDL+A N+L+ + KI+DFGLAR
Sbjct: 103 KLIDFSAQI------AEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153
Query: 470 GDETEGNTTRVVGTY--GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527
+E T R + + APE + G F++KSDV+SFGILL+EIV+ R Y +
Sbjct: 154 DNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMS 208
Query: 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+I + +G + C +E L ++ + C + P++RP
Sbjct: 209 NPEVI----RALERGYRMPRPENCPEE---LYNIM------MRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 51/205 (24%)
Query: 388 FPDGGQ-DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446
F DGG D+Y ++ L RI +GL YL L+I+HRD+K
Sbjct: 80 FMDGGSLDVYRKIPEHVLG-------------RIAVAVVKGLTYLWS---LKILHRDVKP 123
Query: 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSF 506
N+L++ K+ DFG++ VGT YMAPE S Q+ + SDV+S
Sbjct: 124 SNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSL 179
Query: 507 GILLLEIVSGK-------KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT 559
GI +E+ G+ KN+G MP +++ E +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSL-------------------MPLQLLQCIVDEDPPVL 220
Query: 560 EV----IRCIHISLLCVQQHPDDRP 580
V + +H C+++ P +RP
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 44/112 (39%), Positives = 61/112 (54%), Gaps = 11/112 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTY 484
RGL YLH +IHRDLK N+L++ + + KI DFGLAR DE E G T V T
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 485 GYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK---KNRGFYHLDNKLNLI 532
Y APE S +++ D++S G + E+++ K R + +LNLI
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLI 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L +LH ++IHRDLKAGN+LL D + K++DFG++ + T +GT +
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKRDT-FIGTPYW 169
Query: 487 MAPEYA-----SDGQFSVKSDVFSFGILLLEI 513
MAPE D + K+D++S GI L+E+
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 43/98 (43%), Positives = 59/98 (60%), Gaps = 10/98 (10%)
Query: 424 TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT 483
T + L YL ++ L+IIHRD+K N+LLD++ N K+ DFG++ G TR G
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGC 170
Query: 484 YGYMAPE----YASDGQFSVKSDVFSFGILLLEIVSGK 517
YMAPE A DG + V+SDV+S GI L E+ +GK
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 39/92 (42%), Positives = 56/92 (60%), Gaps = 8/92 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
GL LHQ+ RI++RDLK N+LLD + +ISD GLA EG T + VGT G
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV----PEGQTIKGRVGTVG 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
YMAPE + +++ D ++ G LL E+++G+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL YLH I+HRD+K GN+L++ + KI DFGLAR DE++ T VV Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 486 YMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGK 517
Y APE + ++ D++S G + E++ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL YLH + R IHRD+KA NVLL + + K++DFG+A + + NT VGT
Sbjct: 112 KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPF 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE + K+D++S GI +E+ G+
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 46/123 (37%), Positives = 64/123 (52%), Gaps = 16/123 (13%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF--GGDETEG 475
++I+CG L Y+H + ++HRDLK GN+L++ D KI DFGLAR F E G
Sbjct: 112 YQILCG----LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 476 NTTRVVGTYGYMAPEYASDGQFSVKS-DVFSFGILLLEIVSGK---KNRGFYHLDNKLNL 531
T V T Y APE Q K+ DV+S G +L E++ K K + + +LN
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQ 221
Query: 532 IGH 534
I
Sbjct: 222 ILQ 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
+ ++ G G+ YL S + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 103 FTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
E T + APE + +F+ SDV+SFGI++ E++S
Sbjct: 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYG 485
GL +LH+ II+RDLK NVLLD + + KI+DFG+ + G TT GT
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKE---GILGGVTTSTFCGTPD 161
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE S + D ++ G+LL E+++G+
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 44/117 (37%), Positives = 60/117 (51%), Gaps = 20/117 (17%)
Query: 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG- 469
L D KR+ I+ + L Y+H S +IHRDLK N+LL+ D K++DFGLAR+
Sbjct: 104 LEDVHKRY-IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 470 GDETEGNT--TRVVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
+E N T V T Y APE Y V D++S G +L E++ GK
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYT----KGV--DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 23/156 (14%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY-- 484
G+ Y+ R+ +HRDL+A N+L+ +++ K++DFGLAR +E T R +
Sbjct: 114 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPI 167
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMP 544
+ APE A G+F++KSDV+SFGILL E+ + K R Y ++ + + P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCP 225
Query: 545 SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
E + + C C ++ P++RP
Sbjct: 226 PECPESLHDLMCQ-------------CWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 11/104 (10%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG-NT 477
+I + L YLH S+L +IHRD+K NVL++++ K+ DFG++ G +
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAK 160
Query: 478 TRVVGTYGYMAPEY----ASDGQFSVKSDVFSFGILLLEIVSGK 517
T G YMAPE + + VKSDV+S GI ++E+ +G+
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 37/79 (46%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDE---TEGNTTRVVGTYGYMAPEYASDGQ 496
IHRDL A NVLL KI DFGLAR D +GN V +MAPE +
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFNCV 219
Query: 497 FSVKSDVFSFGILLLEIVS 515
++ +SDV+S+GILL EI S
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 40/92 (43%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
GL LH R RI++RDLK N+LLD + +ISD GLA EG T R VGT G
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI----PEGETIRGRVGTVG 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
YMAPE + +++ D + G L+ E++ GK
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+L+LH + I++RD+K NVLLD N ++SD GLA +T T+ GT GY
Sbjct: 107 GILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGY 160
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
MAPE + +S D F+ G + E+V+G+
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 55/164 (33%), Positives = 77/164 (46%), Gaps = 28/164 (17%)
Query: 421 IC-GTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
IC G +GL YLH R IHRD+KAGN+LL + K++DFG A + N+
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV----SPANS-- 170
Query: 480 VVGTYGYMAPE--YASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAW 536
VGT +MAPE A D GQ+ K DV+S GI +E+ K L N +N + +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFN-MNAMSALY 224
Query: 537 KLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+ P+ + N + C+Q+ P DRP
Sbjct: 225 HIAQNDSPTLSSNDWSDYFRNFVD---------SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 16/134 (11%)
Query: 385 MRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444
M P G Y++ LD + L IC +G+ YL R +HRDL
Sbjct: 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQ-----IC---KGMEYL---GSKRYVHRDL 134
Query: 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVG---TYGYMAPEYASDGQFSVKS 501
N+L++ + KI DFGL + D+ E R G + Y APE ++ +FSV S
Sbjct: 135 ATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTESKFSVAS 192
Query: 502 DVFSFGILLLEIVS 515
DV+SFG++L E+ +
Sbjct: 193 DVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 35/91 (38%), Positives = 43/91 (47%), Gaps = 6/91 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF--GGDETEGNTTRVVGTY 484
G+ YL R IHRDL A N+LL D KI DFGL R D V +
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PF 164
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE FS SDV+ FG+ L E+ +
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+H + ++HRDLK N+LL+ + + KI DFGLART E T V T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRW 173
Query: 486 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + +++ DV+S G + E++ K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 48/164 (29%), Positives = 71/164 (43%), Gaps = 29/164 (17%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL LH+ +I+HRDLK+ N+LL + KI D G+++ + +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPH 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK---KNRGFYHLDNKLNLIGHAWKLWNKG 542
YMAPE +S KSD++S G LL E+ + + R L K+ +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-----------QR 215
Query: 543 MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586
I P Y S +L IR +Q P RP ++
Sbjct: 216 GKYPPIPPIY--SQDLQNFIR------SMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 22/100 (22%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG--------LARTFGGDETEGNT 477
RGL YL + + +I+HRD+K N+L++ K+ DFG +A +F
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--------- 158
Query: 478 TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
VGT YM+PE ++V+SD++S G+ L+E+ G+
Sbjct: 159 ---VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 31/78 (39%), Positives = 48/78 (61%), Gaps = 5/78 (6%)
Query: 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF 497
+++HRDL A N+L+ +D K+SDFGLAR + +++ + APE +F
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKF 174
Query: 498 SVKSDVFSFGILLLEIVS 515
S KSDV+S+G+LL E+ S
Sbjct: 175 SSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 45/130 (34%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 392 GQDLYIRMS----ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
G L+I M S LD R D + ++ +GL YLH + + IHRD+KA
Sbjct: 74 GTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAA 130
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG 507
NVLL + + K++DFG+A + + NT VGT +MAPE + K+D++S G
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKADIWSLG 188
Query: 508 ILLLEIVSGK 517
I +E+ G+
Sbjct: 189 ITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 432 HQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY 491
H SR R++HRD+K NV + K+ D GL R F T ++ +VGT YM+PE
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 492 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPC 551
+ ++ KSD++S G LL E+ + + FY +K+NL K+ P P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLFSLCQKIEQCDYPPL---PT 230
Query: 552 YQESCNLTEVIRCIHISLLCVQQHPDDRP 580
S L E++ +C+ PD RP
Sbjct: 231 EHYSEKLRELVS------MCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 47/133 (35%), Positives = 72/133 (54%), Gaps = 19/133 (14%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRF---RIICGTGRGLLYLHQDSRLRIIHRDL 444
+ +GG ++ S+ D+ R RF IICG L +LH+ II+RDL
Sbjct: 77 YLNGGDLMFHIQSSGRFDEARA-------RFYAAEIICG----LQFLHKKG---IIYRDL 122
Query: 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVF 504
K NVLLD+D + KI+DFG+ + E + +T GT Y+APE +++ D +
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQKYNESVDWW 180
Query: 505 SFGILLLEIVSGK 517
SFG+LL E++ G+
Sbjct: 181 SFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 32/92 (34%), Positives = 58/92 (63%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE + + K D++S GI+ +E+V G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 38/94 (40%), Positives = 56/94 (59%), Gaps = 11/94 (11%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR--TFGGDETEGNTTRV-VGT 483
GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG TTR GT
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-----TTRTFCGT 164
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + + D ++FG+LL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 380 GDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439
G L + F +GG DLY + L +++ KLL ++ L YLH+ I
Sbjct: 73 GLLYIVMGFCEGG-DLYHK-----LKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HI 123
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
+HRDLK NV L + K+ D G+AR +T ++GT YM+PE S+ ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 500 KSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT 559
KSDV++ G + E+ + K H N ++ +++ +P D S L
Sbjct: 182 KSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRIIEGKLPPMPKD----YSPELG 231
Query: 560 EVIRCIHISLLCVQQHPDDRPCMPSVI 586
E+I ++L + P+ RP + S++
Sbjct: 232 ELIA----TMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 57/161 (35%), Positives = 71/161 (44%), Gaps = 29/161 (18%)
Query: 388 FPDGGQDLYIRM------------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDS 435
F G D Y+ M S E D E LD R +G+ +L +
Sbjct: 173 FSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---A 229
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET---EGNTTRVVGTYGYMAPEYA 492
IHRD+ A NVLL KI DFGLAR D +GN V +MAPE
Sbjct: 230 SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESI 286
Query: 493 SDGQFSVKSDVFSFGILLLEIVS-GKK-------NRGFYHL 525
D ++V+SDV+S+GILL EI S GK N FY +
Sbjct: 287 FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG--NTTR--VV 481
+GL YLH IIHRD+K N+L+D KISDFG+++ + N R +
Sbjct: 117 KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 482 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
G+ +MAPE ++ K+D++S G L++E+++GK
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 8/92 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
GL LH+++ ++RDLK N+LLD + +ISD GLA EG + R VGT G
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI----PEGESIRGRVGTVG 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
YMAPE ++ ++++ D + G L+ E++ G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL YLH +HRD+K N+L+D + K++DFG+A+ G+ +
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYW 167
Query: 487 MAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 517
MAPE A G + + +D++S G +LE+ +GK
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 29/173 (16%)
Query: 423 GTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVG 482
G G+ YL S + +HRDL A N+L++ ++ K+SDFGL+R D+ EG T G
Sbjct: 115 GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGG 170
Query: 483 TYG--YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LNLIGHAWKL 538
+ APE + +F+ SDV+SFGI++ E++S + R ++ + N + I ++L
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-RPYWDMSNHEVMKAINDGFRL 229
Query: 539 WNKGMPSEMIDPC--YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
P+ M P YQ + L C QQ RP ++ +L
Sbjct: 230 -----PAPMDCPSAVYQ-------------LMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 38/96 (39%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT-- 483
+ YL + IHRDL A N L+ +D K+SDFGLAR D+ T GT
Sbjct: 111 EAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKF 163
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 518
+ PE +FS KSDV+SFG+L+ E+ S K
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 7/112 (6%)
Query: 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465
++R +++ RF I C YLH II+RDLK N+LLD + K+ DFG A
Sbjct: 85 RDRGLFDEYTARFYIACVV-LAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFA 140
Query: 466 RTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+ + T GT Y+APE + + D +S GILL E+++G+
Sbjct: 141 KKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL +LHQ ++IHRD+K NVLL ++ K+ DFG++ D T G +GT
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPY 176
Query: 486 YMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 516
+MAPE + D + KSD++S GI +E+ G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YL + IHRDL A N L+ ++ KISDFG++R G + +
Sbjct: 105 GMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
APE + G+++ +SDV+S+GILL E S
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 432 HQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY 491
H SR R++HRD+K NV + K+ D GL R F T ++ +VGT YM+PE
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 492 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPC 551
+ ++ KSD++S G LL E+ + + FY +K+NL K+ P D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLYSLCKKIEQCDYPPLPSDHY 233
Query: 552 YQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+E L +C+ P+ RP
Sbjct: 234 SEELRQLVN---------MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 5/88 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
L ++H RI+HRD+K NV + K+ D GL R F T ++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEI 513
YM+PE + ++ KSD++S G LL E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L +LHQ L II+RD+K N+LLD + + ++DFGL++ F +E E GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 488 APEY--ASDGQFSVKSDVFSFGILLLEIVSG 516
APE G D +S G+L E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
LL LH I+HRDLK N+LLD+ M KI DFG+++ ++ VVGT Y
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCY 167
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 518
++PE ++ KSD+++ G +L E+ S K+
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
G+ YLH + I+HRD+K N+L D N K+ DFG ++ + G + V GT
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+M+PE S + K+DV+S G ++E+++ K
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 44/120 (36%), Positives = 67/120 (55%), Gaps = 13/120 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L +LH L II+RDLK N+LLD++ + K++DFGL++ + E GT Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 164
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LNLIGHAWKLWNKGMP 544
MAPE + + +D +SFG+L+ E+++G + F D K + +I A KL GMP
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMILKA-KL---GMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 41/90 (45%), Positives = 55/90 (61%), Gaps = 3/90 (3%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ YL +SR R IHRDL A NVL+ +D KI+DFGLAR + T+
Sbjct: 145 RGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK 201
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFGIL+ EI +
Sbjct: 202 WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL YLH I+HRDLK N+L+ D K++DFGLAR+FG + T +VV T
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRW 167
Query: 486 YMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + + + V D++S G + E++
Sbjct: 168 YRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 28/65 (43%), Positives = 38/65 (58%), Gaps = 4/65 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ Y+H I+HRDLK N+L+ D KI+DFGLAR F +E + + V T
Sbjct: 110 KGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRW 165
Query: 486 YMAPE 490
Y APE
Sbjct: 166 YRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 11/103 (10%)
Query: 417 RFRIICGTG-RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG 475
+ ++IC L YLH ++IIHRDLKAGNVLL D + K++DFG++ +T
Sbjct: 111 QIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQ 165
Query: 476 NTTRVVGTYGYMAPEYA-----SDGQFSVKSDVFSFGILLLEI 513
+GT +MAPE D + K+D++S GI L+E+
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 39/107 (36%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL YLH + + IHRD+KA NVLL + K++DFG+A +T+ VGT
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPF 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532
+MAPE + K+D++S GI +E+ G+ H L LI
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 48/140 (34%), Positives = 75/140 (53%), Gaps = 18/140 (12%)
Query: 389 PDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448
P G DL M +L ++R + L ++++ +GL Y+H IIHRDLK GN
Sbjct: 100 PFMGTDLGKLMKHEKLSEDRIQFL----VYQML----KGLKYIHAAG---IIHRDLKPGN 148
Query: 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFG 507
+ +++D KI DFGLAR +T+ T V T Y APE + ++ D++S G
Sbjct: 149 LAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVG 203
Query: 508 ILLLEIVSGKK-NRGFYHLD 526
++ E+++GK +G HLD
Sbjct: 204 CIMAEMLTGKPLFKGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR--VVGT 483
+ L +LH +IHRD+K+ ++LL D K+SDFG F ++ R +VGT
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGT 178
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE S + + D++S GI+++E+V G+
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ Y H R++HRDLK N+L+D++ K++DFGLAR F G T VV T
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLW 164
Query: 486 YMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK 517
Y APE Q+S D++S G + E+V+ +
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 34/88 (38%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L YLH++ R I+HRDL N++L +D I+DFGLA+ E T VVGT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVGTILYS 180
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVS 515
PE + + K+DV++FG +L ++ +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 39/90 (43%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ +L SR + IHRDL A N+LL ++ KI DFGLAR D
Sbjct: 184 RGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+LL EI S
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 40/116 (34%), Positives = 60/116 (51%), Gaps = 14/116 (12%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET----EGNTTRVV 481
GL YLH I+HRD+K N+ LD + K+ DFG A + T E +
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL--A 164
Query: 482 GTYGYMAPEYASDGQFSVK---SDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGH 534
GT YMAPE + G+ +D++S G ++LE+ +GK R + LDN+ ++ H
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFH 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 42/116 (36%), Positives = 63/116 (54%), Gaps = 19/116 (16%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT---TRVVG 482
RGL Y+H + ++HRDLK N+LL+ + + KI DFGLAR D +T T V
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVA 171
Query: 483 TYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK-----KNRGFYHLDNKLNLI 532
T Y APE + ++ D++S G +L E++S + K+ Y ++LNLI
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YL--HQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 9/105 (8%)
Query: 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGG 470
LL+W + +G++YL + R++HRDL A NVL+ + KI+DFGLAR G
Sbjct: 111 LLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161
Query: 471 DETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
DE E N +MA E +F+ +SDV+S+G+ + E+++
Sbjct: 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 42/119 (35%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 401 ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKIS 460
A D+ LD S I G+ YL S +HRDL A N L+ + + KIS
Sbjct: 110 AESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKIS 166
Query: 461 DFGLARTFGGDETEGNTTRVVGT----YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
DFGL+R D + RV +M PE G+F+ +SD++SFG++L EI S
Sbjct: 167 DFGLSR----DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 38/92 (41%), Positives = 53/92 (57%), Gaps = 12/92 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY- 484
+ YL ++ +HRDL A NVL+ +D K+SDFGL + E ++T+ G
Sbjct: 113 EAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLP 162
Query: 485 -GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE + +FS KSDV+SFGILL EI S
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 39/103 (37%), Positives = 59/103 (57%), Gaps = 11/103 (10%)
Query: 417 RFRIICG-TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG 475
+ R++C T L YLH++ +IIHRDLKAGN+L D + K++DFG++ T
Sbjct: 104 QIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQ 158
Query: 476 NTTRVVGTYGYMAPEY-----ASDGQFSVKSDVFSFGILLLEI 513
+GT +MAPE + D + K+DV+S GI L+E+
Sbjct: 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 35/83 (42%), Positives = 50/83 (60%), Gaps = 5/83 (6%)
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYGYMAPEYASD 494
R RI++RDLK N+LLD + +ISD GLA EG T R VGT GYMAPE ++
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAPEVINN 175
Query: 495 GQFSVKSDVFSFGILLLEIVSGK 517
+++ D + G L+ E++ G+
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 38/100 (38%), Positives = 58/100 (58%), Gaps = 13/100 (13%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR--TFGGDETEGNT 477
I+CG L +LH II+RDLK NV+LD+D + KI+DFG+ + FG +
Sbjct: 105 IVCG----LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRA 153
Query: 478 TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+ GT Y+APE +++ D +SFG+LL E++ G+
Sbjct: 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL YL + + +I+HRD+K N+L++ K+ DFG++ G + VGT
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 25/140 (17%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YL + +IHRDL A N L+ ++ K+SDFG+ R F D+ ++T +
Sbjct: 112 GMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKW 167
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKK---------------NRGFYHLDNKL-- 529
+PE S ++S KSDV+SFG+L+ E+ S K N GF +L
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLAS 227
Query: 530 ----NLIGHAWKLWNKGMPS 545
L+ H WK + PS
Sbjct: 228 QSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 39/91 (42%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 425 GRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
RG+ YL + + IHRDL A NVL+ +D KI+DFGLAR + TT
Sbjct: 150 ARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 207 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 46/135 (34%), Positives = 66/135 (48%), Gaps = 24/135 (17%)
Query: 393 QDLYI---RMSAS-------ELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442
QD+Y+ M A+ +LD ER L ++++CG + +LH IIHR
Sbjct: 94 QDVYLVMELMDANLCQVIQMDLDHERMSYL----LYQMLCG----IKHLHSAG---IIHR 142
Query: 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSD 502
DLK N+++ D KI DFGLART G T VV Y Y APE + D
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVD 199
Query: 503 VFSFGILLLEIVSGK 517
++S G ++ E++ G
Sbjct: 200 IWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 13/101 (12%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF---------GGDETEGNT 477
G+ YLH++ I+HRD+KA N+L+D KI+DFGLAR + GG
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 478 TRVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 517
T +V T Y PE + +++ D++ G + E+ + +
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 4/120 (3%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
++R + S+ ++ + L ++ + G+ +L S R +HRDL A N L+
Sbjct: 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQR 154
Query: 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
K+S L++ E ++ ++APE + FS KSDV+SFG+L+ E+ +
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 8e-11
Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 430 YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAP 489
YLH L I++RDLK N+LLD D KI+DFG A+ +G T + GT Y+AP
Sbjct: 116 YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAP 167
Query: 490 EYASDGQFSVKSDVFSFGILLLEIVSG 516
E + D ++ GIL+ E+++G
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+H IIHRDLK N+ +++D KI DFGLAR T+ T V T
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 180
Query: 486 YMAPEYASD-GQFSVKSDVFSFGILLLEIVSGK 517
Y APE + ++ D++S G ++ E+++GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 30/67 (44%), Positives = 40/67 (59%), Gaps = 7/67 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN---TTRVVGT 483
GL Y+H R +I+HRD+KA N+L+ +D K++DFGLAR F + T RVV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 484 YGYMAPE 490
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL YLH+ IHRD+K N+LL +D + K++DFG++ T +GT
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPY 166
Query: 486 YMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE A G + K D+++ GI +E+ +
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 39/91 (42%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 425 GRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
RG+ YL + + IHRDL A NVL+ +D KI+DFGLAR + TT
Sbjct: 144 ARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 201 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 41/100 (41%), Positives = 52/100 (52%), Gaps = 15/100 (15%)
Query: 421 ICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV 480
IC G+ YLH IHRDL A NVLLD D KI DFGLA+ EG+
Sbjct: 116 IC---EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYR 165
Query: 481 VGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
V G + A E + +FS SDV+SFG+ L E+++
Sbjct: 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 53/168 (31%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT--- 483
G+ YL + + +HRDL A NVLL KISDFGL++ G DE N +
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKW 160
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGH-AWKLWNK 541
+ APE + +FS KSDV+SFG+L+ E S Y + G+ ++
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS-------YGQKPYKGMKGNEVTQMIES 213
Query: 542 GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
G E C E +L + LC D+RP V L L
Sbjct: 214 GERMECPQRCPPEMYDLMK---------LCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT 477
RG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R G E
Sbjct: 115 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 168
Query: 478 TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
T +MA E + ++ SDV+S+G+LL EIVS
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 32/92 (34%), Positives = 58/92 (63%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE + + K D++S GI+ +E+V G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YLH R I+HRD+K N+L++ N KI+DFG++R N++ VGT Y
Sbjct: 180 GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAY 234
Query: 487 MAPEYA----SDGQFS-VKSDVFSFGILLLEIVSGK 517
M+PE + G + D++S G+ +LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 424 TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT 483
+G +L L +L II+RD+K N+LLD + + ++DFGL++ F DE E GT
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169
Query: 484 YGYMAPEY--ASDGQFSVKSDVFSFGILLLEIVSG 516
YMAP+ DG D +S G+L+ E+++G
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 47/133 (35%), Positives = 68/133 (51%), Gaps = 16/133 (12%)
Query: 392 GQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451
G DL + + +++ LL + I +G +YL Q + IHRDL A N L+
Sbjct: 83 GGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLV 139
Query: 452 -----DQDMNPKISDFGLARTFGGDETEGNTTRVVGT----YGYMAPEYASDGQFSVKSD 502
D D KI DFGLAR D + + R G +MAPE DG+F+ +SD
Sbjct: 140 SEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSD 195
Query: 503 VFSFGILLLEIVS 515
V+SFG+L+ EI++
Sbjct: 196 VWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT-TRVVGTYGY 486
L YL + +IHRD+K N+LLD N K+ DFG++ G + TR G Y
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGCAAY 180
Query: 487 MAPEY----ASDGQFSVKSDVFSFGILLLEIVSGK 517
MAPE + ++ +++DV+S GI L+E+ +G+
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 45/140 (32%), Positives = 76/140 (54%), Gaps = 15/140 (10%)
Query: 380 GDLIDMRSFPDGGQDLYIRMSASE--LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRL 437
G+L + + +GG DLY +++A L E ++LDW F IC L ++H
Sbjct: 72 GNLYIVMDYCEGG-DLYKKINAQRGVLFPED-QILDW---FVQIC---LALKHVHDR--- 120
Query: 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF 497
+I+HRD+K+ N+ L +D K+ DFG+AR T +GT Y++PE + +
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPY 178
Query: 498 SVKSDVFSFGILLLEIVSGK 517
+ KSD+++ G +L E+ + K
Sbjct: 179 NNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL ++H +R +++RDLK N+LLD+ + +ISD GLA F + + VGT+GY
Sbjct: 109 GLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 487 MAPEYASDG-QFSVKSDVFSFGILLLEIVSG 516
MAPE G + +D FS G +L +++ G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+H ++HRDLK N+L++++ + KI DFGLAR + T V T
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRY 170
Query: 486 YMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGK 517
Y APE Q + V+ D++S G + E++ GK
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT--TRVVGT 483
RGL Y+H + +IHRDLK N+L+++D +I DFG+AR TE T V T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 484 YGYMAPEYA-SDGQFSVKSDVFSFGILLLEIV 514
Y APE S +++ D++S G + E++
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDE--TEGNTTRVVGT 483
+G+ YL + +HRDL A N +LD+ K++DFGLAR E + N T
Sbjct: 109 KGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E +F+ KSDV+SFG+LL E+++
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL +LH ++IHRD+K NVLL ++ K+ DFG++ D T G +GT
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPY 186
Query: 486 YMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 516
+MAPE + D + +SD++S GI +E+ G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 38/94 (40%), Positives = 50/94 (53%), Gaps = 18/94 (19%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ +LH RI+HRDLK N+L+ D KI+DFGLAR + E T VV T
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLW 171
Query: 486 YMAPE------YASDGQFSVKSDVFSFGILLLEI 513
Y APE YA+ V D++S G + E+
Sbjct: 172 YRAPEVLLQSSYAT----PV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 47/125 (37%), Positives = 66/125 (52%), Gaps = 12/125 (9%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
Y SAS+L + K L + I G +GL YLH + +IHRD+KAGN+LL +
Sbjct: 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG 158
Query: 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLE 512
K++DFG A + N+ VGT +MAPE +GQ+ K DV+S GI +E
Sbjct: 159 QVKLADFGSASK----SSPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 212
Query: 513 IVSGK 517
+ K
Sbjct: 213 LAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 38/112 (33%), Positives = 62/112 (55%), Gaps = 15/112 (13%)
Query: 423 GTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVG 482
G G+ YL S + +HRDL A N+L++ ++ K+SDFGL+R D TTR
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--- 167
Query: 483 TYG------YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
G + APE + +F+ SDV+S+GI++ E++S R ++ + N+
Sbjct: 168 --GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-YGERPYWEMSNQ 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 33/92 (35%), Positives = 58/92 (63%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE + + K D++S GI+ +E+V G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 47/125 (37%), Positives = 66/125 (52%), Gaps = 12/125 (9%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
Y SAS+L + K L + I G +GL YLH + +IHRD+KAGN+LL +
Sbjct: 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG 162
Query: 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLE 512
K++DFG A + N+ VGT +MAPE +GQ+ K DV+S GI +E
Sbjct: 163 QVKLADFGSASIA----SPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216
Query: 513 IVSGK 517
+ K
Sbjct: 217 LAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 45/123 (36%), Positives = 67/123 (54%), Gaps = 10/123 (8%)
Query: 400 SASELDQERCKLLDWSKRF----RIICGT---GRGLLYLHQDSRLRIIHRDLKAGNVLLD 452
S S++++E + D K+ +IC + +G+ +L SR + IHRDL A N+LL
Sbjct: 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLS 213
Query: 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 512
++ KI DFGLAR D +MAPE D ++++SDV+SFG+LL E
Sbjct: 214 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 273
Query: 513 IVS 515
I S
Sbjct: 274 IFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
DW+K++ I G+ LHQ IIHRD+K N+L+DQ + K++DFGL+R G
Sbjct: 96 EDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GL 148
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
E + + VGT Y+APE SD +S G ++ E + G
Sbjct: 149 ENK----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 39/90 (43%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ +L SR + IHRDL A N+LL ++ KI DFGLAR D
Sbjct: 185 RGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+LL EI S
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 425 GRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
RG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR + TT
Sbjct: 147 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 204 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 39/89 (43%), Positives = 54/89 (60%), Gaps = 6/89 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YL S + IHRDL A NVL+ +++ KI+DFGL+R G+E T +
Sbjct: 131 GMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVRW 184
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
MA E + ++ KSDV+SFG+LL EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 30/92 (32%), Positives = 57/92 (61%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ + +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPY 181
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE + + K D++S GI+ +E++ G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 10/104 (9%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYGY 486
L YLH +++RDLK N++LD+D + KI+DFGL + ++G T + GT Y
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEY 161
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD-NKL 529
+APE D + D + G+++ E++ G+ FY+ D KL
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 35/92 (38%), Positives = 56/92 (60%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYG 485
GL +LH+ II+RDLK NV+LD + + KI+DFG+ + +G TTR GT
Sbjct: 113 GLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPD 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + + D +++G+LL E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL ++H +R +++RDLK N+LLD+ + +ISD GLA F + + VGT+GY
Sbjct: 109 GLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 487 MAPEYASDGQ-FSVKSDVFSFGILLLEIVSG 516
MAPE G + +D FS G +L +++ G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY-- 484
G+ YL + +HRDL A NVLL KISDFGL++ G D++ R G +
Sbjct: 107 GMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPL 162
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 518
+ APE + +FS +SDV+S+GI + E S G+K
Sbjct: 163 KWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 425 GRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
G +L L +L I++RD+K N+LLD + + ++DFGL++ F +E E T GT
Sbjct: 112 GEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTI 170
Query: 485 GYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSG 516
YMAPE G D +S GIL+ E+++G
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ L YLH +IHRD+K+ ++LL D K+SDFG D + + +VGT
Sbjct: 128 QALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPY 182
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE S + + D++S GI+++E+V G+
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 47/135 (34%), Positives = 64/135 (47%), Gaps = 24/135 (17%)
Query: 393 QDLYIRMS----------ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442
QD+YI M ELD ER L ++++CG + +LH IIHR
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYL----LYQMLCG----IKHLHSAG---IIHR 150
Query: 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSD 502
DLK N+++ D KI DFGLART G T T V T Y APE + D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 503 VFSFGILLLEIVSGK 517
++S G ++ E++ G
Sbjct: 208 IWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTYG 485
GL YLH +I+HRD+K NVL++ KISDFG ++ G T GT
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQ 174
Query: 486 YMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGK 517
YMAPE G + +D++S G ++E+ +GK
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-10
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 320 SRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSF-CMAYTNSDIRGGGSGCAMW 378
D F++ KLP + +S +L+E CL ++ C ++T ++ G GC +W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 379 -FGDLIDMRSFPDGGQDLYIR 398
L D R FP GG DLY +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT--- 483
+ YL + + IHRDL A N L+ ++ K++DFGL+R GD T G
Sbjct: 116 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 168
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE + +FS+KSDV++FG+LL EI +
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 43/131 (32%), Positives = 65/131 (49%), Gaps = 11/131 (8%)
Query: 390 DGGQDLYIRMSASELDQERCKLLDWS--KRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
D QD Y+ M + D ++ S K ++ GL Y+H IIHRDLK G
Sbjct: 90 DEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPG 146
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSF 506
N+ +++D KI DFGLAR + T V T Y APE + ++ D++S
Sbjct: 147 NLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSV 201
Query: 507 GILLLEIVSGK 517
G ++ E+++GK
Sbjct: 202 GCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 55/169 (32%), Positives = 74/169 (43%), Gaps = 41/169 (24%)
Query: 393 QDLYIRMSAS----------ELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442
QD+Y+ M ELD ER L ++++CG + +LH IIHR
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYL----LYQMLCG----IKHLHSAG---IIHR 147
Query: 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSD 502
DLK N+++ D KI DFGLART T T V T Y APE + D
Sbjct: 148 DLKPSNIVVKSDCTLKILDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYKENVD 204
Query: 503 VFSFGILLLEIVSGKK-NRGFYHLDNKLNLIGHAWKLWNK-----GMPS 545
++S G ++ E+V G +G H+D WNK G PS
Sbjct: 205 IWSVGCIMGELVKGSVIFQGTDHIDQ-----------WNKVIEQLGTPS 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 26/171 (15%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT--- 483
G+ YL+ + +HRDL A N ++ D KI DFG+ R D E + R G
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKG 542
+MAPE DG F+ SD++SFG++L EI + + + L N+ L K G
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSNEQVL-----KFVMDG 237
Query: 543 MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593
+ D C + +L +C Q +P RP ++ +L ++
Sbjct: 238 GYLDQPDNCPERVTDLMR---------MCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ Y+HQ RI+HRDLKA N+ L ++ KI DFG++R G T GT Y
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEI 513
M+PE + KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 27/188 (14%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
Y SAS+L + K L + + G +GL YLH + +IHRD+KAGN+LL +
Sbjct: 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPG 152
Query: 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLE 512
K+ DFG A VGT +MAPE +GQ+ K DV+S GI +E
Sbjct: 153 LVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 513 IVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCV 572
+ ++ +++ N ++ + H ++ P Q S + +E R S C+
Sbjct: 207 L--AERKPPLFNM-NAMSALYHI---------AQNESPALQ-SGHWSEYFRNFVDS--CL 251
Query: 573 QQHPDDRP 580
Q+ P DRP
Sbjct: 252 QKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 27/173 (15%)
Query: 423 GTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVG 482
G G+ YL S + +HRDL A N+L++ ++ K+SDFGL+R D ++ T +G
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 483 ---TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LNLIGHAWK 537
+ APE + +F+ SDV+S+GI++ E++S + R ++ + N+ +N I ++
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-RPYWDMSNQDVINAIEQDYR 229
Query: 538 LWNKGMPSEMIDPCYQESCNLTEVIRCIHISLL-CVQQHPDDRPCMPSVILML 589
L P M P +H +L C Q+ + RP ++ L
Sbjct: 230 L-----PPPMDCPTA------------LHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL YL + + +I+HRD+K N+L++ K+ DFG++ G + VGT
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 10/168 (5%)
Query: 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468
L + I G++YL + L +HRDL N L+ Q + KI DFG++R
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172
Query: 469 GGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
+ R + +M PE +F+ +SD++SFG++L EI + K + +Y L N
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK-QPWYQLSNT 231
Query: 529 --LNLIGHAWKLWN-KGMPSEMID---PCYQESCNLTEVIRCIHISLL 570
+ I +L + P E+ C+Q VI+ IH L
Sbjct: 232 EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 36/79 (45%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET---EGNTTRVVGTYGYMAPEYASDGQ 496
IHRDL A N+LL KI DFGLAR D +GN V +MAPE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 497 FSVKSDVFSFGILLLEIVS 515
++ +SDV+S+GILL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 30/90 (33%), Positives = 54/90 (60%), Gaps = 5/90 (5%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L++LH+ +I+RDLK N+LLD + + K++DFG+ + G TT GT Y+
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE--GILNGVTTTTFCGTPDYI 163
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVSGK 517
APE + ++ D ++ G+L+ E+++G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 39/99 (39%), Positives = 56/99 (56%), Gaps = 11/99 (11%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR-TFGGDETEGNTT 478
IICG L +LH I++RDLK N+LLD D + KI+DFG+ + GD T
Sbjct: 105 IICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTC 154
Query: 479 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
GT Y+APE +++ D +SFG+LL E++ G+
Sbjct: 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYG 485
GL YLH++ +I++RDLK N+LLD + KI+DFGL + G+ T GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE---GMGFGDRTSTFCGTPE 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
++APE ++ ++ D + G+L+ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 44/145 (30%), Positives = 66/145 (45%), Gaps = 24/145 (16%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT---YGYMAPEYASDGQ 496
IHRDL A N L+D K+SDFGL+R DE T VG+ + PE +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 497 FSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQES 555
FS KSDV++FG+L+ E+ S GK ++ + + +L+ + SE + Y
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKV---YA-- 232
Query: 556 CNLTEVIRCIHISLLCVQQHPDDRP 580
I C + ++RP
Sbjct: 233 -----------IMYSCWHEKAEERP 246
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 37/105 (35%), Positives = 60/105 (57%), Gaps = 9/105 (8%)
Query: 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGG 470
LL+W + +G+ YL + +R++HRDL A NVL+ + KI+DFGLAR
Sbjct: 111 LLNWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161
Query: 471 DETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
DETE + +MA E +F+ +SDV+S+G+ + E+++
Sbjct: 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 38/94 (40%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTY 484
RG+ Y H R++HRDLK N+L+D+ N K++DFGLAR F G T VV T
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TL 167
Query: 485 GYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE +S D++S G + E+V+ K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + + + +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
M+PE DG F+ SDV+SFG++L EI +
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 8e-10
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ +LH + I+HRDLK N+LL+ KI DFGLAR +G T++V T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVVTLW 171
Query: 486 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE ++S D++S G + E+++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART-FGGD-ETEGNTTRVVGTY 484
G+ YL S IHRDL A N +L +DM ++DFGL++ + GD +G ++
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PV 179
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
++A E +D ++ KSDV++FG+ + EI +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 40/125 (32%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+L+ H R++HRDLK N+L+D K++DFGLAR F G T VV T Y
Sbjct: 113 GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWY 167
Query: 487 MAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS 545
APE +S D++S G + E+ + + +H D++++ + +++ G P+
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRIL--GTPT 222
Query: 546 EMIDP 550
E + P
Sbjct: 223 EDVWP 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 9/93 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR-TFGGD-ETEG-NTTRVVG 482
G+ YLH + +IH+D+ A N ++D+++ KI+D L+R F D G N R V
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV- 183
Query: 483 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E + ++S SDV+SFG+LL E+++
Sbjct: 184 --KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 35/76 (46%), Positives = 42/76 (55%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
+HRDL A NVLL Q KI DFGLAR D + +MAPE D ++
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 500 KSDVFSFGILLLEIVS 515
SDV+S+GILL EI S
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+H IIHRDLK NV +++D +I DFGLAR + + T V T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRW 180
Query: 486 YMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK 517
Y APE + ++ D++S G ++ E++ GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+H IIHRDLK N+ +++D KI DFGLAR T+ T V T
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 182
Query: 486 YMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK 517
Y APE + ++ D++S G ++ E+++G+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 35/92 (38%), Positives = 56/92 (60%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYG 485
GL +LH II+RDLK NV+LD + + KI+DFG+ + + +G TT+ GT
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTKTFCGTPD 166
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + + D ++FG+LL E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 31/99 (31%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART-FGGD-ETEGN 476
R + G+ YL S IHRDL A N +L+++M ++DFGL++ + GD +G
Sbjct: 117 RFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 477 TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+++ ++A E +D ++ SDV++FG+ + EI++
Sbjct: 174 ASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 39/94 (41%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL YLH++ IIHRDLK N+LL KI+DFGLART+ G + T +VV T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173
Query: 486 YMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + D+++ G +L E+++ K
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF---GGDETEGNTTRVV-G 482
G+ YLH + ++HRD+K NV+L + K+ DFG AR G T N + + G
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 483 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
T +MAPE ++ + KSD++S G + E+ +GK
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 37/91 (40%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 425 GRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R G E T
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 187
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E + ++ SDV+S+G+LL EIVS
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 15/95 (15%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART------FGGDETEGNTTRV 480
G+ YL S + +HRDL N L+ ++M KI+DFGL+R + E + R
Sbjct: 142 GMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR- 197
Query: 481 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+M PE +++ +SDV+++G++L EI S
Sbjct: 198 -----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
R L YLH +IHRD+K+ ++LL D K+SDFG + + + +VGT
Sbjct: 129 RALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPY 183
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE S + + D++S GI+++E++ G+
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYGY 486
L++LH II+RDLK NVLLD + + K++DFG+ + G TT GT Y
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE---GIFNGKTTSTFCGTPDY 162
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
+APE + + D ++ G+LL E++ G
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 31/91 (34%), Positives = 52/91 (57%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
LL +H +IHRD+K+ N+LL + K+ DFG ++ + ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVSGKK 518
APE +S K+D+FS G+LL E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 41/125 (32%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ---DMNPKISDF 462
ER L +G YL ++ IHRD+ A N LL KI+DF
Sbjct: 107 PERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF 163
Query: 463 GLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS------- 515
G+AR R + +M PE DG F+ K+DV+SFG+LL EI S
Sbjct: 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223
Query: 516 GKKNR 520
G+ N+
Sbjct: 224 GRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 34/86 (39%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 431 LHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490
LH L IHRDLK N L+D + K++DFGL++ G T N+ VVG+ YMAPE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPE 168
Query: 491 YASDGQFSVKSDVFSFGILLLEIVSG 516
+ D +S G +L E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
I+ G GL +LH + RIIHRD+K N+LL + K+ DFG++ NT+
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 480 VVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 516
VGT +MAPE + D + + DV+S GI +E+ G
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 47/135 (34%), Positives = 64/135 (47%), Gaps = 24/135 (17%)
Query: 393 QDLYIRMS----------ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442
QD+Y+ M ELD ER L ++++CG + +LH IIHR
Sbjct: 95 QDVYLVMELMDANLCQVIQMELDHERMSYL----LYQMLCG----IKHLHSAG---IIHR 143
Query: 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSD 502
DLK N+++ D KI DFGLART G T T V T Y APE + D
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 503 VFSFGILLLEIVSGK 517
++S G ++ E+V K
Sbjct: 201 IWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
G+ YLH + I+HRD+K N+L D N K+ DFG ++ G R V GT
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+M+PE S + K+DV+S G ++E+++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 32/94 (34%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT-TRVVGTY 484
+G+ + H++ R++HRDLK N+L+++ K++DFGLAR FG NT + V T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTL 164
Query: 485 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGK 517
Y AP+ + +S D++S G ++ E+++G+
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 12/122 (9%)
Query: 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453
DLY ++ +R + L + I GL YLH RIIHRD+K N+ ++
Sbjct: 142 DLYTYLT------KRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFIND 192
Query: 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 513
I D G A+ + GT APE + +++ K+D++S GI+L E+
Sbjct: 193 VDQVCIGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
Query: 514 VS 515
++
Sbjct: 250 LA 251
|
Length = 357 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR-TFGGDETEGNTTRVVGTY 484
R L Y+H + + HRDLK N+L + D KI DFGLAR F T T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 485 GYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGK 517
Y APE +++ D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 38/127 (29%), Positives = 67/127 (52%), Gaps = 11/127 (8%)
Query: 389 PDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448
P G ++R LD +R LL+W + +G+ YL + R++HR+L A N
Sbjct: 91 PLGSLLDHVRQHRDSLDPQR--LLNWCVQI------AKGMYYLEEH---RMVHRNLAARN 139
Query: 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGI 508
+LL D +I+DFG+A D+ + + +MA E G+++ +SDV+S+G+
Sbjct: 140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGV 199
Query: 509 LLLEIVS 515
+ E++S
Sbjct: 200 TVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 36/166 (21%)
Query: 425 GRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART-FGGD-ETEGNTTRVVG 482
G+ YL S IHRDL A N +L+++MN ++DFGL++ + GD +G ++
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM-- 176
Query: 483 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-------GKKNRGFYHLDNKLNLIGHA 535
++A E +D ++ KSDV+SFG+ + EI + G +N Y + N +
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ- 235
Query: 536 WKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC 581
P + +D Y + C +P DRP
Sbjct: 236 --------PPDCLDGLYS-------------LMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 42/128 (32%), Positives = 65/128 (50%), Gaps = 16/128 (12%)
Query: 392 GQDLYIRMSASELDQERCKLLDWSKRFRI--ICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449
G DL M Q + KL + RF IC L +LH+ II+RDLK NV
Sbjct: 80 GGDLMFHM------QRQRKLPEEHARFYAAEIC---IALNFLHERG---IIYRDLKLDNV 127
Query: 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 509
LLD D + K++D+G+ + G T+ GT Y+APE ++ D ++ G+L
Sbjct: 128 LLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL 185
Query: 510 LLEIVSGK 517
+ E+++G+
Sbjct: 186 MFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 430 YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAP 489
YLH II+RDLK N+LLD + K++DFG A+ + T + GT Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 490 EYASDGQFSVKSDVFSFGILLLEIVSG 516
E D ++ G+LL E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
GL ++H +I+HRD+K+ N+ L ++ M K+ DFG+AR D E T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYT-CVGTPY 167
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK---KNRGFYHL 525
Y++PE + ++ K+D++S G +L E+ + K + + L
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 41/116 (35%), Positives = 57/116 (49%), Gaps = 13/116 (11%)
Query: 404 LDQERCKLLDWSKRF---RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKIS 460
L +ERC L+ RF + G YLH L II+RDLK N+LLD + ++
Sbjct: 87 LQRERC-FLEPRARFYAAEVASAIG----YLHS---LNIIYRDLKPENILLDSQGHVVLT 138
Query: 461 DFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
DFGL + G E E T+ GT Y+APE + D + G +L E++ G
Sbjct: 139 DFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 14/106 (13%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT--- 483
G++YL + +HRDL N L+ D+ KI DFG++R D + RV G
Sbjct: 134 GMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTML 186
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDN 527
+M PE +F+ +SDV+SFG++L EI + GK+ +Y L N
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--WYGLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 16/98 (16%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG- 485
G+ YL ++S IHRDL A N L+ K+SDFG+ R DE + G
Sbjct: 112 GMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGA 161
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 518
+ PE + ++S KSDV+SFG+L+ E+ + K
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ + Y H IIHRD+K N+L+ + K+ DFG AR T V T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA-RPASPLTDYVATRW 166
Query: 486 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSG 516
Y APE D + DV++ G ++ E++ G
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L YLH +++RD+K N++LD+D + KI+DFGL + G GT Y+
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
APE D + D + G+++ E++ G+ FY+ D++
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR-TFGGD--ETE 474
I+ G+ +L S ++H+DL NVL+ +N KISD GL R + D +
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
GN+ + +M+PE G+FS+ SD++S+G++L E+ S
Sbjct: 184 GNSLLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L YLH + +++RDLK N++LD+D + KI+DFGL + G + GT Y
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEY 162
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
+APE D + D + G+++ E++ G+ FY+ D++
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL + H R++HRDLK N+L++ + K++DFGLAR F G T VV T Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWY 166
Query: 487 MAPEYASDGQF-SVKSDVFSFGILLLEIVSGK 517
APE ++ S D++S G + E+V+ +
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 8/108 (7%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L YL R +HRD+ A NVL+ K+ DFGL+R DE+ ++ +M
Sbjct: 120 LAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWM 175
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGH 534
APE + +F+ SDV+ FG+ + EI+ G K F + N ++IG
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP--FQGVKNN-DVIGR 220
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
G+ YLH + I+HRD+K N+L D N K+ DFG ++ G + V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+M+PE S + K+D++S G ++E+++ K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 9/105 (8%)
Query: 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGG 470
LL+W + +G+ YL + R++HRDL A NVL+ + KI+DFGLA+ G
Sbjct: 111 LLNWCVQI------AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161
Query: 471 DETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
DE E + +MA E ++ +SDV+S+G+ + E+++
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 34/80 (42%), Positives = 46/80 (57%), Gaps = 8/80 (10%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT----YGYMAPEYASDG 495
IHRDL A N L+ + KISDFG++R +E +G G + APE + G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 496 QFSVKSDVFSFGILLLEIVS 515
++S +SDV+SFGILL E S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 11/121 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL +LH R++HRDLK N+L+ K++DFGLAR + + T VV T
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS 545
Y APE ++ D++S G + E+ + + + + ++ +G + G+P
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKILDV--IGLPG 229
Query: 546 E 546
E
Sbjct: 230 E 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
I+C L YLH I++RDLK N+LLD++ + K++DFG A+ + T
Sbjct: 110 IVCA----LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWT 157
Query: 480 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+ GT Y+APE + D ++ GIL+ E++ G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 28/79 (35%), Positives = 47/79 (59%), Gaps = 2/79 (2%)
Query: 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS 498
+IHRD+K+ ++LL D K+SDFG + + +VGT +MAPE S +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYG 194
Query: 499 VKSDVFSFGILLLEIVSGK 517
+ D++S GI+++E+V G+
Sbjct: 195 PEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 12/105 (11%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
RI +GL +L ++ IIHRD+K NVL++ + K+ DFG++ + N
Sbjct: 106 RITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-- 161
Query: 479 RVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSGK 517
+G YMAPE G ++V+SDV+S G+ +LE+ G+
Sbjct: 162 --IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 25/144 (17%)
Query: 387 SFPDGGQDLYIRMS-------ASELDQERCKL------LDWSKRFRIICGTGRGLLYLHQ 433
SF G LYI M ++ +R KL L W F +C G+ ++H+
Sbjct: 66 SFEADGH-LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHIHE 118
Query: 434 DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS 493
R++HRD+K+ N+ L Q+ K+ DFG AR T VGT Y+ PE
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWE 173
Query: 494 DGQFSVKSDVFSFGILLLEIVSGK 517
+ ++ KSD++S G +L E+ + K
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L YLH +I++RDLK N++LD+D + KI+DFGL + G GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEY 161
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
+APE D + D + G+++ E++ G+ FY+ D++
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 9/105 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART-FGGD--ETEGNTTRVVGT 483
G+ YL L +HRDL N L+ ++ KI+DFG++R + D +G R
Sbjct: 142 GMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG---RAPLP 195
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
+MA E G+F+ KSDV++FG+ L EI++ + + + HL ++
Sbjct: 196 IRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 28/76 (36%), Positives = 45/76 (59%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
+H+DL A N+L+ + ++ KISD GL+R + + + +M PE G+FS
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 500 KSDVFSFGILLLEIVS 515
SD++SFG++L EI S
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 39/118 (33%), Positives = 54/118 (45%), Gaps = 13/118 (11%)
Query: 402 SELDQERCKLLDWSKRF---RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPK 458
L +ER + RF I G YLH L II+RDLK N+LLD +
Sbjct: 85 FHLQRERS-FPEPRARFYAAEIASALG----YLHS---LNIIYRDLKPENILLDSQGHVV 136
Query: 459 ISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
++DFGL + G E T+ GT Y+APE + D + G +L E++ G
Sbjct: 137 LTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 30/181 (16%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF-GGDETEGN 476
F+I+ RG+ + H + IIHRD+K N+L+ Q K+ DFG ART E
Sbjct: 107 FQIL----RGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--- 156
Query: 477 TTRVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGKKNRGF---------YHLD 526
T V T Y APE D ++ D+++ G L+ E+++G F YH+
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG--EPLFPGDSDIDQLYHII 214
Query: 527 NKL-NLIGHAWKLWNKGMP-SEMIDPCYQESCNLTEVIRCIHISLL-----CVQQHPDDR 579
L NLI +++ K + M P +E L + + +L C++ PDDR
Sbjct: 215 KCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274
Query: 580 P 580
P
Sbjct: 275 P 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L YLH+ II+RDLK NVLLD + + K++D+G+ + G T+ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNY 162
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+APE + D ++ G+L+ E+++G+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YL + IHRDL A N L+ ++ KISDFG++R + + + +
Sbjct: 105 GMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKW 160
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
APE + G++S +SDV+S+GILL E S
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 11/93 (11%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYGY 486
L +LH+ II+RDLK NVLLD + + K++D+G+ + G+TT GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---GDTTSTFCGTPNY 162
Query: 487 MAPEY--ASDGQFSVKSDVFSFGILLLEIVSGK 517
+APE D FSV D ++ G+L+ E+++G+
Sbjct: 163 IAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 32/76 (42%), Positives = 42/76 (55%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
+HRDL A NVL+ + KI DFGLAR D + +MAPE + ++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 500 KSDVFSFGILLLEIVS 515
SDV+SFGILL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL +LH + I+HRDLK N+L+ K++DFGLAR + + T VV T
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLW 172
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE ++ D++S G + E+ K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTY 484
+G+ YLH + I+HRD+K N+L D N K+ DFG ++ G + V GT
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+M+PE S + K+DV+S ++E+++ K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 3/89 (3%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YL + L +HRDL N L+ KI+DFG++R + R V +
Sbjct: 141 GMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW 197
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
MA E G+F+ SDV++FG+ L E+ +
Sbjct: 198 MAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 27/137 (19%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD-------------E 472
GL LH+ +HRDL N+ ++ KI+DFGLAR +G
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 473 TEGNTTRVVGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529
E T++VV T Y APE A F+V D++S G + E+++GK + +N++
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGKP---LFPGENEI 240
Query: 530 NLIGHAWKLWNKGMPSE 546
+ +G ++L G P+E
Sbjct: 241 DQLGRIFEL--LGTPNE 255
|
Length = 335 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART-FGGD--ETEGNTTRVVGT 483
G+ YL S L +HRDL N L+ +++ KI+DFG++R + GD +G R V
Sbjct: 150 GMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQG---RAVLP 203
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E G+F+ SDV++FG+ L EI+
Sbjct: 204 IRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 42/129 (32%), Positives = 61/129 (47%), Gaps = 13/129 (10%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
+ +GG+ Y L +ERC L+ RF L YLH L I++RDLK
Sbjct: 77 YINGGELFY------HLQRERC-FLEPRARF-YAAEIASALGYLHS---LNIVYRDLKPE 125
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG 507
N+LLD + ++DFGL + E G T+ GT Y+APE + D + G
Sbjct: 126 NILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 183
Query: 508 ILLLEIVSG 516
+L E++ G
Sbjct: 184 AVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL Y H+ + L HRD+K N+LL+ K++DFGLAR + +E+ T +V+ T Y
Sbjct: 128 GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183
Query: 487 MAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
PE + ++ DV+S G +L E+ + K
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
+II T + + + H+ IHRD+K N+L+ + K+ DFG AR G + T
Sbjct: 104 KIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYT 158
Query: 479 RVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSG 516
V T Y APE D Q+ DV++ G + E+++G
Sbjct: 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQ-DMNPKISDFGLARTFGGD-ETEGNTTRVVGT 483
RGL Y+H + ++HRDLK NV ++ D+ KI DFGLAR +G + + T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 484 YGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 517
Y +P S ++ D+++ G + E+++GK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 27/76 (35%), Positives = 34/76 (44%), Gaps = 22/76 (28%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP----KISDFGLARTF--------GGDETE 474
G+ YLH + ++HRDLK N+L+ + KI D GLAR F D
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--- 173
Query: 475 GNTTRVVGTYGYMAPE 490
VV T Y APE
Sbjct: 174 ----PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 8/87 (9%)
Query: 439 IIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDE-----TEGNTTRVVGTYGYMAPE 490
I+HRDLK N+++ + K+ DFG+ G T TT V+GT Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 491 YASDGQFSVKSDVFSFGILLLEIVSGK 517
+ SD++++G++ LE ++G+
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 424 TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT 483
T +GL YLH ++ HRD+K N+LL + + K++DFG+A T +GT
Sbjct: 115 TLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGT 169
Query: 484 YGYMAPEYAS---DGQFSVKSDVFSFGILLLEI 513
+MAPE A+ +G ++ D+++ GI +E+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
L W +R +I G + L +LH ++ +L +++D P + L D
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531
++ Y+APE + KSD++ FG++L+E+++GK D + +
Sbjct: 836 TKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA-----DAEFGV 884
Query: 532 IGHAWKLWNKGMPSEM-----IDPC--YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584
G + W + S+ IDP S N E++ ++++L C P RPC
Sbjct: 885 HGSIVE-WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943
Query: 585 VILMLGS 591
V+ L S
Sbjct: 944 VLKTLES 950
|
Length = 968 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL +LH + + IHRD+K N+LL + K+ DFG++ NT+ VGT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 487 MAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 516
MAPE + D + + DV+S GI +E+ G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 36/105 (34%), Positives = 59/105 (56%), Gaps = 9/105 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART-FGGD--ETEGNTTRVVGT 483
G+ YL S L +HRDL N L+ ++ KI+DFG++R + GD +G R V
Sbjct: 142 GMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG---RAVLP 195
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
+M+ E G+F+ SDV++FG+ L EI++ K + + L ++
Sbjct: 196 IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 11/115 (9%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
L S+ I G++YL + +HRDL N L+ ++ KI DFG++R D
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----D 172
Query: 472 ETEGNTTRVVG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 522
+ RV G +M PE +F+ +SDV+SFG++L EI + K F
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L L + +I+RDLK N+LLD + + DFGL + D+ + NT GT Y+
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYL 160
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVSG 516
APE ++ D ++ G+LL E+++G
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L +LH+ I++RDLK N+LLD + + DFGL++ D NT GT Y+
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYL 163
Query: 488 APEYASDGQ-FSVKSDVFSFGILLLEIVSG 516
APE D + ++ D +S G+L+ E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
L S+ I G++YL + +HRDL N L+ +++ KI DFG++R D
Sbjct: 117 LTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----D 169
Query: 472 ETEGNTTRVVG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527
+ RV G +M PE +F+ +SDV+S G++L EI + K + +Y L N
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK-QPWYQLSN 228
Query: 528 K--LNLIGHAWKLWN-KGMPSEMID---PCYQESCNLTEVIRCIHISL 569
+ I L + P E+ D C+Q ++ I+ IH L
Sbjct: 229 NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 9/97 (9%)
Query: 421 ICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR- 479
IC +G+ YL SR + +HRDL A NVL++ + KI DFGL + D+ E T +
Sbjct: 118 IC---KGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKD 170
Query: 480 -VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ + APE +F + SDV+SFG+ L E+++
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 30/114 (26%)
Query: 430 YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG-GDETEGNTTR--------- 479
+H+ L IHRD+K N+L+D D + K++DFGL + + E
Sbjct: 116 SVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 480 -----------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
VGT Y+APE + ++ D +S G++L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 35/108 (32%), Positives = 60/108 (55%), Gaps = 6/108 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y H R +++HRDLK N+L+++ K++DFGLAR T+ + VV T
Sbjct: 115 RGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLW 169
Query: 486 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532
Y P+ ++S + D++ G + E+ SG+ ++++L+LI
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN--TTRVVGTYG 485
L +LHQ II+RDLK N+LLD + K++DFGL + + T GT
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIE 165
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
YMAPE D +S G L+ ++++G
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-07
Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 22/114 (19%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE--- 474
F IC T + Y+H S+ ++HRDLK N+LL I D+G A +E +
Sbjct: 119 FHKICAT---IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 475 ----------GNTT---RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ T ++VGT YMAPE S +D+++ G++L ++++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 399 MSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPK 458
M+ EL + R + L + + + L ++H++ I HRD+K N+L+ D K
Sbjct: 84 MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILK 139
Query: 459 ISDFGLARTFGGDETEGNTTRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVS 515
++DFG R ++ T + T Y APE +DG + K D+++ G + EI+S
Sbjct: 140 LADFGSCRGI---YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 12/127 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTY 484
+G+ + H + ++HRDLK N+L+D+ KI+D GL R F + T + T
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHEIVTL 175
Query: 485 GYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGM 543
Y APE +S D++S G + E+ + + D++L + H +KL G
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP---LFPGDSELQQLLHIFKLL--GT 230
Query: 544 PSEMIDP 550
P+E + P
Sbjct: 231 PTEQVWP 237
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 24/78 (30%), Positives = 46/78 (58%)
Query: 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF 497
+++HRDLK+ N+ L K+ DFG ++ + + + GT Y+APE ++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 498 SVKSDVFSFGILLLEIVS 515
S K+D++S G++L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 424 TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT 483
T +GL YLH + +HRD+K N+LL + + K++DFG++ T +GT
Sbjct: 115 TLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGT 169
Query: 484 YGYMAPEYAS---DGQFSVKSDVFSFGILLLEI 513
+MAPE A+ G ++ D+++ GI +E+
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 5/80 (6%)
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ 496
L I++RDLK N+LLD+D K++DFG A+ + T + GT Y+APE +
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVG 204
Query: 497 FSVKSDVFSFGILLLEIVSG 516
+D ++ GI + EI+ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
R + YLH++ RIIHRD+KA N+ ++ + + DFG A F D GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
APE + + D++S GI+L E+ +
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y H R +++HRDLK N+L+++ K++DFGLAR T+ + VV T
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLW 169
Query: 486 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y P+ +S + D++ G + E+ +G+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y H + +I+HRDLK N+L+++ K++DFGLAR T+ + VV T
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLW 168
Query: 486 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y P+ ++S D++ G +L E+ +G+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS 498
I+HRD+K N+L+ + K+ DFG AR + + N T V T Y +PE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 499 VKSDVFSFGILLLEIVSGK 517
D++S G +L E+ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 425 GRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
+L +H +L +HRD+K NVLLD + + +++DFG D T ++ VGT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTP 167
Query: 485 GYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGK 517
Y++PE G++ + D +S G+ + E++ G+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 429 LYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMA 488
L +H ++ +HRD+K NVL+D+ + K++DFG A ++ N+ VGT Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIA 171
Query: 489 PEY------ASDGQFSVKSDVFSFGILLLEIVSGK 517
PE G + V+ D +S G++ E++ G+
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L YLH + I++RDLK N+LLD + ++DFGL + G TT GT Y
Sbjct: 108 ALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEY 162
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
+APE + D + G +L E++ G
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 3e-06
Identities = 19/44 (43%), Positives = 25/44 (56%), Gaps = 2/44 (4%)
Query: 594 VLPQPKQPGFLADRKSIGPDSLLSIP--ESSSSNSITISELEAR 635
+PQPKQPGF R DS S ES + N +T+S ++AR
Sbjct: 5 EIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 382 LIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441
+I +G D ++R +L +L+ ++ G G+ YL S + +H
Sbjct: 82 MIVTEYMSNGALDSFLRKHEGQLVAG--QLMG------MLPGLASGMKYL---SEMGYVH 130
Query: 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG--YMAPEYASDGQFSV 499
+ L A VL++ D+ KIS F + D++E T + G + APE FS
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 500 KSDVFSFGILLLEIVS 515
SDV+SFGI++ E++S
Sbjct: 188 ASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 37/122 (30%), Positives = 58/122 (47%), Gaps = 6/122 (4%)
Query: 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453
DLY M D + LL R I+ + Y+H ++IHRD+K N+ L+
Sbjct: 248 DLYSFMYDEAFDWKDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302
Query: 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 513
D + DFG A F E E VGT +PE + + +D++S G++LL++
Sbjct: 303 DGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 514 VS 515
+S
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 13/79 (16%)
Query: 393 QDL--YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450
QDL Y ++D E K S F+++ +GL + H ++HRDLK N+L
Sbjct: 83 QDLKKYFDSCNGDIDPEIVK----SFMFQLL----KGLAFCHSH---NVLHRDLKPQNLL 131
Query: 451 LDQDMNPKISDFGLARTFG 469
++++ K++DFGLAR FG
Sbjct: 132 INKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 38/128 (29%), Positives = 64/128 (50%), Gaps = 14/128 (10%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+H I+HRDLK N+L+ K++DFGLAR ++ ++ VV T
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLW 168
Query: 486 YMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKG 542
Y P+ A+D +S D++ G + +E++ G+ F + + + W + G
Sbjct: 169 YRPPDVLLGATD--YSSALDIWGAGCIFIEMLQGQP--AFPGVSDVFEQLEKIWTVL--G 222
Query: 543 MPSEMIDP 550
+P+E P
Sbjct: 223 VPTEDTWP 230
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 9/107 (8%)
Query: 426 RGLL----YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV 481
R LL YLH IIHRD+K N+ LD+ N + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 482 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
GT +PE + + K+D++S G++L E+ KN + K
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV--KNVTLFGKQVK 293
|
Length = 392 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 11/94 (11%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT--TRVVGTY 484
GL ++H + HRDLK N+L+ KI+DFGLAR E T V T
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTR 162
Query: 485 GYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE +S D+++ G ++ E+ + +
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 18/130 (13%)
Query: 392 GQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451
G DL MS ++ ++ W+K + T +L L + +IHRD+K N+LL
Sbjct: 127 GGDLVNLMSNYDVPEK------WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLL 175
Query: 452 DQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEY----ASDGQFSVKSDVFSF 506
D+ + K++DFG DET VGT Y++PE DG + + D +S
Sbjct: 176 DKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 507 GILLLEIVSG 516
G+ L E++ G
Sbjct: 234 GVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 21/41 (51%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR 466
RGL Y HQ R++HRDLK N+L+ + K++DFGLAR
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY----ASDG 495
IHRD+K N+LLD+ + K++DFG + T VGT Y++PE DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDG 222
Query: 496 QFSVKSDVFSFGILLLEIVSG 516
+ + D +S G+ L E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 31/103 (30%), Positives = 46/103 (44%), Gaps = 12/103 (11%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART-FGGDETEGNT 477
R+ C GLL+LHQ IH DL N L D++ KI D+GLA + D
Sbjct: 104 RMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160
Query: 478 TRVVGTYGYMAPEYASDGQFSV-------KSDVFSFGILLLEI 513
V ++APE + KS+++S G+ + E+
Sbjct: 161 CHAV-PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 424 TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT 483
T +L L + IHRD+K N+LLD+ + K++DFG + T VGT
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGT 206
Query: 484 YGYMAPEY----ASDGQFSVKSDVFSFGILLLEIVSG 516
Y++PE DG + + D +S G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 34/119 (28%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART------------------- 467
L YLH L I++RDLK N+LL + + +SDF L++
Sbjct: 115 ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 468 --------FGGDETEGNTTRVVGTYGYMAPEYAS-DGQ-FSVKSDVFSFGILLLEIVSG 516
+E + VGT Y+APE S DG +V D ++ GILL E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 25/87 (28%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-- 493
+L +HRD+K N+L+D + + +++DFG D T ++ VGT Y++PE
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAM 178
Query: 494 ---DGQFSVKSDVFSFGILLLEIVSGK 517
G++ + D +S G+ + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+HQ I+HRDLK N+L+ K++DFGLAR + V T
Sbjct: 114 RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLW 168
Query: 486 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSG 516
Y P+ ++S D++ G + +E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
+L + +L +HRD+K NVLLD++ + +++DFG D T + VGT Y+
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYI 170
Query: 488 APEY-----ASDGQFSVKSDVFSFGILLLEIVSGK 517
+PE G++ + D +S G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 35/114 (30%), Positives = 52/114 (45%), Gaps = 24/114 (21%)
Query: 438 RIIHRDLKAGNVLLD-------------QDMN----PKISDFGLARTFGGDETEGNTTRV 480
R++HRDLK N+ L ++N KI DFGL++ G E
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSC 201
Query: 481 VGTYGYMAPEYA--SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532
VGT Y +PE + KSD+++ G ++ E+ SGK F+ +N LI
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP--FHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 36/153 (23%), Positives = 59/153 (38%), Gaps = 40/153 (26%)
Query: 377 MWFG---DLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQ 433
M +G DL+ FP+G +L I I+ L Y+H
Sbjct: 81 MAYGSCEDLLK-THFPEGLPELAIAF--------------------ILKDVLNALDYIHS 119
Query: 434 DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-------- 485
IHR +KA ++LL D +S + + G RVV +
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLP 173
Query: 486 YMAPE--YASDGQFSVKSDVFSFGILLLEIVSG 516
+++PE + ++ KSD++S GI E+ +G
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 25/140 (17%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLL----DQDMNPKISDFGLARTFGGD-ETEGNTTRVV 481
G+ YLH + ++HRDLK N+L+ + KI+D G AR F + + VV
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 482 GTYGYMAPEYASDGQFSVKS-DVFSFGILLLEIVSGK----------KNRGFYH---LDN 527
T+ Y APE + K+ D+++ G + E+++ + K YH LD
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236
Query: 528 KLNLIGH-AWKLWN--KGMP 544
N++G A K W K MP
Sbjct: 237 IFNVMGFPADKDWEDIKKMP 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 16/102 (15%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR----TFGGDETEGNTTR---- 479
L YLH I+HRDLK N+L+ + K++DFGL++ + + EG+ +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 480 -----VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
V GT Y+APE + D ++ GI+L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 30/123 (24%), Positives = 50/123 (40%), Gaps = 41/123 (33%)
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET-----EGNTTRV---------- 480
++ IHRD+K N+L+D+D + K++DFGL F +G+ R
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 481 --------------------------VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 514
VGT Y+APE ++ D +S G++L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 515 SGK 517
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 38/132 (28%), Positives = 59/132 (44%), Gaps = 32/132 (24%)
Query: 411 LLDW-------SKRF--RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNP- 457
LLDW S R +II TG L Y H + L ++H DLK N+L+ D ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275
Query: 458 ------------KISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFS 505
+I D G G + + T +V T Y +PE + +D++S
Sbjct: 276 TNRALPPDPCRVRICDLG-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330
Query: 506 FGILLLEIVSGK 517
G ++ E+ +GK
Sbjct: 331 MGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 28/117 (23%), Positives = 44/117 (37%), Gaps = 36/117 (30%)
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD----------ETEGNTTR------ 479
+L IHRD+K N+LLD + K+SDFGL +
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 480 --------------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
VGT Y+APE ++ + D +S G+++ E++ G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 18/39 (46%), Positives = 27/39 (69%), Gaps = 3/39 (7%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR 466
L YLH+ IIHRDLK N+L+ + + K++DFGL++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 16/33 (48%), Positives = 24/33 (72%)
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468
+L IHRD+K N+L+D+ + K+SDFGL+ F
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLL----DQDMNPKISDFGLARTFGGD-ETEGNTTRVV 481
G+ YLH + ++HRDLK N+L+ + KI+D G AR F + + VV
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 482 GTYGYMAPEYASDGQFSVKS-DVFSFGILLLEIVSGK 517
T+ Y APE + K+ D+++ G + E+++ +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 30/127 (23%), Positives = 51/127 (40%), Gaps = 45/127 (35%)
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF----------GGDETEGNTT------- 478
++ IHRD+K N+L+D+D + K++DFGL F GD ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 479 ----------------------------RVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
+VGT Y+APE ++ D +S G++L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 511 LEIVSGK 517
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 24/112 (21%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
I+ G RGL YLHQ+ IHR++KA ++L+ D +S GL+ + G +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVR-NGQKAK 159
Query: 480 VVGTYGYMAPEYASDGQ--------------FSVKSDVFSFGILLLEIVSGK 517
VV Y P++++ ++VKSD++S GI E+ +G+
Sbjct: 160 VV----YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 635 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.94 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.93 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.92 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.92 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.91 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.91 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.91 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.91 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.91 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.91 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.9 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.9 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.9 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.9 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.9 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.9 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.9 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.9 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.9 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.9 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.9 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.9 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.9 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.9 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.9 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.9 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.89 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.89 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.89 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.89 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.89 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.89 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.89 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.89 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.89 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.89 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.89 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.89 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.89 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.89 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.88 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.88 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.88 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.88 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.88 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.88 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.88 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.88 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.88 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.88 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.88 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.88 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.88 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.88 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.88 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.88 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.87 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.87 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.87 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.87 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.87 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.87 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.87 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.87 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.87 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.87 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.87 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.87 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.87 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.87 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.87 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.87 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.87 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.87 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.87 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.87 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.87 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.87 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.87 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.87 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.87 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.87 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.87 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.87 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.87 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.86 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.86 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.86 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.86 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.86 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.86 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.86 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.86 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.86 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.86 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.86 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.86 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.86 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.85 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.85 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.85 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.85 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.85 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.85 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.85 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.85 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.85 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.84 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.84 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.84 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.84 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.84 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.83 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.83 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.83 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.83 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.83 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.82 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.82 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.82 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.82 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.82 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.82 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.82 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.82 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.81 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.81 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.8 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.8 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.8 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.79 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.79 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.78 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.75 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.75 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.75 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.74 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.73 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.68 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.66 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.66 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.61 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.6 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.57 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.55 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.54 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.53 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.51 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.49 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.38 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.34 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.34 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.32 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.31 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.23 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.21 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.18 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.11 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.07 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.03 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.01 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 98.97 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 98.78 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.68 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.67 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.66 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.63 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.61 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.59 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.2 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.2 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.14 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.12 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.1 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.09 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 97.98 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 97.98 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 97.97 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 97.95 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.93 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.68 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.17 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 96.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 96.67 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 96.6 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 96.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 96.26 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 96.2 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 95.51 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 95.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 95.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 95.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 94.91 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 94.32 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 93.41 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.13 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 88.91 | |
| PF00024 | 79 | PAN_1: PAN domain This Prosite entry concerns appl | 87.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 87.24 | |
| smart00223 | 79 | APPLE APPLE domain. Four-fold repeat in plasma kal | 86.7 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 85.55 | |
| PRK11138 | 394 | outer membrane biogenesis protein BamB; Provisiona | 85.29 | |
| TIGR03300 | 377 | assembly_YfgL outer membrane assembly lipoprotein | 85.16 | |
| PRK11138 | 394 | outer membrane biogenesis protein BamB; Provisiona | 83.35 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 83.21 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 81.55 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.11 Aligned_cols=218 Identities=34% Similarity=0.595 Sum_probs=187.4
Q ss_pred eeeeccccccccccCCCCc-cEEEEecccchhh------hhcc-ccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 375 CAMWFGDLIDMRSFPDGGQ-DLYIRMSASELDQ------ERCK-LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~-~lyl~~~~~~~~~------~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
..+.|+||+.+.++|..+. ..+|+.||+..+. .+.. .|+|++|++||.++|+||+|||+.+.++|||||||+
T Consensus 126 s~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKs 205 (361)
T KOG1187|consen 126 SRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKS 205 (361)
T ss_pred hcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCH
Confidence 3557999999999998777 4999999987421 1122 889999999999999999999999988999999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeee-eeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV-VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+|||||+++++||+|||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+....
T Consensus 206 sNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~ 283 (361)
T KOG1187|consen 206 SNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP 283 (361)
T ss_pred HHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence 9999999999999999999765431 1111112 799999999999999999999999999999999999999876665
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccc-cCCCH-HHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQ-ESCNL-TEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
.....++.|++..+.++...+++|+.+. ..... +++.++..++++|++.+|.+||+|.||+++|+.+..
T Consensus 284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 5566689999999999999999999987 55554 799999999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=276.92 Aligned_cols=200 Identities=29% Similarity=0.389 Sum_probs=161.7
Q ss_pred eeeeccccccccccCCCCc-cEEEEecccchhh------h-hccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 375 CAMWFGDLIDMRSFPDGGQ-DLYIRMSASELDQ------E-RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~-~lyl~~~~~~~~~------~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
..+.|||||.+.+.+.... .+-|++||++.+. . ....+++..+++++.|||+|+.|||+++. |||||||+
T Consensus 94 ~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~ 171 (362)
T KOG0192|consen 94 SRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKS 171 (362)
T ss_pred HhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccCh
Confidence 3478999999999998776 7899999997421 2 36789999999999999999999999984 99999999
Q ss_pred cceEeccCC-CCccCccccceecCCCCCCCceeeeeeccCCCCccccc--CCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 447 GNVLLDQDM-NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS--DGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 447 ~NIlld~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+|||++.++ ++||+|||+++...... .......||+.|||||.+. ..+++.|+|||||||++|||++|+.||...
T Consensus 172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~ 249 (362)
T KOG0192|consen 172 DNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL 249 (362)
T ss_pred hhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence 999999997 99999999998765332 1222367999999999999 669999999999999999999999998654
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.. ...+......+....+... ....+..++.+||+.||++||++.+|+.+|+.+.
T Consensus 250 ~~------~~~~~~v~~~~~Rp~~p~~---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 250 AP------VQVASAVVVGGLRPPIPKE---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CH------HHHHHHHHhcCCCCCCCcc---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 32 2222333334444443332 3446778999999999999999999999998663
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-31 Score=280.76 Aligned_cols=193 Identities=24% Similarity=0.373 Sum_probs=159.4
Q ss_pred cceeeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 373 SGCAMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 373 ~gC~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
.-|.+.|+|||+++.+.++.+.+||++|.++.. .++++.+++.++..+++||+.||.|||+.+ |||||||..
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLG 147 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLG 147 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchh
Confidence 347889999999999999999999999988632 246789999999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|++++++.++||+|||||..+..+... ..+..||+-|.|||++....++..+||||+|||+|-|+.|++||+.....+
T Consensus 148 NlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke 225 (592)
T KOG0575|consen 148 NLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE 225 (592)
T ss_pred heeecCcCcEEecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH
Confidence 999999999999999999988654332 345899999999999999999999999999999999999999997543222
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
....++..+.. .+........+|+..+|+.||.+|||+++|+.
T Consensus 226 -------ty~~Ik~~~Y~----------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 226 -------TYNKIKLNEYS----------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -------HHHHHHhcCcc----------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22222221111 11122234557888999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-31 Score=279.00 Aligned_cols=200 Identities=28% Similarity=0.388 Sum_probs=162.7
Q ss_pred eeeeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 375 CAMWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
-.+.|++||+++.++..+..+||++|++... ......++..+.+.++.|||+|++||++++ +|||||.++
T Consensus 256 k~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAAR 332 (468)
T KOG0197|consen 256 KKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAAR 332 (468)
T ss_pred HhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhh
Confidence 3568999999999999888999999999742 234677888999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~ 526 (635)
||||+++..+||+|||||+...++....... ..-++.|.|||.+....++.|+|||||||+||||+| |+.|++....
T Consensus 333 NiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn- 410 (468)
T KOG0197|consen 333 NILVDEDLVVKISDFGLARLIGDDEYTASEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN- 410 (468)
T ss_pred heeeccCceEEEcccccccccCCCceeecCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-
Confidence 9999999999999999999665544432222 334779999999999999999999999999999998 7777654321
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
.++.+.+.+|.. ...+..++..+.+||..||+.+|++|||++.+...|+....
T Consensus 411 ------~ev~~~le~GyR---------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 411 ------EEVLELLERGYR---------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ------HHHHHHHhccCc---------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 223333344433 33445566678899999999999999999999999887643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=262.31 Aligned_cols=193 Identities=25% Similarity=0.337 Sum_probs=152.9
Q ss_pred eccccccccccCCCCc-cEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQ-DLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~-~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIl 450 (635)
.|++||..++.+.... .++|.||||+... ...+.+++...-+++.+|++||.|||+ .+ ||||||||+|||
T Consensus 135 ~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlL 211 (364)
T KOG0581|consen 135 QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLL 211 (364)
T ss_pred CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHee
Confidence 5788888888776555 5999999998532 223568899999999999999999996 66 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++..+.+||+|||.+..+-+. ...+.+||..|||||.+.+..|+.++||||||+.++|+..|+.|+.... .....
T Consensus 212 vNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~ 286 (364)
T KOG0581|consen 212 VNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLD 286 (364)
T ss_pred eccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCC
Confidence 999999999999999876443 3455899999999999999999999999999999999999999986541 11111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. .....+-.+.++.+.+. ....++..++..||++||.+||+++|+++
T Consensus 287 ~~-~Ll~~Iv~~ppP~lP~~--------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 287 IF-ELLCAIVDEPPPRLPEG--------EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HH-HHHHHHhcCCCCCCCcc--------cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 12223334444444433 23345778999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=260.68 Aligned_cols=194 Identities=24% Similarity=0.270 Sum_probs=153.7
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.||+||+++.+.......|++||+++.+. ...+.+.+..-..+++|++.|+.|||++| |+||||||+|||
T Consensus 232 kL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNIL 308 (475)
T KOG0615|consen 232 KLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENIL 308 (475)
T ss_pred hcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEE
Confidence 4579999999999999999999999998532 34567788888899999999999999999 999999999999
Q ss_pred eccC---CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc---ccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 451 LDQD---MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS---VKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 451 ld~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
+..+ ..+||+|||+|+..+.. ....+..||+.|.|||.+..+.++ .|+|+||+|||||-+++|.+||....
T Consensus 309 l~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 309 LSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred eccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 9866 66999999999987522 234458999999999999776533 58899999999999999999996543
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+. .+ .+.+..|..... .....+..++..+++.++|..||++|||+.|+++
T Consensus 386 ~~~--sl----~eQI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 386 TDP--SL----KEQILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred CCc--cH----HHHHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222 11 222233333221 1122345567788999999999999999999985
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=227.18 Aligned_cols=111 Identities=47% Similarity=0.711 Sum_probs=81.4
Q ss_pred CCeEEEeccCCCCCCCC--CceEEEecCCcEEEEccCCceEEEe-ecccCCCCceEEEEccCCCeEEecccCCCCceeee
Q 046703 69 VKTVVWVANRLNLINDS--SGFLMINKTGNLVLTSKSNIVVWSA-YLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFW 145 (635)
Q Consensus 69 ~~t~vW~Anr~~pv~~~--~~~l~~~~~g~l~l~~~~~~~vwss-~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~W 145 (635)
++||||+|||++|+... ..+|.|+.||+|+|+|.+|+++|++ ++.+.....+.|+|+|+|||||++.. +.+||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~----~~~lW 76 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS----GNVLW 76 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT----SEEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec----ceEEE
Confidence 47999999999999643 4789999999999999999999999 56654413449999999999999864 69999
Q ss_pred eeccCCCCcccCCCeeccccccccceeEEEeccCCCCC
Q 046703 146 QSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPS 183 (635)
Q Consensus 146 qSFd~PTDTlLpgq~l~~~~~tg~~~~L~S~~s~~dps 183 (635)
|||||||||+||||+|+.+..+|....++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999988888777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=241.95 Aligned_cols=200 Identities=24% Similarity=0.327 Sum_probs=159.7
Q ss_pred eeeccccccccc--cCCCCccEEEEecccch---------hhhhccccCcccchhhhhhhccccchhhccc-cceEEeec
Q 046703 376 AMWFGDLIDMRS--FPDGGQDLYIRMSASEL---------DQERCKLLDWSKRFRIICGTGRGLLYLHQDS-RLRIIHRD 443 (635)
Q Consensus 376 ~l~h~nLv~l~~--~~~~~~~lyl~~~~~~~---------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-~~~iiH~d 443 (635)
.+.|||||+.+. +.+..+.+||+||+++. ..+.++.++++.+++++.|+++||..+|..- +..|+|||
T Consensus 74 QL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRD 153 (375)
T KOG0591|consen 74 QLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRD 153 (375)
T ss_pred hcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeecc
Confidence 468999998876 33455569999998873 2345678899999999999999999999943 22499999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
|||.||+++.++.+||+|||+++++...... ..+.+||+.||+||.+.+.+|+.|+||||+||++|||..-+.||...
T Consensus 154 IKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 154 IKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred CcchheEEcCCCceeeccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 9999999999999999999999998655443 34479999999999999999999999999999999999999998653
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
+ .....+.+.+|..+.+.+ ......+..|+..|+..||+.||+...+++.+...
T Consensus 232 ------n-~~~L~~KI~qgd~~~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 232 ------N-LLSLCKKIEQGDYPPLPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred ------c-HHHHHHHHHcCCCCCCcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1 222344455665554433 34556677889999999999999966666655543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=241.69 Aligned_cols=207 Identities=20% Similarity=0.256 Sum_probs=159.7
Q ss_pred eeeccccccccccCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|+|||++.+++.....+|+++||++. .+.....++.+...+++.|+++|+.|+|+++ +|||||||+|||
T Consensus 57 qLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENIL 133 (396)
T KOG0593|consen 57 QLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENIL 133 (396)
T ss_pred hcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheE
Confidence 56899999999999999999999999974 1234556788888999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+..++.+||+|||+|+.+.. .....+..+.|..|+|||.+.+ .+|...+||||+||++.||++|.+-|+.....+..
T Consensus 134 it~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 134 ITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL 211 (396)
T ss_pred EecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence 99999999999999998753 2222334678999999999876 78999999999999999999999999877655544
Q ss_pred cHHHHH--------HHHhhcC------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHA--------WKLWNKG------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~--------~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..+... .+.+... .+++..++..-+.--+....-+++++..|++.||++|++-++++.
T Consensus 212 y~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 212 YLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 444322 1222211 122222221111111122335789999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=254.94 Aligned_cols=204 Identities=22% Similarity=0.282 Sum_probs=157.6
Q ss_pred eccccccccccCCCCc-cEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQ-DLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~-~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|||++.++..+.. .+|+++|+++- -..+.+.++++++..|+.||++||+|+|++| +.|||+||+|||+
T Consensus 67 ~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi 143 (538)
T KOG0661|consen 67 PHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILI 143 (538)
T ss_pred CCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEe
Confidence 3999999999886665 99999999972 3455889999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccc-cCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
..+..+||+|||+|+....... .+..+.|+.|+|||++ +.+-|+.+.|||++|||++|+.+-++-|++....+...
T Consensus 144 ~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~ 220 (538)
T KOG0661|consen 144 SGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY 220 (538)
T ss_pred cccceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence 9999999999999998754332 2336789999999986 56789999999999999999999999998765444333
Q ss_pred HHHHHHH-----HhhcC---------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWK-----LWNKG---------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~-----~~~~~---------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.+-.+.. .|.+| ..+......+..-.+ .....+++++..|+..||++|||++|.+++
T Consensus 221 KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 221 KICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 3322211 11111 111111111111112 255678889999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=247.45 Aligned_cols=234 Identities=23% Similarity=0.303 Sum_probs=171.2
Q ss_pred CCCCCCcceeccCCHHHHHHHHhhcCCcccccccccCCCCcceeeeccccccccccCCCCccEEEEecccchh-------
Q 046703 333 LPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSASELD------- 405 (635)
Q Consensus 333 ~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~i~~~~~gC~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------- 405 (635)
.|-+.+. -.+.++++.|... +..-. +. ...--++.||||+.....+-.+..+|++|+++..+
T Consensus 48 ~p~~e~V-AIK~inLEkc~~~-ld~l~------kE---~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik 116 (516)
T KOG0582|consen 48 IPTNEVV-AIKIINLEKCNND-LDALR------KE---VQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIK 116 (516)
T ss_pred cccCCEE-EEEEeehhhhhhh-HHHHH------HH---HHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHH
Confidence 3444332 3477889888654 32111 11 11224558999999999999999999999999853
Q ss_pred hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCce--eeeeec
Q 046703 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT--TRVVGT 483 (635)
Q Consensus 406 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~--~~~~gt 483 (635)
......+++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||....+-........ ....|+
T Consensus 117 ~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgt 193 (516)
T KOG0582|consen 117 TYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGT 193 (516)
T ss_pred HHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCc
Confidence 233456888899999999999999999999 999999999999999999999999998765433222111 346899
Q ss_pred cCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHH
Q 046703 484 YGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEV 561 (635)
Q Consensus 484 ~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 561 (635)
+.|||||.+.. ..|+.|+||||||+...|+.+|..||....+.+ +.-.--++.++...-..+..+......
T Consensus 194 p~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl~tLqn~pp~~~t~~~~~d~~k~~~ 266 (516)
T KOG0582|consen 194 PCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLLLTLQNDPPTLLTSGLDKDEDKKFS 266 (516)
T ss_pred ccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCCCCcccccCChHHhhhhc
Confidence 99999999543 468999999999999999999999997554332 111122444443332222222233344
Q ss_pred HHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 562 IRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 562 ~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+.+.+++..||++||.+|||++++++
T Consensus 267 ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 267 KSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 46778899999999999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=254.52 Aligned_cols=192 Identities=21% Similarity=0.321 Sum_probs=155.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|||+..+..-.+.+++++|||++... .....+++.++..+++++++||+|||.++ |||||||.+|||++
T Consensus 327 ~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~ 403 (550)
T KOG0578|consen 327 LHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLT 403 (550)
T ss_pred ccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEec
Confidence 479999988777666789999999998632 34556899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++..+..... +..+.+||+.|||||.+..+.|.+|+||||||++++||+-|++||-... .+
T Consensus 404 ~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------Pl 475 (550)
T KOG0578|consen 404 MDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PL 475 (550)
T ss_pred cCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hH
Confidence 999999999999988765544 3345899999999999999999999999999999999999999985421 12
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...+.....|. .++.. ...-...+.++..+||+.|+++||++.|+|+
T Consensus 476 rAlyLIa~ng~-P~lk~-------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 476 RALYLIATNGT-PKLKN-------PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHhhcCC-CCcCC-------ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 22222222333 33322 1222334667899999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=266.43 Aligned_cols=200 Identities=24% Similarity=0.321 Sum_probs=163.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-------------------hhhccccCcccchhhhhhhccccchhhcccc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-------------------QERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.+.|+|||.+.+++..++-+|+++||+..+ ......|+..+.+.||.|||.|+.||-++.
T Consensus 545 ~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~- 623 (774)
T KOG1026|consen 545 ELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH- 623 (774)
T ss_pred hccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-
Confidence 457999999999999999999999999731 011345888999999999999999999998
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
.|||||..+|+||.++..+||+||||++.....+.-.....-.-+++|||||.+..+++|.++|||||||+||||++
T Consensus 624 --FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsy 701 (774)
T KOG1026|consen 624 --FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSY 701 (774)
T ss_pred --ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcc
Confidence 99999999999999999999999999986543322211111234789999999999999999999999999999997
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
|+.|+..... +++++.+++|++.+-.+ .++.++..||+.||+.+|++||+++||-..|+....
T Consensus 702 G~QPy~glSn-------~EVIe~i~~g~lL~~Pe---------~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 702 GKQPYYGLSN-------QEVIECIRAGQLLSCPE---------NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ccCcccccch-------HHHHHHHHcCCcccCCC---------CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 8888754432 34666777777754433 455578999999999999999999999999987654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=243.51 Aligned_cols=197 Identities=23% Similarity=0.338 Sum_probs=147.4
Q ss_pred eeccccccccccCCCCc--cEEEEecccchhh-----hhcc-ccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQ--DLYIRMSASELDQ-----ERCK-LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~--~lyl~~~~~~~~~-----~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|||+.++...... .++|.|||...+. .+.+ .|++..+..+++||++||+|||+++ ||||||||+|
T Consensus 71 l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~N 147 (313)
T KOG0198|consen 71 LNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPAN 147 (313)
T ss_pred CCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccce
Confidence 34899999888643333 6899999987532 1122 6999999999999999999999999 9999999999
Q ss_pred eEecc-CCCCccCccccceecCC-CCCCCceeeeeeccCCCCcccccCCC-CcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 449 VLLDQ-DMNPKISDFGLARTFGG-DETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 449 Illd~-~~~~kl~Dfgla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
||++. ++.+||+|||+++.... ...........||+.|||||.+..+. ...++||||+||++.||++|++||...
T Consensus 148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-- 225 (313)
T KOG0198|consen 148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-- 225 (313)
T ss_pred EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--
Confidence 99999 79999999999987653 11112233478999999999998643 336999999999999999999998653
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.....+......+...+.+.+ .......+++..|++.||++|||++++++..-
T Consensus 226 ---~~~~~~~~~ig~~~~~P~ip~---------~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 226 ---FEEAEALLLIGREDSLPEIPD---------SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---cchHHHHHHHhccCCCCCCCc---------ccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 112222333333332232222 22334567899999999999999999998653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=247.12 Aligned_cols=141 Identities=27% Similarity=0.395 Sum_probs=126.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|||.+..+...+..+|++|||+.+. ..+++.+++.....++.|||.||++||+++ ||||||||+||||
T Consensus 66 l~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLL 142 (429)
T KOG0595|consen 66 LKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILL 142 (429)
T ss_pred cCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEe
Confidence 46999999999999999999999999852 245668999999999999999999999999 9999999999999
Q ss_pred ccC------CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 452 DQD------MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 452 d~~------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+.. -.+||+|||+|+.+... ....+..|++.|||||++...+|+.|+|+||+|+|||++++|+.||+..
T Consensus 143 s~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 143 STTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred ccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 865 45799999999988633 3344588999999999999999999999999999999999999999744
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-28 Score=257.01 Aligned_cols=201 Identities=24% Similarity=0.260 Sum_probs=162.4
Q ss_pred eeeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 375 CAMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
-++.|+|++.++.+......+|+++||.+.+ ..+++.|.++++.+++.||+.|+.|+|..+ |+|||+||+|+
T Consensus 67 kLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENl 143 (786)
T KOG0588|consen 67 KLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENL 143 (786)
T ss_pred HHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhh
Confidence 4678999999999999999999999999753 356788999999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc-ccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|||...++||+|||+|.+-..+. ...+-+|.++|.+||++.+.+|. .++||||+|||||-|++|+.||+.. +.
T Consensus 144 LLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Ni 217 (786)
T KOG0588|consen 144 LLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NI 217 (786)
T ss_pred hhhcccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cH
Confidence 99999999999999998744332 23446899999999999999986 9999999999999999999999732 22
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HHcCCCCCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL--MLGSEIVLPQP 598 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~p~p 598 (635)
..++.. .+.|... +. .....++.+|+.+|+..||++|.|++||++ .|.+-..+|.+
T Consensus 218 r~LLlK----V~~G~f~-MP---------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 218 RVLLLK----VQRGVFE-MP---------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HHHHHH----HHcCccc-CC---------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 223322 2333321 11 122234667899999999999999999998 45665555544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=250.59 Aligned_cols=165 Identities=30% Similarity=0.410 Sum_probs=126.7
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.+++.+++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 4677788889999999999999999 9999999999999999999999999998654332222222234567899999
Q ss_pred cccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
.+.+..++.++||||||+++|||++ |..||......+ ........+...... ......+.+++.
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~---------~~~~~~l~~li~ 311 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRAP---------ENATPEIYRIML 311 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCCC---------CCCCHHHHHHHH
Confidence 9999999999999999999999997 999986533211 112222233222111 122335778999
Q ss_pred HhcccCCCCCCChHHHHHHHcCCC
Q 046703 570 LCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
+||+.||++|||+.||+++|+...
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-28 Score=251.65 Aligned_cols=195 Identities=22% Similarity=0.270 Sum_probs=155.9
Q ss_pred eee-eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 375 CAM-WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 375 C~l-~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.+ .||.+++|+....+...+|.++++.+.+ ..+...+++.....++.+|+.||+|||+.| ||||||||+|
T Consensus 128 ~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPEN 204 (604)
T KOG0592|consen 128 TQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPEN 204 (604)
T ss_pred HHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhh
Confidence 455 6999999999999999999999998742 245678899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC---------Cce--eeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE---------GNT--TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~ 517 (635)
||+|+++.+||.|||-|+.+...... ... .+.+||..|.+||.+.+...+..+|+|+||||||.|+.|+
T Consensus 205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~ 284 (604)
T KOG0592|consen 205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQ 284 (604)
T ss_pred eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCC
Confidence 99999999999999999987532221 112 4589999999999999999999999999999999999999
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
+||...+.- ...+.+... + -++++.-++...+|+.+.|..||++|+|..+|-+..
T Consensus 285 PPFra~Ney---liFqkI~~l----------~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 285 PPFRAANEY---LIFQKIQAL----------D----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred CCCccccHH---HHHHHHHHh----------c----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 998643321 122222111 0 111122224466788899999999999999988743
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=249.91 Aligned_cols=197 Identities=25% Similarity=0.357 Sum_probs=158.3
Q ss_pred eeeeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 375 CAMWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
..+.|+|||...++|...-.+.|+|||+.... +....++-+....+..+||.|+.|||.+. |||||||.-||
T Consensus 167 RkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNi 243 (904)
T KOG4721|consen 167 RKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNI 243 (904)
T ss_pred HhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCce
Confidence 35689999999999998889999999997532 23456777778899999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
||..+..+||+|||-++...... ....+.||..|||||.+++.+.+.|+||||||||||||+||..||...+....
T Consensus 244 LIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI- 319 (904)
T KOG4721|consen 244 LISYDDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI- 319 (904)
T ss_pred EeeccceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-
Confidence 99999999999999998764332 23347899999999999999999999999999999999999999864332211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
+|.-|. ..+.-..+..+++-+.-|+.+||+..|..||++.+|+..|+-.
T Consensus 320 --------IwGVGs------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 320 --------IWGVGS------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred --------EEeccC------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 111111 1111223344555677788999999999999999999999654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=201.50 Aligned_cols=115 Identities=47% Similarity=0.724 Sum_probs=101.0
Q ss_pred CccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccCCceEEE
Q 046703 30 QTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWS 109 (635)
Q Consensus 30 ~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~vws 109 (635)
+.|..|++|+|+++.|++|||.+......+++|||.+.+ +++||+|||+.|. ...++|.|+.||+|+|+|.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 468889999999999999999987654489999998876 8899999999984 45688999999999999999999999
Q ss_pred eecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCC
Q 046703 110 AYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYP 151 (635)
Q Consensus 110 s~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~P 151 (635)
|++.+ ......|+|+|+|||||++.+ +.+||||||||
T Consensus 80 S~~~~-~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~P 116 (116)
T cd00028 80 SNTTR-VNGNYVLVLLDDGNLVLYDSD----GNFLWQSFDYP 116 (116)
T ss_pred ecccC-CCCceEEEEeCCCCEEEECCC----CCEEEcCCCCC
Confidence 99876 233448999999999999876 58999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=242.75 Aligned_cols=207 Identities=21% Similarity=0.251 Sum_probs=154.5
Q ss_pred eeeccccccccccCC--CCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPD--GGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~--~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|+||+.|+++-- ....+|+++|||+.+ ....-.++..++..++.|++.||.|+|..+ |+|||||.+|
T Consensus 172 ~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SN 248 (560)
T KOG0600|consen 172 RLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSN 248 (560)
T ss_pred hcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccc
Confidence 457999999988763 357999999999854 233557899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
||||.+|.+||+|||||+++........+ ..+-|..|+|||.+.+. .|+.++|+||.||||.||+.|++.|......+
T Consensus 249 iLidn~G~LKiaDFGLAr~y~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 249 ILIDNNGVLKIADFGLARFYTPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred eEEcCCCCEEeccccceeeccCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 99999999999999999988765544433 46779999999998875 79999999999999999999999987655444
Q ss_pred cccHHHHHH-----HHhhcCCCC--cCC------CCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAW-----KLWNKGMPS--EMI------DPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~-----~~~~~~~~~--~~~------d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+..+-... ..|+...++ ..+ .+++.+. -..-....++|+..+|..||++|.|+.++++
T Consensus 328 Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 328 QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 333332211 011111111 111 1111111 0011223567888889999999999988875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-27 Score=240.72 Aligned_cols=183 Identities=24% Similarity=0.247 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||-||++....++..++|+++++...+ ..+...+++..+.-++.+|+.||.|||+.+ ||||||||+|||+
T Consensus 82 v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILL 158 (357)
T KOG0598|consen 82 IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILL 158 (357)
T ss_pred CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeee
Confidence 68999999999999999999999998752 345667889988999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
|.+|.++|+||||++...... ..+.+..||+.|||||++.+..++..+|.||+|+++|||++|.+||...+...
T Consensus 159 d~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~---- 232 (357)
T KOG0598|consen 159 DEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK---- 232 (357)
T ss_pred cCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH----
Confidence 999999999999998654332 23445899999999999999999999999999999999999999996543221
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 580 (635)
..+.+..+.... .+..-.....+++...++.||++|-
T Consensus 233 ---~~~~I~~~k~~~---------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 233 ---MYDKILKGKLPL---------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---HHHHHhcCcCCC---------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 122222222111 1111223466788889999999995
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=247.21 Aligned_cols=186 Identities=23% Similarity=0.296 Sum_probs=150.5
Q ss_pred ccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
||||+.+.++......+|++|||..... ...+.+.+.++..+++|++.|++|||+.+ |+||||||+|||++.
T Consensus 79 HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 79 HPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDG 155 (370)
T ss_pred CCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecC
Confidence 9999999999988888999999987521 23678889999999999999999999999 999999999999999
Q ss_pred C-CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC-Cc-ccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 454 D-MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FS-VKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 454 ~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+ +++||+|||++.... .......+..|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....
T Consensus 156 ~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---- 229 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---- 229 (370)
T ss_pred CCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----
Confidence 9 999999999998874 1122334578999999999999987 86 8999999999999999999999752111
Q ss_pred HHHHHHHHhhcCCC--CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMP--SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~--~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+.. +..+. ...+..++.+|++.||.+|+|+.+|+.
T Consensus 230 ---~l~~ki~~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 230 ---NLYRKIRKGEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HHHHHHhcCCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11122222221 11111 345678999999999999999999993
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=241.03 Aligned_cols=202 Identities=21% Similarity=0.263 Sum_probs=146.9
Q ss_pred eccccccccccCCCCccEEEEecccchhh------------------------hhccccCcccchhhhhhhccccchhhc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------------------------ERCKLLDWSKRFRIICGTGRGLLYLHQ 433 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~ 433 (635)
.|+|++.+..+......+|+++++.+... .....+++.+++.++.||+.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 68999999888877788999999875311 011346778889999999999999999
Q ss_pred cccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhh
Q 046703 434 DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 513 (635)
Q Consensus 434 ~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~ei 513 (635)
.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||
T Consensus 157 ~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99 999999999999999999999999999865433221112223457789999999888999999999999999999
Q ss_pred hhC--CCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 514 VSG--KKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 514 ltG--~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
+++ ..||..... ...+..+...+......... ..++..+..+.+++.+||+.||++|||+.+|.+.|+.
T Consensus 234 ~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 234 LMLCKEQPYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHccCCCCCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 875 455543221 12222222222111111000 0111233467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=235.56 Aligned_cols=195 Identities=23% Similarity=0.302 Sum_probs=150.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh-------h--------------hccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-------E--------------RCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|++++.+..+.......|+++++.+... . ....+++.+++.++.|++.||.|||+.+
T Consensus 66 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~- 144 (283)
T cd05048 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH- 144 (283)
T ss_pred CCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 58899988888877788999998875311 0 0145778888999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++|+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++
T Consensus 145 --i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~ 222 (283)
T cd05048 145 --FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222 (283)
T ss_pred --eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999986543322222222456788999999988899999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
|..||...... .....+..+..... +...+..+.+|+.+||+.||++||+++||++.|++
T Consensus 223 g~~p~~~~~~~-------~~~~~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 223 GLQPYYGFSNQ-------EVIEMIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCCHH-------HHHHHHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 99998543221 12222333332221 12334567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=239.57 Aligned_cols=194 Identities=17% Similarity=0.242 Sum_probs=147.6
Q ss_pred eeeccccccccccCCC----CccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhcc-ccceEEeeccC
Q 046703 376 AMWFGDLIDMRSFPDG----GQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLK 445 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~----~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik 445 (635)
.+.|+|++.+..+... ...+|+++|+..... .+.+.+++..++.++.|++.||.|||+. + ++|||||
T Consensus 74 ~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlk 150 (283)
T PHA02988 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLT 150 (283)
T ss_pred hcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCC
Confidence 3478999998876533 457899999987421 2345788999999999999999999985 6 8899999
Q ss_pred CcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 446 ~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
|+||+++.++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 151 p~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 151 SVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred hhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999987653221 12457889999999976 68999999999999999999999998643
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.. ...... ....+.... .+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 226 ~~---~~~~~~---i~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 226 TT---KEIYDL---IINKNNSLK---------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CH---HHHHHH---HHhcCCCCC---------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 21 111111 111111111 1112334577899999999999999999999999765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=265.01 Aligned_cols=199 Identities=25% Similarity=0.312 Sum_probs=158.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------h------hccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------E------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
-+.|+||+.+.+++-.....+|.+|||+... + +...|+.++.+.++.|||+|..||+++. .||||
T Consensus 751 ~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRD 827 (1025)
T KOG1095|consen 751 KFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRD 827 (1025)
T ss_pred cCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcc
Confidence 3569999999999988899999999998421 1 2456888899999999999999999998 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGF 522 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~ 522 (635)
|.++|+||++...+||+|||+|+-+.+.+.-.......-+..|||||.++++.++.|+|||||||+||||++ |..||..
T Consensus 828 LAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 828 LAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred hhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999995433332222222234579999999999999999999999999999998 7788765
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.+..+. .. .....|+ -..+..++..+.+||..||+.+|++||++..|++.+..+.
T Consensus 908 ~~n~~v---~~---~~~~ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 908 RSNFEV---LL---DVLEGGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred cchHHH---HH---HHHhCCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 432221 11 1122331 1234556678889999999999999999999999887764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-26 Score=227.60 Aligned_cols=218 Identities=26% Similarity=0.312 Sum_probs=161.6
Q ss_pred eccccccccccCCCC--ccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGG--QDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~--~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|||.++++-.|. .++|++|+|++.+. .-.+++...++.-++.|+++|++|||... |+|||||++|+|
T Consensus 133 ~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLL 209 (419)
T KOG0663|consen 133 RHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLL 209 (419)
T ss_pred CCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhhee
Confidence 699999999987543 58999999998643 22457888889999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+...|.+||+|||+|+.++... ...+..+-|..|+|||.+.+. .|+...|+||+|||+.|++.+++.|......++.
T Consensus 210 m~~~G~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 210 LSHKGILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred eccCCcEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 9999999999999999886442 223346779999999998775 5899999999999999999999998765544433
Q ss_pred cHHHHHHHHhhcCCCCcCCCC-------------------ccccCCCHH-HHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDP-------------------CYQESCNLT-EVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~-------------------~l~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
..+ ...+ |.+.+.+-+ .++..+... -.+.-.+++...+..||.+|.|++|.++.
T Consensus 288 ~~I---f~ll--GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h- 361 (419)
T KOG0663|consen 288 DKI---FKLL--GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH- 361 (419)
T ss_pred HHH---HHHh--CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-
Confidence 332 2221 111111111 111111111 12344567778899999999999987653
Q ss_pred cCCCCCCCCCCCCcccc
Q 046703 590 GSEIVLPQPKQPGFLAD 606 (635)
Q Consensus 590 ~~~~~~p~p~~p~~~~~ 606 (635)
+=..+.|.|..|.++-.
T Consensus 362 ~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 362 EYFRETPLPIDPSMFPT 378 (419)
T ss_pred cccccCCCCCChhhcCC
Confidence 22357888888877643
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=249.74 Aligned_cols=164 Identities=30% Similarity=0.415 Sum_probs=124.3
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.+++.+++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++................++..|+|||
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 284 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence 4677788999999999999999999 9999999999999999999999999997654332211111233456899999
Q ss_pred cccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
.+.+..++.++|||||||++|||++ |+.||....... ........+...... ......+.+++.
T Consensus 285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~~~~---------~~~~~~l~~li~ 349 (374)
T cd05106 285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQMSRP---------DFAPPEIYSIMK 349 (374)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCccCC---------CCCCHHHHHHHH
Confidence 9998999999999999999999997 999986533211 111122222111110 011245778999
Q ss_pred HhcccCCCCCCChHHHHHHHcCC
Q 046703 570 LCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
+||+.||++|||+.+|+++|+.+
T Consensus 350 ~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 350 MCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=235.79 Aligned_cols=207 Identities=20% Similarity=0.211 Sum_probs=149.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+.........+|+++++.+... .....+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill 133 (287)
T cd07848 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLI 133 (287)
T ss_pred CCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 468999999988888889999999986421 22346888889999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+....
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 134 SHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred cCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999876432211 12235688999999999988999999999999999999999999865432221111
Q ss_pred HHHHH--------HHhh-cCCCCcCCCCcccc------CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAW--------KLWN-KGMPSEMIDPCYQE------SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~--------~~~~-~~~~~~~~d~~l~~------~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+.... ..+. .........+.... .........+.+++.+||+.||++|||++|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 0000 00000000000000 001112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-26 Score=244.33 Aligned_cols=164 Identities=28% Similarity=0.393 Sum_probs=124.8
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.++++.++.++.||++||.|||+.+ |+||||||+||+++.+..+||+|||+++...............++..|+|||
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 286 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE 286 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence 4778888999999999999999998 9999999999999999999999999998764332211112233466799999
Q ss_pred cccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
.+.+..++.++||||||+++|||++ |..||...... ....+.+..+...... ......+.+|+.
T Consensus 287 ~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~~---------~~~~~~l~~li~ 351 (375)
T cd05104 287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRMLSP---------ECAPSEMYDIMK 351 (375)
T ss_pred HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCCCC---------CCCCHHHHHHHH
Confidence 9999999999999999999999998 88887543211 1122222233211110 011235778999
Q ss_pred HhcccCCCCCCChHHHHHHHcCC
Q 046703 570 LCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
+||+.||++||++.||+++|+..
T Consensus 352 ~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-26 Score=236.85 Aligned_cols=201 Identities=21% Similarity=0.210 Sum_probs=143.9
Q ss_pred eccccccccccC-----CCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFP-----DGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~-----~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+|++.+..++ .....+|+++++.... ......+++.++..++.||+.||.|||+.+ |+||||||
T Consensus 62 ~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp 138 (290)
T cd07862 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKP 138 (290)
T ss_pred CCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCH
Confidence 689999887754 2345789999987531 112345788899999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 139 ~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~ 215 (290)
T cd07862 139 QNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215 (290)
T ss_pred HHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH
Confidence 99999999999999999998754331 222356899999999998889999999999999999999999998654322
Q ss_pred CcccHHHHHHHHhhc---CCC-------CcCCCCccc---cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNK---GMP-------SEMIDPCYQ---ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~---~~~-------~~~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+ .+......... ... ......... ....+.....+.+++.+||+.||++|||+.|+++
T Consensus 216 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 216 D---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred H---HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1 11111111100 000 000000000 0000112234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=229.59 Aligned_cols=214 Identities=24% Similarity=0.275 Sum_probs=154.6
Q ss_pred eeeccccccccccCC-----CCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPD-----GGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~-----~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+|++.+..+.. .-.++|++++.++-+. +..+.|+.....-++.||++||.|+|+.+ |+|||+||
T Consensus 77 ~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKP 153 (359)
T KOG0660|consen 77 HLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKP 153 (359)
T ss_pred HhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccch
Confidence 346999987766542 3579999999987543 22344888888899999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-CCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+|++++.+..+||+|||+|+...........+..+.|..|+|||++. ...|+.+.||||.|||+.||++|++-|.+.+.
T Consensus 154 sNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 154 SNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred hheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 99999999999999999999875432223334477899999999875 45799999999999999999999999988765
Q ss_pred CCcccHHHHHHH--------HhhcCC-------CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH--H
Q 046703 526 DNKLNLIGHAWK--------LWNKGM-------PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL--M 588 (635)
Q Consensus 526 ~~~~~~~~~~~~--------~~~~~~-------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~ 588 (635)
.+...++..... .+.... .......-+...++ ......++|+.++|..||.+|+|++|+++ .
T Consensus 234 v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 234 VHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 554444432111 111000 00000000010111 11123578889999999999999999987 4
Q ss_pred HcCCC
Q 046703 589 LGSEI 593 (635)
Q Consensus 589 L~~~~ 593 (635)
|+...
T Consensus 313 l~~~h 317 (359)
T KOG0660|consen 313 LAPYH 317 (359)
T ss_pred hhhhc
Confidence 45443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-26 Score=234.09 Aligned_cols=198 Identities=22% Similarity=0.297 Sum_probs=152.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+..+...+..+|+++++..... .....+++..++.++.||+.||+|||+.+
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 143 (291)
T cd05094 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH- 143 (291)
T ss_pred CCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 68889988888888888999999875211 11245788999999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
|+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++
T Consensus 144 --i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 221 (291)
T cd05094 144 --FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221 (291)
T ss_pred --eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999976533221111122345778999999998999999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
|+.||...... .....+..+...+..+ ..+..+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 222 g~~p~~~~~~~-------~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 222 GKQPWFQLSNT-------EVIECITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCCCCCHH-------HHHHHHhCCCCCCCCc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 99997543221 1222233333332211 123457789999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=230.13 Aligned_cols=198 Identities=21% Similarity=0.283 Sum_probs=148.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+..+ ..+|+++++.... ..+...+++..++.++.||+.||.|||+.+ ++|+||||+||+
T Consensus 66 l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nil 141 (279)
T cd05111 66 LDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNIL 141 (279)
T ss_pred CCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEE
Confidence 368999998887754 3567777776521 123456889999999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||......
T Consensus 142 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--- 218 (279)
T cd05111 142 LKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--- 218 (279)
T ss_pred EcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999987643322222223456778999999998899999999999999999998 99898543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
.....+..+....... .....+.+++.+||+.||++|||+.|+++.|+....
T Consensus 219 ----~~~~~~~~~~~~~~~~---------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 219 ----EVPDLLEKGERLAQPQ---------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ----HHHHHHHCCCcCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1122223333222111 112346678899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=235.94 Aligned_cols=194 Identities=23% Similarity=0.314 Sum_probs=148.5
Q ss_pred eccccccccccCC--CCccEEEEecccchhhh----hccc-cCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPD--GGQDLYIRMSASELDQE----RCKL-LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~--~~~~lyl~~~~~~~~~~----~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|+|++.++-+ ....+||+++|+..... ..+. |++.++.++++++..||.|||.++ ||||||||+|+|
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLL 242 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLL 242 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheE
Confidence 7999999988864 45799999999985432 2334 899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCC---CCCCceeeeeeccCCCCcccccCCC----CcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGD---ETEGNTTRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
|++++.+||+|||.+..+... ..........||+.|+|||...++. .+.+.||||+||.||-++.|+.||-..
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999999999999999876322 1112223368999999999887632 348899999999999999999998432
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
. .......+ +...+.-...+++-+.+.+|+.++|++||++|.+..+|....
T Consensus 323 ~-------~~~l~~KI--------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 323 F-------ELELFDKI--------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred h-------HHHHHHHH--------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 11112211 112222222234455677899999999999999999998765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=227.15 Aligned_cols=196 Identities=24% Similarity=0.354 Sum_probs=149.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|++++.+..+......+|+++++.... ......+++..++.++.|+++||+|||+.+ ++|+||||+||
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~ni 135 (263)
T cd05052 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNC 135 (263)
T ss_pred CCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceE
Confidence 36889999888887788899999987531 122345788889999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++.......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 136 l~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-- 212 (263)
T cd05052 136 LVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-- 212 (263)
T ss_pred EEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 99999999999999998764322111 111223567999999999999999999999999999998 88887543211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
..+.....+...+. +...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 213 -----~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 213 -----QVYELLEKGYRMER---------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----HHHHHHHCCCCCCC---------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12222222211111 111234577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-26 Score=233.49 Aligned_cols=197 Identities=27% Similarity=0.348 Sum_probs=150.0
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+..+...+..+|+++++..... .....+++..++.++.|++.||+|||+.+
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 152 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK- 152 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 58899988888877788999998864210 12356888899999999999999999998
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
|+|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++
T Consensus 153 --ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 153 --CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred --ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcC
Confidence 99999999999999999999999999987643322111222334678999999988899999999999999999997
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|..||...... ........+...+ .+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 231 g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 231 GGSPYPGIPVE-------ELFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCCHH-------HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 88887533211 1222222222111 11223346778999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-26 Score=238.47 Aligned_cols=188 Identities=20% Similarity=0.229 Sum_probs=146.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+......+..+|+++++.+.. ..+.+.+++.++..++.||+.||+|||+.+ |+||||||+||+++
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~ 129 (323)
T cd05571 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLD 129 (323)
T ss_pred CCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEEC
Confidence 6899999888888888999999988642 123457889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 130 ~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------ 201 (323)
T cd05571 130 KDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------ 201 (323)
T ss_pred CCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------
Confidence 99999999999987532211 1223367899999999999999999999999999999999999998542211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
........+.. . + +......+.+++.+||+.||++|| ++.++++
T Consensus 202 -~~~~~~~~~~~-~-----~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 202 -KLFELILMEEI-R-----F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -HHHHHHHcCCC-C-----C----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11111111111 1 1 111233567899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=237.97 Aligned_cols=166 Identities=30% Similarity=0.423 Sum_probs=128.6
Q ss_pred cccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCc
Q 046703 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAP 489 (635)
Q Consensus 410 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 489 (635)
..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 36788999999999999999999998 999999999999999999999999999876433222222234556789999
Q ss_pred ccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHH
Q 046703 490 EYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHIS 568 (635)
Q Consensus 490 E~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 568 (635)
|.+.+..++.++|||||||++|||++ |..||......+ .....+..+..... +......+.+++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~l~ 309 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMRA---------PEYATPEIYSIM 309 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCCC---------CccCCHHHHHHH
Confidence 99999999999999999999999998 999986432211 11122222222211 112234577899
Q ss_pred HHhcccCCCCCCChHHHHHHHcCCC
Q 046703 569 LLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 569 ~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.+||+.+|++||++.||+++|+...
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=191.42 Aligned_cols=113 Identities=47% Similarity=0.732 Sum_probs=98.9
Q ss_pred CccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccCCceEEE
Q 046703 30 QTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWS 109 (635)
Q Consensus 30 ~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~vws 109 (635)
+.|..|+.|+|+++.|++|||.+... ..+++|||.+.+ +++||+|||+.|+.+ ++.|.|+.||+|+|+|.+|.+||+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEE
Confidence 56888999999999999999998654 578999999877 889999999999865 488999999999999999999999
Q ss_pred eecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccC
Q 046703 110 AYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDY 150 (635)
Q Consensus 110 s~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 150 (635)
|++... .+...++|+|+|||||++.. ++++||||||
T Consensus 79 S~t~~~-~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGA-NGNYVLVLLDDGNLVIYDSD----GNFLWQSFDY 114 (114)
T ss_pred ecccCC-CCceEEEEeCCCCEEEECCC----CCEEeCCCCC
Confidence 998722 23348999999999999876 4799999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-26 Score=239.55 Aligned_cols=201 Identities=25% Similarity=0.317 Sum_probs=146.4
Q ss_pred eccccccccccCCCCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+|.||+-..+++..... -|+...++. -.....+++..+.++|++||++|+.|||.++ |||||||..||++
T Consensus 446 RH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 446 RHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFL 521 (678)
T ss_pred chhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEE
Confidence 57777766666543322 333333332 1223467888889999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
.+++.+||+||||+.....-..........|.+-|||||+++ ..+|++.+||||||+|+|||++|..||.....+..
T Consensus 522 ~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI 601 (678)
T KOG0193|consen 522 HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI 601 (678)
T ss_pred ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe
Confidence 999999999999997543222222233456888999999985 45899999999999999999999999873322221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
++.-|+-.-..|.... .....+.|.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 602 ---------ifmVGrG~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 602 ---------IFMVGRGYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ---------EEEecccccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2233333222332221 22345567789999999999999999999998877753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-26 Score=230.13 Aligned_cols=195 Identities=26% Similarity=0.360 Sum_probs=148.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+......+...|+++++.... ......+++.+++.++.|+++||+|||+.+ ++|+||||+||
T Consensus 58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~ni 134 (261)
T cd05072 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANV 134 (261)
T ss_pred CCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhE
Confidence 36899999888887888899999987531 122456788888999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++.......... .....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-- 211 (261)
T cd05072 135 LVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-- 211 (261)
T ss_pred EecCCCcEEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--
Confidence 99999999999999998764332211 112345678999999988889999999999999999998 89998542211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
. ....+..+..... .......+.+++.+|++.+|++||++++++++|+.
T Consensus 212 -~----~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 212 -D----VMSALQRGYRMPR---------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -H----HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 1111222211111 11123457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=233.08 Aligned_cols=194 Identities=27% Similarity=0.437 Sum_probs=142.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+++.+++.....++++++++... ......+++.+++.++.||++||.|||+.+ ++|++|+++||
T Consensus 58 l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~ni 134 (259)
T PF07714_consen 58 LRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNI 134 (259)
T ss_dssp HSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccc
Confidence 47999999999988777899999988632 112357899999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++....................|+|||.+....++.++||||||+++|||++ |+.|+.... .
T Consensus 135 ll~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~ 211 (259)
T PF07714_consen 135 LLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---N 211 (259)
T ss_dssp EEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c
Confidence 999999999999999987632222111122456789999999999999999999999999999999 678864331 1
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
.. ....+.++......+ .....+.+++..||+.||++|||+.+|++.|
T Consensus 212 ~~----~~~~~~~~~~~~~~~---------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 212 EE----IIEKLKQGQRLPIPD---------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HH----HHHHHHTTEETTSBT---------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc----ccccccccccceecc---------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 122222333222211 1234577899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=242.40 Aligned_cols=208 Identities=18% Similarity=0.208 Sum_probs=152.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+||+.+.........+|+++++.... ......+++.+++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 143 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~ 219 (392)
T PHA03207 143 ISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLD 219 (392)
T ss_pred cCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEc
Confidence 46999999888877778899999876532 133567899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++................||..|+|||.+....++.++|||||||++|||++|+.||...........+
T Consensus 220 ~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l 299 (392)
T PHA03207 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299 (392)
T ss_pred CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHH
Confidence 99999999999997665433322233457899999999999999999999999999999999999998654433222222
Q ss_pred HHHHHHhhcCCCCcCCC--------------CccccCCC-------HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMID--------------PCYQESCN-------LTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d--------------~~l~~~~~-------~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
..+........ .+... ...+.... ......+.+++.+||+.||++|||+.|++..
T Consensus 300 ~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 300 RSIIRCMQVHP-LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhccCc-cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22222211100 00000 00000000 0112346678899999999999999999875
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=230.40 Aligned_cols=198 Identities=21% Similarity=0.291 Sum_probs=150.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------------------hhccccCcccchhhhhhhccccchhhccccce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLR 438 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 438 (635)
+.|++++.+..+...+..+|+++++..... .+...+++.+++.++.|++.||+|||+.+
T Consensus 64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--- 140 (288)
T cd05093 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--- 140 (288)
T ss_pred CCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 358899988888888888999999875311 11234889999999999999999999999
Q ss_pred EEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CC
Q 046703 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GK 517 (635)
Q Consensus 439 iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~ 517 (635)
++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||++++||++ |.
T Consensus 141 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~ 220 (288)
T cd05093 141 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220 (288)
T ss_pred eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999976543222111122334678999999998899999999999999999998 88
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.||...... .....+..+......+ . ....+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 221 ~p~~~~~~~-------~~~~~i~~~~~~~~~~-----~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 221 QPWYQLSNN-------EVIECITQGRVLQRPR-----T----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCCCCCCHH-------HHHHHHHcCCcCCCCC-----C----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 887533211 1222223333222111 1 1234788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-26 Score=248.63 Aligned_cols=200 Identities=23% Similarity=0.336 Sum_probs=164.8
Q ss_pred eeeeccccccccccCCCCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 375 CAMWFGDLIDMRSFPDGGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
-.+-||||+.|+++--...-+.|+.|||+. .+.+...+++-+...++++||.|+.||-+.+ +|||||.++|
T Consensus 685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARN 761 (996)
T KOG0196|consen 685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARN 761 (996)
T ss_pred ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhh
Confidence 467899999999999888899999999984 2344566899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeee--ccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVG--TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHL 525 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~ 525 (635)
||++.+...|++|||+++.+.++.... ..+..| +++|.|||.+...++|.++|||||||++||.++ |.+|+.....
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred eeeccceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 999999999999999999876654322 222323 579999999999999999999999999999987 9999753322
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
.+ +++.+ +..++-..+.+++..+.+||+.|||+|-++||.+.+|+.+|.+.+.
T Consensus 841 Qd-------VIkaI---------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 841 QD-------VIKAI---------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HH-------HHHHH---------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 21 22222 2233445567788889999999999999999999999999988754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-26 Score=236.40 Aligned_cols=191 Identities=19% Similarity=0.203 Sum_probs=145.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.........+|+++++.+... .+...+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 50 l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili 126 (312)
T cd05585 50 VNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILL 126 (312)
T ss_pred CCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEE
Confidence 468999998888888889999999886421 23456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 127 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----- 199 (312)
T cd05585 127 DYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----- 199 (312)
T ss_pred CCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----
Confidence 9999999999999875432221 223356899999999999999999999999999999999999998642211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
........+.. .+ +......+.+++..||+.||++||++.++.+.|
T Consensus 200 --~~~~~~~~~~~-~~---------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 200 --EMYRKILQEPL-RF---------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred --HHHHHHHcCCC-CC---------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 11111111111 11 111223467889999999999998654444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-26 Score=233.17 Aligned_cols=212 Identities=24% Similarity=0.301 Sum_probs=148.1
Q ss_pred eeccccccccccCC--CCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPD--GGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~--~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+.. ....+|+++++..... .....+++.+++.++.|+++||.|||+.+ ++|+||||+||+
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nil 139 (283)
T cd05080 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVL 139 (283)
T ss_pred CCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEE
Confidence 35888888777543 3446889999876421 22346899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCc-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..
T Consensus 140 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~ 218 (283)
T cd05080 140 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FE 218 (283)
T ss_pred EcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hh
Confidence 99999999999999987643221111 11123456799999998889999999999999999999999997543211 00
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
................+.++.......+......+.+++..||+.+|++|||+++|+++|+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 000000000000011111111111111223345678899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-26 Score=236.66 Aligned_cols=191 Identities=28% Similarity=0.385 Sum_probs=146.7
Q ss_pred ccccccccccCCCCccEEEEecccchhhh------hccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELDQE------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
|.+||+++.|.-+++.+|++||+.+.+.. ......| .+..+-.|++.|+.++|.++ |||.||||.|+|+-
T Consensus 419 ~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV 494 (677)
T KOG0596|consen 419 HDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV 494 (677)
T ss_pred CceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE
Confidence 56799999999999999999999885432 1222334 56678889999999999999 99999999999886
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-----------CCcccCceeeeehhhHhhhhCCCCCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-----------QFSVKSDVFSFGILLLEIVSGKKNRG 521 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwS~Gvvl~eiltG~~pf~ 521 (635)
.|.+||+|||+|..+..+.+.......+||+.||+||.+... ++++++||||+|||||+|+.|+.||.
T Consensus 495 -kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 495 -KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred -eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 679999999999988877766666778999999999988432 36799999999999999999999985
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCH-HHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNL-TEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.. .+.... +..+.|+.-+-+++. .+-..++++|..||+.||++|||+.|+++.
T Consensus 574 ~~-----~n~~aK---------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 574 QI-----INQIAK---------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HH-----HHHHHH---------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 32 111111 222333322211111 111128899999999999999999999874
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=226.64 Aligned_cols=195 Identities=23% Similarity=0.297 Sum_probs=148.6
Q ss_pred eccccccccccCCCCccEEEEecccchh-------------------hhhccccCcccchhhhhhhccccchhhccccce
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------------------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLR 438 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 438 (635)
.|+|++.+..+...+..+|+++++.+.. ......+++.++..++.|++.||+|||+.+
T Consensus 66 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--- 142 (280)
T cd05049 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--- 142 (280)
T ss_pred CCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---
Confidence 5888888888888788899999987531 112345788888999999999999999999
Q ss_pred EEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CC
Q 046703 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GK 517 (635)
Q Consensus 439 iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~ 517 (635)
++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |.
T Consensus 143 i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~ 222 (280)
T cd05049 143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222 (280)
T ss_pred eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999976533221111122345678999999999999999999999999999998 99
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.||...... ........+...... ......+.+++.+||+.||++||++.||+++|+.
T Consensus 223 ~p~~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 223 QPWYGLSNE-------EVIECITQGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCCCCCCHH-------HHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 997543211 112222233322211 1123457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=247.20 Aligned_cols=192 Identities=17% Similarity=0.159 Sum_probs=149.0
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+......+..+|+++++.+... .....+++.++..++.||+.||.|||+.+ |+||||||+
T Consensus 122 l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~ 198 (478)
T PTZ00267 122 CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSA 198 (478)
T ss_pred CCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHH
Confidence 369999999998888889999999986421 12345788888899999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|||++.++.+||+|||+++...............||..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 199 NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-- 276 (478)
T PTZ00267 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-- 276 (478)
T ss_pred hEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 999999999999999999876543322223345689999999999999999999999999999999999999854221
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ........+..... +......+.+++.+||+.||++||++++++.
T Consensus 277 -~----~~~~~~~~~~~~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 -R----EIMQQVLYGKYDPF---------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -H----HHHHHHHhCCCCCC---------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 11111112222111 1112235778999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=216.71 Aligned_cols=205 Identities=22% Similarity=0.225 Sum_probs=155.8
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+......+-|++|+++.+ ..+...|+..++..++.++++||+|||++. |+||||||.|+|++
T Consensus 59 ~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis 135 (318)
T KOG0659|consen 59 KHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLIS 135 (318)
T ss_pred cCcchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEc
Confidence 5999999999999999999999999843 345667888889999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||+++.+........ ..+-|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|+....-++...
T Consensus 136 ~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~ 213 (318)
T KOG0659|consen 136 SDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK 213 (318)
T ss_pred CCCcEEeecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence 999999999999999875443322 23678999999998764 689999999999999999999887765543333333
Q ss_pred HHHHHHHhhcCCCC---cCCC---------CccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 532 IGHAWKLWNKGMPS---EMID---------PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~~~---~~~d---------~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
+-.+...-.+...+ ++.| +.+. ..-+......++++..++..||.+|+|+.|++++
T Consensus 214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHcCCCCcccCccccccccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 32221111111111 1111 1111 1222344456899999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=229.98 Aligned_cols=196 Identities=21% Similarity=0.254 Sum_probs=149.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+...+..+|+++++.+.. ......+++.+++.++.||+.||+|||+.+ ++||||||+||+
T Consensus 63 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nil 139 (266)
T cd05064 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVL 139 (266)
T ss_pred CCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEE
Confidence 46999999998888888999999988632 122346899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+|++|||.+......... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......
T Consensus 140 i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--- 215 (266)
T cd05064 140 VNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--- 215 (266)
T ss_pred EcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---
Confidence 999999999999987653222111 1111234578999999999999999999999999999775 99998543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. ......++.... .+...+..+.+++..||+.+|++||++++|.+.|+..
T Consensus 216 ~----~~~~~~~~~~~~---------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 D----VIKAVEDGFRLP---------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H----HHHHHHCCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 112222222111 1122334577899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-25 Score=233.37 Aligned_cols=206 Identities=20% Similarity=0.253 Sum_probs=144.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|+++++..... .....+++..+..++.||+.||+|||+++ |+||||||+||++
T Consensus 60 l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~ 136 (288)
T cd07871 60 LKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLI 136 (288)
T ss_pred CCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 468999999888877888999999876321 12335678888999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+...
T Consensus 137 ~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~ 214 (288)
T cd07871 137 NEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214 (288)
T ss_pred CCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999976532221 1122467889999998865 568999999999999999999999986543222111
Q ss_pred HHHHHHH-----HhhcCC----CCcCCCCccccC----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWK-----LWNKGM----PSEMIDPCYQES----CNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~-----~~~~~~----~~~~~d~~l~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+..... .++.-. ......+..... ........+++++.+|++.||.+|||++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111000 000000 000000000000 00011234678999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=241.04 Aligned_cols=206 Identities=18% Similarity=0.174 Sum_probs=145.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.+.|+||+.+..+.......|+++++.... ......+++.+++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 139 ~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll 215 (391)
T PHA03212 139 AINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFI 215 (391)
T ss_pred hCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEE
Confidence 346999999988877777888988876532 123456888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC----
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN---- 527 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~---- 527 (635)
+.++.+||+|||++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.|+-......
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 216 NHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred cCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 999999999999997543211 112223578999999999999999999999999999999999998763221111
Q ss_pred cccHHHHHHHHhhcCCCC-cC--------------------CCCcccc--CCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 528 KLNLIGHAWKLWNKGMPS-EM--------------------IDPCYQE--SCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~-~~--------------------~d~~l~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
....+....... |... +. ..+.... .........+.+++.+||+.||++|||++|
T Consensus 295 ~~~~l~~i~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 295 SDRQIKLIIRRS--GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372 (391)
T ss_pred hhHHHHHHHHHh--cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence 001111111110 0000 00 0000000 000122346778999999999999999999
Q ss_pred HHH
Q 046703 585 VIL 587 (635)
Q Consensus 585 vl~ 587 (635)
+++
T Consensus 373 lL~ 375 (391)
T PHA03212 373 LLD 375 (391)
T ss_pred Hhc
Confidence 985
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-25 Score=224.29 Aligned_cols=196 Identities=19% Similarity=0.270 Sum_probs=144.8
Q ss_pred eccccccccccCCCC------ccEEEEecccchhh-----------hhccccCcccchhhhhhhccccchhhccccceEE
Q 046703 378 WFGDLIDMRSFPDGG------QDLYIRMSASELDQ-----------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~------~~lyl~~~~~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
.|+|++.+..+.... ...++++++..... .....+++..+..++.|++.||+|||+.+ ++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~ 135 (273)
T cd05035 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FI 135 (273)
T ss_pred CCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 477887776654322 24788888765311 12246788889999999999999999998 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCC
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKN 519 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~p 519 (635)
|+||||+||++++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..|
T Consensus 136 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p 215 (273)
T cd05035 136 HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215 (273)
T ss_pred ccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654332222222334678999999988899999999999999999999 8888
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|...... .. .+....+...... ......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 216 ~~~~~~~---~~----~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 216 YPGVENH---EI----YDYLRHGNRLKQP---------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCHH---HH----HHHHHcCCCCCCC---------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7543211 11 1222222222211 12234678899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=228.48 Aligned_cols=196 Identities=21% Similarity=0.283 Sum_probs=146.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhccc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDS 435 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 435 (635)
+.|+|++.+..+......+++++++..... .....+++..+..++.|++.||.|||+.+
T Consensus 65 l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g 144 (283)
T cd05091 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH 144 (283)
T ss_pred CCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence 458899988888777777888888764210 11234777788899999999999999999
Q ss_pred cceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 436 ~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
++||||||+||+++.++.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++
T Consensus 145 ---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 221 (283)
T cd05091 145 ---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221 (283)
T ss_pred ---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 99999999999999999999999999876543222111222345678999999988889999999999999999998
Q ss_pred -CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 516 -GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 516 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
|..||..... .........+...... ...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 222 ~g~~p~~~~~~-------~~~~~~i~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 222 YGLQPYCGYSN-------QDVIEMIRNRQVLPCP---------DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCCCCCCH-------HHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 7777653221 1122222233222111 1223447789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=229.34 Aligned_cols=191 Identities=22% Similarity=0.242 Sum_probs=144.7
Q ss_pred eccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+......+..+|+++++++... .....+++.++..++.|++.||+|||+.+ |+||||||+||+
T Consensus 58 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil 134 (285)
T cd05631 58 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENIL 134 (285)
T ss_pred CCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEE
Confidence 57888888877777788999999876321 12335888899999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||++........ .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~- 210 (285)
T cd05631 135 LDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR- 210 (285)
T ss_pred ECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-
Confidence 99999999999999987543221 12346899999999999999999999999999999999999998754322211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
............ . .+......+.+|+.+||+.||++||+ ++++++
T Consensus 211 --~~~~~~~~~~~~-~---------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 211 --EEVDRRVKEDQE-E---------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --HHHHHHhhcccc-c---------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111111111110 0 11112235678999999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=228.80 Aligned_cols=196 Identities=22% Similarity=0.334 Sum_probs=146.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------h-h--------ccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------E-R--------CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~-~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
+.|+|++.+..+...+...|+++++..... . + ...+++..++.++.|+++||.|||+.+ ++|
T Consensus 66 l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH 142 (277)
T cd05062 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVH 142 (277)
T ss_pred CCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 358899998888887888999999876311 0 0 123567788899999999999999998 999
Q ss_pred eccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCC
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNR 520 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf 520 (635)
+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 143 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 143 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred CCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999876543222111112344678999999998899999999999999999998 67887
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
...... ........+......+ .....+.+++.+||+.+|++|||+.|++++|+.
T Consensus 223 ~~~~~~-------~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 223 QGMSNE-------QVLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCHH-------HHHHHHHcCCcCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 543211 1122222222222111 123357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=231.06 Aligned_cols=202 Identities=25% Similarity=0.326 Sum_probs=152.3
Q ss_pred eccccccccccCCCCccEEEEecccchhh------h---------------hccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------E---------------RCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+.........+|+++++..... . ....+++.+++.++.||++||.|||+.+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g- 157 (304)
T cd05101 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK- 157 (304)
T ss_pred cCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 58899998888877888999999875311 0 1235677888899999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++
T Consensus 158 --ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 158 --CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred --eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987643322222222345678999999988889999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVL 595 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 595 (635)
|..||.... ..........+..... +......+.+++.+||+.+|++|||+.||++.|+.+..+
T Consensus 236 g~~p~~~~~-------~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 236 GGSPYPGIP-------VEELFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCCCcccCC-------HHHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 777764321 1122222233322211 112234577899999999999999999999999887655
Q ss_pred CCC
Q 046703 596 PQP 598 (635)
Q Consensus 596 p~p 598 (635)
..+
T Consensus 300 ~~~ 302 (304)
T cd05101 300 TTN 302 (304)
T ss_pred hhc
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-25 Score=227.71 Aligned_cols=195 Identities=23% Similarity=0.340 Sum_probs=149.1
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------hhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
.|+|++.+..+...+...|+++++..... .....+++..++.++.||+.||.|||+.+ ++|+
T Consensus 67 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 143 (277)
T cd05032 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHR 143 (277)
T ss_pred CCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 58899999888888888999999875211 01224678888999999999999999998 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRG 521 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~ 521 (635)
||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||.
T Consensus 144 di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred ccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 9999999999999999999999876543322222222445778999999988889999999999999999998 888875
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
..... ...+....+......+. ....+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 224 ~~~~~-------~~~~~~~~~~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 224 GLSNE-------EVLKFVIDGGHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCHH-------HHHHHHhcCCCCCCCCC---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 43211 11222223222222211 23467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=224.41 Aligned_cols=194 Identities=24% Similarity=0.366 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+......+|+++++.+.. ......+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 56 l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~ 132 (256)
T cd05114 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCL 132 (256)
T ss_pred CCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEE
Confidence 36899999988888888899999988631 112345788999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... .....++..|+|||.+....++.++||||||+++|||++ |+.||..... .
T Consensus 133 i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~ 208 (256)
T cd05114 133 VSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---Y 208 (256)
T ss_pred EcCCCeEEECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---H
Confidence 9999999999999987653322111 111234568999999988889999999999999999999 8888754321 1
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
... ..+..+..... +. .....+.+++.+||+.+|++||++.||++.|.
T Consensus 209 ~~~----~~i~~~~~~~~--~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 209 EVV----EMISRGFRLYR--PK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHH----HHHHCCCCCCC--CC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 12222221111 11 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=236.14 Aligned_cols=194 Identities=22% Similarity=0.323 Sum_probs=144.2
Q ss_pred eeccccccccccCCCCccEEEEecccchhhhh-ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQER-CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~ 455 (635)
+.|+||+.+..+...+..+|+++++++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 129 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 205 (353)
T PLN00034 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAK 205 (353)
T ss_pred CCCCCcceeeeEeccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCC
Confidence 46999999999888888999999998754322 234566677889999999999999999 99999999999999999
Q ss_pred CCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 456 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
.+||+|||+++....... ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+...
T Consensus 206 ~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~ 283 (353)
T PLN00034 206 NVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS 283 (353)
T ss_pred CEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 999999999987643221 1223568999999998743 234578999999999999999999987332221111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
... ........+ ........+.+++.+||+.||++|||+.||++.
T Consensus 284 ~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 284 LMC----AICMSQPPE---------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHH----HHhccCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111111111 111223457789999999999999999999874
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-25 Score=227.92 Aligned_cols=195 Identities=24% Similarity=0.294 Sum_probs=145.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+......+|+++++.... ......+++.+++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 50 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil 126 (252)
T cd05084 50 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCL 126 (252)
T ss_pred CCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEE
Confidence 35899999988888888899999987531 122345789999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.................+..|+|||.+.+..++.++||||||+++||+++ |..||......
T Consensus 127 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--- 203 (252)
T cd05084 127 VTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--- 203 (252)
T ss_pred EcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---
Confidence 99999999999999875432211111111123457999999998899999999999999999997 88887532211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
........+..... +......+.+++.+|++.+|++|||+.+|+++|+
T Consensus 204 ----~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 204 ----QTREAIEQGVRLPC---------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----HHHHHHHcCCCCCC---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11111111111111 1122346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=236.77 Aligned_cols=194 Identities=20% Similarity=0.236 Sum_probs=147.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+......+..+|+++++.+... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~ 135 (333)
T cd05600 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLID 135 (333)
T ss_pred CCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEC
Confidence 58999999888888889999999986421 23456888899999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++..... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+. .
T Consensus 136 ~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~ 207 (333)
T cd05600 136 ASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---W 207 (333)
T ss_pred CCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---H
Confidence 999999999999976533 12235689999999999999999999999999999999999999864332111 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
... ..+.. ... .+... .........+.+++.+||+.+|++||++++|++.
T Consensus 208 ~~i-~~~~~-~~~---~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 208 ENL-KYWKE-TLQ---RPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHH-Hhccc-ccc---CCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 111 11100 000 00000 0001223456788999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=235.70 Aligned_cols=190 Identities=21% Similarity=0.225 Sum_probs=146.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++++.+.........+|+++++.+... ...+.+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 52 l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll 128 (328)
T cd05593 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLML 128 (328)
T ss_pred CCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEE
Confidence 368999998888888889999999986421 23456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+
T Consensus 129 ~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---- 202 (328)
T cd05593 129 DKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---- 202 (328)
T ss_pred CCCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----
Confidence 9999999999999875322211 1223568999999999999999999999999999999999999985432111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~~ 588 (635)
.......+.. .+ +......+.+++.+||+.||++|| ++.|+++.
T Consensus 203 ---~~~~~~~~~~------~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 203 ---LFELILMEDI------KF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---HHHHhccCCc------cC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1111111111 11 111223467889999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-26 Score=234.15 Aligned_cols=197 Identities=25% Similarity=0.334 Sum_probs=148.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----------------------------hhccccCcccchhhhhhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----------------------------ERCKLLDWSKRFRIICGTGRGL 428 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----------------------------~~~~~l~~~~~~~i~~~ia~aL 428 (635)
.|+||+.+...+......|+++++..... .....+++..++.++.|++.||
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 140 (290)
T cd05045 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGM 140 (290)
T ss_pred CCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHH
Confidence 58899988887777778899988875211 1123577888899999999999
Q ss_pred chhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeeh
Q 046703 429 LYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGI 508 (635)
Q Consensus 429 ~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gv 508 (635)
.|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+
T Consensus 141 ~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 217 (290)
T cd05045 141 QYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217 (290)
T ss_pred HHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHH
Confidence 9999998 9999999999999999999999999997654322211122234567899999998888999999999999
Q ss_pred hhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 509 LLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 509 vl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+++||++ |+.||..... ...+.....+..... +......+.+++.+||+.+|++||++.||++
T Consensus 218 ~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 218 LLWEIVTLGGNPYPGIAP-------ERLFNLLKTGYRMER---------PENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCCCCC---------CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999998 9888854321 122222222211111 1122346778999999999999999999999
Q ss_pred HHcCCC
Q 046703 588 MLGSEI 593 (635)
Q Consensus 588 ~L~~~~ 593 (635)
.|++..
T Consensus 282 ~l~~~~ 287 (290)
T cd05045 282 ELEKMM 287 (290)
T ss_pred HHHHHH
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-26 Score=221.14 Aligned_cols=190 Identities=24% Similarity=0.338 Sum_probs=149.0
Q ss_pred ccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
||+|+++....+....+|++++.+..+ ....-.+++++...|++|+..|+.|||... |+||||||+|||+|+
T Consensus 82 HP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd 158 (411)
T KOG0599|consen 82 HPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD 158 (411)
T ss_pred CCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence 999999999999888899988766532 133456889999999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc------CCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++||+|||++..+..++ +.....||++|+|||.++ ...|+..+|+|++|||+|.++.|.+||-..
T Consensus 159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---- 231 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---- 231 (411)
T ss_pred ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----
Confidence 9999999999998875443 334478999999999884 235889999999999999999999998432
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+++ ....+.+|...- -.+.+. .......+|+.+||+.||.+|.|++|+++
T Consensus 232 -kQml--MLR~ImeGkyqF-~speWa-----dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 232 -KQML--MLRMIMEGKYQF-RSPEWA-----DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHH--HHHHHHhccccc-CCcchh-----hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111 233344554321 111111 22334567999999999999999999975
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=229.10 Aligned_cols=196 Identities=23% Similarity=0.327 Sum_probs=149.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+......+..+|+++++.+... .....+++.+++.++.|++.||.|||+.+ |+|+||||+||++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili 139 (266)
T cd05033 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILV 139 (266)
T ss_pred CCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence 58899988888777788999999876321 22346889999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..||......
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---- 215 (266)
T cd05033 140 NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---- 215 (266)
T ss_pred cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----
Confidence 9999999999999987752222111112334578999999998899999999999999999997 98887432111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
........+..... +......+.+++.+||+.+|++||+++||+++|+.+
T Consensus 216 ---~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 ---DVIKAVEDGYRLPP---------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11222222211111 112234577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=227.37 Aligned_cols=195 Identities=29% Similarity=0.386 Sum_probs=147.9
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+......+|+++++.... ......+++.++..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil 135 (261)
T cd05068 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVL 135 (261)
T ss_pred CCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEE
Confidence 5889988888887788899999987421 111246889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++......... ......+..|+|||.+....++.++||||||+++||+++ |+.||.....
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---- 210 (261)
T cd05068 136 VGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---- 210 (261)
T ss_pred EcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 9999999999999998765322111 111223457999999998899999999999999999999 8888753221
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.........+.... .+......+.+++.+|++.+|++||++.+|++.|+..
T Consensus 211 ---~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 211 ---AEVLQQVDQGYRMP---------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---HHHHHHHHcCCCCC---------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11111221211110 1112335678899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=229.46 Aligned_cols=203 Identities=22% Similarity=0.311 Sum_probs=148.6
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hh-----------ccccCcccchhhhhhhccccchhhccccceEE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ER-----------CKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
+.|+|++.+..+...+..+|+++++..... .+ ...+++..++.++.|++.||+|||+.+ ++
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~ 152 (296)
T cd05051 76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FV 152 (296)
T ss_pred cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cc
Confidence 468899888888777788999998775311 11 126888999999999999999999999 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh--CCC
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKK 518 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt--G~~ 518 (635)
|+||||+||+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred ccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence 999999999999999999999999876543322222223445778999999988889999999999999999998 556
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
||.... ...........+......... ..+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 233 p~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 233 PYEHLT---DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCcC---hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 654322 112222222221111111111 1112233568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-25 Score=232.36 Aligned_cols=193 Identities=21% Similarity=0.190 Sum_probs=144.3
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+.........+|+++++.+... .+.+.+++.++..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~ 139 (332)
T cd05614 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLD 139 (332)
T ss_pred CCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEEC
Confidence 47888888888777888999999986421 23456889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||++......... ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||..........
T Consensus 140 ~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~- 217 (332)
T cd05614 140 SEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS- 217 (332)
T ss_pred CCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH-
Confidence 9999999999999765332221 22235789999999998765 47899999999999999999999986443222211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
.......... +.+. ......+.+++.+||+.||++|| +++++++
T Consensus 218 --~~~~~~~~~~------~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 218 --EVSRRILKCD------PPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --HHHHHHhcCC------CCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111111111 1111 11223466789999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=230.48 Aligned_cols=187 Identities=24% Similarity=0.275 Sum_probs=143.9
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+......+..+|+++++.+... .....+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~ 130 (316)
T cd05592 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLD 130 (316)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEEC
Confidence 68999998888877889999999886421 23456888889999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 131 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------ 202 (316)
T cd05592 131 KDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ 202 (316)
T ss_pred CCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------
Confidence 99999999999997643322 1223356899999999999989999999999999999999999998643211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP-SVI 586 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~-evl 586 (635)
.....+..... . .+......+.+++.+||+.||++||++. +++
T Consensus 203 -~~~~~i~~~~~-~---------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 203 -ELFDSILNDRP-H---------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -HHHHHHHcCCC-C---------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11111111111 0 1111223466789999999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=224.70 Aligned_cols=196 Identities=20% Similarity=0.267 Sum_probs=143.6
Q ss_pred eccccccccccCC------CCccEEEEecccchhh-----------hhccccCcccchhhhhhhccccchhhccccceEE
Q 046703 378 WFGDLIDMRSFPD------GGQDLYIRMSASELDQ-----------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 378 ~h~nLv~l~~~~~------~~~~lyl~~~~~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
.|+|++.+..++. .....+++++++.... .+...++++..+.++.|++.||+|||+.+ |+
T Consensus 58 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 134 (272)
T cd05075 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FI 134 (272)
T ss_pred CCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 5788887765431 2235677777765211 12345788999999999999999999998 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCC
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKN 519 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~p 519 (635)
||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 135 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 135 HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred ccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987643322111122345678999999999999999999999999999999 7888
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|..... . ........+...... ......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 215 ~~~~~~---~----~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 215 YPGVEN---S----EIYDYLRQGNRLKQP---------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCH---H----HHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 754221 1 122223333322111 11233477899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=231.76 Aligned_cols=195 Identities=23% Similarity=0.301 Sum_probs=146.3
Q ss_pred eccccccccccCCCCccEEEEecccchhh----------------------hhccccCcccchhhhhhhccccchhhccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ----------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDS 435 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 435 (635)
.|+|++....+...+...|+++++..... .....+++.+.+.++.|++.||.|||+.+
T Consensus 65 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 144 (283)
T cd05090 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF 144 (283)
T ss_pred CCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC
Confidence 58899888888777788999999875310 01234678888899999999999999999
Q ss_pred cceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 436 ~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++
T Consensus 145 ---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 221 (283)
T cd05090 145 ---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221 (283)
T ss_pred ---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 99999999999999999999999999986543322111222345678999999988889999999999999999998
Q ss_pred -CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 516 -GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 516 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
|..||..... .........+..... +......+.+++.+||+.||++||++.+|.++|.+
T Consensus 222 ~g~~p~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 222 FGLQPYYGFSN-------QEVIEMVRKRQLLPC---------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCCCH-------HHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 8888753221 111222222221111 11122357789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=230.01 Aligned_cols=204 Identities=19% Similarity=0.231 Sum_probs=144.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|++++++.... .....++.+.+..++.||+.||+|||+.+ |+||||||+||++
T Consensus 60 l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill 136 (303)
T cd07869 60 LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLI 136 (303)
T ss_pred CCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 368999999888888889999999986321 22345788889999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...
T Consensus 137 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~ 212 (303)
T cd07869 137 SDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQD 212 (303)
T ss_pred CCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHH
Confidence 9999999999999875432211 1122457889999998865 4578999999999999999999999865321 111
Q ss_pred HHHHHHHHhhcCC---------CCcCCCCccc--cCCCH-------HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGM---------PSEMIDPCYQ--ESCNL-------TEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~---------~~~~~d~~l~--~~~~~-------~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+........... .......... ..... .....+.+++.+||+.||++|||++|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1222111110000 0000000000 00000 01234668999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=232.09 Aligned_cols=190 Identities=20% Similarity=0.276 Sum_probs=144.3
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+......+|+++++++.. ..+.+.+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~ 130 (329)
T cd05618 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLD 130 (329)
T ss_pred CCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEC
Confidence 5899999988888888999999998642 123457889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC--ccc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN--KLN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~--~~~ 530 (635)
.++.+||+|||+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ...
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05618 131 SEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208 (329)
T ss_pred CCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc
Confidence 99999999999987532211 11223568999999999999999999999999999999999999986432211 111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
...+.......... .+ +......+.+++.+||+.||++||++
T Consensus 209 ~~~~~~~~i~~~~~-~~---------p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 209 TEDYLFQVILEKQI-RI---------PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cHHHHHHHHhcCCC-CC---------CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 12222222222211 11 11122346789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=228.57 Aligned_cols=190 Identities=21% Similarity=0.288 Sum_probs=145.5
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+......+|+++++.+... .+.+.+++..+..++.||+.||+|||+.+ |+||||||+||+++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~ 130 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLD 130 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEe
Confidence 48889888888877889999999986421 23457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~ 208 (327)
T cd05617 131 ADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE 208 (327)
T ss_pred CCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH
Confidence 99999999999987532211 1223356899999999999999999999999999999999999999654333322233
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
............ .+ +......+.+++.+||+.||++||++
T Consensus 209 ~~~~~~~~~~~~-~~---------p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 209 DYLFQVILEKPI-RI---------PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhCCC-CC---------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 333333322211 11 11112346689999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=218.77 Aligned_cols=176 Identities=23% Similarity=0.263 Sum_probs=144.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||.++.|.....+...+|++|++.+.. ..+..++++..+.-++.||+.||+|||+.. |++||+||+|||+
T Consensus 101 v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLl 177 (355)
T KOG0616|consen 101 VSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLL 177 (355)
T ss_pred ccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeee
Confidence 46899999999999999999999998753 355678999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
|.+|.+||.|||+|+... ..+.+..||+.|+|||++..+++..++|.|+|||++|||+.|.+||-....
T Consensus 178 D~~G~iKitDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------ 246 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------ 246 (355)
T ss_pred ccCCcEEEEeccceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------
Confidence 999999999999999864 336678999999999999999999999999999999999999999864432
Q ss_pred HHHHHHHhhcCCC--CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCC
Q 046703 532 IGHAWKLWNKGMP--SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579 (635)
Q Consensus 532 ~~~~~~~~~~~~~--~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~R 579 (635)
....+.+.++.. +..+. ..+.+|+...++.|-.+|
T Consensus 247 -~~iY~KI~~~~v~fP~~fs------------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 247 -IQIYEKILEGKVKFPSYFS------------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -HHHHHHHHhCcccCCcccC------------HHHHHHHHHHHhhhhHhh
Confidence 122333333332 22222 234456777788888887
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=235.33 Aligned_cols=189 Identities=20% Similarity=0.236 Sum_probs=145.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIl 450 (635)
+.|++|+.+.........+|+++++.+.. ..+.+.+++.++..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 52 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIl 128 (325)
T cd05594 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLM 128 (325)
T ss_pred CCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEE
Confidence 36899999888888888999999998642 1234568899999999999999999997 67 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 129 l~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--- 203 (325)
T cd05594 129 LDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--- 203 (325)
T ss_pred ECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---
Confidence 99999999999999875432211 1223568999999999999999999999999999999999999985432111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
.......+.. . +... ....+.+++.+||+.||++|+ ++.++++
T Consensus 204 ----~~~~i~~~~~-~-----~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 204 ----LFELILMEEI-R-----FPRT----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ----HHHHHhcCCC-C-----CCCC----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1111111111 0 1111 123466789999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=233.89 Aligned_cols=186 Identities=20% Similarity=0.166 Sum_probs=145.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+......+..+|+++++.... ..+...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 75 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll 151 (329)
T PTZ00263 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLL 151 (329)
T ss_pred CCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEE
Confidence 46999999998888888999999987632 123456788888899999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++..... .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 152 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------ 220 (329)
T PTZ00263 152 DNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------ 220 (329)
T ss_pred CCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------
Confidence 99999999999999875432 1235789999999999999999999999999999999999999853221
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
......+.++... + +.....++.+++..||+.||.+||+ +++++.
T Consensus 221 -~~~~~~i~~~~~~-~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 221 -FRIYEKILAGRLK-F---------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -HHHHHHHhcCCcC-C---------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122222233211 0 0011234668999999999999997 577763
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-25 Score=231.87 Aligned_cols=195 Identities=19% Similarity=0.269 Sum_probs=147.7
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+..+......+|+++++++... .+.+.+++..+..++.||+.||.|||+.+ ++||||||+||+++
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~ 130 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLD 130 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC
Confidence 48999999988888889999999986421 23467899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC--ccc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN--KLN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~--~~~ 530 (635)
.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||+.....+ ...
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05588 131 AEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208 (329)
T ss_pred CCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc
Confidence 99999999999987432111 12223578999999999999999999999999999999999999996533222 111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC------hHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC------MPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt------~~evl~ 587 (635)
......+....+... + +......+.+++.+||+.||++||+ ++++++
T Consensus 209 ~~~~~~~~~~~~~~~-~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 209 TEDYLFQVILEKQIR-I---------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred chHHHHHHHHcCCCC-C---------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112222222222211 1 1112234678999999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-25 Score=263.42 Aligned_cols=210 Identities=22% Similarity=0.413 Sum_probs=163.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
+.|+||+.+.+++......|+++||++... ..-+.++|+++.+++.||++||+|||..+...|+||||||+||+++.+
T Consensus 740 l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~ 819 (968)
T PLN00113 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819 (968)
T ss_pred CCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC
Confidence 479999999999988889999999987432 122358999999999999999999996655559999999999999998
Q ss_pred CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHH
Q 046703 455 MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGH 534 (635)
Q Consensus 455 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~ 534 (635)
+.+++. |+........ ....++..|+|||.+.+..++.|+|||||||++|||++|+.||+... ........+
T Consensus 820 ~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~ 891 (968)
T PLN00113 820 DEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEW 891 (968)
T ss_pred CceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHH
Confidence 887775 5554332111 11357889999999999999999999999999999999999985322 223345555
Q ss_pred HHHHhhcCCCCcCCCCcccc--CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 535 AWKLWNKGMPSEMIDPCYQE--SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
+............+|+.+.. ..+.++..++.+++.+||+.||++||||+||+++|+....
T Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 55444444455556665543 3456778889999999999999999999999999987643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=234.98 Aligned_cols=197 Identities=22% Similarity=0.275 Sum_probs=145.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..++... ..++++++.... ......+++..++.++.||+.||+|||+.+ |+||||||+||+
T Consensus 66 l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nil 141 (316)
T cd05108 66 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVL 141 (316)
T ss_pred CCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheE
Confidence 4689999888776544 456666665432 122345788888999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--- 218 (316)
T cd05108 142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--- 218 (316)
T ss_pred ecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999987654322211111234568999999999999999999999999999997 99998543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
........+..... +......+.+++.+||+.+|++||++.+|+..|....
T Consensus 219 ----~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 219 ----EISSILEKGERLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ----HHHHHHhCCCCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122222211111 1112235678999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=228.23 Aligned_cols=188 Identities=23% Similarity=0.233 Sum_probs=146.4
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+......+|+++++.... ..+...+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~ 130 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLD 130 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEEC
Confidence 5899999988887788999999988642 123447899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------ 202 (318)
T cd05570 131 SEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ 202 (318)
T ss_pred CCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------
Confidence 999999999999875322211 122356899999999999999999999999999999999999998643211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM-----PSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~-----~evl~ 587 (635)
.....+...... .+......+.+++.+||+.||++||++ .++++
T Consensus 203 -~~~~~i~~~~~~----------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 203 -ELFQSILEDEVR----------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -HHHHHHHcCCCC----------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111222222111 011123356789999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-25 Score=230.91 Aligned_cols=140 Identities=25% Similarity=0.358 Sum_probs=118.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+..+|+++++.+.. ....+.+++..+..++.|++.||.|||+.+ .|+||||||+||++
T Consensus 60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~ 137 (331)
T cd06649 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILV 137 (331)
T ss_pred CCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEE
Confidence 46899999998887788999999988642 123456788888999999999999999853 29999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+.++.+||+|||++....... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 138 NSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999987653321 1234688999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-25 Score=240.53 Aligned_cols=210 Identities=16% Similarity=0.190 Sum_probs=146.7
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|+||+.+..+...+...|+++++.... ......+++.+++.++.||++||.|||+.+ |+||||||+|||
T Consensus 216 ~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NIL 292 (461)
T PHA03211 216 RLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVL 292 (461)
T ss_pred HCCCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEE
Confidence 357999999988877677888888866421 122346899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCC-CCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR-GFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf-~~~~~~~~~ 529 (635)
++.++.+||+|||+++...............||..|+|||.+.+..++.++|||||||+||||++|..++ .........
T Consensus 293 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~ 372 (461)
T PHA03211 293 VNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372 (461)
T ss_pred ECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccC
Confidence 9999999999999998764332222222356899999999999999999999999999999999987654 221111111
Q ss_pred cHHHHHHHHhhcCCC--CcCC---CCcc------------ccCCC---H----HHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 530 NLIGHAWKLWNKGMP--SEMI---DPCY------------QESCN---L----TEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~--~~~~---d~~l------------~~~~~---~----~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
.....+.+.+..... .+.. ...+ ..... . .....+.+|+.+||+.||++|||+.||
T Consensus 373 ~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el 452 (461)
T PHA03211 373 PYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452 (461)
T ss_pred CcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence 111112222211111 0000 0000 00000 0 111246679999999999999999999
Q ss_pred HHH
Q 046703 586 ILM 588 (635)
Q Consensus 586 l~~ 588 (635)
++.
T Consensus 453 L~h 455 (461)
T PHA03211 453 LRL 455 (461)
T ss_pred hhC
Confidence 874
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-26 Score=238.39 Aligned_cols=208 Identities=23% Similarity=0.293 Sum_probs=142.5
Q ss_pred eeccccccccccCC-----CCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPD-----GGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~-----~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+|++.+..+.. ....+|++++++.... .....+++..+..++.||++||.|||+.+ |+||||||+
T Consensus 56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~ 132 (338)
T cd07859 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPK 132 (338)
T ss_pred CCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 46899988776542 2245899999986321 23346889999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
||+++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 133 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 133 NILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred HeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999764322111 11123568899999999865 678999999999999999999999986533
Q ss_pred CCCcccHHHH--------HHHHhhcCCCCcCCC-------CccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 525 LDNKLNLIGH--------AWKLWNKGMPSEMID-------PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 525 ~~~~~~~~~~--------~~~~~~~~~~~~~~d-------~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.......+.. ....+......+... ....... +.....+.+++.+||+.||++|||++||++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 2111110000 000000000000000 0000000 0112346789999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=221.50 Aligned_cols=194 Identities=24% Similarity=0.341 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+......+|+++++.... ......+++.+++.++.||+.||+|||+.+ ++|+||||+||+
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nil 132 (256)
T cd05113 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCL 132 (256)
T ss_pred CCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEE
Confidence 36899999988887777899999987532 111336889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 133 i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--- 208 (256)
T cd05113 133 VDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--- 208 (256)
T ss_pred EcCCCCEEECCCccceecCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---
Confidence 9999999999999988654332111 111234578999999988889999999999999999998 98887543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
. .......+....... .....+.+++.+||+.+|++||++.+|++.|+
T Consensus 209 ~----~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 209 E----TVEKVSQGLRLYRPH---------LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred H----HHHHHhcCCCCCCCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1 111222222211111 12346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=235.31 Aligned_cols=186 Identities=20% Similarity=0.220 Sum_probs=144.0
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+......+..+|+++++.+... .+...+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 55 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 131 (318)
T cd05582 55 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILL 131 (318)
T ss_pred CCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEE
Confidence 469999999888888889999999886421 23456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 132 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~ 206 (318)
T cd05582 132 DEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ET 206 (318)
T ss_pred CCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HH
Confidence 999999999999987653321 1223356899999999999888999999999999999999999998643211 11
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
...+...... .+......+.+++.+||+.||++||++.+
T Consensus 207 ----~~~i~~~~~~----------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 ----MTMILKAKLG----------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----HHHHHcCCCC----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111111110 01112234667899999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=226.41 Aligned_cols=194 Identities=25% Similarity=0.340 Sum_probs=146.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+......+|+++++.+.. ......+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~ 132 (256)
T cd05059 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCL 132 (256)
T ss_pred CCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEE
Confidence 35899999888877778899999987532 112346789999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |+.||......+
T Consensus 133 i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-- 209 (256)
T cd05059 133 VGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-- 209 (256)
T ss_pred ECCCCcEEECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--
Confidence 9999999999999997654322111 111223457999999998899999999999999999998 788875432211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
. ......+..... +......+.+++.+||+.+|++|||+.||+++|.
T Consensus 210 -~----~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 210 -V----VESVSAGYRLYR---------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -H----HHHHHcCCcCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1 111112211111 1123346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=229.18 Aligned_cols=188 Identities=19% Similarity=0.197 Sum_probs=144.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+......+..+|+++++.... ..+...+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll 129 (325)
T cd05604 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILL 129 (325)
T ss_pred CCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEE
Confidence 46999999988888888999999988642 123456888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----- 202 (325)
T cd05604 130 DSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----- 202 (325)
T ss_pred CCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----
Confidence 999999999999987532211 1122356899999999999999999999999999999999999998543211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
........+... +. +.....+.+++.+|++.+|.+||++.+.+
T Consensus 203 --~~~~~~~~~~~~--~~--------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 203 --EMYDNILHKPLV--LR--------PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --HHHHHHHcCCcc--CC--------CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 111111121111 01 11223466789999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=233.62 Aligned_cols=189 Identities=21% Similarity=0.258 Sum_probs=145.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+..+...+..+|+++++.+.. ..+...+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 59 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~ 135 (324)
T cd05589 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLD 135 (324)
T ss_pred cCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEEC
Confidence 46999999998888888999999988642 123457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~-- 208 (324)
T cd05589 136 TEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---E-- 208 (324)
T ss_pred CCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---H--
Confidence 99999999999986532211 1122356899999999999999999999999999999999999998643211 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
....+..+... . +......+.+++.+||+.||++||+ +.++++
T Consensus 209 --~~~~i~~~~~~------~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 209 --VFDSIVNDEVR------Y----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --HHHHHHhCCCC------C----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111122111 0 1112234678999999999999994 556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=231.73 Aligned_cols=187 Identities=21% Similarity=0.177 Sum_probs=146.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.....++..+|+++++.... ....+.+++..+..++.||+.||+|||+.+ |+||||||+||++
T Consensus 58 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli 134 (291)
T cd05612 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILL 134 (291)
T ss_pred CCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEE
Confidence 46999999998888888999999987632 123456888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++..... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----- 204 (291)
T cd05612 135 DKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----- 204 (291)
T ss_pred CCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999999765322 12356899999999999989999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~~ 588 (635)
.....+..+... + +......+.+++.+||+.||.+||+ ++|+++.
T Consensus 205 --~~~~~i~~~~~~-~---------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 205 --GIYEKILAGKLE-F---------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --HHHHHHHhCCcC-C---------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111222222211 0 1111234678999999999999995 7777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=234.17 Aligned_cols=189 Identities=20% Similarity=0.240 Sum_probs=145.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+.........+|+++++++... .+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 52 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 128 (323)
T cd05595 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLML 128 (323)
T ss_pred CCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEE
Confidence 368999998888887889999999987421 23456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++........ ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 129 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~- 202 (323)
T cd05595 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---R- 202 (323)
T ss_pred cCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---H-
Confidence 9999999999999875322211 122356899999999999999999999999999999999999998543211 1
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
....+..... .+.. .....+.+++.+||+.||++|| ++.++++
T Consensus 203 ---~~~~~~~~~~------~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 203 ---LFELILMEEI------RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ---HHHHHhcCCC------CCCC----CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1111111111 0111 1223466899999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=232.28 Aligned_cols=189 Identities=23% Similarity=0.245 Sum_probs=145.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+......+..+|+++++..... .+.+.+.+..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 57 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~ 133 (323)
T cd05584 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILL 133 (323)
T ss_pred CCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 469999998888877889999999876421 23455777888889999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~- 207 (323)
T cd05584 134 DAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---K- 207 (323)
T ss_pred CCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---H-
Confidence 9999999999999875432221 122356899999999999888999999999999999999999998643211 1
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
....+..+.. .+ +......+.+++.+||+.||++|| +++++++
T Consensus 208 ---~~~~~~~~~~-~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 208 ---TIDKILKGKL-NL---------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---HHHHHHcCCC-CC---------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1111112211 11 111223567899999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=226.05 Aligned_cols=194 Identities=28% Similarity=0.346 Sum_probs=145.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+.. +...++++++.... ..+.+.+++..+..++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 54 ~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~ 129 (257)
T cd05116 54 DNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLV 129 (257)
T ss_pred CCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEc
Confidence 5778887776654 34678888876632 123456889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCc-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
.++.+||+|||++........... .....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 130 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 205 (257)
T cd05116 130 TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---- 205 (257)
T ss_pred CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 999999999999987643322111 111223578999999988889999999999999999998 99998643211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.....+..+...... ......+.+++.+||+.||++||++.+|+++|++
T Consensus 206 ---~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 206 ---EVTQMIESGERMECP---------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---HHHHHHHCCCCCCCC---------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 112222233222211 1223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-25 Score=227.58 Aligned_cols=202 Identities=19% Similarity=0.250 Sum_probs=145.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhhh-----------------hccccCcccchhhhhhhccccchhhccccceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQE-----------------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 439 (635)
+.|++++.+..+......+|++++++..... ....+++..++.++.|++.||+|||+.+ +
T Consensus 74 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 150 (295)
T cd05097 74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---F 150 (295)
T ss_pred CCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---e
Confidence 3588998888888788889999998763110 0123677888999999999999999999 9
Q ss_pred EeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh--CC
Q 046703 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GK 517 (635)
Q Consensus 440 iH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt--G~ 517 (635)
+|+||||+||+++.++.+||+|||++................++..|+|||.+....++.++||||||++++||++ |.
T Consensus 151 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred eccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999976543222111222344678999999988899999999999999999998 44
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.||..... ...+......+.......... .+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 231 ~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 231 QPYSLLSD---EQVIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCcccCh---HHHHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 55543221 112222211111111100000 11112346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-25 Score=229.98 Aligned_cols=185 Identities=20% Similarity=0.204 Sum_probs=142.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.........+|+++++.+... .+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 53 l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll 129 (323)
T cd05575 53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILL 129 (323)
T ss_pred CCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEE
Confidence 468999999888877889999999986421 23456888888999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----- 202 (323)
T cd05575 130 DSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----- 202 (323)
T ss_pred CCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----
Confidence 999999999999987532221 1122356899999999999999999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
.....+..+... +.. .....+.+++.+||+.||++||++.
T Consensus 203 --~~~~~i~~~~~~------~~~----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 203 --EMYDNILNKPLR------LKP----NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --HHHHHHHcCCCC------CCC----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111111121111 111 1134567899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=222.44 Aligned_cols=190 Identities=20% Similarity=0.273 Sum_probs=157.4
Q ss_pred eeeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 375 CAMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
..+.||+|++++++++....+.|+|+|...+ ...+..|++++..++++||..|+.|+|.+. ++|||||.+||
T Consensus 108 SsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENI 184 (668)
T KOG0611|consen 108 SSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENI 184 (668)
T ss_pred hhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhhe
Confidence 4568999999999999999999999998743 245778999999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc-ccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+|.++++||+|||++.++..... ..++.|.+-|.+||++.+.+|. +.+|-||+||+||.++.|..||+..+..
T Consensus 185 LLD~N~NiKIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-- 259 (668)
T KOG0611|consen 185 LLDQNNNIKIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-- 259 (668)
T ss_pred eecCCCCeeeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--
Confidence 999999999999999988765433 2347899999999999999986 9999999999999999999999765321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
...+.+..|...+-. .+-...-|+.|+|..||++|-|+++|...
T Consensus 260 -----~lvrQIs~GaYrEP~-----------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 260 -----RLVRQISRGAYREPE-----------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -----HHHHHhhcccccCCC-----------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 122333344433321 12234568999999999999999999753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=221.16 Aligned_cols=194 Identities=30% Similarity=0.445 Sum_probs=149.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+...+..+|+++++.+.. ......+++.++..++.||+.||.|||+.+ ++|+||+|+||+
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nil 136 (261)
T cd05148 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNIL 136 (261)
T ss_pred CCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEE
Confidence 5888988888888888899999987531 122356889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++......... .....++..|+|||.+....++.++||||||+++++|++ |+.||......
T Consensus 137 v~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--- 211 (261)
T cd05148 137 VGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--- 211 (261)
T ss_pred EcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 999999999999999765432211 112345678999999988899999999999999999998 88888543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
... .....+.... .+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 212 ~~~----~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 212 EVY----DQITAGYRMP---------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHH----HHHHhCCcCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111 1111211111 1122334577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=236.43 Aligned_cols=203 Identities=26% Similarity=0.317 Sum_probs=156.4
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+|+|.++++.-..+-+||+||.+..+. ...+.++..+++.++.+.|.||+|||++. +|||||.++|+
T Consensus 217 ~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNc 293 (474)
T KOG0194|consen 217 QLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNC 293 (474)
T ss_pred hCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHh
Confidence 4689999999999999999999999987421 22235999999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|+..++.+||+|||+++... ..........-++.|+|||.+....++.++|||||||++||+.+ |..||......
T Consensus 294 L~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-- 369 (474)
T KOG0194|consen 294 LYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-- 369 (474)
T ss_pred eecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--
Confidence 99999999999999987543 11111111234689999999999999999999999999999998 77787543211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCCCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQP 598 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~p~p 598 (635)
+-.......+....... ..+..+..++..||+.+|++||+|.+|.+.|+.+.....+
T Consensus 370 ----~v~~kI~~~~~r~~~~~---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 ----EVKAKIVKNGYRMPIPS---------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----HHHHHHHhcCccCCCCC---------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11112223333333222 3334566678899999999999999999999887654443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-25 Score=237.50 Aligned_cols=165 Identities=29% Similarity=0.366 Sum_probs=126.3
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.+++.+++.++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 4677788899999999999999998 9999999999999999999999999998764332222222234667899999
Q ss_pred cccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
.+.+..++.++||||||+++|||++ |..||....... ........+..... +......+.+++.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~~li~ 374 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYNKIKSGYRMAK---------PDHATQEVYDIMV 374 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHHHHhcCCCCCC---------CccCCHHHHHHHH
Confidence 9998899999999999999999997 888875432111 11122222221111 1123346778999
Q ss_pred HhcccCCCCCCChHHHHHHHcCCC
Q 046703 570 LCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
+||+.||++||++.+|+++|+.+.
T Consensus 375 ~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 375 KCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHCccCHhHCcCHHHHHHHHHHHc
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=229.51 Aligned_cols=187 Identities=23% Similarity=0.260 Sum_probs=143.0
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+.........+|+++++..... .....+++.++..++.||++||+|||+.+ |+||||||+||+++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~ 130 (316)
T cd05620 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLD 130 (316)
T ss_pred CCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC
Confidence 58899988888877889999999886421 23456888889999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------ 202 (316)
T cd05620 131 RDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ 202 (316)
T ss_pred CCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------
Confidence 99999999999987432111 1223356899999999999999999999999999999999999998643211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP-SVI 586 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~-evl 586 (635)
.....+..+.. .. .. .....+.+++.+||+.||++||++. +++
T Consensus 203 -~~~~~~~~~~~-~~-----~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 203 -ELFESIRVDTP-HY-----PR----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -HHHHHHHhCCC-CC-----CC----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11122211111 11 11 1123466799999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=227.92 Aligned_cols=198 Identities=27% Similarity=0.331 Sum_probs=149.2
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+||+.+...+..+..+|+++++..... .....+++.+++.++.|++.||+|||+.+
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g- 154 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK- 154 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 58899999888877788999998875311 01234777888899999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++
T Consensus 155 --ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 155 --CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred --eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999986543222111222334567999999999999999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
|..||..... ......+..+...... ......+.+++.+||+.+|++||++.||++.|+....
T Consensus 233 g~~p~~~~~~-------~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 233 GGSPYPGIPV-------EELFKLLKEGHRMDKP---------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCCCCCCCCH-------HHHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 7888753321 1122222222222211 1223357789999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=228.67 Aligned_cols=194 Identities=25% Similarity=0.301 Sum_probs=142.7
Q ss_pred eccccccccccCCCCccEEEEecccchhh------h------hccccCcccchhhhhhhccccchhhccccceEEeeccC
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------E------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik 445 (635)
.|+||+.+..+.......|+++++.+... . ....+++..++.++.||+.||+|||+.+ ++|+|||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlk 143 (277)
T cd05036 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIA 143 (277)
T ss_pred CCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccc
Confidence 57888888877766777899998875311 0 1125788899999999999999999998 9999999
Q ss_pred CcceEeccCC---CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCC
Q 046703 446 AGNVLLDQDM---NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRG 521 (635)
Q Consensus 446 ~~NIlld~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~ 521 (635)
|+||+++.++ .+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |+.||+
T Consensus 144 p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred hheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999998754 589999999986632221111111233568999999998999999999999999999997 888886
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.....+ . ........... .+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 224 ~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 224 GRTNQE---V----MEFVTGGGRLD---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCHHH---H----HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 432211 1 11111111111 11122345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=236.42 Aligned_cols=207 Identities=23% Similarity=0.304 Sum_probs=145.7
Q ss_pred eeeccccccccccCCCCc-----cEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPDGGQ-----DLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~-----~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+|++.+..+..... .+|+++++...+. .....+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 55 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp 131 (372)
T cd07853 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKP 131 (372)
T ss_pred hCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCh
Confidence 346999998887765544 7899999876321 23456888999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+||+++.++.+||+|||++.......... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus 132 ~Nili~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 132 GNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred HHEEECCCCCEEeccccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999999998654322211 1224568899999998764 478999999999999999999999965432
Q ss_pred CCcccHHHH----------------HHHHhhcC-CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 526 DNKLNLIGH----------------AWKLWNKG-MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 526 ~~~~~~~~~----------------~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.+....+.. ....+... .......... .........+.+++.+||+.||++|||++|+++.
T Consensus 211 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 221111110 00000000 0000000000 0111123457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=225.69 Aligned_cols=202 Identities=20% Similarity=0.268 Sum_probs=144.5
Q ss_pred eccccccccccCCCCccEEEEecccchhh----------------hhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ----------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
.|+|++.+..+...+..+|+++++..... .....+++.++..++.|++.||+|||+.+ ++|
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H 153 (296)
T cd05095 77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVH 153 (296)
T ss_pred CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 57888888877777778899998875310 01134667788999999999999999999 999
Q ss_pred eccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh--CCCC
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKN 519 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt--G~~p 519 (635)
+||||+||+++.++.+||+|||++..+.............++..|++||......++.++|||||||++|||++ |..|
T Consensus 154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred ccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999976543222111222334678999999888889999999999999999998 5667
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
|......+ .+......+......... + .+......+.+++.+||+.||++||++.||++.|+.
T Consensus 234 ~~~~~~~~---~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 234 YSQLSDEQ---VIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ccccChHH---HHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 64332211 111111111111111100 0 011223567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=218.59 Aligned_cols=194 Identities=28% Similarity=0.377 Sum_probs=150.6
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhh--------ccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QER--------CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
.|++++.+..+...+..+|+++++.+.. ... ...+++.++..++.|+++||.|||+.+ ++|+|
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 130 (262)
T cd00192 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRD 130 (262)
T ss_pred CCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCc
Confidence 4889988888887788999999988521 111 367899999999999999999999999 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGF 522 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~ 522 (635)
|+|+||+++.++.+||+|||.+................++..|+|||.+....++.++||||+|++++||++ |..||..
T Consensus 131 i~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred cCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999987754432222223456789999999988899999999999999999999 5888865
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.... ........+..... +......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 211 ~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 211 LSNE-------EVLEYLRKGYRLPK---------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCHH-------HHHHHHHcCCCCCC---------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 4211 12222222221111 1112346778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=232.32 Aligned_cols=191 Identities=25% Similarity=0.382 Sum_probs=154.6
Q ss_pred eeccccccccccCCCCcc-EEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQD-LYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~-lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|||||..++.+..... ++|+|+|++.. ..+...+.++.+..++.|++.|+.|||++. |+|||||+.|
T Consensus 60 ~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~N 136 (426)
T KOG0589|consen 60 LLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCAN 136 (426)
T ss_pred ccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhh
Confidence 489999999888865555 99999999852 334567889999999999999999999887 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|++..+..+||+|||+|+.+..... ...+..||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+...
T Consensus 137 ifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~- 213 (426)
T KOG0589|consen 137 IFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE- 213 (426)
T ss_pred hhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-
Confidence 9999999999999999998865542 3345899999999999999999999999999999999999999987544322
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
++..+ ..+.. . ..+......+..++..|++.+|..||++.+++.+
T Consensus 214 --Li~ki----~~~~~----~-----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 214 --LILKI----NRGLY----S-----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --HHHHH----hhccC----C-----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22111 11111 1 1233344557778899999999999999999864
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=231.40 Aligned_cols=197 Identities=25% Similarity=0.360 Sum_probs=148.8
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+.........+|+++++.... ......+++.++..++.|++.||+|||+.+ ++|+||||+||+
T Consensus 97 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil 173 (302)
T cd05055 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVL 173 (302)
T ss_pred CCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEE
Confidence 4889999888887788899999987532 112233889999999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.+..+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-- 251 (302)
T cd05055 174 LTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-- 251 (302)
T ss_pred EcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--
Confidence 99999999999999986543322111112345678999999998899999999999999999998 888875432111
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
........+..... +......+.+++.+||+.+|++|||+.||++.|+..
T Consensus 252 ----~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 ----KFYKLIKEGYRMAQ---------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----HHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11122222211111 111223577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=232.62 Aligned_cols=183 Identities=21% Similarity=0.248 Sum_probs=143.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+......+|+++++.+.. ..+...+++..+..++.|++.||+|||+.+ |+||||||+||+++
T Consensus 54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~ 130 (320)
T cd05590 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLD 130 (320)
T ss_pred CCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEEC
Confidence 5899999988888888999999998642 123457889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------ 202 (320)
T cd05590 131 HEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------ 202 (320)
T ss_pred CCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------
Confidence 999999999999875432211 122356899999999999999999999999999999999999998643211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
.....+..+... . +......+.+++.+||+.||++||++
T Consensus 203 -~~~~~i~~~~~~-~---------~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 203 -DLFEAILNDEVV-Y---------PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -HHHHHHhcCCCC-C---------CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 112222222111 0 11122356789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=232.13 Aligned_cols=185 Identities=19% Similarity=0.203 Sum_probs=142.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.........+|+++++.+.. ..+.+.+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll 129 (321)
T cd05603 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILL 129 (321)
T ss_pred CCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEE
Confidence 46999999988888888999999998642 123456788888899999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+..
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----- 202 (321)
T cd05603 130 DSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----- 202 (321)
T ss_pred CCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----
Confidence 999999999999987532211 1223356899999999999889999999999999999999999998543211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
.....+..+. .. .+......+.+++.+||+.||++||++.
T Consensus 203 --~~~~~i~~~~-~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 203 --QMYDNILHKP-LQ---------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --HHHHHHhcCC-CC---------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111111111 11 1112234577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=226.76 Aligned_cols=197 Identities=26% Similarity=0.333 Sum_probs=148.7
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+..++.....+|+++++..... .....+++++++.++.||+.||.|||+.+
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g- 154 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR- 154 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 48999999888877778999999875311 01245788888999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++
T Consensus 155 --i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 155 --CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred --eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 99999999999999999999999999986543222111111233467999999988899999999999999999999
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|..||..... .........+...+. +......+.+++.+||+.+|++|||+.|+++.|+...
T Consensus 233 g~~p~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 233 GGSPYPGIPV-------EELFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCCCCCCCH-------HHHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 8888753321 112222223222211 1122335678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-25 Score=230.75 Aligned_cols=189 Identities=20% Similarity=0.200 Sum_probs=142.2
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+.........+|+++++.+... .+...+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~ 130 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLD 130 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC
Confidence 58899998888888889999999886421 23556889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||++........ ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus 131 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------ 202 (330)
T cd05586 131 ATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------ 202 (330)
T ss_pred CCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------
Confidence 999999999999875432211 12235689999999998754 478999999999999999999999854321
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC----hHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC----MPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt----~~evl~ 587 (635)
......+..+... +... .....+.+++.+||+.||++||+ +.++++
T Consensus 203 -~~~~~~i~~~~~~-~~~~--------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 203 -QQMYRNIAFGKVR-FPKN--------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -HHHHHHHHcCCCC-CCCc--------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1112222222211 1111 11234567899999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-25 Score=229.02 Aligned_cols=144 Identities=22% Similarity=0.368 Sum_probs=113.5
Q ss_pred eeccccccccccC--CCCccEEEEecccchhh-------------hhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELDQ-------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
+.|+|++.+.... ..+..+|+++++..... .+...+++..+..++.||+.||.|||+++ |+|
T Consensus 55 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH 131 (317)
T cd07868 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLH 131 (317)
T ss_pred cCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEc
Confidence 3689999887765 34567889988865210 11235778888999999999999999999 999
Q ss_pred eccCCcceEe----ccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhh
Q 046703 442 RDLKAGNVLL----DQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 442 ~dik~~NIll----d~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eilt 515 (635)
|||||+|||+ +..+.+||+|||+++........ .......+|..|+|||.+.+ ..++.++||||+||++|||++
T Consensus 132 rDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 211 (317)
T cd07868 132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (317)
T ss_pred CCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh
Confidence 9999999999 45578999999999876433211 12233567899999999876 458999999999999999999
Q ss_pred CCCCCCCc
Q 046703 516 GKKNRGFY 523 (635)
Q Consensus 516 G~~pf~~~ 523 (635)
|+.||...
T Consensus 212 g~~~f~~~ 219 (317)
T cd07868 212 SEPIFHCR 219 (317)
T ss_pred CCCCccCC
Confidence 99998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=217.58 Aligned_cols=191 Identities=25% Similarity=0.297 Sum_probs=148.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++...........+|+++++.+.. ......+++.+++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~ni 132 (256)
T cd08529 56 LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNL 132 (256)
T ss_pred cCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceE
Confidence 46999999888888788999999987531 122356888889999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++.++.+||+|||+++........ .....++..|+|||...+..++.++|+||||++++||++|+.||.....
T Consensus 133 li~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---- 206 (256)
T cd08529 133 FLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---- 206 (256)
T ss_pred EEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----
Confidence 9999999999999998876433221 1234678899999999999999999999999999999999999864321
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.........+...... ......+.+++.+||+.+|++||++.++++.
T Consensus 207 ---~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 207 ---GALILKIIRGVFPPVS---------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---HHHHHHHHcCCCCCCc---------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111122222222111 1223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-25 Score=231.57 Aligned_cols=188 Identities=20% Similarity=0.257 Sum_probs=145.5
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+......+|+++++.+.. ..+...+++..+..++.||++||.|||+.+ |+||||||+||+++
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~ 130 (321)
T cd05591 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLD 130 (321)
T ss_pred CCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC
Confidence 5889999888888888999999998642 123456888899999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~-- 203 (321)
T cd05591 131 AEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---D-- 203 (321)
T ss_pred CCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---H--
Confidence 999999999999875432211 122356899999999999989999999999999999999999998643211 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-------ChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-------CMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-------t~~evl~ 587 (635)
....+..+... - +......+.+++..||+.||++|| +++++++
T Consensus 204 --~~~~i~~~~~~---~-------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 204 --LFESILHDDVL---Y-------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --HHHHHHcCCCC---C-------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11112122111 0 111123467889999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-25 Score=223.89 Aligned_cols=195 Identities=26% Similarity=0.341 Sum_probs=146.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hh-----hccccCcccchhhhhhhccccchhhccccceEEeecc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QE-----RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di 444 (635)
+.|+||+.+..+.......|+++++.... .. ....+++.+++.++.|++.||+|||+.+ ++|+||
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl 132 (269)
T cd05044 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDL 132 (269)
T ss_pred cCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 46899999988887778899999987521 00 1234788889999999999999999998 999999
Q ss_pred CCcceEeccCC-----CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCC
Q 046703 445 KAGNVLLDQDM-----NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 518 (635)
Q Consensus 445 k~~NIlld~~~-----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~ 518 (635)
||+||+++.+. .+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 133 ~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~ 212 (269)
T cd05044 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212 (269)
T ss_pred ChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCC
Confidence 99999999877 899999999976543322211222345678999999999999999999999999999998 999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
||..... ... ......+.... .+...+..+.+++.+||+.+|++||++.+|+++|+
T Consensus 213 p~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 213 PYPALNN---QEV----LQHVTAGGRLQ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCcccCH---HHH----HHHHhcCCccC---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9853221 111 11111111111 11123346778999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-25 Score=209.89 Aligned_cols=192 Identities=19% Similarity=0.218 Sum_probs=148.5
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.||||+.+.+..+.....|++++.++.. -.++...++..+-+.++||+.||.|+|.++ |||||+||+|++
T Consensus 66 ~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nll 142 (355)
T KOG0033|consen 66 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLL 142 (355)
T ss_pred hcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhhee
Confidence 357999999999988888999999988752 234456777888899999999999999999 999999999999
Q ss_pred eccC---CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 451 LDQD---MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 451 ld~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+... -.+||+|||+|..+.... ......||++|||||+++..+++..+|||+.|||||-++.|..||.....
T Consensus 143 LASK~~~A~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-- 217 (355)
T KOG0033|consen 143 LASKAKGAAVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-- 217 (355)
T ss_pred eeeccCCCceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--
Confidence 9643 348999999999886322 23347899999999999999999999999999999999999999854221
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
....+.+..|... +++.. -....+...+|+.+||..||++|.|+.|.+
T Consensus 218 -----~rlye~I~~g~yd--~~~~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 218 -----HRLYEQIKAGAYD--YPSPE----WDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -----HHHHHHHhccccC--CCCcc----cCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1233333343321 11111 111122345788899999999999998886
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=229.04 Aligned_cols=193 Identities=19% Similarity=0.194 Sum_probs=143.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|++++.+.........+|+++++.+.. ......+++..+..++.||++||.|||+.+ |+||||||+||+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIl 134 (330)
T cd05601 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVL 134 (330)
T ss_pred CCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheE
Confidence 35889998888887788999999988632 122356888999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc------CCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
++.++.+||+|||++......... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....
T Consensus 135 l~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 135 IDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 999999999999999876533222 222346899999999986 4567899999999999999999999985432
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ................+ .......+.+++..|++ +|++||++.++++
T Consensus 214 ~~------~~~~~i~~~~~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 214 SA------KTYNNIMNFQRFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HH------HHHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11 11111111111111111 11122346678888997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=220.56 Aligned_cols=196 Identities=24% Similarity=0.328 Sum_probs=148.6
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+..+......+|+++++.... ..+...+++.++..++.|++.||+|||+.+ ++|+||||+||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili 140 (268)
T cd05063 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILV 140 (268)
T ss_pred CCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEE
Confidence 5889998888888888899999987632 122346889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCcee-eeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTT-RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||++............. ....+..|+|||.+....++.++||||||+++||+++ |+.||......
T Consensus 141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--- 217 (268)
T cd05063 141 NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--- 217 (268)
T ss_pred cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---
Confidence 999999999999998664322211111 1123457999999988889999999999999999997 99998543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+..+..... .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 218 ----~~~~~i~~~~~~~~---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 ----EVMKAINDGFRLPA---------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----HHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12222222211111 112234577899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-25 Score=212.73 Aligned_cols=203 Identities=19% Similarity=0.247 Sum_probs=151.3
Q ss_pred eeeccccccccccC-----CCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 376 AMWFGDLIDMRSFP-----DGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 376 ~l~h~nLv~l~~~~-----~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
.+.|+|++.+..+. ++....||++++.... ..+...+++.+.+.|+.+|++||++||+.. ++++|
T Consensus 74 kf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH 152 (302)
T KOG2345|consen 74 KFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAH 152 (302)
T ss_pred hhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-Ccccc
Confidence 45688887765443 4566799999986531 233457899999999999999999999986 47999
Q ss_pred eccCCcceEeccCCCCccCccccceecCCCCCC-------CceeeeeeccCCCCccccc---CCCCcccCceeeeehhhH
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETE-------GNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLL 511 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~ 511 (635)
|||||.|||+.+.+.++|.|||.+....-.... ........|..|+|||.+. +..+++++|||||||+||
T Consensus 153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 999999999999999999999998765321110 0112246789999999874 346789999999999999
Q ss_pred hhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCC-cCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 512 EIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS-EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 512 eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
+|+.|..||+.... ..|.+. .+....+.-..+....+.+.+++.+|++.||.+||++.+++..++
T Consensus 233 a~mf~~sPfe~~~~--------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 233 AMMFGESPFERIYQ--------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred HHHHcCCcchHHhh--------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 99999999864211 112211 122223322223346678899999999999999999999999887
Q ss_pred CCC
Q 046703 591 SEI 593 (635)
Q Consensus 591 ~~~ 593 (635)
.+.
T Consensus 299 ~Li 301 (302)
T KOG2345|consen 299 DLI 301 (302)
T ss_pred hhc
Confidence 653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-25 Score=227.17 Aligned_cols=157 Identities=29% Similarity=0.440 Sum_probs=128.2
Q ss_pred cccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCc
Q 046703 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAP 489 (635)
Q Consensus 410 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 489 (635)
..+++.++.-++++++.|+.|||.++ .+|||||+.|||+..++.+||+|||++..+....... .+.+||+.||||
T Consensus 106 ~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAP 180 (467)
T KOG0201|consen 106 NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAP 180 (467)
T ss_pred CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccccccccch
Confidence 34488888899999999999999999 9999999999999999999999999998876544433 458999999999
Q ss_pred ccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 490 EYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 490 E~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
|++....|+.|+||||||++.+||.+|.+|+...++...+.++ .+..++ .+.+ .....+.+++.
T Consensus 181 EVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~~PP-----~L~~----~~S~~~kEFV~ 244 (467)
T KOG0201|consen 181 EVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKSAPP-----RLDG----DFSPPFKEFVE 244 (467)
T ss_pred hhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCCCCC-----cccc----ccCHHHHHHHH
Confidence 9999889999999999999999999999998776654433222 222222 2222 22234667888
Q ss_pred HhcccCCCCCCChHHHHH
Q 046703 570 LCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~ 587 (635)
.||+.||+.||+++++++
T Consensus 245 ~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHhhcCcccCcCHHHHhh
Confidence 999999999999999975
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=227.71 Aligned_cols=188 Identities=23% Similarity=0.308 Sum_probs=144.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+.........+|+++++.+... .+...+++.++..++.|++.||.|||+.+ |+||||||+||+++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~ 130 (316)
T cd05619 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLD 130 (316)
T ss_pred CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEEC
Confidence 68999999888888889999999876321 23456888999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~-- 203 (316)
T cd05619 131 TDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---E-- 203 (316)
T ss_pred CCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---H--
Confidence 99999999999987532221 1223456899999999999989999999999999999999999998643211 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP-SVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~-evl~ 587 (635)
....+..+... . +......+.+++.+||+.||++||++. ++.+
T Consensus 204 --~~~~i~~~~~~------~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 204 --LFQSIRMDNPC------Y----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --HHHHHHhCCCC------C----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11111111110 0 111223466889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-25 Score=233.68 Aligned_cols=187 Identities=21% Similarity=0.182 Sum_probs=146.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+..+|++++++.... .+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 88 l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl 164 (340)
T PTZ00426 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLL 164 (340)
T ss_pred CCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEE
Confidence 469999999998888889999999986421 23456888889999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----- 234 (340)
T PTZ00426 165 DKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----- 234 (340)
T ss_pred CCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----
Confidence 99999999999999875322 22367899999999999888999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~~ 588 (635)
.....+..+... . ... ....+.+++.+|++.||++|+ +++++++.
T Consensus 235 --~~~~~i~~~~~~--~----p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 --LIYQKILEGIIY--F----PKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --HHHHHHhcCCCC--C----CCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111222222211 0 111 122456799999999999995 89888764
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-25 Score=227.83 Aligned_cols=196 Identities=23% Similarity=0.303 Sum_probs=146.2
Q ss_pred eeccccccccccCCCCccEEEEecccchhh--------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ--------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~--------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
+.|+|++.+......+...|+++++..... .....+++.+++.++.||+.||+|||+.+
T Consensus 64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~- 142 (280)
T cd05092 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH- 142 (280)
T ss_pred CCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 468899888888777788899998875211 01135788999999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++|+||||+||++++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++
T Consensus 143 --i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 220 (280)
T cd05092 143 --FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220 (280)
T ss_pred --eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999976543221111122334678999999998999999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
|+.||...... . .......+....... ..+..+.+++.+||+.||++||++.||++.|+.
T Consensus 221 g~~p~~~~~~~---~----~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 221 GKQPWYQLSNT---E----AIECITQGRELERPR---------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred CCCCCccCCHH---H----HHHHHHcCccCCCCC---------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 88887432211 1 111111222111111 122346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-25 Score=231.51 Aligned_cols=190 Identities=19% Similarity=0.206 Sum_probs=144.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.........+|+++++.+... .+...+.+..+..++.||++||.|||+.+ |+||||||+||++
T Consensus 53 ~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili 129 (325)
T cd05602 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILL 129 (325)
T ss_pred CCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEE
Confidence 368999998888888889999999987421 23445777788889999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..
T Consensus 130 ~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~ 204 (325)
T cd05602 130 DSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM 204 (325)
T ss_pred CCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HH
Confidence 999999999999987543221 1223356899999999999999999999999999999999999998643211 11
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
...+...... .. +.....+.+++.+|++.||.+||++.+.+..
T Consensus 205 ----~~~i~~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 205 ----YDNILNKPLQ--LK--------PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ----HHHHHhCCcC--CC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1111111111 11 1122346678999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-25 Score=226.90 Aligned_cols=199 Identities=23% Similarity=0.241 Sum_probs=145.3
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+..++.. ...++.+++.+.. ......+++.+++.++.||+.||+|||+.+ ++||||||+||++
T Consensus 67 ~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~ 142 (279)
T cd05109 67 GSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLV 142 (279)
T ss_pred CCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 57788777666543 3466777766531 122346889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 143 ~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 218 (279)
T cd05109 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---- 218 (279)
T ss_pred cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 9999999999999987653322111111234568999999988899999999999999999998 88887532211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCCCC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLP 596 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~p 596 (635)
.....+..+..... +......+.+++..||+.||++||++.++++.|+....-|
T Consensus 219 ---~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 219 ---EIPDLLEKGERLPQ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---HHHHHHHCCCcCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11112222222111 1112345778999999999999999999999998775544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=220.35 Aligned_cols=200 Identities=21% Similarity=0.311 Sum_probs=142.1
Q ss_pred eeeccccccccccCCCCccEEEEecccchhhh----------hccccCcccchhhhhhhccccchhhccccceEEeeccC
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQE----------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik 445 (635)
.+.|+|++.+.........+|+++++++.... ....+++..+..++.|++.||.|||+.+ ++|+|||
T Consensus 51 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlk 127 (269)
T cd05087 51 SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLA 127 (269)
T ss_pred hCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccC
Confidence 34689999988887777889999998763210 1123456677789999999999999999 9999999
Q ss_pred CcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-------CCcccCceeeeehhhHhhhh-CC
Q 046703 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIVS-GK 517 (635)
Q Consensus 446 ~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwS~Gvvl~eilt-G~ 517 (635)
|+||+++.++.+||+|||++................++..|+|||.+... .++.++||||||+++|||++ |+
T Consensus 128 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~ 207 (269)
T cd05087 128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207 (269)
T ss_pred cceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence 99999999999999999998754332221112224467789999988542 35789999999999999996 99
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.||......+ .... .. .+......++.+... ....+.+++..|+ .+|++|||++||++.|+
T Consensus 208 ~p~~~~~~~~---~~~~---~~-~~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 208 QPYRHLSDEQ---VLTY---TV-REQQLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCChHH---HHHH---Hh-hcccCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 9986432211 1111 11 112222222222211 1223566888898 58999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=230.41 Aligned_cols=193 Identities=20% Similarity=0.224 Sum_probs=146.2
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+......+..+|+++++.... ..+...+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~ 135 (350)
T cd05573 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILID 135 (350)
T ss_pred CCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC
Confidence 4899999988888888999999987632 122357889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCC---------------------------CCCceeeeeeccCCCCcccccCCCCcccCceee
Q 046703 453 QDMNPKISDFGLARTFGGDE---------------------------TEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFS 505 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS 505 (635)
.++.+||+|||++....... .........|+..|+|||.+.+..++.++||||
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 215 (350)
T cd05573 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215 (350)
T ss_pred CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEe
Confidence 99999999999998654332 001122356899999999999999999999999
Q ss_pred eehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcC-CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-hH
Q 046703 506 FGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKG-MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-MP 583 (635)
Q Consensus 506 ~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-~~ 583 (635)
|||++|||++|+.||....... ....+... ....... .......+.+++..|++ ||.+||+ ++
T Consensus 216 lG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~-------~~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 216 LGVILYEMLYGFPPFYSDTLQE-------TYNKIINWKESLRFPP-------DPPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred cchhhhhhccCCCCCCCCCHHH-------HHHHHhccCCcccCCC-------CCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 9999999999999986433111 11111110 0000000 00123456678889997 9999999 99
Q ss_pred HHHHH
Q 046703 584 SVILM 588 (635)
Q Consensus 584 evl~~ 588 (635)
++++.
T Consensus 281 ~ll~h 285 (350)
T cd05573 281 EIKSH 285 (350)
T ss_pred HHhcC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-25 Score=225.58 Aligned_cols=201 Identities=21% Similarity=0.219 Sum_probs=142.3
Q ss_pred eccccccccccCC-----CCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPD-----GGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~-----~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+|++.+..+.. ....+|+++++.... ......+++.++..++.||+.||.|||+.+ ++||||||
T Consensus 60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp 136 (288)
T cd07863 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKP 136 (288)
T ss_pred CCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 5889988876643 245688998887531 112235788999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+||+++.++.+||+|||++........ .....++..|+|||.+.+..++.++||||+||++|||++|++||......
T Consensus 137 ~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 137 ENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred HHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 999999999999999999986543221 12246788999999999889999999999999999999999998543221
Q ss_pred CcccHHHHHHHHhhc---CCCC-------cCCCCccc---cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNK---GMPS-------EMIDPCYQ---ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~---~~~~-------~~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ........... .... ....+... ....+.....+.+++.+|++.||++|||+.|++.
T Consensus 214 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 214 D---QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred H---HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 11111111100 0000 00000000 0011122345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-25 Score=230.94 Aligned_cols=195 Identities=25% Similarity=0.330 Sum_probs=146.0
Q ss_pred eccccccccccCCCCccEEEEecccchhhh---------------------hccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQE---------------------RCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+..+......+|+++++.+.... ....+++..++.++.|++.||+|||+.+
T Consensus 61 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~- 139 (297)
T cd05089 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ- 139 (297)
T ss_pred CCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 589999998888777889999998753110 1134778888999999999999999998
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
|+||||||+||+++.++.+||+|||++....... .......+..|+|||.+....++.++|||||||++|||++
T Consensus 140 --ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~ 214 (297)
T cd05089 140 --FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSL 214 (297)
T ss_pred --cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999986432110 1111123457999999988889999999999999999997
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
|+.||...... ........+..... +......+.+++.+||+.+|.+||++++|++.|+....
T Consensus 215 g~~pf~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 215 GGTPYCGMTCA-------ELYEKLPQGYRMEK---------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCCCCCCCHH-------HHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99998543211 11222222211111 11122356789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=220.72 Aligned_cols=197 Identities=21% Similarity=0.290 Sum_probs=149.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|+|++.+..+......+|+++++.+... .+...++++.+..++.||++||.|||+.+ ++|+||||+|
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~n 136 (267)
T cd08228 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPAN 136 (267)
T ss_pred CCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHH
Confidence 58899888877776778899998876321 12345788888999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.....
T Consensus 137 il~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--- 211 (267)
T cd08228 137 VFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--- 211 (267)
T ss_pred EEEcCCCCEEECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---
Confidence 99999999999999998876433211 1224577899999999888899999999999999999999999743211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.... ............. ........+.+++.+||+.+|++||++++|++.|++.
T Consensus 212 -~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 212 -NLFS-LCQKIEQCDYPPL--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -cHHH-HHHHHhcCCCCCC--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111 1112222111111 1122335678899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=231.72 Aligned_cols=138 Identities=25% Similarity=0.319 Sum_probs=115.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+...|+++++.... ....+.+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 114 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill 190 (357)
T PHA03209 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFI 190 (357)
T ss_pred CCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 36899999988887788889999876531 223456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
+.++.+||+|||+++...... ......|+..|+|||.+.+..++.++|||||||++|||+++..++
T Consensus 191 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 191 NDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999999997532211 122356899999999999999999999999999999999866554
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=217.31 Aligned_cols=191 Identities=25% Similarity=0.299 Sum_probs=143.6
Q ss_pred ecccccccccc-CCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSF-PDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~-~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|++++.+..+ ...+..+|+++++.+.. ......+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~ni 133 (256)
T cd05082 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNV 133 (256)
T ss_pred CCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheE
Confidence 57888887764 34556789999987531 112234788899999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||+++....... ....+..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 134 l~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--- 205 (256)
T cd05082 134 LVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--- 205 (256)
T ss_pred EEcCCCcEEecCCccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999876432221 1234568999999988899999999999999999997 8888753211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.........+...... ...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 206 ----~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 206 ----KDVVPRVEKGYKMDAP---------DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----HHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111122222222111 12234577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-25 Score=223.42 Aligned_cols=195 Identities=24% Similarity=0.308 Sum_probs=146.0
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..++. ...+|+++++.+.. ..+...+++.++++++.|++.||.|||+.+ ++|+||||+||++
T Consensus 53 ~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~ 128 (257)
T cd05115 53 DNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLL 128 (257)
T ss_pred CCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEE
Confidence 5888888877765 34688999887631 123456889999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCce-eeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNT-TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||++............ ....++..|+|||.+....++.++||||||+++||+++ |..||......
T Consensus 129 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 205 (257)
T cd05115 129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--- 205 (257)
T ss_pred cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---
Confidence 99999999999999765433221111 11123568999999988889999999999999999996 99998543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.+...+..+.... .+......+.+++..||+.+|++||++.+|.+.|+..
T Consensus 206 ----~~~~~~~~~~~~~---------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 206 ----EVMSFIEQGKRLD---------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----HHHHHHHCCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1222222332211 1122234567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-25 Score=240.65 Aligned_cols=202 Identities=17% Similarity=0.168 Sum_probs=140.5
Q ss_pred eeccccccccccC--------CCCccEEEEecccchhh--------hhccccCcccchhhhhhhccccchhhccccceEE
Q 046703 377 MWFGDLIDMRSFP--------DGGQDLYIRMSASELDQ--------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~--------~~~~~lyl~~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
+.|+|++.+..+. .....+|+++++..... .....+++..+..++.||+.||+|||+.+ |+
T Consensus 116 l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---Ii 192 (440)
T PTZ00036 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---IC 192 (440)
T ss_pred cCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 3688888775542 11234678999876321 23456888889999999999999999999 99
Q ss_pred eeccCCcceEeccCC-CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCC
Q 046703 441 HRDLKAGNVLLDQDM-NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 441 H~dik~~NIlld~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
||||||+|||++.+. .+||+|||+++....... .....+++.|+|||.+.+. .++.++|||||||++|||++|..
T Consensus 193 HrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred cCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999665 699999999986543221 1224678999999988654 68999999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhc---------------CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNK---------------GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
||......+. +......+.. -....+....+...++......+.+++.+||+.||.+|||+.
T Consensus 270 pf~~~~~~~~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 270 IFSGQSSVDQ---LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred CCCCCChHHH---HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 9865432211 1111111100 000011111111111222334678899999999999999999
Q ss_pred HHHH
Q 046703 584 SVIL 587 (635)
Q Consensus 584 evl~ 587 (635)
|+++
T Consensus 347 e~l~ 350 (440)
T PTZ00036 347 EALA 350 (440)
T ss_pred HHhC
Confidence 9984
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=218.31 Aligned_cols=196 Identities=27% Similarity=0.353 Sum_probs=146.9
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+.. +...|+++++.... ..+...+++..++.++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 54 ~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~ 129 (257)
T cd05060 54 DHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLV 129 (257)
T ss_pred CCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEc
Confidence 5788888877765 44678888876532 122346889999999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCc-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
.++.+||+|||+++.......... .....++..|+|||.+....++.++||||||+++||+++ |+.||..... ..
T Consensus 130 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~ 206 (257)
T cd05060 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AE 206 (257)
T ss_pred CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HH
Confidence 999999999999987643322111 111223567999999988899999999999999999998 9999854321 11
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
....+..+..... +......+.+++.+||+.+|++||++.+|++.|++..
T Consensus 207 ----~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 207 ----VIAMLESGERLPR---------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1222222222111 1122345778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-25 Score=242.87 Aligned_cols=196 Identities=22% Similarity=0.190 Sum_probs=151.5
Q ss_pred ccccccccccC------CC-CccEEEEecccch-------hhhhccccCcccchhhhhhhccccchhhccccceEEeecc
Q 046703 379 FGDLIDMRSFP------DG-GQDLYIRMSASEL-------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444 (635)
Q Consensus 379 h~nLv~l~~~~------~~-~~~lyl~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di 444 (635)
|+|||.....+ .+ .-+++|.|||+.. .......|++.++++|+.|+++|+++||... ++||||||
T Consensus 94 h~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDL 172 (738)
T KOG1989|consen 94 HKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDL 172 (738)
T ss_pred CCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-Cccchhhh
Confidence 78887765521 22 3577888888873 1122334999999999999999999999986 77999999
Q ss_pred CCcceEeccCCCCccCccccceecCCCCCCCc-------eeeeeeccCCCCcccc---cCCCCcccCceeeeehhhHhhh
Q 046703 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEGN-------TTRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 445 k~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwS~Gvvl~eil 514 (635)
|.+||||+.++..||+|||-|........... .....-|+.|+|||.+ .+.++++|+|||+|||+||-|+
T Consensus 173 KiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC 252 (738)
T KOG1989|consen 173 KIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC 252 (738)
T ss_pred hhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH
Confidence 99999999999999999999864322211100 0112348899999977 6789999999999999999999
Q ss_pred hCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 515 SGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 515 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
....||+... ...+++..+.-...+.+..++..||..||+.||++||++-+|+..+-.+..
T Consensus 253 y~t~PFe~sg-------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 253 YFTTPFEESG-------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HhCCCcCcCc-------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 9999996421 233444555544456788899999999999999999999999988866643
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=221.20 Aligned_cols=199 Identities=19% Similarity=0.255 Sum_probs=139.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhhh----------hccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQE----------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
+.|+|++.+......+..+|+++++.+.... .....++.....++.||+.||+|||+.+ |+||||||
T Consensus 52 l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp 128 (269)
T cd05042 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLAL 128 (269)
T ss_pred CCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccH
Confidence 4699999998888888899999998864211 1122356677889999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-------CCCcccCceeeeehhhHhhhh-CCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVS-GKK 518 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwS~Gvvl~eilt-G~~ 518 (635)
+||+++.++.+||+|||++................++..|+|||.+.. ..++.++||||||+++|||++ |..
T Consensus 129 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (269)
T cd05042 129 RNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208 (269)
T ss_pred hheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999865432211111122345677999998643 356889999999999999999 777
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
||...... ... ..... .....+.++.+... ....+.+++..|| .||++|||++||+++|.
T Consensus 209 p~~~~~~~---~~~---~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 209 PYPDLSDE---QVL---KQVVR-EQDIKLPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcCCHH---HHH---HHHhh-ccCccCCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 87533211 111 11111 12222222222222 2234556777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=221.45 Aligned_cols=197 Identities=20% Similarity=0.277 Sum_probs=149.5
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|+|++.+......+..+|+++++..... .....+++..++.++.||++||.|||+.+ ++|+||||+|
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~n 136 (267)
T cd08229 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPAN 136 (267)
T ss_pred cCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 68999998888777788999998876321 12356788999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|||++|..||...... .
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~ 213 (267)
T cd08229 137 VFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-L 213 (267)
T ss_pred EEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-H
Confidence 99999999999999998765433221 12245788999999998889999999999999999999999998532111 0
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. .............. ........+.+++.+||+.||++||||.+|+++++..
T Consensus 214 ~----~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 214 Y----SLCKKIEQCDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred H----HHhhhhhcCCCCCC--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0 11111111111111 1112334577899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=222.36 Aligned_cols=188 Identities=18% Similarity=0.289 Sum_probs=141.3
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+|++.+..+.......|+++++.+.. ..+...+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 60 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Ni 136 (262)
T cd05077 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNI 136 (262)
T ss_pred hCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccE
Confidence 346999999999888778889999987632 122346889999999999999999999999 99999999999
Q ss_pred EeccCCC-------CccCccccceecCCCCCCCceeeeeeccCCCCccccc-CCCCcccCceeeeehhhHhhh-hCCCCC
Q 046703 450 LLDQDMN-------PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIV-SGKKNR 520 (635)
Q Consensus 450 lld~~~~-------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvvl~eil-tG~~pf 520 (635)
+++.++. +|++|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ .|+.|+
T Consensus 137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 137 LLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred EEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9987654 799999998654321 1245678899999886 467899999999999999998 577776
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
......+ ... ...+.. .... .....+.+++.+||+.||++||++.+|++.|+
T Consensus 211 ~~~~~~~-------~~~-~~~~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 211 KDKTLAE-------KER-FYEGQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCcchhH-------HHH-HHhcCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 4322111 111 111111 1111 11235678999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=225.48 Aligned_cols=196 Identities=27% Similarity=0.325 Sum_probs=147.3
Q ss_pred eccccccccccCCCCccEEEEecccchhh------h---------------hccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------E---------------RCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|++++.+...+.....+|+++++..... . ....+++.+++.++.|++.||+|||+.+
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g- 160 (307)
T cd05098 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK- 160 (307)
T ss_pred CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 48889988888877888999999876310 0 1135788899999999999999999998
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++|+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++
T Consensus 161 --i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 161 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred --cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876543221111111223468999999988889999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|..||..... .........+...+. +......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 239 g~~p~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 239 GGSPYPGVPV-------EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred CCCCCCcCCH-------HHHHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 8888753221 112222222222211 112234567799999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-25 Score=234.84 Aligned_cols=195 Identities=24% Similarity=0.334 Sum_probs=156.3
Q ss_pred eeccccccccccCCCCccEEEEecccch-------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASEL-------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
++|+|||++.++|-..--+||+.+||.. .+-.+..++--..+.++.||+.|+.||..+. .|||||.++|+
T Consensus 320 ikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNC 396 (1157)
T KOG4278|consen 320 IKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNC 396 (1157)
T ss_pred hcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhc
Confidence 5899999999999999999999999863 2333445566667889999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|+.++..+||+||||++++..+....... ..-++.|.|||-+....++.|+|||+|||+||||.+ |..|++..+.
T Consensus 397 LVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--- 472 (1157)
T KOG4278|consen 397 LVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--- 472 (1157)
T ss_pred cccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---
Confidence 99999999999999999986553322211 223678999999999999999999999999999987 8888765432
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
..++..+..|-..+ .+..++..+.+||+.||+.+|.+||++.||-+.+|.
T Consensus 473 ----SqVY~LLEkgyRM~---------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 473 ----SQVYGLLEKGYRMD---------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ----HHHHHHHhcccccc---------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 23444444443333 334455578899999999999999999999887764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=228.41 Aligned_cols=207 Identities=24% Similarity=0.279 Sum_probs=162.7
Q ss_pred eeeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.+.|+|||.+.+..+....++++.+|...+ ....+.|.++.+..++.++..||.|||+.. |+|||+||+|||+
T Consensus 57 ~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl 133 (808)
T KOG0597|consen 57 SLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILL 133 (808)
T ss_pred hcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeee
Confidence 468999999999999999999999998753 245788999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+..+.+|++|||+|+.+..+.. ...+..||+-|||||...+.+|+..+|+||+|||+||+.+|++||-.. .
T Consensus 134 ~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------s 204 (808)
T KOG0597|consen 134 EKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------S 204 (808)
T ss_pred cCCCceeechhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------H
Confidence 9999999999999998765432 244578999999999999999999999999999999999999998321 1
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--HcCC-CCCCCCCCCCcc
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM--LGSE-IVLPQPKQPGFL 604 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~--L~~~-~~~p~p~~p~~~ 604 (635)
+.+..+.+..... ..+......++.++.-.+++||.+|.|-.+++.. .++. ..++.|..|.+-
T Consensus 205 i~~Lv~~I~~d~v----------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 205 ITQLVKSILKDPV----------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred HHHHHHHHhcCCC----------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 1111111111111 1122334457788889999999999999988752 3333 244455555543
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=221.82 Aligned_cols=197 Identities=22% Similarity=0.327 Sum_probs=147.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+...+..+|+++++.... ......+++.+++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 62 l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nil 138 (269)
T cd05065 62 FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNIL 138 (269)
T ss_pred CCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEE
Confidence 36899999988888888899999987631 122345788999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeee---eccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVV---GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLD 526 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~ 526 (635)
++.++.+||+|||++................ .+..|+|||.+....++.++||||||+++||+++ |..||......
T Consensus 139 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 139 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred EcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999987654322211111111 1357999999998999999999999999999886 99998543211
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
... .......... .+.+.+..+.+++..||+.+|++||++.+|+++|+..
T Consensus 219 ---~~~----~~i~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 ---DVI----NAIEQDYRLP---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---HHH----HHHHcCCcCC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 1111111100 0112234567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=223.66 Aligned_cols=193 Identities=22% Similarity=0.219 Sum_probs=145.6
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|++++.+.........+|+++++++... .....+++.+++.++.||+.||.|||+.+ |+||||||+
T Consensus 50 l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 126 (280)
T cd05608 50 VHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPE 126 (280)
T ss_pred CCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 368888888887777788999999886321 12346889999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
||+++.++.+||+|||++......... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 127 Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 204 (280)
T cd05608 127 NVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 204 (280)
T ss_pred HEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 999999999999999999766433221 223568899999999999999999999999999999999999986432211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
.. .........+.. ..+......+.+++..||+.||++|| +++++++
T Consensus 205 ~~---~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 205 EN---KELKQRILNDSV----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred hH---HHHHHhhcccCC----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11 111111111100 11122334577899999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=221.98 Aligned_cols=196 Identities=22% Similarity=0.254 Sum_probs=146.9
Q ss_pred eccccccccccCCCCccEEEEecccchhhh-hccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCC
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQE-RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN 456 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~ 456 (635)
.|+|++.+..........|+++++.+.... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~ 133 (279)
T cd06619 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQ 133 (279)
T ss_pred CCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCC
Confidence 588898888887777889999998874322 2345677888899999999999999999 999999999999999999
Q ss_pred CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHH
Q 046703 457 PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAW 536 (635)
Q Consensus 457 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~ 536 (635)
+||+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||................
T Consensus 134 ~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 209 (279)
T cd06619 134 VKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209 (279)
T ss_pred EEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH
Confidence 9999999997654321 122467889999999998899999999999999999999999986533222111111112
Q ss_pred HHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 537 KLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
..........+.. ......+.+++.+||+.+|++||+++|+++.
T Consensus 210 ~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVLPV--------GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCCCC--------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2221111111111 1122346789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-25 Score=220.89 Aligned_cols=194 Identities=24% Similarity=0.294 Sum_probs=147.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+.......|+++++.+.. ......+++.+++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 49 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nil 125 (250)
T cd05085 49 YDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCL 125 (250)
T ss_pred CCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEE
Confidence 36899999888887778899999987532 122345788999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++......... ......++..|+|||.+....++.++||||||+++||+++ |..||......
T Consensus 126 i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--- 201 (250)
T cd05085 126 VGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--- 201 (250)
T ss_pred EcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---
Confidence 999999999999998764332211 1111234567999999988899999999999999999998 88898543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
........+..... +......+.+++.+|++.+|++||++.||+++|.
T Consensus 202 ----~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 202 ----QAREQVEKGYRMSC---------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11111222211111 1122346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=221.86 Aligned_cols=196 Identities=21% Similarity=0.296 Sum_probs=145.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------------------------hhccccCcccchhhhhhhccccc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------------ERCKLLDWSKRFRIICGTGRGLL 429 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------------~~~~~l~~~~~~~i~~~ia~aL~ 429 (635)
+.|+|++.+..+...+..+|+++++..... .....+++.+++.++.|++.||+
T Consensus 65 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~ 144 (288)
T cd05050 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144 (288)
T ss_pred cCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 358899988888877888999998765310 00124677788999999999999
Q ss_pred hhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehh
Q 046703 430 YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 509 (635)
Q Consensus 430 yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvv 509 (635)
|||+.+ ++||||||+||+++.++.+||+|||++.................+..|+|||.+.+..++.++|||||||+
T Consensus 145 ~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 221 (288)
T cd05050 145 YLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVV 221 (288)
T ss_pred HHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHH
Confidence 999998 99999999999999999999999999876532221111111234567999999988899999999999999
Q ss_pred hHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 510 LLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 510 l~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
+|||++ |..||..... .........+...... ......+.+++.+||+.+|++|||+.||++.
T Consensus 222 l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 222 LWEIFSYGMQPYYGMAH-------EEVIYYVRDGNVLSCP---------DNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred HHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999997 7778743211 1122222233322111 1123457889999999999999999999999
Q ss_pred HcC
Q 046703 589 LGS 591 (635)
Q Consensus 589 L~~ 591 (635)
|+.
T Consensus 286 l~~ 288 (288)
T cd05050 286 LQR 288 (288)
T ss_pred hhC
Confidence 973
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-25 Score=229.88 Aligned_cols=183 Identities=25% Similarity=0.290 Sum_probs=140.6
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+......+|+++++.+.. ..+...+++.++..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~ 135 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLD 135 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEEC
Confidence 4677777877777778899999987632 123456888999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++....... ......|++.|+|||.+....++.++|||||||++|||++|+.||...... ..
T Consensus 136 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~- 209 (323)
T cd05616 136 SEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL- 209 (323)
T ss_pred CCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HH-
Confidence 999999999999875432211 122356899999999999999999999999999999999999998643211 11
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
...+...... .+......+.+++.+|++.||++|++.
T Consensus 210 ---~~~i~~~~~~----------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 210 ---FQSIMEHNVA----------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---HHHHHhCCCC----------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1112122111 111123356789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=220.61 Aligned_cols=194 Identities=25% Similarity=0.342 Sum_probs=145.0
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+..+......+|+++++..... .....+++++++.++.|++.||+|||+.+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~- 132 (270)
T cd05047 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 132 (270)
T ss_pred cCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 58999999888887888999999875311 01234788889999999999999999998
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++|+||||+||+++.++.+||+|||++...... ........+..|+|||.+....++.++||||||+++|||++
T Consensus 133 --i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 133 --FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred --EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999999999999999998532111 01111223567999999988889999999999999999997
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|+.||...... ........+...+.. ......+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 208 g~~pf~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 208 GGTPYCGMTCA-------ELYEKLPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCccccCHH-------HHHHHHhCCCCCCCC---------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 99998532211 111222222111111 112235778999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=223.06 Aligned_cols=196 Identities=23% Similarity=0.217 Sum_probs=146.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+......+..+|+++++..... .....+++..+..++.||+.||+|||+.+ ++||||||+||
T Consensus 50 l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Ni 126 (277)
T cd05607 50 VNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENV 126 (277)
T ss_pred cCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhE
Confidence 468999998888877889999999886321 12335788888999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++.++.+||+|||++........ .....++..|+|||.+.+..++.++||||+||++|||++|+.||.........
T Consensus 127 li~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~ 203 (277)
T cd05607 127 LLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203 (277)
T ss_pred EEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH
Confidence 999999999999999987643221 12346788999999999889999999999999999999999998643221111
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
. ............. .. . .....+.+++..||+.||++||+++|+++.+.
T Consensus 204 --~-~~~~~~~~~~~~~-~~----~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 204 --E-ELKRRTLEDEVKF-EH----Q----NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred --H-HHHHHhhcccccc-cc----c----cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1 1111111111110 00 0 12234678999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=221.91 Aligned_cols=194 Identities=26% Similarity=0.418 Sum_probs=144.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|++++.+..+.. ....|+++++.... ......++++++..++.|++.||.|||+.+ ++|+||||+||
T Consensus 58 l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Ni 133 (260)
T cd05070 58 LRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANI 133 (260)
T ss_pred cCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceE
Confidence 35778877776654 34688999887531 112345788999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++.......... .....++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 134 li~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--- 209 (260)
T cd05070 134 LVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--- 209 (260)
T ss_pred EEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999998764332111 111234568999999988899999999999999999999 8888854221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.. ....+..+.... .+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 210 ~~----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 210 RE----VLEQVERGYRMP---------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HH----HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 111121211111 111223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=217.77 Aligned_cols=200 Identities=16% Similarity=0.278 Sum_probs=141.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchhhh---------hccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQE---------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+|++.+...+.....+|+++++.+.... ....+++..+..++.||++||+|||+.+ ++|+||||
T Consensus 51 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp 127 (268)
T cd05086 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLAL 127 (268)
T ss_pred ccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCcc
Confidence 34799999999888888889999998864211 1123455566789999999999999998 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-------CCCcccCceeeeehhhHhhhhC-CC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVSG-KK 518 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwS~Gvvl~eiltG-~~ 518 (635)
+||+++.++.+||+|||++................++..|+|||.+.. ..++.++||||||+++|||+++ ..
T Consensus 128 ~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 207 (268)
T cd05086 128 RNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQ 207 (268)
T ss_pred ceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCC
Confidence 999999999999999999864322111111223457789999998743 2457899999999999999974 55
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
||.... .......+ + .+....+.++.+...++ .++.+++..|| .+|++||++++|++.|.
T Consensus 208 p~~~~~---~~~~~~~~---~-~~~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 208 PYSHLS---DREVLNHV---I-KDQQVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCC---HHHHHHHH---H-hhcccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 664321 11111111 1 22223333433332222 34566888899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=226.65 Aligned_cols=144 Identities=23% Similarity=0.371 Sum_probs=113.5
Q ss_pred eeccccccccccC--CCCccEEEEecccchhh-------------hhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELDQ-------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
+.|+|++.+..+. ..+..+|+++++..... .....+++..+..++.||+.||.|||+.+ |+|
T Consensus 55 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH 131 (317)
T cd07867 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLH 131 (317)
T ss_pred CCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEc
Confidence 3588988887765 44567889998875310 11234777888899999999999999999 999
Q ss_pred eccCCcceEe----ccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhh
Q 046703 442 RDLKAGNVLL----DQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 442 ~dik~~NIll----d~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eilt 515 (635)
|||||+||++ +.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 132 ~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t 211 (317)
T cd07867 132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (317)
T ss_pred CCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh
Confidence 9999999999 45678999999999876433221 12233568899999998876 457899999999999999999
Q ss_pred CCCCCCCc
Q 046703 516 GKKNRGFY 523 (635)
Q Consensus 516 G~~pf~~~ 523 (635)
|+.||...
T Consensus 212 g~~~f~~~ 219 (317)
T cd07867 212 SEPIFHCR 219 (317)
T ss_pred CCCCcccc
Confidence 99998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=238.94 Aligned_cols=176 Identities=20% Similarity=0.272 Sum_probs=134.3
Q ss_pred cEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccc
Q 046703 394 DLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464 (635)
Q Consensus 394 ~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgl 464 (635)
.+|+++++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEeccc
Confidence 4678888876421 12345788888999999999999999999 99999999999999999999999999
Q ss_pred ceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCC
Q 046703 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMP 544 (635)
Q Consensus 465 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 544 (635)
++...............||..|+|||.+.+..++.++|||||||++|||++|+.||..... .........+..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~~~~ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLAGRY 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCC
Confidence 9876543222223346789999999999999999999999999999999999999864321 111222222222
Q ss_pred CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 545 SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
..+ +......+.+++..||+.||++||++.+++..
T Consensus 263 ~~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DPL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 11223457789999999999999999999763
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-24 Score=218.78 Aligned_cols=204 Identities=18% Similarity=0.288 Sum_probs=146.9
Q ss_pred eeccccccccccCCC--CccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.+..+... +..+|+++++.+... .....+++.+++.++.||+.||+|||+.+ ++||||||+|
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~N 139 (284)
T cd05079 63 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARN 139 (284)
T ss_pred CCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchhe
Confidence 358888887776543 467899999886321 22345889999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccC--
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL-- 525 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~-- 525 (635)
|+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++||+++++.|......
T Consensus 140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~ 219 (284)
T cd05079 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF 219 (284)
T ss_pred EEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh
Confidence 99999999999999999866432211 111124466789999999888899999999999999999998766421100
Q ss_pred ------CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 526 ------DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 526 ------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
................+..... .......+.+++.+||+.+|++|||+++|++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRVLEEGKRLPR---------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhcccccccccHHHHHHHHHcCccCCC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0001111111222222221111 112334688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=219.31 Aligned_cols=195 Identities=24% Similarity=0.302 Sum_probs=145.2
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|++|+.+..+.......|+++++.... ......+++..++.++.+++.||.|||+++ ++||||+|+||++
T Consensus 50 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili 126 (251)
T cd05041 50 DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLV 126 (251)
T ss_pred CCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEE
Confidence 5888888888877788899999987532 112345788888999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++.................+..|+|||.+.+..++.++|+||||+++||+++ |..||.......
T Consensus 127 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--- 203 (251)
T cd05041 127 GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--- 203 (251)
T ss_pred cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---
Confidence 9999999999999976542211111111233567999999988899999999999999999998 788875432111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
....+..+.... .+...+..+.+++.+||+.+|++|||+.||++.|+.
T Consensus 204 ----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 204 ----TRERIESGYRMP---------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ----HHHHHhcCCCCC---------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 111111111110 111223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=206.32 Aligned_cols=189 Identities=21% Similarity=0.300 Sum_probs=154.1
Q ss_pred eeeeccccccccccCCCCccEEEEecccch-------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 375 CAMWFGDLIDMRSFPDGGQDLYIRMSASEL-------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~~lyl~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
.-+.||||+.++.+.-+...+|+.+||... ...+.+.++++....++.|+|.||.|+|... ||||||||+
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpe 153 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPE 153 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHH
Confidence 346899999999999999999999998752 3346778999999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|+|++..+.+||+|||-+.....+ +..+..||.-|++||...+..++.++|+|++|++.||++.|.+||+.....+
T Consensus 154 nlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 154 NLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred HhccCCCCCeeccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 999999999999999998765422 2335889999999999999999999999999999999999999997654221
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..+.+..-+ +.++ ........+++.+|+..+|.+|.+..||+.
T Consensus 230 -------tYkrI~k~~---~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 230 -------TYKRIRKVD---LKFP-------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -------HHHHHHHcc---ccCC-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 222221111 1111 122234668999999999999999999876
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-25 Score=228.29 Aligned_cols=206 Identities=19% Similarity=0.278 Sum_probs=144.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|+++++.+... .....+++..+..++.||+.||+|||+.+ |+||||||+||++
T Consensus 61 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill 137 (309)
T cd07872 61 LKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLI 137 (309)
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 368999999988888889999999876321 12345788888899999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 215 (309)
T cd07872 138 NERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH 215 (309)
T ss_pred CCCCCEEECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999999765332211 122457889999998865 468899999999999999999999986543322211
Q ss_pred HHHHH--------HHHhhcCC-CCcCCCCcccc----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHA--------WKLWNKGM-PSEMIDPCYQE----SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~--------~~~~~~~~-~~~~~d~~l~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+... |..+.... ......+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 216 LIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 11111 00000000 00000000000 000111234678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=215.83 Aligned_cols=197 Identities=22% Similarity=0.284 Sum_probs=149.9
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|++++............|+++++.+... .....+++++++.++.|+++||+|||+.+ ++|+||+|+|
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~n 136 (267)
T cd08224 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPAN 136 (267)
T ss_pred CCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhh
Confidence 57888888877777778899999876311 12345788899999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 137 il~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--- 211 (267)
T cd08224 137 VFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--- 211 (267)
T ss_pred EEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---
Confidence 99999999999999998765433221 1234678899999999888899999999999999999999999753221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. .......+..+....... ......+.+++.+||+.+|++|||+.+|+++|++.
T Consensus 212 -~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 212 -N-LYSLCKKIEKCDYPPLPA--------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -c-HHHHHhhhhcCCCCCCCh--------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 111112222222221111 12334567899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-25 Score=234.24 Aligned_cols=206 Identities=23% Similarity=0.249 Sum_probs=144.0
Q ss_pred eeccccccccccCC------CCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPD------GGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~------~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.+..+.. ....+|+++++.+... .....+++..+..++.|+++||.|||+.+ |+||||||+|
T Consensus 73 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~N 149 (355)
T cd07874 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149 (355)
T ss_pred hCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHH
Confidence 46888888776543 2245799999876422 12345788888899999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus 150 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 226 (355)
T cd07874 150 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_pred EEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999997653321 11235688999999999998999999999999999999999999865432111
Q ss_pred ccHHHH---------------HHHHhhcCCC--CcC------CCCcc--ccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 529 LNLIGH---------------AWKLWNKGMP--SEM------IDPCY--QESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 529 ~~~~~~---------------~~~~~~~~~~--~~~------~d~~l--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
...... ....+.+... ... .+... ...........+.+++.+||+.||++|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 000000 0000000000 000 00000 0011112234567899999999999999999
Q ss_pred HHHHH
Q 046703 584 SVILM 588 (635)
Q Consensus 584 evl~~ 588 (635)
|+++.
T Consensus 307 ell~h 311 (355)
T cd07874 307 EALQH 311 (355)
T ss_pred HHhcC
Confidence 99984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=225.32 Aligned_cols=193 Identities=25% Similarity=0.341 Sum_probs=144.5
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+..+...+..+|+++++.+... .....+++++++.++.||+.||+|||+.+
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g- 144 (303)
T cd05088 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 144 (303)
T ss_pred CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 58899999888888888999999875210 01235788889999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
++||||||+||+++.++.+||+|||++...... ........+..|+|||.+....++.++||||||+++|||++
T Consensus 145 --i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 145 --FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred --ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhc
Confidence 999999999999999999999999998642111 11111223567999999988889999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|..||...... ........+...+. +......+.+++.+||+.+|++||++.+++++|+..
T Consensus 220 g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 220 GGTPYCGMTCA-------ELYEKLPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred CCCCcccCChH-------HHHHHHhcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99998533211 11111222211111 111223467899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=231.84 Aligned_cols=206 Identities=23% Similarity=0.234 Sum_probs=143.7
Q ss_pred eeccccccccccCC------CCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPD------GGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~------~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.+..+.. ....+|+++++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 80 l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~N 156 (364)
T cd07875 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156 (364)
T ss_pred cCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHH
Confidence 46888888766543 2346899999886422 12345778888899999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus 157 Ill~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 233 (364)
T cd07875 157 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233 (364)
T ss_pred EEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999997653321 11234678999999999999999999999999999999999999865432111
Q ss_pred ccHHHH--------HHHH-------hhcCCC-------CcCCCCcc---ccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 529 LNLIGH--------AWKL-------WNKGMP-------SEMIDPCY---QESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 529 ~~~~~~--------~~~~-------~~~~~~-------~~~~d~~l---~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
...+.. .... ..+..+ .++..... ...........+.+++.+|++.||++|||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~ 313 (364)
T cd07875 234 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313 (364)
T ss_pred HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH
Confidence 100000 0000 000000 00000000 0011111234567899999999999999999
Q ss_pred HHHHH
Q 046703 584 SVILM 588 (635)
Q Consensus 584 evl~~ 588 (635)
|+++.
T Consensus 314 e~L~h 318 (364)
T cd07875 314 EALQH 318 (364)
T ss_pred HHhcC
Confidence 99874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=227.05 Aligned_cols=140 Identities=24% Similarity=0.341 Sum_probs=117.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++..... .+.+.+++.....++.|++.||.|||+. + ++|+||||+||+
T Consensus 60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nil 136 (333)
T cd06650 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNIL 136 (333)
T ss_pred CCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEE
Confidence 368999999988877889999999886421 2345678888889999999999999974 5 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++.++.+||+|||++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 137 i~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 137 VNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred EcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999987553221 12246789999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=220.02 Aligned_cols=193 Identities=27% Similarity=0.410 Sum_probs=143.1
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+..+... ...|+++++.... ......+++..+..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 59 ~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nil 134 (260)
T cd05069 59 RHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANIL 134 (260)
T ss_pred CCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEE
Confidence 47777777666543 4578998887631 112334788889999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--- 210 (260)
T cd05069 135 VGDNLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--- 210 (260)
T ss_pred EcCCCeEEECCCccceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999998764332111 111345678999999988899999999999999999999 88887532211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
. .......+.... .+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 211 ~----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 E----VLEQVERGYRMP---------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred H----HHHHHHcCCCCC---------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 111111211111 111223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-24 Score=228.32 Aligned_cols=206 Identities=23% Similarity=0.258 Sum_probs=143.0
Q ss_pred eeccccccccccCCCC------ccEEEEecccchhhh--hccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGG------QDLYIRMSASELDQE--RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~------~~lyl~~~~~~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+.... ..+|+++++.+.... ....+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~N 153 (359)
T cd07876 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 153 (359)
T ss_pred CCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 4688888877665322 357999998764321 1345778888899999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...+....
T Consensus 154 Il~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 154 IVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred EEECCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999976432211 1224678999999999999999999999999999999999999865422110
Q ss_pred cc------------HHHHH---HHHhhcCCC-------CcCCCCcc-c--cCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 529 LN------------LIGHA---WKLWNKGMP-------SEMIDPCY-Q--ESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 529 ~~------------~~~~~---~~~~~~~~~-------~~~~d~~l-~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
.. ..... ...+..... .+...... . ..........+.+++.+||+.||++|||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 310 (359)
T cd07876 231 WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310 (359)
T ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH
Confidence 00 00000 000000000 00000000 0 001111234567899999999999999999
Q ss_pred HHHHH
Q 046703 584 SVILM 588 (635)
Q Consensus 584 evl~~ 588 (635)
|+++.
T Consensus 311 e~l~h 315 (359)
T cd07876 311 EALRH 315 (359)
T ss_pred HHhcC
Confidence 99873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=222.78 Aligned_cols=194 Identities=20% Similarity=0.308 Sum_probs=159.5
Q ss_pred eeeccccccccccCCCCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
++.|+|||.++++.+...++|+++|..+. --+..+.|++....+++.||..||.|+|... +|||||||+|+
T Consensus 73 LVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENV 149 (864)
T KOG4717|consen 73 LVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENV 149 (864)
T ss_pred HhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCccee
Confidence 45699999999999999999999997764 1245677999999999999999999999988 99999999998
Q ss_pred Eec-cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc-ccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 450 LLD-QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 450 lld-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
.+- +-|.+||.|||++..+..++ +..+..|...|.|||++.+..|. +++||||+|||||.+++|+.||+..+..+
T Consensus 150 VFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 150 VFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred EEeeecCceEeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 664 56789999999998875443 34557899999999999999997 88899999999999999999997655444
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL--MLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 592 (635)
.+.. ++|-.+ ..+..-..+|.+|+..||+.||.+|-+.+||+. .|+..
T Consensus 227 TLTm---------------ImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 227 TLTM---------------IMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred hhhh---------------hhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 3322 233332 345566778999999999999999999999985 34443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-24 Score=220.82 Aligned_cols=191 Identities=23% Similarity=0.223 Sum_probs=145.5
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+......+..+|+++++++.. ......+++..+..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil 134 (285)
T cd05605 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENIL 134 (285)
T ss_pred CCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEE
Confidence 5889998888877778899999988632 112345889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+++++.++|+|||++........ .....|+..|+|||.+.+..++.++||||+|+++||+++|+.||........
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-- 209 (285)
T cd05605 135 LDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-- 209 (285)
T ss_pred ECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--
Confidence 99999999999999987543221 1224678999999999988999999999999999999999999865332211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
.......+..+. . ..+......+.+++..||+.||++|| +++++++
T Consensus 210 -~~~~~~~~~~~~-~---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 210 -REEVERRVKEDQ-E---------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -HHHHHHHhhhcc-c---------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111111111111 0 11122334567899999999999999 7878865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=217.69 Aligned_cols=196 Identities=24% Similarity=0.329 Sum_probs=146.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------hhc-cccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERC-KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|+|++.......+ ..+|+++++.+... ... ..+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 52 ~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~n 127 (257)
T cd05040 52 SLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARN 127 (257)
T ss_pred hcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCccc
Confidence 3468899888777666 78899999875311 111 46889999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLD 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~ 526 (635)
|+++.++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 207 (257)
T cd05040 128 ILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207 (257)
T ss_pred EEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876542211 11112446778999999988899999999999999999998 99998533211
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
...... ...+.... .+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 208 ---~~~~~~---~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 208 ---QILKKI---DKEGERLE---------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---HHHHHH---HhcCCcCC---------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111111 11111111 01122346778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=218.19 Aligned_cols=203 Identities=21% Similarity=0.237 Sum_probs=145.2
Q ss_pred eccc-cccccccCCCCc------cEEEEecccchhhhh-----c---cccCcccchhhhhhhccccchhhccccceEEee
Q 046703 378 WFGD-LIDMRSFPDGGQ------DLYIRMSASELDQER-----C---KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 378 ~h~n-Lv~l~~~~~~~~------~lyl~~~~~~~~~~~-----~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
.|.| ++.+..+..... .+|+++++.+.+..+ . ..++...+..++.||++||+|||+++ |+||
T Consensus 68 ~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHR 144 (323)
T KOG0594|consen 68 SHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHR 144 (323)
T ss_pred CCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 4556 777766665444 899999998753211 1 34666778899999999999999999 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRG 521 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~ 521 (635)
||||+|||+++++.+||+|||+|+...-... .....+.|..|+|||.+.+. .|+...||||+|||+.||++++.-|+
T Consensus 145 DLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp 222 (323)
T KOG0594|consen 145 DLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP 222 (323)
T ss_pred cCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986542221 13346789999999999876 79999999999999999999998887
Q ss_pred CccCCCcccHHHHHHHHhhc---CCCC---cCCCCc-----cccC--CCHHHH---HHHHHHHHHhcccCCCCCCChHHH
Q 046703 522 FYHLDNKLNLIGHAWKLWNK---GMPS---EMIDPC-----YQES--CNLTEV---IRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~---~~~~---~~~d~~-----l~~~--~~~~~~---~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
.... ...+..+.+.+.. ..-+ .+.+-. .... ...... ....+++.+||+.+|++|.|++.+
T Consensus 223 G~se---~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a 299 (323)
T KOG0594|consen 223 GDSE---IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA 299 (323)
T ss_pred CCcH---HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence 6544 2233333332211 0000 001100 0000 000111 256789999999999999999999
Q ss_pred HHH
Q 046703 586 ILM 588 (635)
Q Consensus 586 l~~ 588 (635)
+.+
T Consensus 300 l~h 302 (323)
T KOG0594|consen 300 LTH 302 (323)
T ss_pred hcC
Confidence 875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=215.33 Aligned_cols=194 Identities=20% Similarity=0.262 Sum_probs=145.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ..+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 61 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv 137 (263)
T cd06625 61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILR 137 (263)
T ss_pred CCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 36899999988888888999999987632 123456788888999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCc-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.++|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----- 212 (263)
T cd06625 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----- 212 (263)
T ss_pred cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----
Confidence 9999999999999876543211111 0124567889999999998899999999999999999999999753211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
............... .+......+.+++.+||+.+|++|||+.++++.
T Consensus 213 -~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 213 -MAAIFKIATQPTNPQ---------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -HHHHHHHhccCCCCC---------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111111111111 111223356789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=220.10 Aligned_cols=194 Identities=25% Similarity=0.384 Sum_probs=144.6
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+...... ...|+++++.... ......+++..+..++.|+++||+|||+.+ ++|+||||+||+
T Consensus 59 ~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nil 134 (262)
T cd05071 59 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANIL 134 (262)
T ss_pred CCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEE
Confidence 57788877766543 4578999887631 112345788899999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... .....++..|+|||......++.++||||||+++|||++ |..||......
T Consensus 135 l~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--- 210 (262)
T cd05071 135 VGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--- 210 (262)
T ss_pred EcCCCcEEeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---
Confidence 9999999999999998664332211 112345678999999988899999999999999999999 77787533211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
........+... ....+....+.+++.+|++.+|++||++.++++.|+..
T Consensus 211 ----~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 211 ----EVLDQVERGYRM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----HHHHHHhcCCCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111111111111 11123345678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=215.07 Aligned_cols=191 Identities=22% Similarity=0.298 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+.....++..+|+++++.+.. ..+...++++..+.++.|++.||.|||+.+ ++|+||||+||
T Consensus 55 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~ni 131 (255)
T cd08219 55 MKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNI 131 (255)
T ss_pred CCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceE
Confidence 36899999888888888999999987631 122345788888999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......
T Consensus 132 li~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--- 206 (255)
T cd08219 132 FLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--- 206 (255)
T ss_pred EECCCCcEEEcccCcceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---
Confidence 9999999999999999766432211 12256788999999998888999999999999999999999998542211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. .......+....+. ......+.+++.+||+.||++||++.||+..
T Consensus 207 ~----~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 207 N----LILKVCQGSYKPLP---------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred H----HHHHHhcCCCCCCC---------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1 11122223222211 1122346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-24 Score=219.71 Aligned_cols=196 Identities=22% Similarity=0.335 Sum_probs=148.1
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++++..+...+..+|+++++.+.. ......+++.+++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili 139 (267)
T cd05066 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILV 139 (267)
T ss_pred CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEE
Confidence 6899999988887788899999988632 122345788899999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCce-eeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNT-TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||++............ ....++..|+|||.+.+..++.++|+||||+++||+++ |+.||......+
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-- 217 (267)
T cd05066 140 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-- 217 (267)
T ss_pred CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--
Confidence 99999999999999876533221111 11122457999999998899999999999999999886 999985432211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. .....++.... .....+..+.+++.+|++.+|++||+|.+|++.|+..
T Consensus 218 -~----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 218 -V----IKAIEEGYRLP---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -H----HHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 11122221110 0111234567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-24 Score=219.20 Aligned_cols=187 Identities=20% Similarity=0.286 Sum_probs=139.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+......+...|+++++..... .....+++..++.++.||+.||+|||+.+ |+||||||+||+
T Consensus 56 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nil 132 (258)
T cd05078 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVL 132 (258)
T ss_pred CCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 468999999888877788999999886421 22335788899999999999999999999 999999999999
Q ss_pred eccCCC--------CccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCC-CCC
Q 046703 451 LDQDMN--------PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK-KNR 520 (635)
Q Consensus 451 ld~~~~--------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~-~pf 520 (635)
++.++. +|++|||++...... ....++..|+|||.+.+. .++.++||||||+++||+++|. .|+
T Consensus 133 i~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 133 LIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred EecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 987765 488888887654321 124567899999998764 5789999999999999999985 454
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
....... . .... .. ...+ +......+.+++..||+.||++|||+++|++.|+
T Consensus 207 ~~~~~~~------~-~~~~-~~-~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 207 SALDSQK------K-LQFY-ED-RHQL---------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred hhccHHH------H-HHHH-Hc-cccC---------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 3221110 0 0011 11 1111 1111235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-24 Score=219.08 Aligned_cols=206 Identities=19% Similarity=0.207 Sum_probs=149.0
Q ss_pred eeeccccccccccCC--CC-ccEE--EEecccchh--------hhhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 376 AMWFGDLIDMRSFPD--GG-QDLY--IRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~--~~-~~ly--l~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
.+.|+|||.|..+.. .+ +.+| ++++|++.. ...+..++.-.+.-+..||.+||+|||+.+ |+||
T Consensus 73 ~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHR 149 (364)
T KOG0658|consen 73 KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHR 149 (364)
T ss_pred hcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccC
Confidence 567999999977652 22 2445 477877631 112466777788889999999999999999 9999
Q ss_pred ccCCcceEeccC-CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCC
Q 046703 443 DLKAGNVLLDQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 443 dik~~NIlld~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
||||+|+|+|.+ +.+||+|||.|+.+..++.. .+...++.|+|||.+.+. .|+.+.||||.|||+.||+.|++-|
T Consensus 150 DIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF 226 (364)
T KOG0658|consen 150 DIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF 226 (364)
T ss_pred CCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence 999999999977 89999999999988655443 346779999999988765 7999999999999999999999999
Q ss_pred CCccCCCcccHHHHHHH-----HhhcCCC-------CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 521 GFYHLDNKLNLIGHAWK-----LWNKGMP-------SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~-----~~~~~~~-------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+..+..+....+-.+.. .+....+ .++....+..-.......+.++++.++++.+|.+|.++.|++.
T Consensus 227 pG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 227 PGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 87554433332222111 1111111 1111111111122233445788999999999999999999885
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=217.69 Aligned_cols=203 Identities=23% Similarity=0.312 Sum_probs=146.5
Q ss_pred eccccccccccCCC--CccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFPDG--GQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~~~--~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|+|++.+..+... +...|+++++.+.. ......+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 64 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni 140 (284)
T cd05038 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNI 140 (284)
T ss_pred CCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhE
Confidence 57888877766543 66789999887531 112235899999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++.......... ......++..|+|||.+....++.++||||||++++||++|+.|+........
T Consensus 141 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 220 (284)
T cd05038 141 LVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL 220 (284)
T ss_pred EEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc
Confidence 99999999999999998765322111 11112345679999999888999999999999999999999998743221110
Q ss_pred c--------cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 L--------NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~--------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. ............+... ..+......+.+++.+||+.+|++||||.||+++|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 221 RMIGIAQGQMIVTRLLELLKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccccccccHHHHHHHHHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0 0111111111111111 11112235678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-24 Score=220.10 Aligned_cols=197 Identities=22% Similarity=0.331 Sum_probs=145.5
Q ss_pred eccccccccccCCCCccEEEEecccchh---h---h---------hccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD---Q---E---------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~---~---~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
.|++++.+......+...|+++++.... . . ....++++.+..++.|++.||+|||+.+ |+||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~ 143 (288)
T cd05061 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 143 (288)
T ss_pred CCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 5788888888777777899999987521 0 0 0123455677889999999999999999 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRG 521 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~ 521 (635)
||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 144 dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 144 DLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred CCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543222111122334678999999998899999999999999999998 677874
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
..... ........+...... ......+.+++.+||+.+|++|||+.++++.|+...
T Consensus 224 ~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 224 GLSNE-------QVLKFVMDGGYLDQP---------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCHH-------HHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 32211 111222222221111 112346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-24 Score=226.99 Aligned_cols=182 Identities=24% Similarity=0.287 Sum_probs=137.0
Q ss_pred ccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
|++++.+..+......+|+++++.+... .+...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 136 (324)
T cd05587 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDA 136 (324)
T ss_pred CCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcC
Confidence 3446666666666778999999976421 23456788999999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
++.+||+|||++....... .......|+..|+|||.+.+..++.++||||+||++|||++|+.||...... ..
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~-- 209 (324)
T cd05587 137 EGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL-- 209 (324)
T ss_pred CCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH--
Confidence 9999999999987532211 1223456899999999999999999999999999999999999998643211 11
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
...+..... .. +......+.+++.+||+.||++||+.
T Consensus 210 --~~~i~~~~~-~~---------~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 210 --FQSIMEHNV-SY---------PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --HHHHHcCCC-CC---------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111112111 00 11122346789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-24 Score=224.55 Aligned_cols=204 Identities=23% Similarity=0.330 Sum_probs=143.5
Q ss_pred eeccccccccccC--CCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.+..+. .+...+|+++++.+.. ......+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 62 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~n 138 (284)
T cd05081 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRN 138 (284)
T ss_pred CCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhh
Confidence 3688888876653 3445789999987531 122345889999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCc-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC-
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD- 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~- 526 (635)
|+++.++.+||+|||++........... .....++..|+|||.+.+..++.++||||||+++|||++|..++......
T Consensus 139 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 218 (284)
T cd05081 139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218 (284)
T ss_pred EEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh
Confidence 9999999999999999987643222111 11112344699999998889999999999999999999987664321100
Q ss_pred -----C--c-ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 527 -----N--K-LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 527 -----~--~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. . .............+... .........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 219 MRMMGNDKQGQMIVYHLIELLKNNGRL---------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhcccccccccchHHHHHHHhcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0 00001111111111110 11112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=215.38 Aligned_cols=193 Identities=23% Similarity=0.332 Sum_probs=148.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhc-cccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~ 446 (635)
+.|+|++.+......+..+|+++++.+.. ......+++..++.++.|++.||.|||+ .+ ++|+||+|
T Consensus 66 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~ 142 (269)
T cd08528 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTP 142 (269)
T ss_pred CCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCH
Confidence 46899999988888888999999987531 1223467888899999999999999996 56 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 143 NNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred HHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 99999999999999999998754332 222356788999999999888999999999999999999999997532111
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.. .....++....... . .....+.+++.+||+.||++||++.||..+|+
T Consensus 220 ---~~----~~~~~~~~~~~~~~----~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 ---SL----ATKIVEAVYEPLPE----G----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---HH----HHHHhhccCCcCCc----c----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 11111222111111 1 11235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-24 Score=223.47 Aligned_cols=198 Identities=20% Similarity=0.285 Sum_probs=145.2
Q ss_pred eeccccccccccCC-CCccEEEEecccchh-------hhh------ccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 377 MWFGDLIDMRSFPD-GGQDLYIRMSASELD-------QER------CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 377 l~h~nLv~l~~~~~-~~~~lyl~~~~~~~~-------~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
+.|+|++.+..+.. .+...|+.+++.... ..+ ...+++.+++.++.|++.||+|||+.+ ++|+
T Consensus 65 l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~ 141 (280)
T cd05043 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHK 141 (280)
T ss_pred CCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 36888888777643 356677777766421 111 145889999999999999999999998 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRG 521 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~ 521 (635)
||||+||+++.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||.
T Consensus 142 di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 142 DIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred ccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 9999999999999999999999986543222111112345678999999988889999999999999999998 999985
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.... .. ....+..+..... .......+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 222 ~~~~---~~----~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 222 EIDP---FE----MAAYLKDGYRLAQ---------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCH---HH----HHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 4221 11 1112222211110 1112345778999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-24 Score=230.16 Aligned_cols=184 Identities=20% Similarity=0.219 Sum_probs=146.0
Q ss_pred eccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe-c
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL-D 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll-d 452 (635)
.|+|++.+.....++..+|++++..... ....+.....++.+|+.+|+.|+.|||+++ +||||+||+|||+ +
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~ 450 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDG 450 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecC
Confidence 5999999999999999999999987642 222333333677789999999999999999 9999999999999 5
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
..++++|+|||.++..... ..+..-|..|.|||.+....+++++|+||||++||+|++|+.||.....+
T Consensus 451 ~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------ 519 (612)
T KOG0603|consen 451 SAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------ 519 (612)
T ss_pred CCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------
Confidence 8899999999999876544 22345688999999999999999999999999999999999998654333
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..+...+..+... ........+|+.+|||.||.+||+|.++..
T Consensus 520 ~ei~~~i~~~~~s------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 520 IEIHTRIQMPKFS------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHhhcCCccc------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1222233232222 122234557899999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=219.70 Aligned_cols=197 Identities=21% Similarity=0.265 Sum_probs=141.2
Q ss_pred eeccccccccccC-CCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFP-DGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~-~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+...+ ..+...|+++++..... .....+++..++.++.||++||.|||+.+ ++||||||+||
T Consensus 53 l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~ni 129 (262)
T cd05058 53 FSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNC 129 (262)
T ss_pred CCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceE
Confidence 4688888887754 34556788888875311 12334567778889999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC-CCCCCCccCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGFYHLD 526 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG-~~pf~~~~~~ 526 (635)
+++.++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++| ..||....
T Consensus 130 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-- 207 (262)
T cd05058 130 MLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-- 207 (262)
T ss_pred EEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--
Confidence 9999999999999998765322111 111123456789999999888999999999999999999995 45553221
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
...... ....+..... +...+..+.+++..||+.+|++||++.||++.|+..
T Consensus 208 -~~~~~~----~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 208 -SFDITV----YLLQGRRLLQ---------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -HHHHHH----HHhcCCCCCC---------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111 1112211111 011123577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=213.18 Aligned_cols=193 Identities=26% Similarity=0.372 Sum_probs=144.1
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+.. ....|+++++.... ......+++.+++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 59 ~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~ 134 (260)
T cd05067 59 QHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANIL 134 (260)
T ss_pred CCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEE
Confidence 5778877766653 34688999887531 122346788899999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.++|+|||++.......... .....++..|+|||.+....++.++||||||+++||+++ |+.||......
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 210 (260)
T cd05067 135 VSETLCCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--- 210 (260)
T ss_pred EcCCCCEEEccCcceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---
Confidence 9999999999999998765322111 112345678999999988889999999999999999998 99998543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
. ....+..+..... +......+.+++.+||+.+|++||++++++..|+.
T Consensus 211 ~----~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 211 E----VIQNLERGYRMPR---------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred H----HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 1111222211111 11123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-24 Score=229.26 Aligned_cols=194 Identities=18% Similarity=0.166 Sum_probs=144.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|++++.+......+..+|+++++++.. ......++...+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 100 ~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~ 176 (370)
T cd05596 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD 176 (370)
T ss_pred CCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEc
Confidence 36899999998888888999999998642 122345778888889999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC----CCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
.++.+||+|||++......... ......|++.|+|||.+... .++.++|||||||++|||++|+.||......
T Consensus 177 ~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-- 253 (370)
T cd05596 177 KSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-- 253 (370)
T ss_pred CCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--
Confidence 9999999999999875432211 12235689999999988653 4789999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCC-CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGM-PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD--RPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~evl~~ 588 (635)
. ....+..+. .....+ .......+.+++..||+.+|++ ||+++|+++.
T Consensus 254 ----~-~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 ----G-TYSKIMDHKNSLTFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----H-HHHHHHcCCCcCCCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1 111111111 111111 1112345667899999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-24 Score=218.24 Aligned_cols=191 Identities=27% Similarity=0.354 Sum_probs=146.2
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+.......|+++++.+.. ......+++..+..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 58 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nil 134 (256)
T cd05039 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVL 134 (256)
T ss_pred CCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEE
Confidence 5788888887777778899999987631 111226899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++....... ....+..|+|||.+....++.++||||||+++||+++ |+.||......
T Consensus 135 i~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--- 206 (256)
T cd05039 135 VSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--- 206 (256)
T ss_pred EeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 99999999999999986632221 1234568999999988889999999999999999997 88887533211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
........+...+.. ...+..+.+++.+||+.+|++||+++||+++|+.+
T Consensus 207 ----~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 207 ----DVVPHVEKGYRMEAP---------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----HHHHHHhcCCCCCCc---------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111222222111111 11234577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-24 Score=219.38 Aligned_cols=188 Identities=21% Similarity=0.246 Sum_probs=141.2
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+||+.+..++......|++++|.+... .....+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 72 ~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Ni 148 (274)
T cd05076 72 QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNI 148 (274)
T ss_pred cCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccE
Confidence 3579999999999888888999999887421 22456788999999999999999999998 99999999999
Q ss_pred EeccCC-------CCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhh-hCCCCC
Q 046703 450 LLDQDM-------NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIV-SGKKNR 520 (635)
Q Consensus 450 lld~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eil-tG~~pf 520 (635)
+++..+ .+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++||++ +|+.||
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 222 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222 (274)
T ss_pred EEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCc
Confidence 998643 37999999876432211 1346778999998865 56899999999999999995 688887
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
......+. .. ...... .. ... ....+.+++.+||+.+|++|||+.+|++.|+
T Consensus 223 ~~~~~~~~----~~---~~~~~~--~~-----~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 223 KERTPSEK----ER---FYEKKH--RL-----PEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred cccChHHH----HH---HHHhcc--CC-----CCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 54322111 11 111100 00 001 1124778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-24 Score=231.16 Aligned_cols=183 Identities=22% Similarity=0.279 Sum_probs=149.2
Q ss_pred eccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
.||-|+++....+....+|.+|+|...+ ..+...+++..+.-++..|+.||.|||+++ ||+||||.+|||||.
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDT 503 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcc
Confidence 5888999999999999999999998753 234567899999999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
+|.+||+|||+++..... ...+.+..||+.|||||++.+..|+..+|.|||||+||||+.|..||+..+.++...
T Consensus 504 eGh~kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd--- 578 (694)
T KOG0694|consen 504 EGHVKIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD--- 578 (694)
T ss_pred cCcEEecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---
Confidence 999999999999865422 234567899999999999999999999999999999999999999997654333211
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
.+.... ..++.-...+.+.|+.+.+..+|++|--+
T Consensus 579 ----sI~~d~----------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 ----SIVNDE----------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----HHhcCC----------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111111 11233344567789999999999999866
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=225.29 Aligned_cols=197 Identities=24% Similarity=0.292 Sum_probs=144.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..++... ..++++++.... ......+++..++.++.|++.||.|||+.+ |+|+||||+||+
T Consensus 66 l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nil 141 (303)
T cd05110 66 MDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVL 141 (303)
T ss_pred CCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceee
Confidence 4688988888776543 356666666532 122335788889999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||.....
T Consensus 142 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---- 217 (303)
T cd05110 142 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---- 217 (303)
T ss_pred ecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987643322212222345678999999988899999999999999999997 8888753211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.........+..... +......+.+++..||..+|++||++++|++.|+...
T Consensus 218 ---~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 218 ---REIPDLLEKGERLPQ---------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ---HHHHHHHHCCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111222222221111 1112345778999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=222.66 Aligned_cols=191 Identities=20% Similarity=0.282 Sum_probs=144.8
Q ss_pred eccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
.|+|++.+......+...|+++++.+.. ..+...+++.++..++.|++.||+|||+.+ |+|+||||+||+++.
T Consensus 75 ~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~ 151 (296)
T cd06654 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGM 151 (296)
T ss_pred CCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 5888988888777778899999988632 122345788899999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
++.+||+|||++......... .....++..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------ 223 (296)
T cd06654 152 DGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ 223 (296)
T ss_pred CCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 999999999998765332211 112457889999999988889999999999999999999999985432111
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
........+. .... .+......+.+++.+||+.+|++|||++||++
T Consensus 224 ~~~~~~~~~~-~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 224 ALYLIATNGT-PELQ-------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred hHHHHhcCCC-CCCC-------CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1111111111 1110 11122345678999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=212.66 Aligned_cols=193 Identities=24% Similarity=0.348 Sum_probs=145.7
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|++++.+..+.......|+++++.+.. ......++++.+..++.|++.||+|||+.+ ++|+||||+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i 133 (256)
T cd05112 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLV 133 (256)
T ss_pred CCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEE
Confidence 5788888888777777899999987632 122345788899999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++.......... .....++.+|+|||.+.+..++.++||||||+++||+++ |+.||......
T Consensus 134 ~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---- 208 (256)
T cd05112 134 GENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---- 208 (256)
T ss_pred cCCCeEEECCCcceeecccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999987654332211 111234578999999988899999999999999999998 88887542211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
........+... ..+.. ....+.+++.+||+.+|++|||+.||+++|.
T Consensus 209 ---~~~~~~~~~~~~--~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 209 ---EVVETINAGFRL--YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---HHHHHHhCCCCC--CCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111122222111 11111 2346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-24 Score=215.34 Aligned_cols=193 Identities=25% Similarity=0.331 Sum_probs=147.8
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+|++.+.........+|+++++.... ......+++..+..++.|++.||.|||+.+ ++|+||+|+||
T Consensus 54 ~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni 130 (256)
T cd06612 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNI 130 (256)
T ss_pred hCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceE
Confidence 347899999988888788999999987632 123456889999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 131 ~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~- 207 (256)
T cd06612 131 LLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA- 207 (256)
T ss_pred EECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-
Confidence 999999999999999887643321 12224578899999999988999999999999999999999999864322111
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
........... + ..+......+.+++.+||+.||++|||++||++
T Consensus 208 ------~~~~~~~~~~~-----~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 208 ------IFMIPNKPPPT-----L--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ------hhhhccCCCCC-----C--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00000111100 0 011122345778999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=238.85 Aligned_cols=201 Identities=19% Similarity=0.225 Sum_probs=136.1
Q ss_pred ccccccccccCC-CCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCcceEec
Q 046703 379 FGDLIDMRSFPD-GGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 379 h~nLv~l~~~~~-~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~NIlld 452 (635)
|.+++.+..+.. ....+|+++++.... ..+...+++.++..++.||+.||.|||++ + ||||||||+|||++
T Consensus 190 ~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~ 266 (467)
T PTZ00284 190 RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILME 266 (467)
T ss_pred CcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEe
Confidence 445555555443 334678887765321 12345688999999999999999999984 7 99999999999998
Q ss_pred cCC----------------CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC
Q 046703 453 QDM----------------NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 453 ~~~----------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG 516 (635)
.++ .+||+|||++..... ......||..|+|||.+.+..++.++|||||||++|||++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 765 489999998754221 12236789999999999999999999999999999999999
Q ss_pred CCCCCCccCCCcccHHHHHHH-----------------Hhh-cCCCCcCCCCc----cccC---CCHHHHHHHHHHHHHh
Q 046703 517 KKNRGFYHLDNKLNLIGHAWK-----------------LWN-KGMPSEMIDPC----YQES---CNLTEVIRCIHISLLC 571 (635)
Q Consensus 517 ~~pf~~~~~~~~~~~~~~~~~-----------------~~~-~~~~~~~~d~~----l~~~---~~~~~~~~~~~l~~~C 571 (635)
+.||+.....+....+..... .+. .+......++. +... ....+...+++|+.+|
T Consensus 342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 999975443222211111100 000 00000000000 0000 0001123467899999
Q ss_pred cccCCCCCCChHHHHH
Q 046703 572 VQQHPDDRPCMPSVIL 587 (635)
Q Consensus 572 l~~dP~~RPt~~evl~ 587 (635)
|+.||++|||++|+++
T Consensus 422 L~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 422 LHYDRQKRLNARQMTT 437 (467)
T ss_pred CCcChhhCCCHHHHhc
Confidence 9999999999999986
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-24 Score=223.05 Aligned_cols=183 Identities=24% Similarity=0.290 Sum_probs=138.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+......+|+++++.+... .+...+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~ 135 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLD 135 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC
Confidence 35667777777777778999999986421 23456899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...
T Consensus 136 ~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~- 209 (323)
T cd05615 136 SEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DEL- 209 (323)
T ss_pred CCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH-
Confidence 999999999999875432211 12235689999999999988999999999999999999999999864321 111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
...+..+... . +......+.+++.+||+.+|++|++.
T Consensus 210 ---~~~i~~~~~~-~---------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 210 ---FQSIMEHNVS-Y---------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---HHHHHhCCCC-C---------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111121111 0 11122356789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=223.08 Aligned_cols=205 Identities=18% Similarity=0.239 Sum_probs=144.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.... ......+++..+..++.||++||.|||+.+ ++|+||||+||++
T Consensus 61 l~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~ 137 (301)
T cd07873 61 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLI 137 (301)
T ss_pred cCCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEE
Confidence 36899999999888888999999987631 122345788889999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 138 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~ 215 (301)
T cd07873 138 NERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215 (301)
T ss_pred CCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999998764322111 112356889999998765 457899999999999999999999986543221111
Q ss_pred HHHHH--------HHHhhcC------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHA--------WKLWNKG------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~--------~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+... |..+... .........+. .........+.+++.+|++.||.+|||++||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHcCCCChhhchhhhccccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100 0000000 00000000000 000111234678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-24 Score=229.31 Aligned_cols=190 Identities=21% Similarity=0.310 Sum_probs=147.5
Q ss_pred eeccccccccccCCCCcc--EEEEecccc---h--hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQD--LYIRMSASE---L--DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~--lyl~~~~~~---~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+..+....+... +-++.+.+. + ...+.+.++.+....|++||++||.|||++. ++|||||||..||
T Consensus 98 L~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNI 176 (632)
T KOG0584|consen 98 LKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNI 176 (632)
T ss_pred CCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceE
Confidence 689999999888765555 444444443 1 3455678889999999999999999999986 7899999999999
Q ss_pred EeccC-CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+|+.+ |.+||+|+|||....... ...+.||+.|||||... ..|...+|||||||.++||+|+..||..-
T Consensus 177 FinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC----- 246 (632)
T KOG0584|consen 177 FVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC----- 246 (632)
T ss_pred EEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----
Confidence 99876 789999999998875433 23378999999999887 78999999999999999999999998532
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.-...+++....|..+.-+...- ..+ +.+++.+||.. .++|||+.|+++
T Consensus 247 -~n~AQIYKKV~SGiKP~sl~kV~-----dPe---vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 247 -TNPAQIYKKVTSGIKPAALSKVK-----DPE---VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -CCHHHHHHHHHcCCCHHHhhccC-----CHH---HHHHHHHHhcC-chhccCHHHHhh
Confidence 22234555555665444333221 122 44688999998 999999999986
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=225.05 Aligned_cols=165 Identities=29% Similarity=0.410 Sum_probs=124.5
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++................++..|+|||
T Consensus 175 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 175 VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251 (343)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence 4677788899999999999999999 9999999999999999999999999997653322211222234567899999
Q ss_pred cccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
.+.+..++.++||||||+++|||++ |..||....... ........+....... . ....+.+++.
T Consensus 252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~-----~----~~~~~~~~~~ 316 (343)
T cd05103 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRAPD-----Y----TTPEMYQTML 316 (343)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCCCC-----C----CCHHHHHHHH
Confidence 9988899999999999999999997 888875432211 1122222322221111 1 1124678999
Q ss_pred HhcccCCCCCCChHHHHHHHcCCC
Q 046703 570 LCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.||+.||++|||+.||++.|+.+.
T Consensus 317 ~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=227.40 Aligned_cols=195 Identities=17% Similarity=0.157 Sum_probs=142.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|++++.+......+..+|+++++++.. ..+...++++.+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~ 176 (370)
T cd05621 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLD 176 (370)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEC
Confidence 46899999998888888999999998642 123345788888999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC----CCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
.++.+||+|||++........ .......||..|+|||.+... .++.++||||+||++|||++|+.||......
T Consensus 177 ~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-- 253 (370)
T cd05621 177 KHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-- 253 (370)
T ss_pred CCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--
Confidence 999999999999987643221 112235689999999998654 3789999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD--RPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~evl~~ 588 (635)
................+ .......+.+++..|++.++.+ ||+++|+++.
T Consensus 254 ----~~~~~i~~~~~~~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 ----GTYSKIMDHKNSLNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----HHHHHHHhCCcccCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111111111111 1111234556777888755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=217.59 Aligned_cols=191 Identities=25% Similarity=0.298 Sum_probs=147.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+......+..+|+++++.... ......+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~ 135 (277)
T cd06642 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLS 135 (277)
T ss_pred CCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEe
Confidence 46899999988888888999999988632 123356788899999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---- 209 (277)
T cd06642 136 EQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---- 209 (277)
T ss_pred CCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----
Confidence 999999999999876543221 11224578899999999988999999999999999999999999753321110
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
...+..+.... + .......+.+++.+||+.+|++||++.+|++.
T Consensus 210 ---~~~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 210 ---LFLIPKNSPPT-----L----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---HhhhhcCCCCC-----C----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11111111111 1 11233457789999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=218.63 Aligned_cols=165 Identities=17% Similarity=0.165 Sum_probs=123.7
Q ss_pred cCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCC-----CceeeeeeccCC
Q 046703 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE-----GNTTRVVGTYGY 486 (635)
Q Consensus 412 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y 486 (635)
.++..+..++.|+++||.|||+.+ |+||||||+|||++.++.++|+|||+++.+...... .......||+.|
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y 199 (294)
T PHA02882 123 KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYY 199 (294)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccc
Confidence 467778899999999999999998 999999999999999999999999999876432111 111224689999
Q ss_pred CCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc-cHHH-HHHHHhhcCCCCcCCCCccccCCCHHHHHHH
Q 046703 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL-NLIG-HAWKLWNKGMPSEMIDPCYQESCNLTEVIRC 564 (635)
Q Consensus 487 ~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 564 (635)
+|||.+.+..++.++|||||||+++||++|+.||......... .... .....+..+.. ... .....+
T Consensus 200 ~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~ 268 (294)
T PHA02882 200 AGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI--------KIK---NANKFI 268 (294)
T ss_pred cCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh--------ccC---CCCHHH
Confidence 9999999999999999999999999999999999754222111 0000 01111111111 000 112457
Q ss_pred HHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 565 IHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 565 ~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.+++..|++.+|++||++.++++.|+
T Consensus 269 ~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 269 YDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 78999999999999999999999874
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=215.98 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=144.2
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+...... ...|+++++.... ......+++.+++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 59 ~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~ 134 (260)
T cd05073 59 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANIL 134 (260)
T ss_pred CCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEE
Confidence 57788777666555 6788998887531 112345788888999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... .....++..|+|||.+....++.++|+||||+++||+++ |+.||......
T Consensus 135 i~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--- 210 (260)
T cd05073 135 VSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--- 210 (260)
T ss_pred EcCCCcEEECCCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 9999999999999997664322211 112345678999999988889999999999999999998 88887532211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.....+..+..... .......+.+++.+|++.+|++||++.+++++|+.
T Consensus 211 ----~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 211 ----EVIRALERGYRMPR---------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----HHHHHHhCCCCCCC---------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11112222211111 11223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-24 Score=219.65 Aligned_cols=206 Identities=20% Similarity=0.267 Sum_probs=146.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+...+..+|+++++++.. ..+...+++.++..++.||+.||.|||+.+ ++|+||||+||++
T Consensus 57 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~ 133 (286)
T cd07847 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILI 133 (286)
T ss_pred CCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEE
Confidence 35889999888888888999999988742 123346889999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~ 211 (286)
T cd07847 134 TKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211 (286)
T ss_pred cCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999999876443211 112356788999998866 467899999999999999999999986443222111
Q ss_pred HHHHHHH--------HhhcCCC-CcCCCCccccCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWK--------LWNKGMP-SEMIDPCYQESCNL-----TEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~--------~~~~~~~-~~~~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+..... .+..... .....+......+. .....+.+++.+||+.+|++||++.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 1110000 0000000 00001111111111 12345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-24 Score=236.85 Aligned_cols=207 Identities=18% Similarity=0.179 Sum_probs=140.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---hh------ccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---ER------CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+.......|+++++..... .. .......+...++.||+.||.|||+.+ |+||||||+
T Consensus 220 l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~ 296 (501)
T PHA03210 220 LNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLE 296 (501)
T ss_pred CCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 469999999998888888899887654211 11 112223456679999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|||++.++.+||+|||+++.+...... ......|+..|+|||.+.+..++.++|||||||++|||++|..++.......
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 999999999999999999876533221 1223568999999999999999999999999999999999876432222111
Q ss_pred cccHHHHHHHHhhcCCCCcCCCC-----------ccc---cCC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDP-----------CYQ---ESC-----NLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~-----------~l~---~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
....+......+.. ...++.+. .+. ... .......+.+++.+||+.||++|||+.|+++.
T Consensus 376 ~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 376 PGKQLLKIIDSLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHHHhccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111111111100 00000000 000 000 00011235567889999999999999999863
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=217.58 Aligned_cols=194 Identities=27% Similarity=0.395 Sum_probs=146.7
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+..+......+|+++++.+.. ......+++.++..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nil 135 (261)
T cd05034 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNIL 135 (261)
T ss_pred CCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEE
Confidence 5888888888877778899999987532 112246889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... ......+..|+|||.+.+..++.++||||||++++|+++ |+.||..... .
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~ 211 (261)
T cd05034 136 VGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---R 211 (261)
T ss_pred EcCCCCEEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 9999999999999998764321111 111234568999999998899999999999999999998 9999853221 1
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.... ....+..... +...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 212 ~~~~----~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 212 EVLE----QVERGYRMPR---------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHH----HHHcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111 1111111110 11113457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-24 Score=227.05 Aligned_cols=192 Identities=18% Similarity=0.147 Sum_probs=142.3
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+......+..+|+++++++.. ..+...+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~ 135 (364)
T cd05599 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLD 135 (364)
T ss_pred CCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC
Confidence 5999999998888888999999988642 123456889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCC------------------------------------ceeeeeeccCCCCcccccCCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEG------------------------------------NTTRVVGTYGYMAPEYASDGQ 496 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~ 496 (635)
.++.+||+|||++..+....... ......||+.|+|||.+....
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 99999999999987653211100 011245899999999999999
Q ss_pred CcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCC-CCcCCCCccccCCCHHHHHHHHHHHHHhcccC
Q 046703 497 FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGM-PSEMIDPCYQESCNLTEVIRCIHISLLCVQQH 575 (635)
Q Consensus 497 ~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~d 575 (635)
++.++|||||||++|||++|+.||...... ... ..+.... ....... ......+.+++.+|+. +
T Consensus 216 ~~~~~DiwSlG~il~el~~G~~Pf~~~~~~---~~~----~~i~~~~~~~~~~~~-------~~~s~~~~~li~~ll~-~ 280 (364)
T cd05599 216 YNKECDWWSLGVIMYEMLVGYPPFCSDNPQ---ETY----RKIINWKETLQFPDE-------VPLSPEAKDLIKRLCC-E 280 (364)
T ss_pred CCCeeeeecchhHHHHhhcCCCCCCCCCHH---HHH----HHHHcCCCccCCCCC-------CCCCHHHHHHHHHHcc-C
Confidence 999999999999999999999998643211 111 1111111 0111110 0112245567778886 8
Q ss_pred CCCCCC---hHHHHH
Q 046703 576 PDDRPC---MPSVIL 587 (635)
Q Consensus 576 P~~RPt---~~evl~ 587 (635)
|.+|++ ++|+++
T Consensus 281 p~~R~~~~~~~~ll~ 295 (364)
T cd05599 281 AERRLGNNGVNEIKS 295 (364)
T ss_pred HhhcCCCCCHHHHhc
Confidence 999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-24 Score=219.03 Aligned_cols=208 Identities=19% Similarity=0.246 Sum_probs=148.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+.++...+..+|+++++.+... .+...+++.++..++.||+.||.|||+.+ ++|+||+|+||++
T Consensus 57 l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~ 133 (288)
T cd07833 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILV 133 (288)
T ss_pred cCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 358888888888877888999999887421 23345889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++......... ......++..|+|||.+... .++.++||||||+++||+++|+.||......+...
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 212 (288)
T cd07833 134 SESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212 (288)
T ss_pred CCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999876543321 11224578889999999888 88999999999999999999999986432211110
Q ss_pred HHHHHHHHhh---------cCC--CCcCCCCc----cccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWN---------KGM--PSEMIDPC----YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~---------~~~--~~~~~d~~----l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.......... ... ..+..+.. ....++......+.+++..||+.+|++|||+++|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000000 000 00000000 0011112225668899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=221.84 Aligned_cols=196 Identities=19% Similarity=0.166 Sum_probs=142.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|++++.+......+..+|+++++++.. ..+...++...+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~ 176 (371)
T cd05622 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD 176 (371)
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEC
Confidence 36899999988888888999999988632 123345778888899999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC----CCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
.++.+||+|||++......... ......||+.|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 177 ~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--- 252 (371)
T cd05622 177 KSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--- 252 (371)
T ss_pred CCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---
Confidence 9999999999999876432211 12235689999999998654 378999999999999999999999864321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD--RPCMPSVILML 589 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~evl~~L 589 (635)
.................+ .......+.+++..|++.++.+ ||+++||++..
T Consensus 253 ---~~~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 253 ---VGTYSKIMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---HHHHHHHHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111111111111111 1112234567888899844433 78999988743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-24 Score=219.66 Aligned_cols=196 Identities=21% Similarity=0.251 Sum_probs=146.5
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+..++.. ...++++++.+... .....+++..++.++.||+.||+|||+.+ ++|+||||+||++
T Consensus 67 ~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~ 142 (279)
T cd05057 67 DHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLV 142 (279)
T ss_pred CCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEE
Confidence 58888888777665 67888888875321 12345889999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++...............++..|+|||.+....++.++|+||||+++||+++ |+.||......
T Consensus 143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 218 (279)
T cd05057 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---- 218 (279)
T ss_pred cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----
Confidence 9999999999999987653322111111223567999999988899999999999999999998 99998643221
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
........+..... +......+.+++..||..+|++||++.++++.|+...
T Consensus 219 ---~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 219 ---EIPDLLEKGERLPQ---------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ---HHHHHHhCCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11122222221111 1112234678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=227.05 Aligned_cols=196 Identities=20% Similarity=0.206 Sum_probs=140.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++++.+......+..+|+++|+.+... .+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 58 l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili 134 (381)
T cd05626 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILI 134 (381)
T ss_pred cCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEE
Confidence 368999999888888889999999986421 23456788888899999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCC---------------------------------------------CCceeeeeeccCC
Q 046703 452 DQDMNPKISDFGLARTFGGDET---------------------------------------------EGNTTRVVGTYGY 486 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y 486 (635)
+.++.+||+|||++..+..... ........||..|
T Consensus 135 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 9999999999999764321000 0001234689999
Q ss_pred CCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHH
Q 046703 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIH 566 (635)
Q Consensus 487 ~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 566 (635)
+|||.+.+..++.++|||||||++|||++|+.||......+. ............... ....+ ..+.+
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~~~---~~~~s----~~~~d 281 (381)
T cd05626 215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET------QLKVINWENTLHIPP---QVKLS----PEAVD 281 (381)
T ss_pred cCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCCCC---CCCCC----HHHHH
Confidence 999999988999999999999999999999999864322111 111111011111100 00112 23444
Q ss_pred HHHH--hcccCCCCCCChHHHHHH
Q 046703 567 ISLL--CVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 567 l~~~--Cl~~dP~~RPt~~evl~~ 588 (635)
++.+ |+..+|..||+++||+..
T Consensus 282 li~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 282 LITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHccCcccccCCCCHHHHhcC
Confidence 5544 667778889999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=213.57 Aligned_cols=190 Identities=26% Similarity=0.343 Sum_probs=141.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+...... ...|+++++.... ......+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 56 ~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~ni 131 (254)
T cd05083 56 LHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNI 131 (254)
T ss_pred CCCCCcCeEEEEEcC-CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceE
Confidence 357788777666543 3478889887531 122335788888999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++........ ....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......
T Consensus 132 li~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 204 (254)
T cd05083 132 LVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-- 204 (254)
T ss_pred EEcCCCcEEECCCccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--
Confidence 999999999999999876432211 1233567999999988899999999999999999997 88887543211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
........+...+. ....+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 205 -----~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 205 -----EVKECVEKGYRMEP---------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----HHHHHHhCCCCCCC---------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11222222221111 11223457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=227.29 Aligned_cols=201 Identities=23% Similarity=0.267 Sum_probs=139.9
Q ss_pred eeeccccccccccCCC------CccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPDG------GQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~------~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+|++.+..+... ...+|+++++.... ..+...+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp 146 (343)
T cd07878 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKP 146 (343)
T ss_pred hcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCh
Confidence 3468888887765421 24578888765421 123456899999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+||+++.++.+||+|||++....... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 147 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 147 SNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred hhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999998654321 22467899999999876 5688999999999999999999999864321
Q ss_pred CCcccHHHHHHHHhhc-----------C-------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNK-----------G-------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~-----------~-------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+ .+......... . .........+.... ......+.+++.+|++.||++|||+.|+++
T Consensus 222 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 222 ID---QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HH---HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 11111110000 0 00000000000000 001123678999999999999999999986
Q ss_pred H
Q 046703 588 M 588 (635)
Q Consensus 588 ~ 588 (635)
.
T Consensus 298 h 298 (343)
T cd07878 298 H 298 (343)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-24 Score=220.09 Aligned_cols=202 Identities=19% Similarity=0.236 Sum_probs=142.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+..+...+..+|+++++.+... .....+++..+..++.||++||.|||+.+ ++|+||||+||
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~ni 132 (285)
T cd07861 56 LQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNL 132 (285)
T ss_pred cCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHE
Confidence 458999999988888889999999876311 11256888899999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||++++||++|+.||........
T Consensus 133 l~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 133 LIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred EEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999999999976532211 11123567889999987654 578999999999999999999999864321110
Q ss_pred ccHHHHHHHHhhc----------------CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNK----------------GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~----------------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.......+.. ............. .......++.+++.+||+.||++|||+.+|+.
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 211 ---LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ---HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0000000000000 00012234668999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=213.86 Aligned_cols=193 Identities=24% Similarity=0.278 Sum_probs=143.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+......+...|+++++..... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+
T Consensus 59 l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nil 135 (282)
T cd06643 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNIL 135 (282)
T ss_pred CCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEE
Confidence 368999988887777788999999876321 22356899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
++.++.+||+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|+.||.....
T Consensus 136 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 136 FTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred EccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 99999999999999876532211 122246788999999873 44578899999999999999999999854321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. .. ... ........... +......+.+++.+||+.||++||++.++++.
T Consensus 214 ~---~~---~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 214 M---RV---LLK-IAKSEPPTLAQ-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred H---HH---HHH-HhhcCCCCCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11 111 11111111111 11122356789999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-24 Score=217.94 Aligned_cols=195 Identities=26% Similarity=0.385 Sum_probs=147.7
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+..+......+|+++++..... .+...+++.++..++.||++||.+||+.+ ++|+||||+||+++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~ 132 (260)
T PF00069_consen 56 RHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLD 132 (260)
T ss_dssp TBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEES
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc
Confidence 69999998888877889999999887521 24678899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.++|+|||.+...... ........++..|+|||.+. ....+.++||||+|+++++|++|..||......+....
T Consensus 133 ~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~ 210 (260)
T PF00069_consen 133 ENGEVKLIDFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI 210 (260)
T ss_dssp TTSEEEESSGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH
T ss_pred ccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 9999999999999864211 12222356788999999998 88899999999999999999999999864411111111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.............. . .......+.+++..||+.||++||++.++++
T Consensus 211 ~~~~~~~~~~~~~~-------~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 211 IEKILKRPLPSSSQ-------Q---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHTHHHHHTT-------S---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhhccccccccccc-------c---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111100000000 0 0001156788999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=220.06 Aligned_cols=205 Identities=20% Similarity=0.255 Sum_probs=145.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+......+..+|+++++.+... .+.+.+++..+..++.||++||.|||+ .+ ++|+||||+||+
T Consensus 56 l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil 132 (308)
T cd06615 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNIL 132 (308)
T ss_pred CCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEE
Confidence 468999999988888889999999876321 234567888899999999999999997 46 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 133 ~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 208 (308)
T cd06615 133 VNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208 (308)
T ss_pred EecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence 9999999999999987553221 122467889999999988889999999999999999999999985432111100
Q ss_pred HHHHHHHHhhcCCCC-----------------cCCCCcc----ccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPS-----------------EMIDPCY----QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~-----------------~~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
............... +..+... ...........+.+++.+||+.+|++|||+++|++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000 0000000 000000123347789999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-24 Score=232.45 Aligned_cols=164 Identities=26% Similarity=0.360 Sum_probs=123.6
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 235 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 235 ALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 3566677889999999999999998 9999999999999999999999999998653322111112234678899999
Q ss_pred cccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
.+....++.++||||||+++|||++ |+.||......+ .....+..+..... +......+.+++.
T Consensus 312 ~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~~~~~~~~~~~~~---------p~~~~~~l~~li~ 376 (401)
T cd05107 312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QFYNAIKRGYRMAK---------PAHASDEIYEIMQ 376 (401)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HHHHHHHcCCCCCC---------CCCCCHHHHHHHH
Confidence 9988889999999999999999998 888875432111 11222222221111 1112345778999
Q ss_pred HhcccCCCCCCChHHHHHHHcCC
Q 046703 570 LCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.||+.+|++||+++||++.|+.+
T Consensus 377 ~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 377 KCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=223.82 Aligned_cols=193 Identities=24% Similarity=0.341 Sum_probs=149.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhcccc--CcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLL--DWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
.+.|+|||+..+.+..+..+-|.||..+.+ +.+=.+| ++.++-.+.+||++||.|||++. |||||||-.
T Consensus 628 ~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGD 704 (1226)
T KOG4279|consen 628 TLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGD 704 (1226)
T ss_pred HHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCC
Confidence 457999999888877777777888776542 3344455 67777788999999999999998 999999999
Q ss_pred ceEecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC--CCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 448 NVLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 448 NIlld~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
|+|++. .|.+||+|||-++.+..- ...+.+..||..|||||++..+ .|..++|||||||.+.||.||++||-...
T Consensus 705 NVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 705 NVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred cEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 999974 688999999999876432 2345568899999999999766 47899999999999999999999984322
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... ...++-|... ...+.+.+-..++..++++|+.+||.+||+++++++
T Consensus 783 spq--------AAMFkVGmyK------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 783 SPQ--------AAMFKVGMYK------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred Chh--------Hhhhhhccee------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 111 1112222211 123345566777889999999999999999999986
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=223.26 Aligned_cols=142 Identities=25% Similarity=0.251 Sum_probs=119.9
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+.........+|+++++++.. ..+.+.+++.++..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~ 135 (363)
T cd05628 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLD 135 (363)
T ss_pred CCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEEC
Confidence 5888999888888888999999998642 123567899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCC---------------------------------CCceeeeeeccCCCCcccccCCCCcc
Q 046703 453 QDMNPKISDFGLARTFGGDET---------------------------------EGNTTRVVGTYGYMAPEYASDGQFSV 499 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 499 (635)
.++.+||+|||+++....... ........||..|+|||.+.+..++.
T Consensus 136 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 215 (363)
T cd05628 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK 215 (363)
T ss_pred CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence 999999999999875432110 00012357899999999999999999
Q ss_pred cCceeeeehhhHhhhhCCCCCCC
Q 046703 500 KSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 500 ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
++|||||||++|||++|+.||..
T Consensus 216 ~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 216 LCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred chhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=212.13 Aligned_cols=186 Identities=18% Similarity=0.270 Sum_probs=139.0
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+...... ...|+++++..... .....+++..++.++.||+.||+|||+.+ |+|+||||+||+
T Consensus 58 l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nil 133 (259)
T cd05037 58 LSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNIL 133 (259)
T ss_pred CCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEE
Confidence 468888888776655 66789998876321 11226888999999999999999999998 999999999999
Q ss_pred eccCC-------CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC--CCcccCceeeeehhhHhhhh-CCCCC
Q 046703 451 LDQDM-------NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVS-GKKNR 520 (635)
Q Consensus 451 ld~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvvl~eilt-G~~pf 520 (635)
++.++ .+||+|||++..... .....++..|+|||.+... .++.++||||||+++|||++ |..|+
T Consensus 134 l~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~ 207 (259)
T cd05037 134 VARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207 (259)
T ss_pred EecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence 99887 799999999976533 1123456789999998776 78999999999999999999 46666
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
......+. ...+..... ... .....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 208 ~~~~~~~~-------~~~~~~~~~--~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 208 STLSSSEK-------ERFYQDQHR--LPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ccCCchhH-------HHHHhcCCC--CCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 43321111 011111110 000 01146778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=216.68 Aligned_cols=204 Identities=18% Similarity=0.208 Sum_probs=144.0
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+..+...+|+++++.+... .....+++..+..++.||++||.|||+.+ ++|+||||+||++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~ 132 (284)
T cd07839 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLI 132 (284)
T ss_pred cCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEE
Confidence 468999999888888889999999886321 22456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ...
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~ 208 (284)
T cd07839 133 NKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDD 208 (284)
T ss_pred cCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHH
Confidence 9999999999999976543211 11224567899999988664 468999999999999999999988532211 111
Q ss_pred HHHHHHHHhhcCC------CCcCCCC----cccc-----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGM------PSEMIDP----CYQE-----SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~------~~~~~d~----~l~~-----~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............. ..+..+. .... ...+.....+.+++.+||+.||.+|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 1111111100000 0000000 0000 011112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-24 Score=219.06 Aligned_cols=203 Identities=24% Similarity=0.299 Sum_probs=146.2
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+...+..+|+++++.+... .....+++.+++.++.||++||+|||+.+ ++|+||+|+||++
T Consensus 57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~ 133 (286)
T cd07846 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILV 133 (286)
T ss_pred cCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEE
Confidence 468999999999988889999999886421 22345899999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|++||......+
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~--- 208 (286)
T cd07846 134 SQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID--- 208 (286)
T ss_pred CCCCcEEEEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---
Confidence 99999999999999876433221 122457889999998865 457889999999999999999999885432111
Q ss_pred HHHHHHHHhhc-----------CCC-CcCCCCcccc-----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNK-----------GMP-SEMIDPCYQE-----SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~-----------~~~-~~~~d~~l~~-----~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
........... ... ..+..+.... ...+.....+.+++.+||+.+|++||++++|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 11111110000 000 0000000000 001122456888999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=221.58 Aligned_cols=187 Identities=26% Similarity=0.291 Sum_probs=152.6
Q ss_pred eeeccccccccccCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|||.|+.+++.-....-+++|+|+-. ....+++|.+-++..|..+.+.||+|||+.+ .||||||+.|||
T Consensus 82 ~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNIL 158 (948)
T KOG0577|consen 82 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNIL 158 (948)
T ss_pred hccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceE
Confidence 56899999999998888888999998853 3456789999999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.+.+.+||+|||.|.+... ..+++||+.|||||.+. .+.|+-|+||||+|+...|+...++|.-.
T Consensus 159 Lse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn----- 227 (948)
T KOG0577|consen 159 LSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----- 227 (948)
T ss_pred ecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-----
Confidence 99999999999999976532 33478999999999874 57899999999999999999999888421
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
.....+...+.+...+-+. ..+-...+++++-.||+.-|.+|||.++++
T Consensus 228 --MNAMSALYHIAQNesPtLq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 228 --MNAMSALYHIAQNESPTLQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred --chHHHHHHHHHhcCCCCCC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 1112233344444444433 234456788899999999999999998875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=215.73 Aligned_cols=190 Identities=22% Similarity=0.292 Sum_probs=138.3
Q ss_pred eccccccccccCCC------CccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeecc
Q 046703 378 WFGDLIDMRSFPDG------GQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444 (635)
Q Consensus 378 ~h~nLv~l~~~~~~------~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di 444 (635)
.|+|++.+...... ...+|+++++.... ......+++..+..++.|++.||+|||+.+ |+|+||
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl 137 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDI 137 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 47888776665421 34688999987631 112346788889999999999999999998 999999
Q ss_pred CCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCC
Q 046703 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 445 k~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
||+||+++.++.+||+|||++........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.|
T Consensus 138 ~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p 215 (272)
T cd06637 138 KGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215 (272)
T ss_pred CHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999976533221 122356888999999885 34678899999999999999999999
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
|....... .... ..........+. .....+.+++.+||+.+|.+|||+.||++
T Consensus 216 ~~~~~~~~------~~~~-~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 216 LCDMHPMR------ALFL-IPRNPAPRLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ccccCHHH------HHHH-HhcCCCCCCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 85322111 1111 111111111111 12235778999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=209.13 Aligned_cols=190 Identities=25% Similarity=0.321 Sum_probs=143.1
Q ss_pred eccccccccccCC-CCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFPD-GGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~~-~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|++++.+..... ....+|+++++.+.. ......+++.++..++.|++.||+|||+.+ ++|+||||+||
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~ni 133 (257)
T cd08223 57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNV 133 (257)
T ss_pred CCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhE
Confidence 5777777665543 344688999887531 112345889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||++++|+++|+.||.....
T Consensus 134 l~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---- 207 (257)
T cd08223 134 FLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---- 207 (257)
T ss_pred EEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----
Confidence 999999999999999987643222 12235678899999999999999999999999999999999999853221
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. .....+..+..... +......+.+++.+|++.+|++||++.++++.
T Consensus 208 --~-~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 208 --N-SLVYRIIEGKLPPM---------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --H-HHHHHHHhcCCCCC---------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 11111222322211 11233457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-24 Score=215.29 Aligned_cols=192 Identities=21% Similarity=0.324 Sum_probs=145.6
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+.......|+++++.+... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~ 139 (267)
T cd06628 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILV 139 (267)
T ss_pred cCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEE
Confidence 368999998888877888999998875321 23356788889999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCC----ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEG----NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++.+||+|||+++....+.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-- 217 (267)
T cd06628 140 DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-- 217 (267)
T ss_pred cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--
Confidence 999999999999998765321111 11124578899999999988999999999999999999999999864211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...... ........+ +......+.+++.+||+.||++||++.||++
T Consensus 218 ----~~~~~~-~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 218 ----LQAIFK-IGENASPEI---------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HHHHHH-HhccCCCcC---------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111 111111111 1122345678899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=217.08 Aligned_cols=193 Identities=22% Similarity=0.312 Sum_probs=146.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+......+...|+++++.+... .....+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 76 l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~ 152 (292)
T cd06658 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLT 152 (292)
T ss_pred CCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEc
Confidence 368999998888777889999999886421 22456889999999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++||+++|+.||...... ...
T Consensus 153 ~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~ 227 (292)
T cd06658 153 SDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM 227 (292)
T ss_pred CCCCEEEccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 9999999999998765432221 22356889999999998889999999999999999999999998532211 111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. ...........+ .......+..++.+||+.||++|||++||++.
T Consensus 228 ~----~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 228 R----RIRDNLPPRVKD-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred H----HHHhcCCCcccc-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 111111111111 01122346678889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=221.10 Aligned_cols=143 Identities=18% Similarity=0.214 Sum_probs=114.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+.......|+++++++... .....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 56 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Ni 132 (327)
T cd08227 56 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHI 132 (327)
T ss_pred cCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhE
Confidence 479999999988888889999999886321 12345889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCC-----ceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEG-----NTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+++.++.+++.||+............ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 133 l~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 133 LISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred EEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999998654432111000 0111345678999999876 4688999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=214.82 Aligned_cols=196 Identities=22% Similarity=0.285 Sum_probs=144.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+.........+|+++++.... ..+...+++.++..++.|++.||.|||+.+ |+|+||+|+||++
T Consensus 63 ~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill 139 (267)
T cd06646 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILL 139 (267)
T ss_pred cCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEE
Confidence 36889998888877778899999987632 123456888899999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||........
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~ 217 (267)
T cd06646 140 TDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred CCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence 9999999999999986642211 112245788999999874 34578899999999999999999999743221111
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
. . ....... ..+.... .......+.+++.+||+.+|++|||+++|++.|
T Consensus 218 ~------~-~~~~~~~---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 218 L------F-LMSKSNF---QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred h------e-eeecCCC---CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 0 0000000 0011110 111234677899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=226.83 Aligned_cols=144 Identities=24% Similarity=0.270 Sum_probs=118.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++|+.+.....++..+|+++++++.. ..+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 58 ~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl 134 (382)
T cd05625 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILI 134 (382)
T ss_pred CCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 36899999998888888999999988642 123356788888899999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCC---------------------------------------------CCCceeeeeeccCC
Q 046703 452 DQDMNPKISDFGLARTFGGDE---------------------------------------------TEGNTTRVVGTYGY 486 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~---------------------------------------------~~~~~~~~~gt~~y 486 (635)
+.++.+||+|||++..+.... .........||+.|
T Consensus 135 ~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (382)
T cd05625 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY 214 (382)
T ss_pred CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence 999999999999975331000 00001124689999
Q ss_pred CCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 487 ~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 215 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-23 Score=213.05 Aligned_cols=191 Identities=25% Similarity=0.323 Sum_probs=147.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+.....++..+|+++++.... ......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~ 132 (274)
T cd06609 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLS 132 (274)
T ss_pred cCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEC
Confidence 35888888888777778899999887531 112237899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------ 204 (274)
T cd06609 133 EEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------ 204 (274)
T ss_pred CCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------
Confidence 999999999999987653321 122346788899999999888999999999999999999999998543211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
........+....+.... ....+.+++.+||+.+|++|||++++++
T Consensus 205 -~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 205 -RVLFLIPKNNPPSLEGNK--------FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -HHHHHhhhcCCCCCcccc--------cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111122222222222110 2334678999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=215.10 Aligned_cols=191 Identities=23% Similarity=0.256 Sum_probs=141.7
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+.........+|+++++.... ......+++.++..++.|++.||.|||+.+ |+|+||||+||+
T Consensus 58 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil 134 (285)
T cd05630 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENIL 134 (285)
T ss_pred CCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEE
Confidence 4778888877777777899999987531 112235888889999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.++|+|||++........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~ 211 (285)
T cd05630 135 LDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211 (285)
T ss_pred ECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH
Confidence 99999999999999876543221 112468899999999999999999999999999999999999986532211111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
......... ... . .......+.+++..||+.||++||| ++|+++
T Consensus 212 ~~~~~~~~~----~~~-----~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 212 EVERLVKEV----QEE-----Y----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHhhhhhh----hhh-----c----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111111100 000 0 1111234668899999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=212.82 Aligned_cols=194 Identities=22% Similarity=0.262 Sum_probs=145.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+......+..+|+++++.... ......+++.++..++.|++.||+|||+.+ ++|+||+|+||+
T Consensus 57 ~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~ 133 (262)
T cd06613 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANIL 133 (262)
T ss_pred CCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEE
Confidence 36899999888877788999999987531 122357889999999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC---CCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
++.++.+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||.......
T Consensus 134 i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 134 LTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred ECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876543211 11224578889999998776 88999999999999999999999985432111
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..... ..... ....+. ........+.+++.+||+.+|++|||+++|+.
T Consensus 212 ------~~~~~-~~~~~---~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 212 ------ALFLI-SKSNF---PPPKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ------HHHHH-HhccC---CCcccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111 11100 001111 12233456788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=209.54 Aligned_cols=191 Identities=22% Similarity=0.318 Sum_probs=148.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+......+|+++++.... ..+...+++.++..++.|++++|+|||+.+ ++|+||+|+||+
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~ 133 (256)
T cd08221 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIF 133 (256)
T ss_pred CCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEE
Confidence 5889998888888888999999987631 112345788899999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 134 ~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---- 207 (256)
T cd08221 134 LTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---- 207 (256)
T ss_pred EeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----
Confidence 99999999999999987644332 122356788999999998888999999999999999999999998542211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
. ....+..+...... ......+.+++.+||+.+|++||+++++++.+
T Consensus 208 --~-~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 208 --N-LVVKIVQGNYTPVV---------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --H-HHHHHHcCCCCCCc---------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 11112223322211 12234577899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=218.18 Aligned_cols=205 Identities=22% Similarity=0.256 Sum_probs=144.2
Q ss_pred eccccccccccCCCC--ccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGG--QDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~--~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+..+. ..+|+++++.... ......+++.+++.++.||++||+|||+.+ ++|+||||+||+
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nil 138 (293)
T cd07843 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLL 138 (293)
T ss_pred CCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEE
Confidence 588998887766545 7899999987631 122345899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++......... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+..
T Consensus 139 i~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~ 216 (293)
T cd07843 139 LNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216 (293)
T ss_pred ECCCCcEEEeecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999876543211 1224567889999988654 4689999999999999999999998654322111
Q ss_pred cHHHH--------HHHHhhc------CCCCcCCCCccccCCCHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGH--------AWKLWNK------GMPSEMIDPCYQESCNLT-EVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~--------~~~~~~~------~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..+.. .|..+.+ ..........+...++.. ....+.+++..||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 11100 0110000 000111111111111111 2445678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=215.00 Aligned_cols=193 Identities=26% Similarity=0.370 Sum_probs=143.2
Q ss_pred ccccccccccCCCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCcc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAGN 448 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~N 448 (635)
|+|++.+..........|+++++.... ......+++..+..++.|+++||+|||+. + ++||||||+|
T Consensus 62 ~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~N 138 (288)
T cd06616 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSN 138 (288)
T ss_pred CCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHH
Confidence 788988888777777888888886531 11235688899999999999999999975 6 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC---CCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
|+++.++.+||+|||++......... ....++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 139 il~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~- 214 (288)
T cd06616 139 ILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN- 214 (288)
T ss_pred EEEccCCcEEEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-
Confidence 99999999999999998765432211 223578899999998766 68899999999999999999999986432
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
......... ..+....+ ...........+.+++.+||+.+|++|||+++|++.
T Consensus 215 ----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 215 ----SVFDQLTQV-VKGDPPIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----hHHHHHhhh-cCCCCCcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111 11221111 111112234457889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-23 Score=213.48 Aligned_cols=192 Identities=24% Similarity=0.262 Sum_probs=143.1
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+......+..+|+++++.+... .....+++..+..++.|++.+|.|||+.+ ++|+||||+||++
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili 143 (292)
T cd06644 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLL 143 (292)
T ss_pred CCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEE
Confidence 58888888887777778999999886421 22456899999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+.++.+||+|||++....... .......++..|+|||.+. ...++.++|||||||++|||++|+.||......
T Consensus 144 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 221 (292)
T cd06644 144 TLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221 (292)
T ss_pred cCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH
Confidence 999999999999987543221 1122356788999999884 345788999999999999999999998543211
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
... ............. +......+.+++.+||+.+|++||++++|++.
T Consensus 222 ------~~~-~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 222 ------RVL-LKIAKSEPPTLSQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------HHH-HHHhcCCCccCCC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111 1111221111111 11223356789999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=226.95 Aligned_cols=195 Identities=21% Similarity=0.209 Sum_probs=139.2
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++++.+......+..+|++|++.+... .+.+.+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 58 l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill 134 (376)
T cd05598 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILI 134 (376)
T ss_pred CCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEE
Confidence 468999999888888889999999886321 23456788888889999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCC-----------------------------------------CCCceeeeeeccCCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDE-----------------------------------------TEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE 490 (635)
+.++.+||+|||++..+.... .........||..|+|||
T Consensus 135 ~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 214 (376)
T cd05598 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE 214 (376)
T ss_pred CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHH
Confidence 999999999999975331000 000011246899999999
Q ss_pred cccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLL 570 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 570 (635)
.+.+..++.++|||||||++|||++|+.||......+ .. ... ...... ...+. ....+ ..+.+++.+
T Consensus 215 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~---~~i-~~~~~~-~~~~~-~~~~s----~~~~~li~~ 281 (376)
T cd05598 215 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE---TQ---LKV-INWETT-LHIPS-QAKLS----REASDLILR 281 (376)
T ss_pred HHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHH---HH---HHH-hccCcc-ccCCC-CCCCC----HHHHHHHHH
Confidence 9999999999999999999999999999986533211 11 111 111000 00000 01112 234455556
Q ss_pred hcccCCCCCC---ChHHHHHH
Q 046703 571 CVQQHPDDRP---CMPSVILM 588 (635)
Q Consensus 571 Cl~~dP~~RP---t~~evl~~ 588 (635)
|+ .+|.+|+ ++.|+++.
T Consensus 282 l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 282 LC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred Hh-cCHhhcCCCCCHHHHhCC
Confidence 55 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=218.39 Aligned_cols=192 Identities=20% Similarity=0.281 Sum_probs=145.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+......+..+|+++++..... .....+++.++..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 73 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~ 149 (296)
T cd06655 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLG 149 (296)
T ss_pred cCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 468999998888888889999999876321 22346899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++......... .....++..|+|||.+.+..++.++|||||||++||+++|+.||.......
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~----- 222 (296)
T cd06655 150 MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----- 222 (296)
T ss_pred CCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 9999999999998765433221 122457889999999998889999999999999999999999985432211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...... ......... +......+.+++.+||+.||++||++.+|++
T Consensus 223 -~~~~~~-~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 223 -ALYLIA-TNGTPELQN-------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -HHHHHH-hcCCcccCC-------cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111111 111111111 1111234667899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=218.72 Aligned_cols=192 Identities=22% Similarity=0.296 Sum_probs=146.6
Q ss_pred eccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
.|+|++.+......+...|+++++.+.. ......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.
T Consensus 76 ~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~ 152 (297)
T cd06659 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTL 152 (297)
T ss_pred CCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEcc
Confidence 5899999998888888999999987631 123456889999999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...
T Consensus 153 ~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~- 226 (297)
T cd06659 153 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM- 226 (297)
T ss_pred CCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-
Confidence 99999999999875543221 122356889999999999889999999999999999999999998532211 111
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
..+.......... .......+.+++.+||+.+|++||++++|++.
T Consensus 227 ---~~~~~~~~~~~~~-------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 227 ---KRLRDSPPPKLKN-------AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---HHHhccCCCCccc-------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1111111111000 01112346678999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-23 Score=208.45 Aligned_cols=192 Identities=29% Similarity=0.398 Sum_probs=145.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hhccc-cCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKL-LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+..........|+++++..... ..... +++.++..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil 135 (258)
T smart00219 59 DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCL 135 (258)
T ss_pred CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEE
Confidence 58888888888777788999999875311 11122 899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.++|+|||++............ ...++..|+|||.+....++.++||||+|++++||++ |+.||.... ..
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~ 211 (258)
T smart00219 136 VGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NE 211 (258)
T ss_pred EccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HH
Confidence 999999999999999876544222111 1236789999999988889999999999999999998 777765321 11
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
. .......+...... ......+.+++.+|++.+|++|||+.|++++|
T Consensus 212 ~----~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 212 E----VLEYLKKGYRLPKP---------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred H----HHHHHhcCCCCCCC---------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 11122222222111 11334577899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=225.40 Aligned_cols=195 Identities=18% Similarity=0.171 Sum_probs=140.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++|+.+.....+...+|+++|+.+... .+.+.+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 58 l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll 134 (377)
T cd05629 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILI 134 (377)
T ss_pred CCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEE
Confidence 368999999988888889999999986321 23456788888899999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCC---------------------------------------------CceeeeeeccCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETE---------------------------------------------GNTTRVVGTYGY 486 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y 486 (635)
+.++.+||+|||+++.+...... .......||..|
T Consensus 135 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 214 (377)
T cd05629 135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY 214 (377)
T ss_pred CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccc
Confidence 99999999999998643211000 000124589999
Q ss_pred CCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHH
Q 046703 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIH 566 (635)
Q Consensus 487 ~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 566 (635)
+|||.+.+..++.++|||||||++|||++|+.||......+ ... ..........+.+. ......+.+
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~---~i~~~~~~~~~p~~-------~~~s~~~~d 281 (377)
T cd05629 215 IAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE---TYR---KIINWRETLYFPDD-------IHLSVEAED 281 (377)
T ss_pred cCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH---HHH---HHHccCCccCCCCC-------CCCCHHHHH
Confidence 99999999899999999999999999999999986432211 111 11110111111110 011234566
Q ss_pred HHHHhcccCCCCC---CChHHHHHH
Q 046703 567 ISLLCVQQHPDDR---PCMPSVILM 588 (635)
Q Consensus 567 l~~~Cl~~dP~~R---Pt~~evl~~ 588 (635)
++.+|++ +|.+| +++.|+++.
T Consensus 282 li~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 282 LIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred HHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 7888887 66665 599988874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=211.44 Aligned_cols=197 Identities=19% Similarity=0.254 Sum_probs=140.5
Q ss_pred eeccccccccccCCCC------ccEEEEecccchhh-----------hhccccCcccchhhhhhhccccchhhccccceE
Q 046703 377 MWFGDLIDMRSFPDGG------QDLYIRMSASELDQ-----------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~------~~lyl~~~~~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 439 (635)
+.|+|++.+..+.... ...++.+++..... .....+++.....++.||+.||+|||+.+ |
T Consensus 58 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i 134 (273)
T cd05074 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---F 134 (273)
T ss_pred CCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 3588888877654211 12356666554211 11124677888999999999999999998 9
Q ss_pred EeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCC
Q 046703 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 518 (635)
Q Consensus 440 iH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~ 518 (635)
+|+||||+||+++.++.+||+|||+++...............++..|++||.+....++.++||||||+++|||++ |+.
T Consensus 135 ~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 135 IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred eecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 9999999999999999999999999986543322111222344578999999988899999999999999999999 788
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
||..... .. .......+..... +......+.+++.+||+.+|++||++.||++.|+++
T Consensus 215 p~~~~~~---~~----~~~~~~~~~~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 215 PYAGVEN---SE----IYNYLIKGNRLKQ---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCH---HH----HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8753221 11 1111112211111 112334688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=211.38 Aligned_cols=195 Identities=23% Similarity=0.279 Sum_probs=144.8
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+..+... ...|+++++.+.. ......+++..++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 65 ~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili 140 (270)
T cd05056 65 DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLV 140 (270)
T ss_pred CCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEE
Confidence 57888888777654 4578888887531 112335889999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |..||......+
T Consensus 141 ~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--- 216 (270)
T cd05056 141 SSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--- 216 (270)
T ss_pred ecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---
Confidence 999999999999998764432211 111234568999999988889999999999999999986 999985432211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.. ..+..+..... +......+.+++.+|+..+|++|||+.++++.|+.+.
T Consensus 217 ~~----~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 217 VI----GRIENGERLPM---------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HH----HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 11122221111 1122345778999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=235.08 Aligned_cols=197 Identities=25% Similarity=0.359 Sum_probs=155.7
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhc---------------cccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERC---------------KLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+|++.+.+.+.....+++++++.+.. ..++ ..|+..+.+.++.|||.|++||++..
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~- 438 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP- 438 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 6999999999888788999999988741 1111 23888889999999999999999998
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
+||||+.++|||+..+..+||+|||+++...+..... ......-+..|||||.+....++.|+|||||||+||||++
T Consensus 439 --~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 439 --CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred --ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 9999999999999999999999999998654332221 1110013567999999999999999999999999999998
Q ss_pred -CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 516 -GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 516 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|..|+... ......++.+++|...+..+.+ ..++.++|+.||+.+|++||++.++++.|+..
T Consensus 517 LG~~PYp~~------~~~~~l~~~l~~G~r~~~P~~c---------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 517 LGGTPYPGI------PPTEELLEFLKEGNRMEQPEHC---------SDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCCCCCC------CcHHHHHHHHhcCCCCCCCCCC---------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 77787541 1122335566777766654433 34677899999999999999999999999873
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=213.77 Aligned_cols=191 Identities=25% Similarity=0.302 Sum_probs=148.6
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|++++.+.....++..+|+++++.+... .....+++.+...++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~ 135 (277)
T cd06640 59 CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLS 135 (277)
T ss_pred CCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEc
Confidence 368999999888888889999999886421 23456788888999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.......
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----- 208 (277)
T cd06640 136 EQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----- 208 (277)
T ss_pred CCCCEEEcccccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----
Confidence 9999999999999776433211 222457788999999988889999999999999999999999985432111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.......+... .........+.+++.+||+.+|++||++++|++.
T Consensus 209 --~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 209 --VLFLIPKNNPP---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --HhhhhhcCCCC---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11111111111 1223445567889999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-23 Score=215.54 Aligned_cols=204 Identities=22% Similarity=0.237 Sum_probs=145.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----hhc-cccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERC-KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|+++++..... ... ..+++..+..++.||++||.|||+++ ++|+||+|+||++
T Consensus 59 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill 135 (298)
T cd07841 59 LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLI 135 (298)
T ss_pred cCCCCChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEE
Confidence 458999999988888889999999883211 112 26899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++......... .....++..|+|||.+.+ ..++.++||||||++++||++|..+|...... .
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~ 210 (298)
T cd07841 136 ASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---D 210 (298)
T ss_pred cCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---H
Confidence 99999999999999876433211 112345778999998854 46789999999999999999997776543221 1
Q ss_pred HHHHHHHHhhc---------CCCCcCCCCccccC-----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNK---------GMPSEMIDPCYQES-----CNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~---------~~~~~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........... .............. ........+.+++.+||+.+|++|||++||++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11111111000 00000000000001 111234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-23 Score=217.00 Aligned_cols=191 Identities=22% Similarity=0.303 Sum_probs=145.3
Q ss_pred eccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
.|+|++.+......+..+|+++++.+... .....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~ 150 (297)
T cd06656 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGM 150 (297)
T ss_pred CCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 68899988888877889999999876321 22346788899999999999999999998 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
++.+||+|||++......... .....++..|+|||.+.+..++.++|+||||+++|++++|+.||..........
T Consensus 151 ~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--- 225 (297)
T cd06656 151 DGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--- 225 (297)
T ss_pred CCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---
Confidence 999999999998765433221 122457889999999998889999999999999999999999985432211100
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+.. .. ..+......+.+++.+||+.+|++||++++|++
T Consensus 226 ---~~~~~~~~-~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 ---LIATNGTP-EL-------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---eeccCCCC-CC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001110 00 011122334667899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=215.65 Aligned_cols=204 Identities=20% Similarity=0.261 Sum_probs=144.5
Q ss_pred eeccccccccccCCCC--ccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGG--QDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~--~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+..+.... ..+|+++++.+... .....+++..++.++.||++||+|||+.+ ++|+||+|+||
T Consensus 55 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~ni 131 (287)
T cd07840 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNI 131 (287)
T ss_pred ccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHe
Confidence 3588888887776655 78999999886321 12246889999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++++++.+||+|||++.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 132 l~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~ 210 (287)
T cd07840 132 LINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210 (287)
T ss_pred EEcCCCCEEEccccceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999999999998765432211 122345778999997764 4678999999999999999999999864432211
Q ss_pred ccHHHHHHHHhhc---CC--------------CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNK---GM--------------PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~---~~--------------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.......... .. ........+.......+...+++++.+||+.+|.+||+++++++
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 211 ---LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ---HHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111100 00 00000000111111112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=214.58 Aligned_cols=195 Identities=21% Similarity=0.304 Sum_probs=146.6
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhc---------cccCcccchhhhhhhccccchhhccccceEEee
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERC---------KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
+.|+|++.+..+.......|+++++.+... ... ..+++..+..++.|++.||+|||+.+ |+|+
T Consensus 65 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~ 141 (275)
T cd05046 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHR 141 (275)
T ss_pred cCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccC
Confidence 358999999988888888999999886311 111 15889999999999999999999999 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRG 521 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~ 521 (635)
||||+||+++.++.++++|||++........ .......++..|+|||.+.+...+.++||||||+++|||++ |..||.
T Consensus 142 dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 142 DLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred cCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999865432211 11122355678999999988889999999999999999998 777874
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
..... . .......+...... .......+.+++.+||+.+|++||++.|++++|+
T Consensus 221 ~~~~~---~----~~~~~~~~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 221 GLSDE---E----VLNRLQAGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ccchH---H----HHHHHHcCCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 32211 1 11122222221111 1112346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-23 Score=214.69 Aligned_cols=202 Identities=21% Similarity=0.241 Sum_probs=146.9
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+......+..+|+++++.+... .+...+++.++..++.||+.||.|||+.+ ++|+||||+||+++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~ 132 (283)
T cd05118 56 NHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLIN 132 (283)
T ss_pred cCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEEC
Confidence 58889888888888889999999876321 22347889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|++++|+.||...+..+.
T Consensus 133 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--- 207 (283)
T cd05118 133 TEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--- 207 (283)
T ss_pred CCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 999999999999987654331 11123567789999998776 789999999999999999999999865432211
Q ss_pred HHHHHHHhhcCC---CCcCCC-----------Ccc--ccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGM---PSEMID-----------PCY--QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~---~~~~~d-----------~~l--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.......+.... .....+ ... ...........+.+++..||+.||.+||++++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111110000 000000 000 00111223456889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=220.49 Aligned_cols=193 Identities=20% Similarity=0.166 Sum_probs=145.7
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.++.+|.|++..++.+.+||+|||..++ ..+...|++..+..++.+++.||..||+.| +|||||||+|+|||
T Consensus 199 ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD 275 (550)
T KOG0605|consen 199 DSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLID 275 (550)
T ss_pred CCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeec
Confidence 4567899999999999999999998753 345678899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCC----------------------CCC-----C------------------ceeeeeeccCCC
Q 046703 453 QDMNPKISDFGLARTFGGD----------------------ETE-----G------------------NTTRVVGTYGYM 487 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~----------------------~~~-----~------------------~~~~~~gt~~y~ 487 (635)
..|.+||+||||+.-+... ... . .....+||+-|+
T Consensus 276 ~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYi 355 (550)
T KOG0605|consen 276 AKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYI 355 (550)
T ss_pred CCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcccc
Confidence 9999999999998532110 000 0 012358999999
Q ss_pred CcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHH
Q 046703 488 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHI 567 (635)
Q Consensus 488 aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 567 (635)
|||++.+..|+..+|.||+|||+|||+.|.+||....+.+....+..-...+. .++ ..+...+..++
T Consensus 356 APEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---fP~----------~~~~s~eA~DL 422 (550)
T KOG0605|consen 356 APEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---FPE----------EVDLSDEAKDL 422 (550)
T ss_pred chHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---CCC----------cCcccHHHHHH
Confidence 99999999999999999999999999999999976554433222221111110 011 11111456678
Q ss_pred HHHhcccCCCCCCC---hHHHHH
Q 046703 568 SLLCVQQHPDDRPC---MPSVIL 587 (635)
Q Consensus 568 ~~~Cl~~dP~~RPt---~~evl~ 587 (635)
|.+|+. ||++|-- ++||-+
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhc
Confidence 888888 9999975 666654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=218.16 Aligned_cols=208 Identities=19% Similarity=0.243 Sum_probs=140.1
Q ss_pred eeccccccccccCCC--------CccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 377 MWFGDLIDMRSFPDG--------GQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--------~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
+.|++++.+..++.. ....|+++++..... .....+++.++..++.||+.||.|||+++ ++|+|
T Consensus 68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~d 144 (310)
T cd07865 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRD 144 (310)
T ss_pred CCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 357787777665422 345699999876321 12236889999999999999999999998 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
|||+||+++.++.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||
T Consensus 145 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 145 MKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred CCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999866432211 111224567889999987654 4789999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcC-----CCC-ccccC---------CCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEM-----IDP-CYQES---------CNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~d~-~l~~~---------~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
...........+............... .+. ..... ....+...+.+++.+||+.||++|||++|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 654322222222111110000000000 000 00000 000112346689999999999999999999
Q ss_pred HH
Q 046703 586 IL 587 (635)
Q Consensus 586 l~ 587 (635)
++
T Consensus 305 l~ 306 (310)
T cd07865 305 LN 306 (310)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-23 Score=218.24 Aligned_cols=207 Identities=18% Similarity=0.207 Sum_probs=143.2
Q ss_pred eccccccccccCCCC--ccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPDGG--QDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~--~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+|++.+..+.... ..+|+++++.+... .....++...+..++.||+.||.|||+.+ ++||||||
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp 136 (316)
T cd07842 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKP 136 (316)
T ss_pred CCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCH
Confidence 588888888877655 78999999876311 11135778888899999999999999999 99999999
Q ss_pred cceEecc----CCCCccCccccceecCCCCC-CCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCC
Q 046703 447 GNVLLDQ----DMNPKISDFGLARTFGGDET-EGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 447 ~NIlld~----~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
+||+++. ++.+||+|||++........ ........++..|+|||.+.+ ..++.++||||||++++||++|+.||
T Consensus 137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 9999999 89999999999987643322 111223467889999998765 45789999999999999999999998
Q ss_pred CCccCCCcc------cHHHHHHHHhhcCC---------CCcCCC---CccccCCC---H--------HHHHHHHHHHHHh
Q 046703 521 GFYHLDNKL------NLIGHAWKLWNKGM---------PSEMID---PCYQESCN---L--------TEVIRCIHISLLC 571 (635)
Q Consensus 521 ~~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~d---~~l~~~~~---~--------~~~~~~~~l~~~C 571 (635)
......... ..+......+.... ..+..+ .......+ . .....+.+++.+|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 296 (316)
T cd07842 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296 (316)
T ss_pred cCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHH
Confidence 654332200 01111111110000 000000 00000000 0 2234578899999
Q ss_pred cccCCCCCCChHHHHH
Q 046703 572 VQQHPDDRPCMPSVIL 587 (635)
Q Consensus 572 l~~dP~~RPt~~evl~ 587 (635)
|+.||++|||+.||++
T Consensus 297 l~~~P~~Rps~~eil~ 312 (316)
T cd07842 297 LEYDPTKRITAEEALE 312 (316)
T ss_pred hcCCcccCcCHHHHhc
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=213.97 Aligned_cols=191 Identities=21% Similarity=0.233 Sum_probs=141.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+......+..+|+++++.... ......+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 58 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nil 134 (285)
T cd05632 58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENIL 134 (285)
T ss_pred CCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEE
Confidence 5778887777766677889999887631 112336889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||++........ .....|+..|+|||.+.+..++.++|+||||+++||+++|+.||........
T Consensus 135 i~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-- 209 (285)
T cd05632 135 LDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-- 209 (285)
T ss_pred ECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 99999999999999876532211 1224688999999999988999999999999999999999999864322111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
..........+.. . . .......+.+++..|++.||++||+ +.+++.
T Consensus 210 -~~~~~~~~~~~~~--~----~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 210 -REEVDRRVLETEE--V----Y----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -HHHHHHhhhcccc--c----c----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1111111111110 0 0 1111234567899999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=215.19 Aligned_cols=200 Identities=19% Similarity=0.196 Sum_probs=143.0
Q ss_pred eccccccccccCCCC--ccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGG--QDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~--~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+...+ ..+|+++++.+.. ..+...+++.++..++.|++.||+|||+.+ ++|+||+|+||+
T Consensus 56 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~ 132 (282)
T cd07831 56 PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENIL 132 (282)
T ss_pred CCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEE
Confidence 488898888877655 7899999988632 122356899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++. +.+||+|||++......... ....++..|+|||.+. +..++.++|||||||++|||++|..||......+
T Consensus 133 l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-- 206 (282)
T cd07831 133 IKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-- 206 (282)
T ss_pred EcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--
Confidence 999 99999999999876433221 1235678999999764 4567899999999999999999999986533211
Q ss_pred cHHHHHHH-----------HhhcCCCCcCCCCccc----cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWK-----------LWNKGMPSEMIDPCYQ----ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~-----------~~~~~~~~~~~d~~l~----~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+..... ............+... ..........+.+++.+||+.+|++||+++++++
T Consensus 207 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 207 -QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred -HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111111 0101100000000000 0001123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-23 Score=207.39 Aligned_cols=190 Identities=22% Similarity=0.327 Sum_probs=145.8
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..........|+++++.... ......+++.+++.++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil 133 (256)
T cd08218 57 KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIF 133 (256)
T ss_pred CCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEE
Confidence 5889998888888888999999987531 112235688888999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||++++|+++|+.||..... .
T Consensus 134 ~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~- 207 (256)
T cd08218 134 LTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---K- 207 (256)
T ss_pred EcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---H-
Confidence 999999999999999876432211 1224578889999999888999999999999999999999999853211 1
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
..... ...+..... +......+.+++.+||+.+|++||++.+|++.
T Consensus 208 --~~~~~-~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 208 --NLVLK-IIRGSYPPV---------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HHHHH-HhcCCCCCC---------cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111 122222211 11223457789999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=212.46 Aligned_cols=197 Identities=22% Similarity=0.344 Sum_probs=148.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+.........+|+++++.+... .+.+.+++..+..++.+++.||.|||+ .+ ++|+||+|+||+
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil 136 (284)
T cd06620 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNIL 136 (284)
T ss_pred cCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEE
Confidence 368999998888887889999999886421 223568889999999999999999997 46 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC---
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN--- 527 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~--- 527 (635)
++.++.++|+|||++....... .....++..|+|||.+.+..++.++|||||||++||+++|+.||......+
T Consensus 137 ~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~ 212 (284)
T cd06620 137 VNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212 (284)
T ss_pred ECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh
Confidence 9999999999999986543221 123568899999999988899999999999999999999999987543321
Q ss_pred --cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 528 --KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 528 --~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
............ ......+. .......+.+++.+||+.||++|||++||+++.
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 213 DDPMGILDLLQQIV-QEPPPRLP--------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhhHHHHHHHHHh-hccCCCCC--------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111111111111 11111110 011234577899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-23 Score=209.62 Aligned_cols=198 Identities=25% Similarity=0.329 Sum_probs=146.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|+++++.... ..+...+++..+..++.||+.||.|||+.+ ++|+||+|+||++
T Consensus 65 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~ 141 (272)
T cd06629 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLV 141 (272)
T ss_pred cCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEE
Confidence 46899999988888888999999987532 122356888889999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC--CcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||++................++..|+|||.+.... ++.++|+||||+++||+++|..||.....
T Consensus 142 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---- 217 (272)
T cd06629 142 DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---- 217 (272)
T ss_pred cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----
Confidence 999999999999987654322221222345788999999987654 78999999999999999999999843211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
................ .... .......+.+++..||+.+|++||++++|++.
T Consensus 218 --~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 218 --IAAMFKLGNKRSAPPI-PPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --HHHHHHhhccccCCcC-Cccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111111111111 1111 11223457788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=212.50 Aligned_cols=193 Identities=20% Similarity=0.284 Sum_probs=143.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+......+..+|+++++.+... ...+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 64 ~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~ 140 (267)
T cd06645 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLT 140 (267)
T ss_pred CCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 58999998888877889999999976321 23457889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
.++.+||+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~- 217 (267)
T cd06645 141 DNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA- 217 (267)
T ss_pred CCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-
Confidence 999999999999876543211 122356889999999874 45688999999999999999999999743221111
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............ ..... ......+.+++.+|++.+|++||++++|++
T Consensus 218 -----~~~~~~~~~~~~----~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 218 -----LFLMTKSNFQPP----KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -----HHhhhccCCCCC----ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111111110101 01100 011234678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=214.24 Aligned_cols=202 Identities=18% Similarity=0.217 Sum_probs=143.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+..++..+|+++++.... ......+++..+..++.|+++||+|||+.+ ++|+||+|+||+
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nil 132 (284)
T cd07860 56 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLL 132 (284)
T ss_pred cCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 46899999999888888999999987531 122356788899999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC-CcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++......... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+
T Consensus 133 l~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-- 208 (284)
T cd07860 133 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-- 208 (284)
T ss_pred ECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--
Confidence 999999999999998765432111 12234678899999886644 6889999999999999999999986432111
Q ss_pred cHHHHHHHHhhcC----------------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKG----------------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~----------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............ ............ ........+.+++.+||+.||++|||++++++
T Consensus 209 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 209 -QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred -HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 111111100000 000000000000 00011234668999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=210.93 Aligned_cols=194 Identities=23% Similarity=0.299 Sum_probs=141.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchh---h---hhcccc--CcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD---Q---ERCKLL--DWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~---~---~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
.+.|+|++.+..+...+..+|+++++.... . .+...+ ++..+..++.||+.||+|||+.+ |+|+||||+
T Consensus 61 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~ 137 (268)
T cd06624 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGD 137 (268)
T ss_pred hcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHH
Confidence 346999999998888888999999987531 1 112334 67777889999999999999998 999999999
Q ss_pred ceEecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC--CcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 448 NVLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 448 NIlld~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
||+++. ++.+||+|||++......... .....++..|+|||.+.... ++.++||||||+++||+++|+.||....
T Consensus 138 nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 138 NVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred HEEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999986 678999999998765432221 12245788999999986543 7899999999999999999999985422
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.... ..+......... ..+......+.+++.+||+.+|++|||+.||++.
T Consensus 216 ~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 216 EPQA-----AMFKVGMFKIHP---------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred Chhh-----hHhhhhhhccCC---------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1110 001100000011 1111223457789999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-23 Score=206.75 Aligned_cols=191 Identities=25% Similarity=0.351 Sum_probs=145.6
Q ss_pred eeccccccccccC--CCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhh-----ccccceEE
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLH-----QDSRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~ii 440 (635)
+.|+|++.+.... ..+..+|+++++.... ......+++++++.++.||++||.||| +.+ ++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~ 132 (265)
T cd08217 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VL 132 (265)
T ss_pred cCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ce
Confidence 3688888876643 4556789999887531 112457889999999999999999999 666 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCC
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
|+||+|+||+++.++.+||+|||++......... .....++..|+|||.+....++.++|+||||+++++|++|+.||
T Consensus 133 h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 210 (265)
T cd08217 133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210 (265)
T ss_pred ecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcc
Confidence 9999999999999999999999999876543321 12246788999999998888999999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.... .. ........+....+ +......+.+++.+|++.+|++||++++|++.
T Consensus 211 ~~~~---~~----~~~~~~~~~~~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 211 TARN---QL----QLASKIKEGKFRRI---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCcC---HH----HHHHHHhcCCCCCC---------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 6533 11 11222222222211 12233467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-23 Score=212.04 Aligned_cols=192 Identities=22% Similarity=0.281 Sum_probs=137.2
Q ss_pred eeccccccccccCC--CCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPD--GGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~--~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+..+.. .+..+|+++++.... ......+++..++.++.|++.||.|||+.+ ++|+||+|+||
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~ni 137 (266)
T cd06651 61 LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANI 137 (266)
T ss_pred cCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHE
Confidence 46888888777653 245788888877531 123346888889999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCC-CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDET-EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++||+++|+.||.....
T Consensus 138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--- 214 (266)
T cd06651 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--- 214 (266)
T ss_pred EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---
Confidence 999999999999999876532111 1111224578899999999888899999999999999999999999853211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............. +.+ +......+..++ .||..+|++||+++||++
T Consensus 215 ---~~~~~~~~~~~~~-----~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 ---MAAIFKIATQPTN-----PQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---HHHHHHHhcCCCC-----CCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111111111111 111 111112233344 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.8e-24 Score=241.61 Aligned_cols=195 Identities=24% Similarity=0.313 Sum_probs=148.5
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|||+|..+.+.-..+.+||.|+|++... ......++.....+..|++.|++|||+++ ||||||||.||+
T Consensus 1290 ~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~ 1366 (1509)
T KOG4645|consen 1290 GLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANIL 1366 (1509)
T ss_pred hccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCcccee
Confidence 5689999999999999999999999987421 22334555555667889999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCC--CCceeeeeeccCCCCcccccCC---CCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 451 LDQDMNPKISDFGLARTFGGDET--EGNTTRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
++.++.+|++|||.|+.+..+.. ........||+.|||||.+.+. ....++||||+|||++||+||++||...+
T Consensus 1367 Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d- 1445 (1509)
T KOG4645|consen 1367 LDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD- 1445 (1509)
T ss_pred eecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-
Confidence 99999999999999998865421 1122346899999999998653 45688999999999999999999986433
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
....+ ......|+.+.+... -...-.+++..||+.||++|-++.|+++.
T Consensus 1446 -ne~aI----My~V~~gh~Pq~P~~---------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1446 -NEWAI----MYHVAAGHKPQIPER---------LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -chhHH----HhHHhccCCCCCchh---------hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22111 112234554444332 22234568889999999999888777664
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-23 Score=213.24 Aligned_cols=192 Identities=21% Similarity=0.307 Sum_probs=142.5
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+..+...+..+|+++++.... ......+++..+..++.||++||+|||+ .+ |+||||+|+||++
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill 148 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILL 148 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEE
Confidence 4789999988888888999999987531 1223468888999999999999999997 47 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC----CcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++.+||+|||++......... ....++..|+|||.+.... ++.++||||||+++|||++|+.||......
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~- 224 (296)
T cd06618 149 DASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE- 224 (296)
T ss_pred cCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-
Confidence 99999999999998765432221 1234678899999986553 789999999999999999999998542111
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.. ................ ......+.+++.+||+.||++||++.+|++.
T Consensus 225 -~~----~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 225 -FE----VLTKILQEEPPSLPPN-------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -HH----HHHHHhcCCCCCCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 1111111111111111 0123457789999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-23 Score=212.16 Aligned_cols=192 Identities=21% Similarity=0.313 Sum_probs=140.9
Q ss_pred eccccccccccC-----CCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 378 WFGDLIDMRSFP-----DGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 378 ~h~nLv~l~~~~-----~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
.|+|++.+..+. ..+..+|+++++.+... .....+++..+..++.|+++||.|||+.+ ++|||
T Consensus 73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 149 (286)
T cd06638 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRD 149 (286)
T ss_pred cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 488998887754 34567899999876321 12345777888899999999999999998 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----CCCcccCceeeeehhhHhhhhCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
|||+||+++.++.+||+|||++........ ......|+..|+|||.+.. ..++.++||||+||++|||++|+.
T Consensus 150 lkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 150 VKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred CCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 999999999999999999999987643221 1223468899999998753 457899999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
||....... ... ....+......++. .....+.+++.+||+.||++|||+.||++.
T Consensus 228 p~~~~~~~~------~~~-~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 228 PLADLHPMR------ALF-KIPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCCchhH------HHh-hccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 985432111 111 11111111111111 112357789999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-23 Score=220.97 Aligned_cols=195 Identities=23% Similarity=0.298 Sum_probs=156.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
-+-||+||++-+++. .+-.+|+||...+++ ..+..|+......++.||+.||+|||+.. .|||||.++||
T Consensus 447 nfdHphIikLIGv~~-e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNi 522 (974)
T KOG4257|consen 447 NFDHPHIIKLIGVCV-EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNI 522 (974)
T ss_pred hCCCcchhheeeeee-ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhhe
Confidence 457999999999987 457899998776532 34567788888899999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|+....-+||+|||+++.+.++..-. .....-++.|||||.+.-.+++.++|||.|||.+|||++ |.+||.+....+-
T Consensus 523 LVsSp~CVKLaDFGLSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 523 LVSSPQCVKLADFGLSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred eecCcceeeecccchhhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 99999999999999999886554322 223445789999999999999999999999999999986 9999876543332
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
. ..+..|.. ...++.++..+..|+.+||..||.+||.+.|+...|..
T Consensus 602 I-------~~iEnGeR---------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 602 I-------GHIENGER---------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred E-------EEecCCCC---------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 1 11223332 23455666688899999999999999999998876643
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-23 Score=218.43 Aligned_cols=206 Identities=24% Similarity=0.262 Sum_probs=142.7
Q ss_pred eeccccccccccCC------CCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPD------GGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~------~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.+..+.. ....+|+++++..... .....++..++..++.|++.||+|||+.+ ++||||||+|
T Consensus 72 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~N 148 (353)
T cd07850 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 148 (353)
T ss_pred cCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 35788877765542 2346799999876321 11223788888999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 149 il~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 225 (353)
T cd07850 149 IVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225 (353)
T ss_pred EEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999999999987543221 1224578899999999999999999999999999999999999864432110
Q ss_pred ccHH---------------HHHHHHhhcCCC-------CcCCCCc----cccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 529 LNLI---------------GHAWKLWNKGMP-------SEMIDPC----YQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 529 ~~~~---------------~~~~~~~~~~~~-------~~~~d~~----l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
...+ ............ .++.... ............+.+++.+||+.||++|||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 305 (353)
T cd07850 226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305 (353)
T ss_pred HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH
Confidence 0000 000000000000 0000000 0011112334567789999999999999999
Q ss_pred HHHHHH
Q 046703 583 PSVILM 588 (635)
Q Consensus 583 ~evl~~ 588 (635)
.|+++.
T Consensus 306 ~eiL~~ 311 (353)
T cd07850 306 DDALQH 311 (353)
T ss_pred HHHhcC
Confidence 999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=212.13 Aligned_cols=207 Identities=18% Similarity=0.201 Sum_probs=144.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+.......|+++++.... ......+++.....++.|+++||.|||+++ |+|+||||+||
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Ni 132 (314)
T cd08216 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHI 132 (314)
T ss_pred cCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceE
Confidence 46899999888887788899999987632 112345788888999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCC-----CCceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDET-----EGNTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+++.++.+||+|||.+........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 133 li~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 133 LLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred EEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999998875532111 111122456778999999865 3578999999999999999999999864
Q ss_pred ccCCCcccHHHHHHHHh----hc-------CCCCc----CCCCc----cccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 523 YHLDNKLNLIGHAWKLW----NK-------GMPSE----MIDPC----YQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~----~~-------~~~~~----~~d~~----l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
..... ...+...... .. ..... ..++. ............+.+++.+||+.||++|||++
T Consensus 213 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 290 (314)
T cd08216 213 MPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290 (314)
T ss_pred CCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHH
Confidence 32111 1111110000 00 00000 00000 00111222334677899999999999999999
Q ss_pred HHHHH
Q 046703 584 SVILM 588 (635)
Q Consensus 584 evl~~ 588 (635)
++++.
T Consensus 291 ~ll~~ 295 (314)
T cd08216 291 QLLNH 295 (314)
T ss_pred HHhcC
Confidence 99874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=209.30 Aligned_cols=196 Identities=23% Similarity=0.332 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+...+..+|+++++.... ..+.+.+++..+..++.||+.||.|||+.+ ++|+||+|+||++
T Consensus 60 l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~ 136 (268)
T cd06630 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLI 136 (268)
T ss_pred cCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 46899999999988888999999987642 123456888999999999999999999999 9999999999999
Q ss_pred ccCC-CCccCccccceecCCCCCCC--ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDM-NPKISDFGLARTFGGDETEG--NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~-~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++ .+||+|||++.......... ......++..|+|||.+.+..++.++||||+|++++|+++|+.||........
T Consensus 137 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 216 (268)
T cd06630 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216 (268)
T ss_pred cCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch
Confidence 8776 59999999987764332111 11224578899999999888899999999999999999999999864332211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ............ ...+......+.+++.+|++.+|++||++.|+++
T Consensus 217 ~---~~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 217 L---ALIFKIASATTA---------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred H---HHHHHHhccCCC---------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1 111111111111 1122233456778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-23 Score=222.57 Aligned_cols=143 Identities=25% Similarity=0.252 Sum_probs=119.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+.........+|++++++... ..+...+++..+..++.|++.||.|||+.+ |+||||||+||+++
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~ 135 (360)
T cd05627 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLD 135 (360)
T ss_pred CCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEEC
Confidence 5788888888888888999999998642 123456888899999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCC---------------------------------CCceeeeeeccCCCCcccccCCCCcc
Q 046703 453 QDMNPKISDFGLARTFGGDET---------------------------------EGNTTRVVGTYGYMAPEYASDGQFSV 499 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 499 (635)
.++.+||+|||++........ ........||..|+|||.+.+..++.
T Consensus 136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 215 (360)
T cd05627 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215 (360)
T ss_pred CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence 999999999999875432110 00011346899999999999999999
Q ss_pred cCceeeeehhhHhhhhCCCCCCCc
Q 046703 500 KSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 500 ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++|||||||++|||++|+.||...
T Consensus 216 ~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 216 LCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cceeccccceeeecccCCCCCCCC
Confidence 999999999999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-23 Score=206.26 Aligned_cols=190 Identities=21% Similarity=0.292 Sum_probs=145.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++++.+..+...+..+|+++++.+... .+...+++..+..++.||++||+|||+.+ ++|+||+|+||++
T Consensus 59 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~ 135 (258)
T cd06632 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILV 135 (258)
T ss_pred cCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 368999999888888889999999876321 22345888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC-CcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++....... ......++..|++||.+.... ++.++|+||||+++|++++|+.||.....
T Consensus 136 ~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----- 207 (258)
T cd06632 136 DTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----- 207 (258)
T ss_pred CCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----
Confidence 999999999999988754332 122345788899999987766 89999999999999999999999854321
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...............+ +......+.+++.+||+.+|++||+++++++
T Consensus 208 -~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 208 -VAAVFKIGRSKELPPI---------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -HHHHHHHHhcccCCCc---------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111111111111111 1112345677899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-23 Score=211.10 Aligned_cols=193 Identities=21% Similarity=0.268 Sum_probs=145.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|+++++.+.. ..+...+++..+..++.|++.||+|||+.+ ++|+||+|+||++
T Consensus 59 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~ 135 (265)
T cd06631 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVML 135 (265)
T ss_pred cCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEE
Confidence 46889999888888888999999987632 123346788888999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCC----CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDET----EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++.+||+|||++........ ........++..|+|||.+.+..++.++||||||+++||+++|+.||.......
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 136 MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 9999999999999876532111 111123457889999999998889999999999999999999999985322111
Q ss_pred cccHHHHHHHHh-hcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLW-NKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...... ..+....+ +......+.+++.+||+.+|++||++.|+++
T Consensus 216 ------~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 ------AMFYIGAHRGLMPRL---------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------HHHHhhhccCCCCCC---------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111110 01111111 1122345678999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=214.68 Aligned_cols=141 Identities=21% Similarity=0.261 Sum_probs=116.7
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|++++.+.........+|+++++.+.. ......+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili 135 (332)
T cd05623 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILM 135 (332)
T ss_pred CCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEE
Confidence 6888888888888888999999987632 122356788888999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+.++.+||+|||++......... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 136 ~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 136 DMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred CCCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 99999999999998765332221 122356899999999886 34678999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-23 Score=209.11 Aligned_cols=197 Identities=25% Similarity=0.344 Sum_probs=145.2
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-------h-hccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------E-RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++........+...|+++++.+... . ....+++..+..++.|++.||+|||+.+ ++|+||+|+|
T Consensus 56 l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~n 132 (267)
T cd06610 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGN 132 (267)
T ss_pred cCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHh
Confidence 357888888777777888999999876311 1 1245788899999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCC--ceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEG--NTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
|++++++.+||+|||++.......... ......++..|+|||.+... .++.++|+||||+++|||++|+.||.....
T Consensus 133 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred EEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 999999999999999987665432221 12234678899999998776 789999999999999999999999854322
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ...+.... ......... ........+.+++..||+.||++||++++|++
T Consensus 213 ~~------~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 213 MK------VLMLTLQN-DPPSLETGA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hh------hHHHHhcC-CCCCcCCcc----ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 11111111 111110000 01122345678999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-23 Score=209.87 Aligned_cols=191 Identities=22% Similarity=0.325 Sum_probs=142.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh------h--hhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------Q--ERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~ 447 (635)
..|+|++.+......+..+|+++++++.. . .....+++..+..++.||+.||.|||++ + ++||||||+
T Consensus 57 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~ 133 (283)
T cd06617 57 VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPS 133 (283)
T ss_pred cCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHH
Confidence 35889998888877778899999987631 1 1234678899999999999999999987 7 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC----CCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
||+++.++.+||+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus 134 nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 134 NVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred HEEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 99999999999999999876543211 112457889999998754 45689999999999999999999998532
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ... +...... .+....+... .....+.+++.+||+.+|++||++++|++
T Consensus 211 ~--~~~---~~~~~~~-~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 211 K--TPF---QQLKQVV-EEPSPQLPAE--------KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c--cCH---HHHHHHH-hcCCCCCCcc--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111 1111111 1222221111 12345778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-23 Score=212.53 Aligned_cols=190 Identities=21% Similarity=0.182 Sum_probs=141.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+......+...|+++++..... ...+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~ 131 (279)
T cd05633 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLD 131 (279)
T ss_pred CCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEEC
Confidence 46778777777666778999999876321 23456899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||++........ ....++..|+|||.+.. ..++.++||||||+++|||++|+.||......... .
T Consensus 132 ~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~ 206 (279)
T cd05633 132 EHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E 206 (279)
T ss_pred CCCCEEEccCCcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-H
Confidence 999999999999875532211 12458899999998864 56889999999999999999999998643322111 1
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~~ 588 (635)
....... . .. ..+......+.+++..||+.||++|| +++|+++.
T Consensus 207 ---~~~~~~~-~-----~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 207 ---IDRMTLT-V-----NV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---HHHHhhc-C-----Cc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1111000 0 11 11112234567889999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-23 Score=210.30 Aligned_cols=192 Identities=22% Similarity=0.150 Sum_probs=147.0
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+......+..+|+++++..... .....+++..+..++.||++||.|||+.+ ++|+||+|+||+++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~ 131 (260)
T cd05611 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLID 131 (260)
T ss_pred CCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC
Confidence 68999999888888889999999886421 23356888999999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++..... .....++..|+|||.+.+..++.++||||||+++|||++|..||......
T Consensus 132 ~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------ 199 (260)
T cd05611 132 QTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------ 199 (260)
T ss_pred CCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------
Confidence 999999999999876432 11245778999999998888999999999999999999999998543211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
..+.....+.... ...........+.+++.+||+.+|++||++.++.+.|+-
T Consensus 200 -~~~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 200 -AVFDNILSRRINW------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred -HHHHHHHhcccCC------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1122222221110 001111223457789999999999999988877776643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=205.35 Aligned_cols=190 Identities=25% Similarity=0.329 Sum_probs=143.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++........+..+|+++++.+.. ......+++..+..++.|++++|.|||+++ ++|+||+|+||
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~ni 132 (256)
T cd08220 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNI 132 (256)
T ss_pred CCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 35888888877777778899999987632 112345788899999999999999999999 99999999999
Q ss_pred EeccCC-CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDM-NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.+. .+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 133 l~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-- 207 (256)
T cd08220 133 LLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-- 207 (256)
T ss_pred EEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--
Confidence 998654 579999999987643321 12245788999999999888999999999999999999999998543221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.... ....+....+.+ .....+.+++.+||+.+|++|||++|+++.
T Consensus 208 -~~~~----~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 208 -ALVL----KIMSGTFAPISD---------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -HHHH----HHHhcCCCCCCC---------CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 111222222211 123346789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-23 Score=209.88 Aligned_cols=188 Identities=20% Similarity=0.196 Sum_probs=143.2
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+.........+|+++++.+... .....++++++..++.||++||.|||+.+ ++|+||||+||+++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~ 143 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYD 143 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEe
Confidence 48899988888777778999999875311 22347899999999999999999999999 99999999999999
Q ss_pred cCC-CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDM-NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++ .++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~ 216 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDL 216 (267)
T ss_pred CCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhH
Confidence 998 89999999987654321 235788999999999889999999999999999999999998633221 1111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-MPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-~~evl~ 587 (635)
... .... .. .... .......+.+++..||+.+|.+||+ ++|+++
T Consensus 217 ~~~-~~~~-~~-~~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ESL-LKRQ-QK-KLPF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHH-HHhh-cc-cCCc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111 1111 10 0011 1123345778899999999999996 688874
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-23 Score=213.69 Aligned_cols=204 Identities=19% Similarity=0.248 Sum_probs=142.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+.......|+++++..... .....+++.....++.|+++||.|||+.+ ++|+||||+||++
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~ 136 (291)
T cd07844 60 LKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLI 136 (291)
T ss_pred CCCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEE
Confidence 468899999888888889999999886321 12235788889999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++........ .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... ...
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~ 212 (291)
T cd07844 137 SERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VED 212 (291)
T ss_pred cCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHH
Confidence 99999999999998754321111 111345788999998865 4588999999999999999999999854321 111
Q ss_pred HHHHHHHHhhcCCCC---------cCCC--------CccccCC-CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPS---------EMID--------PCYQESC-NLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~---------~~~d--------~~l~~~~-~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+......... +... ..+.... .......+.+++.+||+.+|++|||++|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 111111111100000 0000 0000000 0011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-23 Score=214.27 Aligned_cols=188 Identities=26% Similarity=0.323 Sum_probs=144.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..++......|+++++.... ....+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 72 l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~ 148 (307)
T cd06607 72 LRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILL 148 (307)
T ss_pred CCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEE
Confidence 46899999988888888899999987531 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++...... ....++..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--- 219 (307)
T cd06607 149 TEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--- 219 (307)
T ss_pred CCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---
Confidence 99999999999998764322 1245678999999874 45688999999999999999999999753221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
...... .......... .......+.+++.+||+.+|++||++.+|++.
T Consensus 220 ---~~~~~~-~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 220 ---MSALYH-IAQNDSPTLS--------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---HHHHHH-HhcCCCCCCC--------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111111 1111111111 11234457889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=208.51 Aligned_cols=193 Identities=23% Similarity=0.287 Sum_probs=145.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+.........+|+++++.+.. ....+.+++.++..++.|++.||.|||+.+ |+|+||+|+||+
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nil 135 (280)
T cd06611 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNIL 135 (280)
T ss_pred CCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEE
Confidence 45899999988888888999999988642 122356899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
++.++.++|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 136 LTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 99999999999999876532211 122356788999999874 34578899999999999999999999854321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. . ....+..+....+.. +......+.+++..||+.+|++||++.+|++.
T Consensus 214 ~------~-~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 214 M------R-VLLKILKSEPPTLDQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred H------H-HHHHHhcCCCCCcCC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 1 111112222111111 11122346788999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=212.69 Aligned_cols=195 Identities=18% Similarity=0.163 Sum_probs=139.4
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|++++.+.........+|+++++.... ......+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 59 ~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill 135 (331)
T cd05624 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLL 135 (331)
T ss_pred CCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEE
Confidence 5888888888888888999999987632 112356788888999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+.++.+||+|||++......... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||......
T Consensus 136 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 136 DMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred cCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 99999999999999876433221 1223568999999998865 46789999999999999999999998543211
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD--RPCMPSVILM 588 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~evl~~ 588 (635)
..............+ .... ......+.+++.+|++.++++ |++++++++.
T Consensus 215 ------~~~~~i~~~~~~~~~-p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ------ETYGKIMNHEERFQF-PSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ------HHHHHHHcCCCcccC-CCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111111111111111 0000 012235667777888765543 4678888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-23 Score=221.06 Aligned_cols=209 Identities=22% Similarity=0.247 Sum_probs=143.6
Q ss_pred eccccccccccCC-----CCccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFPD-----GGQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~~-----~~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|+|++.+..+.. ....+|++++++... ....+.+++..+..++.|+++||.|||+.+ |+||||||+||
T Consensus 61 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Ni 137 (336)
T cd07849 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137 (336)
T ss_pred CCCCcCchhheeecccccccceEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHE
Confidence 4888888776542 234688998887632 223456888999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+++.++.+||+|||++.......... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+...
T Consensus 138 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred EECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999997654322111 1122467889999998654 568899999999999999999999986432111
Q ss_pred cccHHHHHHHHhhcCCC---CcCCCC-----------ccc---cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--
Q 046703 528 KLNLIGHAWKLWNKGMP---SEMIDP-----------CYQ---ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM-- 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~---~~~~d~-----------~l~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~-- 588 (635)
.............. ..+.+. ... ....+.....+.+++.+||+.+|++|||+.|+++.
T Consensus 218 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 218 ---QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred ---HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 11111111100000 000000 000 00001123457789999999999999999999986
Q ss_pred HcCC
Q 046703 589 LGSE 592 (635)
Q Consensus 589 L~~~ 592 (635)
++..
T Consensus 295 ~~~~ 298 (336)
T cd07849 295 LEQY 298 (336)
T ss_pred cccc
Confidence 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-23 Score=237.34 Aligned_cols=199 Identities=20% Similarity=0.209 Sum_probs=144.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----------------hhccccCcccchhhhhhhccccchhhccccceEE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
+.|+|++.+..+...+..+|++|++.+... .....+++..++.++.||++||+|||+.+ |+
T Consensus 59 L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---II 135 (932)
T PRK13184 59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VL 135 (932)
T ss_pred CCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 469999999998888889999999876321 01233456677889999999999999999 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCC----------------CceeeeeeccCCCCcccccCCCCcccCcee
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE----------------GNTTRVVGTYGYMAPEYASDGQFSVKSDVF 504 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVw 504 (635)
||||||+||+++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++|||
T Consensus 136 HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIW 215 (932)
T PRK13184 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIY 215 (932)
T ss_pred ccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHH
Confidence 9999999999999999999999999876211100 011124689999999999999999999999
Q ss_pred eeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-ChH
Q 046703 505 SFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-CMP 583 (635)
Q Consensus 505 S~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-t~~ 583 (635)
||||++|||++|+.||....... .... ... ..+.... .....+..+.+++.+|++.||++|| +++
T Consensus 216 SLGVILyELLTG~~PF~~~~~~k---i~~~--~~i--~~P~~~~-------p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 216 ALGVILYQMLTLSFPYRRKKGRK---ISYR--DVI--LSPIEVA-------PYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred HHHHHHHHHHHCCCCCCCcchhh---hhhh--hhc--cChhhcc-------ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999999985422111 0000 000 0000000 0012233467899999999999996 577
Q ss_pred HHHHHHcCC
Q 046703 584 SVILMLGSE 592 (635)
Q Consensus 584 evl~~L~~~ 592 (635)
++++.|+..
T Consensus 282 eLl~~Le~~ 290 (932)
T PRK13184 282 ELKQDLEPH 290 (932)
T ss_pred HHHHHHHHH
Confidence 777776654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=219.50 Aligned_cols=145 Identities=23% Similarity=0.238 Sum_probs=120.3
Q ss_pred cccccccccCCCCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 380 GDLIDMRSFPDGGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 380 ~nLv~l~~~~~~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
-|+|.++++...-..++|+.|..+. ...+...|+.+.+..++.||+.||.+||+.+ |||+||||+||||..
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKD 324 (586)
T ss_pred eeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeecc
Confidence 3688888988888899999886652 3345567889999999999999999999999 999999999999976
Q ss_pred CC--CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 454 DM--NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 454 ~~--~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.. .+||+|||.+...... ..+...++.|+|||++.+.+|+.+.||||||||+.||++|.+-|+..+..+....
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~ 399 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLAR 399 (586)
T ss_pred CCcCceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence 54 5999999999765322 2246778899999999999999999999999999999999888876654444333
Q ss_pred H
Q 046703 532 I 532 (635)
Q Consensus 532 ~ 532 (635)
+
T Consensus 400 I 400 (586)
T KOG0667|consen 400 I 400 (586)
T ss_pred H
Confidence 3
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-23 Score=210.83 Aligned_cols=192 Identities=22% Similarity=0.305 Sum_probs=145.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+..+...+...|+++++.+.. ......+++.++..++.|++.||+|||+.+ ++||||+|+||+++
T Consensus 73 ~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~ 149 (285)
T cd06648 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLT 149 (285)
T ss_pred cCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEc
Confidence 35888888888777777889999887531 112356888899999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...
T Consensus 150 ~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~- 223 (285)
T cd06648 150 SDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQA- 223 (285)
T ss_pred CCCcEEEcccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHH-
Confidence 9999999999988755432211 1224578899999999888899999999999999999999999853211 111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+....... .......+.+++.+||+.+|++||++.++++
T Consensus 224 ---~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 224 ---MKRIRDNLPPKLKN-------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ---HHHHHhcCCCCCcc-------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11122221111111 1112346788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-23 Score=213.24 Aligned_cols=202 Identities=19% Similarity=0.209 Sum_probs=137.7
Q ss_pred eccccccccccCCCCcc-----EEEEecccchhh------h---hccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 378 WFGDLIDMRSFPDGGQD-----LYIRMSASELDQ------E---RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~-----lyl~~~~~~~~~------~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
.|+|++++..+...... +|+++++.+... . ....+++..++.++.||++||.|||+.+ ++|||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~d 135 (295)
T cd07837 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRD 135 (295)
T ss_pred CCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 35778777766544333 899999886321 1 1245789999999999999999999999 99999
Q ss_pred cCCcceEecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCC
Q 046703 444 LKAGNVLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRG 521 (635)
Q Consensus 444 ik~~NIlld~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~ 521 (635)
|+|+||+++. ++.+||+|||+++........ .....++..|+|||++.+ ..++.++||||||+++|||++|..||.
T Consensus 136 l~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 136 LKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred CChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999998 889999999998765322111 112345778999998865 457899999999999999999999986
Q ss_pred CccCCCcccHHHHHHHHhhcCCC---CcC---CC----Cccc----cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMP---SEM---ID----PCYQ----ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~---~~~---~d----~~l~----~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+ ........+..... ... .+ +... ....+.....+.+++.+||+.||++||+++|++.
T Consensus 214 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 214 GDSELQ---QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCHHH---HHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 432111 11111111100000 000 00 0000 0000122345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=212.89 Aligned_cols=142 Identities=23% Similarity=0.263 Sum_probs=117.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|++++.+......+..+|+++++.... ......+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil 134 (331)
T cd05597 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVL 134 (331)
T ss_pred CCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEE
Confidence 36889999988888888999999987632 122456888889999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----CCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
++.++.+||+|||++......... ......|++.|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 135 LDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 999999999999998765433221 1222468999999999863 4578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-23 Score=211.49 Aligned_cols=190 Identities=22% Similarity=0.305 Sum_probs=137.3
Q ss_pred eccccccccccC------CCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeecc
Q 046703 378 WFGDLIDMRSFP------DGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444 (635)
Q Consensus 378 ~h~nLv~l~~~~------~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di 444 (635)
.|+|++.+..+. .....+|+++++.... ..+...++++.+..++.||+.||.|||+.+ ++|+||
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl 147 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDI 147 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 477887766554 2346789999987531 122345777788899999999999999999 999999
Q ss_pred CCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCC
Q 046703 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 445 k~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
+|+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.|
T Consensus 148 ~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p 225 (282)
T cd06636 148 KGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225 (282)
T ss_pred CHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence 99999999999999999999876532211 122356788999999875 34678899999999999999999999
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
|........ ... .......... .......+.+++.+||+.||.+||++.||++
T Consensus 226 ~~~~~~~~~------~~~-~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 226 LCDMHPMRA------LFL-IPRNPPPKLK--------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccccCHHhh------hhh-HhhCCCCCCc--------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 853321111 111 1111111111 0112345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-23 Score=209.99 Aligned_cols=190 Identities=24% Similarity=0.333 Sum_probs=143.8
Q ss_pred eccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
.|++++.+..+...+...|+++++.... ..+...+++...+.++.|+++||.|||+.+ ++|+||+|+||+++.
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~ 136 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTN 136 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcC
Confidence 3888888888777788899999987532 122347889999999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
++.++|+|||++......... .....|+..|+|||.+..+ .++.++|+||||+++|+|++|+.||.......
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----- 209 (277)
T cd06917 137 TGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR----- 209 (277)
T ss_pred CCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----
Confidence 999999999999876543321 2234678899999988654 57899999999999999999999986432111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ...........+ ... .....+.+++.+||+.||++||++.|++.
T Consensus 210 -~-~~~~~~~~~~~~-----~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 210 -A-MMLIPKSKPPRL-----EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -h-hhccccCCCCCC-----Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0 011111111111 111 12345778999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=209.79 Aligned_cols=191 Identities=23% Similarity=0.340 Sum_probs=142.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hh---ccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ER---CKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~---~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~ 447 (635)
+.|+|++++.........+|+++++.+... .. ...+++..+..++.|+++||.|||+. + ++|+||||+
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~ 132 (286)
T cd06622 56 AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPT 132 (286)
T ss_pred cCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHH
Confidence 368899998888777889999999886421 11 23688999999999999999999974 6 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC------CCcccCceeeeehhhHhhhhCCCCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSGKKNRG 521 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwS~Gvvl~eiltG~~pf~ 521 (635)
||+++.++.+||+|||++........ ....++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 133 NVLVNGNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred HEEECCCCCEEEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999876532221 224577899999988554 35889999999999999999999985
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...... ... .......+....+ +......+.+++.+||+.+|++||++++++.
T Consensus 209 ~~~~~~---~~~-~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 209 PETYAN---IFA-QLSAIVDGDPPTL---------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred Ccchhh---HHH-HHHHHhhcCCCCC---------CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 432211 111 1111122222221 1223445678999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-23 Score=212.34 Aligned_cols=202 Identities=21% Similarity=0.246 Sum_probs=142.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|++++.+..+...+...|+++++.... ......+++..++.++.|+++||.|||+.+ ++|+||+|+||+
T Consensus 55 l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil 131 (283)
T cd07835 55 LNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLL 131 (283)
T ss_pred cCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEE
Confidence 35899999988888888999999987531 111236889999999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.++|+|||++......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........
T Consensus 132 ~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~- 208 (283)
T cd07835 132 IDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ- 208 (283)
T ss_pred EcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 999999999999999765322111 1123457889999987654 578999999999999999999999864322111
Q ss_pred cHHHHHHHHhh--------------c--CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWN--------------K--GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~--------------~--~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...+.+... + ............ .........+.+++.+|++.+|++|||++||++
T Consensus 209 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 209 --LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred --HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000100000 0 000000000000 011112245778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=209.44 Aligned_cols=201 Identities=20% Similarity=0.220 Sum_probs=141.6
Q ss_pred eccccccccccCCCCcc-----EEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPDGGQD-----LYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~-----lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+|++.+..+...... +|+.+++.... ......+++..+..++.|+++||+|||+.+ ++|+||+|
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~ 135 (287)
T cd07838 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKP 135 (287)
T ss_pred CCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCh
Confidence 47888777766644443 88988876421 111235889999999999999999999998 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+||+++.++.+||+|||++......... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||......
T Consensus 136 ~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~ 212 (287)
T cd07838 136 QNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA 212 (287)
T ss_pred hhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence 9999999999999999999876433221 1234678899999999999999999999999999999999888643322
Q ss_pred CcccHHHHHHHHhhcCCCC----c------CCCCccc---cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPS----E------MIDPCYQ---ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~----~------~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+ ............... . ....... ..........+.+++.+||+.||++||+++|+++
T Consensus 213 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 213 D---QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred H---HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1 111111111000000 0 0000000 0111122355678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=216.66 Aligned_cols=191 Identities=21% Similarity=0.217 Sum_probs=151.9
Q ss_pred ccccccccccCCCCccEEEEecccchhhh---hcc-ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELDQE---RCK-LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~~~---~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
|+|++.+....+....+|++||..+..+. -.+ .+++..+..++.||+.++.|||+.+ |+||||||+|+|+...
T Consensus 95 hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~ 171 (382)
T KOG0032|consen 95 HPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASK 171 (382)
T ss_pred CCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccc
Confidence 99999999999999999999999874221 111 3899999999999999999999999 9999999999999644
Q ss_pred ----CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 455 ----MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 455 ----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.+|++|||++..... ........||+.|+|||.+...+|+.++||||+||++|.|++|..||..........
T Consensus 172 ~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 172 DEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred cCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 4699999999998765 334556899999999999999999999999999999999999999986543222111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.+..+.. ++.++ .-......+-+++..++..||.+|+|+.++++.
T Consensus 249 -------~i~~~~~-~f~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 -------AILRGDF-DFTSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------HHHcCCC-CCCCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2223333 11111 122234456678899999999999999999983
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-23 Score=215.14 Aligned_cols=204 Identities=23% Similarity=0.260 Sum_probs=141.3
Q ss_pred eeccccccccccCCC--CccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+..+..+ ...+|+++++.+.. ......+++.++..++.||++||+|||+.+ ++|+||||+||
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~ni 139 (309)
T cd07845 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNL 139 (309)
T ss_pred CCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 368888887776533 25689999987631 122356899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++......... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+
T Consensus 140 l~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~- 216 (309)
T cd07845 140 LLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE- 216 (309)
T ss_pred EECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9999999999999999876533211 111334778999998865 467899999999999999999999986433221
Q ss_pred ccHHHHHHHHhhcC--CC------------CcCCCCcccc--CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKG--MP------------SEMIDPCYQE--SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~--~~------------~~~~d~~l~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
............ .. .......... .........+.+++.+|++.||++|||++||++.
T Consensus 217 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 217 --QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred --HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111111111000 00 0000000000 0000113345679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-23 Score=212.91 Aligned_cols=203 Identities=19% Similarity=0.246 Sum_probs=140.7
Q ss_pred eeccccccccccCCCC----------ccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 377 MWFGDLIDMRSFPDGG----------QDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~----------~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
+.|+|++.+..+.... ..+|+++++.+.. ......+++..+..++.||+.||+|||+.+ |+|
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H 139 (302)
T cd07864 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLH 139 (302)
T ss_pred CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 3578888776655332 3789999987641 112346889999999999999999999999 999
Q ss_pred eccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCC
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
+||||+||++++++.+||+|||++.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 140 ~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~ 218 (302)
T cd07864 140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218 (302)
T ss_pred CCCCHHHEEECCCCcEEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998764332211 112345778999998754 45789999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHhhcCC---CCcCC--------C------CccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGM---PSEMI--------D------PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--------d------~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
...... .......+...... ...+. + ........ ..+..+.+++..||+.+|++||+++
T Consensus 219 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~ 294 (302)
T cd07864 219 QANQEL---AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAE 294 (302)
T ss_pred CCCChH---HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHH
Confidence 643221 11111111111100 00000 0 00000000 1234578899999999999999999
Q ss_pred HHHH
Q 046703 584 SVIL 587 (635)
Q Consensus 584 evl~ 587 (635)
+|++
T Consensus 295 ~il~ 298 (302)
T cd07864 295 EALN 298 (302)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-23 Score=217.71 Aligned_cols=204 Identities=20% Similarity=0.295 Sum_probs=156.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
++||||+.+..+|-.+..+.++++|++... .....+.-+..+.|+.||+.|++||.+.. ++||||.++|+
T Consensus 592 LkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNc 668 (807)
T KOG1094|consen 592 LKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNC 668 (807)
T ss_pred cCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccce
Confidence 389999999999988888999999998421 11122345556789999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhh--hCCCCCCCccCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV--SGKKNRGFYHLDN 527 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eil--tG~~pf~~~~~~~ 527 (635)
|++.++++||+|||+++-+..........+.+-+++|||+|.+.-++++.++|||+||+.+||++ +..+||+....+
T Consensus 669 Lv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e- 747 (807)
T KOG1094|consen 669 LVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE- 747 (807)
T ss_pred eecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-
Confidence 99999999999999998665554444444566789999999999999999999999999999996 577887543322
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
..++.+...+..+... .+ ...+.-++..+.+++++||..|-++||+++++...|+..
T Consensus 748 --~vven~~~~~~~~~~~-~~-----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 748 --QVVENAGEFFRDQGRQ-VV-----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --HHHHhhhhhcCCCCcc-ee-----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2333333333222211 11 122334556678999999999999999999999988754
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-23 Score=215.44 Aligned_cols=206 Identities=21% Similarity=0.274 Sum_probs=142.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+...+..+|+++++.... ......+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 56 l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Ni 132 (328)
T cd08226 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHI 132 (328)
T ss_pred CCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 46999999999988888899999887531 111234778888899999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCc-----eeeeeeccCCCCcccccCC--CCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGN-----TTRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+++.++.+|+.||+.+........... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 133 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 133 LISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred EEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999986543321111100 0112345679999998763 478999999999999999999999864
Q ss_pred ccCCCcccHHHHHH----------------HH----------------hhcCCCCcCCCCccccCCCHHHHHHHHHHHHH
Q 046703 523 YHLDNKLNLIGHAW----------------KL----------------WNKGMPSEMIDPCYQESCNLTEVIRCIHISLL 570 (635)
Q Consensus 523 ~~~~~~~~~~~~~~----------------~~----------------~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 570 (635)
...... ...... .. ...+....+.+..+...........+.+++.+
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 290 (328)
T cd08226 213 MLRTQM--LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290 (328)
T ss_pred cChHHH--HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHH
Confidence 321110 000000 00 00000001111122222233455678899999
Q ss_pred hcccCCCCCCChHHHHH
Q 046703 571 CVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 571 Cl~~dP~~RPt~~evl~ 587 (635)
||+.||++|||++|+++
T Consensus 291 ~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 291 CLQQDPEKRPSASSLLS 307 (328)
T ss_pred HccCCcccCCCHHHHhh
Confidence 99999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=209.47 Aligned_cols=189 Identities=22% Similarity=0.219 Sum_probs=143.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+.........+|+++++.... ..+.+.+++..+..++.|+++||.|||+.+ ++|+||||+||+++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~ 131 (278)
T cd05606 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD 131 (278)
T ss_pred CCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEEC
Confidence 4788888887777778899999987632 123456899999999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||++....... .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||..........
T Consensus 132 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~- 206 (278)
T cd05606 132 EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE- 206 (278)
T ss_pred CCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-
Confidence 99999999999987553221 1224688999999998754 68999999999999999999999986542221111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
....... ...++ +......+.+++.+|++.+|++|| ++.++++
T Consensus 207 ---~~~~~~~-~~~~~---------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 207 ---IDRMTLT-MAVEL---------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---HHHHhhc-cCCCC---------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111111 01111 111234577889999999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=211.09 Aligned_cols=193 Identities=21% Similarity=0.289 Sum_probs=146.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+......+...|+++++.+... .....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 73 l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~ 149 (293)
T cd06647 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 149 (293)
T ss_pred cCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEc
Confidence 468999999888888888999999876321 22346788899999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++......... .....++..|+|||.+....++.++||||||+++||+++|+.||..........
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-- 225 (293)
T cd06647 150 MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-- 225 (293)
T ss_pred CCCCEEEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--
Confidence 9999999999998765433221 122457888999999988889999999999999999999999986432211110
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.....+.. . ..........+.+++.+||+.+|++||++.+++.+
T Consensus 226 ----~~~~~~~~-~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 ----LIATNGTP-E-------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----ehhcCCCC-C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001110 0 00111223356689999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=205.82 Aligned_cols=194 Identities=23% Similarity=0.289 Sum_probs=149.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIl 450 (635)
+.|++++.+..+...+..+|+++++.+.. ..+...+++..++.++.|+++|++|||+ .+ ++|+||+|+||+
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~ 132 (264)
T cd06623 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLL 132 (264)
T ss_pred cCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEE
Confidence 35899999988888788999999988631 1223678899999999999999999999 88 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.++|+|||++......... .....++..|+|||.+....++.++|+||||+++|||++|+.||..........
T Consensus 133 ~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 210 (264)
T cd06623 133 INSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210 (264)
T ss_pred ECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH
Confidence 999999999999999876433222 123567889999999998899999999999999999999999986543212111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHH-HHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLT-EVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
... .+........ +.. ....+.+++..||+.+|++||++.++++.
T Consensus 211 ~~~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 211 LMQ----AICDGPPPSL---------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHH----HHhcCCCCCC---------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 121 1111111111 111 33467789999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=208.79 Aligned_cols=199 Identities=24% Similarity=0.263 Sum_probs=144.7
Q ss_pred eeccccccccccC--CCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhccccceEEeeccC
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik 445 (635)
+.|+||+.+..+. .....+|+++++.+.. ..+...++...+..++.||+.||+|||+.+ ++|+||+
T Consensus 56 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~ 132 (287)
T cd06621 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIK 132 (287)
T ss_pred CCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 4699999987754 3345789999987631 112345778888999999999999999999 9999999
Q ss_pred CcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 446 ~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
|+||+++.++.++|+|||++........ ....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....
T Consensus 133 ~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (287)
T cd06621 133 PSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208 (287)
T ss_pred HHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence 9999999999999999999875432211 124567899999999988999999999999999999999999865432
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ....+ ............+.+.. .. .......+.+++.+||+.+|++|||+.||++
T Consensus 209 ~~-~~~~~-~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 209 PP-LGPIE-LLSYIVNMPNPELKDEP-GN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC-CChHH-HHHHHhcCCchhhccCC-CC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11 11111 11111111111111111 10 0122346788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-23 Score=218.17 Aligned_cols=210 Identities=23% Similarity=0.302 Sum_probs=144.1
Q ss_pred eeeccccccccccCC----CCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 376 AMWFGDLIDMRSFPD----GGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~----~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
.+.|+|++.+..+.. .+..+|+++++..... ...+.+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 60 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~ 136 (334)
T cd07855 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPS 136 (334)
T ss_pred hcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 345888888766542 4457899999876321 22455899999999999999999999998 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
||+++.++.+||+|||++......... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 137 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 137 NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred HEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 999999999999999999765432211 11123467889999998765 468899999999999999999999986432
Q ss_pred CCCcccHHHH--------HHHHhhcCCCCcCCCCc-cccCC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 525 LDNKLNLIGH--------AWKLWNKGMPSEMIDPC-YQESC-----NLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 525 ~~~~~~~~~~--------~~~~~~~~~~~~~~d~~-l~~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.......+.. ...........+..+.. ..... .......+.+++.+||+.+|++||++++++..
T Consensus 217 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 217 YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2111000000 00000000000000000 00000 11234568889999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-22 Score=203.46 Aligned_cols=194 Identities=25% Similarity=0.364 Sum_probs=147.6
Q ss_pred eeccccccccccCCCC--ccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGG--QDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~--~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|++++......... ..+|+++++.... ......+++.++..++.|++.||+|||+.+ ++|+||+|+||
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni 132 (260)
T cd06606 56 LQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANI 132 (260)
T ss_pred cCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHE
Confidence 3588888887777666 7889999887531 122347899999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++.++.+||+|||.+................++..|+|||.+.....+.++||||||+++++|++|+.||....
T Consensus 133 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----- 207 (260)
T cd06606 133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----- 207 (260)
T ss_pred EEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 999999999999999987755432111223567889999999988889999999999999999999999986543
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+..........+ +......+.+++.+|++.+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 208 NPMAALYKIGSSGEPPEI---------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred chHHHHHhccccCCCcCC---------CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111112221111111111 1122456778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=207.29 Aligned_cols=194 Identities=24% Similarity=0.316 Sum_probs=145.3
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+.........+|+++++.... ......+++..+..++.|++.||+|||+ .+ ++|+||||+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~ 133 (265)
T cd06605 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNIL 133 (265)
T ss_pred CCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEE
Confidence 5899998888877778899999987621 1112677888889999999999999999 88 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||.+......... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ..
T Consensus 134 ~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~ 208 (265)
T cd06605 134 VNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DG 208 (265)
T ss_pred ECCCCCEEEeecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-cc
Confidence 999999999999998765322111 1567889999999998899999999999999999999999985432111 11
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
... .......+....+... .....+.+++..||+.||++|||+.+++..
T Consensus 209 ~~~-~~~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 209 IFE-LLQYIVNEPPPRLPSG--------KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHH-HHHHHhcCCCCCCChh--------hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 1122222222111111 123347789999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=210.20 Aligned_cols=192 Identities=23% Similarity=0.313 Sum_probs=140.4
Q ss_pred eccccccccccCC-----CCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 378 WFGDLIDMRSFPD-----GGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 378 ~h~nLv~l~~~~~-----~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
.|+|++.+..+.. .+..+|+++++.+... ...+.+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 153 (291)
T cd06639 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRD 153 (291)
T ss_pred CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 5888888776542 2346899999875311 12456889999999999999999999998 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-----CCcccCceeeeehhhHhhhhCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
|||+||+++.++.+||+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.
T Consensus 154 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 154 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred CCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 9999999999999999999998765432211 1124578899999987543 36899999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
||...... .... .+..+....+.++ ......+.+++.+||+.+|++||++.|+++.
T Consensus 232 p~~~~~~~------~~~~-~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 232 PLFDMHPV------KTLF-KIPRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCcHH------HHHH-HHhcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 98533211 1111 1122222222111 1222357789999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-23 Score=211.61 Aligned_cols=204 Identities=20% Similarity=0.260 Sum_probs=145.1
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+...+..+|+++++.... ......+++.++..++.||++||.|||+.+ ++|+||||+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~ 133 (286)
T cd07832 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLIS 133 (286)
T ss_pred CCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEc
Confidence 4889998888887788999999988321 122356889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.++|+|||++......... ......++..|+|||.+.+. .++.++||||+|++++||++|+++|..... ...
T Consensus 134 ~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~ 209 (286)
T cd07832 134 ADGVLKIADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQ 209 (286)
T ss_pred CCCcEEEeeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHH
Confidence 9999999999999876543221 12224678899999988654 468999999999999999999777653221 111
Q ss_pred HHHHHHHhhcCC------CCcCCC------Cccc----cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 532 IGHAWKLWNKGM------PSEMID------PCYQ----ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~------~~~~~d------~~l~----~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
............ ..++.+ +... ..........+.+++.+||+.+|++|||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111110000 000000 0000 00111223677889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-23 Score=208.25 Aligned_cols=191 Identities=24% Similarity=0.333 Sum_probs=140.3
Q ss_pred eccccccccccCC------CCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 378 WFGDLIDMRSFPD------GGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 378 ~h~nLv~l~~~~~------~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
.|+|++.+..+.. .+..+|+++++.+.. ..+...+++..+..++.|++.||.|||+.+ ++|+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~ 137 (275)
T cd06608 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHR 137 (275)
T ss_pred CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccC
Confidence 4788887766652 345689999988631 111357889999999999999999999999 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----CCCcccCceeeeehhhHhhhhCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGK 517 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvvl~eiltG~ 517 (635)
||+|+||+++.++.+||+|||++........ ......++..|+|||.+.. ..++.++||||||++++|+++|+
T Consensus 138 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~ 215 (275)
T cd06608 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215 (275)
T ss_pred CCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCC
Confidence 9999999999999999999999876543221 1223567889999998743 34678999999999999999999
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.||...... .... ....+....+.. .......+.+++.+||+.||++|||+.+|++
T Consensus 216 ~p~~~~~~~------~~~~-~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 216 PPLCDMHPM------RALF-KIPRNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCccccchH------HHHH-HhhccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 998532211 1111 111221111111 1123446778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=209.75 Aligned_cols=203 Identities=20% Similarity=0.267 Sum_probs=141.2
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+...+...|+++++..... .....+.+..+..++.||+.||.|||+.+ ++|+||||+||+++
T Consensus 61 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~ 137 (291)
T cd07870 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLIS 137 (291)
T ss_pred CCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEc
Confidence 57888888888777788999999875321 12245677788889999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||+++........ .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ....
T Consensus 138 ~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~ 213 (291)
T cd07870 138 YLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQ 213 (291)
T ss_pred CCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHH
Confidence 9999999999998764322111 1223468899999998654 578899999999999999999999864322 1122
Q ss_pred HHHHHHHhhcC---------CCC----cCCCCccccC-----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKG---------MPS----EMIDPCYQES-----CNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~---------~~~----~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+...+..+... ... +......... ....+...+.+++.+|++.||++|||++|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 22222211100 000 0000000000 00011235667899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-23 Score=214.83 Aligned_cols=198 Identities=25% Similarity=0.307 Sum_probs=148.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+...+...|+++++.... ......+++.++..++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 82 l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~ 158 (317)
T cd06635 82 IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILL 158 (317)
T ss_pred CCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEE
Confidence 46889999988887788899999987531 123456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++...... ....++..|+|||.+. ...++.++||||||+++|||++|+.||.... .
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~ 229 (317)
T cd06635 159 TEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---A 229 (317)
T ss_pred CCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---H
Confidence 99999999999998654321 1245788999999873 4568899999999999999999999974321 1
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCCCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQP 598 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~p~p 598 (635)
... ... +..+...... .......+.+++.+||+.+|.+||++.+|++.+-.....+.+
T Consensus 230 ~~~---~~~-~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 230 MSA---LYH-IAQNESPTLQ--------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHH---HHH-HHhccCCCCC--------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 111 111 1111111111 111223467899999999999999999999876555444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=204.03 Aligned_cols=192 Identities=23% Similarity=0.266 Sum_probs=144.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+......+..+|+++++.+... .+...+++..+..++.||++||.|||+.+ ++|+||+|+||++
T Consensus 50 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv 126 (262)
T cd05572 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLL 126 (262)
T ss_pred CCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEE
Confidence 468999988888878889999999876321 23346788899999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++....... ......++..|++||.+....++.++|+||||+++|||++|..||.....+ .
T Consensus 127 ~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~--- 199 (262)
T cd05572 127 DSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-P--- 199 (262)
T ss_pred cCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-H---
Confidence 999999999999998764332 122245788999999998888999999999999999999999998644321 1
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
.. .......+.. ....+......+.+++..||+.+|++||+ ++|+++
T Consensus 200 ~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 200 ME-IYNDILKGNG--------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HH-HHHHHhccCC--------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11 1111111110 00111112346788999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-23 Score=217.60 Aligned_cols=209 Identities=23% Similarity=0.270 Sum_probs=143.6
Q ss_pred eccccccccccCCCC-----ccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGG-----QDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~-----~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|+|++.+..+.... ..+|+++++..... .....+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~N 138 (337)
T cd07858 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSN 138 (337)
T ss_pred CCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 588888776654322 35899999875321 23456889999999999999999999998 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|+++.++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 139 il~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 216 (337)
T cd07858 139 LLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216 (337)
T ss_pred EEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 999999999999999998654321 11222457889999998765 468899999999999999999999986432211
Q ss_pred cccHHHHHHH--------HhhcCC-------CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--Hc
Q 046703 528 KLNLIGHAWK--------LWNKGM-------PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM--LG 590 (635)
Q Consensus 528 ~~~~~~~~~~--------~~~~~~-------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~--L~ 590 (635)
....+..... ...... .....+..... ........+.+++.+||+.+|++|||++|+++. ++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 1111110000 000000 00000000000 011233457889999999999999999999876 55
Q ss_pred CC
Q 046703 591 SE 592 (635)
Q Consensus 591 ~~ 592 (635)
..
T Consensus 296 ~~ 297 (337)
T cd07858 296 SL 297 (337)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-23 Score=212.59 Aligned_cols=207 Identities=20% Similarity=0.220 Sum_probs=140.4
Q ss_pred eeccccccccccC--------CCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 377 MWFGDLIDMRSFP--------DGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~--------~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
+.|+|++.+..+. .....+|+++++.... ......+++.++..++.|+++||.|||+.+ ++|+|
T Consensus 64 l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~d 140 (311)
T cd07866 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRD 140 (311)
T ss_pred cCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 3578887776554 2234678998887631 122456899999999999999999999999 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCC---------ceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhh
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEG---------NTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEI 513 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~ei 513 (635)
|||+||+++.++.+||+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++|||
T Consensus 141 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el 220 (311)
T cd07866 141 IKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220 (311)
T ss_pred CCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHH
Confidence 99999999999999999999997654322111 1122456788999998765 4588999999999999999
Q ss_pred hhCCCCCCCccCCCcccHHHHHHHHhhc------CCCCcCC--------CCccccCCCHHHHHHHHHHHHHhcccCCCCC
Q 046703 514 VSGKKNRGFYHLDNKLNLIGHAWKLWNK------GMPSEMI--------DPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579 (635)
Q Consensus 514 ltG~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--------d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~R 579 (635)
++|+.||...........+......... ....... .+.+.. ........+.+++.+||+.||.+|
T Consensus 221 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R 299 (311)
T cd07866 221 FTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKR 299 (311)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccC
Confidence 9999998643322211111110000000 0000000 000000 001122457789999999999999
Q ss_pred CChHHHHH
Q 046703 580 PCMPSVIL 587 (635)
Q Consensus 580 Pt~~evl~ 587 (635)
||+.|++.
T Consensus 300 ~t~~ell~ 307 (311)
T cd07866 300 LTASDALE 307 (311)
T ss_pred cCHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-23 Score=214.77 Aligned_cols=192 Identities=21% Similarity=0.161 Sum_probs=142.5
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+......+..+|+++++.... ......+++..+..++.|+++||+|||+.+ ++|+||||+||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 135 (316)
T cd05574 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENIL 135 (316)
T ss_pred CCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeE
Confidence 4888888888888888899999987531 112356888889999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCC---------------------------CceeeeeeccCCCCcccccCCCCcccCce
Q 046703 451 LDQDMNPKISDFGLARTFGGDETE---------------------------GNTTRVVGTYGYMAPEYASDGQFSVKSDV 503 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV 503 (635)
++.++.++|+|||++......... .......|+..|+|||.+.+..++.++||
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 215 (316)
T cd05574 136 LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW 215 (316)
T ss_pred EcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHH
Confidence 999999999999998754321110 01112357889999999998899999999
Q ss_pred eeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC--
Q 046703 504 FSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-- 581 (635)
Q Consensus 504 wS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-- 581 (635)
||||+++|+|++|+.||........ ..... ..... . .........+.+++.+||+.||++|||
T Consensus 216 ~slG~ll~~l~~g~~pf~~~~~~~~------~~~~~-~~~~~-~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 280 (316)
T cd05574 216 WTLGILLYEMLYGTTPFKGSNRDET------FSNIL-KKEVT-F-------PGSPPVSSSARDLIRKLLVKDPSKRLGSK 280 (316)
T ss_pred HHHHHHHHHHhhCCCCCCCCchHHH------HHHHh-cCCcc-C-------CCccccCHHHHHHHHHHccCCHhHCCCch
Confidence 9999999999999999864322111 11111 11110 0 001113456788999999999999999
Q ss_pred --hHHHHH
Q 046703 582 --MPSVIL 587 (635)
Q Consensus 582 --~~evl~ 587 (635)
++|++.
T Consensus 281 ~~~~~ll~ 288 (316)
T cd05574 281 RGAAEIKQ 288 (316)
T ss_pred hhHHHHHc
Confidence 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=201.50 Aligned_cols=191 Identities=26% Similarity=0.348 Sum_probs=145.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|++++++..........|+++++.... ......+++..+..++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 54 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~ 130 (253)
T cd05122 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANIL 130 (253)
T ss_pred CCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEE
Confidence 35788888887777778889998887631 112257899999999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.++|+|||.+........ .....++..|+|||.+....++.++||||||+++++|++|+.||.......
T Consensus 131 i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--- 204 (253)
T cd05122 131 LTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--- 204 (253)
T ss_pred EccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---
Confidence 99999999999999877654321 223567889999999988889999999999999999999999985432111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
................. .....+.+++..||+.||++|||+.||++
T Consensus 205 ----~~~~~~~~~~~~~~~~~-------~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 205 ----ALFKIATNGPPGLRNPE-------KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----HHHHHHhcCCCCcCccc-------ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111122211111 11345778999999999999999999886
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-22 Score=202.33 Aligned_cols=196 Identities=25% Similarity=0.384 Sum_probs=145.3
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|++++.+.........+|+++++.+.. ..+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil 131 (264)
T cd06626 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIF 131 (264)
T ss_pred hCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 457899999888888888999999987632 122345788999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCc--eeeeeeccCCCCcccccCCC---CcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGN--TTRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
++.++.+||+|||++........... .....++..|+|||.+.... ++.++||||||++++|+++|+.||.....
T Consensus 132 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred ECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 99999999999999887643322111 11245678999999987766 88999999999999999999999854321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. .. . ... ...+....+... ......+.+++.+||+.+|++|||++|++.
T Consensus 212 ~--~~-~--~~~-~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 212 E--FQ-I--MFH-VGAGHKPPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred h--HH-H--HHH-HhcCCCCCCCcc-------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 11 1 111 111211111110 111334567899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=204.56 Aligned_cols=197 Identities=24% Similarity=0.250 Sum_probs=147.8
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|+|++.+......+..+|+++++..... .+...+++..+..++.||++||+|||+.+ ++|+||+|+||+
T Consensus 49 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil 125 (265)
T cd05579 49 QAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNIL 125 (265)
T ss_pred hCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeE
Confidence 3458999998888888889999999886321 22346889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCC------CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETE------GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
++.++.+||+|||++......... .......++..|+|||.......+.++||||||++++|+++|+.||....
T Consensus 126 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred EcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999998754322110 01222456788999999988889999999999999999999999985432
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
.. ........+..... . .......+.+++..||+.+|++|||+.+|.+.|+
T Consensus 206 ~~-------~~~~~~~~~~~~~~-~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 206 PE-------EIFQNILNGKIEWP-E-------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HH-------HHHHHHhcCCcCCC-c-------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11 11111111111100 0 0001345678999999999999999977777775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-23 Score=214.13 Aligned_cols=199 Identities=22% Similarity=0.142 Sum_probs=146.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+......+..+|+++++.+.. ....+.+++..+..++.|+++||.|||+.+ ++|+||||+||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll 134 (305)
T cd05609 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLI 134 (305)
T ss_pred CCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEE
Confidence 45889998888877788899999988642 123456888889999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCC-------------CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDET-------------EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
+.++.+||+|||+++....... ........++..|+|||.+....++.++|+||||+++||+++|+.
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999864211000 000112356788999999988889999999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
||...... ........+.... +.... .....+.+++.+||+.+|++||++.++.++|+..
T Consensus 215 pf~~~~~~-------~~~~~~~~~~~~~---~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 215 PFFGDTPE-------ELFGQVISDDIEW---PEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred CCCCCCHH-------HHHHHHHhcccCC---CCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 98532211 1112211221111 11111 1223467899999999999999988888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-23 Score=216.79 Aligned_cols=208 Identities=24% Similarity=0.294 Sum_probs=143.2
Q ss_pred eccccccccccCC--CCccEEEEecccchhh---hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPD--GGQDLYIRMSASELDQ---ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~--~~~~lyl~~~~~~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+.. .+..+|+++++..... .+...+++..+..++.||+.||+|||+.+ |+|+||||+||+++
T Consensus 65 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~ 141 (337)
T cd07852 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLN 141 (337)
T ss_pred CCCCccceeeeeccCCCceEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc
Confidence 6899998888653 3456899999876321 12236788888999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCC---CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 453 QDMNPKISDFGLARTFGGDETE---GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
.++.+||+|||++......... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.
T Consensus 142 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~ 221 (337)
T cd07852 142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ 221 (337)
T ss_pred CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9999999999999866433211 12223567889999998754 5678999999999999999999999864322211
Q ss_pred ccHHHHH--------HHHhhcCCCCcCCC----Cccc--cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHA--------WKLWNKGMPSEMID----PCYQ--ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~--------~~~~~~~~~~~~~d----~~l~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
...+... +..+.......+++ .... ..........+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 222 LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 1000000 00000000000000 0000 00001124467889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=232.60 Aligned_cols=193 Identities=21% Similarity=0.264 Sum_probs=140.0
Q ss_pred eeeccccccccccC--CCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhcccc----ceEE
Q 046703 376 AMWFGDLIDMRSFP--DGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR----LRII 440 (635)
Q Consensus 376 ~l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~ii 440 (635)
.+.|+||+.+..+. .....+||+|++..... .....+++..++.|+.||+.||.|||+.+. ..||
T Consensus 68 ~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IV 147 (1021)
T PTZ00266 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVL 147 (1021)
T ss_pred HcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCce
Confidence 34689999887754 44567999999986311 113468999999999999999999998541 2399
Q ss_pred eeccCCcceEecc-----------------CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC--CCCcccC
Q 046703 441 HRDLKAGNVLLDQ-----------------DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD--GQFSVKS 501 (635)
Q Consensus 441 H~dik~~NIlld~-----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ks 501 (635)
||||||+||||+. ...+||+|||++........ .....|++.|+|||.+.. ..++.++
T Consensus 148 HRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KS 224 (1021)
T PTZ00266 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKS 224 (1021)
T ss_pred eccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchh
Confidence 9999999999964 23489999999986543221 223568999999999854 4588999
Q ss_pred ceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 046703 502 DVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC 581 (635)
Q Consensus 502 DVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt 581 (635)
||||||||||||++|+.||..... .......+..+.. +.. ......+.+|+..||+.+|.+||+
T Consensus 225 DVWSLG~ILYELLTGk~PF~~~~~------~~qli~~lk~~p~--lpi--------~~~S~eL~dLI~~~L~~dPeeRPS 288 (1021)
T PTZ00266 225 DMWALGCIIYELCSGKTPFHKANN------FSQLISELKRGPD--LPI--------KGKSKELNILIKNLLNLSAKERPS 288 (1021)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCc------HHHHHHHHhcCCC--CCc--------CCCCHHHHHHHHHHhcCChhHCcC
Confidence 999999999999999999853221 1111222222111 100 011245778999999999999999
Q ss_pred hHHHHH
Q 046703 582 MPSVIL 587 (635)
Q Consensus 582 ~~evl~ 587 (635)
+.|+++
T Consensus 289 a~QlL~ 294 (1021)
T PTZ00266 289 ALQCLG 294 (1021)
T ss_pred HHHHhc
Confidence 999983
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=229.31 Aligned_cols=178 Identities=30% Similarity=0.428 Sum_probs=129.6
Q ss_pred CccEEEEecccchhh----hhcccc--CcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccc
Q 046703 392 GQDLYIRMSASELDQ----ERCKLL--DWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465 (635)
Q Consensus 392 ~~~lyl~~~~~~~~~----~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla 465 (635)
...+||.|+|++... .....+ .-...++++++|+.||+|+|+++ ||||||||.||+++++..+||+|||+|
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccc
Confidence 467999999998421 122223 35667899999999999999999 999999999999999999999999999
Q ss_pred eecC----------------CCCCCCceeeeeeccCCCCcccccCC---CCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 466 RTFG----------------GDETEGNTTRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 466 ~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
.... ........+..+||.-|+|||.+.+. +|+.|+|+||+|||++||+. ||... .
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--M 819 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--M 819 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--H
Confidence 8621 01111133457899999999998665 49999999999999999995 44321 1
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+.. .+...++.+.++.- + .+...+...-.+++.|+++.||++|||+.|++.
T Consensus 820 ERa----~iL~~LR~g~iP~~--~----~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 ERA----SILTNLRKGSIPEP--A----DFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHH----HHHHhcccCCCCCC--c----ccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111 12333445555543 1 112222233457899999999999999998874
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=206.64 Aligned_cols=193 Identities=20% Similarity=0.244 Sum_probs=140.3
Q ss_pred eeccccccccccCCC--CccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|++++....+... ...+|+++++.+.. ..+...+++...+.++.|++.||.|||+.+ ++|+||||+||
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~ni 137 (265)
T cd06652 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANI 137 (265)
T ss_pred cCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHE
Confidence 368888888776543 35688898887532 122345788888999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCC-CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDET-EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++........ ........++..|+|||.+.+..++.++||||||+++||+++|+.||.....
T Consensus 138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--- 214 (265)
T cd06652 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA--- 214 (265)
T ss_pred EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---
Confidence 999999999999999876532111 1112224578899999999888899999999999999999999999853211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
............ ....+......+.+++..|+. +|++||+++||++.
T Consensus 215 ---~~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 215 ---MAAIFKIATQPT---------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---HHHHHHHhcCCC---------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111111111111 011222334456678888885 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=209.08 Aligned_cols=191 Identities=25% Similarity=0.298 Sum_probs=147.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+......+..+|+++++.... ......++++.+..++.|++.|+.|||+.+ ++|+||+|+||+++
T Consensus 59 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~ 135 (277)
T cd06641 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLS 135 (277)
T ss_pred cCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEEC
Confidence 36899999888888888999999987631 122456889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++|+|||++......... .....++..|+|||.+....++.++|+||||+++|||++|..||......
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------ 207 (277)
T cd06641 136 EHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------ 207 (277)
T ss_pred CCCCEEEeecccceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------
Confidence 9999999999998766432211 12245788899999998888999999999999999999999998532211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........+....+ .......+.+++.+||+.+|++||++.++++.
T Consensus 208 -~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 208 -KVLFLIPKNNPPTL---------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -HHHHHHhcCCCCCC---------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111112221111 11223456789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=214.54 Aligned_cols=213 Identities=25% Similarity=0.281 Sum_probs=147.7
Q ss_pred eccccccccccCCCCc-----cEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQ-----DLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~-----~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|+||+.+..+..... .+|+++++..... .+...+++..+..++.||++||+|||+.+ |+|+||||+|
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~n 133 (330)
T cd07834 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSN 133 (330)
T ss_pred CCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 5888888877765443 7899999876321 22347889999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......
T Consensus 134 ili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 134 ILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred EEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 99999999999999999876543210 112234578889999999887 8899999999999999999999998654322
Q ss_pred CcccHHHHHHHH--------hhcCCCCcCCCC-cccc-----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--Hc
Q 046703 527 NKLNLIGHAWKL--------WNKGMPSEMIDP-CYQE-----SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM--LG 590 (635)
Q Consensus 527 ~~~~~~~~~~~~--------~~~~~~~~~~d~-~l~~-----~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~--L~ 590 (635)
+....+...... .......+.+.. .... .........+.+++.+||+.+|++||+++++++. ++
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 293 (330)
T cd07834 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293 (330)
T ss_pred HHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence 111111000000 000000000000 0000 0011123457789999999999999999999974 55
Q ss_pred CCC
Q 046703 591 SEI 593 (635)
Q Consensus 591 ~~~ 593 (635)
+..
T Consensus 294 ~~~ 296 (330)
T cd07834 294 QLH 296 (330)
T ss_pred hhc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=209.53 Aligned_cols=204 Identities=20% Similarity=0.258 Sum_probs=144.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+..+......+|+++++.+... .....+++..+..++.||+.||.|||+.+ ++|+||||+||
T Consensus 55 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni 131 (284)
T cd07836 55 LKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNL 131 (284)
T ss_pred hcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHE
Confidence 368999999988888889999999886321 11245889999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++........ ......++..|++||.+.+. .++.++||||||+++||+++|+.||......+.
T Consensus 132 ~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 209 (284)
T cd07836 132 LINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209 (284)
T ss_pred EECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999976532211 11124567889999987654 568999999999999999999999865432221
Q ss_pred ccHHHHH--------HHHhhcCCCCcCCCCccc------cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHA--------WKLWNKGMPSEMIDPCYQ------ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~--------~~~~~~~~~~~~~d~~l~------~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...+... ++.+.. .......... ....+.....+.+++.+|++.||.+||++++|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 210 LLKIFRIMGTPTESTWPGISQ--LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHHHhCCCChhhHHHHhc--CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111000 111110 0000000000 0011122345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-22 Score=201.93 Aligned_cols=190 Identities=22% Similarity=0.323 Sum_probs=144.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+......+..+|+++++.... ......+++..+..++.|+++||.|||+.+ ++|+||||+||+
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil 133 (257)
T cd08225 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIF 133 (257)
T ss_pred CCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEE
Confidence 5889998888888888999999987531 112235788999999999999999999998 999999999999
Q ss_pred eccCCC-CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMN-PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~-~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++++. +||+|||.+......... .....++..|+|||.+....++.++|+||||++++|+++|+.||....
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----- 206 (257)
T cd08225 134 LSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----- 206 (257)
T ss_pred EcCCCCeEEecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----
Confidence 998854 699999998766432211 122457889999999988889999999999999999999999985322
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........ ..+..... .......+.+++.+|++.+|++|||+.||++.
T Consensus 207 -~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 207 -LHQLVLKI-CQGYFAPI---------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -HHHHHHHH-hcccCCCC---------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111111 12222111 11223457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-22 Score=196.39 Aligned_cols=205 Identities=20% Similarity=0.262 Sum_probs=149.8
Q ss_pred ccccccccccC----CCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 379 FGDLIDMRSFP----DGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 379 h~nLv~l~~~~----~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
|+|||.+..+. .+-..+.|+||.++.+ ....+.++++++..|++||+.|+.|||+.. |.||||||+
T Consensus 114 h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpE 190 (400)
T KOG0604|consen 114 HPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPE 190 (400)
T ss_pred CCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChh
Confidence 78887765554 4556888999998852 334567999999999999999999999999 999999999
Q ss_pred ceEecc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 448 NVLLDQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 448 NIlld~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
|+|... +-.+||+|||+|+.... .....+..-|+.|.|||.+...+|+...|+||+||++|-|++|.+||-..+
T Consensus 191 NLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 191 NLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred heeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 999964 44589999999987542 222334677999999999988899999999999999999999999985443
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HHcCCCCCCCC
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL--MLGSEIVLPQP 598 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~p~p 598 (635)
... +..-....++.|.. ++.++.+. .-.+...++++..|..+|.+|.|+++++. .+.+...+|.-
T Consensus 268 g~a---ispgMk~rI~~gqy-~FP~pEWs-----~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 268 GLA---ISPGMKRRIRTGQY-EFPEPEWS-----CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT 334 (400)
T ss_pred Ccc---CChhHHhHhhccCc-cCCChhHh-----HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence 211 11111222222221 22222221 22344556888889999999999999986 34454455553
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=205.15 Aligned_cols=189 Identities=25% Similarity=0.322 Sum_probs=147.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+|++.+......+...|+++++..... .....+++..+..++.|+++||+|||+.+ ++|+||+|.
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ 132 (256)
T cd08530 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSA 132 (256)
T ss_pred CCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcc
Confidence 358889888888777788999999875311 12356788899999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
||+++.++.+||+|||++....... .....++..|++||.+.+..++.++|+||||+++||+++|+.||......
T Consensus 133 ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~- 207 (256)
T cd08530 133 NILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ- 207 (256)
T ss_pred eEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999999999999999998765431 11245788999999999989999999999999999999999998543211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........+....+ +......+.+++.+|++.+|++||++.++++.
T Consensus 208 ------~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 208 ------DLRYKVQRGKYPPI---------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ------HHHHHHhcCCCCCC---------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111222222221 12334568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-22 Score=203.32 Aligned_cols=190 Identities=24% Similarity=0.247 Sum_probs=146.2
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+.....++..+|+++++..... .+...+++.++..++.||++||.|||+.+ ++|+||+|+||++
T Consensus 57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~ 133 (258)
T cd05578 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILL 133 (258)
T ss_pred CCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEE
Confidence 469999999998888889999999886421 12347888999999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
++++.++|+|||++....... ......++..|+|||.+....++.++|+||||+++|++++|+.||.......
T Consensus 134 ~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 206 (258)
T cd05578 134 DEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---- 206 (258)
T ss_pred cCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----
Confidence 999999999999987654332 1222457889999999988889999999999999999999999986543321
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh--HHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM--PSVI 586 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~--~evl 586 (635)
.......... .. ...+......+.+++.+||+.||.+||++ +|++
T Consensus 207 ~~~~~~~~~~-~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 207 RDQIRAKQET-AD---------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHHhcc-cc---------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111111111 00 01111223567789999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=209.62 Aligned_cols=216 Identities=23% Similarity=0.330 Sum_probs=159.5
Q ss_pred eeeccccccccccCCCCc----cEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccc------cceEEe
Q 046703 376 AMWFGDLIDMRSFPDGGQ----DLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDS------RLRIIH 441 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~----~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~iiH 441 (635)
.++|+||++.......+. .++|++++.+... .+...++|.+..+++..+++||+|||+.- +++|+|
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 469999988766665444 8889988876432 45667999999999999999999999853 457999
Q ss_pred eccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC-Cc-----ccCceeeeehhhHhhhh
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FS-----VKSDVFSFGILLLEIVS 515 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwS~Gvvl~eilt 515 (635)
||||.+||||.++++..|+|||+|..+............+||.+|||||.+.+.. +. .+.||||+|.|||||++
T Consensus 340 RDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 340 RDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred ccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999988777776666689999999999987642 11 57899999999999999
Q ss_pred CCCCCCCccCCCc----------ccHHHHHHHH-hhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 516 GKKNRGFYHLDNK----------LNLIGHAWKL-WNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 516 G~~pf~~~~~~~~----------~~~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
+..-+.-....+. .-.++..+.. ..+...+.+.+..... ..+.-+++.+..||..||+.|.|+.=
T Consensus 420 RC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 420 RCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 7654321111111 0111122222 2233334444433321 34556778899999999999999998
Q ss_pred HHHHHcCCCCC
Q 046703 585 VILMLGSEIVL 595 (635)
Q Consensus 585 vl~~L~~~~~~ 595 (635)
|-+.+..+..+
T Consensus 496 v~eR~~~l~~~ 506 (534)
T KOG3653|consen 496 VEERMAELMML 506 (534)
T ss_pred HHHHHHHHhcc
Confidence 88888766543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-22 Score=205.86 Aligned_cols=204 Identities=22% Similarity=0.270 Sum_probs=143.6
Q ss_pred ccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
|+|++.+..+...+...|+++++..... .....+++.+++.++.|++.+|.|||+.+ ++|+||+|+||+++
T Consensus 57 h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~ 133 (283)
T cd07830 57 HPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVS 133 (283)
T ss_pred CCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEc
Confidence 8899999888888889999999875211 11236799999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.++|+|||++........ .....++..|+|||.+. ...++.++|+||||++++||++|+.||......+....
T Consensus 134 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 134 GPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred CCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 999999999999986643221 11245678999999875 45578999999999999999999999865432211100
Q ss_pred HHHHH-----HHhhcCC-CCcCCCCccc-------cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 532 IGHAW-----KLWNKGM-PSEMIDPCYQ-------ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 532 ~~~~~-----~~~~~~~-~~~~~d~~l~-------~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
..... ..+.++. .....+..+. ..........+.+++.+||+.+|++|||++||+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000 0000000 0000000000 00001113568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-22 Score=207.28 Aligned_cols=186 Identities=22% Similarity=0.208 Sum_probs=144.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+......+..+|+++++.... ..+...+++..+..++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili 134 (290)
T cd05580 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLL 134 (290)
T ss_pred CCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEE
Confidence 45899999988888888999999988532 123467889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++...... .....++..|+|||.+.+...+.++||||||+++|||++|+.||.....
T Consensus 135 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------ 203 (290)
T cd05580 135 DSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------ 203 (290)
T ss_pred CCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 99999999999999876433 1224578899999999888899999999999999999999999854321
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
.........+... + +......+.+++.+||+.||.+|| +++|+++
T Consensus 204 -~~~~~~~~~~~~~-~---------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 204 -IQIYEKILEGKVR-F---------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -HHHHHHHhcCCcc-C---------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111111122211 0 111134567899999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-23 Score=217.50 Aligned_cols=205 Identities=23% Similarity=0.244 Sum_probs=141.7
Q ss_pred eccccccccccCCC------CccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFPDG------GQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~~~------~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|+|++.+..+... ...+|+++++..... .....++++.+..++.|++.||+|||+.+ ++||||||+||
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NI 148 (342)
T cd07879 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNL 148 (342)
T ss_pred CCCCccchhheecccccCCCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 57888877665432 235688888775322 22346888999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 149 ll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~- 222 (342)
T cd07879 149 AVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD- 222 (342)
T ss_pred EECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9999999999999998764321 112456788999999876 468899999999999999999999986432111
Q ss_pred ccHHHHHHHHh-----------hcCC-------CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--
Q 046703 529 LNLIGHAWKLW-----------NKGM-------PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM-- 588 (635)
Q Consensus 529 ~~~~~~~~~~~-----------~~~~-------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~-- 588 (635)
.+...+... .... ........+.. ..+.....+.+++.+||+.||++||+++||++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 223 --QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred --HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 111111100 0000 00000000000 000122357789999999999999999999854
Q ss_pred HcCCCC
Q 046703 589 LGSEIV 594 (635)
Q Consensus 589 L~~~~~ 594 (635)
+++..+
T Consensus 300 f~~~~~ 305 (342)
T cd07879 300 FDSFRD 305 (342)
T ss_pred hhhccc
Confidence 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=209.87 Aligned_cols=202 Identities=22% Similarity=0.252 Sum_probs=140.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+...+...|+++++..... .....+++.....++.||+.||+|||+.+ ++|+||+|+||+
T Consensus 58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nil 134 (294)
T PLN00009 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLL 134 (294)
T ss_pred ccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEE
Confidence 468999999988888889999999986321 11222456667789999999999999998 999999999999
Q ss_pred ecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 LDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++. +..+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+
T Consensus 135 l~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~- 211 (294)
T PLN00009 135 IDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID- 211 (294)
T ss_pred EECCCCEEEEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 985 456899999999765332111 122356789999998865 457899999999999999999999986432211
Q ss_pred ccHHHHHHHHhhcCC---------CCcC-------CCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGM---------PSEM-------IDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~---------~~~~-------~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
........+.... .... ....+. ...+.....+.+++.+|++.+|++||++.++++
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 212 --ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred --HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111110000 0000 000000 001122345778999999999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=206.15 Aligned_cols=190 Identities=23% Similarity=0.232 Sum_probs=140.2
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|++++.+..........|+++++.+.. ......+++.++..++.|+++||.|||+.+ ++|+||+|+|
T Consensus 49 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~N 125 (277)
T cd05577 49 KVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPEN 125 (277)
T ss_pred hCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 345888988888777778899999987631 112236888899999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++|+.||........
T Consensus 126 il~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 202 (277)
T cd05577 126 VLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202 (277)
T ss_pred EEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc
Confidence 999999999999999987654321 11224567899999999888899999999999999999999999865432211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
...+ ...... ... ..+......+.+++.+||+.||++||+..+
T Consensus 203 ~~~~---~~~~~~-~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 203 KEEL---KRRTLE-MAV---------EYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHH---Hhcccc-ccc---------cCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 1111 110000 000 111112345678999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-22 Score=211.66 Aligned_cols=194 Identities=24% Similarity=0.333 Sum_probs=152.0
Q ss_pred cceeeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 373 SGCAMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 373 ~gC~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
..| -||+|+.++...-....++|.++++.++ ..-...|++.++.-+++|++.||.|||++. |||||||+
T Consensus 84 a~C--dHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKA 158 (1187)
T KOG0579|consen 84 AEC--DHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKA 158 (1187)
T ss_pred hcC--CChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccc
Confidence 457 5999998877666677899999998753 234567899999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccc-----cCCCCcccCceeeeehhhHhhhhCCCCCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA-----SDGQFSVKSDVFSFGILLLEIVSGKKNRG 521 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwS~Gvvl~eiltG~~pf~ 521 (635)
.|||+.-+|.++|+|||.+..... ......++.||+.|||||.. .+.+|+.++||||||+.|.||..+.+|-.
T Consensus 159 GNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 159 GNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred cceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 999999999999999999865432 22233458899999999976 56789999999999999999999999843
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... ..++.-.+....++.++.+. .-...+.++..+||..||..||++.++++
T Consensus 237 eln-------pMRVllKiaKSePPTLlqPS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 237 ELN-------PMRVLLKIAKSEPPTLLQPS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccc-------hHHHHHHHhhcCCCcccCcc-------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 221 12233333344455444432 33345678889999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-22 Score=202.03 Aligned_cols=177 Identities=16% Similarity=0.146 Sum_probs=135.9
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+.......|+++++.+... .+...+++..+..++.|+++||.|||+.+ ++||||||+||+++
T Consensus 43 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~ 119 (237)
T cd05576 43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLD 119 (237)
T ss_pred CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc
Confidence 37889888888888889999999886421 23346889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++++|||.+....... ....++..|+|||.+....++.++||||+|+++|||++|+.|+.......
T Consensus 120 ~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----- 189 (237)
T cd05576 120 DRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----- 189 (237)
T ss_pred CCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----
Confidence 99999999999876553221 11334667999999988889999999999999999999998764221000
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
...... ..+......+.+++.+|++.||++||++.
T Consensus 190 -------~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 190 -------NTHTTL---------NIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -------cccccc---------CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 000000 01111234567899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-22 Score=214.74 Aligned_cols=187 Identities=22% Similarity=0.313 Sum_probs=150.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|||||++..+......+|++++|.... ..+...+...++..+..|+.+|++|||+++ |+|||||++|||
T Consensus 111 ~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNil 187 (596)
T KOG0586|consen 111 SLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENIL 187 (596)
T ss_pred hcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcc
Confidence 467999999999999999999999998642 234556667888899999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc-ccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
|+.+.++||+|||++..+.... ...+..|++.|.|||.+.+..+. +++|+||+|++||-|++|..||+.....
T Consensus 188 L~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--- 261 (596)
T KOG0586|consen 188 LDENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--- 261 (596)
T ss_pred cccccceeeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---
Confidence 9999999999999999886332 23447899999999999988775 9999999999999999999999754322
Q ss_pred cHHHHHHHHhhcCCCCcCCCCcccc--CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQE--SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
++-++.+.+ ..+..-...+-+++.+.|-.+|.+|+++++|.+
T Consensus 262 ----------------~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 262 ----------------ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ----------------cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 122222221 111222234667888999999999999999976
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-22 Score=207.89 Aligned_cols=192 Identities=21% Similarity=0.284 Sum_probs=144.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+......+...|+++++.+.. ......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 74 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~ 150 (292)
T cd06657 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLT 150 (292)
T ss_pred cCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 35889998888877788999999987532 122345788899999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++|+|||++......... .....++..|+|||.+....++.++|+||+|+++|||++|+.||...... ...
T Consensus 151 ~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~ 225 (292)
T cd06657 151 HDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM 225 (292)
T ss_pred CCCCEEEcccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 9999999999998765432211 12346788999999998888999999999999999999999998532211 111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+....... .......+.+++.+||+.+|.+||++.+|++
T Consensus 226 ----~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 226 ----KMIRDNLPPKLKN-------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ----HHHHhhCCcccCC-------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1111111111100 0112234667899999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=197.95 Aligned_cols=190 Identities=22% Similarity=0.288 Sum_probs=144.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hh---ccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ER---CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|+|++........+..+|+++++.+... .. ...+++.++..++.++++||.|||+.+ ++|+||+|+|
T Consensus 57 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~n 133 (258)
T cd08215 57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQN 133 (258)
T ss_pred CCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHH
Confidence 47777777766666678899998765311 11 367899999999999999999999998 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.++|+|||++........ ......++..|+|||......++.++|+||+|+++++|++|+.||......
T Consensus 134 il~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-- 209 (258)
T cd08215 134 IFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-- 209 (258)
T ss_pred eEEcCCCcEEECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--
Confidence 9999999999999999987654321 222356788999999998888999999999999999999999998543211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.............+. ......+.+++.+||+.+|++|||+.|+++.
T Consensus 210 -----~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 210 -----ELALKILKGQYPPIP---------SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----HHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111112222222211 1223457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-22 Score=204.58 Aligned_cols=198 Identities=22% Similarity=0.230 Sum_probs=145.2
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+......+..+|+++++..... .+...+++..+..++.|++++|.|||+.+ ++|+||+|+||+++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~ 139 (288)
T cd05583 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLD 139 (288)
T ss_pred CCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC
Confidence 47888888777777778999999876321 12356788888999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC--CcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
.++.++|+|||++......... ......++..|+|||.+.+.. .+.++||||||+++|||++|..||........
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-- 216 (288)
T cd05583 140 SEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-- 216 (288)
T ss_pred CCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--
Confidence 9999999999998765433221 112245788999999987655 78999999999999999999999853321111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+....... . . +......+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus 217 -~~~~~~~~~~~~~-~-----~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 217 -QSEISRRILKSKP-P-----F----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -HHHHHHHHHccCC-C-----C----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111111111110 0 1 111123466789999999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-23 Score=218.57 Aligned_cols=194 Identities=23% Similarity=0.285 Sum_probs=149.6
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|+++|.++++--+ +.+-+++|..++.. .+...|-......++.|||.|+.||.++. .|||||.++|
T Consensus 167 ~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARN 242 (1039)
T KOG0199|consen 167 KLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARN 242 (1039)
T ss_pred hccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhh
Confidence 4679999999998765 67778877766422 22334555666789999999999999998 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCc-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLD 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~ 526 (635)
+|+.....+||+||||.+.++.++.... .....-.+.|.|||.+....++.++|||+|||.||||++ |..||......
T Consensus 243 lllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~ 322 (1039)
T KOG0199|consen 243 LLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI 322 (1039)
T ss_pred heecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH
Confidence 9999999999999999998875433221 111233678999999999999999999999999999998 67787543322
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
. +.+.+|...+-..+..+.+++.+++..||..+|++|||+..|.+.+
T Consensus 323 q----------------IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 323 Q----------------ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred H----------------HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1 1122333333344566788999999999999999999999997443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-22 Score=207.58 Aligned_cols=189 Identities=26% Similarity=0.296 Sum_probs=142.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++++....+.......|+++++.... ......+++.++..++.|++.|+.|||+.+ ++|+||+|+||++
T Consensus 72 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~ 148 (308)
T cd06634 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILL 148 (308)
T ss_pred CCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEE
Confidence 35888888888777778899999987521 122445788899999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++...... ....++..|+|||.+. ...++.++||||||+++|||++|+.||......
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-- 220 (308)
T cd06634 149 SEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-- 220 (308)
T ss_pred CCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--
Confidence 99999999999998765322 1245788999999874 356789999999999999999999997432111
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
... .....+...... .......+.+++.+||+.+|++||++.+|++..
T Consensus 221 ----~~~-~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 221 ----SAL-YHIAQNESPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ----HHH-HHHhhcCCCCcC--------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111 111122211111 112234467899999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-22 Score=211.74 Aligned_cols=206 Identities=21% Similarity=0.234 Sum_probs=146.3
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.+.|+|++.+..+...+..+|+++++..... .....++++....++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 76 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill 152 (335)
T PTZ00024 76 EIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI 152 (335)
T ss_pred hCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence 3468999998888877888999999876321 22446788899999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCC------------CCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDE------------TEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
+.++.+||+|||++....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999998764111 01111123457789999998764 46899999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCC---cC--------C----CCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPS---EM--------I----DPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~----d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
||...... .....+.......... .. . ..... .........+.+++..||+.+|++|||++
T Consensus 233 p~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 233 LFPGENEI---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCHH---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 98644321 1222222211111000 00 0 00000 00111234577899999999999999999
Q ss_pred HHHHH
Q 046703 584 SVILM 588 (635)
Q Consensus 584 evl~~ 588 (635)
|++..
T Consensus 309 ~~l~~ 313 (335)
T PTZ00024 309 EALKH 313 (335)
T ss_pred HHhcC
Confidence 99863
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-22 Score=204.53 Aligned_cols=204 Identities=25% Similarity=0.281 Sum_probs=144.5
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+......+|+++++..... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~ 132 (282)
T cd07829 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILIN 132 (282)
T ss_pred CCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEc
Confidence 48899998888887889999999876321 11246889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||++......... .....++..|+|||.+... .++.++||||||++++|+++|+.||......+....
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 210 (282)
T cd07829 133 RDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210 (282)
T ss_pred CCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 9999999999999776433211 1123456789999998776 889999999999999999999999854332111100
Q ss_pred HH--------HHHHHhhc-----CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IG--------HAWKLWNK-----GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~--------~~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+. ..|..+.. ............ ...+.....+.+++..||+.+|++||++++|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 00000000 000000000000 000111346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-22 Score=200.89 Aligned_cols=197 Identities=20% Similarity=0.234 Sum_probs=142.6
Q ss_pred ccccccCCCCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc---
Q 046703 383 IDMRSFPDGGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ--- 453 (635)
Q Consensus 383 v~l~~~~~~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~--- 453 (635)
++|..+.+.-..+.|+.+.+.. ......++....+..++.|++++++|||+.+ ++|.||||+|||+..
T Consensus 154 v~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEY 230 (415)
T ss_pred EeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccce
Confidence 3455555555566666655431 2234456778889999999999999999999 999999999999942
Q ss_pred -----------------CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC
Q 046703 454 -----------------DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 454 -----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG 516 (635)
+-.+||+|||-|......+ ...+.|..|+|||++.+..++.++||||+||||.|+.+|
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 2347899999998754332 347889999999999999999999999999999999999
Q ss_pred CCCCCCccCCCcccHHHHHHHHh--------------hcCCC-----------CcCCCCcc----ccCCCHHHHHHHHHH
Q 046703 517 KKNRGFYHLDNKLNLIGHAWKLW--------------NKGMP-----------SEMIDPCY----QESCNLTEVIRCIHI 567 (635)
Q Consensus 517 ~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~-----------~~~~d~~l----~~~~~~~~~~~~~~l 567 (635)
..-|...+..+.+.+.+.+...+ ..|.+ ....+++. ......++..++.+|
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 99987766444333333322211 11111 01111110 012344667789999
Q ss_pred HHHhcccCCCCCCChHHHHH
Q 046703 568 SLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 568 ~~~Cl~~dP~~RPt~~evl~ 587 (635)
+..+|..||.+|+|+.|+++
T Consensus 386 l~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHccCccccccHHHHhc
Confidence 99999999999999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=193.03 Aligned_cols=160 Identities=26% Similarity=0.329 Sum_probs=130.7
Q ss_pred ccCCHHHHHHHHhhcCCcccccccccCCCCcceeeeccccccccccCCC-CccEEEEecccchh---------hhhcccc
Q 046703 343 KSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDG-GQDLYIRMSASELD---------QERCKLL 412 (635)
Q Consensus 343 ~~~s~~~C~~~Cl~nCsC~a~~~~~i~~~~~gC~l~h~nLv~l~~~~~~-~~~lyl~~~~~~~~---------~~~~~~l 412 (635)
..+|...|+++-+- ..+.|+|++.+.++.-. +..++++++|.|.+ ..+.+-+
T Consensus 68 tGiS~SAcREiaL~------------------REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~l 129 (438)
T KOG0666|consen 68 TGISMSACREIALL------------------RELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQL 129 (438)
T ss_pred CCcCHHHHHHHHHH------------------HHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccC
Confidence 35678889887541 13579999998887643 88999999999842 2334567
Q ss_pred CcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC----CCCccCccccceecCCCC-CCCceeeeeeccCCC
Q 046703 413 DWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD----MNPKISDFGLARTFGGDE-TEGNTTRVVGTYGYM 487 (635)
Q Consensus 413 ~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~----~~~kl~Dfgla~~~~~~~-~~~~~~~~~gt~~y~ 487 (635)
+-..+..|+.||+.|+.|||++. |+||||||.|||+-.+ |.+||+|||+++++.+.- .......++-|+.|+
T Consensus 130 p~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYR 206 (438)
T KOG0666|consen 130 PRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYR 206 (438)
T ss_pred CHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEec
Confidence 77788899999999999999999 9999999999999877 889999999999886532 222344577899999
Q ss_pred CcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 488 APEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 488 aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
|||.+.+. .||++.|||++|||+.||++-++.|...
T Consensus 207 APELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 207 APELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99998875 6899999999999999999988887554
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=213.37 Aligned_cols=203 Identities=23% Similarity=0.280 Sum_probs=138.5
Q ss_pred eccccccccccC----CCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFP----DGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~----~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|+|++.+.... .....+|+.+++.... ......+++.++..++.||+.||.|||+.+ ++||||||+||
T Consensus 60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Ni 136 (332)
T cd07857 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNL 136 (332)
T ss_pred CCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHe
Confidence 478887776543 2334678888776531 123456889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++||||+|+++|++++|+.||......
T Consensus 137 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~ 216 (332)
T cd07857 137 LVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV 216 (332)
T ss_pred EEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH
Confidence 9999999999999999865432211 11223467889999998765 46889999999999999999999998643311
Q ss_pred CcccHHHHHHHHh-----------hcCC-------CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLW-----------NKGM-------PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~-----------~~~~-------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ......... .... ........+. .........+.+++.+|++.||++|||+.++++
T Consensus 217 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 217 D---QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred H---HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 111111000 0000 0000000000 000111345778999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=205.44 Aligned_cols=188 Identities=26% Similarity=0.337 Sum_probs=142.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+...+...|+++++.... ......+++.+++.++.||+.||.|||+.+ ++|+||+|+||++
T Consensus 78 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili 154 (313)
T cd06633 78 LKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILL 154 (313)
T ss_pred CCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEE
Confidence 46899999988888888999999987421 123456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++..... .....++..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 155 ~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--- 225 (313)
T cd06633 155 TEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--- 225 (313)
T ss_pred CCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---
Confidence 9999999999999864321 11246788999999874 45688999999999999999999999753321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........ .......... .....+.+++.+||+.+|.+||++.++++.
T Consensus 226 ---~~~~~~~~-~~~~~~~~~~--------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 226 ---MSALYHIA-QNDSPTLQSN--------EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---HHHHHHHH-hcCCCCCCcc--------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 1111111111 112346779999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-22 Score=188.33 Aligned_cols=156 Identities=19% Similarity=0.168 Sum_probs=116.6
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCC
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMA 488 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 488 (635)
.+.+++.+++.++.||++||.|||+++ ||+||+++.++.+|+ ||++....... ..|+..|+|
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~a 72 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMA 72 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccC
Confidence 456899999999999999999999886 999999999999999 99998754321 257899999
Q ss_pred cccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHH--HHHHH
Q 046703 489 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEV--IRCIH 566 (635)
Q Consensus 489 PE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~--~~~~~ 566 (635)
||.+.+..++.++|||||||++|||++|+.||...... .......... ......... ....... ..+.+
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~ 143 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNG----MPADDPRDR---SNLESVSAARSFAD 143 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHH----hccCCcccc---ccHHHHHhhhhHHH
Confidence 99999999999999999999999999999998533211 1111111111 111110000 0011112 25888
Q ss_pred HHHHhcccCCCCCCChHHHHHHHcC
Q 046703 567 ISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 567 l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
++.+||+.+|++||++.|+++.+..
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHH
Confidence 9999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=204.71 Aligned_cols=192 Identities=22% Similarity=0.327 Sum_probs=143.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..........|+++++.+.. ......+++.++..++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 72 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~ 148 (286)
T cd06614 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNIL 148 (286)
T ss_pred CCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEE
Confidence 46888888887777778899999987631 111237899999999999999999999998 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 149 i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--- 223 (286)
T cd06614 149 LSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--- 223 (286)
T ss_pred EcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 99999999999999865432211 1122456788999999988889999999999999999999999975332111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... .+.......... .......+.+++.+||+.+|.+||++.+|++
T Consensus 224 ---~~~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 224 ---ALF-LITTKGIPPLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---HHH-HHHhcCCCCCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111 111111111111 0112345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-22 Score=193.60 Aligned_cols=162 Identities=23% Similarity=0.354 Sum_probs=120.0
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCC
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMA 488 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 488 (635)
.++++++..=++...+++||.||.++. .|||||+||+|||+|+.|++|++|||++-.+-+...+. ...|-..|||
T Consensus 185 k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht---rsAGC~~YMa 259 (391)
T KOG0983|consen 185 KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT---RSAGCAAYMA 259 (391)
T ss_pred cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc---cccCCccccC
Confidence 456777777788899999999997754 39999999999999999999999999997765433222 2467889999
Q ss_pred ccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHH
Q 046703 489 PEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCI 565 (635)
Q Consensus 489 PE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 565 (635)
||.+. ...|+.++||||||+.|+|+.||+.||..-..+ ...+.. +.+..++ .+...- .-...++
T Consensus 260 PERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltk----vln~ePP-----~L~~~~--gFSp~F~ 326 (391)
T KOG0983|consen 260 PERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTK----VLNEEPP-----LLPGHM--GFSPDFQ 326 (391)
T ss_pred ccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHH----HHhcCCC-----CCCccc--CcCHHHH
Confidence 99874 346889999999999999999999998753222 112211 1122222 222110 0223467
Q ss_pred HHHHHhcccCCCCCCChHHHHHH
Q 046703 566 HISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 566 ~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
++...||+.|+.+||...++++.
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcC
Confidence 78889999999999999988763
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=169.98 Aligned_cols=93 Identities=47% Similarity=1.122 Sum_probs=87.0
Q ss_pred EEcCCCCCcccc-cCCCCCCCceEEEEeecCceeEEEEEecCCceEEEEEEcee----------------eeeeccCCCc
Q 046703 209 YRTGPWNGLRFS-APSLRPNPVFSFSFVSNDVELYYTFNITNKAVISRIIMNQT----------------LYSDVPRDQC 271 (635)
Q Consensus 209 w~~g~w~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----------------~~~~~~~~~C 271 (635)
||+|+|+|..|+ +|++..+..+.+.|+.+++|.||.|.+.+.+.+.|++|+.+ .+|.+|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999999 99999888899999999999999999999999999999865 6789999999
Q ss_pred cccccCCCCcccccCCCCcccccCCCccCC
Q 046703 272 DTYGLCGAYGICIISQSPVCQCLKGFKHKS 301 (635)
Q Consensus 272 ~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~ 301 (635)
|+|+.||+||+|+.+..+.|+|++||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988888999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=196.23 Aligned_cols=189 Identities=23% Similarity=0.339 Sum_probs=144.2
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+...+...|+++++.+... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~ 133 (254)
T cd06627 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTT 133 (254)
T ss_pred CCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEC
Confidence 57888888777777788999998875311 22357899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++......... .....++..|+|||......++.++||||+|+++++|++|+.||..... .
T Consensus 134 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~ 205 (254)
T cd06627 134 KDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------M 205 (254)
T ss_pred CCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence 9999999999999876543321 1224678899999999888889999999999999999999999853221 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...+... ......+ +......+.+++.+||+.+|++|||+.+++.
T Consensus 206 ~~~~~~~-~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 206 AALFRIV-QDDHPPL---------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHh-ccCCCCC---------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1111111 1111111 1112345678999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-22 Score=197.62 Aligned_cols=177 Identities=27% Similarity=0.366 Sum_probs=141.0
Q ss_pred CccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccc
Q 046703 392 GQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465 (635)
Q Consensus 392 ~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla 465 (635)
..+++|+|+|+.. -+.+++.|++.++..+++..++||+|||... -||||||+.|||++.++.+||+|||.|
T Consensus 100 ~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 100 HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhcccc
Confidence 4578888888753 3467889999999999999999999999988 899999999999999999999999999
Q ss_pred eecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCC
Q 046703 466 RTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS 545 (635)
Q Consensus 466 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (635)
-.+.+. -.+..++.||+.|||||.+..-.|..++||||+|+...||..|++|+...++.... -.++...++
T Consensus 177 GQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------FMIPT~PPP 247 (502)
T KOG0574|consen 177 GQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------FMIPTKPPP 247 (502)
T ss_pred chhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------EeccCCCCC
Confidence 766432 23344588999999999999999999999999999999999999998765544321 111122222
Q ss_pred cCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 546 EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+. .+.+-...+-+++..||-.+|++|-|+-++++
T Consensus 248 TF~-------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TFK-------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCC-------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 211 12334556778999999999999999988775
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=198.05 Aligned_cols=189 Identities=23% Similarity=0.263 Sum_probs=144.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+|++.+..........|+++++.... ......+++.+++.++.|+++||.|||+.+ ++|+||+|+
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~ 135 (260)
T cd08222 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAK 135 (260)
T ss_pred CCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChh
Confidence 35899999888887778899999887531 123456899999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
||+++. ..+||+|||++......... .....++..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 136 nili~~-~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--- 209 (260)
T cd08222 136 NIFLKN-NLLKIGDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--- 209 (260)
T ss_pred heEeec-CCEeecccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---
Confidence 999975 56999999998776433221 122457789999999988888999999999999999999999985321
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... .......+..... +......+.+++.+||+.+|++||++.|+++
T Consensus 210 ---~~~-~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 ---FLS-VVLRIVEGPTPSL---------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---HHH-HHHHHHcCCCCCC---------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 1111122222221 1233346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-22 Score=203.29 Aligned_cols=189 Identities=24% Similarity=0.278 Sum_probs=145.5
Q ss_pred ccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
|+|++.+.....++..+|+++++.+.. ..+...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~ 137 (280)
T cd05581 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDK 137 (280)
T ss_pred CCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECC
Confidence 899999999888888999999988531 123346899999999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCC------------------CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 454 DMNPKISDFGLARTFGGDETE------------------GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
++.++|+|||++......... .......++..|+|||.+....++.++||||||++++++++
T Consensus 138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~ 217 (280)
T cd05581 138 DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217 (280)
T ss_pred CCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh
Confidence 999999999999866433211 11223456889999999988889999999999999999999
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh----HHHHH
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM----PSVIL 587 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~----~evl~ 587 (635)
|+.||..... ..... ... ... ...+......+.+++.+||+.+|++||++ +++++
T Consensus 218 g~~p~~~~~~---~~~~~---~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 218 GKPPFRGSNE---YLTFQ---KIL-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCCCCCccH---HHHHH---HHH-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 9999864321 11111 111 100 01111224467889999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=199.12 Aligned_cols=194 Identities=21% Similarity=0.191 Sum_probs=152.4
Q ss_pred eeeccccccccccCCCCccEEEEecccch-------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASEL-------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+-||=|..++...+....++++|+|+.. +....+.++++.+.-++.+|+-||+|||..| ||.|||||+|
T Consensus 133 ~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPEN 209 (459)
T KOG0610|consen 133 LLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPEN 209 (459)
T ss_pred hcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcce
Confidence 45799999999999999999999999974 3345678899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCC---------------------------------C-C--------------------CC
Q 046703 449 VLLDQDMNPKISDFGLARTFGG---------------------------------D-E--------------------TE 474 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~---------------------------------~-~--------------------~~ 474 (635)
|||-++|.+.|+||.|+..... . . ..
T Consensus 210 ILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 210 ILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred eEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 9999999999999998753210 0 0 01
Q ss_pred CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCcccc
Q 046703 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQE 554 (635)
Q Consensus 475 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (635)
......+||-.|+|||++.+...+.++|.|+|||++|||+.|+.||......+....+. ++..++.+
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv--------~~~l~Fp~----- 356 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV--------GQPLKFPE----- 356 (459)
T ss_pred ccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh--------cCCCcCCC-----
Confidence 12234688999999999999999999999999999999999999998765444321110 11111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC----hHHHHH
Q 046703 555 SCNLTEVIRCIHISLLCVQQHPDDRPC----MPSVIL 587 (635)
Q Consensus 555 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt----~~evl~ 587 (635)
.+.....+.+||...|.+||.+|.- +.||-+
T Consensus 357 --~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 357 --EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred --CCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 1133345678999999999999998 777765
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=206.47 Aligned_cols=204 Identities=22% Similarity=0.283 Sum_probs=140.9
Q ss_pred eeccccccccccCC-CCccEEEEecccchhh---hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPD-GGQDLYIRMSASELDQ---ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~-~~~~lyl~~~~~~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+..+.. .+...|+++++..... .+...+++.....++.|+++||.|||+.+ ++|+||+|+||+++
T Consensus 66 l~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~ 142 (328)
T cd07856 66 LRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILIN 142 (328)
T ss_pred cCCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeEC
Confidence 36889988877653 3567889988875321 12345677778889999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++||+++|+.||...........
T Consensus 143 ~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~ 217 (328)
T cd07856 143 ENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217 (328)
T ss_pred CCCCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999987543211 12356788999998765 5689999999999999999999999865432111111
Q ss_pred HHH--------HHHHhhcCCCCcCCCCc-cccCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 532 IGH--------AWKLWNKGMPSEMIDPC-YQESCNL-----TEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 532 ~~~--------~~~~~~~~~~~~~~d~~-l~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
+.. ....+..+...+++... .....+. .....+.+++.+||+.+|++|||+++++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 01111111111110000 0001111 123467789999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-21 Score=199.41 Aligned_cols=193 Identities=21% Similarity=0.210 Sum_probs=139.7
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+......+..+|+++++.+.. ..+...+++..+..++.|+++||.|||+.+ ++||||+|+||+++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~ 139 (290)
T cd05613 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLD 139 (290)
T ss_pred cCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEC
Confidence 3788888877777777899999988642 123456788888889999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC--CCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
.++.+||+|||++......... ......++..|+|||.+... .++.++||||||+++|||++|+.||........
T Consensus 140 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-- 216 (290)
T cd05613 140 SNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-- 216 (290)
T ss_pred CCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--
Confidence 9999999999999875433221 12235678899999998653 467899999999999999999999864322211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
. ............. .+......+.+++.+||+.||++|| ++++++.
T Consensus 217 ~-~~~~~~~~~~~~~----------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 217 Q-AEISRRILKSEPP----------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred H-HHHHHHhhccCCC----------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1 1111111111110 1111223567899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-21 Score=191.61 Aligned_cols=214 Identities=20% Similarity=0.254 Sum_probs=153.9
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
=|+||+++.++.+++..+|++++.+... ..+++-+++.++.+++.+|+.||.|||.++ |.|||+||+|||..
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCE 210 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeec
Confidence 4999999999999999999999988742 356778999999999999999999999999 99999999999997
Q ss_pred cCCC---CccCccccceecCC--CCC---CCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCC
Q 046703 453 QDMN---PKISDFGLARTFGG--DET---EGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 453 ~~~~---~kl~Dfgla~~~~~--~~~---~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
.... +||+||.+..-..- +-+ .....+.+|...|||||... ...|+.+.|.||||||||-|++|..|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 5543 79999988754321 111 11223468888999999762 33588999999999999999999999
Q ss_pred CCCccCCC-----c---ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH----
Q 046703 520 RGFYHLDN-----K---LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL---- 587 (635)
Q Consensus 520 f~~~~~~~-----~---~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~---- 587 (635)
|...-..+ . ...-......+++|.. ++.|..+. .......+++...+..|+..|-++.+++.
T Consensus 291 FvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 291 FVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY-EFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred ccCccCCcCCccCCCccHHHHHHHHHHHhccCC-cCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 97653221 1 1111222333444432 23333332 12223345667778899999999988876
Q ss_pred -HHcCCCCCCCCCC
Q 046703 588 -MLGSEIVLPQPKQ 600 (635)
Q Consensus 588 -~L~~~~~~p~p~~ 600 (635)
+......+|.|+.
T Consensus 365 ~~~~~ekalptp~v 378 (463)
T KOG0607|consen 365 QRCAPEKALPTPQV 378 (463)
T ss_pred cccchhccCCCCcc
Confidence 3333455666543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-22 Score=233.33 Aligned_cols=158 Identities=16% Similarity=0.208 Sum_probs=113.3
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec-------------------cCCCCccCccccceecC
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD-------------------QDMNPKISDFGLARTFG 469 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld-------------------~~~~~kl~Dfgla~~~~ 469 (635)
...+++.+++.++.||++||.|||+++ |+||||||+||||+ .++.+|++|||+++...
T Consensus 74 ~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~ 150 (793)
T PLN00181 74 DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE 150 (793)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccc
Confidence 345889999999999999999999999 99999999999994 35567888888886432
Q ss_pred CCCC--------------CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHH
Q 046703 470 GDET--------------EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHA 535 (635)
Q Consensus 470 ~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~ 535 (635)
.... ........||+.|+|||.+.+..++.++|||||||+||||++|..|+.... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~--- 222 (793)
T PLN00181 151 ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM--- 222 (793)
T ss_pred cccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH---
Confidence 1000 000112357888999999999999999999999999999999888753210 011
Q ss_pred HHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 536 WKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..+..... .+.. .........++.+||+.+|.+||+|.||++
T Consensus 223 -~~~~~~~~----~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 223 -SSLRHRVL----PPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -HHHHHhhc----Chhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 11111110 1100 111223457888999999999999999976
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-22 Score=211.82 Aligned_cols=198 Identities=26% Similarity=0.315 Sum_probs=139.4
Q ss_pred eeccccccccccCCCC------ccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGG------QDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~------~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+|++.+..+.... ..+|+++++.... ......+++.++..++.|+++||.|||+.+ |+|+||+|+
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~ 147 (343)
T cd07851 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPS 147 (343)
T ss_pred ccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 3588887776654333 3489998887531 122356899999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||......
T Consensus 148 Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~ 222 (343)
T cd07851 148 NIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI 222 (343)
T ss_pred HeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999999765432 112356788999998865 36789999999999999999999998643221
Q ss_pred CcccHHHHHHHHhhcCCCCc-------------------CCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSE-------------------MIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~-------------------~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+ ......... .....+ ........ ........+.+++.+||+.+|++|||+.||++
T Consensus 223 ~---~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 223 D---QLKRIMNLV-GTPDEELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred H---HHHHHHHhc-CCCCHHHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 1 111111100 000000 00000000 00112456889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-22 Score=210.40 Aligned_cols=201 Identities=23% Similarity=0.285 Sum_probs=138.2
Q ss_pred eeeccccccccccCC------CCccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPD------GGQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~------~~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+||+.+..+.. ....+|+++++.... ..+...+++..+..++.||++||+|||+.+ |+||||||
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp 148 (345)
T cd07877 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKP 148 (345)
T ss_pred HcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence 346888888766543 223467777654321 123346889999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 149 ~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 149 SNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred HHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999998764322 122457889999998866 5688999999999999999999999864322
Q ss_pred CCcccHHHHHHHHh-----------hcCC-------CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLW-----------NKGM-------PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~-----------~~~~-------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ......... .... ........... ........+.+++.+|++.||.+||++.+++.
T Consensus 224 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 224 ID---QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HH---HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 11 111110000 0000 00000000000 00012335678999999999999999999886
Q ss_pred H
Q 046703 588 M 588 (635)
Q Consensus 588 ~ 588 (635)
.
T Consensus 300 h 300 (345)
T cd07877 300 H 300 (345)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-22 Score=205.67 Aligned_cols=188 Identities=22% Similarity=0.235 Sum_probs=152.0
Q ss_pred ccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
.+-||.++....+...+|+.||.+-.. ...+..++..+...++.-+.+|+.|||+++ ||.|||||+|.++|.
T Consensus 479 s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~ 555 (732)
T KOG0614|consen 479 SDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDN 555 (732)
T ss_pred chHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeecc
Confidence 667888998888899999999887542 245677888888888999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
+|-+||.|||+|+.++.+ .++.+..||+.|.|||++.++..+.++|.||+|+++||+++|.+||...++....+++-
T Consensus 556 ~Gy~KLVDFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 556 RGYLKLVDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred CCceEEeehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 999999999999988643 45667999999999999999999999999999999999999999998776655444443
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
.....+ .++....+...+++.+....+|.+|.- +.+|-+
T Consensus 633 kGid~i---------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 633 KGIDKI---------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred hhhhhh---------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 322221 122233345667788878889999975 555543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-21 Score=193.39 Aligned_cols=185 Identities=23% Similarity=0.239 Sum_probs=142.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+......+..+|+++++.... ..+...+++.....++.|+++||.|||+.+ ++|+||+|+||+++
T Consensus 51 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~ 127 (250)
T cd05123 51 NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLD 127 (250)
T ss_pred CCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEc
Confidence 4899999888888888999999987421 122346889999999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++|+|||++........ ......++..|++||...+...+.++|+||||+++||+++|+.||..... ...
T Consensus 128 ~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~- 201 (250)
T cd05123 128 ADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI- 201 (250)
T ss_pred CCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH-
Confidence 999999999999987643321 12235678899999999888899999999999999999999999854322 111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
......+.. ..+......+.+++.+||+.||++||++.+
T Consensus 202 ---~~~~~~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 202 ---YEKILKDPL----------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---HHHHhcCCC----------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111111111 111111345678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-21 Score=204.68 Aligned_cols=208 Identities=20% Similarity=0.226 Sum_probs=135.5
Q ss_pred eeccccccccccCCC--------------CccEEEEecccchhh---hhccccCcccchhhhhhhccccchhhccccceE
Q 046703 377 MWFGDLIDMRSFPDG--------------GQDLYIRMSASELDQ---ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--------------~~~lyl~~~~~~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 439 (635)
+.|+|++.+..+... ...+|+++++..... .....+++..+..++.||++||.|||+.+ +
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---i 135 (342)
T cd07854 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---V 135 (342)
T ss_pred cCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 357777776544322 235789998876421 12346888899999999999999999999 9
Q ss_pred EeeccCCcceEecc-CCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhC
Q 046703 440 IHRDLKAGNVLLDQ-DMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 440 iH~dik~~NIlld~-~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG 516 (635)
+||||||+||+++. +..+||+|||++.......... ......++..|+|||.+.. ..++.++|||||||++|||++|
T Consensus 136 vH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 136 LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred ccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence 99999999999974 5578999999997653221111 1112346788999997654 5678999999999999999999
Q ss_pred CCCCCCccCCCcccHHHH--------HHHHhhcCCCCcCCCCccccCCC-----HHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 517 KKNRGFYHLDNKLNLIGH--------AWKLWNKGMPSEMIDPCYQESCN-----LTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 517 ~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
+.||......+....... ......................+ ......+.+++.+||+.||++|||++
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 295 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence 999864322111000000 00000000000000000000000 11224567899999999999999999
Q ss_pred HHHH
Q 046703 584 SVIL 587 (635)
Q Consensus 584 evl~ 587 (635)
||++
T Consensus 296 ell~ 299 (342)
T cd07854 296 EALM 299 (342)
T ss_pred HHhC
Confidence 9985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.6e-22 Score=198.87 Aligned_cols=195 Identities=17% Similarity=0.263 Sum_probs=148.9
Q ss_pred eccccccccccC-CCCccEEEEecccchh-------------hhhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 378 WFGDLIDMRSFP-DGGQDLYIRMSASELD-------------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 378 ~h~nLv~l~~~~-~~~~~lyl~~~~~~~~-------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
.|+||..+..++ +++...++..++...+ ......++-.+...++.|++.|++|||+++ +||.|
T Consensus 345 sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkD 421 (563)
T KOG1024|consen 345 SHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKD 421 (563)
T ss_pred cCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccch
Confidence 499998887776 4556667766665421 122344556677889999999999999999 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGF 522 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~ 522 (635)
|.++|.+||+...+||+|=.+++-+-..+..........+..||+||.+.+..|+.++|||||||+||||++ |+.|+..
T Consensus 422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred hhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 999999999999999999998876544333333333445789999999999999999999999999999997 8888754
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.++.+ ....+++|.. -..+..++.++..+|..||...|++||++++++.-|..
T Consensus 502 IDPfE-------m~~ylkdGyR---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 502 IDPFE-------MEHYLKDGYR---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred cCHHH-------HHHHHhccce---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 33222 2233334332 23345566778999999999999999999999988754
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=192.52 Aligned_cols=191 Identities=20% Similarity=0.232 Sum_probs=138.2
Q ss_pred eccccccccccCCC--CccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDG--GQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~--~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|++++.+..+... +..+|+++++.... ....+.+++.....++.||+.||.|||+.+ ++|+||||+||+
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~ 138 (264)
T cd06653 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANIL 138 (264)
T ss_pred CCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEE
Confidence 57888877665432 35688888876532 122345788888999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCC-CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDET-EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.++|+|||+++....... ........++..|+|||.+.+..++.++|+||||++++|+++|+.||....
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----- 213 (264)
T cd06653 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----- 213 (264)
T ss_pred EcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-----
Confidence 99999999999999976532111 111122457889999999988889999999999999999999999985321
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+......... .+......+.+++..|++ +|.+||++.+++.
T Consensus 214 -~~~~~~~~~~~~~~~~---------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 214 -AMAAIFKIATQPTKPM---------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHHHHHHHHcCCCCCC---------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111111111111 122233457788999998 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-21 Score=196.98 Aligned_cols=217 Identities=19% Similarity=0.216 Sum_probs=155.6
Q ss_pred eeeeccccccccccCC----CCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhc-----cccceEEe
Q 046703 375 CAMWFGDLIDMRSFPD----GGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQ-----DSRLRIIH 441 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~----~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~iiH 441 (635)
-.++|+||+..-.... .-..+||+.+|-+.+ -..+..++-+..+++++.+|.||++||. ++++.|.|
T Consensus 260 vmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 260 VMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred HHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 4678999875544332 224788998887753 3456788899999999999999999995 56788999
Q ss_pred eccCCcceEeccCCCCccCccccceecCCC--CCCCceeeeeeccCCCCcccccCCC----Cc--ccCceeeeehhhHhh
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGD--ETEGNTTRVVGTYGYMAPEYASDGQ----FS--VKSDVFSFGILLLEI 513 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~s--~ksDVwS~Gvvl~ei 513 (635)
||||..|||+.+++...|+|+|||...... .........+||.+|||||.+.+.- +. ..+||||||.|+||+
T Consensus 340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 999999999999999999999999876543 2223345578999999999985431 22 679999999999999
Q ss_pred hhC----------CCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 514 VSG----------KKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 514 ltG----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
..+ +.||....+.+. ..+...+..-..+....+..++. +.+.+..+.++|..||..||+-|-|+-
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DP--s~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDP--SFEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCC--CHHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 753 244432221111 11122222222222222333332 457788899999999999999999999
Q ss_pred HHHHHHcCCCCCC
Q 046703 584 SVILMLGSEIVLP 596 (635)
Q Consensus 584 evl~~L~~~~~~p 596 (635)
.|-+.|.++.+++
T Consensus 495 riKKtl~~l~~~~ 507 (513)
T KOG2052|consen 495 RIKKTLAKLSNSD 507 (513)
T ss_pred HHHHHHHHHhcCh
Confidence 9999888776543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.7e-21 Score=193.62 Aligned_cols=178 Identities=25% Similarity=0.299 Sum_probs=140.0
Q ss_pred ccccccccCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCC
Q 046703 381 DLIDMRSFPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455 (635)
Q Consensus 381 nLv~l~~~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~ 455 (635)
-|+++..+.+.-..+|.+|||... +..+..++.+..+.-++..||-||-|||+++ ||.||||..||++|.++
T Consensus 411 FL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 411 FLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEG 487 (683)
T ss_pred hHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCC
Confidence 456777777888899999999874 3456678889999999999999999999999 99999999999999999
Q ss_pred CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHH
Q 046703 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHA 535 (635)
Q Consensus 456 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~ 535 (635)
.+||+|||+.+.-- .....+.+..||+-|+|||++...+|+..+|.|||||+||||+.|++||+..+.++-
T Consensus 488 HiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------- 558 (683)
T KOG0696|consen 488 HIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------- 558 (683)
T ss_pred ceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------
Confidence 99999999987532 123345668999999999999999999999999999999999999999976543321
Q ss_pred HHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC
Q 046703 536 WKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580 (635)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 580 (635)
.+.+.+... .++..-..+.+.+....+..+|.+|.
T Consensus 559 F~aI~ehnv----------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 FQAIMEHNV----------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHccC----------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 111112111 12223334455666677888898884
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-21 Score=187.97 Aligned_cols=193 Identities=23% Similarity=0.308 Sum_probs=142.9
Q ss_pred cccccccccCCCCccEEEEecccch---------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 380 GDLIDMRSFPDGGQDLYIRMSASEL---------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 380 ~nLv~l~~~~~~~~~lyl~~~~~~~---------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
++||+.++..=...+-+|-||.++. ...+...++++-.-+|..-...||.||.+.- .|||||+||+|||
T Consensus 123 p~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNIL 200 (361)
T KOG1006|consen 123 PNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNIL 200 (361)
T ss_pred cHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheE
Confidence 5677776666556677888877763 2344556778777788888899999997754 4999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc--CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS--DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++..|.+||+|||++-.+.+.. +. +.-.|-..|||||.+. +..|+.++||||+|+.|+|+.+|+.|+...+.
T Consensus 201 ldr~G~vKLCDFGIcGqLv~Si--Ak-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--- 274 (361)
T KOG1006|consen 201 LDRHGDVKLCDFGICGQLVDSI--AK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--- 274 (361)
T ss_pred EecCCCEeeecccchHhHHHHH--Hh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---
Confidence 9999999999999986553321 11 1246788999999884 34589999999999999999999999865432
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+.+ .....-.|.++.+....- ..+....+++++-.|+-+|-++||...++.+
T Consensus 275 --vfe-ql~~Vv~gdpp~l~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 275 --VFE-QLCQVVIGDPPILLFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --HHH-HHHHHHcCCCCeecCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 222 223334566655543222 1234456888999999999999999998875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-22 Score=214.26 Aligned_cols=196 Identities=23% Similarity=0.289 Sum_probs=153.7
Q ss_pred eeeccccccccccCCCCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+-|+||+.+..++.... +-|+.+++.+ -+..+..+--+..+.|..|||+|+.|||++. ++||||.++||
T Consensus 754 sldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNV 829 (1177)
T KOG1025|consen 754 SLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNV 829 (1177)
T ss_pred cCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhhe
Confidence 456888888888887554 4555555543 2345677888899999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|+..-..+||.|||+++....+..........-.+.|||-|.+....++.++|||||||.+||++| |.+|++....+
T Consensus 830 LVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-- 907 (1177)
T KOG1025|consen 830 LVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-- 907 (1177)
T ss_pred eecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--
Confidence 999999999999999998876554433333344678999999999999999999999999999997 88997654322
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
++.+.++.|.. -..++-+...+..++.+||..|++.||+++++...+..
T Consensus 908 -----eI~dlle~geR---------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 908 -----EIPDLLEKGER---------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -----HhhHHHhcccc---------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 23333333332 34456677788899999999999999999999876654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-21 Score=192.28 Aligned_cols=219 Identities=22% Similarity=0.194 Sum_probs=154.1
Q ss_pred eeccccccccccC------CCCccEEEEecccchhhh--hccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFP------DGGQDLYIRMSASELDQE--RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~------~~~~~lyl~~~~~~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.++.+. +.-+++|++++++..... -.-.++-++...|..|++.|++|||+.+ |+||||||+|
T Consensus 72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsn 148 (369)
T KOG0665|consen 72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSN 148 (369)
T ss_pred hcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCccc
Confidence 5699999887765 234689999998874211 1245677788899999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|++..+..+||.|||+++..... ...+..+.+..|+|||.+.+..+.+.+||||.||++.||+.|+.-|...+.-+.
T Consensus 149 ivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 149 IVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred ceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 99999999999999999865432 223346778899999999988899999999999999999999988765432221
Q ss_pred ccHHHH----------------HHHHhh------cCCCC-cCCCCcccc--CCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 529 LNLIGH----------------AWKLWN------KGMPS-EMIDPCYQE--SCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 529 ~~~~~~----------------~~~~~~------~~~~~-~~~d~~l~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
...+.. +..... .-... -+.|..... +.+........+++.++|-.||++|.++.
T Consensus 226 ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 226 WNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 111111 000000 00001 111211111 11223334456789999999999999999
Q ss_pred HHHH--HHc---CCCCCCCCCCC
Q 046703 584 SVIL--MLG---SEIVLPQPKQP 601 (635)
Q Consensus 584 evl~--~L~---~~~~~p~p~~p 601 (635)
++++ .++ ...+++.|+.+
T Consensus 306 daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 306 DALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred HHhcCCeeeeecccccccCCCCc
Confidence 9997 344 44456666655
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-21 Score=207.00 Aligned_cols=202 Identities=23% Similarity=0.259 Sum_probs=137.7
Q ss_pred eeccccccccccCCCC------ccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGG------QDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~------~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+.... ..+|+++++.... ......+++..+..++.||++||+|||+.+ |+||||||+
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~ 147 (343)
T cd07880 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPG 147 (343)
T ss_pred cCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 3588888777665432 2457888876421 122357889999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
||+++.++.+||+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||......
T Consensus 148 Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 222 (343)
T cd07880 148 NLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222 (343)
T ss_pred HEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999997653221 12456789999998876 45889999999999999999999998643211
Q ss_pred CcccHHH--------HHHHHhhcCC-------CCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIG--------HAWKLWNKGM-------PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~--------~~~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+. .....+.... ........+. .........+.+++.+|++.||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 223 DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1000000 0000000000 0000000000 000112234678999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-21 Score=208.18 Aligned_cols=190 Identities=23% Similarity=0.340 Sum_probs=138.4
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCc---ccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDW---SKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~---~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|+|+|..+....+.+.+||.+|.+... ......+.. -..+.+..|+++||++||+.+ ||||||||+||
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNI 637 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNI 637 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceE
Confidence 5999998888888999999999877531 111111111 234678899999999999988 99999999999
Q ss_pred Eecc---C--CCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC-CCCCCC
Q 046703 450 LLDQ---D--MNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGF 522 (635)
Q Consensus 450 lld~---~--~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG-~~pf~~ 522 (635)
||+. + ..++|+|||+++.+..+... .......||-+|+|||.+....-+.++||+|+|||+|+.++| ..||+.
T Consensus 638 LI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 638 LISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred EEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 9976 3 46899999999988755433 223447799999999999998889999999999999999986 789864
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
.-.. ...++ .+... +. .++ ...++ ...+|+.++++.+|..||++.+|+
T Consensus 718 ~~~R--------~~NIl-~~~~~-L~--~L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 718 SLER--------QANIL-TGNYT-LV--HLE--PLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hHHh--------hhhhh-cCccc-ee--eec--cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 2111 11111 11110 00 001 11111 456789999999999999999997
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-21 Score=195.50 Aligned_cols=185 Identities=25% Similarity=0.282 Sum_probs=132.8
Q ss_pred cccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCc
Q 046703 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAP 489 (635)
Q Consensus 410 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 489 (635)
..++++.++-++.+|+-||++||... ||.||+||+|||+|+.|+++|+|+|||..+...+... ..+||.+||||
T Consensus 282 ~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~---~rvGT~GYMAP 355 (591)
T KOG0986|consen 282 PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR---GRVGTVGYMAP 355 (591)
T ss_pred CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCccc---cccCcccccCH
Confidence 46889999999999999999999999 9999999999999999999999999999887665432 24899999999
Q ss_pred ccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHH
Q 046703 490 EYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 490 E~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 569 (635)
|++.+..|+...|.||+||+||||+.|+.||..........-+++ ...+ .. .+++..-.+.+..+..
T Consensus 356 Evl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r~~~-~~---------~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 356 EVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---RTLE-DP---------EEYSDKFSEEAKSLCE 422 (591)
T ss_pred HHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---HHhc-ch---------hhcccccCHHHHHHHH
Confidence 999999999999999999999999999999864432222111111 1100 11 1222222334445666
Q ss_pred HhcccCCCCCCC-----hHHHH----------HHHcCC-CCCCCCCCCCccccccCCCCC
Q 046703 570 LCVQQHPDDRPC-----MPSVI----------LMLGSE-IVLPQPKQPGFLADRKSIGPD 613 (635)
Q Consensus 570 ~Cl~~dP~~RPt-----~~evl----------~~L~~~-~~~p~p~~p~~~~~~~~~~~~ 613 (635)
..|+.||++|-- +.+|- +.|+.- .+-|--|.|..+..-++.|-+
T Consensus 423 ~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIe 482 (591)
T KOG0986|consen 423 GLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIE 482 (591)
T ss_pred HHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhh
Confidence 678999999864 34553 344433 344444556655555554444
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-21 Score=187.50 Aligned_cols=205 Identities=21% Similarity=0.251 Sum_probs=149.7
Q ss_pred eccccccccccCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.||-|..+++..+....+..+|+|... +..+.+.+++....-+...|+.||.|||+.+ ||.||+|.+|.|+|
T Consensus 226 ~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLD 302 (516)
T KOG0690|consen 226 RHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLD 302 (516)
T ss_pred cCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheec
Confidence 688788888777777788888887753 3355677888888889999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.+|.+||+|||+++.-- .....+.+..||+.|+|||.+.+..|..++|.|-+||++|||++|+.||-..+.+.-..++
T Consensus 303 kDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 303 KDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred cCCceEeeecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 99999999999997532 2233455689999999999999999999999999999999999999998654433222221
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH--HcCC-------CCCCCC
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVILM--LGSE-------IVLPQP 598 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~~--L~~~-------~~~p~p 598 (635)
. -+ |-+......+ +...|..-.|..||.+|. .++||.+. ..++ ..++.|
T Consensus 381 l-------~e------d~kFPr~ls~----eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PP 443 (516)
T KOG0690|consen 381 L-------ME------DLKFPRTLSP----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPP 443 (516)
T ss_pred H-------hh------hccCCccCCH----HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCC
Confidence 1 00 1111111111 234466677899999995 35565542 1221 245666
Q ss_pred CCCCcc
Q 046703 599 KQPGFL 604 (635)
Q Consensus 599 ~~p~~~ 604 (635)
=.|++-
T Consensus 444 fKPqVt 449 (516)
T KOG0690|consen 444 FKPQVT 449 (516)
T ss_pred CCCCcc
Confidence 666653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-21 Score=189.47 Aligned_cols=211 Identities=23% Similarity=0.297 Sum_probs=146.6
Q ss_pred eeeeccccccccccCCC-----CccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccC
Q 046703 375 CAMWFGDLIDMRSFPDG-----GQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~-----~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik 445 (635)
|.++|.|++....+-.. -+++|++.|.+.-+. .....|+-..+.-++.||++||.|||+.+ |.|||||
T Consensus 107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIK 183 (449)
T KOG0664|consen 107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIK 183 (449)
T ss_pred HhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCC
Confidence 88999998765444322 246666655443222 22456777788889999999999999999 9999999
Q ss_pred CcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 446 ~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
|.|.|++.+..+||+|||+++....++....+ ..+-|..|+|||++.+. .|+.+.||||.|||+.|++.++.-|....
T Consensus 184 PGNLLVNSNCvLKICDFGLARvee~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 184 PGNLLVNSNCILKICDFGLARTWDQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred CccEEeccCceEEecccccccccchhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 99999999999999999999976554443322 24557899999999875 68999999999999999999988887766
Q ss_pred CCCcccHHHH--------HHHHhhcCCCCcCCCCc---------cccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 525 LDNKLNLIGH--------AWKLWNKGMPSEMIDPC---------YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 525 ~~~~~~~~~~--------~~~~~~~~~~~~~~d~~---------l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+.+...++.. +.+..-+|-..-++... +.-..+...-...+.+.+.++..||++|.+..+.+.
T Consensus 263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 6555444432 11111222211111111 111111111223455677789999999999999887
Q ss_pred HH
Q 046703 588 ML 589 (635)
Q Consensus 588 ~L 589 (635)
.+
T Consensus 343 ~~ 344 (449)
T KOG0664|consen 343 HR 344 (449)
T ss_pred cc
Confidence 65
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=185.74 Aligned_cols=191 Identities=26% Similarity=0.311 Sum_probs=143.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..........++++++..... .....++++.+..++.++++++.|||+.+ ++|+||+|+||+++
T Consensus 45 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~ 121 (244)
T smart00220 45 KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLD 121 (244)
T ss_pred CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEEC
Confidence 67788888877777778889888775411 11223788899999999999999999998 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.++|+|||.+....... ......++..|++||.+....++.++||||||++++++++|..||.... +.
T Consensus 122 ~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~---- 192 (244)
T smart00220 122 EDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QL---- 192 (244)
T ss_pred CCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cH----
Confidence 99999999999998765432 1223457889999999988889999999999999999999999985421 11
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.........+....... .......+.+++.+|+..+|++||++.++++
T Consensus 193 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 193 LELFKKIGKPKPPFPPP-------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHhccCCCCccc-------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11122222221111000 0002346788999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-20 Score=197.20 Aligned_cols=189 Identities=22% Similarity=0.244 Sum_probs=146.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.||.+|+++..++....+|++||....+ ...+..|+++.-..++.||+.||+|||.++ |+|+||||+|||
T Consensus 620 l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVL 696 (888)
T KOG4236|consen 620 LHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVL 696 (888)
T ss_pred cCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchhee
Confidence 46999999999999999999999987642 345667888888889999999999999999 999999999999
Q ss_pred eccCC---CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 451 LDQDM---NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 451 ld~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+...- .+||+|||+|+.++.... ..+++||+.|+|||.++.+.|...-|+||.|||+|--++|..||... ++
T Consensus 697 Las~~~FPQvKlCDFGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--Ed 771 (888)
T KOG4236|consen 697 LASASPFPQVKLCDFGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--ED 771 (888)
T ss_pred eccCCCCCceeeccccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cc
Confidence 97653 489999999999865433 23478999999999999999999999999999999999999998532 22
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
....++.+. ... - ...-.+.....++++...||..-.+|.|...-+
T Consensus 772 IndQIQNAa-------FMy--P----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 772 INDQIQNAA-------FMY--P----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhHHhhccc-------ccc--C----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 112222111 111 1 111112333467788888898999999987664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.8e-21 Score=182.41 Aligned_cols=209 Identities=22% Similarity=0.314 Sum_probs=145.7
Q ss_pred eeeccccccccccCC--------CCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 376 AMWFGDLIDMRSFPD--------GGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~--------~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
.+.|+|++++.+++. ....+|+++.+++.+ .....+++..++.+++.++..||.|+|... |+||
T Consensus 72 ~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHR 148 (376)
T KOG0669|consen 72 LLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHR 148 (376)
T ss_pred HhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhh
Confidence 457999988877662 234699999988743 234467888899999999999999999998 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCC--CCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDET--EGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
|+|+.|+||+.++.+||+|||+++.+...+. ....+..+-|..|++||.+.+ ..++++.|||.-|||+.||.+|.+.
T Consensus 149 DmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 149 DMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred cccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence 9999999999999999999999976643222 112223456899999998866 4689999999999999999999988
Q ss_pred CCCccCCCcccHHHHHHHH-----hhcCCCCcC---C--CCccccCC--CHHHH------HHHHHHHHHhcccCCCCCCC
Q 046703 520 RGFYHLDNKLNLIGHAWKL-----WNKGMPSEM---I--DPCYQESC--NLTEV------IRCIHISLLCVQQHPDDRPC 581 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~-----~~~~~~~~~---~--d~~l~~~~--~~~~~------~~~~~l~~~Cl~~dP~~RPt 581 (635)
+..........++...... |++-.-.++ + .+..++.. -.... ...++++..++..||.+|+.
T Consensus 229 mqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 229 MQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred ccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc
Confidence 7655444333333321111 111000000 0 00000000 00111 13567888899999999999
Q ss_pred hHHHHH
Q 046703 582 MPSVIL 587 (635)
Q Consensus 582 ~~evl~ 587 (635)
+.+++.
T Consensus 309 ad~aln 314 (376)
T KOG0669|consen 309 ADQALN 314 (376)
T ss_pred hHhhhc
Confidence 988874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=185.51 Aligned_cols=198 Identities=23% Similarity=0.309 Sum_probs=142.3
Q ss_pred eeccccccccccCC-CCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPD-GGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~-~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+-|++||.++.+.. +...+.-+++|++. ...+.+.++++++..|+.||..||.||.+.. ++|||-||||.|||
T Consensus 524 LDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 524 LDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNIL 602 (775)
T ss_pred cCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEE
Confidence 46889999888774 55667778898874 3466788999999999999999999999875 77999999999999
Q ss_pred ec---cCCCCccCccccceecCCCCCC-----CceeeeeeccCCCCcccccCC----CCcccCceeeeehhhHhhhhCCC
Q 046703 451 LD---QDMNPKISDFGLARTFGGDETE-----GNTTRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 451 ld---~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
+. ..|.+||.||||++.+..+... ..+....||+.|++||.+.-+ .++.|+||||+|||+|.++.|++
T Consensus 603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 95 3577999999999998754332 123346789999999987433 57899999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
||...-... .++.+ ..++....+.--..+ .-.-....++.+||++.-++|....++.
T Consensus 683 PFGhnqsQQ--dILqe-NTIlkAtEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 683 PFGHNQSQQ--DILQE-NTILKATEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCCCchhHH--HHHhh-hchhcceeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 996432211 11111 001111111110111 1112344688999999999997655543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-20 Score=212.00 Aligned_cols=87 Identities=25% Similarity=0.357 Sum_probs=75.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++|+.++........+|++++++.... ...+.+++..++.++.||+.||.|||..+ |+||||||+|||+
T Consensus 61 l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl 137 (669)
T cd05610 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLI 137 (669)
T ss_pred cCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEE
Confidence 468899988887777888999999876321 22345788889999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccce
Q 046703 452 DQDMNPKISDFGLAR 466 (635)
Q Consensus 452 d~~~~~kl~Dfgla~ 466 (635)
+.++.+||+|||+++
T Consensus 138 ~~~g~vkL~DFGls~ 152 (669)
T cd05610 138 SNEGHIKLTDFGLSK 152 (669)
T ss_pred cCCCCEEEEeCCCCc
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-20 Score=205.04 Aligned_cols=164 Identities=16% Similarity=0.136 Sum_probs=105.3
Q ss_pred cchhhhhhhccccchhhccccceEEeeccCCcceEecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC
Q 046703 416 KRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD 494 (635)
Q Consensus 416 ~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 494 (635)
.+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+..
T Consensus 256 ~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~ 331 (566)
T PLN03225 256 IIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIM 331 (566)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhc
Confidence 34578999999999999998 999999999999986 578999999999865432221 1223567899999996532
Q ss_pred C----------------------CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHH------HHhhcCCCCc
Q 046703 495 G----------------------QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAW------KLWNKGMPSE 546 (635)
Q Consensus 495 ~----------------------~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~ 546 (635)
. .++.++|||||||+||||+++..+++.. ...+..... ..+.......
T Consensus 332 ~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~ 407 (566)
T PLN03225 332 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPR 407 (566)
T ss_pred cCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccc
Confidence 2 2345679999999999999876654211 000000000 0000000000
Q ss_pred CCCCccccCC--CHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 547 MIDPCYQESC--NLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 547 ~~d~~l~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
..+.+...+ .........+|+.+||+.||++|||++|+++.
T Consensus 408 -~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 408 -ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred -cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 000000000 00011234579999999999999999999873
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-19 Score=196.01 Aligned_cols=143 Identities=25% Similarity=0.371 Sum_probs=119.8
Q ss_pred eeeccccccccccCCCCc------cEEEEecccch--------hhhhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 376 AMWFGDLIDMRSFPDGGQ------DLYIRMSASEL--------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~------~lyl~~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
.+.|+|||.+..+.+... ...++|+|+.. ..+....|++.+.+.++.++..||.|||+++ |+|
T Consensus 67 KLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvH 143 (732)
T KOG4250|consen 67 KLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVH 143 (732)
T ss_pred HcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---cee
Confidence 456999999888876543 44577888764 2345678999999999999999999999999 999
Q ss_pred eccCCcceEec--cCCC--CccCccccceecCCCCCCCceeeeeeccCCCCccccc-CCCCcccCceeeeehhhHhhhhC
Q 046703 442 RDLKAGNVLLD--QDMN--PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 442 ~dik~~NIlld--~~~~--~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwS~Gvvl~eiltG 516 (635)
|||||.||++- +++. -||+|||.|+.+.++. ...+..||..|++||... .+.|+..+|.|||||++||++||
T Consensus 144 RDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG 220 (732)
T KOG4250|consen 144 RDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATG 220 (732)
T ss_pred ccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhcc
Confidence 99999999984 3333 6999999999876554 455689999999999998 58999999999999999999999
Q ss_pred CCCCCCcc
Q 046703 517 KKNRGFYH 524 (635)
Q Consensus 517 ~~pf~~~~ 524 (635)
..||....
T Consensus 221 ~lPF~p~~ 228 (732)
T KOG4250|consen 221 ELPFIPFG 228 (732)
T ss_pred CCCCCcCC
Confidence 99986543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8e-19 Score=174.36 Aligned_cols=188 Identities=22% Similarity=0.308 Sum_probs=142.9
Q ss_pred eccccccccccCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.||-||-+..+.+....+|.+.+|... .-.+..+|+++.+..+...|+.||.|||+.+ ||.||+|..|+|+|
T Consensus 309 n~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlld 385 (593)
T KOG0695|consen 309 NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLD 385 (593)
T ss_pred CCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEc
Confidence 356677777777778888888888763 2345567888988889999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc-ccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK-LNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~-~~~ 531 (635)
..+.+||.|+|+.+.--. ....+.+..||+.|.|||++++..|...+|.|++||+++||+.|+.||+....++. .+.
T Consensus 386 aeghikltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt 463 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT 463 (593)
T ss_pred cCCceeecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch
Confidence 999999999999875322 22345568999999999999999999999999999999999999999987543332 223
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 580 (635)
.++..+.+.+.++. .+..-..+...+...-|++||.+|.
T Consensus 464 edylfqvilekqir----------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 464 EDYLFQVILEKQIR----------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hHHHHHHHhhhccc----------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 33444443332211 1111222345677778899999884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.8e-19 Score=161.22 Aligned_cols=238 Identities=20% Similarity=0.230 Sum_probs=165.5
Q ss_pred CCeEEeeccCCCCCCCcceeccCCHHHHHHHHhhcCCcccccccccCCCCcceeeeccccccccccCCCCccEEEEeccc
Q 046703 323 DGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGGQDLYIRMSAS 402 (635)
Q Consensus 323 ~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~i~~~~~gC~l~h~nLv~l~~~~~~~~~lyl~~~~~ 402 (635)
...+.++++.+-+.+.. +-...-+++|+- -.+.|+|||.+..+-..+.++-++++++
T Consensus 27 ~eivalkrvrlddddeg-----vpssalreicll------------------kelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 27 HEIVALKRVRLDDDDEG-----VPSSALREICLL------------------KELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred cceEEEEEEeccCCCCC-----CcHHHHHHHHHH------------------HHhhhcceeehhhhhccCceeEEeHHHh
Confidence 46778888888776553 233456777773 1357999999999988889999999998
Q ss_pred chhhh-----hccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCce
Q 046703 403 ELDQE-----RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT 477 (635)
Q Consensus 403 ~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~ 477 (635)
..+.+ -...++.+....++.|+++||.|+|++. +.|||+||+|.+++.++++|++|||+++.++-.. ...
T Consensus 84 dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv--rcy 158 (292)
T KOG0662|consen 84 DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCY 158 (292)
T ss_pred hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--Eee
Confidence 75432 2556788888899999999999999999 9999999999999999999999999999875322 112
Q ss_pred eeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCC---CcCCCCcc
Q 046703 478 TRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMP---SEMIDPCY 552 (635)
Q Consensus 478 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~~l 552 (635)
...+-|..|++|..+.+. -|+...|+||-|||+.|+.. |++-|+..+.++....+-+......+... ..+.|-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 224568899999998775 47899999999999999986 55556655544433333222222122211 12222111
Q ss_pred ccCCCH----HH-HH----HHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 553 QESCNL----TE-VI----RCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 553 ~~~~~~----~~-~~----~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
-..++. .+ +. +=.++....+.-+|..|.++++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111111 11 11 12345556666699999999888763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-19 Score=198.94 Aligned_cols=137 Identities=25% Similarity=0.344 Sum_probs=117.8
Q ss_pred cccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCC
Q 046703 382 LIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN 456 (635)
Q Consensus 382 Lv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~ 456 (635)
|+++.+.+++...+|++|+|+.++. .+...+++.-+..++..|..||.-||+.| +|||||||+|||||..|.
T Consensus 137 iv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 137 IVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 6788888899999999999998531 23336888888888999999999999999 999999999999999999
Q ss_pred CccCccccceecCCCCCCCceeeeeeccCCCCccccc----C-CCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 457 PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS----D-GQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 457 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+||+|||.+..+..+... .....+||+-|.+||++. + +.|.+.+|.||+||++|||+.|..||-.
T Consensus 214 ikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred EeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 999999999887644333 234478999999999984 2 5789999999999999999999999843
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-18 Score=191.41 Aligned_cols=191 Identities=24% Similarity=0.347 Sum_probs=147.7
Q ss_pred eccccccccccC-----CCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccC
Q 046703 378 WFGDLIDMRSFP-----DGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445 (635)
Q Consensus 378 ~h~nLv~l~~~~-----~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik 445 (635)
.|+|++..+++. ..++.++++||++..+ ..+...+.|..+.-|++.++.|+.+||... +||||||
T Consensus 74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDik 150 (953)
T KOG0587|consen 74 HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIK 150 (953)
T ss_pred CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeeccc
Confidence 577776654433 5778999999999742 123667888999999999999999999998 9999999
Q ss_pred CcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCC
Q 046703 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 446 ~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
-.|||++.++.+||.|||++..+.. +..+..+..||+.|||||.+. +..|+..+|+||||++..||.-|.+|+
T Consensus 151 G~NiLLT~e~~VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl 228 (953)
T KOG0587|consen 151 GQNVLLTENAEVKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL 228 (953)
T ss_pred CceEEEeccCcEEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence 9999999999999999999987642 333444578999999999884 335779999999999999999999997
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
-..++.. +.-.++...++.+ ..+..-.+.+.+++..||..|..+||++.++++
T Consensus 229 ~DmHPmr-------aLF~IpRNPPPkL-------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 229 CDMHPMR-------ALFLIPRNPPPKL-------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCcchhh-------hhccCCCCCCccc-------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 5433221 1111222222222 224456678889999999999999999988875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.4e-19 Score=166.13 Aligned_cols=128 Identities=29% Similarity=0.402 Sum_probs=103.1
Q ss_pred CCccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcc
Q 046703 391 GGQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDF 462 (635)
Q Consensus 391 ~~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Df 462 (635)
...+++|-||.+... ..+...+++...=+|+..|..||.|||++- .+||||+||+|||++.+|.+|++||
T Consensus 116 regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 116 REGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred ccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 345788988877642 133456667777799999999999999975 5999999999999999999999999
Q ss_pred ccceecCCCCCCCceeeeeeccCCCCccccc----CCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 463 GLARTFGGDETEGNTTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 463 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
|.+-.+.+.... + -..|...|||||.+. ...|+.|+||||+|+.+.||.+++.|++..
T Consensus 194 GIsG~L~dSiAk--t-~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 194 GISGYLVDSIAK--T-MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ccceeehhhhHH--H-HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999876543221 1 135677999999874 347899999999999999999999998653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-18 Score=184.29 Aligned_cols=142 Identities=24% Similarity=0.323 Sum_probs=115.7
Q ss_pred ccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCC
Q 046703 383 IDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP 457 (635)
Q Consensus 383 v~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~ 457 (635)
|.|++.+.+...+|.+|+|...+ ..+...+.+..+..++.++.-|+++.|..| .|||||||+|||||.+|.+
T Consensus 692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCce
Confidence 44566678888999999998753 245667778888888889999999999999 9999999999999999999
Q ss_pred ccCccccceecC---------CCC-------------------------------CCCceeeeeeccCCCCcccccCCCC
Q 046703 458 KISDFGLARTFG---------GDE-------------------------------TEGNTTRVVGTYGYMAPEYASDGQF 497 (635)
Q Consensus 458 kl~Dfgla~~~~---------~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 497 (635)
||.||||+.-+. .+. ........+||..|+|||.+....+
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 999999985321 000 0001123689999999999999999
Q ss_pred cccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 498 SVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 498 s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+..+|.||.|||||||+.|+.||....+.+
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 999999999999999999999996654443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-17 Score=159.23 Aligned_cols=159 Identities=31% Similarity=0.497 Sum_probs=129.2
Q ss_pred eccccccccccCCCCccEEEEecccchh---h-hhc--cccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD---Q-ERC--KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~---~-~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|++++.+..+.......|+++++.... . ... ..+++..+..++.++++++.+||+.+ ++|+||+|.||++
T Consensus 49 ~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~ 125 (215)
T cd00180 49 NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILL 125 (215)
T ss_pred CCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEE
Confidence 4567777777766667888888877621 1 111 35888999999999999999999998 9999999999999
Q ss_pred cc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 452 DQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+. +..++|+|||.+........ ......+...|++||..... ..+.+.|+|++|+++++|
T Consensus 126 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------- 187 (215)
T cd00180 126 DSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------- 187 (215)
T ss_pred eCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------
Confidence 99 89999999999987644321 12224567899999998777 888999999999999999
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3567799999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.9e-17 Score=176.75 Aligned_cols=166 Identities=20% Similarity=0.169 Sum_probs=108.6
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++......... ......+++.|+|||
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE 380 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence 3567778889999999999999998 999999999999999999999999999765332111 111123478999999
Q ss_pred cccCCCC----------------------cccCceeeeehhhHhhhhCCC-CCCCccCCC-cc---cHHHHHHHHhhcCC
Q 046703 491 YASDGQF----------------------SVKSDVFSFGILLLEIVSGKK-NRGFYHLDN-KL---NLIGHAWKLWNKGM 543 (635)
Q Consensus 491 ~~~~~~~----------------------s~ksDVwS~Gvvl~eiltG~~-pf~~~~~~~-~~---~~~~~~~~~~~~~~ 543 (635)
.+..... ..+.||||+||+++||++|.. |+....... .. ......|.......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8753321 135799999999999999875 553211000 00 00111122221211
Q ss_pred CCcCCCCccccCCCHHHHHHHHHHHHHhcccCC---CCCCChHHHHHH
Q 046703 544 PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHP---DDRPCMPSVILM 588 (635)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP---~~RPt~~evl~~ 588 (635)
.. + ...........+++.++|..+| .+|+|++|+++.
T Consensus 461 ~~-~-------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YD-F-------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC-c-------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 0 0011122345667888888655 789999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-17 Score=171.25 Aligned_cols=171 Identities=20% Similarity=0.153 Sum_probs=122.8
Q ss_pred cccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCC-CccCccccceecCCCCCCCceeeeeeccCCCC
Q 046703 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN-PKISDFGLARTFGGDETEGNTTRVVGTYGYMA 488 (635)
Q Consensus 410 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~-~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 488 (635)
-.|..+.+..++.|+..||..|...+ |+|.||||.|||+++..+ +||+|||.|.....++... ..-...|.|
T Consensus 531 vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRa 603 (752)
T KOG0670|consen 531 VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRA 603 (752)
T ss_pred cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccccH----HHHHHhccC
Confidence 34667777889999999999999999 999999999999997654 8999999998765543321 234568999
Q ss_pred cccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHH-----HhhcCC--------------------
Q 046703 489 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWK-----LWNKGM-------------------- 543 (635)
Q Consensus 489 PE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~-----~~~~~~-------------------- 543 (635)
||++.+.+|+...|+||.||.|||+.+|+..|+.....+.+.+...... ++..|.
T Consensus 604 PEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~v 683 (752)
T KOG0670|consen 604 PEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKV 683 (752)
T ss_pred cceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecccc
Confidence 9999999999999999999999999999988876543332222221111 111111
Q ss_pred -------CCcCCCC------ccc-----cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 544 -------PSEMIDP------CYQ-----ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 544 -------~~~~~d~------~l~-----~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+...+.+ .+. ..-.+..+..+.+|+-.|+..||++|.|..++++
T Consensus 684 T~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 684 TEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred ccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0001111 011 0112345556778899999999999999988875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.4e-17 Score=171.75 Aligned_cols=136 Identities=26% Similarity=0.355 Sum_probs=118.9
Q ss_pred eccccccccccCCCCccEEEEecccc----h--hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASE----L--DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~----~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+.++...+||.+|.-. + .-+.+..+++.++..|.+||+.|+++||+++ |||||||-+|+.+
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenviv 703 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIV 703 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEE
Confidence 39999999999999999999987532 1 1245678999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc-ccCceeeeehhhHhhhhCCCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvvl~eiltG~~pf 520 (635)
+.+|-+||+|||.+.....+. ....+||..|.|||.+.+.+|- ..-|||++|++||.++....||
T Consensus 704 d~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999999999999998765443 3358999999999999988875 6679999999999999988886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.9e-17 Score=180.80 Aligned_cols=204 Identities=21% Similarity=0.218 Sum_probs=145.0
Q ss_pred cceeeeccccccccccCCCCccEEEEecccchh---h-hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 373 SGCAMWFGDLIDMRSFPDGGQDLYIRMSASELD---Q-ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 373 ~gC~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~---~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.++.+.|+|++............+-.|++++.+ . .....++..++..++.|++.|+.|+|+.| |.|||+|++|
T Consensus 374 i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~en 450 (601)
T KOG0590|consen 374 IGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLEN 450 (601)
T ss_pred ecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCcccc
Confidence 457788998765433333222333336666541 1 22236888889999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCCCCc-ccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+++..++.+||+|||.+..+...... .......|.-.|+|||.+.+..|. ...||||.|+++..|++|+.||.....
T Consensus 451 ll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 451 LLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred EEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 99999999999999999877644332 334457889999999999999887 567999999999999999999866543
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+... ............. -........+.+...++.++|+.||.+|.|+++|++
T Consensus 531 ~~~~~------~~~~~~~~~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 531 SDNSF------KTNNYSDQRNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccch------hhhcccccccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 33221 0000000000000 001112234456678999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.2e-16 Score=151.65 Aligned_cols=195 Identities=19% Similarity=0.262 Sum_probs=131.3
Q ss_pred eccccccccccCCCCccEEE-Eecccchhhhh----ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYI-RMSASELDQER----CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl-~~~~~~~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|.+|++-+...=...+.|+ ++|+.+..... ...+.+.-..+++.|+++||.|||++. +||||||.+||||-
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif 155 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIF 155 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEe
Confidence 68999988776543444555 56766643211 234455556788999999999999999 99999999999994
Q ss_pred c--CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-----CCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 453 Q--DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 453 ~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
. ..++||+|||+.+..+.- -.....+..|.+||..... ...+.+|+|.||++++.+++|+.||.....
T Consensus 156 ~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred cCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 2 346999999998764321 1123345678999976432 345889999999999999999999974433
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
.+. .-+-|..|.++....+.+.-- .+ ..++.++-.+-+..+|++|--..++-++.
T Consensus 231 ~d~---~Y~~~~~w~~rk~~~~P~~F~--~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 231 MDK---PYWEWEQWLKRKNPALPKKFN--PF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCc---hHHHHHHHhcccCccCchhhc--cc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 332 224455565655554433211 11 12344555677888999996555555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-15 Score=157.54 Aligned_cols=138 Identities=25% Similarity=0.400 Sum_probs=107.0
Q ss_pred cccccccccCCCCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC-CC
Q 046703 380 GDLIDMRSFPDGGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD-MN 456 (635)
Q Consensus 380 ~nLv~l~~~~~~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~-~~ 456 (635)
.|++.+..+...++..-+++||.+... .-...++..++..+++.+.+||+++|..| ||||||||+|+|.+.. +.
T Consensus 95 ~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 95 DNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hhhhcchhhhccCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCC
Confidence 346666677777788889999887432 22345778888999999999999999999 9999999999999855 45
Q ss_pred CccCccccceecCC------------------------------------------CCCCCceeeeeeccCCCCcccccC
Q 046703 457 PKISDFGLARTFGG------------------------------------------DETEGNTTRVVGTYGYMAPEYASD 494 (635)
Q Consensus 457 ~kl~Dfgla~~~~~------------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~ 494 (635)
-.|.|||+|..... ...........||+||+|||.+..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 78999999972100 000001112468999999998855
Q ss_pred -CCCcccCceeeeehhhHhhhhCCCCC
Q 046703 495 -GQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 495 -~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
...+.+.||||.|||++.+++++.||
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred ccCcCCccceeeccceeehhhcccccc
Confidence 46789999999999999999999997
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.3e-16 Score=147.02 Aligned_cols=199 Identities=19% Similarity=0.202 Sum_probs=130.2
Q ss_pred ccccccccccCCC--CccEEEEecccchh--hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 379 FGDLIDMRSFPDG--GQDLYIRMSASELD--QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 379 h~nLv~l~~~~~~--~~~lyl~~~~~~~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
|+||+.+..+-.+ +...-+++|+.... ..-...|+--.+...+.++++||.|+|+.| |.|||+||+|+++|..
T Consensus 92 g~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~ 168 (338)
T KOG0668|consen 92 GPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHE 168 (338)
T ss_pred CCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechh
Confidence 6788777665432 22333444443311 112345667777889999999999999999 9999999999999965
Q ss_pred -CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 455 -MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 455 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
..++|+|.|+|.+..... .-...+.+..|-.||.+-+. .++..-|+|||||+|.+|+..+.||-.. .++..+++
T Consensus 169 ~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG-~dN~DQLV 244 (338)
T KOG0668|consen 169 LRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG-HDNYDQLV 244 (338)
T ss_pred hceeeeeecchHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC-CCCHHHHH
Confidence 459999999998875432 22334567788999988654 5778899999999999999999997322 22222222
Q ss_pred HHHHHHh---------hcCCCCcCCCCccc----------------cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLW---------NKGMPSEMIDPCYQ----------------ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~---------~~~~~~~~~d~~l~----------------~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+.+.+ ..-.+. +|+... .+...-...+.++++-..|..|..+|||++|.+.
T Consensus 245 -kIakVLGt~el~~Yl~KY~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 245 -KIAKVLGTDELYAYLNKYQID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred -HHHHHhChHHHHHHHHHHccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111 111110 111111 0111111234667888889999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1e-15 Score=148.69 Aligned_cols=193 Identities=17% Similarity=0.203 Sum_probs=142.6
Q ss_pred eeeeccccccccccCCCCccEEEEecccch-------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 375 CAMWFGDLIDMRSFPDGGQDLYIRMSASEL-------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 375 C~l~h~nLv~l~~~~~~~~~lyl~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
..+.|||+..+...++..-.+.+...++.. .....-.++-.++.+++.+|++|++|||+... .|..-.++..
T Consensus 242 rifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~ 320 (448)
T KOG0195|consen 242 RIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSK 320 (448)
T ss_pred eeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccc
Confidence 456799999988888877777777666653 23334566788899999999999999999862 3555578999
Q ss_pred ceEeccCCCCccC--ccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc---ccCceeeeehhhHhhhhCCCCCCC
Q 046703 448 NVLLDQDMNPKIS--DFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS---VKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 448 NIlld~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
.+++|++.+++|+ |--++.. .. .....+.||+||.++.++-+ .++|+|||+++|||+.+...||..
T Consensus 321 hvmidedltarismad~kfsfq--------e~-gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 321 HVMIDEDLTARISMADTKFSFQ--------EV-GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred eEEecchhhhheecccceeeee--------cc-ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 9999999988875 3222111 00 12346789999999877654 789999999999999999999976
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
..+.+-.. +. .-..++...++.....+.+++.-|..+||.+||.+..|+-+||.-
T Consensus 392 lspmecgm------ki---------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 392 LSPMECGM------KI---------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCchhhhh------hh---------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 55443221 11 112233344556667789999999999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.7e-15 Score=161.42 Aligned_cols=191 Identities=23% Similarity=0.258 Sum_probs=135.7
Q ss_pred eccccccccccCCCCccEEEEecccchhhhh-----ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQER-----CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+...+..-....++|.|+|+..+..+ -..|++.++....+...+|+.|||+++ -+|||||-.||++.
T Consensus 70 ~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanillt 146 (829)
T KOG0576|consen 70 RHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLT 146 (829)
T ss_pred CCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeec
Confidence 5666665555444455666666666533221 346788888899999999999999999 89999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccc---cCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+.+.+|++|||.+..+.. ...+.....||+.|||||.. +.+.|..++|||++|+...|+-.-++|.-..++.
T Consensus 147 d~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--- 221 (829)
T KOG0576|consen 147 DEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--- 221 (829)
T ss_pred ccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---
Confidence 999999999999876542 22333457899999999976 4567999999999999999998777663211111
Q ss_pred cHHHHHHHHhh--cCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWN--KGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
++..... .-++..+.|+. .-...+-+++..|+-.+|++||+++.+++
T Consensus 222 ----r~l~LmTkS~~qpp~lkDk~-------kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 222 ----RALFLMTKSGFQPPTLKDKT-------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----HHHHHhhccCCCCCcccCCc-------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111111 11233333322 22234567888899999999999987754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.9e-15 Score=158.68 Aligned_cols=206 Identities=20% Similarity=0.252 Sum_probs=141.8
Q ss_pred eccccccccccCCCCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|.|+..+.+.+-.+..++++-+++.- .......++|.-...++++|++||+|||... -..|+.++.+|.++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClv 82 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLV 82 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecccccee
Confidence 467777666666555666666665542 1123456788888899999999999999876 13999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-------CCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
|..+.+||+|||+.................-...|.|||.+... ..+.++||||||++++||++.+.||+...
T Consensus 83 d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~ 162 (484)
T KOG1023|consen 83 DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRN 162 (484)
T ss_pred eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccccc
Confidence 99999999999998776421111111112235679999998663 14788999999999999999999997654
Q ss_pred CCCcc-cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 525 LDNKL-NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 525 ~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
..... .++.+ +.. .......+.+.... +....++.++..||..+|++||++++|-..++..
T Consensus 163 ~~~~~~eii~~----~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 163 LVEDPDEIILR----VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccCChHHHHHH----HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 33222 22222 222 11111222221110 2222578899999999999999999999888765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-15 Score=146.28 Aligned_cols=141 Identities=28% Similarity=0.354 Sum_probs=113.7
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccc-cCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKL-LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|++++.+..........|+++++..... ..... +++..+..++.+++.++.+||+.+ ++|+||++.||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v 131 (225)
T smart00221 55 KHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILL 131 (225)
T ss_pred CCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 46777777777666678888888775311 11223 788889999999999999999998 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccc-cCCCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+.++.++|+|||.+......... ......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 132 GMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999999999999877543211 12235677889999998 667788899999999999999999999843
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.9e-14 Score=148.86 Aligned_cols=106 Identities=17% Similarity=0.178 Sum_probs=74.4
Q ss_pred eccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc------ccHHHHHH-----HHhhc---------
Q 046703 482 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK------LNLIGHAW-----KLWNK--------- 541 (635)
Q Consensus 482 gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~------~~~~~~~~-----~~~~~--------- 541 (635)
.|..|+|||.+.+..|+..+||||++|++|||+||..-|+-...... ..++.+.. .....
T Consensus 413 QTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFn 492 (590)
T KOG1290|consen 413 QTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFN 492 (590)
T ss_pred hhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhc
Confidence 35679999999999999999999999999999999998866543321 11221111 11112
Q ss_pred --CCCCcCCC-------Ccc--ccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 542 --GMPSEMID-------PCY--QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 542 --~~~~~~~d-------~~l--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
|.+..+-. ..+ .-..+.++...+.+++.-+|+.+|++|||+.+.++
T Consensus 493 r~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 493 RRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred cccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 22211110 001 12567788999999999999999999999998875
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-14 Score=113.66 Aligned_cols=66 Identities=42% Similarity=0.942 Sum_probs=58.3
Q ss_pred ccCCCCeEEeeccCCCCCCCcceeccCCHHHHHHHHhhcCCcccccccccCCCCcceeeeccccccc
Q 046703 319 YSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDM 385 (635)
Q Consensus 319 C~~~~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~i~~~~~gC~l~h~nLv~l 385 (635)
|+.+++|+++.+|++|+++...++.+.++++|++.|++||+|+||+|.++. ++++|.+|+.+|+++
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 445689999999999999877666779999999999999999999997665 678899999999875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.9e-14 Score=149.55 Aligned_cols=167 Identities=26% Similarity=0.371 Sum_probs=119.3
Q ss_pred cEEEEecccch--------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccc
Q 046703 394 DLYIRMSASEL--------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465 (635)
Q Consensus 394 ~lyl~~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla 465 (635)
.+||.|..++. +.......++...++++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 46777776653 23334566788889999999999999 66 999999999999999999999999999
Q ss_pred eecCCCC----CCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC-CCCCCCccCCCcccHHHHHHHHhh
Q 046703 466 RTFGGDE----TEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGFYHLDNKLNLIGHAWKLWN 540 (635)
Q Consensus 466 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG-~~pf~~~~~~~~~~~~~~~~~~~~ 540 (635)
....... .........||..||+||.+.+..|+.|+||||||+||+|++.- ...++ ...+...++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence 8765444 12233446899999999999999999999999999999999971 11111 011222333
Q ss_pred cCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 541 KGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
.|.++...- ...+. -..+..+++...|.+||++.++
T Consensus 474 ~g~ip~~~~----~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIPPEFL----QDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCChHHh----hcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 444431111 11111 2357889999999999955443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-12 Score=132.59 Aligned_cols=177 Identities=19% Similarity=0.208 Sum_probs=116.2
Q ss_pred CccEEEEecccchhh---hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec--cCC--CCccCcccc
Q 046703 392 GQDLYIRMSASELDQ---ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD--QDM--NPKISDFGL 464 (635)
Q Consensus 392 ~~~lyl~~~~~~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld--~~~--~~kl~Dfgl 464 (635)
+..+|++|....... .-...++.....-++.|+++|+.|||.++ |.|||+|.+|||+. ++. .+.|+|||.
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccce
Confidence 457888886543111 11334667777889999999999999999 99999999999994 333 357899998
Q ss_pred ceecCCCCCC----CceeeeeeccCCCCcccccCCC-----C-cccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHH
Q 046703 465 ARTFGGDETE----GNTTRVVGTYGYMAPEYASDGQ-----F-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGH 534 (635)
Q Consensus 465 a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-----~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~ 534 (635)
+.-......+ ...-...|....||||+....+ + -.|+|.|+.|.+.|||+...-||-..... ....
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~--- 467 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDT--- 467 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eech---
Confidence 8543221111 1111234666789999874432 1 28999999999999999999998432111 1110
Q ss_pred HHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 535 AWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
...++.+++.+.+... ..+.+++...|+.||++||+..-..
T Consensus 468 --r~Yqe~qLPalp~~vp---------p~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 468 --RTYQESQLPALPSRVP---------PVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred --hhhhhhhCCCCcccCC---------hHHHHHHHHHhcCCccccCCccHHH
Confidence 0123334444433322 2355678888999999999864443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.3e-12 Score=132.57 Aligned_cols=201 Identities=25% Similarity=0.305 Sum_probs=137.8
Q ss_pred ccccccccCCCCccEEEEecccchhh-----hhc---cccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 381 DLIDMRSFPDGGQDLYIRMSASELDQ-----ERC---KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 381 nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+++.+..........|+++++..... ... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++
T Consensus 59 ~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~ 135 (384)
T COG0515 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLD 135 (384)
T ss_pred ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeec
Confidence 56666655544444788877765321 111 25778888999999999999999999 99999999999999
Q ss_pred cCC-CCccCccccceecCCCCCCC----ceeeeeeccCCCCcccccC---CCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 453 QDM-NPKISDFGLARTFGGDETEG----NTTRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 453 ~~~-~~kl~Dfgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
... .+++.|||++.......... ......++..|++||.+.. ...+...|+||+|+++++++.|..|+....
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 988 69999999998665433221 2345788999999999987 578899999999999999999999965433
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.. .........+........ ...............+.+++..|+..+|..|.++.+....
T Consensus 216 ~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 216 NS---SATSQTLKIILELPTPSL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc---ccHHHHHHHHHhcCCccc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 21 011112222211111100 0000000002223456678888999999999998877653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-12 Score=136.16 Aligned_cols=187 Identities=21% Similarity=0.206 Sum_probs=127.8
Q ss_pred CCccEEEEecccc--h---hhhh-ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC-----CCCcc
Q 046703 391 GGQDLYIRMSASE--L---DQER-CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD-----MNPKI 459 (635)
Q Consensus 391 ~~~~lyl~~~~~~--~---~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~-----~~~kl 459 (635)
....-||+|.... + .... .+.++..+.+.++.|++.+|.+||+.| ++||||||.|+++... ..+.|
T Consensus 92 ~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 92 TEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred CCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEE
Confidence 3445677765432 1 1112 367899999999999999999999999 9999999999999865 35899
Q ss_pred CccccceecC--CCCC----CC-c-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 460 SDFGLARTFG--GDET----EG-N-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 460 ~Dfgla~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.|||+++... .... .. . ....+||..|.++..+.+...+.+.|+||++.++.|++.|..||...........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~ 248 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK 248 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH
Confidence 9999998322 1111 11 1 1235699999999999999999999999999999999999999855433222111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
...... ...... .....+.+.. ++...+-..+..++|....+...|+..
T Consensus 249 ~~~~~~---~~~~~~------~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 249 FEKDPR---KLLTDR------FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHhh---hhcccc------ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111111 000010 1112233333 344444457999999999998887655
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.2e-13 Score=136.60 Aligned_cols=140 Identities=22% Similarity=0.303 Sum_probs=94.3
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcc
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 490 (635)
.+....++.+..|+++.+++||..+ ++|+||+|+|++++.+|.++|+||+.+...+..... ...+..|.+||
T Consensus 141 ~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe 212 (288)
T PF14531_consen 141 PLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPE 212 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HH
T ss_pred hhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChh
Confidence 3445566778899999999999999 999999999999999999999999888764321111 23356799999
Q ss_pred cccC--------CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHH
Q 046703 491 YASD--------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVI 562 (635)
Q Consensus 491 ~~~~--------~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 562 (635)
.... ..++.+.|.|++|+++|.|.+++.||+.......... .+ ..+. +.++
T Consensus 213 ~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------~f-----~~C~-~~Pe 271 (288)
T PF14531_consen 213 LESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------DF-----SRCR-DMPE 271 (288)
T ss_dssp HHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------GG-----TTSS----H
T ss_pred hhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------cc-----hhcC-CcCH
Confidence 7633 2578999999999999999999999875432221100 11 1223 4455
Q ss_pred HHHHHHHHhcccCCCCC
Q 046703 563 RCIHISLLCVQQHPDDR 579 (635)
Q Consensus 563 ~~~~l~~~Cl~~dP~~R 579 (635)
.+..|+...|+.||++|
T Consensus 272 ~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 272 PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCcccC
Confidence 66678889999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.1e-13 Score=149.56 Aligned_cols=166 Identities=17% Similarity=0.215 Sum_probs=110.8
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceec--CCCCCCCce---eeeeec
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF--GGDETEGNT---TRVVGT 483 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~--~~~~~~~~~---~~~~gt 483 (635)
+..|..-+..=|+.|++.||..+|+.+ |+|||||.+||||..=.-+.|+||.--+.. ..+...... .+-..-
T Consensus 114 RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRR 190 (1431)
T KOG1240|consen 114 RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRR 190 (1431)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCce
Confidence 344555566678999999999999999 999999999999998888999999765432 222221111 111223
Q ss_pred cCCCCcccccC----------CC-CcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCc
Q 046703 484 YGYMAPEYASD----------GQ-FSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPC 551 (635)
Q Consensus 484 ~~y~aPE~~~~----------~~-~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (635)
..|.|||.+-. .+ .+++-||||+||++.||++ |+++|... ++.. .+.|. .......
T Consensus 191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a-----Yr~~~-~~~~e~~ 258 (1431)
T KOG1240|consen 191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA-----YRSGN-ADDPEQL 258 (1431)
T ss_pred eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh-----HhccC-ccCHHHH
Confidence 46999997633 12 6789999999999999987 57777431 1111 11111 0000111
Q ss_pred cccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 552 YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 552 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
++.-.+ ..+.++++.|+|.||++|-++++.++.-.|..
T Consensus 259 Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 259 LEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 111001 13557999999999999999999998866653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.3e-12 Score=138.27 Aligned_cols=134 Identities=26% Similarity=0.292 Sum_probs=108.2
Q ss_pred eccccccccccCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+-++.+....+...++|+.+.+... ...+....++.........++-++.++|+.+ |+|||+|++||+++
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld 131 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLL 131 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeec
Confidence 466777788887778888888776543 1223334455555666778889999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
.+|.+|+.|||+.+..-..+. ..||+.|||||++. .....+|-||||++.+|+++|..||..
T Consensus 132 ~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 132 LEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 999999999999987543322 27899999999987 677899999999999999999999854
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-11 Score=99.48 Aligned_cols=71 Identities=17% Similarity=0.184 Sum_probs=61.8
Q ss_pred ccCCCCeEEeeccCCCCCCCcceeccCCHHHHHHHHhh---cCCcccccccccCCCCcceeeecccc-ccccccCCCCcc
Q 046703 319 YSRQDGFMKFTELKLPDATPSWVSKSMNLKESREGCLE---NSFCMAYTNSDIRGGGSGCAMWFGDL-IDMRSFPDGGQD 394 (635)
Q Consensus 319 C~~~~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~i~~~~~gC~l~h~nL-v~l~~~~~~~~~ 394 (635)
|...++|+++.++++|++.. .++++|++.|++ ||+|.||+|.+. +.||.+|+.++ ++++....++.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44457899999999998754 689999999999 999999999653 46899999999 999998888899
Q ss_pred EEEE
Q 046703 395 LYIR 398 (635)
Q Consensus 395 lyl~ 398 (635)
+|++
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.8e-12 Score=144.18 Aligned_cols=140 Identities=25% Similarity=0.277 Sum_probs=101.1
Q ss_pred hccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCC-------------CCCCceeeeeeccCCCCcc
Q 046703 424 TGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD-------------ETEGNTTRVVGTYGYMAPE 490 (635)
Q Consensus 424 ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~-------------~~~~~~~~~~gt~~y~aPE 490 (635)
++.+++|||+.+ |+|||+||+|.+|..-+.+|+.|||+.+..... ........++||+.|.|||
T Consensus 152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378999999999 999999999999999999999999998753210 0111123468999999999
Q ss_pred cccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHH
Q 046703 491 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLL 570 (635)
Q Consensus 491 ~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 570 (635)
++....|...+|.|++|+|+||.+.|..||....+++-...+......|.++ | +..+. +...++.+
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~------d-----ea~p~---Ea~dli~~ 294 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE------D-----EALPP---EAQDLIEQ 294 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc------C-----cCCCH---HHHHHHHH
Confidence 9999999999999999999999999999986543332211111111111111 1 11222 34456777
Q ss_pred hcccCCCCCC
Q 046703 571 CVQQHPDDRP 580 (635)
Q Consensus 571 Cl~~dP~~RP 580 (635)
.|+++|.+|-
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 8999999995
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.1e-11 Score=118.17 Aligned_cols=119 Identities=20% Similarity=0.271 Sum_probs=100.9
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCC-----CCccCccccceecCCCCCCC-----cee
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM-----NPKISDFGLARTFGGDETEG-----NTT 478 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~-----~~kl~Dfgla~~~~~~~~~~-----~~~ 478 (635)
...++.++++.+|.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|+...+..+.. ...
T Consensus 118 gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~K 194 (449)
T KOG1165|consen 118 GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHK 194 (449)
T ss_pred cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccc
Confidence 557888999999999999999999999 99999999999997433 47899999999876544332 223
Q ss_pred eeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 479 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 479 ~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
...||.+||+--...+...+.+.|+-|+|-|++..+-|..||.....+....
T Consensus 195 SLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~ 246 (449)
T KOG1165|consen 195 SLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE 246 (449)
T ss_pred ccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence 4789999999999999999999999999999999999999998765554433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.8e-11 Score=124.98 Aligned_cols=111 Identities=21% Similarity=0.141 Sum_probs=78.1
Q ss_pred cEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeecc-CCcceEeccCCCCccCccccceecCCCC
Q 046703 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL-KAGNVLLDQDMNPKISDFGLARTFGGDE 472 (635)
Q Consensus 394 ~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di-k~~NIlld~~~~~kl~Dfgla~~~~~~~ 472 (635)
..|++|++.+...... ........++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+++.+....
T Consensus 92 ~~~LVmE~~~G~~L~~--~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL--ARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred CcEEEEEccCCCCHHH--hCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 4799999876432211 111112568889999999999999 999999 9999999999999999999999775432
Q ss_pred CCCc------eeeeeeccCCCCcccccCCC------CcccCcee-eeehh
Q 046703 473 TEGN------TTRVVGTYGYMAPEYASDGQ------FSVKSDVF-SFGIL 509 (635)
Q Consensus 473 ~~~~------~~~~~gt~~y~aPE~~~~~~------~s~ksDVw-S~Gvv 509 (635)
.... .....++..|+|||.+...+ .+..+|.| .-|=+
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDl 216 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKK 216 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCE
Confidence 2111 12356778899999985432 33446766 33433
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.9e-10 Score=93.47 Aligned_cols=80 Identities=43% Similarity=0.938 Sum_probs=63.8
Q ss_pred CCCccCC---CCeEEeeccCCCCCCCcceeccCCHHHHHHHHhhcCCcccccccccCCCCcceeeeccccccccccCCCC
Q 046703 316 PLNYSRQ---DGFMKFTELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGG 392 (635)
Q Consensus 316 ~l~C~~~---~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~i~~~~~gC~l~h~nLv~l~~~~~~~ 392 (635)
+++|... +.|+++.++++|+.... . .++++++|++.|++||+|.||+|.+ ++.+|.+|...+.+.......+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~-~-~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASA-I-TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhh-h-ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567544 68999999999987654 3 7789999999999999999999964 3678999988888776655556
Q ss_pred ccEEEEec
Q 046703 393 QDLYIRMS 400 (635)
Q Consensus 393 ~~lyl~~~ 400 (635)
..+||+++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78898863
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-10 Score=129.02 Aligned_cols=194 Identities=23% Similarity=0.300 Sum_probs=138.0
Q ss_pred ccccccccccCCCCccEEEEecccchhhh------hcc-ccCcccchhhhhhhccccchhh-ccccceEEeeccCCcceE
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELDQE------RCK-LLDWSKRFRIICGTGRGLLYLH-QDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~~~------~~~-~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiH~dik~~NIl 450 (635)
|.|++.+.......+..++.+++...... ... ..+....-....|+..++.|+| ..+ +.|+||||+|.+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSL 156 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccch
Confidence 88888888888888888888877654221 111 3455566778899999999999 888 999999999999
Q ss_pred eccCC-CCccCccccceecCC-CCCCCceeeeee-ccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 451 LDQDM-NPKISDFGLARTFGG-DETEGNTTRVVG-TYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 451 ld~~~-~~kl~Dfgla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
++..+ ..|++|||+|..+.. +..........| +..|+|||...+. -..+..|+||.|+++.-+++|..|+......
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99999 999999999998876 444444455677 9999999998875 4458899999999999999999998765433
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.... ..+.+.... ........-.....++...++..+|+.|.+.+++..
T Consensus 237 ~~~~------~~~~~~~~~------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 237 DGRY------SSWKSNKGR------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccc------eeecccccc------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 3110 000010000 000001111123445666778889999999877753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.6e-10 Score=109.96 Aligned_cols=121 Identities=21% Similarity=0.238 Sum_probs=98.9
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC---CCCccCccccceecCCCCCC-----Cceeee
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD---MNPKISDFGLARTFGGDETE-----GNTTRV 480 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~---~~~kl~Dfgla~~~~~~~~~-----~~~~~~ 480 (635)
.+.++.++.+-++.|++.-++|+|.++ .|||||||+|+|..-. ..+.++|||+++.+.+..+. ......
T Consensus 105 ~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l 181 (341)
T KOG1163|consen 105 SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL 181 (341)
T ss_pred hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence 456888899999999999999999999 9999999999999644 34789999999987543322 222346
Q ss_pred eeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 481 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 481 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.||.+|.+-..+.+...+.+.|+-|+|.+|..+.-|..||.........+..
T Consensus 182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 7899999998888888999999999999999999999999776544443333
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-09 Score=107.90 Aligned_cols=101 Identities=14% Similarity=0.194 Sum_probs=73.0
Q ss_pred CccEEEEecccchhhhh-ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCC
Q 046703 392 GQDLYIRMSASELDQER-CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGG 470 (635)
Q Consensus 392 ~~~lyl~~~~~~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~ 470 (635)
....|++||+.+..... ...++ .....+++.+|..+|+.+ ++|||++|+||+++.++ ++|.|||.......
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~~~----~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e 186 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPEIS----EDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQ 186 (232)
T ss_pred cCCeEEEEEEECCccHHHhhhcc----HHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccc
Confidence 45688999988743221 11122 235668999999999999 99999999999999888 99999998865421
Q ss_pred CCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhh
Q 046703 471 DETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 471 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eil 514 (635)
+... ..+.....+..++|+|+||+.+..+.
T Consensus 187 ~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 187 RKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 1110 11344556678999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-09 Score=104.86 Aligned_cols=121 Identities=18% Similarity=0.101 Sum_probs=83.5
Q ss_pred EEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeecc-CCcceEeccCCCCccCccccceecCCCCC
Q 046703 395 LYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL-KAGNVLLDQDMNPKISDFGLARTFGGDET 473 (635)
Q Consensus 395 lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di-k~~NIlld~~~~~kl~Dfgla~~~~~~~~ 473 (635)
.|+++++.+...... .+.. ....++.|++++|.++|+.+ |+|||| ||.||+++.++.++|+|||++........
T Consensus 73 ~~lvmeyI~G~~L~~-~~~~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 73 RHLDRSYLAGAAMYQ-RPPR-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEEEeeecCccHHh-hhhh-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 577777765332211 1111 22457789999999999999 999999 79999999999999999999986543221
Q ss_pred C----Cc-------eeeeeeccCCCCcccccCC-CCc-ccCceeeeehhhHhhhhCCCCC
Q 046703 474 E----GN-------TTRVVGTYGYMAPEYASDG-QFS-VKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 474 ~----~~-------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwS~Gvvl~eiltG~~pf 520 (635)
. .. ......++.|+.|+...-. ..+ ...+.++.|.-+|.++|++.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 00 0112246677777754322 333 5567778999999999998875
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.68 E-value=7.6e-08 Score=85.35 Aligned_cols=89 Identities=25% Similarity=0.358 Sum_probs=64.7
Q ss_pred eEEEecCCcEEEEccC-CceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeeccccc
Q 046703 88 FLMINKTGNLVLTSKS-NIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLE 166 (635)
Q Consensus 88 ~l~~~~~g~l~l~~~~-~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~ 166 (635)
++.++.||+||+++.. +.+||++++..+......+.|+++|||||++.+ +.++|+|= |-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~-----t~----------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD----GRVVWSSN-----TT----------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC----CCEEEEec-----cc-----------
Confidence 3556789999999865 589999998765433348999999999999876 47899981 10
Q ss_pred cccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcC
Q 046703 167 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 212 (635)
Q Consensus 167 tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g 212 (635)
...|.|.+.++++|+.+++-. ...+.|.+.
T Consensus 83 ---------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 83 ---------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 124668899999998765422 235788753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.4e-09 Score=99.83 Aligned_cols=71 Identities=21% Similarity=0.149 Sum_probs=58.8
Q ss_pred EEEEecccchh-----hhhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcceEeccCCCCccCccccceec
Q 046703 395 LYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468 (635)
Q Consensus 395 lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~ 468 (635)
.|++|++.+.. ......++..+...++.|++.++.++|+ .+ |+||||||+||+++ ++.++|+|||++...
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 37888877642 1223456777888999999999999999 88 99999999999999 789999999999865
Q ss_pred C
Q 046703 469 G 469 (635)
Q Consensus 469 ~ 469 (635)
.
T Consensus 168 ~ 168 (190)
T cd05145 168 D 168 (190)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-08 Score=103.00 Aligned_cols=191 Identities=16% Similarity=0.157 Sum_probs=117.1
Q ss_pred eeeccccccccccCCCCc-----cEEEEecccchh-------h--hhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 376 AMWFGDLIDMRSFPDGGQ-----DLYIRMSASELD-------Q--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~-----~lyl~~~~~~~~-------~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
.+-|.||+....+..+.. ..-.+.+|++-. + ...+.+..+...+++.||..||.|||+.. ++|+|
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppiih 201 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPIIH 201 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccccc
Confidence 345888887766653321 233445666521 1 12345566666789999999999999975 77999
Q ss_pred eccCCcceEeccCCCCccCcccccee--cCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCC
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLART--FGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
+++..+.|++..++-+|+.--.-... .-+...........+.++|.+||.=.....+.++|||+||+..+||..+..-
T Consensus 202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 99999999999888888754211100 0000111112224567899999987777788999999999999999877543
Q ss_pred CCCcc-CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 520 RGFYH-LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 520 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..... .......+..+... +-+... ..++..|++.+|+.||+|.+++.
T Consensus 282 ~tnseS~~~~ee~ia~~i~~--------len~lq------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 282 STNSESKVEVEENIANVIIG--------LENGLQ------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred cCCCcceeehhhhhhhheee--------ccCccc------------cCcCcccccCCCCCCcchhhhhc
Confidence 21110 00000011111111 111111 12556799999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-08 Score=99.43 Aligned_cols=69 Identities=20% Similarity=0.103 Sum_probs=56.9
Q ss_pred EEEecccchh-----hhhccccCcccchhhhhhhccccchh-hccccceEEeeccCCcceEeccCCCCccCccccceec
Q 046703 396 YIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYL-HQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468 (635)
Q Consensus 396 yl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~ 468 (635)
||+||+.+.. ......++.++...++.|++.+|.++ |+.+ |+||||||+||+++ ++.++|+|||++...
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 6777776531 12235678888999999999999999 7888 99999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.4e-07 Score=83.90 Aligned_cols=89 Identities=22% Similarity=0.329 Sum_probs=64.5
Q ss_pred EEEec-CCcEEEEccC-CceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeeccccc
Q 046703 89 LMINK-TGNLVLTSKS-NIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLE 166 (635)
Q Consensus 89 l~~~~-~g~l~l~~~~-~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~ 166 (635)
+.++. +|+||+++.. +++||++++..+......+.|+++|||||++.+ +.++|+|=-
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~~----------------- 82 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS----GTVVWSSNT----------------- 82 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC----CcEEEEecc-----------------
Confidence 44565 8999999765 589999998764333448999999999999876 478999810
Q ss_pred cccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 167 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 167 tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
. .+.+.+.+.|+++|+.+++-.+ ..+.|.+..
T Consensus 83 -~-------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 83 -T-------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred -c-------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 0 0246788999999987664332 467888654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.6e-08 Score=112.76 Aligned_cols=109 Identities=22% Similarity=0.184 Sum_probs=91.2
Q ss_pred hccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc-------CCCCccCccccceecCCCCCCCceeee
Q 046703 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ-------DMNPKISDFGLARTFGGDETEGNTTRV 480 (635)
Q Consensus 408 ~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~-------~~~~kl~Dfgla~~~~~~~~~~~~~~~ 480 (635)
..+.++|...+.++.|+++-+..||..+ |||+||||+|++|.. +..++|+|||.+.-+.--.........
T Consensus 787 ~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~ 863 (974)
T KOG1166|consen 787 TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAV 863 (974)
T ss_pred cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeee
Confidence 4567899999999999999999999999 999999999999942 345899999998654322222334456
Q ss_pred eeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCC
Q 046703 481 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 481 ~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
.+|-.+-.+|...+.+.+.++|.|.++.+++-|+.|+..
T Consensus 864 ~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 864 WHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 778899999999999999999999999999999998654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.7e-06 Score=72.78 Aligned_cols=100 Identities=27% Similarity=0.450 Sum_probs=67.6
Q ss_pred CCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEec-cCCCCCCCCCceEEEecCCcEEEEccCCceEEEeecc
Q 046703 35 GRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVA-NRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLS 113 (635)
Q Consensus 35 ~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~A-nr~~pv~~~~~~l~~~~~g~l~l~~~~~~~vwss~~~ 113 (635)
++++.+.+|.+.|-|...|+ |-| |. ...++||.. +...... ....+.|..+|||||+|.++.++|+|...
T Consensus 11 ~~p~~~~s~~~~L~l~~dGn-----Lvl-~~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ 81 (114)
T PF01453_consen 11 NSPLTSSSGNYTLILQSDGN-----LVL-YD--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY 81 (114)
T ss_dssp TEEEEECETTEEEEEETTSE-----EEE-EE--TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS
T ss_pred ccccccccccccceECCCCe-----EEE-Ec--CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC
Confidence 45676656899999988776 233 32 235779999 4444432 45789999999999999999999999432
Q ss_pred cCCCCceEEEEcc--CCCeEEecccCCCCceeeeeeccCC
Q 046703 114 KEVRTPVVLQLLD--SGNLVLRGEQDGDSETYFWQSFDYP 151 (635)
Q Consensus 114 ~~~~~~~~~~l~d--~GNlvl~~~~~~~~~~~~WqSFd~P 151 (635)
+ ..+ .+..++ .||++ +... ..+.|.|=+.|
T Consensus 82 -p-tdt-~L~~q~l~~~~~~-~~~~----~~~sw~s~~dp 113 (114)
T PF01453_consen 82 -P-TDT-LLPGQKLGDGNVT-GKND----SLTSWSSNTDP 113 (114)
T ss_dssp -S-S-E-EEEEET--TSEEE-EEST----SSEEEESS---
T ss_pred -C-ccE-EEeccCcccCCCc-cccc----eEEeECCCCCC
Confidence 2 223 678888 88888 6543 36899986665
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.6e-07 Score=98.37 Aligned_cols=151 Identities=17% Similarity=0.237 Sum_probs=97.4
Q ss_pred hhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCC-CC------ceeeeeeccCCCCccccc
Q 046703 421 ICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET-EG------NTTRVVGTYGYMAPEYAS 493 (635)
Q Consensus 421 ~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~-~~------~~~~~~gt~~y~aPE~~~ 493 (635)
+.+++.|+.|+|... .+||+.|.|++|.+++.+..||+.|+.+........ .. ..-.......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445668999999877 499999999999999999999999998865433111 00 001123356799999999
Q ss_pred CCCCcccCceeeeehhhHhhhhCCCC-CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhc
Q 046703 494 DGQFSVKSDVFSFGILLLEIVSGKKN-RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCV 572 (635)
Q Consensus 494 ~~~~s~ksDVwS~Gvvl~eiltG~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl 572 (635)
....+.++|+||+|+++|.+..|..+ +........ +.. ++...+..........+ .++.+=+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~----~~~~~~~~~~~~s~~~p----~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSF----SRNLLNAGAFGYSNNLP----SELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhh----hhcccccccccccccCc----HHHHHHHHHHh
Confidence 98889999999999999999955444 332211111 000 11111111111112222 23444556678
Q ss_pred ccCCCCCCChHHHH
Q 046703 573 QQHPDDRPCMPSVI 586 (635)
Q Consensus 573 ~~dP~~RPt~~evl 586 (635)
..++..||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999776664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-06 Score=94.00 Aligned_cols=188 Identities=21% Similarity=0.290 Sum_probs=127.6
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhcc----ccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGR----GLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~iiH~dik~~N 448 (635)
-|++.+.-.....+++.+|+-.|.+... ......+..........+..+ ||.++|+.. ++|-|+||.|
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~ 252 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPAN 252 (524)
T ss_pred ccccccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhh
Confidence 4666666556667888899988876521 122333555566666666666 999999999 9999999999
Q ss_pred eEeccC-CCCccCccccceecCCCCCCCc---eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 449 VLLDQD-MNPKISDFGLARTFGGDETEGN---TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 449 Illd~~-~~~kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
|++..+ ...++.|||++..+........ ..+..+...|++||.. .+.++.+.|+|++|.++.|...+........
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 999999 7899999999998876542211 1223567789999976 4567899999999999999998876543211
Q ss_pred CCCcccHHHHHHHHhhcCCC-CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMP-SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
.. .|..++.+.+ .+.++.. ..++..++..+++.+|..|++...+.
T Consensus 332 ~~--------~W~~~r~~~ip~e~~~~~---------s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 332 NS--------SWSQLRQGYIPLEFCEGG---------SSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred CC--------CccccccccCchhhhcCc---------chhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00 1222222221 1111111 11233377788999999999876654
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.6e-06 Score=63.24 Aligned_cols=44 Identities=52% Similarity=0.690 Sum_probs=39.1
Q ss_pred CCCCCCCCCCCccccccCCCCCCCCCCC--CCcCCcceEeeeccCC
Q 046703 592 EIVLPQPKQPGFLADRKSIGPDSLLSIP--ESSSSNSITISELEAR 635 (635)
Q Consensus 592 ~~~~p~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 635 (635)
...+|.||+|+|+..+...+.++++... ..+|+|+||+|+++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4689999999999999988888766655 8899999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-06 Score=86.39 Aligned_cols=83 Identities=14% Similarity=0.136 Sum_probs=56.9
Q ss_pred eccccccccccCCCC---ccEE-EEecccc-----hhh-hhccccCcccchhhhhhhcccc-chhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPDGG---QDLY-IRMSASE-----LDQ-ERCKLLDWSKRFRIICGTGRGL-LYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~---~~ly-l~~~~~~-----~~~-~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.++++...+ ..+| +++++.. +.. .+...+++. ..++.+++.++ +|||+++ |+||||||
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp 133 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKP 133 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCH
Confidence 489999888776543 3445 5677722 111 112234333 35577888888 9999999 99999999
Q ss_pred cceEecc----CCCCccCccccc
Q 046703 447 GNVLLDQ----DMNPKISDFGLA 465 (635)
Q Consensus 447 ~NIlld~----~~~~kl~Dfgla 465 (635)
+||+++. +..++|+|++.+
T Consensus 134 ~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 134 QNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHEEEeccCCCCCcEEEEECCCC
Confidence 9999974 347999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.1e-06 Score=88.39 Aligned_cols=71 Identities=17% Similarity=0.125 Sum_probs=54.5
Q ss_pred EEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceec
Q 046703 395 LYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468 (635)
Q Consensus 395 lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~ 468 (635)
.|+++++..... .....+...+...++.||+.++.+||+.+ .++|+||||+||+++ ++.++|+|||.+...
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 367777665421 11223344456789999999999999987 399999999999999 788999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.4e-06 Score=85.08 Aligned_cols=71 Identities=17% Similarity=0.076 Sum_probs=54.5
Q ss_pred EEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecC
Q 046703 395 LYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469 (635)
Q Consensus 395 lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~ 469 (635)
.++++++.+...... .........++.++++++.++|+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 106 ~~lv~e~~~g~~L~~-~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 106 HAVVMEYIDGVELYR-VRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ceEEEEEeCCcchhh-ccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 467777665322111 1111445678899999999999998 9999999999999999999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.8e-07 Score=100.47 Aligned_cols=83 Identities=19% Similarity=0.226 Sum_probs=60.1
Q ss_pred eccccccccccCCCCccEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCC
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP 457 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~ 457 (635)
.|++++....+.......|+++++.+...... .+ .....++.+++++|.+||+.+ ++||||||+||++ .++.+
T Consensus 394 ~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~-~l--~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 394 RRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKD-VL--EGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred cccCCCeeEEEEEeCCCCEEEEEecCCCcHHH-HH--HHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcE
Confidence 34444433333333445788888876432111 11 145678999999999999999 9999999999999 57789
Q ss_pred ccCcccccee
Q 046703 458 KISDFGLART 467 (635)
Q Consensus 458 kl~Dfgla~~ 467 (635)
+|+|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.3e-06 Score=93.14 Aligned_cols=135 Identities=14% Similarity=0.194 Sum_probs=96.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCC
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~ 455 (635)
.++||+|+......+....+||+.|...--...-+.+......--+.||+.||.|||..+ .++|++|....|+++..|
T Consensus 65 tlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~G 142 (690)
T KOG1243|consen 65 TLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESG 142 (690)
T ss_pred hccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCC
Confidence 568999999888887777999998765422222233444445556789999999999776 399999999999999999
Q ss_pred CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC
Q 046703 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 456 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG 516 (635)
.-||++|.++.....-.. ......--..|..|+.+.... -..|.|-||++++|++.|
T Consensus 143 eWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 143 EWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 999999998865432111 011112223456666542221 345999999999999998
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.9e-06 Score=83.95 Aligned_cols=68 Identities=25% Similarity=0.338 Sum_probs=51.5
Q ss_pred cEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 394 ~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
..|+++++.+...... .+.... ..++.+++++|.+||+.+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 71 ~~~lv~e~~~g~~l~~-~~~~~~-~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 71 NKTIVMEYIEGKPLKD-VIEEGN-DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCEEEEEEECCccHHH-HHhhcH-HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 4577888765322111 111111 178999999999999999 99999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.9e-06 Score=81.74 Aligned_cols=50 Identities=22% Similarity=0.158 Sum_probs=46.0
Q ss_pred ccchhhhhhhccccchhhc-cccceEEeeccCCcceEeccCCCCccCccccceec
Q 046703 415 SKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468 (635)
Q Consensus 415 ~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~ 468 (635)
.+...++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+|||.+...
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 6677899999999999999 88 99999999999999 889999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.2e-06 Score=84.27 Aligned_cols=71 Identities=27% Similarity=0.318 Sum_probs=54.6
Q ss_pred CccEEEEecccchhhhh--ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 392 GQDLYIRMSASELDQER--CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 392 ~~~lyl~~~~~~~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
....|+++++.+..... -..... ++..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 34567888877532111 001112 66789999999999999999 99999999999999 78899999998864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.95 E-value=2.9e-06 Score=85.54 Aligned_cols=45 Identities=29% Similarity=0.364 Sum_probs=41.7
Q ss_pred hhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 420 i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
.+.+|+++|.+||+.+ |+|+||||.|||++.++.++|+|||.+..
T Consensus 147 ~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 147 QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 4678999999999999 99999999999999888999999998865
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.93 E-value=2e-05 Score=64.12 Aligned_cols=71 Identities=38% Similarity=0.739 Sum_probs=53.4
Q ss_pred CCeEEeeccCCCCCCCcceeccCCHHHHHHHHhh-cCCcccccccccCCCCcceeeec-cccccccccCCCCccEEE
Q 046703 323 DGFMKFTELKLPDATPSWVSKSMNLKESREGCLE-NSFCMAYTNSDIRGGGSGCAMWF-GDLIDMRSFPDGGQDLYI 397 (635)
Q Consensus 323 ~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~i~~~~~gC~l~h-~nLv~l~~~~~~~~~lyl 397 (635)
..|+++.++.+++.... .....++++|++.|+. +|+|.||.|.. ++.+|.+|+ ..+.+.......+.++|.
T Consensus 4 ~~f~~~~~~~l~~~~~~-~~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~ 76 (78)
T smart00473 4 DCFVRLPNTKLPGFSRI-VISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYE 76 (78)
T ss_pred ceeEEecCccCCCCcce-eEcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEE
Confidence 46899999999865443 2456799999999999 99999999954 456799999 666666533444445554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.87 E-value=9e-06 Score=74.28 Aligned_cols=74 Identities=26% Similarity=0.183 Sum_probs=57.3
Q ss_pred CccEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 392 GQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 392 ~~~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
....|+++++....... .++......++.++++++++||......++|+|++|.||+++..+.+++.|||.+..
T Consensus 65 ~~~~~~v~e~~~g~~~~--~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 65 DGWSYLLMEWIEGETLD--EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCccEEEEEecCCeecc--cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 35678888776532211 114566678899999999999986444599999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=7.3e-05 Score=78.40 Aligned_cols=112 Identities=14% Similarity=0.227 Sum_probs=88.0
Q ss_pred hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccC
Q 046703 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485 (635)
Q Consensus 406 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 485 (635)
..+....+|.-.++.++.++.+.+-||+.| .+-+|++++|+|+.++..+.|.|-..-....+ .......+|...
T Consensus 108 Rqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n---g~~~~cpVg~~e 181 (637)
T COG4248 108 RQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN---GTLHLCPVGVSE 181 (637)
T ss_pred cccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccC---CceEecccCccc
Confidence 344566789999999999999999999999 88899999999999999888887443333211 112223577889
Q ss_pred CCCccccc-----CCCCcccCceeeeehhhHhhhhC-CCCCCCc
Q 046703 486 YMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG-KKNRGFY 523 (635)
Q Consensus 486 y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG-~~pf~~~ 523 (635)
|.+||... +..-+...|.|-+|+++++++.| +.||...
T Consensus 182 ftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 182 FTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 99999764 33456889999999999999886 8898664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=2e-05 Score=90.67 Aligned_cols=109 Identities=28% Similarity=0.331 Sum_probs=85.9
Q ss_pred cCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCC---------------------
Q 046703 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGG--------------------- 470 (635)
Q Consensus 412 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~--------------------- 470 (635)
++.+-....+..+.+++.|||... ++|+|++|.|+++..++..++.||+.......
T Consensus 901 ~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~ 977 (1205)
T KOG0606|consen 901 LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSR 977 (1205)
T ss_pred cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccc
Confidence 444455556667888999999987 89999999999999999999999984432210
Q ss_pred ----CCCC----CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 471 ----DETE----GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 471 ----~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
.... .......+|..|.+||...+......+|.|+.|++++|.++|..||...
T Consensus 978 ~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 978 SERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0000 0122357899999999999999999999999999999999999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.68 E-value=4.2e-05 Score=83.62 Aligned_cols=156 Identities=19% Similarity=0.205 Sum_probs=103.9
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC-CCCccCccccceecCCCCCCCceeeeeeccCC-
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYGY- 486 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y- 486 (635)
...++...++++..|++.++-++|+.. ++|+|+||+||++..+ +..+++||+....+.-... ........|
T Consensus 360 ~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~----~~~~~~r~~p 432 (524)
T KOG0601|consen 360 SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG----VFHHIDRLYP 432 (524)
T ss_pred HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc----cccccccccc
Confidence 445677888999999999999999998 9999999999999886 7889999998853211111 111223334
Q ss_pred CCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHH
Q 046703 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIH 566 (635)
Q Consensus 487 ~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 566 (635)
.+++......+-.++|++|||.-+.|.+++..--+... .+..++.+....... .. ..+..
T Consensus 433 ~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~~~~p~~~~-------~~---~~~q~ 492 (524)
T KOG0601|consen 433 IAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRSGDTPNLPG-------LK---LQLQV 492 (524)
T ss_pred cchhhccccccccccccccccccccccccCcccCcccc----------cceeeecccccCCCc-------hH---Hhhhh
Confidence 35666677788899999999999999998865421110 111122222222111 11 22333
Q ss_pred HHHHhcccCCCCCCChHHHHHHHcC
Q 046703 567 ISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 567 l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
+....+..++..||.+.++..+.+-
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchh
Confidence 4445678899999998887766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.43 E-value=7.2e-05 Score=72.61 Aligned_cols=54 Identities=17% Similarity=0.054 Sum_probs=44.7
Q ss_pred cCcccchhhhhhhccccchh-hccccceEEeeccCCcceEeccCCCCccCccccceecC
Q 046703 412 LDWSKRFRIICGTGRGLLYL-HQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469 (635)
Q Consensus 412 l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~ 469 (635)
++.++...+..+++.+|..| |+.+ ++|+|+++.||++. ++.+.|+|||.+....
T Consensus 121 ~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 121 LNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 33344566788999999988 8888 99999999999997 4679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0002 Score=67.47 Aligned_cols=68 Identities=24% Similarity=0.123 Sum_probs=48.9
Q ss_pred EEEecccchhhhhccccCcccchhhhhhhccccchhhccc--cceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDS--RLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 396 yl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
++++++.+....... ......++.+++++|+.||... ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus 67 ~lv~e~i~G~~l~~~---~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 67 VLITEFIEGSELLTE---DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred eEEEEecCCCccccc---cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 677777654321111 1122346778999999999987 23469999999999999 66799999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.00063 Score=74.73 Aligned_cols=74 Identities=19% Similarity=0.174 Sum_probs=52.8
Q ss_pred CccEEEEecccchhhhh----ccccCcccchhhhhhhcc-ccchhhccccceEEeeccCCcceEeccCCCCccCccccce
Q 046703 392 GQDLYIRMSASELDQER----CKLLDWSKRFRIICGTGR-GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR 466 (635)
Q Consensus 392 ~~~lyl~~~~~~~~~~~----~~~l~~~~~~~i~~~ia~-aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~ 466 (635)
...-+++|++.+..... ..... ..+..++.+++. .+..+|..+ ++|+|++|.||+++.++.+++.|||++.
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~-~~~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~ 305 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAG-LDRKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVG 305 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcC-CCHHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCee
Confidence 34568888887642211 00011 133456666666 467889988 9999999999999999999999999997
Q ss_pred ecC
Q 046703 467 TFG 469 (635)
Q Consensus 467 ~~~ 469 (635)
.+.
T Consensus 306 ~l~ 308 (437)
T TIGR01982 306 RLS 308 (437)
T ss_pred ECC
Confidence 653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0017 Score=62.69 Aligned_cols=51 Identities=27% Similarity=0.346 Sum_probs=39.4
Q ss_pred cccchhhhhhhccccch-hhccccceEEeeccCCcceEeccCCCCccCccccceec
Q 046703 414 WSKRFRIICGTGRGLLY-LHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468 (635)
Q Consensus 414 ~~~~~~i~~~ia~aL~y-LH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~ 468 (635)
.+....++.+++..+.. +|..+ |+|+|+.+.||+++++ .+.|+|||.+...
T Consensus 105 ~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 105 PEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp GSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred chhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 45566777888886655 57888 9999999999999987 9999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0021 Score=69.54 Aligned_cols=120 Identities=18% Similarity=0.259 Sum_probs=86.5
Q ss_pred eccccccccccCC----CCccEEEEecccch---------------------hhhhccccCcccchhhhhhhccccchhh
Q 046703 378 WFGDLIDMRSFPD----GGQDLYIRMSASEL---------------------DQERCKLLDWSKRFRIICGTGRGLLYLH 432 (635)
Q Consensus 378 ~h~nLv~l~~~~~----~~~~lyl~~~~~~~---------------------~~~~~~~l~~~~~~~i~~~ia~aL~yLH 432 (635)
-|+|+|.++++.. ++..+.++..|... ......+.+++..+.++.|+..||.++|
T Consensus 331 ~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH 410 (655)
T KOG3741|consen 331 CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH 410 (655)
T ss_pred ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH
Confidence 4777777776653 34455555554431 1233456778889999999999999999
Q ss_pred ccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHh
Q 046703 433 QDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 512 (635)
Q Consensus 433 ~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~e 512 (635)
+.| +.-+-+.+.+|+++.+.+++|+..|.......+.. +| +. --.+-|.-.||.+++-
T Consensus 411 ssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------------~~--le---~~Qq~D~~~lG~ll~a 468 (655)
T KOG3741|consen 411 SSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------------EP--LE---SQQQNDLRDLGLLLLA 468 (655)
T ss_pred hcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC--------------cc--hh---HHhhhhHHHHHHHHHH
Confidence 999 88899999999999999999988887765533320 01 10 1245688889999999
Q ss_pred hhhCCCC
Q 046703 513 IVSGKKN 519 (635)
Q Consensus 513 iltG~~p 519 (635)
+.+|...
T Consensus 469 LAt~~~n 475 (655)
T KOG3741|consen 469 LATGTEN 475 (655)
T ss_pred Hhhcccc
Confidence 9999655
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0013 Score=62.48 Aligned_cols=68 Identities=28% Similarity=0.322 Sum_probs=49.7
Q ss_pred cEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 394 ~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
.-.|+|++.+....+ ..+ ++....++..+-.-+.-||..+ |+|+|+.++||.+.... +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lk-d~l-~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLK-DAL-EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHH-HHH-HhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 344666666532211 111 1224678888888899999999 99999999999998664 99999999874
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0014 Score=64.47 Aligned_cols=53 Identities=32% Similarity=0.394 Sum_probs=47.1
Q ss_pred cCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCC---CCccCcccccee
Q 046703 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM---NPKISDFGLART 467 (635)
Q Consensus 412 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~---~~kl~Dfgla~~ 467 (635)
++......++.++++.++-||+.+ |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 115 ~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 115 LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 456667789999999999999999 99999999999999886 788999988765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.0014 Score=67.09 Aligned_cols=52 Identities=23% Similarity=0.211 Sum_probs=44.5
Q ss_pred CcccchhhhhhhccccchhhccccceEEeeccCCcceEecc-------CCCCccCcccccee
Q 046703 413 DWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ-------DMNPKISDFGLART 467 (635)
Q Consensus 413 ~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~-------~~~~kl~Dfgla~~ 467 (635)
+...+..++.+++..++-||..+ |+|+|++++|||++. +..+.++||+.+..
T Consensus 136 ~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 136 DPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 34456688999999999999999 999999999999985 45688999998754
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.013 Score=47.18 Aligned_cols=48 Identities=15% Similarity=0.301 Sum_probs=33.7
Q ss_pred eccCCCCCCCcceeccCCHHHHHHHHhhcCCcccccccccCCCCcceeeecc
Q 046703 329 TELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFG 380 (635)
Q Consensus 329 ~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~i~~~~~gC~l~h~ 380 (635)
.++.++..+.... ...+.++|++.|+.+++|.||.|.. +...|.++..
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 4555555444322 3568999999999999999999953 3455876543
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.0065 Score=57.64 Aligned_cols=47 Identities=38% Similarity=0.576 Sum_probs=41.0
Q ss_pred hhhhhhhccccchhhccccceEEeeccCCcceEeccCCC---CccCcccccee
Q 046703 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN---PKISDFGLART 467 (635)
Q Consensus 418 ~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~---~kl~Dfgla~~ 467 (635)
..++..|-+.+.-||..+ |||+||..+||++..++. +-+.|||++..
T Consensus 116 ~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 116 AELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 678889999999999999 999999999999976654 47899999854
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.0049 Score=69.04 Aligned_cols=75 Identities=15% Similarity=0.120 Sum_probs=46.4
Q ss_pred CccEEEEecccchhhhhc-cccCcc--cchhhhhhhccc-cchhhccccceEEeeccCCcceEeccCC----CCccCccc
Q 046703 392 GQDLYIRMSASELDQERC-KLLDWS--KRFRIICGTGRG-LLYLHQDSRLRIIHRDLKAGNVLLDQDM----NPKISDFG 463 (635)
Q Consensus 392 ~~~lyl~~~~~~~~~~~~-~~l~~~--~~~~i~~~ia~a-L~yLH~~~~~~iiH~dik~~NIlld~~~----~~kl~Dfg 463 (635)
...-+++||+.+...... ..+... .+..++...+.. +..++..+ ++|+|+||.||+++.++ .+++.|||
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFG 309 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFG 309 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecc
Confidence 445678888876432111 001100 111233222222 23345677 99999999999999887 89999999
Q ss_pred cceecC
Q 046703 464 LARTFG 469 (635)
Q Consensus 464 la~~~~ 469 (635)
++..+.
T Consensus 310 ivg~l~ 315 (537)
T PRK04750 310 IVGSLN 315 (537)
T ss_pred eEEECC
Confidence 998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.0071 Score=59.16 Aligned_cols=53 Identities=9% Similarity=0.059 Sum_probs=45.5
Q ss_pred cCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCC--CccCcccccee
Q 046703 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN--PKISDFGLART 467 (635)
Q Consensus 412 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~--~kl~Dfgla~~ 467 (635)
.+..++..+..++++.++-||..+ +.|+|+.+.||+++.++. ++++||.-.+.
T Consensus 125 ~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 125 YSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred cchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 455566789999999999999999 999999999999986666 88999876653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.02 Score=56.18 Aligned_cols=31 Identities=29% Similarity=0.435 Sum_probs=26.1
Q ss_pred ceEEeeccCCcceEecc--CCCCccCcccccee
Q 046703 437 LRIIHRDLKAGNVLLDQ--DMNPKISDFGLART 467 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~--~~~~kl~Dfgla~~ 467 (635)
..++|+|+++.||+++. +..+.|.||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 35899999999999998 55678999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.024 Score=55.84 Aligned_cols=67 Identities=19% Similarity=0.167 Sum_probs=47.5
Q ss_pred ccEEEEecccchhhhh-ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 393 QDLYIRMSASELDQER-CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 393 ~~lyl~~~~~~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
...++++|+.++.... ...++. .++..+.+++.-||+.| ++|+|.+|.|+++..+ .+++.||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIEDIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchhcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence 3455788887743211 111211 34566778899999999 9999999999999855 489999976654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.046 Score=55.15 Aligned_cols=68 Identities=21% Similarity=0.098 Sum_probs=44.6
Q ss_pred EEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 397 IRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 397 l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
++|++.+.....+-+++-+..-.++..|+.-+.-+-..| +||+|+++-||++++++.+.++||--+..
T Consensus 184 VvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 184 VVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred eeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCccccc
Confidence 344444332222333334444455555555555555667 99999999999999999999999865543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.038 Score=53.42 Aligned_cols=58 Identities=17% Similarity=0.055 Sum_probs=51.1
Q ss_pred ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceec
Q 046703 411 LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF 468 (635)
Q Consensus 411 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~ 468 (635)
.-+|+.|.+|+.++++.+.+|+..-...+.-.|++++|+-+++++++|+.|...+...
T Consensus 55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4689999999999999999998855455999999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.91 E-value=0.24 Score=52.14 Aligned_cols=85 Identities=21% Similarity=0.204 Sum_probs=59.5
Q ss_pred ccccccccC-CCCccEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCcc
Q 046703 381 DLIDMRSFP-DGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKI 459 (635)
Q Consensus 381 nLv~l~~~~-~~~~~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl 459 (635)
++.....+. .++..+|+.++..-......+.-.|++.+.++.+-+.-+.-+...- +.-||++.-.||+|+ +|++.|
T Consensus 286 ~~e~~~vv~~de~~y~yl~~kdhgt~is~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtL 362 (488)
T COG5072 286 FLETLKVVSLDETLYLYLHFKDHGTPISIIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTL 362 (488)
T ss_pred hhhcceEEecCCceEEEEEEecCCceeeeeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEE
Confidence 333344444 3445566666544323344556678888888887766666555443 589999999999999 999999
Q ss_pred Cccccceec
Q 046703 460 SDFGLARTF 468 (635)
Q Consensus 460 ~Dfgla~~~ 468 (635)
+||-+++.-
T Consensus 363 IDfklsRl~ 371 (488)
T COG5072 363 IDFKLSRLS 371 (488)
T ss_pred EEeeeeecc
Confidence 999999853
|
|
| >PF00024 PAN_1: PAN domain This Prosite entry concerns apple domains, a subset of PAN domains; InterPro: IPR003014 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=87.66 E-value=0.55 Score=37.75 Aligned_cols=55 Identities=16% Similarity=0.335 Sum_probs=40.6
Q ss_pred CeEEeeccCCCCCCCcceeccCCHHHHHHHHhhcCC-cccccccccCCCCcceeeecccc
Q 046703 324 GFMKFTELKLPDATPSWVSKSMNLKESREGCLENSF-CMAYTNSDIRGGGSGCAMWFGDL 382 (635)
Q Consensus 324 ~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCs-C~a~~~~~i~~~~~gC~l~h~nL 382 (635)
.|.++.+..+.......+ ...++++|.+.|+.+-. |.+|.|.. ....|.+...+-
T Consensus 3 ~f~~~~~~~l~~~~~~~~-~v~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~L~~~~~ 58 (79)
T PF00024_consen 3 AFERIPGYRLSGHSIKEI-NVPSLEECAQLCLNEPRRCKSFNYDP---SSKTCYLSSSDR 58 (79)
T ss_dssp TEEEEEEEEEESCEEEEE-EESSHHHHHHHHHHSTT-ESEEEEET---TTTEEEEECSSS
T ss_pred CeEEECCEEEeCCcceEE-cCCCHHHHHhhcCcCcccCCeEEEEC---CCCEEEEcCCCC
Confidence 477788877766444333 45599999999999999 99999954 345688766543
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs It has been shown that, the N-terminal N domains of members of the plasminogen/hepatocyte growth factor family, the apple domains of the plasma prekallikrein/coagulation factor XI family, and domains of various nematode proteins belong to the same module superfamily, the PAN module []. PAN contains a conserved core of three disulphide bridges. In some members of the family there is an additional fourth disulphide bridge that links the N and C termini of the domain.; PDB: 1GP9_C 2QJ2_B 1GMO_H 1NK1_B 3MKP_B 1BHT_B 3HN4_A 1GMN_A 3HMS_A 3HMT_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=87.24 E-value=0.48 Score=53.21 Aligned_cols=91 Identities=22% Similarity=0.272 Sum_probs=69.9
Q ss_pred hhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC
Q 046703 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF 497 (635)
Q Consensus 418 ~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 497 (635)
..+.+.-.++++++|+.. -+|+| ||+..+ ...|..||+....+.+.. ......++..++|||......+
T Consensus 339 ~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 339 AYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTI 407 (829)
T ss_pred hhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccccc
Confidence 345556678999999875 58888 666554 678999999887664432 2334678999999999999999
Q ss_pred cccCceeeeehhhHhhhhCCCC
Q 046703 498 SVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 498 s~ksDVwS~Gvvl~eiltG~~p 519 (635)
..+.|+|+.++--.++.-|-.|
T Consensus 408 ~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 408 DGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ccCCCccCCCcchhhcCCCCCC
Confidence 9999999999876666666655
|
|
| >smart00223 APPLE APPLE domain | Back alignment and domain information |
|---|
Probab=86.70 E-value=0.83 Score=37.42 Aligned_cols=51 Identities=10% Similarity=0.160 Sum_probs=35.2
Q ss_pred eccCCCCCCCcceeccCCHHHHHHHHhhcCCcccccccccCCCCcceeeecc
Q 046703 329 TELKLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFG 380 (635)
Q Consensus 329 ~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~i~~~~~gC~l~h~ 380 (635)
.++.++..+.. .....++++|++.|..+=.|.+|+|..-......|.+++.
T Consensus 7 ~~~df~G~Dl~-~~~~~~~~~Cq~~Ct~~~~C~~FTf~~~~~~~~~C~LK~s 57 (79)
T smart00223 7 KNVDFRGSDIN-TVYVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLKDS 57 (79)
T ss_pred cCccccCceee-eeecCCHHHHHHhhcCCCCccEEEeeCCCCCCCEeEeCcC
Confidence 45555555544 2356789999999999999999999653222236877643
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. |
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
Probab=85.55 E-value=0.5 Score=33.51 Aligned_cols=32 Identities=28% Similarity=0.687 Sum_probs=25.7
Q ss_pred CCccccc-cCCCCcccccC-CCCcccccCCCccC
Q 046703 269 DQCDTYG-LCGAYGICIIS-QSPVCQCLKGFKHK 300 (635)
Q Consensus 269 ~~C~~~~-~CG~~g~C~~~-~~~~C~C~~gf~~~ 300 (635)
++|.... .|++++.|... ++-.|.|++||+..
T Consensus 3 dEC~~~~~~C~~~~~C~N~~Gsy~C~C~~Gy~~~ 36 (42)
T PF07645_consen 3 DECAEGPHNCPENGTCVNTEGSYSCSCPPGYELN 36 (42)
T ss_dssp STTTTTSSSSSTTSEEEEETTEEEEEESTTEEEC
T ss_pred cccCCCCCcCCCCCEEEcCCCCEEeeCCCCcEEC
Confidence 6788754 79999999875 55679999999843
|
Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A .... |
| >PRK11138 outer membrane biogenesis protein BamB; Provisional | Back alignment and domain information |
|---|
Probab=85.29 E-value=28 Score=37.51 Aligned_cols=76 Identities=18% Similarity=0.289 Sum_probs=44.6
Q ss_pred CCCeEEEeccCCCCCCCC----Cce-EEEecCCcEEEEcc-CCceEEEeecccCC------CCce-----EEEEccCCCe
Q 046703 68 PVKTVVWVANRLNLINDS----SGF-LMINKTGNLVLTSK-SNIVVWSAYLSKEV------RTPV-----VLQLLDSGNL 130 (635)
Q Consensus 68 ~~~t~vW~Anr~~pv~~~----~~~-l~~~~~g~l~l~~~-~~~~vwss~~~~~~------~~~~-----~~~l~d~GNl 130 (635)
.+..++|..+...++..+ .++ +.-+.+|.|+-.|. +|.++|+.....+. ..++ ...-..+|.+
T Consensus 138 ~tG~~~W~~~~~~~~~ssP~v~~~~v~v~~~~g~l~ald~~tG~~~W~~~~~~~~~~~~~~~sP~v~~~~v~~~~~~g~v 217 (394)
T PRK11138 138 EDGEVAWQTKVAGEALSRPVVSDGLVLVHTSNGMLQALNESDGAVKWTVNLDVPSLTLRGESAPATAFGGAIVGGDNGRV 217 (394)
T ss_pred CCCCCcccccCCCceecCCEEECCEEEEECCCCEEEEEEccCCCEeeeecCCCCcccccCCCCCEEECCEEEEEcCCCEE
Confidence 456679988765544321 233 33456788888885 79999987643210 1110 1223456667
Q ss_pred EEecccCCCCceeeee
Q 046703 131 VLRGEQDGDSETYFWQ 146 (635)
Q Consensus 131 vl~~~~~~~~~~~~Wq 146 (635)
+..+..+ ++.+|+
T Consensus 218 ~a~d~~~---G~~~W~ 230 (394)
T PRK11138 218 SAVLMEQ---GQLIWQ 230 (394)
T ss_pred EEEEccC---Chhhhe
Confidence 6666554 788997
|
|
| >TIGR03300 assembly_YfgL outer membrane assembly lipoprotein YfgL | Back alignment and domain information |
|---|
Probab=85.16 E-value=45 Score=35.60 Aligned_cols=75 Identities=20% Similarity=0.333 Sum_probs=39.8
Q ss_pred CCeEEEeccCCCCCCCC----Cce-EEEecCCcEEEEcc-CCceEEEeecccCC------CCce-----EEEEccCCCeE
Q 046703 69 VKTVVWVANRLNLINDS----SGF-LMINKTGNLVLTSK-SNIVVWSAYLSKEV------RTPV-----VLQLLDSGNLV 131 (635)
Q Consensus 69 ~~t~vW~Anr~~pv~~~----~~~-l~~~~~g~l~l~~~-~~~~vwss~~~~~~------~~~~-----~~~l~d~GNlv 131 (635)
...++|......++..+ ++. +.-+.+|.|+..|. +|.++|........ ...+ ...-..+|.++
T Consensus 124 tG~~~W~~~~~~~~~~~p~v~~~~v~v~~~~g~l~a~d~~tG~~~W~~~~~~~~~~~~~~~sp~~~~~~v~~~~~~g~v~ 203 (377)
T TIGR03300 124 DGKELWRAKLSSEVLSPPLVANGLVVVRTNDGRLTALDAATGERLWTYSRVTPALTLRGSASPVIADGGVLVGFAGGKLV 203 (377)
T ss_pred CCcEeeeeccCceeecCCEEECCEEEEECCCCeEEEEEcCCCceeeEEccCCCceeecCCCCCEEECCEEEEECCCCEEE
Confidence 45677876654433211 223 33356677887775 78888876543210 1110 11123456666
Q ss_pred EecccCCCCceeeee
Q 046703 132 LRGEQDGDSETYFWQ 146 (635)
Q Consensus 132 l~~~~~~~~~~~~Wq 146 (635)
..+..+ ++.+|+
T Consensus 204 ald~~t---G~~~W~ 215 (377)
T TIGR03300 204 ALDLQT---GQPLWE 215 (377)
T ss_pred EEEccC---CCEeee
Confidence 666543 678886
|
Members of this protein family are YfgL, a lipoprotein component of a complex that acts protein insertion into the bacterial outer membrane. Other members of this complex are NlpB, YfiO, and YaeT. This protein contains multiple copies of a repeat that, in other contexts, are associated with binding of the coenzyme PQQ. |
| >PRK11138 outer membrane biogenesis protein BamB; Provisional | Back alignment and domain information |
|---|
Probab=83.35 E-value=17 Score=39.18 Aligned_cols=54 Identities=20% Similarity=0.300 Sum_probs=34.0
Q ss_pred EecCCcEEEEcc-CCceEEEeecccCCCC------ceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 91 INKTGNLVLTSK-SNIVVWSAYLSKEVRT------PVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 91 ~~~~g~l~l~~~-~~~~vwss~~~~~~~~------~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
-+.+|.|+-.|. +|.++|+......... .....-..+|.|+-.|..+ ++++|+-
T Consensus 126 ~~~~g~l~ald~~tG~~~W~~~~~~~~~ssP~v~~~~v~v~~~~g~l~ald~~t---G~~~W~~ 186 (394)
T PRK11138 126 GSEKGQVYALNAEDGEVAWQTKVAGEALSRPVVSDGLVLVHTSNGMLQALNESD---GAVKWTV 186 (394)
T ss_pred EcCCCEEEEEECCCCCCcccccCCCceecCCEEECCEEEEECCCCEEEEEEccC---CCEeeee
Confidence 346688887784 7999998876532111 1122234466677777654 7889975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=83.21 E-value=0.7 Score=55.32 Aligned_cols=149 Identities=18% Similarity=0.204 Sum_probs=94.9
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCc---ceEeccCCCCccC--ccccceecCCCCCCCceeeeeec
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG---NVLLDQDMNPKIS--DFGLARTFGGDETEGNTTRVVGT 483 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~---NIlld~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt 483 (635)
...++..+.+.+..++.+|++|+|+.. +.|.-+..+ +-..+..+...++ ||+..+........ ....-+
T Consensus 280 v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~ 353 (1351)
T KOG1035|consen 280 VGSIPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLA 353 (1351)
T ss_pred ccccCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCc
Confidence 445667777788899999999999986 555555444 4444555555655 88877665433221 112234
Q ss_pred cCCCCcccccCCCCc--ccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHH
Q 046703 484 YGYMAPEYASDGQFS--VKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEV 561 (635)
Q Consensus 484 ~~y~aPE~~~~~~~s--~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 561 (635)
..+.++|........ ...|+|.+|..+..+..|..+-.... .+..+++... . .
T Consensus 354 ~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~~~----~-~-- 408 (1351)
T KOG1035|consen 354 EIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA------------------VPVSLLDVLS----T-S-- 408 (1351)
T ss_pred cccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc------------------chhhhhcccc----c-h--
Confidence 567788877666554 44799999999999998876632110 0111111110 0 0
Q ss_pred HHHHHHHHHhcccCCCCCCChHHHHHHH
Q 046703 562 IRCIHISLLCVQQHPDDRPCMPSVILML 589 (635)
Q Consensus 562 ~~~~~l~~~Cl~~dP~~RPt~~evl~~L 589 (635)
.+......|+..++++|+++.+++...
T Consensus 409 -~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 409 -ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred -hhhhhhhhhcchhhhhccchhhhhhch
Confidence 234456689999999999999998765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=81.55 E-value=0.92 Score=45.51 Aligned_cols=50 Identities=24% Similarity=0.244 Sum_probs=40.6
Q ss_pred cchhhhhhhccccchhhc-cccceEEeeccCCcceEeccCCCCccCccccceecC
Q 046703 416 KRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469 (635)
Q Consensus 416 ~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~ 469 (635)
+...+..++++.+.-|-. .+ +||+||..-|||+. ++.+.|+|++-+....
T Consensus 167 e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 167 EAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 455667777788777765 55 99999999999999 8899999999887543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 635 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-30 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-05 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-79
Identities = 72/186 (38%), Positives = 107/186 (57%), Gaps = 3/186 (1%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
LDW KR RI G+ RGL YLH +IIHRD+KA N+LLD++ + DFGLA+
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN--RGFYHLDNKL 529
+T TT V GT G++APEY S G+ S K+DVF +G++LLE+++G++ D+ +
Sbjct: 188 DT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
L+ L + ++D Q + EV + I ++LLC Q P +RP M V+ ML
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 590 GSEIVL 595
+ +
Sbjct: 307 EGDGLA 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 250 bits (642), Expect = 1e-78
Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 14/189 (7%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
+ L W R +I G G+ +LH++ IHRD+K+ N+LLD+ KISDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGL 179
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
AR T+R+VGT YMAPE G+ + KSD++SFG++LLEI++G
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA----- 233
Query: 525 LDNKL---NLIGHAWKLW-NKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+D L+ ++ + + ID + T V ++ C+ + + RP
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 581 CMPSVILML 589
+ V +L
Sbjct: 293 DIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-64
Identities = 59/178 (33%), Positives = 95/178 (53%), Gaps = 3/178 (1%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
+ W +R I G RGL YLH + IIHRD+K+ N+LLD++ PKI+DFG+++
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531
+ +T V GT GY+ PEY G+ + KSDV+SFG++L E++ + +NL
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
A + N G +++DP + + + ++ C+ +DRP M V+ L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-56
Identities = 46/203 (22%), Positives = 79/203 (38%), Gaps = 24/203 (11%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQD-------SRLRIIHRDLKAGNVLLDQDMNPKIS 460
+ ++ W++ I RGL YLH+D + I HRD+K+ NVLL ++ I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 461 DFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVS 515
DFGLA F ++ G+T VGT YMAPE ++ D+++ G++L E+ S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEM--------IDPCYQESCNLTEVIRCI-H 566
+ L ++ +M P ++ + +
Sbjct: 234 RCTAADGPVDEYMLPF---EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 567 ISLLCVQQHPDDRPCMPSVILML 589
C + R V +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-44
Identities = 46/223 (20%), Positives = 76/223 (34%), Gaps = 31/223 (13%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQD------SRLRIIHRDLKAGNVLLDQDMNPKISD 461
DW R+ RGL YLH + + I HRDL + NVL+ D ISD
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 462 FGLARTFGG------DETEGNTTRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGI 508
FGL+ G E + VGT YMAPE + D+++ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 509 LLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMID--------PCYQESCNLTE 560
+ EI + + + ++ N +M P + E+
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 561 VIRCIHISLL--CVQQHPDDRPCMPSVILMLGSEIVLPQPKQP 601
+ + C Q + R + +E+++ +
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERM-AELMMIWERNK 324
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 50/199 (25%), Positives = 80/199 (40%), Gaps = 21/199 (10%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN-PKISDFG 463
E + +G+ YLH +IHRDLK N+LL KI DFG
Sbjct: 92 GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151
Query: 464 LARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523
A + + + T G+ +MAPE +S K DVFS+GI+L E+++ +K F
Sbjct: 152 TAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FD 204
Query: 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583
+ I W + N P +I + + ++ C + P RP M
Sbjct: 205 EIGGPAFRI--MWAVHNGTRP-PLIKNLPKP---IESLMTR------CWSKDPSQRPSME 252
Query: 584 SVILMLGS-EIVLPQPKQP 601
++ ++ P +P
Sbjct: 253 EIVKIMTHLMRYFPGADEP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 20/196 (10%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
+ LD +R + +G+ YLH I+HR+LK+ N+L+D+ K+ DFGL
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
+R T ++ GT +MAPE D + KSDV+SFG++L E+ + ++ +
Sbjct: 186 SRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PWG 240
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584
LN + K E+ + + +I C P RP +
Sbjct: 241 ---NLNPAQVVAAVGFKCKRLEIPRNLNPQ---VAAIIE------GCWTNEPWKRPSFAT 288
Query: 585 VILMLGS--EIVLPQP 598
++ +L + +P P
Sbjct: 289 IMDLLRPLIKSAVPPP 304
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 21/183 (11%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
+ K I T RG+ YLH IIHRDLK+ N+ L +D KI DFGLA
Sbjct: 117 FEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173
Query: 472 ETEGNTTRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
++ G+ +MAPE +S +SDV++FGI+L E+++G+ + +++N+
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNR 231
Query: 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCN--LTEVIRCIHISLLCVQQHPDDRPCMPSVI 586
+I + P +C + ++ C+++ D+RP P ++
Sbjct: 232 DQIIEMVGR--GSLSPDLSKVR---SNCPKRMKRLMA------ECLKKKRDERPSFPRIL 280
Query: 587 LML 589
+
Sbjct: 281 AEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 42/191 (21%), Positives = 86/191 (45%), Gaps = 26/191 (13%)
Query: 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ-----DMNPKIS 460
++ + WS + R++ G+ Y+ I+HRDL++ N+ L + K++
Sbjct: 113 LDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 461 DFGLARTFGGDETEGNTTRVVGTYGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGKK 518
DFGL++ ++ + + ++G + +MAPE A + ++ K+D +SF ++L I++G+
Sbjct: 172 DFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD 578
+ + I + +G+ + + C L VI LC P
Sbjct: 227 ---PFD-EYSYGKIKFINMIREEGLRPTIPEDCPPR---LRNVIE------LCWSGDPKK 273
Query: 579 RPCMPSVILML 589
RP ++ L
Sbjct: 274 RPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 27/190 (14%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP--------KI 459
K + RG+ YLH ++ + IIHRDLK+ N+L+ Q + KI
Sbjct: 98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 460 SDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519
+DFGLAR + G Y +MAPE FS SDV+S+G+LL E+++G+
Sbjct: 158 TDFGLAR----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV- 212
Query: 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579
+ ++ + A+ + + + C + +++ C P R
Sbjct: 213 --PFR---GIDGLAVAYGVAMNKLALPIPSTCPEP---FAKLME------DCWNPDPHSR 258
Query: 580 PCMPSVILML 589
P +++ L
Sbjct: 259 PSFTNILDQL 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 39/220 (17%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
WS+R G+ YLH + IIHRDL + N L+ ++ N ++DFGLAR +
Sbjct: 105 YPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161
Query: 472 ETEGNTTR------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519
+T+ R VVG +MAPE + + K DVFSFGI+L EI+
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
Query: 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579
+L ++ + ++ P + I++ C P+ R
Sbjct: 222 DP-DYLPRTMDFGLNVRGFLDRYCPPNCPPSFFP-------------ITVRCCDLDPEKR 267
Query: 580 PCMPSVILML--------GSEIVLPQPKQ--PGFLADRKS 609
P + L G + PQ +Q GF +
Sbjct: 268 PSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRR 307
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 36/189 (19%), Positives = 77/189 (40%), Gaps = 26/189 (13%)
Query: 404 LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG 463
L + ++D S+ + RG+ +LH L I L + +V++D+DM +IS
Sbjct: 100 LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMAD 158
Query: 464 LARTFGGDETEGNTTRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVSGKKNR 520
+ +F + + ++APE + +D++SF +LL E+V+ +
Sbjct: 159 VKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV-- 209
Query: 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+ L+ + K+ +G+ + L + +C+ + P RP
Sbjct: 210 -PFA---DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK---------ICMNEDPAKRP 256
Query: 581 CMPSVILML 589
++ +L
Sbjct: 257 KFDMIVPIL 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 47/209 (22%), Positives = 76/209 (36%), Gaps = 36/209 (17%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLR-----IIHRDLKAGNVLLDQDMNPKISDF 462
+ LD ++ + GL +LH + I HRDLK+ N+L+ ++ I+D
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186
Query: 463 GLARTF--GGDETEGNTTRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIV 514
GLA F +E + VGT YM PE + Q + +D++SFG++L E+
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
Query: 515 SGKKNRGF-------YHLDNKLNLIGHAWKLW--NKGM-----PSEMIDPCYQESCNLTE 560
+ G YH + + K + D C ++ L
Sbjct: 247 RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT 306
Query: 561 VIRCIHISLLCVQQHPDDRPCMPSVILML 589
C +P R V L
Sbjct: 307 --ECWA-------HNPASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 13/127 (10%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLR-----IIHRDLKAGNVLLDQDMNPKISDF 462
+ LD RI+ GL +LH + I HRDLK+ N+L+ ++ I+D
Sbjct: 98 QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157
Query: 463 GLAR--TFGGDETEGNTTRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIV 514
GLA + ++ + VGT YMAPE + D+++FG++L E+
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 515 SGKKNRG 521
+ G
Sbjct: 218 RRMVSNG 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 44/192 (22%), Positives = 72/192 (37%), Gaps = 35/192 (18%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG-- 469
LD +K +I +G+ YLH I+H+DLK+ NV D + I+DFGL G
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182
Query: 470 -GDETEGNTTRVVGTYGYMAPE---------YASDGQFSVKSDVFSFGILLLEIVSGKKN 519
E G ++APE FS SDVF+ G + E+ + +
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCN--LTEVIRCIHISLLCVQQHPD 577
+ +I GM + Q +++++ C +
Sbjct: 243 ---FKTQPAEAIIWQM----GTGMKPNLS----QIGMGKEISDILL------FCWAFEQE 285
Query: 578 DRPCMPSVILML 589
+RP ++ ML
Sbjct: 286 ERPTFTKLMDML 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 45/209 (21%), Positives = 73/209 (34%), Gaps = 44/209 (21%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQD-----SRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR 466
+ ++ T GL +LH + + I HRDLK+ N+L+ ++ I+D GLA
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 467 TF--GGDETEGNTTRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKK 518
D + VGT YMAPE + ++D+++ G++ EI
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255
Query: 519 NRGF---YHLDNKLNLIGHAWKLWNKGMPS--EMID-----------PCYQESCNLTEVI 562
G Y L + PS EM P +SC V+
Sbjct: 256 IGGIHEDYQL---------PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 306
Query: 563 RCIHISLL--CVQQHPDDRPCMPSVILML 589
++ C + R + L
Sbjct: 307 A----KIMRECWYANGAARLTALRIKKTL 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 42/201 (20%), Positives = 71/201 (35%), Gaps = 39/201 (19%)
Query: 392 GQDL--YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449
++L ++ S D+E L F I + +LH ++HRDLK N+
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHI---FIQIAE---AVEFLHS---KGLMHRDLKPSNI 195
Query: 450 LLDQDMNPKISDFGLAR----------TFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
D K+ DFGL T VGT YM+PE +S
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 500 KSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT 559
K D+FS G++L E+ Y ++ + ++ + Q+
Sbjct: 256 KVDIFSLGLILFEL--------LYSFSTQMERV----RIITDVRNLKFPLLFTQKYPQEH 303
Query: 560 EVIRCIHISLLCVQQHPDDRP 580
+++ + P +RP
Sbjct: 304 MMVQ------DMLSPSPTERP 318
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 34/208 (16%)
Query: 386 RSFPDGGQDLYIRMS-------ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLR 438
S + L+I+M +++ R + LD + +G+ Y+H +
Sbjct: 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---K 142
Query: 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS 498
+I+RDLK N+ L KI DFGL + + +G TR GT YM+PE S +
Sbjct: 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDYG 199
Query: 499 VKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNL 558
+ D+++ G++L E++ F K + I +
Sbjct: 200 KEVDLYALGLILAELLHVCD-TAFE-----------TSKFFTDLRDGI-ISDIF--DKKE 244
Query: 559 TEVIRCIHISLLCVQQHPDDRPCMPSVI 586
+++ + + P+DRP ++
Sbjct: 245 KTLLQ------KLLSKKPEDRPNTSEIL 266
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 42/201 (20%), Positives = 69/201 (34%), Gaps = 39/201 (19%)
Query: 392 GQDLY--IRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449
++L + + ++ER L F I + +LH ++HRDLK N+
Sbjct: 99 KENLKDWMNGRCTIEERERSVCLHI---FLQIA---EAVEFLHS---KGLMHRDLKPSNI 149
Query: 450 LLDQDMNPKISDFGLAR----------TFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
D K+ DFGL T VGT YM+PE +S
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209
Query: 500 KSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT 559
K D+FS G++L E++ F ++ + Y
Sbjct: 210 KVDIFSLGLILFELL-----YPFSTQMERVRT----LTDVRNLKFPPLFTQKYPC---EY 257
Query: 560 EVIRCIHISLLCVQQHPDDRP 580
+++ +L P +RP
Sbjct: 258 VMVQ----DMLSPS--PMERP 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 37/202 (18%)
Query: 392 GQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451
LY + + L+Q+R + FR I L Y+H IIHRDLK N+ +
Sbjct: 99 NGTLYDLIHSENLNQQRDEYWRL---FRQIL---EALSYIHS---QGIIHRDLKPMNIFI 149
Query: 452 DQDMNPKISDFGLARTF------------GGDETEGNTTRVVGTYGYMAPE-YASDGQFS 498
D+ N KI DFGLA+ + N T +GT Y+A E G ++
Sbjct: 150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 499 VKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNL 558
K D++S GI+ E++ F ++N+ K D +
Sbjct: 210 EKIDMYSLGIIFFEMIY-----PFSTGMERVNI----LKKLRSVSIEFPPDFDDNKMKVE 260
Query: 559 TEVIRCIHISLLCVQQHPDDRP 580
++IR L+ P+ RP
Sbjct: 261 KKIIR----LLIDHD--PNKRP 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 46/203 (22%), Positives = 84/203 (41%), Gaps = 33/203 (16%)
Query: 387 SFPDGGQDLYIRMS-------ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439
SF + G LYI M ++ ++ L + L ++H +I
Sbjct: 91 SFEENGS-LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
+HRD+K+ N+ L +D ++ DFG+AR +GT Y++PE + ++
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNN 204
Query: 500 KSDVFSFGILLLEIVSGKKNRGFY--HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCN 557
KSD+++ G +L E+ + K F + N + I G + Y S +
Sbjct: 205 KSDIWALGCVLYELCTLK--HAFEAGSMKNLVLKI-------ISGSFPP-VSLHY--SYD 252
Query: 558 LTEVIRCIHISLLCVQQHPDDRP 580
L ++ +++P DRP
Sbjct: 253 LRSLVS------QLFKRNPRDRP 269
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 48/203 (23%), Positives = 70/203 (34%), Gaps = 56/203 (27%)
Query: 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465
+ L +++ G+ YL IHRDL A N L+ + KISDFG++
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMS 260
Query: 466 RTFGGDETEGNTTRVVGTYGY----MAPEYASDGQFSVKSDVFSFGILLLEIVS------ 515
R +E +G G APE + G++S +SDV+SFGILL E S
Sbjct: 261 R----EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
Query: 516 -GKKN--------RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIH 566
N +G L P D ++
Sbjct: 317 PNLSNQQTREFVEKG-GRLP----------------CPELCPDAVFR------------- 346
Query: 567 ISLLCVQQHPDDRPCMPSVILML 589
+ C P RP ++ L
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 46/200 (23%), Positives = 75/200 (37%), Gaps = 33/200 (16%)
Query: 387 SFPDGGQDLYIRM-----SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441
++ +GG LY++ S + + L ++ + + T L +LH ++H
Sbjct: 125 AWEEGGI-LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVH 180
Query: 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKS 501
D+K N+ L K+ DFGL G G G YMAPE G + +
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGDPRYMAPE-LLQGSYGTAA 236
Query: 502 DVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAW-KLWNKGMPSEMIDPCYQESCNLTE 560
DVFS G+ +LE+ + G W +L +P E S L
Sbjct: 237 DVFSLGLTILEVACNME-----LPHG-----GEGWQQLRQGYLPPEFTAGL---SSELRS 283
Query: 561 VIRCIHISLLCVQQHPDDRP 580
V+ + ++ P R
Sbjct: 284 VLV------MMLEPDPKLRA 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L ++H R++HRD+K NV + K+ D GL R F T ++ +VGT Y
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 202
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSE 546
M+PE + ++ KSD++S G LL E+ + + FY +K+NL K+ +
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--GDKMNLYSLCKKI-EQCDYPP 257
Query: 547 MIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
+ Y S L +++ +C+ P+ RP
Sbjct: 258 LPSDHY--SEELRQLVN------MCINPDPEKRP 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 14/137 (10%)
Query: 390 DGGQD---LYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440
D G+ LY+ M + + + + L + I+ G L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPL-APPRAVAIVRQIGSALDAAHAA---GAT 156
Query: 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVK 500
HRD+K N+L+ D + DFG+A DE VGT YMAPE S+ + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 501 SDVFSFGILLLEIVSGK 517
+D+++ +L E ++G
Sbjct: 216 ADIYALTCVLYECLTGS 232
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 48/156 (30%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 427 GLLYLHQ--DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
L H+ D ++HRDLK NV LD N K+ DFGLAR D + T VGT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTP 180
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMP 544
YM+PE + ++ KSD++S G LL E+ + F ++ L +G
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTA-FSQKELA----GKIREGKF 233
Query: 545 SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
I Y S L E+I + RP
Sbjct: 234 RR-IPYRY--SDELNEIIT------RMLNLKDYHRP 260
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
+I + L +LH S+L +IHRD+K NVL++ K+ DFG++ +
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDI 168
Query: 479 RVVGTYGYMAPE----YASDGQFSVKSDVFSFGILLLEIVSGK 517
G YMAPE + +SVKSD++S GI ++E+ +
Sbjct: 169 -DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 28/135 (20%), Positives = 50/135 (37%), Gaps = 20/135 (14%)
Query: 389 PDGGQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442
G YI M S ++ L ++ + L YLH + +++
Sbjct: 153 RHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---SIGLVYN 206
Query: 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSD 502
DLK N++L ++ K+ D G + GT G+ APE +V +D
Sbjct: 207 DLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVR-TGPTVATD 258
Query: 503 VFSFGILLLEIVSGK 517
+++ G L +
Sbjct: 259 IYTVGRTLAALTLDL 273
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
L G+ + H +RI+HRD+K N+L+D + KI DFG+A+ +
Sbjct: 108 LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SE 163
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+ T V+GT Y +PE A +D++S GI+L E++ G+
Sbjct: 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
++ +GL YL + +I+HRD+K N+L++ K+ DFG++ ++ N+
Sbjct: 135 KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS- 189
Query: 479 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
VGT YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 190 -FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 4e-22
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 29/168 (17%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
+ +HQ I+H DLK N L+ D K+ DFG+A D T VG Y
Sbjct: 167 AVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 487 MAPE-----------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHA 535
M PE S + S KSDV+S G +L + GK F + N+++
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQIS----- 275
Query: 536 WKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583
KL P+ I+ +L +V++C C+++ P R +P
Sbjct: 276 -KLHAIIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 316
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 4/107 (3%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
+ + +I + L + H + IIHRD+K N+++ K+ DFG+AR
Sbjct: 113 MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 472 E-TEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+ T V+GT Y++PE A +SDV+S G +L E+++G+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 41/107 (38%), Positives = 56/107 (52%), Gaps = 17/107 (15%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG----LARTFGGDETE 474
+I T + L +L L+IIHRD+K N+LLD+ N K+ DFG L +
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA----- 181
Query: 475 GNTTRVVGTYGYMAPE----YASDGQFSVKSDVFSFGILLLEIVSGK 517
TR G YMAPE AS + V+SDV+S GI L E+ +G+
Sbjct: 182 --KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 7e-22
Identities = 21/135 (15%), Positives = 38/135 (28%), Gaps = 9/135 (6%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
+P +L K L R ++ R L LH ++H L+
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPV 240
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE-----YASDGQFSVKSD 502
+++LDQ ++ F G R A + D
Sbjct: 241 DIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
Query: 503 VFSFGILLLEIVSGK 517
++ G+ + I
Sbjct: 300 TWTLGLAIYWIWCAD 314
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 68/236 (28%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+ G L D +++ + LD R LL +S + IC +G+ YL
Sbjct: 108 LPSGCLRD-----------FLQRHRARLDASR--LLLYSSQ---IC---KGMEYLGS--- 145
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAPEY 491
R +HRDL A N+L++ + + KI+DFGLA+ D+ VV G + APE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSPIFWYAPES 201
Query: 492 ASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDP 550
SD FS +SDV+SFG++L E+ + K+ + +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSAEFLRMMG 242
Query: 551 CYQESCNLTEVIRCI-----------------HISLLCVQQHPDDRPCMPSVILML 589
C ++ L+ ++ + + LC P DRP ++ L
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 33/148 (22%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
M FG L+D Y+R + + LL+W I +G+ YL
Sbjct: 98 MPFGCLLD-----------YVREHKDNIGSQY--LLNWC---VQIA---KGMNYL---ED 135
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAPEY 491
R++HRDL A NVL+ + KI+DFGLA+ G +E E + G +MA E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALES 190
Query: 492 ASDGQFSVKSDVFSFGILLLEIVS-GKK 518
++ +SDV+S+G+ + E+++ G K
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
+ +HQ I+H DLK N L+ D K+ DFG+A D T VGT Y
Sbjct: 120 AVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 487 MAPE-----------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHA 535
M PE S + S KSDV+S G +L + GK F + N+++
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS----- 228
Query: 536 WKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583
KL P+ I+ +L +V++C C+++ P R +P
Sbjct: 229 -KLHAIIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
+ +HQ I+H DLK N L+ D K+ DFG+A D T VGT Y
Sbjct: 139 AVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194
Query: 487 MAPE-----------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHA 535
M PE S + S KSDV+S G +L + GK F + N+++
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS----- 247
Query: 536 WKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583
KL P+ I+ +L +V++C C+++ P R +P
Sbjct: 248 -KLHAIIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 16/109 (14%)
Query: 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469
KL+D+S G+ ++ + IHRDL+A N+L+ + KI+DFGLAR
Sbjct: 285 KLIDFS------AQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335
Query: 470 GDETEGNTTRVVGT---YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+E T G + APE + G F++KSDV+SFGILL+EIV+
Sbjct: 336 DNE----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 49/226 (21%), Positives = 82/226 (36%), Gaps = 65/226 (28%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+ +G L D Y++ +D + LL ++ + IC +G+ YL
Sbjct: 126 LPYGSLRD-----------YLQKHKERIDHIK--LLQYTSQ---IC---KGMEYL---GT 163
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAPEY 491
R IHRDL N+L++ + KI DFGL + D+ V G + APE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEPGESPIFWYAPES 219
Query: 492 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPC 551
++ +FSV SDV+SFG++L E+ + + + + M
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQMIVF----- 270
Query: 552 YQESCNLTEVIRCI-----------------HISLLCVQQHPDDRP 580
+I + I C + + RP
Sbjct: 271 --------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 31/144 (21%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+ +G L D Y++ +D + LL ++ + IC +G+ YL
Sbjct: 95 LPYGSLRD-----------YLQKHKERIDHIK--LLQYTSQ---IC---KGMEYL---GT 132
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAPEY 491
R IHRDL N+L++ + KI DFGL + D+ V G + APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEPGESPIFWYAPES 188
Query: 492 ASDGQFSVKSDVFSFGILLLEIVS 515
++ +FSV SDV+SFG++L E+ +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 38/93 (40%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT-- 483
G+ ++ IHRDL+A N+L+ ++ KI+DFGLAR +E T G
Sbjct: 120 EGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKF 172
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE + G F++KSDV+SFGILL EIV+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 41/227 (18%), Positives = 81/227 (35%), Gaps = 68/227 (29%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+ G L + Y+ + ++++ ++ L ++ + IC +G+ YL
Sbjct: 107 LPSGSLKE-----------YLPKNKNKINLKQ--QLKYAVQ---IC---KGMDYL---GS 144
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAPEY 491
+ +HRDL A NVL++ + KI DFGL + D+ V + APE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY----YTVKDDRDSPVFWYAPEC 200
Query: 492 ASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDP 550
+F + SDV+SFG+ L E+++ + + +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSD-------------------SSPMALFLKMIG 241
Query: 551 CYQESCNLTEVIRCI-----------------HISLLCVQQHPDDRP 580
+T ++ + + C + P +R
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT 288
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 35/144 (24%), Positives = 66/144 (45%), Gaps = 32/144 (22%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+ G L+D ++R L + LL+W + I +G+ YL
Sbjct: 96 LPLGSLLD-----------HVRQHRGALGPQL--LLNWGVQ---IA---KGMYYL---EE 133
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAPEY 491
++HR+L A NVLL +++DFG+A D+ + + +MA E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALES 188
Query: 492 ASDGQFSVKSDVFSFGILLLEIVS 515
G+++ +SDV+S+G+ + E+++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 18/108 (16%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG----LARTFGGDETE 474
++ + L YL + +IHRD+K N+LLD+ K+ DFG L
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---- 181
Query: 475 GNTTRVVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 517
R G YMAPE + + +++DV+S GI L+E+ +G+
Sbjct: 182 ---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 41/111 (36%), Positives = 56/111 (50%), Gaps = 18/111 (16%)
Query: 410 KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFG 469
+LL ++++ IC G+ YLH IHRDL A NVLLD D KI DFGLA+
Sbjct: 135 QLLLFAQQ---IC---EGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 470 GDETEGNTTRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
V G + APE + +F SDV+SFG+ L E+++
Sbjct: 186 EGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ YL + + +HRDL A N +LD+ K++DFGLAR D + V
Sbjct: 135 RGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQQHRH 187
Query: 486 ------YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ A E +F+ KSDV+SFG+LL E+++
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 45/236 (19%), Positives = 80/236 (33%), Gaps = 47/236 (19%)
Query: 390 DGGQDLYIRM---SASELDQERCKLLDWSKRF------RIICGTGRGLLYLHQDSRLRII 440
+ ++ + L E +L D ++ G RGL +H
Sbjct: 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYA 156
Query: 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV-------GTYGYMAPE--- 490
HRDLK N+LL + P + D G + T Y APE
Sbjct: 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 491 ---YASDGQFSVKSDVFSFGILLLEIVSGKK--NRGFYHLDNKLNLIGHAWKLWNKGMPS 545
+ + ++DV+S G +L ++ G+ + F D+ + + + P
Sbjct: 217 VQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI-----P- 267
Query: 546 EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPKQP 601
P + S L +++ + P RP +P ++ L + P P Q
Sbjct: 268 --QSPRH--SSALWQLLNS------MMTVDPHQRPHIPLLLSQL-EALQPPAPGQH 312
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ YL + + +HRDL A N +LD+ K++DFGLAR D + V G
Sbjct: 139 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTG 191
Query: 486 ------YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E +F+ KSDV+SFG+LL E+++
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 404 LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG 463
L E K L + + G+ Y+ R+ +HRDL+A N+L+ +++ K++DFG
Sbjct: 269 LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFG 325
Query: 464 LARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523
LAR +E + APE A G+F++KSDV+SFGILL E+ + K +
Sbjct: 326 LARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-KGRVPYP 383
Query: 524 HLDNK--LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC 581
+ N+ L+ + +++ P E + + + C ++ P++RP
Sbjct: 384 GMVNREVLDQVERGYRM---PCPPECPESLHD-------------LMCQCWRKEPEERPT 427
Query: 582 MPSVILMLGSEIVLPQP 598
+ L +P
Sbjct: 428 FEYLQAFLEDYFTSTEP 444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 36/95 (37%), Positives = 46/95 (48%), Gaps = 14/95 (14%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG- 485
G+ YL +HRDL A NVLL KISDFGL++ DE
Sbjct: 129 GMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HG 180
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE + +FS KSDV+SFG+L+ E S
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 33/142 (23%), Positives = 62/142 (43%), Gaps = 29/142 (20%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+G+L Y+ + + L L+ +S + IC + + YL
Sbjct: 94 YPYGELGH-----------YLERNKNSLKVLT--LVLYSLQ---IC---KAMAYL---ES 131
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT---YGYMAPEYAS 493
+ +HRD+ N+L+ K+ DFGL+R ++ + T +M+PE +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YKASVTRLPIKWMSPESIN 187
Query: 494 DGQFSVKSDVFSFGILLLEIVS 515
+F+ SDV+ F + + EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 45/142 (31%), Positives = 63/142 (44%), Gaps = 29/142 (20%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
M G L D Y+R E LL +C G+ YL
Sbjct: 85 MEHGCLSD-----------YLRTQRGLFAAE--TLLGMCLD---VC---EGMAYL---EE 122
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT---YGYMAPEYAS 493
+IHRDL A N L+ ++ K+SDFG+ R D+ T GT + +PE S
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY----TSSTGTKFPVKWASPEVFS 178
Query: 494 DGQFSVKSDVFSFGILLLEIVS 515
++S KSDV+SFG+L+ E+ S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 33/123 (26%), Positives = 48/123 (39%), Gaps = 16/123 (13%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
+R L ++ + + G+ YL R IHRDL A N+LL
Sbjct: 110 RLRKHQGHFLLGT--LSRYAVQ---VA---EGMGYL---ESKRFIHRDLAARNLLLATRD 158
Query: 456 NPKISDFGLARTFGGDETEGNTTRVVGT---YGYMAPEYASDGQFSVKSDVFSFGILLLE 512
KI DFGL R ++ + + APE FS SD + FG+ L E
Sbjct: 159 LVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 216
Query: 513 IVS 515
+ +
Sbjct: 217 MFT 219
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR D + + T G
Sbjct: 168 RGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK-KTTNG 219
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 33/145 (22%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
M G L ++R + + L+ + + G+ YL S
Sbjct: 132 MENGSLDT-----------FLRTHDGQFTIMQ--LVGMLRG---VG---AGMRYL---SD 169
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG------YMAPE 490
L +HRDL A NVL+D ++ K+SDFGL+R D TT G + APE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPE 224
Query: 491 YASDGQFSVKSDVFSFGILLLEIVS 515
+ FS SDV+SFG+++ E+++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 32/144 (22%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
M FG L+D Y+R + + LL+W I +G+ YL
Sbjct: 98 MPFGCLLD-----------YVREHKDNIGSQY--LLNWC---VQIA---KGMNYL---ED 135
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAPEY 491
R++HRDL A NVL+ + KI+DFGLA+ G +E E + G +MA E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALES 190
Query: 492 ASDGQFSVKSDVFSFGILLLEIVS 515
++ +SDV+S+G+ + E+++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 12/92 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ YL +HRDL A NVL+ +D K+SDFGL + E ++T+ G
Sbjct: 300 EAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLP 349
Query: 486 Y--MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
APE + +FS KSDV+SFGILL EI S
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 36/145 (24%), Positives = 58/145 (40%), Gaps = 33/145 (22%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
G L ++ E+ + + + + G+ YL
Sbjct: 91 AGGGPLHK-----------FLVGKREEIPVSN--VAELLHQ---VS---MGMKYL---EE 128
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG------YMAPE 490
+HRDL A NVLL KISDFGL++ G D++ + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPE 183
Query: 491 YASDGQFSVKSDVFSFGILLLEIVS 515
+ +FS +SDV+S+G+ + E +S
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 48/132 (36%), Positives = 74/132 (56%), Gaps = 11/132 (8%)
Query: 392 GQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445
DL+I M S S++ + R K L + I+ T +GL YLH R IHRD+K
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIK 152
Query: 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFS 505
AGN+LL+ + + K++DFG+A + NT V+GT +MAPE + ++ +D++S
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWS 210
Query: 506 FGILLLEIVSGK 517
GI +E+ GK
Sbjct: 211 LGITAIEMAEGK 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-20
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT-- 483
G+ +L + IHRDL A N L+D+D+ K+SDFG+ R D+ VGT
Sbjct: 115 EGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----VSSVGTKF 167
Query: 484 -YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE ++S KSDV++FGIL+ E+ S
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGT--- 483
+ YL + +HRDL A N L++ K+SDFGL+R DE T VG+
Sbjct: 132 AMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSVGSKFP 184
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ PE +FS KSD+++FG+L+ EI S
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G++YL + +HRDL N L+ ++ KI DFG++R D + RV G +
Sbjct: 144 SGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV-GGHT 195
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+M PE +F+ +SDV+SFG++L EI +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 4e-20
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 404 LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG 463
L E K L + + G+ Y+ R+ +HRDL+A N+L+ +++ K++DFG
Sbjct: 352 LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFG 408
Query: 464 LARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523
LAR +E + APE A G+F++KSDV+SFGILL E+ + K +
Sbjct: 409 LARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-KGRVPYP 466
Query: 524 HLDNK--LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC 581
+ N+ L+ + +++ P E + + + C ++ P++RP
Sbjct: 467 GMVNREVLDQVERGYRM---PCPPECPESLHD-------------LMCQCWRKEPEERPT 510
Query: 582 MPSVILMLGSEIVLPQP 598
+ L +P
Sbjct: 511 FEYLQAFLEDYFTSTEP 527
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ YL + IHRDL A N L+ ++ K++DFGL+R GD T +
Sbjct: 122 SAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFP 175
Query: 486 Y--MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
APE + +FS+KSDV++FG+LL EI +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDE-TEGNTTRVVGTY 484
+ YL + IHR+L A N L+ ++ K++DFGL+R GD T +
Sbjct: 329 SAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PI 383
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE + +FS+KSDV++FG+LL EI +
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 36/95 (37%), Positives = 57/95 (60%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ YL + ++++HRDL A N+L+ + KISDFGL+R D E ++ + G
Sbjct: 161 QGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEEDSYV-KRSQG 212
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E D ++ +SDV+SFG+LL EIV+
Sbjct: 213 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 23/146 (15%)
Query: 377 MWFGDLID--MRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQD 434
+GDL++ R D ++ S LL +S + + +G+ +L
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD--LLHFSSQ---VA---QGMAFL--- 180
Query: 435 SRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG-----YMAP 489
+ IHRD+ A NVLL KI DFGLAR D + V +MAP
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIV-KGNARLPVKWMAP 235
Query: 490 EYASDGQFSVKSDVFSFGILLLEIVS 515
E D ++V+SDV+S+GILL EI S
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 25/141 (17%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
M G L ++R E + L+ G G+ YL +
Sbjct: 128 MENGALDK-----------FLREKDGEFSVLQ--LVGML------RGIAAGMKYL---AN 165
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY--MAPEYASD 494
+ +HRDL A N+L++ ++ K+SDFGL+R D+ E T G APE S
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 495 GQFSVKSDVFSFGILLLEIVS 515
+F+ SDV+SFGI++ E+++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR D + + T G
Sbjct: 214 RGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK-KTTNG 265
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ +L + IHRDL A N+LL KI DFGLAR D + V
Sbjct: 156 KGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYV-VKGNA 207
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE + ++ +SDV+S+GI L E+ S
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ +L + + IHRDL A N+LL + KI DFGLAR D +
Sbjct: 159 KGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV-RKGDA 210
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++++SDV+SFG+LL EI S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 40/95 (42%), Positives = 55/95 (57%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ YL + + IHRDL A NVL+ +D KI+DFGLAR D + + T G
Sbjct: 202 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK-KTTNG 253
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G++YL + L +HRDL N L+ Q + KI DFG++R D + RV G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRV-GGRT 220
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+M PE +F+ +SDV+SFG++L EI +
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ YL S +HRDL A N +L DM ++DFGL++ G+ R G
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYR-QGRIA 209
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
++A E +D ++ KSDV++FG+ + EI +
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 35/141 (24%), Positives = 59/141 (41%), Gaps = 27/141 (19%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
G+L ++++ LD L+ ++ + + L YL
Sbjct: 97 CTLGELRS-----------FLQVRKYSLDLA--SLILYAYQ---LS---TALAYL---ES 134
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY--GYMAPEYASD 494
R +HRD+ A NVL+ + K+ DFGL+R G +MAPE +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINF 191
Query: 495 GQFSVKSDVFSFGILLLEIVS 515
+F+ SDV+ FG+ + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEILM 212
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ +L +HRDL A NVL+ KI DFGLAR D + V
Sbjct: 183 KGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYV-VRGNA 234
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE +G +++KSDV+S+GILL EI S
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 20/96 (20%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ YL +HRDL A NVL+ +D K+SDFGL + + +
Sbjct: 128 EAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDT 173
Query: 486 ------YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ APE + +FS KSDV+SFGILL EI S
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ YL + + +HRDL A N ++ +D KI DFG+ R D E + R G G
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRK-GGKG 200
Query: 486 Y-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
M+PE DG F+ SDV+SFG++L EI +
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 16/95 (16%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R G + V T G
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVY------VKKTMG 201
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E + ++ SDV+S+G+LL EIVS
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 37/91 (40%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G YLH+ R+IHRDLK GN+ L++D+ KI DFGLA D GT Y
Sbjct: 153 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNY 207
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+APE S S + DV+S G ++ ++ GK
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G YLH R R+IHRDLK GN+ L++D+ KI DFGLA D GT Y
Sbjct: 127 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNY 181
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+APE S S + DV+S G ++ ++ GK
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 22/141 (15%), Positives = 44/141 (31%), Gaps = 20/141 (14%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
+P +L K L R ++ R L LH ++H L+
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPV 235
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----------GQ 496
+++LDQ ++ F +G + G+ PE +
Sbjct: 236 DIVLDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 497 FSVKSDVFSFGILLLEIVSGK 517
+ D ++ G+++ I
Sbjct: 290 MTFSFDAWALGLVIYWIWCAD 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ YL S IHRDL A N +L +DM ++DFGL+R G+ R G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQ-GCAS 199
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
++A E +D ++V SDV++FG+ + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ YL S + +HRDL N L+ ++M KI+DFGL+R + + +
Sbjct: 185 AGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYK-ADGND 236
Query: 486 Y-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
M PE +++ +SDV+++G++L EI S
Sbjct: 237 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+ YL S + +HRDL A N+L++ ++ K+SDFGL R D+ E T G
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPI 214
Query: 487 --MAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKG- 542
+PE + +F+ SDV+S+GI+L E++S G+ R ++ + N+ K ++G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQ-----DVIKAVDEGY 267
Query: 543 -MPSEMI--DPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPK 599
+P M YQ + L C Q+ ++RP ++ +L I P
Sbjct: 268 RLPPPMDCPAALYQ-------------LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL 314
Query: 600 QPGFLADRKSIGPDSLLSIPESSSSNSI 627
+ A + S + ++ +
Sbjct: 315 KIITSAAARPSNLLLDQSNVDITTFRTT 342
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ YL S ++H+DL NVL+ +N KISD GL R + + ++
Sbjct: 139 AGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL-LGNS 190
Query: 486 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE G+FS+ SD++S+G++L E+ S
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 420 IIC-GTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
I +GL YLH + + IHRD+KA NVLL + K++DFG+A + + NT
Sbjct: 123 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT- 178
Query: 479 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
VGT +MAPE + K+D++S GI +E+ G+
Sbjct: 179 -FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ +L + + +HRDL A N +LD+ K++DFGLAR D + V G
Sbjct: 203 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTG 255
Query: 486 ------YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MA E +F+ KSDV+SFG+LL E+++
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 21/156 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLD-QDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
+GL +LH + IIHRDLK N+ + + KI D GLA + V+GT
Sbjct: 140 KGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTP 194
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMP 544
+MAPE + + DV++FG+ +LE+ + + + N + ++ G+
Sbjct: 195 EFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE--YPYSECQNAAQI----YRRVTSGVK 247
Query: 545 SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
D + E+I C++Q+ D+R
Sbjct: 248 PASFDK--VAIPEVKEIIE------GCIRQNKDERY 275
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 25/195 (12%), Positives = 44/195 (22%), Gaps = 18/195 (9%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
P DL + S + + R L ++H
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPD 223
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY--ASDGQFSVKSDVFS 505
N+ + D + D G Y E+ AS F+ + +
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 506 FGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCI 565
G+ + + F + + L G S C + +I
Sbjct: 279 LGLSIYRVWCLF--LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR- 335
Query: 566 HISLLCVQQHPDDRP 580
L R
Sbjct: 336 ---FLNF--DRRRRL 345
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 4e-19
Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465
+ + + S ++ G+ YL +HR+L A NVLL KISDFGL+
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 466 RTFGGDETEGNTTRVVGTYGY--MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+ G D++ T R G + APE + +FS +SDV+S+G+ + E +S
Sbjct: 484 KALGADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 32/99 (32%), Positives = 60/99 (60%), Gaps = 6/99 (6%)
Query: 420 IIC-GTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
+C + L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 175
Query: 479 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+VGT +MAPE + + K D++S GI+ +E++ G+
Sbjct: 176 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTR---VV 481
GL YLH RI+H D+KA NVLL D + + DFG A D + +
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 482 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
GT +MAPE K D++S ++L +++G
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 5/91 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
G+LYLH I+HRDL N+LL ++MN KI+DFGLA + T GT Y
Sbjct: 124 GMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNY 178
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
++PE A+ ++SDV+S G + ++ G+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ L YLH +IHRD+K+ ++LL D K+SDFG D + + +VGT
Sbjct: 152 QALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPY 206
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+MAPE S ++ + D++S GI+++E+V G+
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 46/135 (34%), Positives = 64/135 (47%), Gaps = 19/135 (14%)
Query: 392 GQDLYIRM-----SASELDQERCKLLDWSKRFRIIC-GTGRGLLYLHQDSRLRIIHRDLK 445
++ M SAS+L + K L + G +GL YLH +IHRD+K
Sbjct: 126 EHTAWLVMEYCLGSASDLLEVHKKPLQ-EVEIAAVTHGALQGLAYLHSH---NMIHRDVK 181
Query: 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE---YASDGQFSVKSD 502
AGN+LL + K+ DFG A N+ VGT +MAPE +GQ+ K D
Sbjct: 182 AGNILLSEPGLVKLGDFGSASIM----APANS--FVGTPYWMAPEVILAMDEGQYDGKVD 235
Query: 503 VFSFGILLLEIVSGK 517
V+S GI +E+ K
Sbjct: 236 VWSLGITCIELAERK 250
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 9e-19
Identities = 31/99 (31%), Positives = 45/99 (45%), Gaps = 12/99 (12%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLL-----DQDMNPKISDFGLARTFGGDETE-GNTTRV 480
GL +LH L I+HRDLK N+L+ + ISDFGL + + V
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 481 VGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSG 516
GT G++APE + D+FS G + ++S
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 36/98 (36%), Positives = 44/98 (44%), Gaps = 16/98 (16%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLD---QDMNPKISDFGLARTFGGDETEGNTTRVVG 482
G YL IHRD+ A N LL KI DFG+AR D + R G
Sbjct: 151 CGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK-G 202
Query: 483 TYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
M PE +G F+ K+D +SFG+LL EI S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+G+ +L + + IHRDL A N+LL + KI DFGLAR D
Sbjct: 204 KGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515
+MAPE D ++++SDV+SFG+LL EI S
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 36/98 (36%), Positives = 43/98 (43%), Gaps = 16/98 (16%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLD---QDMNPKISDFGLARTFGGDETEGNTTRVVG 482
G YL IHRD+ A N LL KI DFG+AR D R G
Sbjct: 192 CGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRK-G 243
Query: 483 TYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 515
M PE +G F+ K+D +SFG+LL EI S
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 37/94 (39%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLD---QDMNPKISDFGLARTFGGDETEGNTTRVVGT 483
L YLH+ RIIHRDLK N++L Q + KI D G A+ E T VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGT 186
Query: 484 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE +++V D +SFG L E ++G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDM-NPKISDFGLARTFGGDETEGNTTRVVGTY 484
GL YLH + +I+HRD+K NVL++ KISDFG ++ G T GT
Sbjct: 133 EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTL 187
Query: 485 GYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527
YMAPE + +D++S G ++E+ +GK FY L
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFYELGE 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
GL ++H +++RDLK N+LLD+ + +ISD GLA F + VGT+GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 487 MAPEYASDGQ---FSVKSDVFSFGILLLEIVSGK 517
MAPE G S D FS G +L +++ G
Sbjct: 357 MAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 34/195 (17%), Positives = 66/195 (33%), Gaps = 51/195 (26%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-------------------KISDFGLAR 466
RGL Y+H ++H D+K N+ + + P KI D G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 467 TFGGDETEGNTTRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525
+ E G ++A E + K+D+F+ + ++ + L
Sbjct: 183 RISSPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE------PL 230
Query: 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585
G W +G I S TE+++ + + P+ R PS
Sbjct: 231 PRN----GDQWHEIRQGRLPR-IPQVL--SQEFTELLK------VMIHPDPERR---PSA 274
Query: 586 ILMLGSEIVLPQPKQ 600
+ ++ ++L ++
Sbjct: 275 MALVKHSVLLSASRK 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 35/141 (24%), Positives = 57/141 (40%), Gaps = 27/141 (19%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
G+L ++++ LD L+ ++ L YL
Sbjct: 472 CTLGELRS-----------FLQVRKFSLDLAS--LILYAY------QLSTALAYL---ES 509
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTY--GYMAPEYASD 494
R +HRD+ A NVL+ + K+ DFGL+R G +MAPE +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINF 566
Query: 495 GQFSVKSDVFSFGILLLEIVS 515
+F+ SDV+ FG+ + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEILM 587
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 41/232 (17%), Positives = 79/232 (34%), Gaps = 74/232 (31%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+ FG L Y++ + + ++ L+ +K+ + + +L
Sbjct: 94 VKFGSLDT-----------YLKKNKNCINIL--WKLEVAKQ---LA---AAMHFL---EE 131
Query: 437 LRIIHRDLKAGNVLLDQDMNP--------KISDFGLARTFGGDETEGNTTRVVGTYGY-- 486
+IH ++ A N+LL ++ + K+SD G++ T +
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQER 180
Query: 487 ---MAPEYASDG-QFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK--LNLIGHAWKLW 539
+ PE + ++ +D +SFG L EI S G K LD++ L
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQRKLQFY------- 231
Query: 540 NKG--MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
+P+ + C+ PD RP ++I L
Sbjct: 232 EDRHQLPAPKAAELAN-------------LINNCMDYEPDHRPSFRAIIRDL 270
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 18/103 (17%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLL----DQDMNPKISDFGLARTFGGDETEGNTTRVVG 482
G+ +L + I+HR++K GN++ D K++DFG AR DE + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177
Query: 483 TYGYMAPE--------YASDGQFSVKSDVFSFGILLLEIVSGK 517
T Y+ P+ ++ D++S G+ +G
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 13/106 (12%)
Query: 416 KRFR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE 474
F+ +I G + YLH +IIHRD+K N+L+ +D + KI+DFG++ F G +
Sbjct: 141 FYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIVSGK 517
+ T VGT +MAPE S+ + DV++ G+ L V G+
Sbjct: 194 LSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 392 GQDLYIRM------SASELDQERCKLLDWSKRFRIIC-GTGRGLLYLHQDSRLRIIHRDL 444
L+I + + + E + L + +++C L +LH RIIHRDL
Sbjct: 88 DGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVVCRQMLEALNFLHSK---RIIHRDL 143
Query: 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE-----YASDGQFSV 499
KAGNVL+ + + +++DFG++ + ++ +GT +MAPE D +
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 500 KSDVFSFGILLLEIVSGK 517
K+D++S GI L+E+ +
Sbjct: 202 KADIWSLGITLIEMAQIE 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 18/103 (17%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLL----DQDMNPKISDFGLARTFGGDETEGNTTRVVG 482
G+ +L + I+HR++K GN++ D K++DFG AR DE + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177
Query: 483 TYGYMAPE--------YASDGQFSVKSDVFSFGILLLEIVSGK 517
T Y+ P+ ++ D++S G+ +G
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 28/127 (22%), Positives = 56/127 (44%), Gaps = 15/127 (11%)
Query: 396 YIRMSASELDQERCKLLDWSKR--FR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452
+ C + + + ++ Y+H + I HRD+K N+L+D
Sbjct: 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNS----FSYIH--NEKNICHRDVKPSNILMD 186
Query: 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE-YASDGQFS-VKSDVFSFGILL 510
++ K+SDFG + + + + GTY +M PE ++++ ++ K D++S GI L
Sbjct: 187 KNGRVKLSDFGESEYMVDKKIK--GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
Query: 511 LEIVSGK 517
+
Sbjct: 243 YVMFYNV 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 11/104 (10%)
Query: 420 IIC-GTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
IC RGL +LHQ ++IHRD+K NVLL ++ K+ DFG++ NT
Sbjct: 133 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 188
Query: 479 RVVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 517
+GT +MAPE D + KSD++S GI +E+ G
Sbjct: 189 -FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 30/92 (32%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV-GTYG 485
L Y H R+IHRD+K N+LL KI+DFG + + + GT
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTDLCGTLD 172
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+ PE K D++S G+L E + GK
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L YLH IIHRDLK N+LL++DM+ +I+DFG A+ + + VGT Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+PE ++ SD+++ G ++ ++V+G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 48/219 (21%), Positives = 77/219 (35%), Gaps = 39/219 (17%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTF---------- 468
+I T R + ++H+ + IIHRDLK N+LL K+ DFG A T
Sbjct: 140 KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 469 -GGDETEGNTTRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
E TR T Y PE S+ K D+++ G +L + + +
Sbjct: 199 QRRALVEEEITR-NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ---HPFE 254
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584
KL ++ G S +IR +Q +P++R +
Sbjct: 255 DGAKLRIV--------NGKYSIPPHDTQ--YTVFHSLIRA------MLQVNPEERLSIAE 298
Query: 585 VI----LMLGSEIVLPQPKQPGFLADRKSIGPDSLLSIP 619
V+ + + V P+ L G +L P
Sbjct: 299 VVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 59/271 (21%), Positives = 96/271 (35%), Gaps = 63/271 (23%)
Query: 393 QDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452
QDL + S+ + + K + R I G+ +LH L+IIHRDLK N+L+
Sbjct: 96 QDLVESKNVSDENLKLQKEYNPISLLRQIA---SGVAHLHS---LKIIHRDLKPQNILVS 149
Query: 453 -------------QDMNPKISDFGLARTFGGDETEGNTTR--VVGTYGYMAPE------- 490
+++ ISDFGL + ++ T GT G+ APE
Sbjct: 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN 209
Query: 491 YASDGQFSVKSDVFSFGILLLEIVSG-------KKNRGFYHLDNKLNLIGHAWKLWNKGM 543
+ + + D+FS G + I+S K +R + +L +
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLI 269
Query: 544 PSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPKQPGF 603
E+ +L I ++ P RP V L + P+ K+ F
Sbjct: 270 A---------EATDL---IS----QMIDHD--PLKRPTAMKV---LRHPLFWPKSKKLEF 308
Query: 604 LAD-------RKSIGPDSLLSIPESSSSNSI 627
L P +LL ++ S I
Sbjct: 309 LLKVSDRLEIENRDPPSALLMKFDAGSDFVI 339
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
I+ G L +LHQ II+RDLK NVLLD D N +ISD GLA +T+
Sbjct: 298 IVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-- 348
Query: 480 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
GT G+MAPE ++ D F+ G+ L E+++ +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 38/97 (39%), Positives = 55/97 (56%), Gaps = 9/97 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG----LARTFGGDETEGNTTRVV 481
GL YLH++ IHRD+KAGN+LL +D + +I+DFG LA + T V
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-FV 187
Query: 482 GTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
GT +MAPE + K+D++SFGI +E+ +G
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 10/105 (9%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT-- 477
I+ G + L Y+H +HR +KA ++L+ D +S +
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 478 ---TRVVGTYGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 517
V +++PE + + KSD++S GI E+ +G
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 420 IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR 479
I CG L LH R RI++RDLK N+LLD + +ISD GLA +T
Sbjct: 295 ICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKG 344
Query: 480 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
VGT GYMAPE + +++ D ++ G LL E+++G+
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 27/92 (29%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV-GTYG 485
L Y H ++IHRD+K N+L+ KI+DFG + R + GT
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV-----HAPSLRRRTMCGTLD 177
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+ PE K D++ G+L E + G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 15/104 (14%)
Query: 418 FR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN 476
F ++ G YLH + I HRD+K N+LLD+ N KISDFGLA F + E
Sbjct: 111 FHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 477 TTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSG 516
++ GT Y+APE + DV+S GI+L +++G
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAG 204
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 32/106 (30%), Positives = 46/106 (43%), Gaps = 16/106 (15%)
Query: 418 FR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN 476
F +I G L YLH I+H+D+K GN+LL KIS G+A +
Sbjct: 115 FCQLIDG----LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 477 TTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGK 517
G+ + PE A+ G K D++S G+ L I +G
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 12/106 (11%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL--DQDMNPKISDFGLARTFGGDETEG 475
R I L YLH I HRD+K N L ++ K+ DFGL++ F
Sbjct: 174 MRQIFS---ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE 227
Query: 476 NT--TRVVGTYGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 517
T GT ++APE ++ + K D +S G+LL ++ G
Sbjct: 228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 15/104 (14%)
Query: 418 FR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN 476
F ++ G YLH + I HRD+K N+LLD+ N KISDFGLA F + E
Sbjct: 111 FHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 477 TTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSG 516
++ GT Y+APE + DV+S GI+L +++G
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAG 204
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 31/107 (28%), Positives = 45/107 (42%), Gaps = 18/107 (16%)
Query: 415 SKRFR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET 473
S FR ++ G YL IIHRD+K N+++ +D K+ DFG A E
Sbjct: 133 SYIFRQLVSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ER 182
Query: 474 EGNTTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSG 516
GT Y APE G + +++S G+ L +V
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFE 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 41/107 (38%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 416 KRFR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE 474
+FR I+ Y H + RI+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 118 SKFRQIVSAVQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170
Query: 475 GNTTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSGK 517
+ G Y APE DG + DV+S G++L +VSG
Sbjct: 171 -DAF--CGAPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGS 211
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 15/107 (14%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L YL RIIHRD+K N+LLD+ + I+DF +A + T + GT Y
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPY 180
Query: 487 MAPE-YASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
MAPE ++S F+V D +S G+ E++ G+ R ++ +
Sbjct: 181 MAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR--RPYHIRSST 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT 477
R + + LH+ L I+HRDLK N+LLD DMN K++DFG + E
Sbjct: 130 MRALLE---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---L 180
Query: 478 TRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILL 510
V GT Y+APE + + + D++S G+++
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 19/103 (18%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT 477
R + + +LH I+HRDLK N+LLD +M ++SDFG + E
Sbjct: 206 MRSLLE---AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---L 256
Query: 478 TRVVGTYGYMAPE------YASDGQFSVKSDVFSFG----ILL 510
+ GT GY+APE + + + D+++ G LL
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 13/102 (12%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
R + G+ Y+H+ +I+HRDLK N+LL +D N +I DFGL+ F +
Sbjct: 132 IRQVLS---GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK- 184
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
+GT Y+APE G + K DV+S G++L ++SG
Sbjct: 185 --MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 15/109 (13%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ + G+ YLH+ I+HRDLK N+LL ++D KI DFGL+ F +
Sbjct: 142 IKQVLS---GVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK- 194
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523
+GT Y+APE ++ K DV+S G++L +++G F
Sbjct: 195 --MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY--PPFG 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 10/140 (7%)
Query: 381 DLIDMRSFPDGGQDLYIRMSASELDQERC---KLLDWSKRFRIICGTGRGLLYLHQDSRL 437
++ + + QD+Y+ M + + + +L + ++ G+ +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHS---A 183
Query: 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF 497
IIHRDLK N+++ D KI DFGLART G T T V T Y APE +
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 498 SVKSDVFSFGILLLEIVSGK 517
D++S G ++ E+V K
Sbjct: 241 KENVDIWSVGCIMGEMVRHK 260
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 13/102 (12%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ I G+ YLH+ I+HRD+K N+LL + +N KI DFGL+ F D
Sbjct: 152 MKQILS---GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK- 204
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
+GT Y+APE +++ K DV+S G+++ ++ G
Sbjct: 205 --LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 13/102 (12%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ + G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F +
Sbjct: 127 IKQVFS---GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
+GT Y+APE G + K DV+S G++L ++SG
Sbjct: 180 --MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 22/135 (16%)
Query: 388 FPDGGQDL--YIRMSASELDQERCKLLDWSKRFR-IICGTGRGLLYLHQDSRLRIIHRDL 444
P+ QDL +I L +E + F ++ + + H ++HRD+
Sbjct: 129 RPEPVQDLFDFI-TERGALQEELAR-----SFFWQVLEA----VRHCH---NCGVLHRDI 175
Query: 445 KAGNVLLDQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSD 502
K N+L+D + K+ DFG + T GT Y PE+ ++ +
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 503 VFSFGILLLEIVSGK 517
V+S GILL ++V G
Sbjct: 232 VWSLGILLYDMVCGD 246
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 34/92 (36%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ +LH IIHRDLK N+++ D KI DFGLART T T V T
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRY 191
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + D++S G ++ E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 41/141 (29%), Positives = 70/141 (49%), Gaps = 13/141 (9%)
Query: 381 DLIDMRSFPDGGQDLYIRMSASELDQERC---KLLDWSKRFRIICGTGRGLLYLHQDSRL 437
D+ S D Y+ M + D ++ K + ++ ++ +GL Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-LVYQMLKGLKYIHSAG-- 146
Query: 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA-SDGQ 496
++HRDLK GN+ +++D KI DFGLAR + T TR + Y APE S
Sbjct: 147 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----W-YRAPEVILSWMH 200
Query: 497 FSVKSDVFSFGILLLEIVSGK 517
++ D++S G ++ E+++GK
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 36/134 (26%), Positives = 56/134 (41%), Gaps = 22/134 (16%)
Query: 388 FPDGGQDL--YIRMSASELDQERCKLLDWSKRFR-IICGTGRGLLYLHQDSRLRIIHRDL 444
P QDL YI L + + F ++ + + H ++HRD+
Sbjct: 119 RPLPAQDLFDYI-TEKGPLGEGPSR-----CFFGQVVAA----IQHCH---SRGVVHRDI 165
Query: 445 KAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSD 502
K N+L+D K+ DFG + T GT Y PE+ S Q+ + +
Sbjct: 166 KDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPPEWISRHQYHALPAT 221
Query: 503 VFSFGILLLEIVSG 516
V+S GILL ++V G
Sbjct: 222 VWSLGILLYDMVCG 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 18/100 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTY 484
R + LH S + + HRD+K NVL+++ K+ DFG A+ E N + Y
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRY 196
Query: 485 GYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE Y + D++S G + E++ G+
Sbjct: 197 -YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 17/100 (17%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ + + YLH+ I+HRDLK N+L +++ I+DFGL++
Sbjct: 112 IQQVLS---AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----N 161
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
G + GT GY+APE + +S D +S G ILL
Sbjct: 162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 17/100 (17%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ + + Y H+ L + HRDLK N L D K+ DFGLA F +
Sbjct: 112 MKDVLS---AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM- 164
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
VGT Y++P+ +G + + D +S G +LL
Sbjct: 165 --MRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLL 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 13/96 (13%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ + L Y H ++H+DLK N+L KI DFGLA F DE
Sbjct: 130 MKQMMN---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
+T GT YMAPE + K D++S G+++
Sbjct: 183 --STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ + G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F +
Sbjct: 127 IKQVFS---GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
+GT Y+APE G + K DV+S G ILL
Sbjct: 180 --MKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILL 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 13/97 (13%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL----DQDMNPKISDFGLARTFGGDET 473
+ I G+ YLH L+I H DLK N++L KI DFGLA
Sbjct: 120 LKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 474 EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
+ GT ++APE + +++D++S G++
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 39/99 (39%), Positives = 56/99 (56%), Gaps = 18/99 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RG+ + HQ RI+HRDLK N+L++ D K++DFGLAR F G T VV T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLW 184
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y AP+ Y++ SV D++S G + E+++GK
Sbjct: 185 YRAPDVLMGSKKYST----SV--DIWSIGCIFAEMITGK 217
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 15/99 (15%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
F + + YLH IIHRDLK NVLL ++D KI+DFG ++ G
Sbjct: 120 FYQMLL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 475 GNTTRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILL 510
+ GT Y+APE ++ D +S G++L
Sbjct: 173 --MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 30/96 (31%), Positives = 39/96 (40%), Gaps = 11/96 (11%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
R I L Y H IIHRD+K VLL + K+ FG+A G
Sbjct: 136 MRQILE---ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
VGT +MAPE + DV+ G++L
Sbjct: 190 AGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL-DQDMNP-KISDFGLARTFGGDETEGN 476
+ IC G+ ++HQ + I+H DLK N+L ++D KI DFGLAR + E
Sbjct: 194 KQICE---GIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244
Query: 477 TTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
GT ++APE + S +D++S G +LL
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y+H IIHRDLK N+ +++D KI DFGLAR + T TR
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 486 YMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + ++ D++S G ++ E+++G+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL Y+H IIHRDLK GN+ +++D KI DFGLAR + T TR
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 486 YMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + +++ D++S G ++ E+++GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 9e-14
Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 18/100 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL + H ++HRDLK N+L++++ K+++FGLAR F G + VV T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLW 166
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGKK 518
Y P+ Y++ S+ D++S G + E+ + +
Sbjct: 167 YRPPDVLFGAKLYST----SI--DMWSAGCIFAELANAGR 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 37/107 (34%), Positives = 53/107 (49%), Gaps = 18/107 (16%)
Query: 416 KRFR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE 474
+ F+ I+ Y H R ++HRDLK NVLLD MN KI+DFGL+ E
Sbjct: 115 RLFQQILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167
Query: 475 GNTTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSGK 517
T+ G+ Y APE S G + D++S G++L ++ G
Sbjct: 168 -RTS--CGSPNYAAPEVISGRLYAGP---EVDIWSCGVILYALLCGT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 26/94 (27%), Positives = 40/94 (42%), Gaps = 11/94 (11%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP--KISDFGLARTFGGDETEGN 476
R C GL ++H+ I+H D+K N++ + KI DFGLA DE
Sbjct: 156 RQACE---GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---I 206
Query: 477 TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
T + APE +D+++ G+L
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT-TRVVGTY 484
RGL Y+H S ++HRDLK N+LL+ + KI DFGLAR D T V T
Sbjct: 139 RGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 485 GYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + ++ D++S G +L E++S +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 17/101 (16%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL----DQDMNPKISDFGLARTFGGDET 473
+ I G+ YLH RI H DLK N++L + K+ DFG+A
Sbjct: 114 LKQILD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 474 EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
+ GT ++APE + +++D++S G ILL
Sbjct: 168 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL YLHQ I+HRDLK N+LLD++ K++DFGLA++F G T +VV T
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRW 177
Query: 486 YMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE + + + V D+++ G +L E++
Sbjct: 178 YRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 18/99 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+GL + H++ +I+HRDLK N+L+++ K+ DFGLAR F G ++ VV T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLW 173
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y AP+ Y++ S+ D++S G +L E+++GK
Sbjct: 174 YRAPDVLMGSRTYST----SI--DIWSCGCILAEMITGK 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 15/99 (15%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
F + + YLH+ IIHRDLK NVLL ++D KI+DFG ++ G
Sbjct: 245 FYQMLL---AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 297
Query: 475 GNTTRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILL 510
+ GT Y+APE ++ D +S G++L
Sbjct: 298 --MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
GL LH+ ++HRDL GN+LL + + I DF LAR D + N T V
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRW 198
Query: 486 YMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE F+ D++S G ++ E+ + K
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 20/102 (19%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN---TTRVVG 482
GL Y+H++ +I+HRD+KA NVL+ +D K++DFGLAR F + T RVV
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190
Query: 483 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
T Y PE Y D++ G ++ E+ +
Sbjct: 191 TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL +LH R++HRDLK N+L+ K++DFGLAR + T+ VV T
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV-TLW 184
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE ++ D++S G + E+ K
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ I G+ YLHQ I+H DLK N+LL + KI DFG++R G
Sbjct: 137 IKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
++GT Y+APE + + +D+++ GI+
Sbjct: 190 --LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 1e-13
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 18/99 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ Y H R++HRDLK N+L++++ KI+DFGLAR F G T +V T
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLW 165
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y AP+ Y++ ++ D++S G + E+V+G
Sbjct: 166 YRAPDVLMGSKKYST----TI--DIWSVGCIFAEMVNGT 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 33/100 (33%), Positives = 45/100 (45%), Gaps = 16/100 (16%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ I + YLH+ I+HRDLK N+L D KI+DFGL++
Sbjct: 154 VKQILE---AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
V GT GY APE + + D++S G ILL
Sbjct: 207 --MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 18/107 (16%)
Query: 416 KRFR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE 474
+ F+ IIC Y H R +I+HRDLK N+LLD ++N KI+DFGL+
Sbjct: 112 RFFQQIICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164
Query: 475 GNTTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSGK 517
T+ G+ Y APE + G + DV+S GI+L ++ G+
Sbjct: 165 -KTS--CGSPNYAAPEVINGKLYAGP---EVDVWSCGIVLYVMLVGR 205
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 19/103 (18%), Positives = 33/103 (32%), Gaps = 14/103 (13%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLL-----------DQDMNPKISDFGLARTFGGDETE 474
+ +H IIH D+K N +L D + D G +
Sbjct: 183 YMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
T T G+ E S+ ++ + D F + ++ G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 18/99 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL Y H+ +++HRDLK N+L+++ K++DFGLAR T+ VV T
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLW 165
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y P+ Y S + D++ G + E+ +G+
Sbjct: 166 YRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 20/100 (20%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTY 484
R L Y+H I HRD+K N+LLD D K+ DFG A+ E N + + Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY 221
Query: 485 GYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE Y + DV+S G +L E++ G+
Sbjct: 222 -YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
RGL +LH + I+HRDLK N+L+ K++DFGLAR + T VV T
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVV-TLW 184
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE ++ D++S G + E+ K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTY 484
R + ++H L I HRD+K N+L++ N K+ DFG A+ +E + + +
Sbjct: 152 RAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF 206
Query: 485 GYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE +++ D++S G + E++ GK
Sbjct: 207 -YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 13/97 (13%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP----KISDFGLARTFGGDET 473
+ I G+ YLH +I H DLK N++L P K+ DFGLA
Sbjct: 121 IKQILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 474 EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
+ GT ++APE + +++D++S G++
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 12/96 (12%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-KISDFGLARTFGGDETEGNTTRVVGTY 484
R L Y+H + I HRD+K N+LLD K+ DFG A+ E N + + Y
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY 206
Query: 485 GYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE A+ ++ D++S G ++ E++ G+
Sbjct: 207 -YRAPELIFGAT--NYTTNIDIWSTGCVMAELMQGQ 239
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 13/97 (13%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL----DQDMNPKISDFGLARTFGGDET 473
+ I G+ YLH +I H DLK N++L + K+ DFGLA
Sbjct: 121 IKQILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 474 EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
+ GT ++APE + +++D++S G++
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 416 KRFR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE 474
+ F+ I+ G Y H R ++HRDLK NVLLD MN KI+DFGL+ E
Sbjct: 120 RLFQQILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172
Query: 475 GNTTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSGK 517
T+ G+ Y APE S G + D++S G++L ++ G
Sbjct: 173 -RTS--CGSPNYAAPEVISGRLYAGP---EVDIWSSGVILYALLCGT 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 11/97 (11%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
+ +H+ L +HRD+K N+LLD+ + +++DFG D T + VGT Y
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229
Query: 487 MAPE-------YASDGQFSVKSDVFSFGILLLEIVSG 516
++PE G + + D ++ G+ E+ G
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 30/100 (30%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ I + Y H I+HR+LK N+LL + K++DFGLA E
Sbjct: 134 IQQILE---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
GT GY++PE +S D+++ G ILL
Sbjct: 187 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV-GTYG 485
L YLH S +++RDLK N++LD+D + KI+DFGL + +G T + GT
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKTFCGTPE 314
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE D + D + G+++ E++ G+
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 30/100 (30%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ I + Y H I+HR+LK N+LL + K++DFGLA E
Sbjct: 111 IQQILE---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
GT GY++PE +S D+++ G ILL
Sbjct: 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
+ +HQ L +HRD+K N+L+D + + +++DFG D T ++ VGT Y
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242
Query: 487 MAPE-----YASDGQFSVKSDVFSFGILLLEIVSG 516
++PE G++ + D +S G+ + E++ G
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 11/94 (11%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP--KISDFGLARTFGGDETEGN 476
+C L +LH I H D++ N++ + KI +FG AR +
Sbjct: 109 HQVCE---ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--- 159
Query: 477 TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
+ Y APE S +D++S G L+
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 18/99 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
+ + + H+ IHRD+K N+L+ + K+ DFG AR ++ V T
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRW 167
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y +PE Y V DV++ G + E++SG
Sbjct: 168 YRSPELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLD-QDMNPKISDFGLARTFGGDETEGNT-TRVVGT 483
RGL Y+H + ++HRDLK N+ ++ +D+ KI DFGLAR + + + T
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 484 YGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y +P S ++ D+++ G + E+++GK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 15/100 (15%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ I +L+ HQ + ++HR+LK N+LL + K++DFGLA G++
Sbjct: 116 IQQILE---AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 510
GT GY++PE + D+++ G ILL
Sbjct: 170 WFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 8/70 (11%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP----KISDFGLARTFGG-DETEGNTTRV 480
G+ YLH + ++HRDLK N+L+ + KI+D G AR F + + V
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 481 VGTYGYMAPE 490
V T+ Y APE
Sbjct: 196 VVTFWYRAPE 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 35/106 (33%), Positives = 51/106 (48%), Gaps = 20/106 (18%)
Query: 418 FR-IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD--MNPKISDFGLARTFGGDETE 474
F+ ++ G Y H ++I HRDLK N LLD KI DFG +++
Sbjct: 122 FQQLLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 475 GNTTRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSG 516
+T VGT Y+APE DG+ +DV+S G+ L ++ G
Sbjct: 175 -KST--VGTPAYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVG 214
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 11/94 (11%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP--KISDFGLARTFGGDETEGN 476
R +C GL ++H+ +H DLK N++ + K+ DFGL + +
Sbjct: 262 RQVCK---GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S 312
Query: 477 TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
GT + APE A +D++S G+L
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 33/99 (33%), Positives = 45/99 (45%), Gaps = 18/99 (18%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ + H IIHRD+K N+L+ Q K+ DFG ART E V T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRW 189
Query: 486 YMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE Y +V DV++ G L+ E+ G+
Sbjct: 190 YRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV-GTYG 485
L YLH +++RD+K N++LD+D + KI+DFGL + ++G T + GT
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPE 170
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE D + D + G+++ E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L +LH+ L II+RD+K N+LLD + + ++DFGL++ F DETE GT Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 487 MAPEYASDGQ----FSVKSDVFSFGILLLEIVSGK 517
MAP+ G +V D +S G+L+ E+++G
Sbjct: 227 MAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLD-QDMNPKISDFGLARTFGGDETEGNTTRVVGTY 484
+ L Y H S I+HRD+K NV++D + ++ D+GLA + RV Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY 195
Query: 485 GYMAPEYASDGQFSVKS-DVFSFGILLLEIVSGKK 518
+ PE D Q S D++S G +L ++ K+
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L +LH L II+RDLK N+LLD++ + K++DFGL++ E + + GT Y
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
MAPE + + +D +SFG+L+ E+++G
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNT-------- 477
R + LH + +IHRDLK N+L++ + + K+ DFGLAR + +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 478 TRVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 517
V T Y APE + ++S DV+S G +L E+ +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 13/99 (13%)
Query: 415 SKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGD 471
++ R I + +LH I HRD+K N+L ++D K++DFG A+
Sbjct: 131 AEIMRDIGT---AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--- 181
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
T+ T Y+APE ++ D++S G+++
Sbjct: 182 -TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L +LHQ II+RDLK N++L+ + K++DFGL + D T +T GT Y
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
MAPE + D +S G L+ ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 11/96 (11%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
R + + ++H + ++HRDLK N+L + ++ KI DFG AR D
Sbjct: 112 MRKLVS---AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
T T Y APE + + D++S G++L
Sbjct: 166 LKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L +H + IHRD+K N+LLD+ + K++DFG + T VGT Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYI 236
Query: 488 APE----YASDGQFSVKSDVFSFGILLLEIVSG 516
+PE DG + + D +S G+ L E++ G
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
L YLH+ II+RDLK NVLLD + + K++D+G+ + G+TT GT
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPN 175
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + D ++ G+L+ E+++G+
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
GL +L II+RDLK NV+LD + + KI+DFG+ + + +G TT+ GT
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCGTPD 186
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + + D ++FG+LL E+++G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV-GTYG 485
L YLH+ II+RDLK NVLLD + + K++D+G+ + G+TT GT
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPN 218
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + D ++ G+L+ E+++G+
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 12/97 (12%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL-DQDMNP---KISDFGLARTFGGDET 473
I + YLH ++HRDLK N+L D+ NP +I DFG A+ +
Sbjct: 122 LFTITK---TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 474 EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
T T ++APE + D++S G+LL
Sbjct: 176 LLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 32/104 (30%), Positives = 45/104 (43%), Gaps = 23/104 (22%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-----KISDFGLARTFGGDETEGNTTRV 480
G+ + H R +HRDLK N+LL KI DFGLAR F G T +
Sbjct: 143 NGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEI 198
Query: 481 VGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 517
+ T Y PE Y++ SV D++S + E++
Sbjct: 199 I-TLWYRPPEILLGSRHYST----SV--DIWSIACIWAEMLMKT 235
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
L++LH II+RDLK NVLLD + + K++DFG+ + G TT GT
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFCGTPD 189
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + + D ++ G+LL E++ G
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
L YLH L I++RDLK N+LLD + ++DFGL + + +TT GT
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCGTPE 204
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + D + G +L E++ G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 7/92 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVV-GTYG 485
GL +L II+RDLK NV+LD + + KI+DFG+ + + +G TT+ GT
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCGTPD 507
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y+APE + + D ++FG+LL E+++G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 24/71 (33%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G+ Y+H S I+HRDLK N L++QD + K+ DFGLART E + +
Sbjct: 167 VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 486 YMAPEYASDGQ 496
M +
Sbjct: 224 DMNLVTFPHTK 234
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 7/91 (7%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTR-VVGTYG 485
GL +LH I++RDLK N+LLD+D + KI+DFG+ + + T GT
Sbjct: 130 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCGTPD 183
Query: 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
Y+APE +++ D +SFG+LL E++ G
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 8/89 (8%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
YLH L +I+RDLK N+L+DQ +++DFG A+ +G T + GT +
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEAL 205
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVSG 516
APE ++ D ++ G+L+ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 30/106 (28%), Positives = 44/106 (41%), Gaps = 19/106 (17%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTF--GGDE 472
+ + L +LH I HRDLK N+L +Q KI DF L GD
Sbjct: 117 VQDVAS---ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 473 TEGNTTR---VVGTYGYMAPE-----YASDGQFSVKSDVFSFGILL 510
+ +T G+ YMAPE + + D++S G++L
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 23/71 (32%), Positives = 31/71 (43%), Gaps = 3/71 (4%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485
G ++H IIHRDLK N LL+QD + K+ DFGLART ++ +
Sbjct: 140 LGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 486 YMAPEYASDGQ 496
Q
Sbjct: 197 PGPHNKNLKKQ 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 12/96 (12%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLARTFGGDETE 474
+ I + YLH + I HRD+K N+L + K++DFG A+ +
Sbjct: 167 MKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 219
Query: 475 GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 510
T T Y+APE ++ D++S G+++
Sbjct: 220 --LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-11
Identities = 23/127 (18%), Positives = 48/127 (37%), Gaps = 20/127 (15%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
+++T+ + L G++L + + + Y + T VW +N L
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCNL------VLYDH---STSVWASNTGILGK 50
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETY 143
++ GN V+ +W+++ + VL L + GN+V+ G +
Sbjct: 51 KGC-KAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQEDGNVVIYG-------SD 101
Query: 144 FWQSFDY 150
W + Y
Sbjct: 102 IWSTGTY 108
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 8/90 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGY 486
L YLH II+RDLK N+LLD++ + KI+DFG A+ T + GT Y
Sbjct: 118 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDY 169
Query: 487 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
+APE S ++ D +SFGIL+ E+++G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 5e-11
Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 21/124 (16%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
+++ S QTL+ +L + G++ L + + + Y+N +W +N
Sbjct: 3 NVLLSGQTLHADHSLQA--GAYTLTIQNKCNL------VKYQN---GRQIWASNTDR--R 49
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETY 143
S L + GNLV+ +N VW + + L L G V+ G
Sbjct: 50 GSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD-NGKYALVLQKDGRFVIYGPV------- 101
Query: 144 FWQS 147
W
Sbjct: 102 LWSL 105
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 33/112 (29%), Positives = 54/112 (48%), Gaps = 23/112 (20%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRV----- 480
+ + YLH S ++HRD+K N+LL+ + + K++DFGL+R+F N +
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 481 --------------VGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 517
V T Y APE +++ D++S G +L EI+ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-10
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 20/124 (16%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
+ ++S +L G +L S+ L + + Y + VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASNTGG--L 49
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETY 143
S L ++ GNLV+ +SN V+W + + VL L N+V+ G
Sbjct: 50 GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGK-EDHYVLVLQQDRNVVIYGPV------- 101
Query: 144 FWQS 147
W +
Sbjct: 102 VWAT 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 3e-09
Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 19/124 (15%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
D + S L+ G +L G + + + + Y N VW +
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYDN---NRAVWASGTNG--K 48
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETY 143
S L + GNLV+ S S +W++ + L L N+V+ +S
Sbjct: 49 ASGCVLKMQNDGNLVIYSGSR-AIWASN-TNRQNGNYYLILQRDRNVVIY----DNSNNA 102
Query: 144 FWQS 147
W +
Sbjct: 103 IWAT 106
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 7e-09
Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 14/112 (12%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
+I+ S +TL+ G L +G + + + Y +W N
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV---DKPIWATNTGG--L 48
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGE 135
D L + GNLV+ S N +W++ E V L N+V+ G
Sbjct: 49 DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGE-NGNYVCVLQKDRNVVIYGT 99
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 13/97 (13%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP------KISDFGLARTFGGDETEGNTTRV 480
GL Y+H R IIH D+K NVL++ +P KI+D G A + + T
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEH----YTNS 195
Query: 481 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+ T Y +PE + +D++S L+ E+++G
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 25/123 (20%), Positives = 44/123 (35%), Gaps = 17/123 (13%)
Query: 21 FAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLN 80
+ + S QTL+ L K+G F+L N+ + W +N N
Sbjct: 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDC------------NLVLYNGNWQSNTAN 46
Query: 81 LINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDS 140
N L + G LV+ + VW + ++ V+ + G LV+ G
Sbjct: 47 --NGRDCKLTLTDYGELVIKNGDGSTVWKSG-AQSVKGNYAAVVHPDGRLVVFGPSVFKI 103
Query: 141 ETY 143
+ +
Sbjct: 104 DPW 106
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 24/114 (21%), Positives = 41/114 (35%), Gaps = 15/114 (13%)
Query: 19 FSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANR 78
F +++ S Q L L + + +L + + Y W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYGG----KYGWQSNT 49
Query: 79 LNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVL 132
N FL +N G L++ +WS+ S + + VL L D G V+
Sbjct: 50 HG--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSK-QGEYVLILQDDGFGVI 100
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-07
Identities = 20/127 (15%), Positives = 42/127 (33%), Gaps = 21/127 (16%)
Query: 23 PDIITSSQTLNDGRTL--ISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLN 80
Q L+ +L + + + + + Y N +W N
Sbjct: 8 QPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN---NNPIWATNTGG 58
Query: 81 LINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDS 140
+ ++ G LV+ + N+ VW + ++ + VL L N+V+ G+
Sbjct: 59 --LGNGCRAVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQPDRNVVIYGDA---- 111
Query: 141 ETYFWQS 147
W +
Sbjct: 112 ---LWAT 115
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 3e-07
Identities = 24/102 (23%), Positives = 33/102 (32%), Gaps = 22/102 (21%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
F GG DL +Q R KL + I+ L LR HRDL G
Sbjct: 143 FEFGGIDL---------EQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAP 489
NVLL + K+ ++ + + G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVS 222
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-07
Identities = 20/114 (17%), Positives = 39/114 (34%), Gaps = 12/114 (10%)
Query: 21 FAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLN 80
+++ SSQ + D L + + L + + K +VW +
Sbjct: 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESGTSG 54
Query: 81 LINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRG 134
F+ + +G L +T V+ + + VL L +G V+ G
Sbjct: 55 --RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAVVYG 105
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 1e-06
Identities = 30/153 (19%), Positives = 48/153 (31%), Gaps = 13/153 (8%)
Query: 20 SFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSS--KNRYVGIWYKNIPVKTVVWVAN 77
++ + QTL+ G+ L+S + F+L G+ ++ +W N +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPL 70
Query: 78 RLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAY----LSKEVRTPVVLQLLDSGNLVLR 133
R + L L S VW S + L L D GN+VL
Sbjct: 71 R-----NKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLV 125
Query: 134 GEQDG--DSETYFWQSFDYPSDTLLPGMKLGWD 164
+ S L PG +L
Sbjct: 126 DSLALWNGTPAIPLVPGAIDSLLLAPGSELVQG 158
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 11/99 (11%), Positives = 21/99 (21%), Gaps = 32/99 (32%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
R + H R + V + D G
Sbjct: 133 RAMQSLAAAADAAH---RAGVALSIDHPSRVRVSID--------GDV------------- 168
Query: 479 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
V+ M + + D+ G L ++ +
Sbjct: 169 -VLAYPATMPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 34/170 (20%), Positives = 52/170 (30%), Gaps = 67/170 (39%)
Query: 408 RCKLLDWSKRFR-----------IICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL----- 451
LL W + II +GL YLH ++ RIIH D+K N+LL
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQ 185
Query: 452 --------------------------------------------DQDMNPKISDFGLART 467
+ + KI+D G A
Sbjct: 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW 245
Query: 468 FGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
TE TR Y + E ++ +D++S + E+ +G
Sbjct: 246 VHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP--KISDFGLARTFGGDETEGNTTRVVGTY 484
L LH + RIIH DLK N+LL Q K+ DFG + + E + T + +
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY---EHQRVYTYIQSRF 264
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y APE ++ + D++S G +L E+++G
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 28/93 (30%), Positives = 44/93 (47%), Gaps = 8/93 (8%)
Query: 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP--KISDFGLARTFGGDETEGNTTRVVGTY 484
LL+L L IIH DLK N+LL KI DFG + G + + +
Sbjct: 169 ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR----IYQYIQSR 222
Query: 485 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
Y +PE + + D++S G +L+E+ +G+
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 16/51 (31%), Positives = 24/51 (47%), Gaps = 9/51 (17%)
Query: 418 FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKISDFGLA 465
+ I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 123 MKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 87/655 (13%), Positives = 181/655 (27%), Gaps = 230/655 (35%)
Query: 24 DIITSSQTLNDGR----TLISKDGSFELGFFSPGSSKNRYVGIW------YKNIPVKTVV 73
II S ++ TL+SK F N Y + + + T +
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRM 111
Query: 74 WVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLR 133
++ R L ND+ F +K N V ++R +L+L + N+++
Sbjct: 112 YIEQRDRLYNDNQVF------------AKYN--VSRLQPYLKLRQ-ALLELRPAKNVLID 156
Query: 134 G-------------EQDGDSETY-----FWQSF-DYPSDTLLPGMKLGWDLETGLERRVT 174
G + FW + + S + +++ L ++ T
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV--LEMLQKLLYQIDPNWT 214
Query: 175 SWKSFDDPSPGDFIWAIER-------QDNPE--VVM---WKGSRKFYRTGPWNGLRFSAP 222
S + +V+ + K WN S
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ--NAKA-----WNAFNLSCK 267
Query: 223 SL---RPNPVFSFSFVSNDVELYYTFNITN--------KAVISRIIMNQTLYSDVPRDQC 271
L R V F +S + + + + K+++ + + D+PR+
Sbjct: 268 ILLTTRFKQVTDF--LSAATTTHISLDHHSMTLTPDEVKSLLLKYL--DCRPQDLPREVL 323
Query: 272 DTYGLCGAYGICIISQSPVCQCLKGFKHKSGGYVDWSKGCVRNKPLNYSRQDGFMKFTEL 331
T + II++S ++ W + + K
Sbjct: 324 TTNPRR----LSIIAES-----IRDGLAT------W----------DNWKHVNCDK---- 354
Query: 332 KLPDATPSWVSKSMNLKESREGCLENSFCMAYTNSDIRGGGSGCAMWFGDL-IDMRSFPD 390
L E L ++ R F L + FP
Sbjct: 355 ---------------LTTIIESSLNV-----LEPAEYRK-------MFDRLSV----FPP 383
Query: 391 GGQDLYI----------RMSASELDQERCKLLD------WSKRFRIICGTGRGLLYLHQD 434
+I + S++ KL K I +
Sbjct: 384 ---SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI---------SIPS- 430
Query: 435 SRLRIIHRDLKAGNVLLDQDMNPKISD-FGLARTFGGDETEGNTTRVVGTY-----GYMA 488
I+ +LK + + ++ I D + + +TF +++ + Y G+
Sbjct: 431 -----IYLELKV-KLENEYALHRSIVDHYNIPKTF---DSDDLIPPYLDQYFYSHIGH-- 479
Query: 489 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAW------------ 536
+ + + + +F ++ L + F L+ K+ AW
Sbjct: 480 --HLKNIEHPERMTLFR--MVFL-------DFRF--LEQKIRHDSTAWNASGSILNTLQQ 526
Query: 537 -KLW------NKGMPSEMID------PCYQESCNLTEVIRCIHISLLCVQQHPDD 578
K + N +++ P +E+ ++ + I+L D+
Sbjct: 527 LKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL----MAEDE 577
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 27/111 (24%)
Query: 426 RGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNP-------------------KISDFGLAR 466
L +LH ++ H DLK N+L +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 467 TFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
TF + + T +V T Y PE + ++ DV+S G +L E G
Sbjct: 190 TFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 635 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.98 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.94 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.93 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.93 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.93 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.93 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.92 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.92 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.92 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.92 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.92 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.92 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.92 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.92 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.92 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.92 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.92 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.92 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.92 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.92 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.92 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.92 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.92 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.92 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.92 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.92 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.92 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.92 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.92 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.92 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.92 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.92 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.92 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.91 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.91 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.91 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.91 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.91 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.91 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.91 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.91 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.91 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.91 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.91 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.91 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.91 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.91 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.91 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.91 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.91 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.91 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.91 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.91 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.91 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.91 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.91 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.91 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.91 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.91 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.91 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.91 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.91 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.91 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.9 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.9 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.9 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.9 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.9 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.9 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.9 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.9 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.9 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.9 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.9 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.9 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.9 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.9 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.89 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.88 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.88 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.86 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.84 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.83 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.83 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.77 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.74 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.74 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.72 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.68 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.67 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.61 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.6 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.55 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.42 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.41 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.36 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.26 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.22 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.19 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.18 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.12 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 98.98 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.67 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.13 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.87 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.53 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 95.8 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 89.43 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 88.0 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 86.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 85.79 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.65 Aligned_cols=174 Identities=21% Similarity=0.238 Sum_probs=149.7
Q ss_pred cccccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCC----CceEEEecCC
Q 046703 20 SFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDS----SGFLMINKTG 95 (635)
Q Consensus 20 ~~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~----~~~l~~~~~g 95 (635)
+++.|+|.+|++|++|++|+|++|.|+||||.++ ++|+ |+ +.+ +||+|||++||.++ +++|+|+.||
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 5678999999999999999999999999999543 5776 66 667 99999999999875 7899999999
Q ss_pred cEEE--EccCCceEEEeecccCC----CCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecccccccc
Q 046703 96 NLVL--TSKSNIVVWSAYLSKEV----RTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLETGL 169 (635)
Q Consensus 96 ~l~l--~~~~~~~vwss~~~~~~----~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~tg~ 169 (635)
+||| .|++|.+||+|+++... .+...|+|+|+|||||++ +.+|||| ||||||||||+|+.++++|.
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC------CceeeCc--ccccccccccccccccccCc
Confidence 9999 78889999999976421 123389999999999997 3789999 99999999999999999984
Q ss_pred ceeEEEeccCCCCCCCceEEEEecCCCceEEEec-CCeeeEEcCCCCCc
Q 046703 170 ERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWK-GSRKFYRTGPWNGL 217 (635)
Q Consensus 170 ~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~yw~~g~w~~~ 217 (635)
.| ++.+||++|.|++.++++|. +++++ +..+||++|+|++.
T Consensus 154 --~L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~ 195 (276)
T 3m7h_A 154 --EL---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKG 195 (276)
T ss_dssp --EE---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTT
T ss_pred --cc---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCc
Confidence 46 67899999999999999995 44565 45899999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.33 Aligned_cols=202 Identities=23% Similarity=0.338 Sum_probs=150.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|||||.+..++.. ..+||+|||++... .....++|.+++.++.||++||.|||+++ ||||||||+||
T Consensus 88 ~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NI 163 (307)
T 3omv_A 88 KTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNI 163 (307)
T ss_dssp TCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSE
T ss_pred hCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHE
Confidence 3579999999998764 46899999997421 23457999999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC---CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|+++++.+||+|||+|+...............||+.|||||.+.. .+++.++|||||||+||||++|+.||......
T Consensus 164 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~ 243 (307)
T 3omv_A 164 FLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR 243 (307)
T ss_dssp EEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred EECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH
Confidence 999999999999999987654333333445689999999999853 46899999999999999999999998643211
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.........+.....+. ..+...+..+.+|+.+||+.||++||||.||+++|+.+
T Consensus 244 ------~~~~~~~~~~~~~p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 244 ------DQIIFMVGRGYASPDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ------HHHHHHHHTTCCCCCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222222222211111 11122334577899999999999999999999999765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.11 Aligned_cols=200 Identities=23% Similarity=0.275 Sum_probs=153.2
Q ss_pred eeeccccccccccCCCCccEEEEecccchhhh--------------------hccccCcccchhhhhhhccccchhhccc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQE--------------------RCKLLDWSKRFRIICGTGRGLLYLHQDS 435 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 435 (635)
.+.|||||.+.+++..+..+||+|||++.... ....++|.+++.++.||++||+|||+.+
T Consensus 99 ~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 178 (329)
T 4aoj_A 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178 (329)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 45799999999999989999999999974211 1346899999999999999999999998
Q ss_pred cceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 436 ~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
||||||||+|||++.++.+||+|||+++...............||+.|||||.+.+..++.++|||||||+||||++
T Consensus 179 ---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt 255 (329)
T 4aoj_A 179 ---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255 (329)
T ss_dssp ---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHc
Confidence 99999999999999999999999999987654433333344678999999999999999999999999999999998
Q ss_pred -CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 516 -GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 516 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
|+.||..... . .+...+..+...+..+ ..+..+.+|+.+||+.||++||||+||+++|+.+.+
T Consensus 256 ~G~~Pf~~~~~---~----~~~~~i~~g~~~~~p~---------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 256 YGKQPWYQLSN---T----EAIDCITQGRELERPR---------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TSCCTTCSSCH---H----HHHHHHHHTCCCCCCT---------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCH---H----HHHHHHHcCCCCCCcc---------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 8999864321 1 2223333443332221 223457789999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.75 Aligned_cols=200 Identities=22% Similarity=0.274 Sum_probs=161.6
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQD 434 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 434 (635)
.+.|||||.+.+++.....+||++||++... .....++|.++++++.||++||.|||++
T Consensus 85 ~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 164 (308)
T 4gt4_A 85 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 164 (308)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4579999999999988899999999987421 1134689999999999999999999999
Q ss_pred ccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhh
Q 046703 435 SRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 435 ~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eil 514 (635)
+ ||||||||+||||++++.+||+|||+++...............||+.|||||.+.+..++.++|||||||+||||+
T Consensus 165 ~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 165 H---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence 9 9999999999999999999999999998765433333334467899999999999999999999999999999999
Q ss_pred h-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 515 S-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 515 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
+ |+.||..... ..+...+..+......+ ..+..+.+|+.+||+.||++||||+||++.|+...
T Consensus 242 t~g~~Pf~~~~~-------~~~~~~i~~~~~~~~p~---------~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 242 SYGLQPYCGYSN-------QDVVEMIRNRQVLPCPD---------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TTTCCTTTTCCH-------HHHHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred hCCCCCCCCCCH-------HHHHHHHHcCCCCCCcc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 8 8999864321 12233334444333222 23345778999999999999999999999998764
Q ss_pred C
Q 046703 594 V 594 (635)
Q Consensus 594 ~ 594 (635)
.
T Consensus 306 n 306 (308)
T 4gt4_A 306 N 306 (308)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.33 Aligned_cols=209 Identities=14% Similarity=0.206 Sum_probs=158.2
Q ss_pred ccccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEE
Q 046703 21 FAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLT 100 (635)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~ 100 (635)
++.|+|.+|++|.+|++| ++|.|+|||+.+++. . +|.. +++||+|||+.| .+++|+|+.||+|||+
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl-----~-ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL-----V-LFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE-----E-EEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE-----E-EEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 567999999999999999 599999999977652 2 3443 799999999988 4688999999999999
Q ss_pred ccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcc-cCCCeecccc-cccc-----ceeE
Q 046703 101 SKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTL-LPGMKLGWDL-ETGL-----ERRV 173 (635)
Q Consensus 101 ~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTl-Lpgq~l~~~~-~tg~-----~~~L 173 (635)
|++|.+||+|++....... .|+|+|+|||||++ .++||||||||||+ |||| +.|. .+|+ +++|
T Consensus 72 d~~~~~vW~s~~~~~~~~~-~~~l~d~Gnlvl~~-------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L 141 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNY-VLVLQPDRTVTIYG-------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTL 141 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCC-EEEECSSSCEEEEC-------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEE
T ss_pred cCCCcEEEeCCccccCCcE-EEEEeCCCCEEEec-------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceE
Confidence 9999999999986543334 89999999999994 27999999999887 6665 5554 5554 5678
Q ss_pred EEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCCCCCcccc-cCCCCCCCceEEEEeecCceeEEEEEecCCce
Q 046703 174 TSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPVFSFSFVSNDVELYYTFNITNKAV 252 (635)
Q Consensus 174 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~w~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (635)
++ .+||++|.|++.++++| +++++++..+||++++|++. +. .+.+..... .+.+..++.+.++.|...+..
T Consensus 142 ~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gn-l~ly~~~~~~vw~s~~~~~~~- 213 (236)
T 1dlp_A 142 HA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGR-MDVLTNQNIAVWTSGNSRSAG- 213 (236)
T ss_dssp CS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTE-EEEEETTTEEEEECCCCCSSS-
T ss_pred Ec---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCc-EEEEeCCCcEEEEeCCCCCCC-
Confidence 74 78999999999999998 67788888899999999653 32 333332221 122333444555555443333
Q ss_pred EEEEEEcee
Q 046703 253 ISRIIMNQT 261 (635)
Q Consensus 253 ~~~~~l~~~ 261 (635)
..|++++.+
T Consensus 214 ~~rl~Ld~d 222 (236)
T 1dlp_A 214 RYVFVLQPD 222 (236)
T ss_dssp CCEEEECSS
T ss_pred CEEEEEcCC
Confidence 467777665
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.14 Aligned_cols=199 Identities=21% Similarity=0.285 Sum_probs=160.7
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------------------hhccccCcccchhhhhhhccccchhhccccc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRL 437 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 437 (635)
.+.|||||.+++++..+..+||+|||++... .....|+|.++++++.||++||.|||+++
T Consensus 71 ~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-- 148 (299)
T 4asz_A 71 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-- 148 (299)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 3579999999999998899999999997421 12346999999999999999999999998
Q ss_pred eEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-C
Q 046703 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-G 516 (635)
Q Consensus 438 ~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G 516 (635)
||||||||+|||++.++.+||+|||+++...............||+.|||||.+.+..++.++|||||||+||||++ |
T Consensus 149 -iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G 227 (299)
T 4asz_A 149 -FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 227 (299)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred -cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999987644332222233578999999999999999999999999999999998 8
Q ss_pred CCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 517 KKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 517 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
+.||..... ..+...+..+......+ ..+..+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 228 ~~Pf~~~~~-------~~~~~~i~~~~~~~~p~---------~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 228 KQPWYQLSN-------NEVIECITQGRVLQRPR---------TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp CCTTTTSCH-------HHHHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCH-------HHHHHHHHcCCCCCCCc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 999864321 12233334444333221 22345778999999999999999999999998763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=309.17 Aligned_cols=197 Identities=25% Similarity=0.348 Sum_probs=157.7
Q ss_pred eccccccccccCC-CCccEEEEecccchhh-------h--------------hccccCcccchhhhhhhccccchhhccc
Q 046703 378 WFGDLIDMRSFPD-GGQDLYIRMSASELDQ-------E--------------RCKLLDWSKRFRIICGTGRGLLYLHQDS 435 (635)
Q Consensus 378 ~h~nLv~l~~~~~-~~~~lyl~~~~~~~~~-------~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 435 (635)
+|+|||.+.+++. .+..+||+|||++... . ....|++.+++.++.||++||.|||+++
T Consensus 126 hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~ 205 (353)
T 4ase_A 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 205 (353)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC
Confidence 4689999998764 4567999999997421 0 1345899999999999999999999999
Q ss_pred cceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 436 ~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
||||||||+|||+++++.+||+|||+|+...............||+.|||||.+.+..++.++|||||||+||||++
T Consensus 206 ---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 206 ---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 99999999999999999999999999987765544434445789999999999999999999999999999999998
Q ss_pred -CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 516 -GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 516 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|+.||......+ .....+.++......+. ....+.+++.+||+.||++||||+||++.|+.+
T Consensus 283 ~G~~Pf~~~~~~~------~~~~~i~~g~~~~~p~~---------~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 283 LGASPYPGVKIDE------EFCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TSCCSSTTCCCSH------HHHHHHHHTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH------HHHHHHHcCCCCCCCcc---------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 899986543221 22333444443333221 223577899999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.84 Aligned_cols=213 Identities=19% Similarity=0.207 Sum_probs=154.9
Q ss_pred eeeccccccccccCCCC----ccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccc-----cceEEee
Q 046703 376 AMWFGDLIDMRSFPDGG----QDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDS-----RLRIIHR 442 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~----~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiH~ 442 (635)
.+.|+|||.+..++... ..+||++||++.. ..+...++|+++++++.|+++||+|||+++ ...||||
T Consensus 53 ~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHR 132 (303)
T 3hmm_A 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECS
T ss_pred cCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeec
Confidence 35799999998887422 3689999999742 234567999999999999999999999872 2349999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCC------CCcccCceeeeehhhHhhh
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwS~Gvvl~eil 514 (635)
||||+|||++.++.+||+|||+++........ .......||+.|||||.+.+. .++.++|||||||+||||+
T Consensus 133 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 99999999999999999999999876543221 122346799999999998754 4788999999999999999
Q ss_pred hCCCCCCCccCCCc--------ccHHHHHHHHhhcCCCCcCCCCccc-cCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 515 SGKKNRGFYHLDNK--------LNLIGHAWKLWNKGMPSEMIDPCYQ-ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 515 tG~~pf~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
+|+.|+......+. ............... .++.+. ...+.+.+..+.+|+.+||+.||++||||.||
T Consensus 213 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HCCCCCCccccccccchhcccccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99887654322110 011122222222221 111111 11234566778899999999999999999999
Q ss_pred HHHHcCC
Q 046703 586 ILMLGSE 592 (635)
Q Consensus 586 l~~L~~~ 592 (635)
+++|+.+
T Consensus 289 ~~~L~~l 295 (303)
T 3hmm_A 289 KKTLSQL 295 (303)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.88 Aligned_cols=199 Identities=21% Similarity=0.188 Sum_probs=154.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|||||.++.+...+..+||+|||++... .+.+.+++.++..++.||+.||.|||+++ ||||||||+|||+
T Consensus 107 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl 183 (336)
T 4g3f_A 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLL 183 (336)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEE
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEE
Confidence 479999999999988889999999997421 34567999999999999999999999999 9999999999999
Q ss_pred ccCC-CCccCccccceecCCCCCC---CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDM-NPKISDFGLARTFGGDETE---GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~-~~kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++ .+||+|||+++.+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......+
T Consensus 184 ~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 9987 5999999999987543221 11233579999999999999999999999999999999999999996544332
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. ...+. .+.... ...+......+.+++.+||+.||++|||+.||++.|...
T Consensus 264 ~---~~~i~----~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 264 L---CLKIA----SEPPPI-------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp C---HHHHH----HSCCGG-------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHH----cCCCCc-------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2 21111 111110 011122234567899999999999999999999877543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.70 Aligned_cols=192 Identities=22% Similarity=0.297 Sum_probs=154.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|||.++.+......+||+|||++.+ ......+++.++..++.||+.||.|||+++ ||||||||+|||++
T Consensus 128 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~ 204 (346)
T 4fih_A 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLT 204 (346)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEC
Confidence 46999999999998889999999999752 233567999999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++.+..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...
T Consensus 205 ~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~-- 277 (346)
T 4fih_A 205 HDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLK-- 277 (346)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHH--
T ss_pred CCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHH--
Confidence 999999999999988754322 2334789999999999999999999999999999999999999996432 111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
....+..+....+.. .......+.+++.+||+.||++|||++|+++
T Consensus 278 --~~~~i~~~~~~~~~~-------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 278 --AMKMIRDNLPPRLKN-------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --HHHHHHHSSCCCCSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHHHHcCCCCCCCc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222222322222111 1112235678999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-34 Score=296.64 Aligned_cols=190 Identities=21% Similarity=0.243 Sum_probs=155.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|||||.++.+......+||+||+++.. ..+.+.+++.++..++.||+.||.|||+++ |+||||||+|||+
T Consensus 89 l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl 165 (311)
T 4aw0_A 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILL 165 (311)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEE
Confidence 47999999999999999999999998742 234567999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+|+.+..........+..||+.|||||.+.+..++.++||||+||++|||++|+.||.... ...
T Consensus 166 ~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~- 241 (311)
T 4aw0_A 166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGL- 241 (311)
T ss_dssp CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-
T ss_pred cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHH-
Confidence 9999999999999998765544444556789999999999999999999999999999999999999996432 111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
....+..+... +. ...+ ..+.+++.+||+.||++|||++|++
T Consensus 242 ---~~~~i~~~~~~-~p-----~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 242 ---IFAKIIKLEYD-FP-----EKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---HHHHHHHTCCC-CC-----TTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---HHHHHHcCCCC-CC-----cccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 22222233221 11 1122 3467899999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-34 Score=298.06 Aligned_cols=191 Identities=22% Similarity=0.308 Sum_probs=151.7
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|||||.++.+......+||+|||++.. ..+...+++.+++.++.||+.||.|||+++ ||||||||+|
T Consensus 79 ~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~N 155 (350)
T 4b9d_A 79 NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQN 155 (350)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGG
T ss_pred HCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHH
Confidence 347999999999998889999999998742 123345688889999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
||++.++.+||+|||+++...... .......||+.|||||.+.+..|+.++|||||||+||||++|+.||.....
T Consensus 156 ILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--- 230 (350)
T 4b9d_A 156 IFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--- 230 (350)
T ss_dssp EEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred EEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---
Confidence 999999999999999998753221 112336799999999999999999999999999999999999999964321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ....+..+...... .. ....+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~----~~~~i~~~~~~~~~-----~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 231 KN----LVLKIISGSFPPVS-----LH----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HH----HHHHHHHTCCCCCC-----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----HHHHHHcCCCCCCC-----cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 22222233332211 11 2235678999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-33 Score=287.94 Aligned_cols=192 Identities=21% Similarity=0.329 Sum_probs=147.2
Q ss_pred eeeccccccccccCC----CCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPD----GGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~----~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|||||.++.+.. +...+||+||+++... .+...+++.++..++.||++||.|||+++ .+||||||||
T Consensus 81 ~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp 159 (290)
T 3fpq_A 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKC 159 (290)
T ss_dssp TCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCG
T ss_pred hCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccCh
Confidence 357999999988653 3456899999987422 34567999999999999999999999986 3599999999
Q ss_pred cceEecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+|||++. ++.+||+|||+|+.... .......||+.|||||.+.+ +++.++|||||||++|||++|+.||.....
T Consensus 160 ~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 160 DNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred hheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 9999984 78999999999976432 22345789999999998865 699999999999999999999999853221
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.......+..+......+ ...+ ..+.+|+.+||+.||++|||++|+++
T Consensus 235 ------~~~~~~~i~~~~~~~~~~----~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 235 ------AAQIYRRVTSGVKPASFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------HHHHHHHHTTTCCCGGGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHHHcCCCCCCCC----ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233333333222111 1112 24677999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-33 Score=301.42 Aligned_cols=192 Identities=22% Similarity=0.298 Sum_probs=154.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|||.++.+......+||+|||++.+ ..+...+++.++..++.||+.||.|||+++ ||||||||+||||+
T Consensus 205 l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~ 281 (423)
T 4fie_A 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLT 281 (423)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEEC
T ss_pred CCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEc
Confidence 47999999999998889999999999752 234567999999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++.+..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...
T Consensus 282 ~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~-- 354 (423)
T 4fie_A 282 HDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLK-- 354 (423)
T ss_dssp TTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHH--
T ss_pred CCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHH--
Confidence 999999999999988754322 2334789999999999999999999999999999999999999985432 111
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+...+..+....+... ......+.+|+.+||+.||++|||++|+++
T Consensus 355 --~~~~i~~~~~~~~~~~-------~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 355 --AMKMIRDNLPPRLKNL-------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --HHHHHHHSCCCCCSCT-------TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHHHHcCCCCCCccc-------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222223322221111 111235678999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-33 Score=285.86 Aligned_cols=188 Identities=19% Similarity=0.267 Sum_probs=143.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.||||+.++.+......+|++||+++.+ ..+...+++.++..++.||+.||+|||+++ |+||||||+|||++
T Consensus 70 l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~ 146 (275)
T 3hyh_A 70 LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLD 146 (275)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEEC
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEEC
Confidence 47999999999998899999999998642 134567999999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||+|+...... ...+..||+.|||||.+.+..+ +.++||||+||++|||++|+.||.... ..
T Consensus 147 ~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~-- 218 (275)
T 3hyh_A 147 EHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IP-- 218 (275)
T ss_dssp TTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH--
T ss_pred CCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HH--
Confidence 99999999999998754322 2234689999999999998876 589999999999999999999996422 11
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+... + .... ...+.+++.+||+.||++|||++|+++
T Consensus 219 --~~~~~i~~~~~~-~-----p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 219 --VLFKNISNGVYT-L-----PKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --HHHHHHHHTCCC-C-----CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHcCCCC-C-----CCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122222233221 1 1111 234678999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-33 Score=289.41 Aligned_cols=190 Identities=21% Similarity=0.232 Sum_probs=149.1
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|||||.++.+......+|++||+++.. ..+.+.+++.++..++.||+.||.|||+++ |+||||||+|||
T Consensus 82 ~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NIL 158 (304)
T 3ubd_A 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENIL 158 (304)
T ss_dssp CCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEE
T ss_pred HCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeE
Confidence 457999999999998889999999998742 234567999999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||+|+....... ......||+.|||||.+.+..++.++||||+||++|||++|+.||..... ..
T Consensus 159 l~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~ 233 (304)
T 3ubd_A 159 LDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KE 233 (304)
T ss_dssp ECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred EcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HH
Confidence 99999999999999986543322 22346899999999999999999999999999999999999999964321 11
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM-----PSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~-----~evl~ 587 (635)
. ...+..+.+. . .... ...+.+++.+||+.||++|||+ +|+++
T Consensus 234 ~----~~~i~~~~~~-~-----p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 234 T----MTMILKAKLG-M-----PQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp H----HHHHHHCCCC-C-----CTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred H----HHHHHcCCCC-C-----CCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 1222222221 1 1111 2346789999999999999985 56653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=274.40 Aligned_cols=215 Identities=29% Similarity=0.492 Sum_probs=182.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhhh---------hccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQE---------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+......+|+++++.+.... ....+++.+++.++.||++||.|||+.+ |+||||||+
T Consensus 92 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~ 168 (321)
T 2qkw_B 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSI 168 (321)
T ss_dssp CCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCST
T ss_pred CCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHH
Confidence 4699999999999888899999998863211 1235888999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
||+++.++.+||+|||+++...............|+..|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 169 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~ 248 (321)
T 2qkw_B 169 NILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248 (321)
T ss_dssp TEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred HEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH
Confidence 99999999999999999987543332222334568999999999998999999999999999999999999998766666
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
......+.......+.....+++.+...........+.+++.+||+.||++|||+.||++.|+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 6666666666666777888888888777888899999999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-31 Score=273.40 Aligned_cols=190 Identities=23% Similarity=0.279 Sum_probs=131.0
Q ss_pred eeccccccccccCC------------CCccEEEEecccchhh-----hhcc---ccCcccchhhhhhhccccchhhcccc
Q 046703 377 MWFGDLIDMRSFPD------------GGQDLYIRMSASELDQ-----ERCK---LLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 377 l~h~nLv~l~~~~~------------~~~~lyl~~~~~~~~~-----~~~~---~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
+.|||||.++.... ....+|++||+++... .... ..++..++.++.||++||.|||+++
T Consensus 60 l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~- 138 (299)
T 4g31_A 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG- 138 (299)
T ss_dssp CCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc-
Confidence 47999999887642 2234899999987421 1122 2334457789999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCC----------CceeeeeeccCCCCcccccCCCCcccCceeee
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE----------GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSF 506 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~ 506 (635)
|+||||||+|||++.++.+||+|||+|+.+...... .......||+.|||||.+.+..++.++|||||
T Consensus 139 --IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 216 (299)
T 4g31_A 139 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216 (299)
T ss_dssp --CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred --CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence 999999999999999999999999999876543221 11233579999999999999999999999999
Q ss_pred ehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 507 GILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 507 Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
||++|||++ ||... .... ...........+.. .........+++.+||+.||++|||+.||+
T Consensus 217 Gvilyell~---Pf~~~-----~~~~-~~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil 278 (299)
T 4g31_A 217 GLILFELLY---PFSTQ-----MERV-RTLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINII 278 (299)
T ss_dssp HHHHHHHHS---CCSSH-----HHHH-HHHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHcc---CCCCc-----cHHH-HHHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 999999996 65321 1111 11122222222111 112223356789999999999999999998
Q ss_pred H
Q 046703 587 L 587 (635)
Q Consensus 587 ~ 587 (635)
+
T Consensus 279 ~ 279 (299)
T 4g31_A 279 E 279 (299)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=269.44 Aligned_cols=216 Identities=35% Similarity=0.558 Sum_probs=178.6
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+.......|+++++.+... .....+++..+..++.|++.||.|||+.....|+||||||+
T Consensus 84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 369999999999988889999999986411 12334899999999999999999999991112999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc--C
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH--L 525 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~--~ 525 (635)
||+++.++.+||+|||++......... ......||..|+|||.+.+..++.++||||||+++|||++|+.||+... .
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hEEECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 999999999999999999876533222 2233568999999999988899999999999999999999999996432 2
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
........+............+.+..+.......+...+.+++.+||+.||++|||++||+++|++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 33444555666666677777888888888888999999999999999999999999999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=277.60 Aligned_cols=203 Identities=20% Similarity=0.279 Sum_probs=147.6
Q ss_pred eeccccccccccCC------CCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFPD------GGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~~------~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
+.|+|||.++.+.. ....+||+||+++.+. .+.+.+++.++..++.||+.||.|||+++ ||||||||
T Consensus 110 l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP 186 (398)
T 4b99_A 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKP 186 (398)
T ss_dssp CCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCG
T ss_pred cCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCc
Confidence 46999999987643 4468999999997431 34567999999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCC--CCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDE--TEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+|||++.++.+||+|||+++.+.... .........||+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 187 ~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 187 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp GGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 99999999999999999998764321 12223346899999999998775 5689999999999999999999999754
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCc------------c--ccCCCH-----HHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPC------------Y--QESCNL-----TEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~------------l--~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
...+ .+..+... .+.+....... + ....+. .....+.+|+.+||+.||++|||++|
T Consensus 267 ~~~~---~l~~I~~~--~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 267 NYVH---QLQLIMMV--LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341 (398)
T ss_dssp SHHH---HHHHHHHH--HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CHHH---HHHHHHHh--cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 3222 22221111 11111000000 0 000011 11235678999999999999999999
Q ss_pred HHH
Q 046703 585 VIL 587 (635)
Q Consensus 585 vl~ 587 (635)
+++
T Consensus 342 ~L~ 344 (398)
T 4b99_A 342 ALR 344 (398)
T ss_dssp HTT
T ss_pred Hhc
Confidence 886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=272.34 Aligned_cols=141 Identities=23% Similarity=0.318 Sum_probs=118.0
Q ss_pred eccccccccccCCCCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC-
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD- 454 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~- 454 (635)
.|+||+.++.+......+|++||+++... ...+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTT
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCC
Confidence 58999999999888899999999987422 22356899999999999999999999999 9999999999999877
Q ss_pred CCCccCccccceecCCCCCC--------------------------CceeeeeeccCCCCcccccCC-CCcccCceeeee
Q 046703 455 MNPKISDFGLARTFGGDETE--------------------------GNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFG 507 (635)
Q Consensus 455 ~~~kl~Dfgla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~G 507 (635)
+.+||+|||+|+........ .......||+.|+|||.+.+. .++.++||||+|
T Consensus 155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG 234 (361)
T 4f9c_A 155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG 234 (361)
T ss_dssp TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence 78999999999865432111 112235799999999998775 489999999999
Q ss_pred hhhHhhhhCCCCCC
Q 046703 508 ILLLEIVSGKKNRG 521 (635)
Q Consensus 508 vvl~eiltG~~pf~ 521 (635)
|++|||++|+.||.
T Consensus 235 ~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 235 VIFLSLLSGRYPFY 248 (361)
T ss_dssp HHHHHHHHTCSSSS
T ss_pred HHHHHHHHCCCCCC
Confidence 99999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=284.61 Aligned_cols=190 Identities=21% Similarity=0.195 Sum_probs=150.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|||||.++........+|++|+|+..+ ..+...+++..+..++.||+.||.|||+++ ||||||||+||||
T Consensus 249 ~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILl 325 (689)
T 3v5w_A 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILL 325 (689)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEE
T ss_pred CCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEE
Confidence 36999999999999999999999999752 234567999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+|+.+.... ..+..||+.|||||++.. ..|+.++|+||+||+||||++|+.||......+...
T Consensus 326 d~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~ 401 (689)
T 3v5w_A 326 DEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401 (689)
T ss_dssp CTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred eCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999999999999998765432 234689999999999964 579999999999999999999999996543332211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
+. .......+. +. ... ...+.+|+.+||+.||++|++ ++||++
T Consensus 402 i~----~~i~~~~~~-~p-----~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 402 ID----RMTLTMAVE-LP-----DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HH----HHHHHCCCC-CC-----TTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HH----HhhcCCCCC-CC-----ccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11 111121111 11 111 234678999999999999998 677764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=258.40 Aligned_cols=210 Identities=23% Similarity=0.325 Sum_probs=156.7
Q ss_pred eeccccccccccCCC----CccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhcc----------ccce
Q 046703 377 MWFGDLIDMRSFPDG----GQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQD----------SRLR 438 (635)
Q Consensus 377 l~h~nLv~l~~~~~~----~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------~~~~ 438 (635)
+.|+||+.+..+... ...+|+++++.+.. ..+...+++.+++.++.||++||+|||+. +
T Consensus 75 l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--- 151 (322)
T 3soc_A 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--- 151 (322)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---
T ss_pred CCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---
Confidence 469999998887643 34589999998642 22345689999999999999999999998 7
Q ss_pred EEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----CCCcccCceeeeehhhHhh
Q 046703 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEI 513 (635)
Q Consensus 439 iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvvl~ei 513 (635)
|+||||||+||+++.++.+||+|||+++...............||..|+|||.+.+ ..++.++||||||+++|||
T Consensus 152 ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el 231 (322)
T 3soc_A 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231 (322)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHH
Confidence 99999999999999999999999999988765443333334678999999999876 3567889999999999999
Q ss_pred hhCCCCCCCccCCCcccHH---------HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 514 VSGKKNRGFYHLDNKLNLI---------GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 514 ltG~~pf~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
++|+.||............ ...............+.... ........+.+++.+||+.||++|||+.|
T Consensus 232 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGC 308 (322)
T ss_dssp HTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHH
Confidence 9999998764332221111 11111111222211111111 12345667889999999999999999999
Q ss_pred HHHHHcCC
Q 046703 585 VILMLGSE 592 (635)
Q Consensus 585 vl~~L~~~ 592 (635)
|++.|+.+
T Consensus 309 ll~~L~~l 316 (322)
T 3soc_A 309 VGERITQM 316 (322)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-29 Score=281.39 Aligned_cols=192 Identities=17% Similarity=0.237 Sum_probs=151.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.||||+.++.+......+||+||+++... .+...+++.++..++.||+.||.|||+++ |+||||||+|||
T Consensus 211 l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nil 287 (573)
T 3uto_A 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIM 287 (573)
T ss_dssp TCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhcc
Confidence 469999999999999999999999987421 23457899999999999999999999999 999999999999
Q ss_pred eccC--CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 LDQD--MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~--~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++.+ +.+||+|||+++.+.... ......||+.|||||++.+..++.++||||+||++|||++|+.||......
T Consensus 288 l~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-- 362 (573)
T 3uto_A 288 FTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-- 362 (573)
T ss_dssp ESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--
T ss_pred ccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--
Confidence 9854 789999999999875332 234568999999999999999999999999999999999999999643221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ....+..+... ..+... ... ...+.+|+.+||+.||++|||+.|+++
T Consensus 363 -~----~~~~i~~~~~~-~~~~~~-~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 363 -E----TLRNVKSCDWN-MDDSAF-SGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -H----HHHHHHTTCCC-CCSGGG-TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -H----HHHHHHhCCCC-CCcccc-cCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11222222211 111111 111 234678999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-29 Score=262.82 Aligned_cols=196 Identities=21% Similarity=0.280 Sum_probs=149.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..++..+ ..|+++++.... ......+++..++.++.||++||.|||+.+ |+||||||+||+
T Consensus 74 l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl 149 (327)
T 3poz_A 74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVL 149 (327)
T ss_dssp CCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEE
Confidence 4699999998887654 467777776531 223456899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 150 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 227 (327)
T 3poz_A 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 227 (327)
T ss_dssp EEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--
T ss_pred ECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--
Confidence 99999999999999988765443333334556889999999999999999999999999999999 999986543222
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. ...+..+..... +......+.+++.+||+.||++|||+.||++.|+..
T Consensus 228 -~----~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 228 -I----SSILEKGERLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -H----HHHHHTTCCCCC---------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -H----HHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 111222221111 112234577899999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-28 Score=260.24 Aligned_cols=197 Identities=25% Similarity=0.331 Sum_probs=154.9
Q ss_pred eccccccccccCCCCccEEEEecccchhh------h---------------hccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------E---------------RCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+||+.+..+......+|+++++.+... . ....+++.+++.++.||++||.|||+++
T Consensus 145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 223 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK- 223 (370)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 59999999999888889999999986311 0 1134788899999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
|+||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++
T Consensus 224 --ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 224 --CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654333222233456788999999999999999999999999999999
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|+.||......+ ....+..+...... ......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 302 g~~p~~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 302 GGSPYPGIPVEE-------LFKLLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp SCCSSTTCCGGG-------HHHHHHTTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHH-------HHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999986543221 11222233322211 122345778999999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-28 Score=250.74 Aligned_cols=211 Identities=30% Similarity=0.456 Sum_probs=162.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++..++.++.||++||.|||+.+ |+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 36999999999988888999999987531 112346899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||++................|+..|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999999999999999987654332222233568999999998764 588999999999999999999999976544433
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
...+...... ......+.+++.+ ...+......+.+++..||+.||++|||+++|++.|+.+.
T Consensus 243 ~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEIED-EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHHHT-TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhhh-hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222111110 1111222333333 2345677788999999999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=251.66 Aligned_cols=206 Identities=21% Similarity=0.266 Sum_probs=152.8
Q ss_pred eeccccccccccC----CCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhh--------ccccceEE
Q 046703 377 MWFGDLIDMRSFP----DGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLH--------QDSRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~----~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ii 440 (635)
+.|+||+.+..+. .....+|+++++.+.. ..+...+++..++.++.||++||.||| +.+ |+
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---iv 135 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IA 135 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EE
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---ee
Confidence 4799999887663 3456789999988642 223457899999999999999999999 777 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCC--ceeeeeeccCCCCcccccCC------CCcccCceeeeehhhHh
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG--NTTRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLE 512 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwS~Gvvl~e 512 (635)
||||||+||+++.++.+||+|||+++......... ......||..|+|||.+.+. .++.++||||||+++||
T Consensus 136 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~e 215 (301)
T 3q4u_A 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215 (301)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHH
Confidence 99999999999999999999999998765432221 11224789999999999876 56689999999999999
Q ss_pred hhhC----------CCCCCCccCCCcccHHHHHHHHh-hcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 046703 513 IVSG----------KKNRGFYHLDNKLNLIGHAWKLW-NKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC 581 (635)
Q Consensus 513 iltG----------~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt 581 (635)
|++| +.||......... ........ ..+....... ..........+.+++.+||+.||++|||
T Consensus 216 l~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 216 VARRMVSNGIVEDYKPPFYDVVPNDPS--FEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HHhhhcCccccccccccccccCCCCcc--hhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 9999 7777543322221 11111111 1111221111 1123356678899999999999999999
Q ss_pred hHHHHHHHcC
Q 046703 582 MPSVILMLGS 591 (635)
Q Consensus 582 ~~evl~~L~~ 591 (635)
+.||+++|+.
T Consensus 290 ~~~i~~~L~~ 299 (301)
T 3q4u_A 290 ALRIKKTLTK 299 (301)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhc
Confidence 9999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-28 Score=252.22 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=146.0
Q ss_pred eeccccccccccCCCCccEEEEecccchhh--------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ--------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+......+|+++++.+... .....+++..++.++.||++||+|||+.+ .+|+||||||+|
T Consensus 91 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~N 169 (309)
T 3p86_A 91 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPN 169 (309)
T ss_dssp CCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGG
T ss_pred CCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhh
Confidence 369999999999888888999999886421 11234899999999999999999999986 349999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 170 Ill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-- 245 (309)
T 3p86_A 170 LLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-- 245 (309)
T ss_dssp EEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--
T ss_pred EEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9999999999999999976533221 123367899999999999999999999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
..... ........++. ......+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 246 -~~~~~---~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 246 -QVVAA---VGFKCKRLEIP---------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -HHHHH---HHHSCCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -HHHHH---HHhcCCCCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11111111111 1122357789999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-28 Score=251.72 Aligned_cols=197 Identities=20% Similarity=0.276 Sum_probs=151.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+.. +..+|+++++.... ......+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 72 l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil 147 (325)
T 3kex_A 72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVL 147 (325)
T ss_dssp CCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEE
T ss_pred CCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEE
Confidence 36999999998876 45688899887632 122457899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 148 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 225 (325)
T 3kex_A 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-- 225 (325)
T ss_dssp ESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--
T ss_pred ECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--
Confidence 99999999999999988755444333444667889999999999999999999999999999999 999986543221
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
....+..+........ ....+.+++.+||+.||++|||+.||++.|+...
T Consensus 226 -----~~~~~~~~~~~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 226 -----VPDLLEKGERLAQPQI---------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -----HHHHHHTTCBCCCCTT---------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -----HHHHHHcCCCCCCCCc---------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122222222211111 1113567999999999999999999999997764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-28 Score=254.65 Aligned_cols=198 Identities=25% Similarity=0.349 Sum_probs=152.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++.+++.++.||++||+|||+.+ |+||||||+||+
T Consensus 64 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 140 (310)
T 3s95_A 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCL 140 (310)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred CCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEE
Confidence 36999999999988888999999998642 122467899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCc------------eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGN------------TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
++.++.+||+|||++........... .....||+.|+|||.+.+..++.++||||||+++|||++|..
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 220 (310)
T 3s95_A 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220 (310)
T ss_dssp ECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred ECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCC
Confidence 99999999999999987643322110 113568999999999999999999999999999999999999
Q ss_pred CCCCccCCCc--ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 519 NRGFYHLDNK--LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 519 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|+........ ......... .. .+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~---~~-------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 221 ADPDYLPRTMDFGLNVRGFLD---RY-------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp SSTTTSCBCTTSSBCHHHHHH---HT-------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcchhhhHHHHhhhhhcccc---cc-------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9865432221 111111111 00 01111224678999999999999999999999998763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=257.83 Aligned_cols=197 Identities=24% Similarity=0.295 Sum_probs=153.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++++.. ......+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 169 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil 245 (377)
T 3cbl_A 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCL 245 (377)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEE
Confidence 36999999999988888999999998632 123446899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 246 ~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--- 322 (377)
T 3cbl_A 246 VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--- 322 (377)
T ss_dssp ECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---
T ss_pred EcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987543322111122345778999999998999999999999999999998 99998643211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
........+..... +...+..+.+++.+||+.||++|||+++|++.|+.+
T Consensus 323 ----~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 323 ----QTREFVEKGGRLPC---------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 12222223322211 111233577899999999999999999999999764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-28 Score=247.57 Aligned_cols=204 Identities=12% Similarity=0.072 Sum_probs=154.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+...+...|+++++.... ......+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 140 (298)
T 1csn_A 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIG 140 (298)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEEC
T ss_pred cCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEec
Confidence 3667777777777778899999987421 122346899999999999999999999999 99999999999998
Q ss_pred cCCC-----CccCccccceecCCCCCC-----CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 453 QDMN-----PKISDFGLARTFGGDETE-----GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 453 ~~~~-----~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
.++. +||+|||++......... .......||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 141 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 141 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 7765 999999999877543221 112345789999999999999999999999999999999999999976
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.......................+.. . .....+.+++.+||+.||++||++++|++.|+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 221 LKAATNKQKYERIGEKKQSTPLRELC-----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHT-----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hhccccHHHHHHHHhhccCccHHHHH-----h----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 54433333332222211111111110 0 11235778999999999999999999999998763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-28 Score=260.30 Aligned_cols=208 Identities=26% Similarity=0.336 Sum_probs=159.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hh---------------ccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ER---------------CKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+||+.+..+......+|+++++.+... .. ...+++.+++.++.||+.||+|||+.+
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 211 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 211 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 69999999999888889999999986311 11 135899999999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
|+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++
T Consensus 212 --ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 212 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987654333233333567889999999999999999999999999999999
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVL 595 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 595 (635)
|+.||..... ......+..+....... .....+.+++.+||+.||++|||++||++.|+.+...
T Consensus 290 g~~p~~~~~~-------~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 290 GGSPYPGVPV-------EELFKLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp SCCSSTTCCH-------HHHHHHHHTTCCCCCCS---------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCH-------HHHHHHHHcCCCCCCCc---------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 9999864321 12233333333222211 1223577899999999999999999999999988644
Q ss_pred CCCCCCCcc
Q 046703 596 PQPKQPGFL 604 (635)
Q Consensus 596 p~p~~p~~~ 604 (635)
.......++
T Consensus 354 ~~~~~~~~~ 362 (382)
T 3tt0_A 354 TSNQEMGYY 362 (382)
T ss_dssp SCSCC----
T ss_pred HhcCCCCCC
Confidence 443333333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=246.35 Aligned_cols=192 Identities=20% Similarity=0.295 Sum_probs=150.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++.++..++.|++.||.|||+.+ |+||||||+||+++
T Consensus 74 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 150 (297)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEC
Confidence 46999999998887788999999988632 123446889999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++......... .....||..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------ 222 (297)
T 3fxz_A 151 MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------ 222 (297)
T ss_dssp TTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCCEEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 9999999999999876543322 23357899999999999999999999999999999999999998543211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.........+.. .... +......+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~-~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 223 RALYLIATNGTP-ELQN-------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHHHCSC-CCSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhCCCC-CCCC-------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111112211 1111 1122335778999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=248.92 Aligned_cols=203 Identities=24% Similarity=0.267 Sum_probs=150.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 76 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~ 152 (311)
T 3niz_A 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLI 152 (311)
T ss_dssp CCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred cCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEE
Confidence 36999999999998889999999998742 123345889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++....... ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~- 229 (311)
T 3niz_A 153 NSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL- 229 (311)
T ss_dssp CTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH-
T ss_pred CCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH-
Confidence 9999999999999987643222 1223467999999999876 56899999999999999999999999765443322
Q ss_pred HHHHHHHHhhcCCCCcC----------------CCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEM----------------IDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~----------------~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............... .+..............+.+++.+||+.||++|||++|+++
T Consensus 230 --~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 230 --PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp --HHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --HHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222222111111110 0000000001112245778999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-28 Score=252.76 Aligned_cols=199 Identities=21% Similarity=0.282 Sum_probs=155.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------h-----------------------hccccCcccchhhhhhhccc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------E-----------------------RCKLLDWSKRFRIICGTGRG 427 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~-----------------------~~~~l~~~~~~~i~~~ia~a 427 (635)
+.|+||+.+..+...+..+|+++++.+... . ....+++.+++.++.||++|
T Consensus 107 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~ 186 (343)
T 1luf_A 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186 (343)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHH
Confidence 369999999999888889999999886311 0 01568899999999999999
Q ss_pred cchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeee
Q 046703 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG 507 (635)
Q Consensus 428 L~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~G 507 (635)
|.|||+++ |+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||
T Consensus 187 l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 263 (343)
T 1luf_A 187 MAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263 (343)
T ss_dssp HHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHH
Confidence 99999999 999999999999999999999999999876433222223335678899999999989999999999999
Q ss_pred hhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 508 ILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 508 vvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
+++|||++ |+.||..... ......+..+......+ .....+.+++.+||+.||++|||+.+|+
T Consensus 264 ~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~~~ 327 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMAH-------EEVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIH 327 (343)
T ss_dssp HHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHhcCCCcCCCCCh-------HHHHHHHhCCCcCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 99999999 9999854321 11222333333322211 1223577899999999999999999999
Q ss_pred HHHcCCCC
Q 046703 587 LMLGSEIV 594 (635)
Q Consensus 587 ~~L~~~~~ 594 (635)
++|+.+.+
T Consensus 328 ~~L~~~~~ 335 (343)
T 1luf_A 328 RILQRMCE 335 (343)
T ss_dssp HHHHHTTC
T ss_pred HHHHHHHh
Confidence 99988753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=255.78 Aligned_cols=200 Identities=24% Similarity=0.316 Sum_probs=153.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 107 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 183 (325)
T 3kul_A 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVL 183 (325)
T ss_dssp CCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEE
Confidence 36999999999998888999999998641 123357899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCc-eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
++.++.+||+|||+++.......... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 184 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-- 261 (325)
T 3kul_A 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-- 261 (325)
T ss_dssp ECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--
T ss_pred ECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 99999999999999987654322211 122345778999999998999999999999999999999 99998543211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVL 595 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 595 (635)
.....+..+..... +......+.+++..||+.||++|||+.||+++|+.+...
T Consensus 262 -----~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 262 -----DVISSVEEGYRLPA---------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHHcCCCCCC---------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11222222221111 112234577899999999999999999999999887543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=240.49 Aligned_cols=198 Identities=24% Similarity=0.310 Sum_probs=154.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++.+.. ....+.+++.+++.++.|++.||.|||+.+ |+||||||+||+
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil 136 (268)
T 3sxs_A 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCL 136 (268)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEE
T ss_pred CCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEE
Confidence 35999999999998888999999988632 123456899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 137 ~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--- 212 (268)
T 3sxs_A 137 VDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--- 212 (268)
T ss_dssp ECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---
T ss_pred ECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---
Confidence 9999999999999998765432211 112345678999999998899999999999999999999 99998643211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
........+...... ......+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 213 ----~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 213 ----EVVLKVSQGHRLYRP---------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----HHHHHHHTTCCCCCC---------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----HHHHHHHcCCCCCCC---------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 111112222211111 1112357789999999999999999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-28 Score=254.13 Aligned_cols=163 Identities=29% Similarity=0.402 Sum_probs=129.1
Q ss_pred cCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccc
Q 046703 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEY 491 (635)
Q Consensus 412 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 491 (635)
+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++................+|..|+|||.
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence 888899999999999999999999 99999999999999999999999999987654433333344678899999999
Q ss_pred ccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHH
Q 046703 492 ASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLL 570 (635)
Q Consensus 492 ~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 570 (635)
+.+..++.++||||||+++|||++ |+.||......+ ........+......+ .....+.+++..
T Consensus 267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~---------~~~~~l~~li~~ 331 (359)
T 3vhe_A 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRAPD---------YTTPEMYQTMLD 331 (359)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCCCT---------TCCHHHHHHHHH
T ss_pred hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCCCC---------CCCHHHHHHHHH
Confidence 999999999999999999999998 999986543221 1222222332222211 112347789999
Q ss_pred hcccCCCCCCChHHHHHHHcCC
Q 046703 571 CVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 571 Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
||+.||++|||++||++.|+.+
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-28 Score=256.45 Aligned_cols=209 Identities=13% Similarity=0.146 Sum_probs=154.1
Q ss_pred eeeccccccccccCCC----CccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPDG----GQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~----~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+||+.+..+... ...+|++++++... ......+++.+++.++.||+.||.|||+.+ |+||||||
T Consensus 104 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp 180 (364)
T 3op5_A 104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKA 180 (364)
T ss_dssp TCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCH
Confidence 3469999988877533 24589999987421 123367999999999999999999999999 99999999
Q ss_pred cceEec--cCCCCccCccccceecCCCCCC-----CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCC
Q 046703 447 GNVLLD--QDMNPKISDFGLARTFGGDETE-----GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 447 ~NIlld--~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
+|||++ .++.+||+|||+++.+...... .......||..|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 8899999999999876432211 111234589999999999999999999999999999999999999
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|....... .......... ...+.+++++++... ..+..+.+++..||+.||++||++.+|+++|+...
T Consensus 261 f~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 261 WEDNLKDP--KYVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TGGGTTCH--HHHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccccccCH--HHHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 97432221 1111111111 112223333332211 11235678899999999999999999999997763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=250.30 Aligned_cols=202 Identities=15% Similarity=0.095 Sum_probs=154.3
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++++.+..+...+...|+++++.... ....+.+++.+++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~ 139 (330)
T 2izr_A 63 SGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIG 139 (330)
T ss_dssp SCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred CCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeec
Confidence 5889998888887788899999988421 122467999999999999999999999999 99999999999999
Q ss_pred cCCC-----CccCccccceecCCCCCCC-----ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 453 QDMN-----PKISDFGLARTFGGDETEG-----NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 453 ~~~~-----~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
.++. +||+|||+++......... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 140 ~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 140 RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 8876 9999999998765432211 12346789999999999999999999999999999999999999976
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
....+................. + .+.. ..+ .+.+++..||+.||.+||++++|++.|+..
T Consensus 220 ~~~~~~~~~~~~i~~~~~~~~~-~----~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 220 LKADTLKERYQKIGDTKRATPI-E----VLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCH-H----HHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHhhhccCCH-H----HHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 5433332222222111110000 0 0000 012 677899999999999999999999988644
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-28 Score=267.02 Aligned_cols=197 Identities=23% Similarity=0.338 Sum_probs=154.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..++.....+|+++++++.. ......+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 273 l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NI 349 (495)
T 1opk_A 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNC 349 (495)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhE
Confidence 46999999999998888999999998631 122356889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|++.++.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |+.||......+
T Consensus 350 ll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~- 427 (495)
T 1opk_A 350 LVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ- 427 (495)
T ss_dssp EECGGGCEEECCTTCEECCTTCCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EECCCCcEEEeecccceeccCCceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999998764332111 112345678999999999999999999999999999999 999986543221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
. ...+..+..... +......+.+|+.+||+.||++|||+.+|+++|+...
T Consensus 428 --~----~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 428 --V----YELLEKDYRMER---------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --H----HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --H----HHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1 122222221111 1122345778999999999999999999999998874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-27 Score=247.45 Aligned_cols=197 Identities=25% Similarity=0.327 Sum_probs=154.0
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------h-----------------------hccccCcccchhhhhhhccc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------E-----------------------RCKLLDWSKRFRIICGTGRG 427 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~-----------------------~~~~l~~~~~~~i~~~ia~a 427 (635)
+.|+||+.+..+......+|+++++.+... . ....+++.+++.++.||++|
T Consensus 83 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 162 (314)
T 2ivs_A 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162 (314)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHH
T ss_pred CCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHH
Confidence 369999999999888889999999976311 0 12348888999999999999
Q ss_pred cchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeee
Q 046703 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG 507 (635)
Q Consensus 428 L~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~G 507 (635)
|.|||+++ |+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||
T Consensus 163 l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 239 (314)
T 2ivs_A 163 MQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239 (314)
T ss_dssp HHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHH
T ss_pred HHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHH
Confidence 99999999 999999999999999999999999999876544332222334567889999999999999999999999
Q ss_pred hhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 508 ILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 508 vvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
+++|||++ |+.||....... ....+..+...... ......+.+++.+||+.||++|||+.||+
T Consensus 240 ~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 240 VLLWEIVTLGGNPYPGIPPER-------LFNLLKTGHRMERP---------DNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp HHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHH-------HHHHhhcCCcCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999 999986543221 11222232222211 12234577899999999999999999999
Q ss_pred HHHcCC
Q 046703 587 LMLGSE 592 (635)
Q Consensus 587 ~~L~~~ 592 (635)
+.|+.+
T Consensus 304 ~~l~~~ 309 (314)
T 2ivs_A 304 KDLEKM 309 (314)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-27 Score=251.14 Aligned_cols=195 Identities=24% Similarity=0.328 Sum_probs=149.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+...|+++++.+... .....+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 62 l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll 138 (323)
T 3tki_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLL 138 (323)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEE
Confidence 469999999999888889999999986421 23446889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++................||..|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-- 216 (323)
T 3tki_A 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-- 216 (323)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--
T ss_pred eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--
Confidence 9999999999999987643322222334678999999999987775 7899999999999999999999865432211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. ...+...... ..+ .......+.+++.+||+.||++|||++||++.
T Consensus 217 ~----~~~~~~~~~~--~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 217 E----YSDWKEKKTY--LNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp H----HHHHHTTCTT--STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred H----HHHHhccccc--CCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1 1111111111 000 01122346689999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=249.29 Aligned_cols=208 Identities=15% Similarity=0.139 Sum_probs=152.3
Q ss_pred eeccccccccccCCC----CccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDG----GQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~----~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+... ...+|+++++.... ....+.+++.+++.++.||+.||.|||+.+ |+||||||+|
T Consensus 105 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 181 (345)
T 2v62_A 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAAN 181 (345)
T ss_dssp CSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHH
Confidence 468999988777543 67899999997321 122347899999999999999999999999 9999999999
Q ss_pred eEeccCC--CCccCccccceecCCCCCC-----CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCC
Q 046703 449 VLLDQDM--NPKISDFGLARTFGGDETE-----GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 521 (635)
Q Consensus 449 Illd~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~ 521 (635)
|+++.++ .+||+|||+++........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999887 8999999999876432211 11123578999999999999999999999999999999999999985
Q ss_pred CccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
...... ............... ..+..... ....+..+.+++..||+.||++|||+++|++.|+...
T Consensus 262 ~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 262 QNLKDP--VAVQTAKTNLLDELP-QSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp GGTTCH--HHHHHHHHHHHHTTT-HHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccccc--HHHHHHHHhhccccc-HHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 422111 111111111111111 11100000 0012235778999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=246.83 Aligned_cols=210 Identities=21% Similarity=0.243 Sum_probs=151.2
Q ss_pred eeccccccccccCCCC----ccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhcc--------ccceEE
Q 046703 377 MWFGDLIDMRSFPDGG----QDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQD--------SRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~----~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------~~~~ii 440 (635)
+.|+||+.+..+.... ..+|+++++.+.. ..+...+++.+++.++.|++.||.|||+. + |+
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---iv 164 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IA 164 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EE
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EE
Confidence 4699999887776433 6899999998642 22345789999999999999999999998 7 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCCc--eeeeeeccCCCCcccccCCCCccc------CceeeeehhhHh
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGN--TTRVVGTYGYMAPEYASDGQFSVK------SDVFSFGILLLE 512 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k------sDVwS~Gvvl~e 512 (635)
||||||+||+++.++.+||+|||++........... .....||..|+|||.+.+...+.+ +|||||||++||
T Consensus 165 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 244 (337)
T 3mdy_A 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244 (337)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHH
T ss_pred ecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHH
Confidence 999999999999999999999999987643322211 123468999999999987766654 999999999999
Q ss_pred hhhC----------CCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 513 IVSG----------KKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 513 iltG----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
|++| +.||......... .................... .........+.+++.+||+.||++|||+
T Consensus 245 l~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 245 VARRCVSGGIVEEYQLPYHDLVPSDPS--YEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHhccCcccccccccccHhhhcCCCCc--hhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 9999 5565433222211 11111111111111111111 1123567778999999999999999999
Q ss_pred HHHHHHHcCCCC
Q 046703 583 PSVILMLGSEIV 594 (635)
Q Consensus 583 ~evl~~L~~~~~ 594 (635)
.||++.|+.+.+
T Consensus 320 ~ell~~L~~l~~ 331 (337)
T 3mdy_A 320 LRVKKTLAKMSE 331 (337)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-27 Score=244.16 Aligned_cols=202 Identities=21% Similarity=0.270 Sum_probs=151.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 68 l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~ 144 (294)
T 4eqm_A 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILI 144 (294)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 46999999999998888999999998642 123457899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------ 217 (294)
T 4eqm_A 145 DSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------ 217 (294)
T ss_dssp CTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------
T ss_pred CCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------
Confidence 9999999999999976543221 122335689999999999999999999999999999999999999864321
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHHcCCCC
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-CMPSVILMLGSEIV 594 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~ 594 (635)
........... .... ........+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 218 ~~~~~~~~~~~-~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 218 VSIAIKHIQDS-VPNV-----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHHSSC-CCCH-----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHHHHhhcc-CCCc-----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11122222221 1111 0011112234577899999999999998 89999999988754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-27 Score=241.29 Aligned_cols=195 Identities=17% Similarity=0.135 Sum_probs=147.5
Q ss_pred cccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe---ccCCCC
Q 046703 386 RSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNP 457 (635)
Q Consensus 386 ~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll---d~~~~~ 457 (635)
..+...+...|+++++.... ......+++.+++.++.||+.||.|||+.+ |+||||||+||++ +.++.+
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~ 147 (296)
T 4hgt_A 71 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCE
T ss_pred eeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeE
Confidence 33334566788999987421 122457899999999999999999999999 9999999999999 788999
Q ss_pred ccCccccceecCCCCCCC-----ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 458 KISDFGLARTFGGDETEG-----NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 458 kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
||+|||+++......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||............
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 999999998775433211 122357899999999999999999999999999999999999999765544444433
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
............... ... .+..+.+++..||+.||++|||+++|++.|+.+
T Consensus 228 ~~~~~~~~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 228 ERISEKKMSTPIEVL-----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHHHHSCHHHH-----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhcccccchhhhh-----hcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 333222111111000 001 123577899999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-27 Score=244.29 Aligned_cols=202 Identities=26% Similarity=0.388 Sum_probs=142.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+.. ...+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 77 l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil 152 (289)
T 3og7_A 77 TRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIF 152 (289)
T ss_dssp CCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCCCcEEEEEeecc-CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 46999998888754 45688999987631 123456889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
++.++.+||+|||++................|+..|+|||.+. ...++.++||||||+++|||++|+.||......
T Consensus 153 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~- 231 (289)
T 3og7_A 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR- 231 (289)
T ss_dssp EETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-
T ss_pred ECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-
Confidence 9999999999999998654322222333467899999999986 667889999999999999999999998643221
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.........+......... ....+..+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 232 -----~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 232 -----DQIIEMVGRGSLSPDLSKV-----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -----HHHHHHHHHTSCCCCTTSS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----HHHHHHhcccccCcchhhc-----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1122222233222211111 1122346788999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-27 Score=238.95 Aligned_cols=197 Identities=26% Similarity=0.349 Sum_probs=145.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+|++.+..+...+..+|+++++.+.. ..+.+.+++..++.++.|+++||.|||+++..+|+||||||+||+++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~ 142 (271)
T 3dtc_A 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILIL 142 (271)
T ss_dssp CCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEES
T ss_pred cCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEe
Confidence 46999999999988888999999998632 22346789999999999999999999999855689999999999998
Q ss_pred c--------CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 453 Q--------DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 453 ~--------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
. ++.+||+|||++........ ....|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 143 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 143 QKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp SCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6 67799999999986543221 23568999999999999999999999999999999999999986432
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.. ............... +......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 219 ~~------~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 219 GL------AVAYGVAMNKLALPI---------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HH------HHHHHHHTSCCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HH------HHHHhhhcCCCCCCC---------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 111111111111111 112234577899999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-28 Score=256.73 Aligned_cols=198 Identities=23% Similarity=0.337 Sum_probs=143.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+||||||+||+
T Consensus 103 l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 179 (373)
T 2qol_A 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNIL 179 (373)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEE
Confidence 36999999999998888999999998631 122346899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 180 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-- 257 (373)
T 2qol_A 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-- 257 (373)
T ss_dssp ECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--
T ss_pred EcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999998765432211 1112345678999999999999999999999999999998 99998543211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.....+..+... ..+......+.+++.+||+.||++||++++|+++|+.+.
T Consensus 258 -----~~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 258 -----DVIKAVDEGYRL---------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -----HHHHHHHTTEEC---------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCC---------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111222222111 111223346788999999999999999999999998763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-27 Score=255.01 Aligned_cols=198 Identities=22% Similarity=0.256 Sum_probs=152.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------------hhccccCcccchhhhhhhccccchhhccccceEEeecc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di 444 (635)
+.|+||+.+..+...+...|+++++.+... .....+++.+++.++.||++||.|||+.+ |+||||
T Consensus 131 l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDl 207 (367)
T 3l9p_A 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDI 207 (367)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred CCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 369999999999888889999999986311 11235888899999999999999999999 999999
Q ss_pred CCcceEeccCC---CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCC
Q 046703 445 KAGNVLLDQDM---NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNR 520 (635)
Q Consensus 445 k~~NIlld~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf 520 (635)
||+|||++.++ .+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 208 kp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999554 599999999986533222222333567889999999999999999999999999999998 99998
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
...... .....+..+...... ......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 288 ~~~~~~-------~~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 288 PSKSNQ-------EVLEFVTSGGRMDPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCCHH-------HHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHH-------HHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 643211 122222233222211 112235778999999999999999999999997663
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-27 Score=249.12 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=153.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hh----------------------ccccCcccchhhhhhhccccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ER----------------------CKLLDWSKRFRIICGTGRGLL 429 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~----------------------~~~l~~~~~~~i~~~ia~aL~ 429 (635)
.|+||+.+..+......+|+++++.+... .. ...+++.+++.++.||+.||.
T Consensus 107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 186 (344)
T 1rjb_A 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186 (344)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence 69999999998888889999999885311 11 123788999999999999999
Q ss_pred hhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehh
Q 046703 430 YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 509 (635)
Q Consensus 430 yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvv 509 (635)
|||+.+ |+||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||++
T Consensus 187 ~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 263 (344)
T 1rjb_A 187 FLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263 (344)
T ss_dssp HHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHH
Confidence 999999 99999999999999999999999999987654433222334567889999999999999999999999999
Q ss_pred hHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 510 LLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 510 l~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
+|||++ |+.||....... ........+..... +......+.+++.+||+.||++|||+.||++.
T Consensus 264 l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 264 LWEIFSLGVNPYPGIPVDA------NFYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHTTTSCCSSTTCCCSH------HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCcccCCcHH------HHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999998 999986543221 11222222221111 11123457789999999999999999999999
Q ss_pred HcCCC
Q 046703 589 LGSEI 593 (635)
Q Consensus 589 L~~~~ 593 (635)
|+...
T Consensus 329 l~~~~ 333 (344)
T 1rjb_A 329 LGCQL 333 (344)
T ss_dssp HHHHC
T ss_pred HHHHH
Confidence 98764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-27 Score=246.45 Aligned_cols=211 Identities=22% Similarity=0.251 Sum_probs=150.3
Q ss_pred eeccccccccc-----cCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhcc---------ccce
Q 046703 377 MWFGDLIDMRS-----FPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQD---------SRLR 438 (635)
Q Consensus 377 l~h~nLv~l~~-----~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------~~~~ 438 (635)
+.|+|++.+.. ...+...+|+++++.+.. ..+...+++..++.++.||++||.|||+. +
T Consensus 64 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--- 140 (336)
T 3g2f_A 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--- 140 (336)
T ss_dssp CCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---
T ss_pred ccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---
Confidence 46899988764 445566789999998642 12345568889999999999999999999 7
Q ss_pred EEeeccCCcceEeccCCCCccCccccceecCCCCCC------CceeeeeeccCCCCcccccC-------CCCcccCceee
Q 046703 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETE------GNTTRVVGTYGYMAPEYASD-------GQFSVKSDVFS 505 (635)
Q Consensus 439 iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwS 505 (635)
|+||||||+|||++.++.+||+|||+++........ .......||..|+|||.+.+ ..++.++||||
T Consensus 141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws 220 (336)
T 3g2f_A 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220 (336)
T ss_dssp EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence 999999999999999999999999999876532211 11122468999999999876 45678999999
Q ss_pred eehhhHhhhhCCCCCCCccC-CCcccHH----------HHHHHHhh-cCCCCcCCCCccccCCCHHHHHHHHHHHHHhcc
Q 046703 506 FGILLLEIVSGKKNRGFYHL-DNKLNLI----------GHAWKLWN-KGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQ 573 (635)
Q Consensus 506 ~Gvvl~eiltG~~pf~~~~~-~~~~~~~----------~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~ 573 (635)
||+++|||++|+.|+..... ....... ........ ......+.+.. .........+.+++.+||+
T Consensus 221 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~ 297 (336)
T 3g2f_A 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWD 297 (336)
T ss_dssp HHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhc
Confidence 99999999999777533221 1111110 01111111 11111111111 1123456678899999999
Q ss_pred cCCCCCCChHHHHHHHcCCC
Q 046703 574 QHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 574 ~dP~~RPt~~evl~~L~~~~ 593 (635)
.||++|||++||++.|+.+.
T Consensus 298 ~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 298 QDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred CChhhCcchHHHHHHHHHHH
Confidence 99999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-27 Score=244.83 Aligned_cols=204 Identities=17% Similarity=0.209 Sum_probs=149.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 58 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~ 134 (292)
T 3o0g_A 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLI 134 (292)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 36999999999988888999999998742 122467899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC-CcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ ......+|..|+|||.+.+.. ++.++||||||+++|||++|..|+-.. .....
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~ 210 (292)
T 3o0g_A 135 NRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDD 210 (292)
T ss_dssp CTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHH
T ss_pred cCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHH
Confidence 9999999999999987643322 122356799999999987766 799999999999999999998885221 12222
Q ss_pred HHHHHHHHhhcCCCCcC------CC---------CccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEM------ID---------PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~------~d---------~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
................. .+ ..............+.+++.+||+.||++|||++|+++
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 22222222111100000 00 00000111223345678999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-27 Score=261.72 Aligned_cols=197 Identities=24% Similarity=0.364 Sum_probs=148.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+... ..+|+++++++.. ....+.+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 236 l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Ni 311 (452)
T 1fmk_A 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 311 (452)
T ss_dssp CCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhE
Confidence 469999999888765 6789999998631 122356899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|++.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-- 388 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-- 388 (452)
T ss_dssp EECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--
T ss_pred EECCCCCEEECCCccceecCCCceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998764332211 122456788999999999999999999999999999999 89998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
.....+..+..... +...+..+.+++.+||+.||++|||+++|+++|+....
T Consensus 389 -----~~~~~i~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 389 -----EVLDQVERGYRMPC---------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -----HHHHHHHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -----HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 12222223322111 12233457789999999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-27 Score=248.78 Aligned_cols=199 Identities=19% Similarity=0.196 Sum_probs=133.9
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+......+|+++++.+.. ....+.+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 64 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~ 140 (325)
T 3kn6_A 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFT 140 (325)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEe
Confidence 3999999999998889999999998642 133467899999999999999999999999 99999999999997
Q ss_pred cCC---CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 453 QDM---NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 453 ~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
.++ .+||+|||+++....... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 141 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 218 (325)
T 3kn6_A 141 DENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218 (325)
T ss_dssp C----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C
T ss_pred cCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc
Confidence 665 799999999987643322 123356799999999999999999999999999999999999999765433222
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.........+..+..... .... ......+.+++.+||+.||++|||++||++
T Consensus 219 ~~~~~~~~~i~~~~~~~~-~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 219 TSAVEIMKKIKKGDFSFE-GEAW-----KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCHHHHHHHHTTTCCCCC-SHHH-----HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccHHHHHHHHHcCCCCCC-cccc-----cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 223333344434332210 0000 112345778999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-27 Score=258.82 Aligned_cols=196 Identities=25% Similarity=0.380 Sum_probs=151.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+.. ...+|+++++++.. ......+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 240 l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Ni 315 (454)
T 1qcf_A 240 LQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANI 315 (454)
T ss_dssp CCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGE
T ss_pred CCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 46999999988876 56789999998631 122346888899999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|++.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-- 392 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-- 392 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998764321111 111345778999999998999999999999999999999 99998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
. ....+..+..... +...+..+.+++.+||+.||++|||+++|+++|+...
T Consensus 393 -~----~~~~i~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 393 -E----VIRALERGYRMPR---------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -H----HHHHHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -H----HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1 1222222222111 1122345778999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-27 Score=249.69 Aligned_cols=198 Identities=21% Similarity=0.269 Sum_probs=144.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+...+ ..++++++.... ......+++..++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 74 l~hp~iv~~~~~~~~~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl 149 (327)
T 3lzb_A 74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVL 149 (327)
T ss_dssp CCBTTBCCCCEEEESS-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCCCCeeEEEEEEecC-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEE
Confidence 3699999998887654 367777766531 223456889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 150 ~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-- 227 (327)
T 3lzb_A 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 227 (327)
T ss_dssp EEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--
T ss_pred EcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--
Confidence 99999999999999987654433333333456788999999999999999999999999999999 999986543222
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
.. ..+..+..... +......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 228 -~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 228 -IS----SILEKGERLPQ---------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -HH----HHHHTTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -HH----HHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 11222221111 11123357789999999999999999999999987753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=239.34 Aligned_cols=193 Identities=17% Similarity=0.126 Sum_probs=145.8
Q ss_pred cCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe---ccCCCCcc
Q 046703 388 FPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---DQDMNPKI 459 (635)
Q Consensus 388 ~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll---d~~~~~kl 459 (635)
+...+...|+++++... .......+++.+++.++.||+.||.|||+++ |+||||||+||++ +.++.+||
T Consensus 73 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 149 (296)
T 3uzp_A 73 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEE
T ss_pred ccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEE
Confidence 33456678899998742 1123457899999999999999999999999 9999999999999 58889999
Q ss_pred CccccceecCCCCCCC-----ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHH
Q 046703 460 SDFGLARTFGGDETEG-----NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGH 534 (635)
Q Consensus 460 ~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~ 534 (635)
+|||++.......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..............
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 3uzp_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred eeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence 9999998775433211 12335789999999999999999999999999999999999999976544443333333
Q ss_pred HHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 535 AWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
............+ ... ....+.+++.+||+.||++|||+++|++.|+..
T Consensus 230 ~~~~~~~~~~~~~-----~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 230 ISEKKMSTPIEVL-----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHHSCHHHH-----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hcccccCCchHHH-----Hhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 2222111110000 011 123577899999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-27 Score=244.65 Aligned_cols=193 Identities=22% Similarity=0.295 Sum_probs=150.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+||+.+..+...+..+|+++++.+.. ......+++.++..++.||++||.|||+.+ |+||||||+||+++
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 36999999988887788999999988642 123456899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++......... .....||..|+|||.+.+..++.++||||||+++|||++|+.||..... ..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~-- 248 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQ-- 248 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HH--
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH--
Confidence 9999999999999876543222 2335789999999999999999999999999999999999999854321 11
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
....+.......... .......+.+++.+||+.||++|||++||++.
T Consensus 249 --~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 --AMKRLRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHHHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122222222222111 11122346789999999999999999999873
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-27 Score=251.03 Aligned_cols=189 Identities=23% Similarity=0.314 Sum_probs=149.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++++.. ......+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 71 l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll 147 (328)
T 3fe3_A 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLL 147 (328)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEE
Confidence 46999999999998889999999998632 123467899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCc-ccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++....... ......||+.|+|||.+.+..+. .++||||+||++|||++|+.||......
T Consensus 148 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---- 220 (328)
T 3fe3_A 148 DADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---- 220 (328)
T ss_dssp CTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred cCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----
Confidence 999999999999997664332 12235689999999999888775 8999999999999999999998643211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........+... + +......+.+++.+||+.||++|||++|+++.
T Consensus 221 ---~~~~~i~~~~~~-~---------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 221 ---ELRERVLRGKYR-I---------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---HHHHHHHHCCCC-C---------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---HHHHHHHhCCCC-C---------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 122222222211 0 11122346789999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-27 Score=254.91 Aligned_cols=192 Identities=25% Similarity=0.310 Sum_probs=148.6
Q ss_pred eeccccccccccCC-CCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPD-GGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~-~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+.. ....+|+++++++.. ......+++..++.++.||++||+|||+++ |+||||||+|
T Consensus 243 l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~N 319 (450)
T 1k9a_A 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 319 (450)
T ss_dssp CCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhh
Confidence 46999999988753 344799999998631 112234788899999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDN 527 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~ 527 (635)
||++.++.+||+|||+++...... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 320 ill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 320 VLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp EEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred EEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998643221 12356789999999999999999999999999999998 999986543322
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.. ..+..+..... +...+..+.+++..||+.||++|||+.+|++.|+.+
T Consensus 395 ---~~----~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 395 ---VV----PRVEKGYKMDA---------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ---HH----HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HH----HHHHcCCCCCC---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 22223322221 112234577899999999999999999999999765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-27 Score=244.46 Aligned_cols=185 Identities=19% Similarity=0.284 Sum_probs=143.9
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+...+..+|+++++.... ......+++.++..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLG 191 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEC
Confidence 6999999999988888999999988632 123456999999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||++........ .....||..|+|||.+.+ .++.++||||||+++|||++|..++...
T Consensus 192 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~--------- 258 (311)
T 3p1a_A 192 PRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG--------- 258 (311)
T ss_dssp GGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---------
T ss_pred CCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---------
Confidence 999999999999987643321 223568999999998875 7899999999999999999997765321
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..+..+..+.... .+.. .....+.+++.+||+.||++|||++||++
T Consensus 259 -~~~~~~~~~~~~~----~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 -EGWQQLRQGYLPP----EFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHHHHHTTTCCCH----HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cHHHHHhccCCCc----cccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1122222222111 1111 12345778999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-27 Score=244.37 Aligned_cols=197 Identities=23% Similarity=0.329 Sum_probs=153.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh------hh-----------------ccccCcccchhhhhhhccccchhhcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------ER-----------------CKLLDWSKRFRIICGTGRGLLYLHQD 434 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~-----------------~~~l~~~~~~~i~~~ia~aL~yLH~~ 434 (635)
.|+||+.+..+...+...|+++++.+... .. ...+++.+++.++.||++||.|||+.
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 164 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 69999999998888889999999875311 11 12488999999999999999999999
Q ss_pred ccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhh
Q 046703 435 SRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 435 ~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eil 514 (635)
+ |+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||+
T Consensus 165 ~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 241 (313)
T 1t46_A 165 N---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (313)
T ss_dssp T---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 9 9999999999999999999999999998765443322233356788999999999999999999999999999999
Q ss_pred h-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 515 S-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 515 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
+ |+.||........ .......+..... +......+.+++.+||+.||++|||+.||+++|+..
T Consensus 242 t~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 242 SLGSSPYPGMPVDSK------FYKMIKEGFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp TTTCCSSTTCCSSHH------HHHHHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCcccchhH------HHHHhccCCCCCC---------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 8 9999865432211 1122222211111 111234577899999999999999999999999765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=239.84 Aligned_cols=204 Identities=24% Similarity=0.357 Sum_probs=146.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh--------hhccccCcccchhhhhhhccccchhhc---cccceEEeeccC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ--------ERCKLLDWSKRFRIICGTGRGLLYLHQ---DSRLRIIHRDLK 445 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~---~~~~~iiH~dik 445 (635)
+.|+||+.+..+..+ ..|+++++.+... .....+++..++.++.||++||+|||+ ++ |+|||||
T Consensus 58 l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlk 132 (307)
T 2eva_A 58 VNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLK 132 (307)
T ss_dssp CCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCS
T ss_pred CCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCC
Confidence 369999999888763 4799999886311 112246778889999999999999999 66 9999999
Q ss_pred CcceEeccCCC-CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 446 AGNVLLDQDMN-PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 446 ~~NIlld~~~~-~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
|+||+++.++. +||+|||++...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 133 p~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 133 PPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp GGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred hhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 99999998887 799999999765322 122468999999999999999999999999999999999999986432
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC-CCCCCCCCCc
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI-VLPQPKQPGF 603 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~-~~p~p~~p~~ 603 (635)
... ....+. ...+....... . ....+.+++.+||+.||++|||++||+++|+.+. .++.+..|..
T Consensus 208 ~~~----~~~~~~-~~~~~~~~~~~-----~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 208 GPA----FRIMWA-VHNGTRPPLIK-----N----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp SSH----HHHHHH-HHTTCCCCCBT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred ccH----HHHHHH-HhcCCCCCccc-----c----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 211 111111 12222222211 1 1235678999999999999999999999998764 4455444444
Q ss_pred c
Q 046703 604 L 604 (635)
Q Consensus 604 ~ 604 (635)
+
T Consensus 274 ~ 274 (307)
T 2eva_A 274 Y 274 (307)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=245.37 Aligned_cols=198 Identities=20% Similarity=0.280 Sum_probs=141.6
Q ss_pred eeccccccccccCCCCcc------EEEEecccchhh-----------hhccccCcccchhhhhhhccccchhhccccceE
Q 046703 377 MWFGDLIDMRSFPDGGQD------LYIRMSASELDQ-----------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~------lyl~~~~~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 439 (635)
+.|+||+.+..+...... .|+++++.+... .....+++.+++.++.||++||.|||+.+ |
T Consensus 82 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i 158 (323)
T 3qup_A 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---F 158 (323)
T ss_dssp CCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred CCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 368999988877644433 389999876421 11125889999999999999999999999 9
Q ss_pred EeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCC
Q 046703 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 518 (635)
Q Consensus 440 iH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~ 518 (635)
+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 159 vH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp CCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654433222333456788999999999999999999999999999999 899
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
||......+ .. ..+..+..... +......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 239 p~~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 239 PYAGIENAE---IY----NYLIGGNRLKQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp TTTTCCGGG---HH----HHHHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccChHH---HH----HHHhcCCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 986533221 11 11122221111 1122245778999999999999999999999998774
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-27 Score=243.48 Aligned_cols=196 Identities=23% Similarity=0.315 Sum_probs=151.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++.+.. ......++++.++.++.|+++||.|||+.+ |+||||||+||+
T Consensus 62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil 138 (269)
T 4hcu_A 62 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCL 138 (269)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEE
Confidence 35999999999988888999999998642 123456899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||......
T Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--- 214 (269)
T 4hcu_A 139 VGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--- 214 (269)
T ss_dssp ECGGGCEEECCTTGGGGBCCHHHHS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred EcCCCCEEecccccccccccccccc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---
Confidence 9999999999999998654322111 112345778999999998999999999999999999999 89998643211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+..+..... +......+.+++..||+.||++|||++|+++.|+.+
T Consensus 215 ----~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 215 ----EVVEDISTGFRLYK---------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ----HHHHHHHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHhcCccCCC---------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11222222211111 111123577899999999999999999999999765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-27 Score=246.98 Aligned_cols=201 Identities=20% Similarity=0.232 Sum_probs=145.2
Q ss_pred eccccccccccCCCCc-----cEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPDGGQ-----DLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~-----~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.+..+..... .+|+++++.... ......+++.++..++.||+.||+|||+.+ |+||||||
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp 148 (308)
T 3g33_A 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKP 148 (308)
T ss_dssp CCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCT
T ss_pred CCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 4899998887764322 578999887632 112234899999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+||+++.++.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 149 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 149 ENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp TTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred HHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999976543222 22356899999999999999999999999999999999999998643322
Q ss_pred CcccHHHHHHHHhhcCCCCcCC------CCccc-------cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMI------DPCYQ-------ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~------d~~l~-------~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
................... ..... .....+....+.+++.+||+.||++|||+.|+++
T Consensus 226 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 226 ---DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp ---HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 2222222221111000000 00000 0001122345778999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-27 Score=243.06 Aligned_cols=204 Identities=22% Similarity=0.284 Sum_probs=147.2
Q ss_pred eeccccccccccCC--CCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPD--GGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~--~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+.. +...+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||+|
T Consensus 68 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~N 144 (295)
T 3ugc_A 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRN 144 (295)
T ss_dssp CCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhh
Confidence 35899999887653 335689999988531 122345899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccC--
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL-- 525 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~-- 525 (635)
|+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 145 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~ 224 (295)
T 3ugc_A 145 ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224 (295)
T ss_dssp EEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH
T ss_pred EEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH
Confidence 99999999999999999876533221 111223467789999999999999999999999999999999998754210
Q ss_pred -------CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 526 -------DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 526 -------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
................+..... +......+.+++.+||+.||++|||++||+++|+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 225 MRMIGNDKQGQMIVFHLIELLKNNGRLPR---------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhcCccccchhHHHHHHHHhccCcCCC---------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111111122222222222211 112234577899999999999999999999999765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-27 Score=245.75 Aligned_cols=197 Identities=24% Similarity=0.316 Sum_probs=152.3
Q ss_pred eccccccccccCCCCccEEEEecccchhh-------h------------hccccCcccchhhhhhhccccchhhccccce
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-------E------------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLR 438 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 438 (635)
.|+||+.+..+...+..+|+++++.+... . ....+++..++.++.||+.||.|||+.+
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 184 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--- 184 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---
Confidence 69999999999888889999999875311 0 0235788999999999999999999999
Q ss_pred EEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CC
Q 046703 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GK 517 (635)
Q Consensus 439 iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~ 517 (635)
|+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |.
T Consensus 185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 264 (333)
T 2i1m_A 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264 (333)
T ss_dssp EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999987654333222233567889999999999999999999999999999998 88
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.||....... ........+..... +......+.+++..||+.||++|||+.||++.|+..
T Consensus 265 ~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 265 NPYPGILVNS------KFYKLVKDGYQMAQ---------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp CSSTTCCSSH------HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccchhH------HHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 8986433221 11122222221111 111124577899999999999999999999999754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-27 Score=240.08 Aligned_cols=195 Identities=24% Similarity=0.301 Sum_probs=140.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+.. ...+|+++++.+.. ......+++.+++.++.|+++||.|||+.+ |+||||||+||+
T Consensus 73 l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 148 (281)
T 1mp8_A 73 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVL 148 (281)
T ss_dssp CCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEE
Confidence 36999999888764 45789999987642 122346899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||......+
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-- 225 (281)
T 1mp8_A 149 VSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-- 225 (281)
T ss_dssp EEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--
T ss_pred ECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--
Confidence 999999999999999876433221 1222456778999999998999999999999999999996 999986543221
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
... .+..+..... +......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 226 -~~~----~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 226 -VIG----RIENGERLPM---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -HHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHH----HHHcCCCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 1222222111 112234577899999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-27 Score=243.05 Aligned_cols=203 Identities=21% Similarity=0.277 Sum_probs=146.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 133 (288)
T 1ob3_A 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLI 133 (288)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred cCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 46999999999888888999999987632 122356888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~ 208 (288)
T 1ob3_A 134 NREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---D 208 (288)
T ss_dssp CTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H
T ss_pred cCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence 9999999999999987643221 1223567999999999876 45899999999999999999999998643221 1
Q ss_pred HHHHHHHHhhcCCCCcC--------CCCccc-------cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEM--------IDPCYQ-------ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~--------~d~~l~-------~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
................. .++... ..........+.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 22222222111100000 000000 0111122345678999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=246.97 Aligned_cols=189 Identities=20% Similarity=0.221 Sum_probs=148.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++|+.+.........+|+++++.+.. ..+...+++.++..++.||+.||.|||+++ |+||||||+|||+
T Consensus 62 l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll 138 (337)
T 1o6l_A 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLML 138 (337)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred CCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEE
Confidence 36999999999888888999999998642 123457899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..
T Consensus 139 ~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~- 212 (337)
T 1o6l_A 139 DKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ER- 212 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH-
T ss_pred CCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HH-
Confidence 999999999999997643222 123346799999999999999999999999999999999999999854321 11
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
....+..+... + .. .....+.+++.+||+.||++|| +++||++
T Consensus 213 ---~~~~i~~~~~~-~-----p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 213 ---LFELILMEEIR-F-----PR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---HHHHHHHCCCC-C-----CT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---HHHHHHcCCCC-C-----CC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11112122111 1 11 1123467899999999999999 8999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=238.58 Aligned_cols=191 Identities=23% Similarity=0.315 Sum_probs=144.9
Q ss_pred eeccccccccccCCC--CccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+... +..+|+++++.+.. ....+.+++.++..++.||++||.|||+.+ |+||||||+||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 369999998887643 66899999988642 123456889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC---CcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
++.++.+||+|||++........ ......||..|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred ECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 99999999999999987653322 122357899999999987665 47889999999999999999999854321
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. .....+...... ..+ .......+.+++.+||+.||++|||+.||++
T Consensus 246 -~----~~~~~~~~~~~~-~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -M----CLHSKIKSQALE-FPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -H----HHHHHHHHCCCC-CCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -H----HHHHHHhcccCC-CCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 111122222111 110 0111235778999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=250.14 Aligned_cols=190 Identities=20% Similarity=0.275 Sum_probs=146.7
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+......+|+++++.+.. ..+...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~ 187 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLD 187 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEC
Confidence 5999999999988888999999998642 233467899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc--cc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~--~~ 530 (635)
.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ..
T Consensus 188 ~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~ 265 (396)
T 4dc2_A 188 SEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265 (396)
T ss_dssp TTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred CCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence 99999999999997532221 223346799999999999999999999999999999999999999965322211 11
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
........+..+... + +......+.+++..||+.||++||++
T Consensus 266 ~~~~~~~~i~~~~~~-~---------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 266 TEDYLFQVILEKQIR-I---------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CHHHHHHHHHHCCCC-C---------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hHHHHHHHHhccccC-C---------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 112222222222211 1 11122356789999999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-27 Score=245.60 Aligned_cols=192 Identities=26% Similarity=0.342 Sum_probs=139.5
Q ss_pred ccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
|+||+.+..+...+..+|+++++.... ....+.+++.++..++.||+.||.|||+.+ |+||||||+|||++ +
T Consensus 68 ~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~ 143 (343)
T 3dbq_A 68 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-D 143 (343)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-T
T ss_pred CCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-C
Confidence 388999999888888999999965431 123467899999999999999999999999 99999999999997 5
Q ss_pred CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----------CCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 455 MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 455 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+.+||+|||+++...............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 144 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 7899999999987654433323334679999999999865 67899999999999999999999998532
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. ................+. +......+.+++.+||+.||++|||+.||++.
T Consensus 224 ~-----~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 224 I-----NQISKLHAIIDPNHEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp C-----SHHHHHHHHHCTTSCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred h-----hHHHHHHHHhcCCcccCC---------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 111222222211111111 11112356789999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-27 Score=245.09 Aligned_cols=203 Identities=21% Similarity=0.247 Sum_probs=147.6
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----h-----hccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----E-----RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
+.|+||+.+..+......+|+++++.+... . ....+++..+..++.||++||.|||+.+ |+||||||
T Consensus 60 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp 136 (317)
T 2pmi_A 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKP 136 (317)
T ss_dssp CCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred cCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCh
Confidence 369999999999988889999999987321 0 1135788889999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+||+++.++.+||+|||++......... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 137 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 137 QNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp GGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHeEEcCCCCEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999999876432211 223568999999999876 4689999999999999999999999865432
Q ss_pred CCcccHHHHHHHHhhcCC---CCc---C--CCCc------------cccCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 526 DNKLNLIGHAWKLWNKGM---PSE---M--IDPC------------YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~---~~~---~--~d~~------------l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
.+ ............. ... + ..+. +...........+.+++.+||+.||++|||++|+
T Consensus 215 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 291 (317)
T 2pmi_A 215 EE---QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291 (317)
T ss_dssp HH---HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HH---HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 21 1222221111000 000 0 0000 0000011122357789999999999999999998
Q ss_pred HH
Q 046703 586 IL 587 (635)
Q Consensus 586 l~ 587 (635)
++
T Consensus 292 l~ 293 (317)
T 2pmi_A 292 LH 293 (317)
T ss_dssp TT
T ss_pred hC
Confidence 75
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-27 Score=242.94 Aligned_cols=199 Identities=22% Similarity=0.310 Sum_probs=154.1
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------h---------hccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------E---------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
+.|+||+.+..+...+...|+++++.+... . ....+++.+++.++.||+.||.|||+++ |+|
T Consensus 85 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H 161 (322)
T 1p4o_A 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVH 161 (322)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred cCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 368999999999888889999999876310 0 0135688899999999999999999999 999
Q ss_pred eccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCC
Q 046703 442 RDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNR 520 (635)
Q Consensus 442 ~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf 520 (635)
|||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 162 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 241 (322)
T 1p4o_A 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence 99999999999999999999999986543322222233456889999999999999999999999999999999 88887
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
..... .........+...... ......+.+++.+||+.||++|||+.||++.|+....
T Consensus 242 ~~~~~-------~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 242 QGLSN-------EQVLRFVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTSCH-------HHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ccCCH-------HHHHHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 54321 1122222233222211 1123357789999999999999999999999988754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-27 Score=246.67 Aligned_cols=188 Identities=21% Similarity=0.263 Sum_probs=148.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+||+.+..+......+|+++++.... ....+.+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 66 l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~ 142 (336)
T 3h4j_B 66 LRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLD 142 (336)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEEC
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEc
Confidence 46999999999988888999999998632 123567899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||++........ .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..........
T Consensus 143 ~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~- 218 (336)
T 3h4j_B 143 DNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK- 218 (336)
T ss_dssp TTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-
T ss_pred CCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-
Confidence 999999999999987644322 223568999999999988776 689999999999999999999996543222110
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+..... ..+......+.+++.+||+.||.+|||++||++
T Consensus 219 --------------~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 219 --------------KVNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --------------CCCSSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --------------HHHcCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000000 111112335678999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-27 Score=242.89 Aligned_cols=195 Identities=22% Similarity=0.282 Sum_probs=151.4
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+......+|+++++.+.. ......+++.+++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 77 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili 153 (283)
T 3gen_A 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLV 153 (283)
T ss_dssp CCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEE
T ss_pred CCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEE
Confidence 5999999999988888999999988632 122456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---- 228 (283)
T 3gen_A 154 NDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---- 228 (283)
T ss_dssp CTTSCEEECSTTGGGGBCCHHHHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----
T ss_pred cCCCCEEEcccccccccccccccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----
Confidence 999999999999998654321111 111345678999999998899999999999999999998 99998643211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+..+...... ......+.+++.+||+.||++|||++||++.|+.+
T Consensus 229 ---~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 229 ---ETAEHIAQGLRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ---HHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHhcccCCCCC---------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111222222111111 11123577899999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-27 Score=240.99 Aligned_cols=196 Identities=24% Similarity=0.329 Sum_probs=153.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+......+|+++++.+.. ......+++..++.++.||+.||.|||+.+ |+|+||||+||
T Consensus 66 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Ni 142 (288)
T 3kfa_A 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNC 142 (288)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGE
T ss_pred CCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceE
Confidence 36999999999988888999999988631 122455889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 143 l~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~- 220 (288)
T 3kfa_A 143 LVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ- 220 (288)
T ss_dssp EECGGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EEcCCCCEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999876433221 2223556789999999999999999999999999999999 999986543221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
... .+........ +......+.+++.+||+.||++|||+.||+++|+..
T Consensus 221 --~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 221 --VYE----LLEKDYRMER---------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --HHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH----HHhccCCCCC---------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111 1112111111 112234577899999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=249.09 Aligned_cols=196 Identities=18% Similarity=0.221 Sum_probs=140.6
Q ss_pred eccccccccccCC----CCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPD----GGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~----~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.+..+.. +...+|+++++++.. ......+++.++..++.||+.||.|||+.+ |+||||||
T Consensus 113 ~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp 189 (400)
T 1nxk_A 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 189 (400)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCc
Confidence 5888888777553 366799999998631 112345899999999999999999999999 99999999
Q ss_pred cceEecc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 447 GNVLLDQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 447 ~NIlld~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+|||++. ++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 190 ~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 190 ENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999997 7889999999998754322 123467899999999999999999999999999999999999999654
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.......... ..+..+... ...+.. ......+.+++.+||+.||++|||+.||++.
T Consensus 267 ~~~~~~~~~~---~~i~~~~~~-~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 267 HGLAISPGMK---TRIRMGQYE-FPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTCSSCCSHH---HHHHHTCCC-CCTTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccccHHHH---HHHHcCccc-CCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 4332111111 111122211 111110 1122357789999999999999999999973
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=242.76 Aligned_cols=208 Identities=19% Similarity=0.197 Sum_probs=153.0
Q ss_pred eeccccccccccCCCCc----cEEEEecccchh----hhhccccCcccchhhhhhhccccchhh--------ccccceEE
Q 046703 377 MWFGDLIDMRSFPDGGQ----DLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLH--------QDSRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~----~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ii 440 (635)
+.|+||+.+..+..... .+|+++++.+.. ......+++.+++.++.||+.||.||| +.+ |+
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---iv 169 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IA 169 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EE
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---ee
Confidence 46999998887765443 799999998642 123456899999999999999999999 777 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCC--ceeeeeeccCCCCcccccCC------CCcccCceeeeehhhHh
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG--NTTRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLE 512 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwS~Gvvl~e 512 (635)
||||||+||+++.++.+||+|||++.......... ......|+..|+|||.+.+. .++.++||||||+++||
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 249 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHH
Confidence 99999999999999999999999998765432211 12235689999999998765 34578999999999999
Q ss_pred hhhC----------CCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 513 IVSG----------KKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 513 iltG----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
|++| +.||........ .................+... ....+....+.+++.+||+.||++|||+
T Consensus 250 l~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~ 324 (342)
T 1b6c_B 250 IARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTA 324 (342)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhccCcCCcccccccCccccCcCcc--cHHHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCH
Confidence 9999 667644322221 112222222222211111111 1234667788899999999999999999
Q ss_pred HHHHHHHcCC
Q 046703 583 PSVILMLGSE 592 (635)
Q Consensus 583 ~evl~~L~~~ 592 (635)
.||++.|+.+
T Consensus 325 ~~i~~~L~~i 334 (342)
T 1b6c_B 325 LRIKKTLSQL 334 (342)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=238.28 Aligned_cols=211 Identities=15% Similarity=0.184 Sum_probs=154.3
Q ss_pred eeccccccccccCCC--CccEEEEecccchhh--------hhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELDQ--------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
+.|+||+.+..+... ...+|+++++.+... .....+++.+++.++.||++||.|||+.+ |+||||||
T Consensus 64 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 140 (319)
T 4euu_A 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKP 140 (319)
T ss_dssp CCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred cCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCH
Confidence 368999998876543 347899999886311 11223899999999999999999999999 99999999
Q ss_pred cceEe----ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc--------CCCCcccCceeeeehhhHhhh
Q 046703 447 GNVLL----DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS--------DGQFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 447 ~NIll----d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwS~Gvvl~eil 514 (635)
+||++ +.++.+||+|||+++....... .....||..|+|||.+. +..++.++||||||+++|||+
T Consensus 141 ~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~ 217 (319)
T 4euu_A 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (319)
T ss_dssp GGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred HHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence 99999 7777899999999987654322 22356899999999886 578899999999999999999
Q ss_pred hCCCCCCCccCCC-cccHHHHHHHHhhcCCCCcCC-----------CCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 515 SGKKNRGFYHLDN-KLNLIGHAWKLWNKGMPSEMI-----------DPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 515 tG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
+|+.||....... ............+......+. +..............+.+++.+||+.||++|||+
T Consensus 218 ~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~ 297 (319)
T 4euu_A 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297 (319)
T ss_dssp HSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred hCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH
Confidence 9999986443222 222222222211111111000 0011123445667778899999999999999999
Q ss_pred HHHHHHHcCCC
Q 046703 583 PSVILMLGSEI 593 (635)
Q Consensus 583 ~evl~~L~~~~ 593 (635)
+|+++......
T Consensus 298 ~ell~h~~d~~ 308 (319)
T 4euu_A 298 DQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHHHHT
T ss_pred HHhhhccHHHh
Confidence 99999887554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=247.31 Aligned_cols=198 Identities=20% Similarity=0.264 Sum_probs=141.7
Q ss_pred eeccccccccccC-CCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFP-DGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~-~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..++ ......|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+||||||+||
T Consensus 147 l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 223 (373)
T 3c1x_A 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNC 223 (373)
T ss_dssp CCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheE
Confidence 4699999999874 4556889999988642 123356788899999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLD 526 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~ 526 (635)
+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 224 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp EECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred EECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 9999999999999999866432211 11222456788999999999999999999999999999999 66676543322
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
+ .... ...+..... +......+.+++.+||+.||++|||++||++.|+.+.
T Consensus 304 ~---~~~~----~~~~~~~~~---------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 304 D---ITVY----LLQGRRLLQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp C---HHHH----HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHHH----HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2 1111 122222111 1112235778999999999999999999999998763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=248.78 Aligned_cols=192 Identities=26% Similarity=0.336 Sum_probs=140.0
Q ss_pred ccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
|+||+.+..+......+|+++++.... ..+...+++.++..++.||+.||.|||+.+ |+||||||+|||++ +
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~ 190 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-D 190 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-S
T ss_pred CCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-C
Confidence 689999988887788899999965421 123456788899999999999999999999 99999999999995 5
Q ss_pred CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----------CCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 455 MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 455 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+.+||+|||+++...............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 191 GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 7899999999987654333222334579999999999865 46889999999999999999999998532
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. ................... ......+.+++.+||+.||++|||+.||++.
T Consensus 271 ~-----~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 271 I-----NQISKLHAIIDPNHEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp C-----CHHHHHHHHHCTTSCCCCC---------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred h-----HHHHHHHHHhCccccCCCC---------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 1111122222111111111 1112356789999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-27 Score=245.16 Aligned_cols=202 Identities=17% Similarity=0.236 Sum_probs=145.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~ 133 (324)
T 3mtl_A 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLI 133 (324)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEE
T ss_pred cCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEE
Confidence 46999999999988888999999998742 122456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+
T Consensus 134 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 208 (324)
T 3mtl_A 134 NERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--- 208 (324)
T ss_dssp CTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---
T ss_pred CCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9999999999999986542221 1223567999999999876 568999999999999999999999986543222
Q ss_pred HHHHHHHHhhcCCCCcCCCCccc-----------------cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQ-----------------ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~-----------------~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............ ..+....... ..........+.+++.+||+.||++|||++||++
T Consensus 209 ~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 209 QLHFIFRILGTP-TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHHHHHCCC-CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCC-ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 222222221111 1110000000 0000112235678999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-27 Score=255.08 Aligned_cols=205 Identities=21% Similarity=0.280 Sum_probs=145.0
Q ss_pred eccccccccccC--CCCccEEEEecccchhh---hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFP--DGGQDLYIRMSASELDQ---ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~--~~~~~lyl~~~~~~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+. .+...+|+++++++... .+...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~ 143 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLN 143 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEc
Confidence 389999988876 34557999999987421 23457888999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCC-------------------CCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHh
Q 046703 453 QDMNPKISDFGLARTFGGDET-------------------EGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLE 512 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~e 512 (635)
.++.+||+|||+++....... ........||+.|+|||.+.+ ..++.++||||+||++||
T Consensus 144 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 223 (388)
T 3oz6_A 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223 (388)
T ss_dssp TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHH
Confidence 999999999999987642110 111233578999999999876 678999999999999999
Q ss_pred hhhCCCCCCCccCCCcccHHHHHHHHhhcCCCC---cCC------------------CCccccC------------CCHH
Q 046703 513 IVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPS---EMI------------------DPCYQES------------CNLT 559 (635)
Q Consensus 513 iltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------------------d~~l~~~------------~~~~ 559 (635)
|++|+.||......+ .+.........-... .+. ....... ....
T Consensus 224 ll~g~~pf~~~~~~~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (388)
T 3oz6_A 224 ILCGKPIFPGSSTMN---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300 (388)
T ss_dssp HHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCC
T ss_pred HHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccccc
Confidence 999999996543222 111111111000000 000 0000000 0001
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 560 EVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 560 ~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
....+.+++.+||+.||++|||++|+++.
T Consensus 301 ~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 301 CNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 12357789999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=254.29 Aligned_cols=202 Identities=22% Similarity=0.219 Sum_probs=143.3
Q ss_pred eeccccccccccCC------CCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPD------GGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~------~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+.. ....+|+++++++... .....+++.++..++.||+.||+|||+.+ |+||||||+|
T Consensus 118 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~N 194 (464)
T 3ttj_A 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 194 (464)
T ss_dssp CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHh
Confidence 46999999887763 2357899999987432 22345889999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...+..+.
T Consensus 195 Ill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~ 271 (464)
T 3ttj_A 195 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271 (464)
T ss_dssp EEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998764322 22346789999999999999999999999999999999999999965432211
Q ss_pred ccHHHHHHHHhhcC-----------------CCCcCCCCccc---------c--CCCHHHHHHHHHHHHHhcccCCCCCC
Q 046703 529 LNLIGHAWKLWNKG-----------------MPSEMIDPCYQ---------E--SCNLTEVIRCIHISLLCVQQHPDDRP 580 (635)
Q Consensus 529 ~~~~~~~~~~~~~~-----------------~~~~~~d~~l~---------~--~~~~~~~~~~~~l~~~Cl~~dP~~RP 580 (635)
...+....... .........+. . .........+.+|+.+||+.||++||
T Consensus 272 ---~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 348 (464)
T 3ttj_A 272 ---WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348 (464)
T ss_dssp ---HHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred ---HHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC
Confidence 11111110000 00000000000 0 00111245678999999999999999
Q ss_pred ChHHHHH
Q 046703 581 CMPSVIL 587 (635)
Q Consensus 581 t~~evl~ 587 (635)
|++|+++
T Consensus 349 ta~e~L~ 355 (464)
T 3ttj_A 349 SVDDALQ 355 (464)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-27 Score=242.22 Aligned_cols=197 Identities=25% Similarity=0.357 Sum_probs=150.9
Q ss_pred eccccccccccCCC-CccEEEEecccchhh------hh---------------ccccCcccchhhhhhhccccchhhccc
Q 046703 378 WFGDLIDMRSFPDG-GQDLYIRMSASELDQ------ER---------------CKLLDWSKRFRIICGTGRGLLYLHQDS 435 (635)
Q Consensus 378 ~h~nLv~l~~~~~~-~~~lyl~~~~~~~~~------~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~ 435 (635)
.|+||+.+..+... +..+|+++++.+... .. ...+++.+++.++.||++||.|||+.+
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 58999998887544 456899999876311 01 122788899999999999999999999
Q ss_pred cceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 436 ~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
|+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++
T Consensus 169 ---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 169 ---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999987654433333334567889999999999999999999999999999998
Q ss_pred -CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 516 -GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 516 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|+.||....... .....+..+....... .....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 246 ~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 246 LGASPYPGVKIDE------EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TSCCSSTTCCCSH------HHHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccchhH------HHHHHhccCccCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999986543221 1122222332222111 1123577899999999999999999999999765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=243.01 Aligned_cols=197 Identities=25% Similarity=0.324 Sum_probs=153.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh------h---------------hccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------E---------------RCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+||+.+..+......+|+++++.+... . ....+++.+++.++.||++||.|||+.+
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 177 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK- 177 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 59999999998888889999999986311 0 1134888899999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
|+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++
T Consensus 178 --ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 178 --CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp --EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987654332222233456788999999998899999999999999999999
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|+.||..... ......+..+...... ......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 256 g~~p~~~~~~-------~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 256 GGSPYPGIPV-------EELFKLLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp SCCSSTTCCH-------HHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCcCCH-------HHHHHHHhcCCCCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999864321 1122222333222211 112235778999999999999999999999998774
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-27 Score=252.19 Aligned_cols=138 Identities=22% Similarity=0.235 Sum_probs=118.2
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+......+|+++++.... ......+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 170 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILL 170 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEE
Confidence 5899999988887778899999987421 122335889999999999999999999999 9999999999999
Q ss_pred cc-------------------------CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeee
Q 046703 452 DQ-------------------------DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSF 506 (635)
Q Consensus 452 d~-------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~ 506 (635)
+. ++.+||+|||++....... ....||..|+|||.+.+..++.++|||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence 75 7889999999998754322 23568999999999999999999999999
Q ss_pred ehhhHhhhhCCCCCCCc
Q 046703 507 GILLLEIVSGKKNRGFY 523 (635)
Q Consensus 507 Gvvl~eiltG~~pf~~~ 523 (635)
||++|||++|+.||...
T Consensus 246 G~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHCCCCCCCC
Confidence 99999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-27 Score=251.06 Aligned_cols=188 Identities=21% Similarity=0.225 Sum_probs=145.1
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+..+......+|++|++++.. ..+...+++.++..++.||+.||.|||+++ |+||||||+|||++
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~ 158 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLD 158 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEEC
Confidence 5899999999988888999999998642 233567899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 159 ~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~-- 231 (353)
T 3txo_A 159 HEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---D-- 231 (353)
T ss_dssp TTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H--
T ss_pred CCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---H--
Confidence 99999999999997543221 2233467999999999999889999999999999999999999998643211 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh------HHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM------PSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~------~evl~ 587 (635)
....+..+... ++......+.+++.+||+.||++||++ +||++
T Consensus 232 --~~~~i~~~~~~----------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 232 --LFEAILNDEVV----------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --HHHHHHHCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --HHHHHHcCCCC----------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 12222222211 011122346789999999999999998 77764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-27 Score=254.51 Aligned_cols=193 Identities=18% Similarity=0.230 Sum_probs=150.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 67 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll 143 (444)
T 3soa_A 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLL 143 (444)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEE
T ss_pred CCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEE
Confidence 46999999999998899999999998642 123467899999999999999999999999 9999999999999
Q ss_pred cc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+. ++.+||+|||++......... .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.... .
T Consensus 144 ~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~ 218 (444)
T 3soa_A 144 ASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---Q 218 (444)
T ss_dssp SBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---H
T ss_pred eccCCCCcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---H
Confidence 84 577999999999876543221 223578999999999999999999999999999999999999985422 1
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. .....+..+.... ..+... .....+.+++.+||+.||++|||+.|+++
T Consensus 219 ~----~~~~~i~~~~~~~-~~~~~~-----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 219 H----RLYQQIKAGAYDF-PSPEWD-----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp H----HHHHHHHHTCCCC-CTTTTT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H----HHHHHHHhCCCCC-Cccccc-----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 1222222332211 111111 11234678999999999999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-27 Score=247.22 Aligned_cols=192 Identities=16% Similarity=0.151 Sum_probs=149.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++.+... .....+++.++..++.||+.||.|||+.+ |+||||||+||+
T Consensus 58 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl 134 (321)
T 1tki_A 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENII 134 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEE
Confidence 369999999999888889999999986421 12346899999999999999999999999 999999999999
Q ss_pred ecc--CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 LDQ--DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++. ++.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 135 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--- 208 (321)
T 1tki_A 135 YQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--- 208 (321)
T ss_dssp ESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---
T ss_pred EccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---
Confidence 987 7889999999998765332 23346789999999999988899999999999999999999999864321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... ...+..+.... +..... .....+.+++.+||+.||++|||+.|+++
T Consensus 209 ~~~----~~~i~~~~~~~--~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 209 QQI----IENIMNAEYTF--DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHH----HHHHHHTCCCC--CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHH----HHHHHcCCCCC--Chhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11122222110 000000 11235778999999999999999999997
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=239.93 Aligned_cols=197 Identities=20% Similarity=0.258 Sum_probs=142.8
Q ss_pred eeccccccccccCCCC-----ccEEEEecccchhh-----------hhccccCcccchhhhhhhccccchhhccccceEE
Q 046703 377 MWFGDLIDMRSFPDGG-----QDLYIRMSASELDQ-----------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~-----~~lyl~~~~~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
+.|+||+.+..+.... ...|+++++.+... .....+++.+++.++.||++||.|||+.+ |+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 169 (313)
T 3brb_A 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FL 169 (313)
T ss_dssp CCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CC
T ss_pred CCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 3689999888775332 24699999876311 23356899999999999999999999999 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCC
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKN 519 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~p 519 (635)
||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 170 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp CCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999987654332222333556889999999999999999999999999999999 8888
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|....... ... ....+...... ......+.+++.+||+.||++|||+++|++.|+.+
T Consensus 250 ~~~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 250 YPGVQNHE---MYD----YLLHGHRLKQP---------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp STTCCGGG---HHH----HHHTTCCCCCB---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccCCHHH---HHH----HHHcCCCCCCC---------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 86433221 111 12222222111 11223577899999999999999999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=238.50 Aligned_cols=204 Identities=18% Similarity=0.272 Sum_probs=152.1
Q ss_pred eeccccccccccCCC--CccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+... +..+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||+|
T Consensus 80 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~N 156 (302)
T 4e5w_A 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARN 156 (302)
T ss_dssp CCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchhe
Confidence 358999998877643 36789999988631 123456899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc---
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH--- 524 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~--- 524 (635)
|+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+....
T Consensus 157 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 236 (302)
T 4e5w_A 157 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236 (302)
T ss_dssp EEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH
Confidence 99999999999999999876543221 11222456778999999999999999999999999999999998854321
Q ss_pred -----CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 525 -----LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 525 -----~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.................+..... +......+.+++.+||+.||++|||+.||+++|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 237 LKMIGPTHGQMTVTRLVNTLKEGKRLPC---------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHCSCCGGGHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccCCcccccCHHHHHHHHhccCCCCC---------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111122222222333322221 112234577899999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=243.83 Aligned_cols=190 Identities=20% Similarity=0.275 Sum_probs=145.5
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+..+......+|+++++.+.. ..+...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 144 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLD 144 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEC
Confidence 5899999999988888999999998632 123457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc--cc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~--~~ 530 (635)
.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..
T Consensus 145 ~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 222 (345)
T 3a8x_A 145 SEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222 (345)
T ss_dssp TTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------
T ss_pred CCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc
Confidence 99999999999998643221 123346789999999999999999999999999999999999999965322111 11
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM 582 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 582 (635)
........+..+... + +......+.+++.+||+.||++||++
T Consensus 223 ~~~~~~~~i~~~~~~-~---------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 223 TEDYLFQVILEKQIR-I---------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CHHHHHHHHHHCCCC-C---------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cHHHHHHHHHcCCCC-C---------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 112222222222211 1 11122356789999999999999996
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=240.51 Aligned_cols=198 Identities=24% Similarity=0.343 Sum_probs=148.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+||||||+||+
T Consensus 103 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl 179 (333)
T 1mqb_A 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNIL 179 (333)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEE
Confidence 36999999999988888999999998641 123356899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
++.++.+||+|||++.......... ......++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 180 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--- 256 (333)
T 1mqb_A 180 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--- 256 (333)
T ss_dssp ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred ECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---
Confidence 9999999999999998765332211 1122345778999999999999999999999999999998 9999854321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
......+..+..... +......+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 257 ----~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 257 ----HEVMKAINDGFRLPT---------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ----HHHHHHHHTTCCCCC---------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHCCCcCCC---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112222223221111 1122345778999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-27 Score=244.74 Aligned_cols=193 Identities=18% Similarity=0.211 Sum_probs=148.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 71 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll 147 (326)
T 2y0a_A 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIML 147 (326)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEE
Confidence 36999999999888888999999998632 123456899999999999999999999999 9999999999999
Q ss_pred ccCC----CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDM----NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++ .+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 148 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 223 (326)
T 2y0a_A 148 LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ- 223 (326)
T ss_dssp SCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-
T ss_pred ecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-
Confidence 9877 799999999987653322 22356899999999999999999999999999999999999998543211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.... .+...... ..+. ... .....+.+++.+||+.||++|||+.|+++.
T Consensus 224 --~~~~----~~~~~~~~-~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 224 --ETLA----NVSAVNYE-FEDE-YFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --HHHH----HHHHTCCC-CCHH-HHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --HHHH----HHHhcCCC-cCcc-ccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 11111111 0000 001 112346789999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-26 Score=244.64 Aligned_cols=202 Identities=18% Similarity=0.154 Sum_probs=149.9
Q ss_pred eccccccccccCC----CCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPD----GGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~----~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~ 446 (635)
.|+|++.+..... .+..+|+++++.... ......+++.++..++.||++||.|||++ + |+||||||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp 175 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKP 175 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSG
T ss_pred CcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCH
Confidence 4788888877654 566899999988632 12235689999999999999999999998 8 99999999
Q ss_pred cceEeccCC-------------------------------------------------CCccCccccceecCCCCCCCce
Q 046703 447 GNVLLDQDM-------------------------------------------------NPKISDFGLARTFGGDETEGNT 477 (635)
Q Consensus 447 ~NIlld~~~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~ 477 (635)
+|||++.++ .+||+|||++.......
T Consensus 176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----- 250 (397)
T 1wak_A 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----- 250 (397)
T ss_dssp GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----
T ss_pred HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----
Confidence 999998764 79999999998764321
Q ss_pred eeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH---HHHHHhh--------cCC---
Q 046703 478 TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG---HAWKLWN--------KGM--- 543 (635)
Q Consensus 478 ~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~---~~~~~~~--------~~~--- 543 (635)
....||..|+|||.+.+..++.++|||||||++|||++|+.||............. ....... .+.
T Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 22468999999999999999999999999999999999999997654433221111 1111110 000
Q ss_pred --------CCcCCCCcc---------ccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 544 --------PSEMIDPCY---------QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 544 --------~~~~~d~~l---------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...+.+... ....+......+.+|+.+||+.||++|||++||++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000000 01235566778899999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-26 Score=246.33 Aligned_cols=191 Identities=21% Similarity=0.303 Sum_probs=148.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.... ......+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 72 l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll 148 (384)
T 4fr4_A 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILL 148 (384)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEE
Confidence 36999999999988888999999998642 123457899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC---CCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++....... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||........
T Consensus 149 ~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 225 (384)
T 4fr4_A 149 DEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225 (384)
T ss_dssp CTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH
T ss_pred CCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH
Confidence 999999999999998764332 2234679999999999864 4589999999999999999999999965433322
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-MPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-~~evl~ 587 (635)
.... ..+...... .+......+.+++.+||+.||++||+ +++|.+
T Consensus 226 ~~~~----~~~~~~~~~----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 226 KEIV----HTFETTVVT----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHH----HHHHHCCCC----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHH----HHHhhcccC----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 2221 111111111 11112245778999999999999998 777664
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-26 Score=253.35 Aligned_cols=200 Identities=17% Similarity=0.166 Sum_probs=149.2
Q ss_pred ccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe---c
Q 046703 381 DLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---D 452 (635)
Q Consensus 381 nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll---d 452 (635)
++..+..+...+...||++++.... ......+++.+++.++.||+.||.|||+++ |+||||||+|||+ +
T Consensus 64 ~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~ 140 (483)
T 3sv0_A 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR 140 (483)
T ss_dssp TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGG
T ss_pred CCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCC
Confidence 3344444445566788999887421 122557999999999999999999999999 9999999999999 6
Q ss_pred cCCCCccCccccceecCCCCCCC-----ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEG-----NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
.++.+||+|||+++......... ......||..|+|||.+.+..++.++|||||||+||||++|+.||.......
T Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 88999999999998875433221 1224678999999999999999999999999999999999999997655444
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
...................+.. . ....+.+++..||+.||++||++++|+++|+.+
T Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~-----~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 221 KKQKYEKISEKKVATSIEALCR-----G----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHHHHHHHHHSCHHHHHT-----T----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhhccccccHHHHhc-----C----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 3333332222211111111111 1 123577899999999999999999999988764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-27 Score=247.66 Aligned_cols=192 Identities=17% Similarity=0.201 Sum_probs=148.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 72 l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll 148 (361)
T 2yab_A 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIML 148 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 35999999999988889999999998632 123457899999999999999999999999 9999999999999
Q ss_pred ccCC----CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDM----NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++ .+||+|||++........ .....||+.|+|||.+.+..++.++|||||||++|||++|..||......
T Consensus 149 ~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~- 224 (361)
T 2yab_A 149 LDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ- 224 (361)
T ss_dssp SCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-
T ss_pred eCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 8776 799999999987654322 22356899999999999999999999999999999999999998543211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ....+..+... .++..... ....+.+++..||+.||++|||+.|+++
T Consensus 225 --~----~~~~i~~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 225 --E----TLANITAVSYD--FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --H----HHHHHHTTCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --H----HHHHHHhcCCC--CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 11112222111 01000011 1234678999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-26 Score=249.08 Aligned_cols=202 Identities=18% Similarity=0.230 Sum_probs=146.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+......+|+++++++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 83 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NI 159 (389)
T 3gni_B 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHI 159 (389)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred CCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 46999999999888888999999998632 122356899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCC-----CCceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDET-----EGNTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
|++.++.+||+|||.+........ ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999875432111 111122367889999999987 5789999999999999999999999965
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCC------------------------------c------cccCCCHHHHHHHHH
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDP------------------------------C------YQESCNLTEVIRCIH 566 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~------------------------------~------l~~~~~~~~~~~~~~ 566 (635)
....... .... .+....+.+. . ............+.+
T Consensus 240 ~~~~~~~---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 312 (389)
T 3gni_B 240 MPATQML---LEKL----NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312 (389)
T ss_dssp CCSTTHH---HHC------------------------------------------------------------CCHHHHH
T ss_pred CCHHHHH---HHHh----cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHH
Confidence 4332211 0000 0000000000 0 000111222345788
Q ss_pred HHHHhcccCCCCCCChHHHHHH
Q 046703 567 ISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 567 l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
++.+||+.||++|||++|+++.
T Consensus 313 li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 313 FVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHhhcCcccCCCHHHHhcC
Confidence 9999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=244.28 Aligned_cols=192 Identities=20% Similarity=0.217 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+......+|+++|+++... .....+++..+..++.||++||.|||+++ |+||||||+
T Consensus 83 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~ 159 (351)
T 3c0i_A 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPH 159 (351)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChH
Confidence 469999999998888889999999986311 11234788999999999999999999999 999999999
Q ss_pred ceEeccCCC---CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 448 NVLLDQDMN---PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 448 NIlld~~~~---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
||+++.++. +||+|||++......... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 160 NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 160 CVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp GEEECSSSTTCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred HeEEecCCCCCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 999987654 999999999876543221 223578999999999999999999999999999999999999986421
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+..+.... .+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 238 --------~~~~~~i~~~~~~~--~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 238 --------ERLFEGIIKGKYKM--NPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --------HHHHHHHHHTCCCC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------HHHHHHHHcCCCCC--Cccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11122222222111 000001 11235678999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-26 Score=235.77 Aligned_cols=198 Identities=20% Similarity=0.246 Sum_probs=148.1
Q ss_pred eecccccccccc-CCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSF-PDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~-~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+|++.+..+ .......|+++++.+.. ......+++.+++.++.|+++||.|||+.+ |+||||||+||
T Consensus 83 l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Ni 159 (298)
T 3f66_A 83 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNC 159 (298)
T ss_dssp CCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheE
Confidence 359999999887 45667889999987641 123456888999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC-CCCCCCccCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGFYHLD 526 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG-~~pf~~~~~~ 526 (635)
+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++| ..||......
T Consensus 160 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp EECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred EECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 9999999999999999876433211 112234567889999999999999999999999999999995 4555433222
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
+ .... ...+...... ......+.+++.+||+.||++|||++||+++|+.+.
T Consensus 240 ~---~~~~----~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 240 D---ITVY----LLQGRRLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp T---HHHH----HHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHHH----HhcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1111 1122211111 111235778999999999999999999999998763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=237.13 Aligned_cols=199 Identities=24% Similarity=0.248 Sum_probs=147.1
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+||+.+..+......+|+++++.+.. ......+++.+++.++.||+.||+|||+.+ |+||||||+||
T Consensus 85 ~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NI 161 (319)
T 2y4i_B 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNV 161 (319)
T ss_dssp TCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTE
T ss_pred cCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhE
Confidence 346999999999888888899999998631 122346899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCC---CCCceeeeeeccCCCCcccccC---------CCCcccCceeeeehhhHhhhhCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDE---TEGNTTRVVGTYGYMAPEYASD---------GQFSVKSDVFSFGILLLEIVSGK 517 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwS~Gvvl~eiltG~ 517 (635)
+++ ++.+||+|||++....... .........|+..|+|||.+.. ..++.++||||||+++|||++|+
T Consensus 162 l~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 240 (319)
T 2y4i_B 162 FYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240 (319)
T ss_dssp EEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 998 6799999999987653211 1112223458899999999864 45789999999999999999999
Q ss_pred CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.||...... ........+.......... ...+.+++..||+.||++|||+.+|+++|+.+.
T Consensus 241 ~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~--------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 241 WPFKTQPAE-------AIIWQMGTGMKPNLSQIGM--------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp CSSSSCCHH-------HHHHHHHTTCCCCCCCSSC--------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCCCCCCHH-------HHHHHhccCCCCCCCcCCC--------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 998643211 1112222332222221111 124678999999999999999999999999885
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-26 Score=232.13 Aligned_cols=195 Identities=21% Similarity=0.412 Sum_probs=146.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+..... |+++++.+.. ..+...+++..++.++.|++.||+|||+.+ .+|+||||||+||+
T Consensus 80 l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil 156 (287)
T 4f0f_A 80 LNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIF 156 (287)
T ss_dssp CCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEE
T ss_pred CCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEE
Confidence 36999999988876544 7888887631 123457899999999999999999999986 34999999999999
Q ss_pred eccCCC-----CccCccccceecCCCCCCCceeeeeeccCCCCcccc--cCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 451 LDQDMN-----PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA--SDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 451 ld~~~~-----~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++.++. +||+|||+++.... ......|+..|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 157 LQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp ESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 987776 99999999975432 22335789999999998 4556789999999999999999999998654
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.... ..........+...... ......+.+++..||+.||++|||++||++.|+.+
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 232 SYGK----IKFINMIREEGLRPTIP---------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCH----HHHHHHHHHSCCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cccH----HHHHHHHhccCCCCCCC---------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 3221 11111111122222111 12234577899999999999999999999999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-26 Score=259.44 Aligned_cols=197 Identities=24% Similarity=0.364 Sum_probs=152.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+... ..+||++++++.. ....+.+++.+++.++.||++||.|||+++ |+||||||+||
T Consensus 319 l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NI 394 (535)
T 2h8h_A 319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 394 (535)
T ss_dssp CCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhE
Confidence 469999999888765 6789999998631 122346899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|++.++.+||+|||+++......... .....++..|+|||.+....++.++|||||||+||||++ |+.||......
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-- 471 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-- 471 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHHT-TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccccceecCCCceec-ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999997654321111 111345778999999999999999999999999999999 89998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
.....+..+..... +......+.+|+.+||+.||++|||+++|+++|+....
T Consensus 472 -----~~~~~i~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 472 -----EVLDQVERGYRMPC---------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -----HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -----HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 12222223322111 11223457789999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=241.06 Aligned_cols=186 Identities=23% Similarity=0.238 Sum_probs=148.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.........+|+++++.+.. ..+...+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 63 l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll 139 (318)
T 1fot_A 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILL 139 (318)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEE
T ss_pred CCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEE
Confidence 46999999999988888999999998642 123456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..
T Consensus 140 ~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~- 210 (318)
T 1fot_A 140 DKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MK- 210 (318)
T ss_dssp CTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HH-
T ss_pred cCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HH-
Confidence 99999999999999875432 2235789999999999999999999999999999999999999854321 11
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
....+..+... . ... ....+.+++.+||+.||++|| +++||++
T Consensus 211 ---~~~~i~~~~~~-~-----p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 211 ---TYEKILNAELR-F-----PPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---HHHHHHHCCCC-C-----CTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHHhCCCC-C-----CCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11112222211 1 111 123467899999999999999 8999884
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=236.26 Aligned_cols=188 Identities=21% Similarity=0.325 Sum_probs=145.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 66 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili 142 (279)
T 3fdn_A 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLL 142 (279)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEE
T ss_pred CCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEE
Confidence 35999999999988888999999998642 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 213 (279)
T 3fdn_A 143 GSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----- 213 (279)
T ss_dssp CTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred cCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----
Confidence 999999999999986543221 22356899999999999999999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.....+...... . +......+.+++.+||+.||++|||++||++.
T Consensus 214 --~~~~~~~~~~~~-~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 214 --ETYKRISRVEFT-F---------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --HHHHHHHHTCCC-C---------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --HHHHHHHhCCCC-C---------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111111 0 11122346789999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=236.95 Aligned_cols=191 Identities=17% Similarity=0.243 Sum_probs=145.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+...+...|+++++.+.. ......+++..++.++.||++||.|||+.+ |+||||||+||+
T Consensus 69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 145 (289)
T 4fvq_A 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNIL 145 (289)
T ss_dssp SCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred CCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEE
Confidence 36999999999988888999999998631 122344899999999999999999999999 999999999999
Q ss_pred eccCCC--------CccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCC
Q 046703 451 LDQDMN--------PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRG 521 (635)
Q Consensus 451 ld~~~~--------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~ 521 (635)
++.++. +||+|||++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|..|+.
T Consensus 146 l~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 146 LIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp EEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 998887 89999999865421 122457889999999987 678999999999999999999655532
Q ss_pred CccCCCcccHHHHHHHHhhc-CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 522 FYHLDNKLNLIGHAWKLWNK-GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
... .. .. ....... ....... ...+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 220 ~~~--~~---~~-~~~~~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 220 SAL--DS---QR-KLQFYEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTS--CH---HH-HHHHHHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccc--ch---HH-HHHHhhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 211 11 11 1111111 1111111 1236679999999999999999999999998865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=244.07 Aligned_cols=195 Identities=19% Similarity=0.253 Sum_probs=149.1
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+...+..+|+++|+.+.. ..+.+.+++.++..++.||+.||.|||+.+ |+||||||+||++.
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~ 150 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYV 150 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEES
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEe
Confidence 5999999999988889999999998642 123456899999999999999999999999 99999999999985
Q ss_pred cC-C---CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 453 QD-M---NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 453 ~~-~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
.. + .+||+|||+++....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 228 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH
T ss_pred cCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH
Confidence 43 2 489999999987654322 12235689999999999888899999999999999999999999965332222
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. .....+..+..... . .........+.+++.+||+.||++|||+.||++
T Consensus 229 ~----~~~~~i~~~~~~~~-~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 229 E----EILARIGSGKFSLS-G-----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp H----HHHHHHHHCCCCCC-S-----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred H----HHHHHHccCCcccC-c-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2 22223333332211 1 011112235678999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=241.00 Aligned_cols=206 Identities=19% Similarity=0.232 Sum_probs=144.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+... .....+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~ 135 (311)
T 4agu_A 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILI 135 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEE
Confidence 369999999999888889999999987421 23456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (311)
T 4agu_A 136 TKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213 (311)
T ss_dssp CTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999987653222 1223568999999999876 678999999999999999999999986543222211
Q ss_pred HHHHHH--------HHhhcCC---CCcCCCCcccc---CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAW--------KLWNKGM---PSEMIDPCYQE---SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~--------~~~~~~~---~~~~~d~~l~~---~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+.... ..+.... .....++.... .........+.+++.+||+.||++|||++||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 111100 0000000 00011100000 000122335778999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=252.98 Aligned_cols=190 Identities=20% Similarity=0.232 Sum_probs=148.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhc-cccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~dik~~NI 449 (635)
.+.|+||+.+..+......+|+++++++.. ..+...+++..+..++.||+.||+|||+ .+ |+||||||+||
T Consensus 204 ~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NI 280 (446)
T 4ejn_A 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENL 280 (446)
T ss_dssp CCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGE
T ss_pred hCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHE
Confidence 346999999999988888999999998642 2335678999999999999999999998 78 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
|++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 281 ll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--- 355 (446)
T 4ejn_A 281 MLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--- 355 (446)
T ss_dssp EECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred EECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---
Confidence 999999999999999975432221 223367899999999999999999999999999999999999998543211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
.. ...+...... . ... ....+.+++.+||+.||++|| +++|+++
T Consensus 356 ~~----~~~i~~~~~~-~-----p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 356 KL----FELILMEEIR-F-----PRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HH----HHHHHHCCCC-C-----CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HH----HHHHHhCCCC-C-----Ccc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 1111111111 1 111 123567899999999999999 9999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-26 Score=242.31 Aligned_cols=205 Identities=25% Similarity=0.306 Sum_probs=153.5
Q ss_pred eeccccccccccC--CCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+. .+...+|+++++.+.. ......+++.+++.++.||+.||+|||+.+ |+||||||+|
T Consensus 81 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~N 157 (327)
T 3lxl_A 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARN 157 (327)
T ss_dssp CCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhh
Confidence 3689999887754 4566799999988532 122456899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC-
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD- 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~- 526 (635)
|+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 158 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 237 (327)
T 3lxl_A 158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 237 (327)
T ss_dssp EEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh
Confidence 99999999999999999876533221 1122245778899999999999999999999999999999999997543211
Q ss_pred -------CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 527 -------NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 527 -------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
...............+..... +......+.+++.+||+.||++|||++||++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 238 LRMMGCERDVPALSRLLELLEEGQRLPA---------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHCC----CCHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hhhcccccccccHHHHHHHhhcccCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111222222223222211 1223345778999999999999999999999998774
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=235.38 Aligned_cols=193 Identities=23% Similarity=0.372 Sum_probs=147.7
Q ss_pred eeccccccccccCC----------------CCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhc
Q 046703 377 MWFGDLIDMRSFPD----------------GGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQ 433 (635)
Q Consensus 377 l~h~nLv~l~~~~~----------------~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 433 (635)
+.|+|++.+..+.. ....+|+++++.+.. ......+++..++.++.||+.||.|||+
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 140 (284)
T 2a19_B 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS 140 (284)
T ss_dssp CCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 35778777665432 245689999987631 1234578999999999999999999999
Q ss_pred cccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhh
Q 046703 434 DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 513 (635)
Q Consensus 434 ~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~ei 513 (635)
.+ |+|+||||+||+++.++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|||
T Consensus 141 ~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 214 (284)
T 2a19_B 141 KK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214 (284)
T ss_dssp TT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHH
T ss_pred CC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHH
Confidence 99 99999999999999999999999999987654322 2234689999999999999999999999999999999
Q ss_pred hhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 514 VSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 514 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
++|..|+... .........+..... .+ ..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 215 ~~~~~~~~~~---------~~~~~~~~~~~~~~~--------~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 215 LHVCDTAFET---------SKFFTDLRDGIISDI--------FD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HSCCSSHHHH---------HHHHHHHHTTCCCTT--------SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HhcCCcchhH---------HHHHHHhhccccccc--------CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9999886311 112222223222211 12 24667999999999999999999999998765
Q ss_pred CCC
Q 046703 594 VLP 596 (635)
Q Consensus 594 ~~p 596 (635)
.-+
T Consensus 274 ~~~ 276 (284)
T 2a19_B 274 KSP 276 (284)
T ss_dssp C--
T ss_pred hCC
Confidence 433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-26 Score=261.67 Aligned_cols=196 Identities=22% Similarity=0.270 Sum_probs=149.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..++.. ..+|+++++++.. ......+++.+++.++.||++||.|||+.+ |+||||||+|||
T Consensus 393 l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NIL 468 (613)
T 2ozo_A 393 LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVL 468 (613)
T ss_dssp CCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEE
Confidence 369999999988765 5699999998642 123456899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
++.++.+||+|||+++......... ......+++.|+|||.+....++.++|||||||++|||++ |+.||......
T Consensus 469 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-- 546 (613)
T 2ozo_A 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-- 546 (613)
T ss_dssp EEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--
T ss_pred EcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--
Confidence 9999999999999998764332211 1112345689999999999999999999999999999998 99998653321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. +...+..+..... +......+.+|+..||+.||++||++.+|++.|+..
T Consensus 547 -~----~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 547 -E----VMAFIEQGKRMEC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -H----HHHHHHTTCCCCC---------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -H----HHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 2222333332222 112334677899999999999999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=235.33 Aligned_cols=198 Identities=20% Similarity=0.236 Sum_probs=147.8
Q ss_pred eeccccccccccCCCCccE-EEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDL-YIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~l-yl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+....... |+++++.... ......+++.+++.++.|++.||.|||+.+ |+||||||+||
T Consensus 79 l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Ni 155 (298)
T 3pls_A 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNC 155 (298)
T ss_dssp CCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence 3699999998887554444 8888887531 122456888999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCC--CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDET--EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+++.++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++|..|+.... .
T Consensus 156 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~ 233 (298)
T 3pls_A 156 MLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--D 233 (298)
T ss_dssp EECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--C
T ss_pred EEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--C
Confidence 999999999999999986543221 111223457889999999999999999999999999999999666642221 1
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
...... ....+..... +......+.+++.+||+.||++|||+++++++|+.+
T Consensus 234 ~~~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 234 PFDLTH----FLAQGRRLPQ---------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp GGGHHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----HhhcCCCCCC---------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 1112221111 111223577899999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=242.98 Aligned_cols=195 Identities=21% Similarity=0.211 Sum_probs=130.8
Q ss_pred ccccccccccC--------CCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 379 FGDLIDMRSFP--------DGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 379 h~nLv~l~~~~--------~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
|+||+.+..+. .....+|+++++.... ......+++.+++.++.||+.||.|||+.+ ..|+|||
T Consensus 85 h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~D 163 (337)
T 3ll6_A 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRD 163 (337)
T ss_dssp STTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCC
T ss_pred CCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEcc
Confidence 88888876554 4556789999988632 122456899999999999999999999875 3499999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCC----------ceeeeeeccCCCCcccc---cCCCCcccCceeeeehhh
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEG----------NTTRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILL 510 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwS~Gvvl 510 (635)
|||+||+++.++.+||+|||++.......... ......++..|+|||.+ .+..++.++||||||+++
T Consensus 164 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp CCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred CCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence 99999999999999999999998765322111 11134589999999998 566789999999999999
Q ss_pred HhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHc
Q 046703 511 LEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLG 590 (635)
Q Consensus 511 ~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~ 590 (635)
|||++|+.||....... . . .+..... ........+.+++.+||+.||++|||+.||++.|+
T Consensus 244 ~el~~g~~p~~~~~~~~---~-------~-~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 244 YLLCFRQHPFEDGAKLR---I-------V-NGKYSIP--------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHHSSCCC-----------------------CCCC--------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCCCcchhHHH---h-------h-cCcccCC--------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999985422111 0 0 0000000 00011123667999999999999999999999998
Q ss_pred CCC
Q 046703 591 SEI 593 (635)
Q Consensus 591 ~~~ 593 (635)
.+.
T Consensus 305 ~~~ 307 (337)
T 3ll6_A 305 EIA 307 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 774
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-26 Score=234.93 Aligned_cols=196 Identities=27% Similarity=0.322 Sum_probs=150.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+. ....+|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+|+||||+||++
T Consensus 75 l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~ 150 (291)
T 1xbb_A 75 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLL 150 (291)
T ss_dssp CCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEE
Confidence 3689999988887 456789999988632 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||++.......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--- 227 (291)
T 1xbb_A 151 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--- 227 (291)
T ss_dssp EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---
T ss_pred eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999999998765432211 1122345688999999998899999999999999999999 99998643211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+..+..... +......+.+++.+||+.||++||++.+|++.|+..
T Consensus 228 ----~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 228 ----EVTAMLEKGERMGC---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ----HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12222233332221 112234577899999999999999999999999765
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-26 Score=243.25 Aligned_cols=204 Identities=23% Similarity=0.235 Sum_probs=150.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~ 145 (346)
T 1ua2_A 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLL 145 (346)
T ss_dssp CCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEE
Confidence 36999999999888888999999998742 122346899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++....... ......+|..|+|||.+.+. .++.++||||||+++|||++|..||..... ..
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~ 220 (346)
T 1ua2_A 146 DENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LD 220 (346)
T ss_dssp CTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred cCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HH
Confidence 9999999999999987643221 12235689999999998664 589999999999999999999999864321 22
Q ss_pred HHHHHHHHhhcCCCCcCC------CCc---cccCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMI------DPC---YQESCN-----LTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~------d~~---l~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.................. +.. .....+ ......+.+++.+||+.||++|||++|+++.
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 221 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 222222221111111000 000 000011 1223467889999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-26 Score=238.98 Aligned_cols=205 Identities=23% Similarity=0.270 Sum_probs=152.9
Q ss_pred eeccccccccccCCC--CccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+... ...+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 90 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil 166 (318)
T 3lxp_A 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVL 166 (318)
T ss_dssp CCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEE
Confidence 358999998887643 56789999988642 223445899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC---
Q 046703 451 LDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD--- 526 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~--- 526 (635)
++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 167 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp ECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred EcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 999999999999999887543221 1122345778899999999999999999999999999999999998542110
Q ss_pred -----CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 527 -----NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 527 -----~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
...............+..... +......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 247 LIGIAQGQMTVLRLTELLERGERLPR---------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHCSCCHHHHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcccccchhHHHHHHHHhcccCCCC---------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 000111112222222222111 1222346788999999999999999999999998763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=244.21 Aligned_cols=185 Identities=20% Similarity=0.194 Sum_probs=148.6
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+..+......+|+++++.+.. ..+...+++.++..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 175 (350)
T 1rdq_E 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLID 175 (350)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEEC
Confidence 6999999999888888999999998631 123457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .
T Consensus 176 ~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~--- 244 (350)
T 1rdq_E 176 QQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---I--- 244 (350)
T ss_dssp TTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---
T ss_pred CCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---H---
Confidence 9999999999999876432 2236799999999999999999999999999999999999999864321 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
.....+..+... + .. .....+.+++.+||+.||++||+ ++||++
T Consensus 245 -~~~~~i~~~~~~-~-----p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 245 -QIYEKIVSGKVR-F-----PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -HHHHHHHHCCCC-C-----CT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -HHHHHHHcCCCC-C-----CC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 122222233221 1 11 12235678999999999999998 888875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=247.18 Aligned_cols=203 Identities=17% Similarity=0.171 Sum_probs=146.5
Q ss_pred eeccccccccccC------CCCccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 377 MWFGDLIDMRSFP------DGGQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 377 l~h~nLv~l~~~~------~~~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
+.|+||+.+..+. .+...+|+++++.... ......+++..+..++.||++||+|||+.+ |+||
T Consensus 89 l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 165 (394)
T 4e7w_A 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHR 165 (394)
T ss_dssp CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred CCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCC
Confidence 3599999887765 2333488999998632 122567888999999999999999999999 9999
Q ss_pred ccCCcceEec-cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCC
Q 046703 443 DLKAGNVLLD-QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 443 dik~~NIlld-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
||||+|||++ .++.+||+|||+++........ ....+|..|+|||.+.+. .++.++|||||||++|||++|+.||
T Consensus 166 Dlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999 7899999999999876433222 235679999999998765 5899999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHh---------------hcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 521 GFYHLDNKLNLIGHAWKLW---------------NKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
......+ .+....... ............+...........+.+++.+||+.||++|||+.|+
T Consensus 243 ~~~~~~~---~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (394)
T 4e7w_A 243 PGESGID---QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319 (394)
T ss_dssp CCSSHHH---HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCHHH---HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence 6543221 111111110 0011111111111111122233467889999999999999999999
Q ss_pred HHH
Q 046703 586 ILM 588 (635)
Q Consensus 586 l~~ 588 (635)
++.
T Consensus 320 l~h 322 (394)
T 4e7w_A 320 LCH 322 (394)
T ss_dssp HTS
T ss_pred hcC
Confidence 873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=234.77 Aligned_cols=195 Identities=21% Similarity=0.289 Sum_probs=146.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+... ...|+++++.+.. ......+++..+..++.||++||.|||+.+ |+||||||+||+
T Consensus 70 l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil 145 (281)
T 3cc6_A 70 LDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNIL 145 (281)
T ss_dssp HCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEE
T ss_pred CCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEE
Confidence 368999998887664 3568889887631 123345899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 146 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-- 222 (281)
T 3cc6_A 146 VASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-- 222 (281)
T ss_dssp EEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--
T ss_pred ECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--
Confidence 999999999999999876433221 1222456788999999998999999999999999999998 999986433222
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
... ....+......+ .....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 223 -~~~----~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 223 -VIG----VLEKGDRLPKPD---------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -HHH----HHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHH----HHhcCCCCCCCC---------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111 111222111111 1223577899999999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=233.29 Aligned_cols=196 Identities=23% Similarity=0.311 Sum_probs=151.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+|++.+..+......+|+++++.+.. ......+++..++.++.|+++||.|||+.+ ++|+||||+||+
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil 136 (267)
T 3t9t_A 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCL 136 (267)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEE
T ss_pred CCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEE
Confidence 36999999999888888999999988631 122356889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 137 i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--- 212 (267)
T 3t9t_A 137 VGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--- 212 (267)
T ss_dssp ECGGGCEEECCTTGGGGBCCHHHHS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred ECCCCCEEEcccccccccccccccc-cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---
Confidence 9999999999999997654321111 112345678999999998899999999999999999999 89998643211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+..+..... +......+.+++.+||+.||++|||++++++.|+.+
T Consensus 213 ----~~~~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 213 ----EVVEDISTGFRLYK---------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ----HHHHHHHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHhcCCcCCC---------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11222222221111 111223577899999999999999999999999765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-26 Score=234.56 Aligned_cols=195 Identities=23% Similarity=0.276 Sum_probs=151.2
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+.. ...+|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+||||||+||++
T Consensus 68 ~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili 143 (287)
T 1u59_A 68 DNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLL 143 (287)
T ss_dssp CCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEE
Confidence 6899999888874 45689999987631 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 144 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 220 (287)
T 1u59_A 144 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--- 220 (287)
T ss_dssp EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---
T ss_pred cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence 99999999999999876533221 11122345788999999988899999999999999999998 99998643221
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. ....+..+..... +......+.+++..||+.||++||++.+|++.|+..
T Consensus 221 ~----~~~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 221 E----VMAFIEQGKRMEC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp H----HHHHHHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHHhcCCcCCC---------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1222223322221 112234577899999999999999999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=244.63 Aligned_cols=205 Identities=20% Similarity=0.247 Sum_probs=145.2
Q ss_pred eeccccccccccCCC--------CccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 377 MWFGDLIDMRSFPDG--------GQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--------~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
+.|+|++.+..+... +..+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+|||
T Consensus 73 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 149 (351)
T 3mi9_A 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRD 149 (351)
T ss_dssp CCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred ccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 358888887776533 45789999998731 123356899999999999999999999999 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
|||+||+++.++.+||+|||+++........ .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 150 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999876532211 12233567999999998876 56899999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCc------------cccCCCH-HH------HHHHHHHHHHhcccCCCCCCC
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPC------------YQESCNL-TE------VIRCIHISLLCVQQHPDDRPC 581 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~------------l~~~~~~-~~------~~~~~~l~~~Cl~~dP~~RPt 581 (635)
........ ........ .....+..... ....... .. ...+.+++.+||+.||++|||
T Consensus 230 ~~~~~~~~---~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 305 (351)
T 3mi9_A 230 QGNTEQHQ---LALISQLC-GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305 (351)
T ss_dssp CCSSHHHH---HHHHHHHH-CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCChHHH---HHHHHHHh-CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence 65432221 11111111 11111110000 0000011 11 224678999999999999999
Q ss_pred hHHHHHH
Q 046703 582 MPSVILM 588 (635)
Q Consensus 582 ~~evl~~ 588 (635)
++|+++.
T Consensus 306 ~~e~l~h 312 (351)
T 3mi9_A 306 SDDALNH 312 (351)
T ss_dssp HHHHHTS
T ss_pred HHHHhCC
Confidence 9999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=242.36 Aligned_cols=188 Identities=26% Similarity=0.333 Sum_probs=147.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.... ......+++.++..++.|+++||.|||+.+ |+||||||+||++
T Consensus 111 l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 187 (348)
T 1u5q_A 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILL 187 (348)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEE
T ss_pred CCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 46999999999888888999999998632 123567899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++...... ....||..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 188 ~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--- 258 (348)
T 1u5q_A 188 SEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--- 258 (348)
T ss_dssp ETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred CCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---
Confidence 99999999999999765322 2356899999999884 56789999999999999999999999854321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........ .+........ . ....+.+++.+||+.||++|||+++|++.
T Consensus 259 ---~~~~~~~~-~~~~~~~~~~----~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 259 ---MSALYHIA-QNESPALQSG----H----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---HHHHHHHH-HSCCCCCCCT----T----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---HHHHHHHH-hcCCCCCCCC----C----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122222 2222211111 1 12346789999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=231.47 Aligned_cols=194 Identities=24% Similarity=0.334 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+...+...|+++++.+... .....+++.++..++.||+.||.|||+.+ ++|+||||+||++
T Consensus 62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~ 138 (276)
T 2yex_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLL 138 (276)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEE
Confidence 368999999888888889999999876311 22346888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++................|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-- 216 (276)
T 2yex_A 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-- 216 (276)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--
T ss_pred ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--
Confidence 9999999999999987643322222233568999999999987765 7899999999999999999999865432211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ...+...... ... .......+.+++.+||+.||++|||++||++
T Consensus 217 ~----~~~~~~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 217 E----YSDWKEKKTY--LNP------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp H----HHHHHTTCTT--STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred H----HHHhhhcccc--cCc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1 1111111111 000 0112235678999999999999999999876
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=233.96 Aligned_cols=190 Identities=24% Similarity=0.390 Sum_probs=127.8
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+|++.+..+......+|+++++.+.. ......+++.++..++.||++||.|||+.+ ++|+||||+||
T Consensus 67 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Ni 143 (278)
T 3cok_A 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNL 143 (278)
T ss_dssp TBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGE
T ss_pred hCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHE
Confidence 346999999999988888999999998631 122356899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+..
T Consensus 144 li~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 144 LLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp EECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred EEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 999999999999999987643221 122356899999999999889999999999999999999999998654322111
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... ... +... +......+.+++.+||+.||++|||+++|++
T Consensus 222 -------~~~---~~~---~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 -------NKV---VLA---DYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---------C---CSS---CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------HHH---hhc---ccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 000 0011 1112235678999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-26 Score=261.16 Aligned_cols=196 Identities=27% Similarity=0.330 Sum_probs=150.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..++.. ..+|+++++++.. ....+.+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 427 l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl 502 (635)
T 4fl3_A 427 LDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLL 502 (635)
T ss_dssp CCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEE
Confidence 469999999998864 4689999998742 123457899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 452 DQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++ |+.||......
T Consensus 503 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--- 579 (635)
T 4fl3_A 503 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--- 579 (635)
T ss_dssp EETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---
T ss_pred eCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999876543221 11222456788999999999999999999999999999998 99998643221
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+..+...... ......+.+++..||+.||++||++++|++.|+..
T Consensus 580 ----~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 580 ----EVTAMLEKGERMGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp ----HHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122333333322221 12234577899999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=245.62 Aligned_cols=206 Identities=19% Similarity=0.308 Sum_probs=139.7
Q ss_pred eeccccccccccC--CCCccEEEEecccchhh-------------hhccccCcccchhhhhhhccccchhhccccceEEe
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELDQ-------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 441 (635)
+.|+||+.+..+. ..+..+|+++++.+... .....+++..+..++.||+.||.|||+.+ |+|
T Consensus 75 l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH 151 (405)
T 3rgf_A 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLH 151 (405)
T ss_dssp CCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeC
Confidence 4699999998887 56778999999987321 11224889999999999999999999999 999
Q ss_pred eccCCcceEe----ccCCCCccCccccceecCCCCC-CCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhh
Q 046703 442 RDLKAGNVLL----DQDMNPKISDFGLARTFGGDET-EGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 442 ~dik~~NIll----d~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eilt 515 (635)
|||||+|||+ +.++.+||+|||+++....... ........||..|+|||.+.+. .++.++|||||||++|||++
T Consensus 152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 231 (405)
T 3rgf_A 152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231 (405)
T ss_dssp CCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh
Confidence 9999999999 6778999999999987643211 1223346789999999998774 58999999999999999999
Q ss_pred CCCCCCCccCCC------cccHHHHHHHHhhcCCCCcCCCCccc-----------------cCCCH---------HHHHH
Q 046703 516 GKKNRGFYHLDN------KLNLIGHAWKLWNKGMPSEMIDPCYQ-----------------ESCNL---------TEVIR 563 (635)
Q Consensus 516 G~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~-----------------~~~~~---------~~~~~ 563 (635)
|+.||....... ....+......+. .+....-..+. ..... .....
T Consensus 232 g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG--FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp SSCTTCCCC------CCCCHHHHHHHHHHHC--CCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred CCCCCCCccccccccccchHHHHHHHHHhhC--CCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 999996543211 1122222222211 11100000000 00000 01235
Q ss_pred HHHHHHHhcccCCCCCCChHHHHH
Q 046703 564 CIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 564 ~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+.+|+.+||+.||++|||++|+++
T Consensus 310 ~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCCcccCCCHHHHhc
Confidence 678999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-26 Score=232.60 Aligned_cols=195 Identities=26% Similarity=0.372 Sum_probs=148.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+..+... ...|+++++.+.. ......+++.+++.++.|++.||.|||+.+ |+||||||+||
T Consensus 65 l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Ni 140 (279)
T 1qpc_A 65 LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140 (279)
T ss_dssp CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred CCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhE
Confidence 368999988887653 4689999987531 112236899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
+++.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 141 l~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 217 (279)
T 1qpc_A 141 LVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-- 217 (279)
T ss_dssp EECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--
T ss_pred EEcCCCCEEECCCcccccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--
Confidence 99999999999999998765332111 112345778999999998899999999999999999999 89898643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.....+..+..... +......+.+++.+||+.||++|||+.+|+++|+..
T Consensus 218 -----~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 218 -----EVIQNLERGYRMVR---------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -----HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHhcccCCCC---------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11222222221111 111224577899999999999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=240.93 Aligned_cols=183 Identities=19% Similarity=0.231 Sum_probs=146.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++.... ......+++..+..++.||+.||.|||+.+ |+||||||+||+
T Consensus 86 l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 162 (335)
T 3dls_A 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIV 162 (335)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEE
Confidence 36999999999988888999999976421 123456899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||++........ .....||..|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 163 l~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--- 236 (335)
T 3dls_A 163 IAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--- 236 (335)
T ss_dssp ECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---
T ss_pred EcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---
Confidence 99999999999999987654322 234678999999999988877 89999999999999999999998532110
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
...... .+......+.+++.+||+.||++|||++||++.
T Consensus 237 ------------------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ------------------VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------------------TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------------------HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000112347789999999999999999999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-26 Score=232.92 Aligned_cols=192 Identities=25% Similarity=0.316 Sum_probs=142.0
Q ss_pred eeccccccccccC-CCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFP-DGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~-~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.+..+. .....+|+++++.+.. ......+++..++.++.|+++||.|||+.+ ++|+||||+|
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~N 147 (278)
T 1byg_A 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 147 (278)
T ss_dssp CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcce
Confidence 4699999988874 4455789999987631 122234888999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDN 527 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~ 527 (635)
|+++.++.+||+|||++....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 148 il~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 148 VLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp EEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred EEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987653221 12456889999999999999999999999999999998 999986543221
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.. .....+..... +......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 223 ---~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 223 ---VV----PRVEKGYKMDA---------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---HH----HHHTTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HH----HHHhcCCCCCC---------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11 12222221111 112234577899999999999999999999999765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-27 Score=247.08 Aligned_cols=187 Identities=24% Similarity=0.293 Sum_probs=147.7
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+.........+|+++++.+.. ..+...+++.++..++.||+.||.|||+++ |+||||||+||+++
T Consensus 76 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 152 (345)
T 1xjd_A 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLD 152 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred CCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEEC
Confidence 6999999999988888999999998642 123467899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 153 ~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------ 224 (345)
T 1xjd_A 153 KDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ 224 (345)
T ss_dssp TTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred CCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------
Confidence 999999999999976432221 233467899999999999999999999999999999999999998643211
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP-SVI 586 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~-evl 586 (635)
.....+..+... . .. .....+.+++.+||+.||++||++. ||+
T Consensus 225 -~~~~~i~~~~~~-~-----p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 225 -ELFHSIRMDNPF-Y-----PR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -HHHHHHHHCCCC-C-----CT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -HHHHHHHhCCCC-C-----Cc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 112222222211 1 11 1123567899999999999999997 665
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-26 Score=246.80 Aligned_cols=192 Identities=18% Similarity=0.247 Sum_probs=148.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+... .....+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 85 l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll 161 (362)
T 2bdw_A 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLL 161 (362)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEE
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEE
Confidence 469999999999888889999999986421 23456889999999999999999999999 9999999999999
Q ss_pred ccCC---CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDM---NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.+. .+||+|||++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--- 235 (362)
T 2bdw_A 162 ASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--- 235 (362)
T ss_dssp SCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---
Confidence 8654 599999999987653322 2235789999999999999999999999999999999999999854321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. .....+..+.... ..+.+ . .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~----~~~~~i~~~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 236 H----RLYAQIKAGAYDY-PSPEW-D----TVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp H----HHHHHHHHTCCCC-CTTGG-G----GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred H----HHHHHHHhCCCCC-Ccccc-c----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 1222222332211 11111 1 11234678999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-27 Score=245.27 Aligned_cols=206 Identities=22% Similarity=0.269 Sum_probs=146.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 81 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~ 157 (331)
T 4aaa_A 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILV 157 (331)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEE
Confidence 36999999999988888999999998742 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+...
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 235 (331)
T 4aaa_A 158 SQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235 (331)
T ss_dssp CTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999976543221 12235689999999998775 78999999999999999999999986543221111
Q ss_pred HHHH--------HHHHhh------cCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGH--------AWKLWN------KGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~--------~~~~~~------~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+.. ....+. .....+...........+.....+.+++.+||+.||++|||++||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1100 000000 11111111111111111123456788999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=233.65 Aligned_cols=191 Identities=21% Similarity=0.291 Sum_probs=138.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~ 447 (635)
+.|+|++.+..+...+..+|+++++.+.. ......+++..+..++.||+.||.|||++ + |+||||||+
T Consensus 63 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~ 139 (290)
T 3fme_A 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPS 139 (290)
T ss_dssp CCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGG
T ss_pred CCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHH
Confidence 36899999999888888999999998631 12346789999999999999999999998 8 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccc----cCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
||+++.++.+||+|||++........ .....|+..|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 140 Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 140 NVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp GCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred HEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 99999999999999999987643322 2224689999999996 5667899999999999999999999998642
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. . ............ ...... .....+.+++.+||+.||++|||+.||++
T Consensus 217 ~~--~---~~~~~~~~~~~~-~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 217 GT--P---FQQLKQVVEEPS-PQLPAD--------KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SC--H---HHHHHHHHHSCC-CCCCTT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cc--h---HHHHHHHhccCC-CCcccc--------cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 21 1 111222222221 111111 11235778999999999999999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-26 Score=248.82 Aligned_cols=195 Identities=17% Similarity=0.126 Sum_probs=148.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|++|+.+..+......+|++|++++.. ..+...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 126 l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~ 202 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD 202 (410)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeEC
Confidence 46999999999998899999999998642 223456888999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC----CcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
.++.+||+|||+++....... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||......
T Consensus 203 ~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-- 279 (410)
T 3v8s_A 203 KSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-- 279 (410)
T ss_dssp TTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--
T ss_pred CCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--
Confidence 999999999999987643321 1122467999999999997665 889999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD--RPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~evl~~ 588 (635)
.....+......-.... .. .....+.+++.+||+.+|.+ ||+++||++.
T Consensus 280 -~~~~~i~~~~~~~~~p~--~~--------~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 -GTYSKIMNHKNSLTFPD--DN--------DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HHHHHHHTHHHHCCCCT--TC--------CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -hHHHHHHhccccccCCC--cc--------cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11111111100001110 00 11234667899999999988 9999999973
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-26 Score=245.92 Aligned_cols=192 Identities=19% Similarity=0.185 Sum_probs=148.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++|+.+.. ......+++.+++.++.||++||.|||+.+ |+||||||+|||
T Consensus 143 l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 219 (373)
T 2x4f_A 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENIL 219 (373)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEE
Confidence 36999999999988888999999998632 123456899999999999999999999999 999999999999
Q ss_pred e--ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 L--DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 l--d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+ +.++.+||+|||+++....... .....||+.|+|||.+....++.++|||||||++|||++|+.||......
T Consensus 220 l~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-- 294 (373)
T 2x4f_A 220 CVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-- 294 (373)
T ss_dssp EEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--
T ss_pred EecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9 5567899999999987654322 22346899999999999999999999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...... . ..... ...... .. ....+.+++.+||+.||++|||+.|+++
T Consensus 295 -~~~~~i---~-~~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 295 -ETLNNI---L-ACRWD-LEDEEF-QD----ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -HHHHHH---H-HTCCC-SCSGGG-TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHH---H-hccCC-CChhhh-cc----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111 1 11111 111111 11 1235778999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-27 Score=245.53 Aligned_cols=203 Identities=18% Similarity=0.185 Sum_probs=142.2
Q ss_pred eeccccccccccCCCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.|+||+.+..+...+..+|+++++.+... .+...+++.++..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~ 166 (329)
T 3gbz_A 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLS 166 (329)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred cCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEe
Confidence 469999999999888889999999987421 23456899999999999999999999999 99999999999995
Q ss_pred -----cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 453 -----QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 453 -----~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
..+.+||+|||++........ ......+|..|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 167 ~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 244 (329)
T 3gbz_A 167 VSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244 (329)
T ss_dssp C-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 445599999999987643222 12235679999999998774 4899999999999999999999998653221
Q ss_pred CcccHHHHHHHHhhcCCC----------------CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMP----------------SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~----------------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............... .......+...........+.+++.+||+.||++|||++|+++
T Consensus 245 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 245 ---DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp ---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 111112111110000 0000000000000112245678999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=244.85 Aligned_cols=179 Identities=10% Similarity=0.045 Sum_probs=130.1
Q ss_pred ccEEEEecccchh-----hhhccccCcccc------hhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCc
Q 046703 393 QDLYIRMSASELD-----QERCKLLDWSKR------FRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISD 461 (635)
Q Consensus 393 ~~lyl~~~~~~~~-----~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~D 461 (635)
..+|+++|+++.. ......+.+..+ +.++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 161 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~D 237 (371)
T 3q60_A 161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGD 237 (371)
T ss_dssp EEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECC
T ss_pred eeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEe
Confidence 4589999997631 122345666666 788899999999999999 99999999999999999999999
Q ss_pred cccceecCCCCCCCceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHh
Q 046703 462 FGLARTFGGDETEGNTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLW 539 (635)
Q Consensus 462 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~ 539 (635)
||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +
T Consensus 238 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~ 304 (371)
T 3q60_A 238 VSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------W 304 (371)
T ss_dssp GGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------C
T ss_pred cceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------h
Confidence 9999875322 112456799999999987 679999999999999999999999997543221100 0
Q ss_pred hcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 540 NKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
............+...........+.+++.+||+.||++|||+.|+++
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000011111111111122345778999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=247.28 Aligned_cols=137 Identities=28% Similarity=0.390 Sum_probs=110.1
Q ss_pred eeccccccccccC-----CCCccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFP-----DGGQDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~-----~~~~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+. .....+|++++++.... .....+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 109 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~ 185 (458)
T 3rp9_A 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPA 185 (458)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChh
Confidence 3699999988876 34467999999886421 23456899999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCC-------------------------CceeeeeeccCCCCcccc-cCCCCcccC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETE-------------------------GNTTRVVGTYGYMAPEYA-SDGQFSVKS 501 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ks 501 (635)
|||++.++.+||+|||+++........ .......||+.|+|||.+ ....++.++
T Consensus 186 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~ 265 (458)
T 3rp9_A 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265 (458)
T ss_dssp GEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHH
T ss_pred hEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHh
Confidence 999999999999999999876422111 112335789999999976 566799999
Q ss_pred ceeeeehhhHhhhhC
Q 046703 502 DVFSFGILLLEIVSG 516 (635)
Q Consensus 502 DVwS~Gvvl~eiltG 516 (635)
|||||||++|||++|
T Consensus 266 DiwSlG~il~elltg 280 (458)
T 3rp9_A 266 DVWSIGCIFAELLNM 280 (458)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999999994
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=245.71 Aligned_cols=193 Identities=18% Similarity=0.193 Sum_probs=148.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+|||
T Consensus 105 l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIl 181 (387)
T 1kob_A 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIM 181 (387)
T ss_dssp CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeE
Confidence 36999999999988889999999988632 122346899999999999999999999999 999999999999
Q ss_pred ecc--CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 LDQ--DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++. .+.+||+|||++....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 182 l~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--- 255 (387)
T 1kob_A 182 CETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--- 255 (387)
T ss_dssp ESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---
T ss_pred EecCCCCceEEEecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---
Confidence 974 4679999999998765332 22345789999999999999999999999999999999999999864321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
...... +...... .+... .......+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~----i~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 256 LETLQN----VKRCDWE--FDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHH----HHHCCCC--CCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHH----HHhCCCC--CCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111 1121111 01100 11122357789999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=231.61 Aligned_cols=191 Identities=20% Similarity=0.260 Sum_probs=145.3
Q ss_pred eeccccccccccC--CCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+. .....+|+++++.+.. ....+.+++.++..++.||++||.|||+++ |+||||||+|
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~N 139 (305)
T 2wtk_C 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGN 139 (305)
T ss_dssp CCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCccc
Confidence 3699999988876 5567899999997632 223456889999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC--CcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|+++.++.+||+|||++................|+..|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 140 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 218 (305)
T 2wtk_C 140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI- 218 (305)
T ss_dssp EEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred EEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-
Confidence 999999999999999998765433333333456899999999987644 47899999999999999999999864321
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+..+... + ... ....+.+++.+||+.||++|||++|+++
T Consensus 219 ------~~~~~~i~~~~~~-~-----~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 219 ------YKLFENIGKGSYA-I-----PGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ------HHHHHHHHHCCCC-C-----CSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------HHHHHHHhcCCCC-C-----CCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122222222211 1 111 2235678999999999999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-26 Score=241.02 Aligned_cols=194 Identities=22% Similarity=0.225 Sum_probs=138.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ....+.+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 73 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill 149 (361)
T 3uc3_A 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLL 149 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEE
T ss_pred CCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 46999999999988888999999998632 123457899999999999999999999999 9999999999999
Q ss_pred ccCCC--CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCccc-CceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMN--PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVK-SDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~--~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++. +||+|||+++..... .......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||........
T Consensus 150 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 226 (361)
T 3uc3_A 150 DGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226 (361)
T ss_dssp CSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred cCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence 87765 999999999753222 12233578999999999988887655 8999999999999999999865433222
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. . ........... ..+ .......+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~--~-~~~~~~~~~~~-~~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 227 YR--K-TIQRILSVKYS-IPD-------DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HH--H-HHHHHHTTCCC-CCT-------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HH--H-HHHHHhcCCCC-CCC-------cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11 1 11111111111 000 0011235678999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-26 Score=250.55 Aligned_cols=202 Identities=20% Similarity=0.187 Sum_probs=143.5
Q ss_pred eeccccccccccC------CCCccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 377 MWFGDLIDMRSFP------DGGQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 377 l~h~nLv~l~~~~------~~~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
+.|+||+.+..+. .+...+|+++++.+.. ......+++..+..++.||++||+|||+.+ |+||
T Consensus 104 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHr 180 (420)
T 1j1b_A 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHR 180 (420)
T ss_dssp CCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECS
T ss_pred cCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 3699999887665 2223467899987631 123467889999999999999999999999 9999
Q ss_pred ccCCcceEeccC-CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCC
Q 046703 443 DLKAGNVLLDQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 443 dik~~NIlld~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
||||+|||++.+ +.+||+|||+++....... .....+|..|+|||.+.+. .++.++|||||||++|||++|+.||
T Consensus 181 Dlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf 257 (420)
T 1j1b_A 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257 (420)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 999999999965 5689999999987643322 1235689999999998765 7899999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHh--------h--cCCCCcCCCCc-----cccCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 521 GFYHLDNKLNLIGHAWKLW--------N--KGMPSEMIDPC-----YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~d~~-----l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
...... ..+......+ . .....+..-+. +...+.......+.+|+.+||+.||++|||+.|+
T Consensus 258 ~~~~~~---~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~ 334 (420)
T 1j1b_A 258 PGDSGV---DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334 (420)
T ss_dssp CCSSHH---HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCHH---HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence 654322 1121111111 0 00111111111 1111112223467889999999999999999999
Q ss_pred HH
Q 046703 586 IL 587 (635)
Q Consensus 586 l~ 587 (635)
++
T Consensus 335 l~ 336 (420)
T 1j1b_A 335 CA 336 (420)
T ss_dssp HT
T ss_pred hC
Confidence 85
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=246.75 Aligned_cols=187 Identities=19% Similarity=0.190 Sum_probs=146.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|++|+.+.........+|++|++.+.. ..+...+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 96 ~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll 172 (373)
T 2r5t_A 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILL 172 (373)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEE
Confidence 47999999999988889999999998642 123456888899999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 173 ~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----- 245 (373)
T 2r5t_A 173 DSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----- 245 (373)
T ss_dssp CTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-----
T ss_pred CCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----
Confidence 9999999999999976432221 233467899999999999999999999999999999999999998543211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
.....+..+... + ... ....+.+++.+||+.||.+||++.+.
T Consensus 246 --~~~~~i~~~~~~-~-----~~~----~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 246 --EMYDNILNKPLQ-L-----KPN----ITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp --HHHHHHHHSCCC-C-----CSS----SCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred --HHHHHHHhcccC-C-----CCC----CCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 112222222111 1 111 12346789999999999999998543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-26 Score=252.46 Aligned_cols=139 Identities=21% Similarity=0.217 Sum_probs=118.8
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+|++.+.........+|+++++.... ......+++..+..++.||++||+|||+.+ |+||||||+|||+
T Consensus 157 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl 233 (429)
T 3kvw_A 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILL 233 (429)
T ss_dssp SCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEE
T ss_pred CCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 5788998888887778899999988632 122345899999999999999999999999 9999999999999
Q ss_pred ccCCC--CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 452 DQDMN--PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 452 d~~~~--~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
+.++. +||+|||++...... .....||..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 234 ~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 234 KQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99887 999999999765322 223568999999999999999999999999999999999999986543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=243.50 Aligned_cols=188 Identities=22% Similarity=0.236 Sum_probs=147.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+..+......+|+++++.+.. ..+...+++.++..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~ 155 (353)
T 2i0e_A 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLD 155 (353)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEc
Confidence 5899999999888888999999998642 123457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..
T Consensus 156 ~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~-- 228 (353)
T 2i0e_A 156 SEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DE-- 228 (353)
T ss_dssp TTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--
T ss_pred CCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HH--
Confidence 99999999999998643222 123346799999999999999999999999999999999999999864321 11
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
....+..+... . +......+.+++.+||+.||++||+ ++||++
T Consensus 229 --~~~~i~~~~~~-~---------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 229 --LFQSIMEHNVA-Y---------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --HHHHHHHCCCC-C---------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --HHHHHHhCCCC-C---------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12222222211 1 1112235778999999999999996 466654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.4e-26 Score=240.77 Aligned_cols=191 Identities=12% Similarity=0.011 Sum_probs=148.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh----------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ----------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
.|++++.+..........|+++++++... .....+++.+++.++.||++||+|||+.+ |+||||||+
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~ 201 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPD 201 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGG
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHH
Confidence 48899999888888889999999987311 12456899999999999999999999999 999999999
Q ss_pred ceEecc-----------CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC
Q 046703 448 NVLLDQ-----------DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 448 NIlld~-----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG 516 (635)
|||++. ++.+||+|||+++.+.............||..|+|||.+.+..++.++|||||||++|||++|
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999998 899999999999876432222233345789999999999999999999999999999999999
Q ss_pred CCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCC-CChHHHHHHHcCC
Q 046703 517 KKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR-PCMPSVILMLGSE 592 (635)
Q Consensus 517 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~R-Pt~~evl~~L~~~ 592 (635)
+.||......... +...+..... ...+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 282 ~~pf~~~~~~~~~------------------~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 282 TYMKVKNEGGECK------------------PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp SCCCEEEETTEEE------------------ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred CCccccCCCCcee------------------echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 9998533221100 0111111111 2345568888999999999 5788888888765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-26 Score=241.50 Aligned_cols=193 Identities=14% Similarity=0.206 Sum_probs=142.7
Q ss_pred CccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCC--CCccCccc
Q 046703 392 GQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM--NPKISDFG 463 (635)
Q Consensus 392 ~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~--~~kl~Dfg 463 (635)
+..+|+++++... .......+++.+++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 130 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg 206 (352)
T 2jii_A 130 DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYG 206 (352)
T ss_dssp TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGG
T ss_pred CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCc
Confidence 5688999998742 1112367999999999999999999999999 99999999999999988 89999999
Q ss_pred cceecCCCCCC-----CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHH
Q 046703 464 LARTFGGDETE-----GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKL 538 (635)
Q Consensus 464 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~ 538 (635)
+++........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+......
T Consensus 207 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~ 284 (352)
T 2jii_A 207 FAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT--EDIMKQKQK 284 (352)
T ss_dssp GCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--HHHHHHHHH
T ss_pred ceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH--HHHHHHHHh
Confidence 99876432211 11122478999999999999999999999999999999999999986543221 112222221
Q ss_pred hhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 539 WNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 539 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
+. .....+.+...... .....+.+++.+||+.||++|||+++|+++|+.+.
T Consensus 285 ~~-~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 285 FV-DKPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp HH-HSCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cc-CChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 11 12222222221110 11235778999999999999999999999998763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-26 Score=234.48 Aligned_cols=199 Identities=21% Similarity=0.287 Sum_probs=143.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+......+|+++++.+... .....+++.+++.++.||+.||.|||+.+ ++|+||||+
T Consensus 89 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~ 165 (310)
T 2wqm_A 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPA 165 (310)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred CCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHH
Confidence 368999999888877889999999876311 12456889999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 166 NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~- 242 (310)
T 2wqm_A 166 NVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN- 242 (310)
T ss_dssp GEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-
T ss_pred HEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-
Confidence 99999999999999999986543322 122356899999999999999999999999999999999999998543211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.. .....+..+........ .....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 243 ---~~-~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 243 ---LY-SLCKKIEQCDYPPLPSD--------HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ---HH-HHHHHHHTTCSCCCCTT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HH-HHHHHhhcccCCCCccc--------ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11 11222223322222111 11235778999999999999999999999998774
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-26 Score=235.21 Aligned_cols=200 Identities=20% Similarity=0.252 Sum_probs=143.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+|+||||+||++
T Consensus 91 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~ 167 (309)
T 2h34_A 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILV 167 (309)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred cCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEE
Confidence 36899999988888788999999987631 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 241 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----- 241 (309)
T ss_dssp CTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----
T ss_pred cCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----
Confidence 99999999999999766433221 122356899999999999999999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHHcCCCC
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-CMPSVILMLGSEIV 594 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~ 594 (635)
............ . ..........+.+++.+||+.||++|| +++++++.|+....
T Consensus 242 --~~~~~~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 242 --VMGAHINQAIPR-P------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp --HHHHHHHSCCCC-G------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred --HHHHHhccCCCC-c------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 111111111111 0 001111223467899999999999999 99999999987754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-27 Score=245.17 Aligned_cols=201 Identities=17% Similarity=0.220 Sum_probs=144.0
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||+|||+.+ |+||||||+||+++
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCE 145 (316)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEES
T ss_pred CCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEc
Confidence 5999999999888888999999998632 123457899999999999999999999999 99999999999999
Q ss_pred cCCC---CccCccccceecCCCCC-----CCceeeeeeccCCCCcccccC-----CCCcccCceeeeehhhHhhhhCCCC
Q 046703 453 QDMN---PKISDFGLARTFGGDET-----EGNTTRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 453 ~~~~---~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
.++. +||+|||++........ ........||..|+|||.+.. ..++.++||||||+++|||++|+.|
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 8766 89999999876542211 111123458999999999875 5688999999999999999999999
Q ss_pred CCCccCCCcc--------cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 520 RGFYHLDNKL--------NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 520 f~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
|......+.. .........+..+... ...... . .....+.+++.+||+.||++|||++|+++
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDKDW-A----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCHHHH-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcc-cCchhc-c----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 9764322210 0011122222222221 110000 0 11235778999999999999999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=236.78 Aligned_cols=202 Identities=24% Similarity=0.357 Sum_probs=144.8
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh-------------hhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
.+.|+||+.+..+......+|+++++.+... .....+++..+..++.||+.||.|||+.+ ++|+
T Consensus 69 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~ 145 (303)
T 2vwi_A 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHR 145 (303)
T ss_dssp CCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred hcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCC
Confidence 3479999999988877888999999885311 12355899999999999999999999999 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCC---CCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDET---EGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
||||+||+++.++.+||+|||++........ ........|+..|+|||.+.. ..++.++||||||+++|||++|+.
T Consensus 146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999976543211 111223568999999999865 568999999999999999999999
Q ss_pred CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 519 NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
||....... .... .. .+.....................+.+++.+||+.||++|||+.||++
T Consensus 226 pf~~~~~~~---~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 226 PYHKYPPMK---VLML---TL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTTTSCGGG---HHHH---HH-TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccCchhh---HHHH---Hh-ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 986543221 1111 11 11111111111111111112235778999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-26 Score=238.34 Aligned_cols=198 Identities=23% Similarity=0.270 Sum_probs=149.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------h------hccccCcccchhhhhhhccccchhhccccceEEeecc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------E------RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di 444 (635)
+.|+||+.+..+.......|+++++.+... . ....+++.+++.++.||+.||.|||+.+ |+||||
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dl 166 (327)
T 2yfx_A 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDI 166 (327)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred CCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcC
Confidence 369999999999888888999999885310 1 1134888899999999999999999999 999999
Q ss_pred CCcceEecc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCC
Q 046703 445 KAGNVLLDQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNR 520 (635)
Q Consensus 445 k~~NIlld~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf 520 (635)
||+||+++. +..+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999984 44699999999976543332222223456889999999998999999999999999999998 88898
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
...... .....+..+...... ......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 247 ~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 247 PSKSNQ-------EVLEFVTSGGRMDPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTCCHH-------HHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCHH-------HHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 543211 122222232222111 112235778999999999999999999999998663
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-26 Score=240.73 Aligned_cols=192 Identities=19% Similarity=0.250 Sum_probs=144.4
Q ss_pred eccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.|+|++.+..+......+|+++++.+.. ......+++.+++.++.||+.||+|||+.+ |+||||||+||+
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl 163 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNIL 163 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEE
Confidence 4689999999888888999999988642 122356889999999999999999999999 999999999999
Q ss_pred ecc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 451 LDQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 451 ld~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
++. ++.+||+|||+++....... .....|++.|+|||.+....++.++||||||+++|||++|+.||......
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 239 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ- 239 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-
Confidence 998 78999999999987643321 22357899999999999999999999999999999999999998543211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.... .+....... ... ........+.+++.+||+.||++|||++|+++.
T Consensus 240 --~~~~----~i~~~~~~~-~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 --ETYL----NISQVNVDY-SEE-----TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HHHH----HHHHTCCCC-CTT-----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --HHHH----HHHhccccc-Cch-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111 111111110 000 011122357789999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-26 Score=244.44 Aligned_cols=188 Identities=18% Similarity=0.155 Sum_probs=136.1
Q ss_pred CCccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec-cCCCCccCc
Q 046703 391 GGQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD-QDMNPKISD 461 (635)
Q Consensus 391 ~~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld-~~~~~kl~D 461 (635)
....+|+++++.+.. ......+++..+..++.||++||.|||+.+ |+||||||+||+++ .++.+||+|
T Consensus 109 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~D 185 (383)
T 3eb0_A 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCD 185 (383)
T ss_dssp -CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECC
T ss_pred CceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEE
Confidence 344588999998732 123467899999999999999999999999 99999999999998 678899999
Q ss_pred cccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhh
Q 046703 462 FGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWN 540 (635)
Q Consensus 462 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~ 540 (635)
||+++....... .....++..|+|||.+.+. .++.++||||+||++|||++|+.||......+ .+........
T Consensus 186 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~g 259 (383)
T 3eb0_A 186 FGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID---QLVRIIQIMG 259 (383)
T ss_dssp CTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHC
T ss_pred CCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence 999987644322 2235678999999998765 48999999999999999999999986543221 1111111110
Q ss_pred ---------------cCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 541 ---------------KGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 541 ---------------~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+-.........+....+......+.+++.+||+.||++|||+.|+++
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111111111111222223445788999999999999999999984
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-26 Score=238.75 Aligned_cols=194 Identities=19% Similarity=0.226 Sum_probs=140.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 105 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll 181 (349)
T 2w4o_A 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLY 181 (349)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEE
Confidence 46999999999988888999999998632 123456889999999999999999999999 9999999999999
Q ss_pred cc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+. ++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 182 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~- 257 (349)
T 2w4o_A 182 ATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ- 257 (349)
T ss_dssp SSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-
T ss_pred ecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-
Confidence 75 7889999999998754321 1223578999999999999999999999999999999999999985432111
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.....+..+... ...+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 258 -----~~~~~i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 258 -----FMFRRILNCEYY-FISPW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----HHHHHHHTTCCC-CCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----HHHHHHHhCCCc-cCCch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222222211 11111 11123357789999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-26 Score=241.06 Aligned_cols=195 Identities=22% Similarity=0.209 Sum_probs=146.3
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+......+|+++++.+.. ......+++.++..++.||++||.|||+.+ |+||||||+|||++
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 193 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLD 193 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 4888988888877778899999998631 123457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
.++.+||+|||+++........ ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||..........
T Consensus 194 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 272 (355)
T 1vzo_A 194 SNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272 (355)
T ss_dssp TTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred CCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH
Confidence 9999999999999876432221 1223568999999999975 357899999999999999999999986543332221
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVILML 589 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~~L 589 (635)
.+ .......... .+......+.+++.+||+.||++|| +++|+++..
T Consensus 273 ~~---~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 273 EI---SRRILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HH---HHHHHHCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HH---HHHHhccCCC----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 1111111111 1111223467899999999999999 999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-26 Score=240.46 Aligned_cols=189 Identities=22% Similarity=0.203 Sum_probs=143.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+..+|+++++.+.. ..+...+++.++..++.||+.||.|||+++ |+||||||+||++
T Consensus 78 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill 154 (327)
T 3a62_A 78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIML 154 (327)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEE
T ss_pred CCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEE
Confidence 36999999998888888999999998632 123456888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..... ...
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~ 229 (327)
T 3a62_A 155 NHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKT 229 (327)
T ss_dssp CTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH
T ss_pred CCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHH
Confidence 9999999999999975432211 12235689999999999999999999999999999999999999864321 111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
.. .+..+... + +......+.+++.+||+.||++|| ++.|+++
T Consensus 230 ~~----~i~~~~~~-~---------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 ID----KILKCKLN-L---------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HH----HHHHTCCC-C---------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HH----HHHhCCCC-C---------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 11121111 0 111223567899999999999999 6778875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.1e-26 Score=231.83 Aligned_cols=198 Identities=22% Similarity=0.262 Sum_probs=148.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+.... ..|+++++.+.. ......+++.++..++.||++||.|||+.+ ++|+||||+||+
T Consensus 78 l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil 153 (291)
T 1u46_A 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLL 153 (291)
T ss_dssp CCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCCCcccEEEEEccC-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEE
Confidence 3689999988887654 488888887631 122356899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 154 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-- 231 (291)
T 1u46_A 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-- 231 (291)
T ss_dssp EEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred EcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--
Confidence 999999999999999876543221 11223456778999999998899999999999999999999 99998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.. .......+..... +......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 232 -~~---~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 232 -QI---LHKIDKEGERLPR---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -HH---HHHHHTSCCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -HH---HHHHHccCCCCCC---------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11 1111111111111 1122345778999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.7e-26 Score=228.76 Aligned_cols=195 Identities=16% Similarity=0.220 Sum_probs=147.0
Q ss_pred eeeccccccccccCCCC--ccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPDGG--QDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~--~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+||+.+..+.... ..+|+++++.+.. ......+++.+++.++.||++||.|||+.+ ..++||||||
T Consensus 63 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp 141 (271)
T 3kmu_A 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNS 141 (271)
T ss_dssp CCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSG
T ss_pred hcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCcc
Confidence 34699999999887654 7889999988641 112225899999999999999999999875 3499999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcc---cCceeeeehhhHhhhhCCCCCCCc
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+||+++.++.++|.|||+....... ...+|..|+|||.+.+...+. ++||||||+++|||++|+.||...
T Consensus 142 ~Nil~~~~~~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 142 RSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp GGEEECTTSCEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ceEEEcCCcceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999999988887543211 245789999999998765544 899999999999999999998643
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.. ..........+....... .....+.+++..||+.||++|||++||++.|+.+.
T Consensus 215 ~~------~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 215 SN------MEIGMKVALEGLRPTIPP---------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CH------HHHHHHHHHSCCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred Ch------HHHHHHHHhcCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 21 111122222222222211 12235778999999999999999999999997653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-26 Score=246.94 Aligned_cols=163 Identities=14% Similarity=0.109 Sum_probs=123.0
Q ss_pred EEEEecccchhh----hhcc-------ccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccc
Q 046703 395 LYIRMSASELDQ----ERCK-------LLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG 463 (635)
Q Consensus 395 lyl~~~~~~~~~----~~~~-------~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfg 463 (635)
.|+++|+..... ...+ .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 175 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG 251 (377)
T 3byv_A 175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 251 (377)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEech
Confidence 788888875311 1112 2334788899999999999999999 9999999999999999999999999
Q ss_pred cceecCCCCCCCceeeeeeccCCCCcccccCC-----------CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 464 LARTFGGDETEGNTTRVVGTYGYMAPEYASDG-----------QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 464 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
+++.... ......| ..|+|||.+.+. .++.++|||||||++|||++|+.||..........
T Consensus 252 ~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~-- 323 (377)
T 3byv_A 252 HLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-- 323 (377)
T ss_dssp GCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG--
T ss_pred hheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh--
Confidence 9986422 2233567 999999999887 89999999999999999999999986433221110
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+... . ... ...+.+++.+||+.||++|||+.|+++
T Consensus 324 -------------~~~~~-~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 324 -------------WIFRS-C-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp -------------GGGSS-C-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred -------------hhhhh-c-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 00000 0 111 235778999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.9e-26 Score=245.93 Aligned_cols=195 Identities=16% Similarity=0.152 Sum_probs=147.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|++|+.+..+......+|+++++++.. ......+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 131 ~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NIL 207 (437)
T 4aw2_A 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNIL 207 (437)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHee
Confidence 36999999999998889999999998632 122467899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
++.++.+||+|||+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred EcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999876543221 122357999999999987 56789999999999999999999999864321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDD--RPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~evl~ 587 (635)
. .....+......-..+... .. ....+.+++.+||+.+|++ ||+++||++
T Consensus 287 ~---~~~~~i~~~~~~~~~p~~~-----~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 287 V---ETYGKIMNHKERFQFPTQV-----TD----VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp H---HHHHHHHTHHHHCCCCSSC-----CC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred h---HHHHhhhhccccccCCccc-----cc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1 1111111111111111111 01 1234667888999888888 999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-26 Score=241.31 Aligned_cols=201 Identities=21% Similarity=0.296 Sum_probs=139.4
Q ss_pred eeeccccccccccCCC----CccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 376 AMWFGDLIDMRSFPDG----GQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~----~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.+.|+||+.+..+... +..+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||
T Consensus 68 ~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp 144 (311)
T 3ork_A 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKP 144 (311)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred cCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCH
Confidence 3479999998776532 23459999998631 123456899999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+||+++.++.+||+|||++......... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 145 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp GGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999999876433221 222335689999999999999999999999999999999999999854321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH-HHHcCC
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI-LMLGSE 592 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl-~~L~~~ 592 (635)
................ .. .......+.+++.+||+.||++||++.+++ ..|...
T Consensus 225 ------~~~~~~~~~~~~~~~~---~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 225 ------VSVAYQHVREDPIPPS---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ------HHHHHHHHHCCCCCHH---HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCcc---cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1112222222111100 00 011223577899999999999999765554 455444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-26 Score=238.66 Aligned_cols=201 Identities=19% Similarity=0.199 Sum_probs=145.2
Q ss_pred ccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
|.+++.+..+......+|+++++.... ......+++.++..++.||++||+|||+.+ |+||||||+||+++
T Consensus 76 ~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 152 (339)
T 1z57_A 76 TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFV 152 (339)
T ss_dssp TTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEES
T ss_pred ceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 445777777776677899999988531 122236788999999999999999999999 99999999999998
Q ss_pred c-------------------CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhh
Q 046703 453 Q-------------------DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 513 (635)
Q Consensus 453 ~-------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~ei 513 (635)
. ++.+||+|||++....... ....||..|+|||.+.+..++.++||||||+++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred ccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence 7 6679999999998754321 235689999999999999999999999999999999
Q ss_pred hhCCCCCCCccCCCcccHHHHHHHHh-----hcCCCCcC---------------------CCCcc-ccCCCHHHHHHHHH
Q 046703 514 VSGKKNRGFYHLDNKLNLIGHAWKLW-----NKGMPSEM---------------------IDPCY-QESCNLTEVIRCIH 566 (635)
Q Consensus 514 ltG~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---------------------~d~~l-~~~~~~~~~~~~~~ 566 (635)
++|+.||......+....+....... ........ ..+.. ...........+.+
T Consensus 228 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp HHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 99999987543222111111110000 00000000 00000 01123345677889
Q ss_pred HHHHhcccCCCCCCChHHHHH
Q 046703 567 ISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 567 l~~~Cl~~dP~~RPt~~evl~ 587 (635)
++.+||+.||++|||++||++
T Consensus 308 li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHhCcCcccccCHHHHhc
Confidence 999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-26 Score=232.40 Aligned_cols=192 Identities=18% Similarity=0.246 Sum_probs=147.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+...|+++++.+.. ......+++.++..++.|++.||.|||+.+ |+||||||+||++
T Consensus 62 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~ 138 (284)
T 3kk8_A 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLL 138 (284)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEE
Confidence 46999999999888888999999988632 123456899999999999999999999999 9999999999999
Q ss_pred ccCCC---CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMN---PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++. +||+|||++........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 139 ~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-- 213 (284)
T 3kk8_A 139 ASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-- 213 (284)
T ss_dssp SSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred ecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--
Confidence 87655 99999999987653322 12356899999999999999999999999999999999999998543211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. .......+.... ..+.. . .....+.+++.+||+.||++|||++|+++
T Consensus 214 -~----~~~~~~~~~~~~-~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 214 -R----LYAQIKAGAYDY-PSPEW-D----TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -H----HHHHHHHTCCCC-CTTTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -H----HHHHHHhccccC-Cchhh-c----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 111222222111 11110 0 11234678999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-26 Score=242.99 Aligned_cols=203 Identities=24% Similarity=0.307 Sum_probs=148.0
Q ss_pred eeccccccccccCCCC------ccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGG------QDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~------~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+.... ..+|++++++... ..+...+++..+..++.||++||.|||+.+ |+||||||+
T Consensus 81 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~ 157 (367)
T 1cm8_A 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPG 157 (367)
T ss_dssp CCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred CCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHH
Confidence 4689999887765433 4579999987421 123456889999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
||+++.++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++||||+||+++||++|+.||......
T Consensus 158 NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 232 (367)
T 1cm8_A 158 NLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232 (367)
T ss_dssp GEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999875432 223567999999999877 68999999999999999999999998654322
Q ss_pred CcccHHHHHHHHhhcCCC--------------------CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMP--------------------SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~--------------------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
+ .+....... |.+ .......+. .........+.+++.+||+.||++|||++|++
T Consensus 233 ~---~l~~i~~~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l 306 (367)
T 1cm8_A 233 D---QLKEIMKVT--GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306 (367)
T ss_dssp H---HHHHHHHHH--CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred H---HHHHHHHhc--CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHh
Confidence 1 111111110 110 011111111 01112234577899999999999999999999
Q ss_pred H--HHcCCC
Q 046703 587 L--MLGSEI 593 (635)
Q Consensus 587 ~--~L~~~~ 593 (635)
+ .++...
T Consensus 307 ~hp~f~~~~ 315 (367)
T 1cm8_A 307 AHPYFESLH 315 (367)
T ss_dssp HSGGGTTTC
T ss_pred cChHHHhhc
Confidence 8 455443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-26 Score=233.21 Aligned_cols=189 Identities=25% Similarity=0.367 Sum_probs=149.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ....+.+++.++..++.||++||.|||+.+ ++|+||||+||++
T Consensus 72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~ 148 (294)
T 2rku_A 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFL 148 (294)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEE
Confidence 36999999999988888999999998632 123457899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++......... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 221 (294)
T 2rku_A 149 NEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----- 221 (294)
T ss_dssp CTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred cCCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999999876432221 22356899999999999989999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+... + ... ....+.+++.+||+.||++|||++|+++
T Consensus 222 --~~~~~~~~~~~~-~-----~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 222 --ETYLRIKKNEYS-I-----PKH----INPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --HHHHHHHTTCCC-C-----CTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --HHHHHHhhccCC-C-----ccc----cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111112222111 1 111 1234678999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-26 Score=240.13 Aligned_cols=189 Identities=25% Similarity=0.370 Sum_probs=149.2
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+||||||+||++
T Consensus 98 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~ 174 (335)
T 2owb_A 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFL 174 (335)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEE
Confidence 36999999999988888999999998632 123467899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++......... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 247 (335)
T 2owb_A 175 NEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----- 247 (335)
T ss_dssp CTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred cCCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----
Confidence 99999999999999876432221 22356899999999999999999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+... + .... ...+.+++.+||+.||++|||++|+++
T Consensus 248 --~~~~~~~~~~~~-~-----~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 248 --ETYLRIKKNEYS-I-----PKHI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --HHHHHHHHTCCC-C-----CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --HHHHHHhcCCCC-C-----CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112222111 1 1111 234667999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=238.97 Aligned_cols=137 Identities=21% Similarity=0.241 Sum_probs=113.8
Q ss_pred ccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhc--cccceEEeeccCCcceE
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQ--DSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~--~~~~~iiH~dik~~NIl 450 (635)
|.+++.+.........+|+++++.... ......+++..+..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIl 191 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENIL 191 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEE
T ss_pred ceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEE
Confidence 445777777766677899999988632 1222458999999999999999999995 56 999999999999
Q ss_pred ec--cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 451 LD--QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 451 ld--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++ .++.+||+|||++....... ....+|..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 192 l~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 192 LCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 94 47789999999998764321 2356889999999999999999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-26 Score=249.00 Aligned_cols=188 Identities=24% Similarity=0.326 Sum_probs=149.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ..+...+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 73 l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll 149 (476)
T 2y94_A 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLL 149 (476)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEE
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEE
Confidence 46999999999988888999999998532 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ .....|++.|+|||.+.+..+ +.++|||||||++|||++|+.||...... .
T Consensus 150 ~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~ 223 (476)
T 2y94_A 150 DAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---T 223 (476)
T ss_dssp CTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---H
T ss_pred ecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---H
Confidence 9999999999999987654322 223578999999999988765 68999999999999999999998643211 1
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
....+..+... . ... ....+.+++.+||+.||++|||++||++
T Consensus 224 ----~~~~i~~~~~~-~-----p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 224 ----LFKKICDGIFY-T-----PQY----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----HHHHHHTTCCC-C-----CTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHhcCCcC-C-----Ccc----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 12222222211 0 011 1234678999999999999999999997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-26 Score=236.31 Aligned_cols=173 Identities=24% Similarity=0.322 Sum_probs=127.1
Q ss_pred cEEEEecccchhh--------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccc
Q 046703 394 DLYIRMSASELDQ--------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465 (635)
Q Consensus 394 ~lyl~~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla 465 (635)
.+|+++++.+... ......++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 211 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcc
Confidence 4899999986421 11223344557899999999999999999 999999999999999999999999999
Q ss_pred eecCCCCCC----------CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHH
Q 046703 466 RTFGGDETE----------GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHA 535 (635)
Q Consensus 466 ~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~ 535 (635)
+........ .......||..|+|||.+.+..++.++||||||+++|||++|..|+.. ....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~ 282 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVRI 282 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHH
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHHH
Confidence 887543211 111234689999999999999999999999999999999998776421 0111
Q ss_pred HHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 536 WKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+..... .......+.+++.+||+.||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 283 ITDVRNLKFPLL---------FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHTTCCCHH---------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHhhccCCCcc---------cccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 111222211111 1122345678999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-26 Score=238.71 Aligned_cols=200 Identities=18% Similarity=0.254 Sum_probs=146.8
Q ss_pred eeccccccccccCC----CCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 377 MWFGDLIDMRSFPD----GGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~~----~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
+.|+||+.+..+.. ....+|+++++.+... .....+++.+++.++.||++||.|||+.+ |+|||
T Consensus 83 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~d 159 (317)
T 2buj_A 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRD 159 (317)
T ss_dssp CCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred cCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 36899988877653 4568899999886411 12466899999999999999999999999 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCC-------ceeeeeeccCCCCcccccCCC---CcccCceeeeehhhHhh
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEG-------NTTRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEI 513 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwS~Gvvl~ei 513 (635)
|||+||+++.++.+||+|||++.......... ......|+..|+|||.+.... ++.++||||||+++|||
T Consensus 160 lkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 239 (317)
T 2buj_A 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239 (317)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999987643211100 001234688999999987554 68999999999999999
Q ss_pred hhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 514 VSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 514 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
++|+.||......... .. .. ..... .. .........+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 240 ~~g~~p~~~~~~~~~~-~~-~~---~~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 240 MFGEGPYDMVFQKGDS-VA-LA---VQNQL--SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHSSCTTHHHHHTTSC-HH-HH---HHCC----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HhCCCChhhhhcccch-hh-HH---hhccC--CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 9999998542211111 11 11 11110 00 001112345778999999999999999999999998875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.7e-26 Score=238.57 Aligned_cols=195 Identities=20% Similarity=0.185 Sum_probs=141.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhhhh---------------------------------------------ccc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQER---------------------------------------------CKL 411 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~~---------------------------------------------~~~ 411 (635)
+.|+||+.+..+......+|+++++.+..... ...
T Consensus 85 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (345)
T 3hko_A 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164 (345)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHH
T ss_pred CCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 36999999999988888999999998531100 112
Q ss_pred cCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCC--CCccCccccceecCCCCCC--CceeeeeeccCCC
Q 046703 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM--NPKISDFGLARTFGGDETE--GNTTRVVGTYGYM 487 (635)
Q Consensus 412 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~ 487 (635)
+++..+..++.||++||.|||+.+ |+||||||+||+++.++ .+||+|||++......... .......|++.|+
T Consensus 165 ~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 165 QREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence 355667789999999999999999 99999999999998766 8999999999876432211 1223467899999
Q ss_pred CcccccC--CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHH
Q 046703 488 APEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCI 565 (635)
Q Consensus 488 aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 565 (635)
|||.+.+ ..++.++||||||+++|||++|+.||...... ............. ..+.. ......+.
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~--~~~~~-----~~~~~~~~ 308 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF--ENPNY-----NVLSPLAR 308 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT--TSGGG-----GGSCHHHH
T ss_pred CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc--CCccc-----ccCCHHHH
Confidence 9999865 67899999999999999999999998643211 1112222111111 11111 01123577
Q ss_pred HHHHHhcccCCCCCCChHHHHH
Q 046703 566 HISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 566 ~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+++.+||+.||++|||+.|+++
T Consensus 309 ~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 309 DLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCCCHHHHhc
Confidence 8999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=234.67 Aligned_cols=194 Identities=25% Similarity=0.346 Sum_probs=149.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+||+.+..+......+|+++++.+... .....+++.+++.++.||++||.|||+.+
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 162 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 162 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 69999999998888889999999885311 11236899999999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
|+||||||+||+++.++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++
T Consensus 163 --ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 163 --FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp --EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcC
Confidence 999999999999999999999999998743211 11222456789999999998899999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|+.||..... ......+..+..... +......+.+++.+||+.||++|||++|+++.|+...
T Consensus 238 g~~pf~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 238 GGTPYCGMTC-------AELYEKLPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp SCCTTTTCCH-------HHHHHHGGGTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCcH-------HHHHHHhhcCCCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999854321 112222333321111 1112245778999999999999999999999987664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=251.65 Aligned_cols=192 Identities=21% Similarity=0.234 Sum_probs=149.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|++|+.+.........+|++|++++... .....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 241 l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNI 317 (576)
T 2acx_A 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENI 317 (576)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheE
Confidence 469999999998888889999999986321 11234889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
|++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 318 Lld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~ 394 (576)
T 2acx_A 318 LLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394 (576)
T ss_dssp EECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred EEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence 99999999999999998765332 223357999999999999999999999999999999999999999754332222
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
..+ ...+..... .. +......+.+++.+||+.||++|| +++||++
T Consensus 395 ~~i---~~~i~~~~~-~~---------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 395 EEV---ERLVKEVPE-EY---------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHH---HHHHHHCCC-CC---------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHH---HHHhhcccc-cC---------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 222 222222111 11 111123567899999999999999 7788874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=234.47 Aligned_cols=208 Identities=18% Similarity=0.190 Sum_probs=145.6
Q ss_pred eccccccccccCC----CCccEEEEecccch------hhhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPD----GGQDLYIRMSASEL------DQERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~----~~~~lyl~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~ 446 (635)
.|+||+.+..+.. .+..+|+++++... .......+++..+..++.||+.||+|||++ + |+||||||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp 160 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKP 160 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCh
Confidence 5888888777654 23478889888642 112234588999999999999999999998 8 99999999
Q ss_pred cceEecc------CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCC
Q 046703 447 GNVLLDQ------DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 447 ~NIlld~------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
+||+++. .+.+||+|||++....... ....+|..|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred HHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 9999953 3479999999998764321 2246899999999999999999999999999999999999999
Q ss_pred CCccCCCcc---cHHHHHHHHhhc-------------------CCCCcCCCCc---------cccCCCHHHHHHHHHHHH
Q 046703 521 GFYHLDNKL---NLIGHAWKLWNK-------------------GMPSEMIDPC---------YQESCNLTEVIRCIHISL 569 (635)
Q Consensus 521 ~~~~~~~~~---~~~~~~~~~~~~-------------------~~~~~~~d~~---------l~~~~~~~~~~~~~~l~~ 569 (635)
......... ..+......... +....+.... .....+......+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 754322211 111111111100 0000000000 011344567778899999
Q ss_pred HhcccCCCCCCChHHHHH--HHcCCC
Q 046703 570 LCVQQHPDDRPCMPSVIL--MLGSEI 593 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~--~L~~~~ 593 (635)
+||+.||++|||++||++ .+.+..
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHhccCccccCCHHHHhhChhhhccc
Confidence 999999999999999987 445443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-26 Score=232.11 Aligned_cols=187 Identities=18% Similarity=0.243 Sum_probs=147.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+...+..+|+++++.+.. ..+...+++.++..++.||++||.|||+.+ |+|+||||+||++
T Consensus 71 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~ 147 (284)
T 2vgo_A 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLM 147 (284)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEE
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEE
Confidence 36999999999888888999999998631 123456899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~- 219 (284)
T 2vgo_A 148 GYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---E- 219 (284)
T ss_dssp CTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---H-
T ss_pred cCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---H-
Confidence 999999999999997654321 22356899999999999999999999999999999999999998643211 1
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
....+...... . +......+.+++.+||+.||++|||++||++
T Consensus 220 ---~~~~~~~~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 220 ---THRRIVNVDLK------F----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---HHHHHHTTCCC------C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHhccccC------C----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111121111 1 1112235678999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-26 Score=259.55 Aligned_cols=188 Identities=22% Similarity=0.243 Sum_probs=149.4
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|++|+.+..+......+|++|++.+.. ..+...+++.++..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~ 476 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLD 476 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEEC
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEc
Confidence 5899999999988889999999998642 123467899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 477 ~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~--- 548 (674)
T 3pfq_A 477 SEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---D--- 548 (674)
T ss_dssp SSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---
T ss_pred CCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---H---
Confidence 999999999999986433222 23346799999999999999999999999999999999999999864321 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM-----PSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~-----~evl~ 587 (635)
.....+..+... ++......+.+|+..||+.||++||++ +||++
T Consensus 549 -~~~~~i~~~~~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 549 -ELFQSIMEHNVA----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -HHHHHHHSSCCC----------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -HHHHHHHhCCCC----------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 122222222211 111123357789999999999999998 77763
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=244.10 Aligned_cols=141 Identities=28% Similarity=0.396 Sum_probs=112.5
Q ss_pred eeccccccccccCCCC-----ccEEEEecccchhh----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGG-----QDLYIRMSASELDQ----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~-----~~lyl~~~~~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+.... ..+|+++++++... .....+++..+..++.||++||.|||+.+ |+||||||+
T Consensus 82 l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~ 158 (432)
T 3n9x_A 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPA 158 (432)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred cCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHH
Confidence 4689999988876443 67999999887421 23456899999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCC--------------------CceeeeeeccCCCCcccc-cCCCCcccCceeee
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETE--------------------GNTTRVVGTYGYMAPEYA-SDGQFSVKSDVFSF 506 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwS~ 506 (635)
|||++.++.+||+|||+++........ .......||+.|+|||.+ ....++.++||||+
T Consensus 159 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp GEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred HeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 999999999999999999876433211 112346789999999986 56679999999999
Q ss_pred ehhhHhhhhCCCCC
Q 046703 507 GILLLEIVSGKKNR 520 (635)
Q Consensus 507 Gvvl~eiltG~~pf 520 (635)
||++|||++|..||
T Consensus 239 G~il~ell~g~~p~ 252 (432)
T 3n9x_A 239 GCIFAELLNMLQSH 252 (432)
T ss_dssp HHHHHHHHTTCTTT
T ss_pred HHHHHHHHhccccc
Confidence 99999999865554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=240.21 Aligned_cols=207 Identities=16% Similarity=0.212 Sum_probs=153.4
Q ss_pred eeccccccccccCCC--CccEEEEecccchhh--------hhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFPDG--GQDLYIRMSASELDQ--------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~~~--~~~lyl~~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
+.|+||+.+..+... +..+|+++++.+... .....+++.+++.++.||+.||.|||+.+ |+||||||
T Consensus 64 l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 140 (396)
T 4eut_A 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKP 140 (396)
T ss_dssp CCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred cCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCH
Confidence 369999998877643 347899999986311 11223899999999999999999999999 99999999
Q ss_pred cceEe----ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC--------CCCcccCceeeeehhhHhhh
Q 046703 447 GNVLL----DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD--------GQFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 447 ~NIll----d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwS~Gvvl~eil 514 (635)
+||++ +.++.+||+|||+++....... .....||..|+|||.+.. ..++.++|||||||++|||+
T Consensus 141 ~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~ 217 (396)
T 4eut_A 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (396)
T ss_dssp GGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH
Confidence 99999 7777899999999987654322 123568999999998864 56789999999999999999
Q ss_pred hCCCCCCCccCCC-cccHHHHHHHHhhcCCCCcCCC---------------CccccCCCHHHHHHHHHHHHHhcccCCCC
Q 046703 515 SGKKNRGFYHLDN-KLNLIGHAWKLWNKGMPSEMID---------------PCYQESCNLTEVIRCIHISLLCVQQHPDD 578 (635)
Q Consensus 515 tG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d---------------~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~ 578 (635)
+|+.||....... ........ ..+.+...+. ..............+.+++.+||+.||++
T Consensus 218 tg~~Pf~~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~ 293 (396)
T 4eut_A 218 TGSLPFRPFEGPRRNKEVMYKI----ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293 (396)
T ss_dssp HSSCSEECTTCTTTCHHHHHHH----HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred HCCCCCCCCCcccchHHHHHHH----hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhh
Confidence 9999986543322 22222222 2222221110 00112334567777889999999999999
Q ss_pred CCChHHHHHHHcCCC
Q 046703 579 RPCMPSVILMLGSEI 593 (635)
Q Consensus 579 RPt~~evl~~L~~~~ 593 (635)
||++.|+++.|+.+.
T Consensus 294 R~s~~e~l~~l~~il 308 (396)
T 4eut_A 294 CWGFDQFFAETSDIL 308 (396)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred hccHHHHHHHHHHHh
Confidence 999999998887653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-25 Score=227.91 Aligned_cols=183 Identities=15% Similarity=0.251 Sum_probs=141.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|+||+.+..+......+|+++++.+... .....+++.++..++.||++||.|||+++ |+||||||+|
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~N 145 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSN 145 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHH
Confidence 69999999988888889999999986311 11256899999999999999999999999 9999999999
Q ss_pred eEeccC-------------------CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeeh
Q 046703 449 VLLDQD-------------------MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGI 508 (635)
Q Consensus 449 Illd~~-------------------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gv 508 (635)
|+++.+ ..+||+|||++....... ...|+..|+|||.+.+. .++.++||||||+
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 999844 478999999998764332 13588999999998766 6778999999999
Q ss_pred hhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 509 LLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 509 vl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
++|||++|..++... . .+..+..+....+.. . ....+.+++.+||+.||++|||+.|+++.
T Consensus 220 il~~l~~~~~~~~~~------~----~~~~~~~~~~~~~~~-----~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 220 TVVCAAGAEPLPRNG------D----QWHEIRQGRLPRIPQ-----V----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHTTCCCCCSSS------H----HHHHHHTTCCCCCSS-----C----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHhcCCCCCcch------h----HHHHHHcCCCCCCCc-----c----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 999999998775321 1 122223333332221 1 12357789999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-25 Score=230.22 Aligned_cols=190 Identities=25% Similarity=0.305 Sum_probs=149.4
Q ss_pred eccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
.|+|++.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+|+||||+||+++.
T Consensus 78 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~ 154 (303)
T 3a7i_A 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSE 154 (303)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECC
Confidence 6889998888887778899999988632 223457899999999999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
++.+||+|||++......... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------- 225 (303)
T 3a7i_A 155 HGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------- 225 (303)
T ss_dssp TSCEEECCCTTCEECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred CCCEEEeecccceecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------
Confidence 999999999999876543222 22356899999999999999999999999999999999999998643211
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
........+....+. ... ...+.+++..||+.||++|||+.||++.
T Consensus 226 ~~~~~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 226 KVLFLIPKNNPPTLE-----GNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHSCCCCCC-----SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHhhcCCCCCCc-----ccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111122222222211 111 2347789999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-26 Score=236.62 Aligned_cols=193 Identities=17% Similarity=0.197 Sum_probs=148.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~ 148 (321)
T 2a2a_A 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIML 148 (321)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEE
Confidence 35899999999888888999999998531 123456889999999999999999999999 9999999999999
Q ss_pred ccCC----CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDM----NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++ .+||+|||++........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 149 ~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 224 (321)
T 2a2a_A 149 LDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ- 224 (321)
T ss_dssp SCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-
T ss_pred ecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-
Confidence 9887 799999999987654322 22356899999999999999999999999999999999999998543211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
. ....+...... .++.... .....+.+++.+||+.||++|||+.|+++.
T Consensus 225 --~----~~~~i~~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 225 --E----TLANITSVSYD--FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --H----HHHHHHTTCCC--CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --H----HHHHHHhcccc--cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111121110 0110001 112346789999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-25 Score=235.07 Aligned_cols=203 Identities=22% Similarity=0.274 Sum_probs=148.1
Q ss_pred eccccccccccCC--CCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFPD--GGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~~--~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|+||+.+..+.. +...+|+++++.+.. ......+++.+++.++.||++||.|||+.+ |+||||||+||
T Consensus 100 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NI 176 (326)
T 2w1i_A 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNI 176 (326)
T ss_dssp CCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceE
Confidence 5899998877653 334789999987631 122345899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCcc----
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH---- 524 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~---- 524 (635)
+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 177 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 256 (326)
T 2w1i_A 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM 256 (326)
T ss_dssp EEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH
T ss_pred EEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH
Confidence 99999999999999998765432211 1112346778999999998899999999999999999999998875321
Q ss_pred -----CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 525 -----LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 525 -----~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.................+..... +......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 257 RMIGNDKQGQMIVFHLIELLKNNGRLPR---------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHCTTCCTHHHHHHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhccccchhhhHHHHHHHhhcCCCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00001111112222222221111 112234577899999999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=244.43 Aligned_cols=193 Identities=23% Similarity=0.239 Sum_probs=148.8
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|++|+.+.........+|+++++.+... .....+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 242 l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~ 318 (543)
T 3c4z_A 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPE 318 (543)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChH
Confidence 469999999998888889999999986421 11346888999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|||++.++.+||+|||+++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 319 NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~ 396 (543)
T 3c4z_A 319 NVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 396 (543)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC
T ss_pred HEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch
Confidence 999999999999999999876543322 233579999999999999999999999999999999999999996543222
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCM-----PSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~-----~evl~ 587 (635)
.. ......+..+... . +......+.+++.+||+.||++||++ ++|++
T Consensus 397 ~~---~~~~~~i~~~~~~-~---------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 397 EN---KELKQRVLEQAVT-Y---------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CH---HHHHHHHHHCCCC-C---------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hH---HHHHHHHhhcccC-C---------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11 1122222222111 1 11122356789999999999999975 56653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-26 Score=239.86 Aligned_cols=140 Identities=24% Similarity=0.338 Sum_probs=118.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+...+..+|+++++.+.. ..+...+++..+..++.|++.||.|||+. + |+||||||+||+
T Consensus 88 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil 164 (360)
T 3eqc_A 88 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNIL 164 (360)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEE
T ss_pred CCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEE
Confidence 36999999999888788999999998641 12345688999999999999999999996 7 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++.++.+||+|||++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 165 VNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999998755321 122357899999999999999999999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-26 Score=231.50 Aligned_cols=190 Identities=19% Similarity=0.223 Sum_probs=146.4
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe-
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL- 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll- 451 (635)
.|+||+.+..+...+..+|+++++.+.. ......+++.++..++.|++.||.|||+.+ |+|+||||+||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~ 140 (277)
T 3f3z_A 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFL 140 (277)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEES
T ss_pred CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEe
Confidence 6999999999988888999999998632 123556899999999999999999999999 9999999999999
Q ss_pred --ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 452 --DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 452 --d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+.++.+||+|||++........ .....++..|+|||.+.+ .++.++||||||+++|||++|+.||......
T Consensus 141 ~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 213 (277)
T 3f3z_A 141 TDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--- 213 (277)
T ss_dssp SSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred cCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---
Confidence 7888999999999987653322 223568999999998865 4899999999999999999999998643211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+..... .... . .....+.+++.+||+.||++|||+.|+++
T Consensus 214 ----~~~~~~~~~~~~~~-~~~~-~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 214 ----EVMLKIREGTFTFP-EKDW-L----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----HHHHHHHHCCCCCC-HHHH-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----HHHHHHHhCCCCCC-chhh-h----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222222221110 0000 0 11235778999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-26 Score=245.58 Aligned_cols=194 Identities=16% Similarity=0.134 Sum_probs=145.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|++|+.+.........+|+++++++.. ......+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 118 ~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NIL 194 (412)
T 2vd5_A 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNIL 194 (412)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHee
Confidence 36999999999988889999999998531 122347899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-------CCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-------DGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++.++.+||+|||+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 999999999999999876543221 122357999999999987 457899999999999999999999998643
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCC---CChHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR---PCMPSVIL 587 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~R---Pt~~evl~ 587 (635)
... .....+......-.... .... ....+.+++.+||+ +|.+| |+++||++
T Consensus 274 ~~~---~~~~~i~~~~~~~~~p~-----~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 274 STA---ETYGKIVHYKEHLSLPL-----VDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp SHH---HHHHHHHTHHHHCCCC---------C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CHH---HHHHHHHhcccCcCCCc-----cccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 221 11111111100111111 0111 12356789999999 99998 58999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=227.94 Aligned_cols=189 Identities=25% Similarity=0.350 Sum_probs=140.2
Q ss_pred eccccccccccCCCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.|+||+.+..+......+|+++++.+.. ......+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 78 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~N 154 (285)
T 3is5_A 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPEN 154 (285)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred CCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHH
Confidence 6899999999988888999999988631 122367899999999999999999999999 9999999999
Q ss_pred eEe---ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 449 VLL---DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 449 Ill---d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
|++ +.++.+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|||++|+.||.....
T Consensus 155 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 155 ILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp EEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 999 4557899999999976543321 22356899999999875 5789999999999999999999999864321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ................. .. ....+.+++.+||+.||++|||+.||++
T Consensus 231 ~-------~~~~~~~~~~~~~~~~~---~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 231 E-------EVQQKATYKEPNYAVEC---RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp H-------HHHHHHHHCCCCCCC-----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred H-------HHHhhhccCCccccccc---Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11111111111111110 01 1234668999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-26 Score=236.90 Aligned_cols=201 Identities=20% Similarity=0.205 Sum_probs=146.1
Q ss_pred eccccccccccCC-----CCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPD-----GGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~-----~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.+..+.. ....+|+++++.... ......+++.++..++.||+.||.|||+.+ |+||||||
T Consensus 72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp 148 (326)
T 1blx_A 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKP 148 (326)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred CCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCH
Confidence 5899988877654 567889999987632 112334889999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (326)
T 1blx_A 149 QNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225 (326)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999997654221 122356899999999999999999999999999999999999998643221
Q ss_pred CcccHHHHHHHHhhcCCCCcC----------CC---CccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEM----------ID---PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~----------~d---~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.................. .. ..............+.+++.+||+.||++|||+.|+++
T Consensus 226 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 ---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp ---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 122222221110000000 00 00000111122345778999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=237.30 Aligned_cols=198 Identities=17% Similarity=0.210 Sum_probs=141.2
Q ss_pred cccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe----
Q 046703 382 LIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL---- 451 (635)
Q Consensus 382 Lv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll---- 451 (635)
++.+..+......+|+++++.... ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSE 160 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCC
T ss_pred EEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccc
Confidence 455555555566889999987632 122346899999999999999999999999 9999999999999
Q ss_pred ---------------ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC
Q 046703 452 ---------------DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 452 ---------------d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG 516 (635)
+.++.+||+|||++....... ....||..|+|||.+.+..++.++||||||+++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence 667889999999998754322 225689999999999999999999999999999999999
Q ss_pred CCCCCCccCCCcccHHHHHHHHhh-----cCCCCcC-CC--------------------C-ccccCCCHHHHHHHHHHHH
Q 046703 517 KKNRGFYHLDNKLNLIGHAWKLWN-----KGMPSEM-ID--------------------P-CYQESCNLTEVIRCIHISL 569 (635)
Q Consensus 517 ~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-~d--------------------~-~l~~~~~~~~~~~~~~l~~ 569 (635)
+.||......+....+.......+ ....... .. + .........+...+.+++.
T Consensus 236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 315 (355)
T 2eu9_A 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315 (355)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence 999865432211111111100000 0000000 00 0 0001122344567889999
Q ss_pred HhcccCCCCCCChHHHHH
Q 046703 570 LCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 570 ~Cl~~dP~~RPt~~evl~ 587 (635)
+||+.||++|||+.||++
T Consensus 316 ~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 316 RMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHTCSSTTTSCCHHHHTT
T ss_pred HHhcCChhhCcCHHHHhc
Confidence 999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-26 Score=241.22 Aligned_cols=205 Identities=23% Similarity=0.291 Sum_probs=146.2
Q ss_pred eeccccccccccCCC-----CccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDG-----GQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~-----~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+... ...+|+++++.+.. ..+...+++.++..++.||+.||.|||+.+ |+||||||+|
T Consensus 82 l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 158 (364)
T 3qyz_A 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSN 158 (364)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred cCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHh
Confidence 468999988776532 25789999988742 223456899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|+++.++.+||+|||++.......... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 159 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred EEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 999999999999999998765332211 1233578999999998654 55899999999999999999999998654433
Q ss_pred CcccHHHHHHHHhhcCCC---------------CcCCCCc-c-ccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMP---------------SEMIDPC-Y-QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~---------------~~~~d~~-l-~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+.. ............ ....... . ...........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 239 DQL---NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp GHH---HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH---HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 222 221111100000 0000000 0 00000112235778999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-25 Score=238.33 Aligned_cols=201 Identities=22% Similarity=0.208 Sum_probs=138.0
Q ss_pred eeccccccccccCCCC------ccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGG------QDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~------~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+.... ..+|+++++.+... .-...+++.++..++.||+.||.|||+.+ |+||||||+|
T Consensus 81 l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~N 157 (371)
T 2xrw_A 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 157 (371)
T ss_dssp CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHH
Confidence 3689998887765433 37899999987422 22346888999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
|+++.++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......+
T Consensus 158 Il~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~- 233 (371)
T 2xrw_A 158 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID- 233 (371)
T ss_dssp EEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999999999999998654321 1223578999999999999999999999999999999999999986533211
Q ss_pred ccHHHHHHHHh------------------hcCCCCcCCC--------Ccccc---CCCHHHHHHHHHHHHHhcccCCCCC
Q 046703 529 LNLIGHAWKLW------------------NKGMPSEMID--------PCYQE---SCNLTEVIRCIHISLLCVQQHPDDR 579 (635)
Q Consensus 529 ~~~~~~~~~~~------------------~~~~~~~~~d--------~~l~~---~~~~~~~~~~~~l~~~Cl~~dP~~R 579 (635)
......... .... ..... ..... .........+.+++.+||+.||++|
T Consensus 234 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 234 --QWNKVIEQLGTPCPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp --HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSS-CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred --HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhC-ccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 111111000 0000 00000 00000 0011235568899999999999999
Q ss_pred CChHHHHH
Q 046703 580 PCMPSVIL 587 (635)
Q Consensus 580 Pt~~evl~ 587 (635)
||++|+++
T Consensus 311 ~t~~e~l~ 318 (371)
T 2xrw_A 311 ISVDEALQ 318 (371)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhC
Confidence 99999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.7e-26 Score=236.19 Aligned_cols=194 Identities=26% Similarity=0.303 Sum_probs=129.4
Q ss_pred eeccccccccccCCCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~ 446 (635)
+.|+||+.+..+.......|+++++.+... .....+++..+..++.|++.||.|||+. + |+||||||
T Consensus 78 ~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp 154 (327)
T 3aln_A 78 SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKP 154 (327)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCG
T ss_pred CCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCH
Confidence 469999999998888889999999987421 1246788999999999999999999998 8 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccc----cCCCCcccCceeeeehhhHhhhhCCCCCCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIVSGKKNRGF 522 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~ 522 (635)
+||+++.++.+||+|||++........ .....|+..|+|||.+ .+..++.++||||||+++|||++|+.||..
T Consensus 155 ~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 155 SNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp GGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred HHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999977643321 2224689999999998 456789999999999999999999999864
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..... . .......+....+.. .........+.+++.+||+.||++|||+.||++
T Consensus 232 ~~~~~-----~-~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 232 WNSVF-----D-QLTQVVKGDPPQLSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-------------CCCCCSCCCCCCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cchHH-----H-HHHHHhcCCCCCCCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 32110 0 001111111111111 111122345778999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.1e-26 Score=230.14 Aligned_cols=197 Identities=24% Similarity=0.259 Sum_probs=146.1
Q ss_pred eeccccccccccC--CCCccEEEEecccchh---------hhhccccCcccchhhhhhhccccchhhccc--cceEEeec
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELD---------QERCKLLDWSKRFRIICGTGRGLLYLHQDS--RLRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~d 443 (635)
+.|+||+.+..+. ..+..+|+++++.+.. ......+++..++.++.||+.||.|||+.+ ...|+|+|
T Consensus 62 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~d 141 (279)
T 2w5a_A 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141 (279)
T ss_dssp CCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCC
T ss_pred cCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEec
Confidence 3689999988754 4566899999998631 111234899999999999999999999976 23499999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
|||+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 142 l~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 142 LKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 999999999999999999999976543211 112246789999999999999999999999999999999999998643
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.. ......+..+....+.. .....+.+++.+||+.||++|||+.||++.+..
T Consensus 220 ~~-------~~~~~~i~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 220 SQ-------KELAGKIREGKFRRIPY---------RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp SH-------HHHHHHHHHTCCCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CH-------HHHHHHHhhcccccCCc---------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 21 11222333343322211 122357789999999999999999999987643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=239.64 Aligned_cols=200 Identities=23% Similarity=0.285 Sum_probs=134.0
Q ss_pred eeccccccccccCCC------CccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDG------GQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~------~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+... ...+|+++++.... ..+...+++..+..++.||++||.|||+.+ |+||||||+
T Consensus 85 l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~ 161 (367)
T 2fst_X 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS 161 (367)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred CCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHh
Confidence 368899888776533 25689998887531 122356899999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
||+++.++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 162 NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 236 (367)
T 2fst_X 162 NLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236 (367)
T ss_dssp GEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999865322 223578999999999877 67899999999999999999999998654322
Q ss_pred CcccHHHHHHHHhhcC------------------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 527 NKLNLIGHAWKLWNKG------------------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
+ .+.......... .........+.. ........+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~---~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 237 D---QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp H---HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H---HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1 111111111000 000000000000 000112346789999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=237.53 Aligned_cols=204 Identities=20% Similarity=0.221 Sum_probs=143.7
Q ss_pred eeccccccccccCCC-----CccEEEEecccchhh---hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDG-----GQDLYIRMSASELDQ---ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~-----~~~lyl~~~~~~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+... ...+|+++++..... .....+++.++..++.||+.||.|||+.+ |+||||||+|
T Consensus 66 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~N 142 (353)
T 2b9h_A 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSN 142 (353)
T ss_dssp CCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 368999888776543 367899999886421 22356899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCC--------ceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEG--------NTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
|+++.++.+||+|||++.......... ......||..|+|||.+.. ..++.++||||||+++|||++|+.|
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 222 (353)
T 2b9h_A 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222 (353)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999998765322111 1122467999999998754 6789999999999999999999999
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcC-------------------CCCccccCCCHHHHHHHHHHHHHhcccCCCCCC
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEM-------------------IDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 580 (635)
|......+ ................. ....+. .........+.+++.+||+.||++||
T Consensus 223 f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (353)
T 2b9h_A 223 FPGRDYRH---QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRI 298 (353)
T ss_dssp CCCSSHHH---HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCcHH---HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCC
Confidence 86543211 11111111110000000 000000 00012234577899999999999999
Q ss_pred ChHHHHH
Q 046703 581 CMPSVIL 587 (635)
Q Consensus 581 t~~evl~ 587 (635)
|++||++
T Consensus 299 t~~ell~ 305 (353)
T 2b9h_A 299 TAKEALE 305 (353)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-25 Score=229.91 Aligned_cols=191 Identities=26% Similarity=0.352 Sum_probs=137.2
Q ss_pred ccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
|++++.+..+......+|+++++.... ....+.+++.++..++.||++||.|||+.+ |+||||||+||++++
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD- 162 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred CCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence 588888888887788899999965421 123457888999999999999999999999 999999999999964
Q ss_pred CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-----------CCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 455 MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 455 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+.+||+|||++................|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 7899999999987654333222334578999999999865 47889999999999999999999998532
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ...................+ .....+.+++.+||+.||++|||+.||++
T Consensus 243 ~-----~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 243 I-----NQISKLHAIIDPNHEIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp C-----SHHHHHHHHHCTTSCCCCCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H-----HHHHHHHHHHhcccccCCcc---------cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 2 11111222221111111111 11235678999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-25 Score=241.39 Aligned_cols=192 Identities=23% Similarity=0.278 Sum_probs=138.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+.. ...+|+++++++... ...+.+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 197 l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll 272 (419)
T 3i6u_A 197 LNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 272 (419)
T ss_dssp CCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEE
Confidence 46999999988865 446899999986421 23457889999999999999999999999 9999999999999
Q ss_pred ccC---CCCccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 452 DQD---MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 452 d~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+.+ ..+||+|||+++...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 754 459999999998764322 223467899999999985 36788999999999999999999999865432
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... ... .+..+...... .... .....+.+++.+||+.||++|||++|+++
T Consensus 350 ~~~--~~~----~i~~~~~~~~~--~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 350 QVS--LKD----QITSGKYNFIP--EVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCC--HHH----HHHTTCCCCCH--HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHH--HHH----HHhcCCCCCCc--hhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 221 111 11222211110 0000 12335778999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.9e-26 Score=240.41 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=139.3
Q ss_pred eeccccccccccC-----CCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 377 MWFGDLIDMRSFP-----DGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 377 l~h~nLv~l~~~~-----~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
+.|+||+.+..+. .....+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||
T Consensus 86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 162 (362)
T 3pg1_A 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHP 162 (362)
T ss_dssp CCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred CCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCCh
Confidence 4699999887765 4456789999998742 123446899999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+||+++.++.+||+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999997543322 1223568899999999876 6789999999999999999999999865332
Q ss_pred CCcccHHHHHHHHhhc-------------------CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 526 DNKLNLIGHAWKLWNK-------------------GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~-------------------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
.+ ........... ............ .........+.+++.+||+.||++|||+.|++
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 240 YN---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp HH---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HH---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 11 11111111100 011111111110 01112234577899999999999999999998
Q ss_pred H
Q 046703 587 L 587 (635)
Q Consensus 587 ~ 587 (635)
+
T Consensus 316 ~ 316 (362)
T 3pg1_A 316 R 316 (362)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=9.8e-26 Score=230.41 Aligned_cols=192 Identities=17% Similarity=0.219 Sum_probs=145.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||++||.|||+.+ ++|+||||+||++
T Consensus 65 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~ 141 (283)
T 3bhy_A 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIML 141 (283)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEE
Confidence 36999999999888888999999988531 123457899999999999999999999999 9999999999999
Q ss_pred ccCC----CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDM----NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++ .+||+|||++........ .....++..|+|||.+....++.++||||||+++|||++|+.||......
T Consensus 142 ~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~- 217 (283)
T 3bhy_A 142 LDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ- 217 (283)
T ss_dssp SCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred ecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-
Confidence 8876 799999999987643321 22356899999999999999999999999999999999999998643211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+...... ....... .....+.+++.+||+.||++|||+.|+++
T Consensus 218 ------~~~~~~~~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 218 ------ETLTNISAVNYD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ------HHHHHHHTTCCC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------HHHHHhHhcccC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 111111111111 0000001 11235778999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-25 Score=227.48 Aligned_cols=191 Identities=25% Similarity=0.341 Sum_probs=148.6
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ ++|+||||+||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~ 158 (314)
T 3com_A 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILL 158 (314)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEE
Confidence 6899999888877778899999998641 123567899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------ 230 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------ 230 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred CCCCCEEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------
Confidence 99999999999999876543221 2235689999999999999999999999999999999999999864321
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..... ............ +......+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 231 MRAIF-MIPTNPPPTFRK-------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHH-HHHHSCCCCCSS-------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHH-HHhcCCCcccCC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11111 111222111111 1111235778999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-25 Score=241.37 Aligned_cols=195 Identities=25% Similarity=0.335 Sum_probs=137.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh----hhc-------cccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ----ERC-------KLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~----~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.+......+..+|++++++.... ... ...++..++.++.||+.||.|||+.+ |+||||||
T Consensus 67 ~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp 143 (434)
T 2rio_A 67 DHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKP 143 (434)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCCh
Confidence 59999999988888889999999986311 000 11244556789999999999999999 99999999
Q ss_pred cceEeccC-------------CCCccCccccceecCCCCCCC--ceeeeeeccCCCCcccccC-------CCCcccCcee
Q 046703 447 GNVLLDQD-------------MNPKISDFGLARTFGGDETEG--NTTRVVGTYGYMAPEYASD-------GQFSVKSDVF 504 (635)
Q Consensus 447 ~NIlld~~-------------~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVw 504 (635)
+|||++.+ +.+||+|||+++......... ......||..|+|||.+.+ ..++.++|||
T Consensus 144 ~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 99999754 479999999998875433221 1233579999999999865 6789999999
Q ss_pred eeehhhHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 046703 505 SFGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583 (635)
Q Consensus 505 S~Gvvl~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ 583 (635)
||||++|||++ |+.||....... ... . .+... . +......+......+.+++.+||+.||++|||+.
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~-----~~i---~-~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRE-----SNI---I-RGIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHH-----HHH---H-HTCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHHHHHHHHHhCCCCCCCCchhhH-----HHH---h-cCCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHH
Confidence 99999999999 899985322110 111 1 11111 0 0111112345566788999999999999999999
Q ss_pred HHHH
Q 046703 584 SVIL 587 (635)
Q Consensus 584 evl~ 587 (635)
||++
T Consensus 292 eil~ 295 (434)
T 2rio_A 292 KVLR 295 (434)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-25 Score=231.66 Aligned_cols=198 Identities=18% Similarity=0.250 Sum_probs=151.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+...+..+|+++++.+.. ....+.+++.++..++.||+.||.|||+.+ |+|+||||+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~ 139 (304)
T 2jam_A 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLY 139 (304)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEE
T ss_pred CCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEE
Confidence 36899999998888888999999998631 123456889999999999999999999999 9999999999999
Q ss_pred ---ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 ---DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 ---d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 140 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 212 (304)
T 2jam_A 140 LTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--- 212 (304)
T ss_dssp SSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred ecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---
Confidence 77889999999998764322 11224688999999999999999999999999999999999999854321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HHcCCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL--MLGSEIV 594 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 594 (635)
. .....+.++... ...+ ........+.+++.+||+.||++|||++|+++ .+++...
T Consensus 213 ~----~~~~~i~~~~~~-~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 213 S----KLFEKIKEGYYE-FESP-----FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp H----HHHHHHHHCCCC-CCTT-----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred H----HHHHHHHcCCCC-CCcc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 1 112222222211 1011 11112345778999999999999999999986 4555443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=234.69 Aligned_cols=201 Identities=17% Similarity=0.198 Sum_probs=125.5
Q ss_pred eccccccccccCCC----CccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPDG----GQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~~----~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+|++.+..+... +..+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ |+||||||
T Consensus 80 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp 156 (336)
T 3fhr_A 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKP 156 (336)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred CCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 57888877766532 55689999998641 112246899999999999999999999999 99999999
Q ss_pred cceEeccC---CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 447 GNVLLDQD---MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 447 ~NIlld~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+||+++.+ +.+||+|||++....... .....++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred HHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999864 459999999998754322 22356799999999998889999999999999999999999998644
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HHcCCCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL--MLGSEIV 594 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 594 (635)
........ .......+.. ....+ ........+.+++.+||+.||++|||++|+++ .+.....
T Consensus 233 ~~~~~~~~---~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 233 TGQAISPG---MKRRIRLGQY-GFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp ----------------------CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred cchhhhhh---HHHhhhcccc-ccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 32211000 0000001100 00000 01122345778999999999999999999997 4554433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=231.27 Aligned_cols=201 Identities=14% Similarity=0.140 Sum_probs=144.4
Q ss_pred ccccccccccCCC--CccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 379 FGDLIDMRSFPDG--GQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 379 h~nLv~l~~~~~~--~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
|+|++.+..+... ....|+++++.+... ...+.+++.++..++.||+.||+|||+.+ |+||||||+||+++.+
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~ 166 (330)
T 3nsz_A 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE 166 (330)
T ss_dssp STTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred CCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCC
Confidence 8888888877654 667899999886421 22345888999999999999999999999 9999999999999977
Q ss_pred C-CCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 455 M-NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 455 ~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
+ .+||+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...+
T Consensus 167 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l 241 (330)
T 3nsz_A 167 HRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQL 241 (330)
T ss_dssp TTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHH
T ss_pred CCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHH
Confidence 6 799999999987654322 223568899999999877 67899999999999999999999998432211 1111
Q ss_pred HHHH---------HHhhcCCC--------------CcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAW---------KLWNKGMP--------------SEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~---------~~~~~~~~--------------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.... ..+..... ...................+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 11111110 0000111111111123446788999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-25 Score=239.05 Aligned_cols=198 Identities=23% Similarity=0.292 Sum_probs=141.2
Q ss_pred eeccccccccccCCCCcc------EEEEecccchh--hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQD------LYIRMSASELD--QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~------lyl~~~~~~~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+...... +|+++++.... ......+++.++..++.||+.||.|||+.+ |+||||||+|
T Consensus 98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 174 (371)
T 4exu_A 98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGN 174 (371)
T ss_dssp CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHH
Confidence 368999988887654443 39999988742 222455899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|+++.++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+
T Consensus 175 Ill~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 249 (371)
T 4exu_A 175 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 249 (371)
T ss_dssp EEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred eEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999999865332 122467899999999877 688999999999999999999999986533211
Q ss_pred cccHHHHHHHHhhcCCCC-c-------------------CCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPS-E-------------------MIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~-~-------------------~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......... +... + .....+. .........+.+++.+||+.||++|||++|+++
T Consensus 250 ---~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 250 ---QLTQILKVT--GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp ---HHHHHHHHH--CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ---HHHHHHHHh--CCCcHHHHHHhhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 111111110 0000 0 0000000 000112345778999999999999999999986
Q ss_pred H
Q 046703 588 M 588 (635)
Q Consensus 588 ~ 588 (635)
.
T Consensus 324 h 324 (371)
T 4exu_A 324 H 324 (371)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-25 Score=229.08 Aligned_cols=192 Identities=23% Similarity=0.318 Sum_probs=141.8
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhh--ccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QER--CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+......+|+++++.+.. ... ...+++..+..++.||+.||.|||+.+ ++|+||||+|
T Consensus 76 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~N 152 (295)
T 2clq_A 76 LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDN 152 (295)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhh
Confidence 36999999988887788899999988531 111 224567778889999999999999999 9999999999
Q ss_pred eEecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC--CcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 449 VLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 449 Illd~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
|+++. ++.+||+|||++......... .....|+..|+|||.+.+.. ++.++||||||+++|||++|+.||.....
T Consensus 153 il~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 153 VLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp EEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred EEEECCCCCEEEeecccccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 99987 889999999999876432211 22356899999999987654 78999999999999999999999854321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ..............+ +......+.+++.+||+.||++|||++|+++
T Consensus 231 ~~-----~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 231 PQ-----AAMFKVGMFKVHPEI---------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HH-----HHHHHHHHHCCCCCC---------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred hh-----HHHHhhccccccccc---------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 011111111111111 1112235678999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.9e-25 Score=231.14 Aligned_cols=198 Identities=21% Similarity=0.258 Sum_probs=148.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----------hhh--ccccCcccchhhhhhhccccchhhc-cccceEEee
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----------QER--CKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHR 442 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----------~~~--~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~ 442 (635)
+.|+||+.+..+......+|+++++.+.. ... ...+++..+..++.||+.||.|||+ .+ |+|+
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~ 176 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHR 176 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECC
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eeec
Confidence 36999999999888888999999998641 111 4678899999999999999999999 88 9999
Q ss_pred ccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcc-cCceeeeehhhHhhhhCCCCC
Q 046703 443 DLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSV-KSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 443 dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwS~Gvvl~eiltG~~pf 520 (635)
||||+||+++.++.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999876433 22235689999999999877 6666 999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcCCC------Cccc---cCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEMID------PCYQ---ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...... . .....+..+......+ +... ..........+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~--~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 253 SLKISL--V----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCSSCS--H----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcH--H----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 654321 1 1222222222211100 0000 0000122345778999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-25 Score=236.70 Aligned_cols=199 Identities=22% Similarity=0.259 Sum_probs=141.2
Q ss_pred eeccccccccccCCCCc------cEEEEecccchh--hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDGGQ------DLYIRMSASELD--QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~------~lyl~~~~~~~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+..+..... .+|+++++.... ......+++.++..++.||+.||.|||+++ |+||||||+|
T Consensus 80 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 156 (353)
T 3coi_A 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGN 156 (353)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGG
T ss_pred cCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 35889988877765443 459999987642 222345889999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+
T Consensus 157 Il~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 231 (353)
T 3coi_A 157 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231 (353)
T ss_dssp EEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH
T ss_pred EeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999764322 223567999999999876 678999999999999999999999986543211
Q ss_pred cccHHHHHHHHhhcC------------------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKG------------------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+.......... .........+. .........+.+++.+||+.||++|||++|+++
T Consensus 232 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 232 ---QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp ---HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ---HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111110000 00000000010 111123446778999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-24 Score=223.93 Aligned_cols=191 Identities=21% Similarity=0.325 Sum_probs=143.0
Q ss_pred eeccccccccccC----CCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFP----DGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~----~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+. .+...+|+++++.+.. ......+++..+..++.||+.||.|||+.+ .+|+|+||||+
T Consensus 82 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~ 160 (290)
T 1t4h_A 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCD 160 (290)
T ss_dssp CCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGG
T ss_pred CCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHH
Confidence 3689999887654 3456789999988632 123467899999999999999999999986 34999999999
Q ss_pred ceEec-cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLD-QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
||+++ .++.+||+|||++...... ......|+..|+|||.+. ..++.++||||||+++|||++|+.||.....
T Consensus 161 Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 234 (290)
T 1t4h_A 161 NIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN- 234 (290)
T ss_dssp GEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-
T ss_pred HEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-
Confidence 99998 7889999999999754322 223356899999999876 4589999999999999999999999854221
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..........+......+. . ....+.+++..||+.||++|||++||++
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~----~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 235 -----AAQIYRRVTSGVKPASFDK----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----HHHHHHHHTTTCCCGGGGG----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHHhccCCccccCC----C----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112222222222211111 1 1234778999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-25 Score=252.55 Aligned_cols=195 Identities=23% Similarity=0.270 Sum_probs=147.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+... ..+|+++++.+.. ......+++..++.++.||++||.|||+++ |+||||||+|||
T Consensus 448 l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NIL 523 (656)
T 2j0j_A 448 FDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVL 523 (656)
T ss_dssp CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEE
Confidence 469999999888754 5689999998742 122346889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |..||......
T Consensus 524 l~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--- 599 (656)
T 2j0j_A 524 VSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--- 599 (656)
T ss_dssp EEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred EeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---
Confidence 999999999999999876433221 1222456789999999998999999999999999999997 99998643211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. ....+..+...... ......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 600 ~----~~~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 600 D----VIGRIENGERLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp H----HHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHHHcCCCCCCC---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 12222223222211 12234577899999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-25 Score=236.09 Aligned_cols=191 Identities=19% Similarity=0.320 Sum_probs=146.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+......+|+++++.+... .....+++..+..++.||+.||.|||+.+ |+|+||||+||+++
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLD 234 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 58999999888888889999999986421 23457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC------CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
.++.+||+|||++........ .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 235 ~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-- 309 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-- 309 (365)
T ss_dssp TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred CCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--
Confidence 999999999999987654322 223578999999998863 368899999999999999999999985422
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... ....+..+..... .+.+ .. ....+.+++.+||+.||++|||+.|+++
T Consensus 310 -~~~----~~~~i~~~~~~~~-~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 310 -QIL----MLRMIMEGQYQFS-SPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHH----HHHHHHHTCCCCC-HHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHH----HHHHHHhCCCCCC-Cccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 1112222221110 0000 01 1234778999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-25 Score=246.26 Aligned_cols=191 Identities=23% Similarity=0.313 Sum_probs=147.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++++.. ..+...+++.++..++.||++||.|||+.+ |+||||||+||++
T Consensus 93 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~ 169 (494)
T 3lij_A 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLL 169 (494)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEE
Confidence 36999999999998889999999998642 123457899999999999999999999999 9999999999999
Q ss_pred ccC---CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQD---MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.. +.+||+|||++........ .....||+.|+|||.+. ..++.++||||+||++|||++|+.||......
T Consensus 170 ~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-- 243 (494)
T 3lij_A 170 ESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-- 243 (494)
T ss_dssp SCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred eCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 764 4599999999987654322 22356899999999876 56999999999999999999999998643221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+.... ..+.+. . ....+.+++.+||+.||++|||+.|+++
T Consensus 244 -----~~~~~i~~~~~~~-~~~~~~-~----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 244 -----EILRKVEKGKYTF-DSPEWK-N----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----HHHHHHHHTCCCC-CSGGGT-T----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHHhCCCCC-Cchhcc-c----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1222222222211 111111 1 1234678999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-25 Score=237.52 Aligned_cols=202 Identities=17% Similarity=0.197 Sum_probs=143.4
Q ss_pred eeccccccccccCCC-------CccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhh--ccccceE
Q 046703 377 MWFGDLIDMRSFPDG-------GQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLH--QDSRLRI 439 (635)
Q Consensus 377 l~h~nLv~l~~~~~~-------~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~i 439 (635)
+.|+||+.+..+... ...+|+++++.+.. ......+++..+..++.|++.||.||| +.+ |
T Consensus 76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---i 152 (360)
T 3e3p_A 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---V 152 (360)
T ss_dssp HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---C
T ss_pred cCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---e
Confidence 368999888776521 22378999988642 123456788888999999999999999 888 9
Q ss_pred EeeccCCcceEecc-CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCC
Q 046703 440 IHRDLKAGNVLLDQ-DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK 517 (635)
Q Consensus 440 iH~dik~~NIlld~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~ 517 (635)
+||||||+||+++. ++.+||+|||++......... ....||..|+|||.+.+. .++.++||||||+++|||++|+
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999997 889999999999876543221 224678999999998665 4899999999999999999999
Q ss_pred CCCCCccCCCcccHHHHHHHHh-----------hcCC-CCcCCCCc------cccCCCHHHHHHHHHHHHHhcccCCCCC
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLW-----------NKGM-PSEMIDPC------YQESCNLTEVIRCIHISLLCVQQHPDDR 579 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~-----------~~~~-~~~~~d~~------l~~~~~~~~~~~~~~l~~~Cl~~dP~~R 579 (635)
.||....... ......... .... .....+.. ............+.+++.+||+.||++|
T Consensus 230 ~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 306 (360)
T 3e3p_A 230 PIFRGDNSAG---QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306 (360)
T ss_dssp CSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGS
T ss_pred CCcCCCChHH---HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcccc
Confidence 9986543221 111111110 0000 00000000 0011112245578899999999999999
Q ss_pred CChHHHHH
Q 046703 580 PCMPSVIL 587 (635)
Q Consensus 580 Pt~~evl~ 587 (635)
||+.||++
T Consensus 307 pt~~e~l~ 314 (360)
T 3e3p_A 307 MKPYEALC 314 (360)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-25 Score=227.02 Aligned_cols=191 Identities=20% Similarity=0.283 Sum_probs=137.4
Q ss_pred eccccccccccCCCCccEEEEecccch-----hhhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASEL-----DQERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+......+|+++++... .......+++..+..++.||++||.|||+. + |+|+||||+||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~ 158 (318)
T 2dyl_A 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILL 158 (318)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEE
T ss_pred CCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEE
Confidence 689999999888888899999998752 122246789999999999999999999995 8 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+.++.+||+|||++........ .....++..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~- 234 (318)
T 2dyl_A 159 DERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT- 234 (318)
T ss_dssp CTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-
T ss_pred CCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-
Confidence 9999999999999976543221 22356899999999984 45688999999999999999999999864221
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.... ......+........ . .....+.+++.+||+.||++|||++||++
T Consensus 235 -~~~~----~~~~~~~~~~~~~~~---~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 235 -DFEV----LTKVLQEEPPLLPGH---M----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -HHHH----HHHHHHSCCCCCCSS---S----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cHHH----HHHHhccCCCCCCcc---C----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 111222222221110 0 11234678999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-25 Score=227.17 Aligned_cols=189 Identities=23% Similarity=0.307 Sum_probs=139.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+|++.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ ++|+||||+||++
T Consensus 68 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~ 144 (276)
T 2h6d_A 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLL 144 (276)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEE
T ss_pred CCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEE
Confidence 36999999998888888999999987531 123456889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ .....++..|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----- 216 (276)
T 2h6d_A 145 DAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----- 216 (276)
T ss_dssp CTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred CCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----
Confidence 9999999999999987643321 223568899999999987765 6899999999999999999999854321
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
......+..+... . ... ....+.+++.+||+.||++|||++||++.
T Consensus 217 --~~~~~~~~~~~~~-~-----~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 217 --PTLFKKIRGGVFY-I-----PEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --HHHHHHHHHCCCC-C-----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHhhcCccc-C-----chh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122222222211 1 111 12346789999999999999999999973
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-25 Score=237.71 Aligned_cols=193 Identities=23% Similarity=0.288 Sum_probs=137.4
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+.........+|++++++... ......+.+.+++.++.||++||.|||+.+ |+||||||+||+++
T Consensus 76 ~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~ 152 (432)
T 3p23_A 76 EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILIS 152 (432)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEEC
T ss_pred CCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEe
Confidence 5999999998888888999999988632 122234556677899999999999999999 99999999999994
Q ss_pred c-----CCCCccCccccceecCCCCC-CCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhh-CCCCCCC
Q 046703 453 Q-----DMNPKISDFGLARTFGGDET-EGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVS-GKKNRGF 522 (635)
Q Consensus 453 ~-----~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~ 522 (635)
. ...+||+|||+++....... ........||+.|+|||.+. ...++.++|||||||++|||++ |..||..
T Consensus 153 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp CCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred cCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 3 33577999999987653321 12223357899999999987 4567889999999999999999 8888843
Q ss_pred ccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 523 YHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.... .. ............. ........+.+++.+||+.||++|||++||++
T Consensus 233 ~~~~-------~~-~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 233 SLQR-------QA-NILLGACSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTTH-------HH-HHHTTCCCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHH-------HH-HHHhccCCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 2111 11 1111111111111 11233445678999999999999999999983
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-25 Score=228.13 Aligned_cols=192 Identities=22% Similarity=0.271 Sum_probs=142.7
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ ++|+||||+||+
T Consensus 73 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil 149 (302)
T 2j7t_A 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVL 149 (302)
T ss_dssp CCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEE
T ss_pred CCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEE
Confidence 36899999988887788999999998642 123466899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccc-----cCCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA-----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
++.++.+||+|||++....... .......|+..|+|||.+ ....++.++||||||+++|||++|+.||.....
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 150 MTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp ECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 9999999999999975432111 111235689999999988 467789999999999999999999999864321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ..... ...+....... +......+.+++.+||+.||++|||+.+|++
T Consensus 228 ~------~~~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 228 M------RVLLK-IAKSDPPTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp H------HHHHH-HHHSCCCCCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred H------HHHHH-HhccCCcccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 11111 11222221111 1112235778999999999999999999876
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-25 Score=245.16 Aligned_cols=192 Identities=24% Similarity=0.306 Sum_probs=146.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ....+.+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 78 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~ 154 (486)
T 3mwu_A 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILL 154 (486)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEE
Confidence 46999999999998889999999998642 123467899999999999999999999999 9999999999999
Q ss_pred c---cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 D---QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d---~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+ .++.+||+|||++........ .....||+.|+|||.+.+ .++.++||||+||++|||++|+.||.....
T Consensus 155 ~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--- 227 (486)
T 3mwu_A 155 ESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--- 227 (486)
T ss_dssp SSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 5 456799999999976643321 223568999999999875 599999999999999999999999854321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.. ....+..+...... +.+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~----~~~~i~~~~~~~~~-~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 228 YD----ILKRVETGKYAFDL-PQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HH----HHHHHHHTCCCSCS-GGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HH----HHHHHHhCCCCCCC-ccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 12222233222111 111 1122356789999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-24 Score=227.70 Aligned_cols=190 Identities=23% Similarity=0.298 Sum_probs=136.1
Q ss_pred eccccccccccCCC------CccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeecc
Q 046703 378 WFGDLIDMRSFPDG------GQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444 (635)
Q Consensus 378 ~h~nLv~l~~~~~~------~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~di 444 (635)
.|+||+.+..+... ...+|+++++.+.. ......+++..+..++.||+.||.|||+.+ |+|+||
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dl 155 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDI 155 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 58888877666532 56899999998631 122356888899999999999999999999 999999
Q ss_pred CCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCC
Q 046703 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 445 k~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
||+||+++.++.+||+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.|
T Consensus 156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 156 KGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp SGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999976543211 122356899999999986 56789999999999999999999999
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
|...... .... .............. ....+.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~------~~~~-~~~~~~~~~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 234 LCDMHPM------RALF-LIPRNPAPRLKSKK--------WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp TTTSCHH------HHHH-HHHHSCCCCCSCSC--------SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcHH------HHHH-HhhcCccccCCccc--------cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 8543211 1111 11222222221111 1235778999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-25 Score=245.79 Aligned_cols=191 Identities=23% Similarity=0.280 Sum_probs=148.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++++.. ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 103 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILL 179 (504)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEE
Confidence 36999999999998899999999998642 123467899999999999999999999999 9999999999999
Q ss_pred ccCC---CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDM---NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++ .+||+|||++........ .....||+.|+|||.+. ..++.++||||+||++|+|++|+.||......
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-- 253 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-- 253 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred ecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 8775 589999999987654322 22356899999999886 56899999999999999999999998643221
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+....... .+ .. ....+.+++.+||+.||.+|||++|+++
T Consensus 254 -----~~~~~i~~~~~~~~~~-~~-~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 254 -----DIIKKVEKGKYYFDFN-DW-KN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----HHHHHHHHCCCCCCHH-HH-TT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHHcCCCCCCcc-cc-CC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1222222332211000 00 01 1235778999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-25 Score=246.10 Aligned_cols=191 Identities=24% Similarity=0.305 Sum_probs=147.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.... ....+.+++.++..++.||+.||.|||+++ |+||||||+||++
T Consensus 83 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLL 159 (484)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEE
Confidence 36999999999988888999999987632 123567899999999999999999999999 9999999999999
Q ss_pred ---ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 ---DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 ---d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++........ .....||+.|+|||.+.+ .++.++||||+||++|||++|+.||.....
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--- 232 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--- 232 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---
Confidence 4678899999999987643321 223568999999999865 689999999999999999999999864321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ....+..+...... +.+ ......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~----~~~~i~~~~~~~~~-~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 233 YD----ILKKVEKGKYTFEL-PQW-----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HH----HHHHHHHCCCCCCS-GGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----HHHHHHcCCCCCCC-ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11 12222233221111 111 112235678999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-25 Score=225.70 Aligned_cols=191 Identities=20% Similarity=0.272 Sum_probs=147.1
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+......+|+++++.+.. ......+++.++..++.||+.||.|||+.+ ++|+||||+||+++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~ 158 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEc
Confidence 3899999999888888999999998631 123457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc------CCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
.++.+||+|||++........ .....++..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~- 234 (298)
T 1phk_A 159 DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ- 234 (298)
T ss_dssp TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred CCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-
Confidence 999999999999987653322 22356889999999885 45688999999999999999999999854321
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. .....+..+..... .+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 235 --~----~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 --M----LMLRMIMSGNYQFG-SPEW-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --H----HHHHHHHHTCCCCC-TTTG-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --H----HHHHHHhcCCcccC-cccc-----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 11122222222111 1110 122345778999999999999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-25 Score=228.19 Aligned_cols=192 Identities=24% Similarity=0.296 Sum_probs=142.4
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+.... ..|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 72 l~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~ 147 (322)
T 2ycf_A 72 LNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 147 (322)
T ss_dssp CCCTTBCCEEEEEESS-SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCCCceEeeEEcCC-ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEE
Confidence 3689999988876544 489999988632 123457889999999999999999999999 9999999999999
Q ss_pred ccCCC---CccCccccceecCCCCCCCceeeeeeccCCCCccccc---CCCCcccCceeeeehhhHhhhhCCCCCCCccC
Q 046703 452 DQDMN---PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHL 525 (635)
Q Consensus 452 d~~~~---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~ 525 (635)
+.++. +||+|||++....... ......|+..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 148 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 148 SSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp SSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 87654 9999999998764321 112246889999999874 56789999999999999999999999865433
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
... +... +..+..... +.... .....+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~--~~~~----~~~~~~~~~--~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 225 QVS--LKDQ----ITSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSC--HHHH----HHHTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHH--HHHH----HHhCccccC--chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 221 1111 112221110 00001 12345778999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-25 Score=231.96 Aligned_cols=179 Identities=21% Similarity=0.323 Sum_probs=141.7
Q ss_pred ccccccccccCCCCccEEEEecccch----h--hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASEL----D--QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~----~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
|+|++.+..+......+|+++++... . ......+++..+..++.||++||.|||+.+ |+||||||+||+++
T Consensus 107 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183 (320)
T ss_dssp SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred CCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEe
Confidence 68899888888888889999988652 1 123467899999999999999999999999 99999999999999
Q ss_pred -cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 453 -QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 453 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
.++.+||+|||++....... .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------ 253 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 253 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred CCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------
Confidence 67899999999998765322 223568999999999877665 788999999999999999999985321
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. . .+... . .... ...+.+++.+||+.||++|||++||++
T Consensus 254 ---~~---~-~~~~~--~----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ---EI---I-RGQVF--F----RQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HH---H-HCCCC--C----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hh---h-ccccc--c----cccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 11110 0 1111 235778999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.1e-25 Score=227.16 Aligned_cols=204 Identities=19% Similarity=0.203 Sum_probs=139.7
Q ss_pred eccccccccccC--------------CCCccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEE
Q 046703 378 WFGDLIDMRSFP--------------DGGQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 378 ~h~nLv~l~~~~--------------~~~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
.|+|++.+..+. .....+|+++++.+.. ......+++..+..++.||++||+|||+.+ |+
T Consensus 66 ~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 142 (320)
T 2i6l_A 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VL 142 (320)
T ss_dssp CCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred CCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 588888876553 3446889999988632 123456888999999999999999999999 99
Q ss_pred eeccCCcceEec-cCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCC
Q 046703 441 HRDLKAGNVLLD-QDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGK 517 (635)
Q Consensus 441 H~dik~~NIlld-~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~ 517 (635)
||||||+||+++ .++.+||+|||+++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+
T Consensus 143 H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCC
Confidence 999999999997 5678999999999875432111 11122456889999998865 67899999999999999999999
Q ss_pred CCCCCccCCCcccHHHHHHHHhhc----------CCCCcCCCCccc-c-----CCCHHHHHHHHHHHHHhcccCCCCCCC
Q 046703 518 KNRGFYHLDNKLNLIGHAWKLWNK----------GMPSEMIDPCYQ-E-----SCNLTEVIRCIHISLLCVQQHPDDRPC 581 (635)
Q Consensus 518 ~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~d~~l~-~-----~~~~~~~~~~~~l~~~Cl~~dP~~RPt 581 (635)
.||......+ ........... ......+..... . .........+.+++.+||+.||++|||
T Consensus 223 ~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 223 TLFAGAHELE---QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp CSSCCSSHHH---HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCCCCCHHH---HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 9986543211 11111110000 000000000000 0 000112345778999999999999999
Q ss_pred hHHHHH
Q 046703 582 MPSVIL 587 (635)
Q Consensus 582 ~~evl~ 587 (635)
++|+++
T Consensus 300 ~~ell~ 305 (320)
T 2i6l_A 300 AEEALS 305 (320)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-24 Score=225.48 Aligned_cols=181 Identities=20% Similarity=0.297 Sum_probs=138.3
Q ss_pred eccccccccccCCCCccEEEEecc-cch---h--hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSA-SEL---D--QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~-~~~---~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+.......|+++++ ... . ......+++.+++.++.||++||.|||+.+ |+||||||+||++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILI 172 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEE
Confidence 699999999988878888999887 331 1 123456899999999999999999999999 9999999999999
Q ss_pred c-cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 452 D-QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+ .++.+||+|||++....... .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----- 243 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----- 243 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence 9 78899999999998765432 223568999999999877666 469999999999999999999985321
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
... .... . . +......+.+++.+||+.||++|||++||++.
T Consensus 244 ----~~~----~~~~-~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ----EIL----EAEL-H-----F----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HHH----HTCC-C-----C----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----HHh----hhcc-C-----C----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 1111 0 0 11122356789999999999999999999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.9e-24 Score=217.56 Aligned_cols=191 Identities=23% Similarity=0.281 Sum_probs=144.6
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|+++++.+.. ......+++.+++.++.||+.||.|||+.+ ++|+||||+||++
T Consensus 78 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv 154 (287)
T 2wei_A 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILL 154 (287)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred ccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEE
Confidence 36899999988888888999999987532 123457899999999999999999999999 9999999999999
Q ss_pred ccC---CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQD---MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.+ ..+||+|||++........ .....++..|+|||.+.+ .++.++||||||+++|||++|+.||......
T Consensus 155 ~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-- 228 (287)
T 2wei_A 155 ESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-- 228 (287)
T ss_dssp SCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred ecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--
Confidence 764 4699999999986643322 122457899999998865 4899999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+....... .. .. ....+.+++.+||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~~~~~~~~-~~-~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 229 -----DILKRVETGKYAFDLP-QW-RT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----HHHHHHHHCCCCCCSG-GG-TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HHHHHHHcCCCCCCch-hh-hh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1122222332211110 00 11 1235778999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-24 Score=221.19 Aligned_cols=193 Identities=23% Similarity=0.302 Sum_probs=132.2
Q ss_pred ecccccccccc-------------CCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccce
Q 046703 378 WFGDLIDMRSF-------------PDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLR 438 (635)
Q Consensus 378 ~h~nLv~l~~~-------------~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 438 (635)
.|+|++.+..+ ......+|+++++.+.. ......+++.+++.++.||++||+|||+++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--- 136 (303)
T 1zy4_A 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--- 136 (303)
T ss_dssp CCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred CchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---
Confidence 46777666543 23457889999998631 123345778888999999999999999999
Q ss_pred EEeeccCCcceEeccCCCCccCccccceecCCCCC------------CCceeeeeeccCCCCcccccCC-CCcccCceee
Q 046703 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET------------EGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFS 505 (635)
Q Consensus 439 iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS 505 (635)
|+|+||||+||+++.++.+||+|||++........ ........|+..|+|||.+.+. .++.++||||
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 216 (303)
T 1zy4_A 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216 (303)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHH
T ss_pred eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHH
Confidence 99999999999999999999999999986542210 1112335689999999998764 6899999999
Q ss_pred eehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 506 FGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 506 ~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
||+++|||++ ||.... + .......+..... .+....+......+.+++.+||+.||++|||+.++
T Consensus 217 lG~il~~l~~---p~~~~~--~----~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 281 (303)
T 1zy4_A 217 LGIIFFEMIY---PFSTGM--E----RVNILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281 (303)
T ss_dssp HHHHHHHHHS---CCSSHH--H----HHHHHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHh---ccCCch--h----HHHHHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHH
Confidence 9999999998 432110 0 1111122222111 11111222334457789999999999999999999
Q ss_pred HHH
Q 046703 586 ILM 588 (635)
Q Consensus 586 l~~ 588 (635)
++.
T Consensus 282 l~h 284 (303)
T 1zy4_A 282 LNS 284 (303)
T ss_dssp HHS
T ss_pred hCC
Confidence 873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-24 Score=233.15 Aligned_cols=148 Identities=16% Similarity=0.166 Sum_probs=117.2
Q ss_pred ccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCC
Q 046703 409 CKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMA 488 (635)
Q Consensus 409 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 488 (635)
...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....| ..|+|
T Consensus 205 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~a 275 (413)
T 3dzo_A 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAP 275 (413)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeC
Confidence 456788899999999999999999999 999999999999999999999999999875322 233567 99999
Q ss_pred cccc----------cCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCH
Q 046703 489 PEYA----------SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNL 558 (635)
Q Consensus 489 PE~~----------~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 558 (635)
||.+ ....++.++|||||||++|||++|+.||.......... .++... ...
T Consensus 276 PE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~-- 336 (413)
T 3dzo_A 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE---------------WIFRSC--KNI-- 336 (413)
T ss_dssp HHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCC--
T ss_pred chhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccC--
Confidence 9998 55568899999999999999999999986543222111 111100 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 559 TEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 559 ~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
+..+.+++.+||+.||++||++.+++
T Consensus 337 --~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 337 --PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 24577899999999999999976664
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=240.76 Aligned_cols=182 Identities=19% Similarity=0.255 Sum_probs=138.3
Q ss_pred eeeccccccccccCCCCcc-----EEEEecccch---hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 376 AMWFGDLIDMRSFPDGGQD-----LYIRMSASEL---DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~-----lyl~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
.+.|+||+.+..+...... .||++++.+. .......+++.+++.++.||++||.|||+++ |+||||||+
T Consensus 135 ~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~ 211 (681)
T 2pzi_A 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPE 211 (681)
T ss_dssp GCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred hcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChH
Confidence 3469999999887643333 7999999863 2222347899999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
||+++.+ .+||+|||+++..... ....||+.|+|||.+.+.. +.++|||||||++|||++|..|+.......
T Consensus 212 NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~ 283 (681)
T 2pzi_A 212 NIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG 283 (681)
T ss_dssp GEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS
T ss_pred HeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc
Confidence 9999986 8999999999876432 2356899999999987654 899999999999999999988865321110
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-hHHHHHHHcC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-MPSVILMLGS 591 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-~~evl~~L~~ 591 (635)
+. ...........+.+++.+||+.||++||+ ++++...|.+
T Consensus 284 -------------------~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 -------------------LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -------------------CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------------cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00011122345778999999999999995 6666666554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6e-23 Score=232.30 Aligned_cols=202 Identities=23% Similarity=0.276 Sum_probs=140.6
Q ss_pred eeccccccccccCCC------CccEEEEecccchhh--------hhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 377 MWFGDLIDMRSFPDG------GQDLYIRMSASELDQ--------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 377 l~h~nLv~l~~~~~~------~~~lyl~~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
+.|+||+.+..++.. +...|+++++.+... .....+++..+..++.||+.||.|||+.+ |+||
T Consensus 69 L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHr 145 (676)
T 3qa8_A 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHR 145 (676)
T ss_dssp CCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCC
T ss_pred CCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccC
Confidence 469999988777644 677899999885311 11236899999999999999999999999 9999
Q ss_pred ccCCcceEeccCCC---CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCC
Q 046703 443 DLKAGNVLLDQDMN---PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 443 dik~~NIlld~~~~---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
||||+||+++.++. +||+|||++........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus 146 DLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~P 222 (676)
T 3qa8_A 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222 (676)
T ss_dssp CCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 99999999997665 89999999987654322 2235789999999999999999999999999999999999999
Q ss_pred CCCccCCCcc---cHHHHHHHHhhcCCCCcC--CCCc--cccCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 520 RGFYHLDNKL---NLIGHAWKLWNKGMPSEM--IDPC--YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 520 f~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~d~~--l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
|......... .................. .... ............+.+++.+||+.||++|||++|
T Consensus 223 f~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred CCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 8542100000 000000000000000000 0000 111233445677889999999999999999966
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=168.77 Aligned_cols=105 Identities=18% Similarity=0.347 Sum_probs=89.9
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEcc
Q 046703 23 PDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSK 102 (635)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~ 102 (635)
.|+|.+||.|.+|++|.| |.|.|.|+.+++ |.++. ..++||+|||+.|... .++|+|+.||||||+|+
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECC
Confidence 378999999999999987 889999998887 44542 3689999999999754 57899999999999999
Q ss_pred CCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 103 SNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 103 ~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
+|.+||+|++....... .|+|+|+|||||++ .+||||
T Consensus 69 ~~~~vWss~t~~~~~~~-~l~L~ddGNlVly~-------~~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNY-ILILQDDGNVIIYG-------SDIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCE-EEEECTTSCEEEEE-------SEEEEC
T ss_pred CcEEEEEecCCCCCCCE-EEEEeCCCeEEEEC-------CcEecC
Confidence 99999999987654434 89999999999995 359998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-22 Score=210.06 Aligned_cols=179 Identities=17% Similarity=0.232 Sum_probs=128.7
Q ss_pred eccccccccccCCC----CccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPDG----GQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~~----~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.+..+... ...+|+++++.+.. ......+++.++..++.||+.||.|||+.+ |+||||||
T Consensus 69 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp 145 (299)
T 3m2w_A 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 145 (299)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred cCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCH
Confidence 58888887776543 67789999988631 112236899999999999999999999999 99999999
Q ss_pred cceEecc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 447 GNVLLDQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 447 ~NIlld~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+||+++. ++.+||+|||++.... +..++.++||||||+++|||++|+.||...
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred HHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998 7889999999986532 244678999999999999999999998543
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCC----HHHHHHHHHHHHHhcccCCCCCCChHHHHH--HHcCCCCCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCN----LTEVIRCIHISLLCVQQHPDDRPCMPSVIL--MLGSEIVLP 596 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~p 596 (635)
...... ......+..... ..+ ......+.+++.+||+.||++|||++|+++ .+.+....+
T Consensus 202 ~~~~~~-----------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 202 HGLAIS-----------PGMKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp -----------------CCSCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred cchhhh-----------HHHHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 221100 000011111000 111 112345778999999999999999999997 344443333
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-20 Score=165.52 Aligned_cols=109 Identities=27% Similarity=0.381 Sum_probs=94.2
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEcc
Q 046703 23 PDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSK 102 (635)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~ 102 (635)
+|+|.+||.|.+|++|+ ++|.|+|+|+.+|+. ++|. ..++||+||++.|. .+++++|..+|||||+|.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGnl------vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCNF------VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSCE------EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCcE------EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 47899999999999999 999999999988862 5675 37999999998773 357899999999999999
Q ss_pred CCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCC
Q 046703 103 SNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYP 151 (635)
Q Consensus 103 ~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~P 151 (635)
+|.++|+|.+....... .++|+|+|||||++. ++||||+||
T Consensus 69 ~~~~~W~S~t~~~~g~~-~l~l~~dGnlvl~~~-------~~W~S~~~~ 109 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHY-VLVLQQDRNVVIYGP-------VVWATGSGP 109 (110)
T ss_dssp TCCEEEECCCCCSSSCC-EEEECTTSCEEEECS-------EEEECSCCC
T ss_pred CCcEEEecCCCCCCCCE-EEEEeCCccEEEECC-------CEecCCCcC
Confidence 99999999987544333 899999999999853 599999998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=167.69 Aligned_cols=108 Identities=19% Similarity=0.321 Sum_probs=93.3
Q ss_pred ccccccCCCCccCCCCeEE--eCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEE
Q 046703 21 FAPDIITSSQTLNDGRTLI--SKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLV 98 (635)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~--S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~ 98 (635)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+|+. +||.+ +++||+|||+.| +.+++|+|+.+||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgnl------vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSCE------EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCCE------EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 5678999999999999999 9999999999988762 57865 799999999877 345789999999999
Q ss_pred EEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 99 LTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 99 l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
|+|.+|.++|+|.+..... ...++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g-~~~l~l~~~Gnlvl~~-------~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAG-HYVLVLQPDRNVVIYG-------DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSS-CEEEEECTTSCEEEEE-------SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCC-CEEEEEECCCcEEEEC-------ccEeCC
Confidence 9999999999998765433 3389999999999996 269998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.83 E-value=9.1e-22 Score=202.31 Aligned_cols=174 Identities=9% Similarity=-0.022 Sum_probs=126.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
+.|+||+.+..+......+|++|++.+.. ..-.......++..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 88 l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~ 164 (286)
T 3uqc_A 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSI 164 (286)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEET
T ss_pred CCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcC
Confidence 46999999999888888999999998631 111222455568889999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHHH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~~ 533 (635)
++.+||++++ |++ +++.++||||||+++|||++|+.||......+......
T Consensus 165 ~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~ 215 (286)
T 3uqc_A 165 DGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215 (286)
T ss_dssp TSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC
T ss_pred CCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH
Confidence 9999987443 333 36899999999999999999999997543322110000
Q ss_pred HHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 534 HAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
... .+.. .. ...........+.+++.+||+.||++| |+.|+++.|+...
T Consensus 216 ---~~~-~~~~---~~---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 216 ---RDT-AGQP---IE---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp ---BCT-TSCB---CC---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ---HHh-ccCC---CC---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000 0000 00 000011123357789999999999999 9999999998753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.83 E-value=7.3e-22 Score=207.34 Aligned_cols=183 Identities=15% Similarity=0.042 Sum_probs=134.0
Q ss_pred ccccccccccCCC-------------CccEEEEecccch----hhhhccccCcccchhhhhhhccccchhh-ccccceEE
Q 046703 379 FGDLIDMRSFPDG-------------GQDLYIRMSASEL----DQERCKLLDWSKRFRIICGTGRGLLYLH-QDSRLRII 440 (635)
Q Consensus 379 h~nLv~l~~~~~~-------------~~~lyl~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ii 440 (635)
|+||+.+..+... ...+|++||+++. .....+.+++.++..++.||+.||.||| +.+ |+
T Consensus 108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---iv 184 (336)
T 2vuw_A 108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR---FE 184 (336)
T ss_dssp CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHC---CB
T ss_pred cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 8888887766432 6789999999753 2233466889999999999999999999 898 99
Q ss_pred eeccCCcceEeccCC--------------------CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCccc
Q 046703 441 HRDLKAGNVLLDQDM--------------------NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVK 500 (635)
Q Consensus 441 H~dik~~NIlld~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k 500 (635)
||||||+|||++.++ .+||+|||+++..... ...||..|+|||.+.+.. +.+
T Consensus 185 HrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~ 256 (336)
T 2vuw_A 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQ 256 (336)
T ss_dssp CSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHH
T ss_pred ECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccc
Confidence 999999999999887 8999999999876432 357899999999998766 899
Q ss_pred Cceeeeehh-hHhhhhCCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCC
Q 046703 501 SDVFSFGIL-LLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579 (635)
Q Consensus 501 sDVwS~Gvv-l~eiltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~R 579 (635)
+||||++++ .+++++|..||.... ........+....... ..............+.+++.+||+.|
T Consensus 257 ~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 257 FDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFK---TKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp HHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCS---SCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred eehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccC---cccchhhhhhcCHHHHHHHHHHhccC----
Confidence 999998766 888999999973210 0011111111111100 01111122345667889999999865
Q ss_pred CChHHHH
Q 046703 580 PCMPSVI 586 (635)
Q Consensus 580 Pt~~evl 586 (635)
|++|++
T Consensus 324 -sa~e~l 329 (336)
T 2vuw_A 324 -SATDLL 329 (336)
T ss_dssp -SHHHHH
T ss_pred -CHHHHH
Confidence 999988
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.2e-20 Score=162.42 Aligned_cols=110 Identities=23% Similarity=0.323 Sum_probs=92.5
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEcc
Q 046703 23 PDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSK 102 (635)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~ 102 (635)
.|+|.+||.|.+|++|+ +|.|+|+|+.+++. ++|. ..++||+|||+.|. .+++|+|+.+|||||+|.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgnl------vly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCNL------VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSCE------EEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCcE------EEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 47999999999999998 89999999987752 2354 38899999999883 467899999999999999
Q ss_pred CCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCC
Q 046703 103 SNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSD 153 (635)
Q Consensus 103 ~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTD 153 (635)
++.++|+|.+....... .++|+|+|||||++. ++||||.++..
T Consensus 69 ~~~~vW~S~~~~~~g~~-~l~l~~dGnlvl~~~-------~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKY-ALVLQKDGRFVIYGP-------VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCC-EEEECTTSCEEEECS-------EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCE-EEEEeCCCeEEEECC-------CEEECCCCCCc
Confidence 99999999886443334 899999999999942 69999988754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.9e-20 Score=159.88 Aligned_cols=110 Identities=21% Similarity=0.397 Sum_probs=92.3
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEcc
Q 046703 23 PDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSK 102 (635)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~ 102 (635)
+|+|.+||.|.+|++| .+|.|+|+|+.+|+. ++|.+ .++||+||++.+ +.+++|+|..+|||||+|
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgnl------vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCNL------VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSCE------EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCcE------EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 5899999999999999 589999999998873 35654 689999999764 345789999999999999
Q ss_pred CCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCC
Q 046703 103 SNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYP 151 (635)
Q Consensus 103 ~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~P 151 (635)
++.++|+|.+....... .++|+++|||||++.. +.++||||++.
T Consensus 67 ~~~~~W~S~~~~~~g~~-~l~l~~dGnlvl~~~~----~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNY-YLILQRDRNVVIYDNS----NNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCC-EEEECTTSCEEEECTT----SCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCE-EEEEeCCCcEEEECCC----CceEEECCCcc
Confidence 88999999876543333 8999999999999754 47899999975
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=151.88 Aligned_cols=103 Identities=26% Similarity=0.401 Sum_probs=86.8
Q ss_pred cccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccC
Q 046703 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKS 103 (635)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~ 103 (635)
++|.+||.|.+|++|+ +|.|.|+|+.+|+ .+ .|.. .++||++|++.+ +.++.|+|+.||||||+|.+
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---Lv---ly~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---LV---LYDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC---EE---EEET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---EE---EEeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 6899999999999996 7999999998886 22 2544 689999999876 34578999999999999999
Q ss_pred CceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 104 NIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 104 ~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
+.++|++++..... ...|+|+|+|||||++. ++|||
T Consensus 69 ~~~~W~S~t~~~~~-~~~~~L~ddGNlvly~~-------~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENG-NYVCVLQKDRNVVIYGT-------ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSS-CEEEEECTTSCEEEEES-------CCCCC
T ss_pred CCEEEECCCCCCCC-CEEEEEeCCCEEEEECC-------CEEeC
Confidence 99999999865433 34899999999999963 59998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.5e-20 Score=205.63 Aligned_cols=133 Identities=18% Similarity=0.109 Sum_probs=94.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+|++.+..+.+++..+||+||+.+... .+...++. .+|+.||+.||+|+|+++ ||||||||+|||++
T Consensus 300 ~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~ 373 (569)
T 4azs_A 300 AGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVD 373 (569)
T ss_dssp TTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEEC
T ss_pred CCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEEC
Confidence 58899999999999999999999998522 23344544 358899999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~p 519 (635)
.++.+||+|||+|+........ .....||+.|+|||.+.+ .+..++|+||+|++++++.++..+
T Consensus 374 ~dg~vKL~DFGlAr~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 374 ARQHARLIDFGSIVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TTSCEEECCCTTEESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCEEEeecccCeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999999999876543322 234679999999999865 467789999999999999876544
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.6e-18 Score=147.44 Aligned_cols=105 Identities=23% Similarity=0.358 Sum_probs=86.0
Q ss_pred ccccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEE
Q 046703 21 FAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLT 100 (635)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~ 100 (635)
+++|+|.+||.|..|+.|+| |.|.|.|...|+ |.+ |.. .+||++|++.. +.+++|+|+.+|||||+
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 57899999999999999998 458888877765 333 543 48999999863 34578999999999999
Q ss_pred ccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 101 SKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 101 ~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
|.+|.++|++++....... .|+|+|+|||||++ ..+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~-~~~L~~dGNlvly~-------~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEY-VLILQDDGFGVIYG-------PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCC-EEEECTTSCEEEEC-------SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCE-EEEEcCCccEEEec-------CCEecC
Confidence 9999999999986543334 89999999999996 359987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.72 E-value=4.1e-17 Score=143.19 Aligned_cols=108 Identities=19% Similarity=0.282 Sum_probs=88.7
Q ss_pred ccccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEE
Q 046703 21 FAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLT 100 (635)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~ 100 (635)
.+.|+|.+||.|.+|+.|. +|.|.|.|...|+ |.++ .. ...++||++|+..+ +.+++|+|+.+|||||+
T Consensus 4 ~~~~tL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----LvL~-~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLA--TRDYSLVMRDDCN-----LVLT-KG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCSSEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEE-ET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred ccCCEeCCCCEECCCCEeE--cCCEEEEEcCCCE-----EEEE-EC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence 4678999999999999996 4889999988776 4443 22 24789999999876 33578999999999999
Q ss_pred ccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 101 SKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 101 ~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
|.++.++|++++....... .|+|+|+|||||++ ..+|+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~-~~~L~~dGnlvly~-------~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDY-VLILQINGQAVVYG-------PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCC-EEEECTTSCEEEEC-------SEEEES
T ss_pred CCCCCEEEECCCcCCCCCE-EEEEcCCceEEEec-------CCEecC
Confidence 9999999999986543334 89999999999996 359997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=140.25 Aligned_cols=96 Identities=24% Similarity=0.444 Sum_probs=77.8
Q ss_pred CCCCCCceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCe
Q 046703 81 LINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMK 160 (635)
Q Consensus 81 pv~~~~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~ 160 (635)
|+.+...+|.|+.||+|+|++. +++||++++.....+. .|+|+++|||||++ . +.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~-~l~l~~~GNLvl~d-~----~~~~W~S~~----------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGC-VLKMQNDGNLVIYS-G----SRAIWASNT----------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSE-EEEECTTSCEEEEE-T----TEEEEECCC-----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCE-EEEEeCCCCEEEEc-C----CEEEEECCc-----------
Confidence 3334467899999999999987 7999999986543334 89999999999998 4 489999994
Q ss_pred eccccccccceeEEEeccCCCCCCCceEEEEecCCCceEEEec-CCeeeEEcCCCCC
Q 046703 161 LGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWK-GSRKFYRTGPWNG 216 (635)
Q Consensus 161 l~~~~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~yw~~g~w~~ 216 (635)
+|++|.|++.++++|+ ++++. ...+||++++|+|
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 3467889999999997 45565 5679999999976
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-16 Score=138.76 Aligned_cols=109 Identities=23% Similarity=0.353 Sum_probs=88.5
Q ss_pred ccccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEE
Q 046703 21 FAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLT 100 (635)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~ 100 (635)
.+.|||.+||.|..|+.| .+|.|.|.|+.+|+.. .|.. +|.+|+..+ +.+++|+|+.||||||+
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGNLv------l~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNLV------LYNG------NWQSNTANN--GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSCEE------EETT------TEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCeEE------EEeC------eEEcCCCCC--CCcEEEEEcCCCeEEEE
Confidence 368999999999999999 5799999998888732 2321 699998865 34578999999999999
Q ss_pred ccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCC
Q 046703 101 SKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPG 158 (635)
Q Consensus 101 ~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpg 158 (635)
|.++.++|++++....... .|+|+|+|||||++ ..+|+| .|.+||
T Consensus 65 d~~~~~vWss~t~~~~~~~-~~~L~~dGNlvly~-------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 65 NGDGSTVWKSGAQSVKGNY-AAVVHPDGRLVVFG-------PSVFKI-----DPWVRG 109 (109)
T ss_dssp CTTSCEEEECCCCCSSSCC-EEEEETTTEEEEEC-------SEEEEE-----CTTSCC
T ss_pred eCCCCEEEcCCCcCCCcCE-EEEEcCCCeEEEEe-------cCEECC-----CCccCC
Confidence 9999999999886533333 89999999999996 359998 666554
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-16 Score=138.45 Aligned_cols=89 Identities=24% Similarity=0.372 Sum_probs=73.9
Q ss_pred CCceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeeccc
Q 046703 85 SSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWD 164 (635)
Q Consensus 85 ~~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~ 164 (635)
...+|.|+.||||||++ .+++||++++.....+. .++|+++|||||++.+ +.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~-~l~l~~dGNLVl~~~~----~~~~W~S~t--------------- 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGC-RLTLHNNGNLVIYDQS----NRVIWQTKT--------------- 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSC-EEEECTTSCEEEECTT----CCEEEECCC---------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcE-EEEEeCCCCEEEECCC----CcEEEecCC---------------
Confidence 45789999999999998 58999999987554444 8999999999999865 579999992
Q ss_pred cccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCCC
Q 046703 165 LETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 214 (635)
Q Consensus 165 ~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~w 214 (635)
++++|.|++.++++|+ ++++++ +||+++++
T Consensus 79 ----------------~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 79 ----------------NGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 4567899999999997 455665 89999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=2.7e-15 Score=132.69 Aligned_cols=87 Identities=21% Similarity=0.302 Sum_probs=72.1
Q ss_pred CceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecccc
Q 046703 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDL 165 (635)
Q Consensus 86 ~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~ 165 (635)
..+|.|+.||+|||++. +++||++++..+..+. .|+|+|+|||||++.+ +.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~-~l~l~~dGNLVl~d~~----~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGC-RAVLQPDGVLVVITNE----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSC-EEEECTTSCEEEECTT----CCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCce-EEEEccCCEEEEEeCC----CcEEEcCC-----------------
Confidence 35699999999999987 8999999987554444 8999999999999865 57999999
Q ss_pred ccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 166 ETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 166 ~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
++|++|.|++.++++|+ +++++ .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34567999999999998 45555 38999987
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=4.6e-15 Score=130.63 Aligned_cols=91 Identities=21% Similarity=0.358 Sum_probs=74.8
Q ss_pred CceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecccc
Q 046703 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDL 165 (635)
Q Consensus 86 ~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~ 165 (635)
..+|.|+.||+|+|++ .+++||++++..+..+. .++|+++|||||++.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~-~l~l~~~GnLvl~d~~----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGC-RLTLLSDGNLVIYDHN----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSC-EEEECTTSCEEEECTT----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCce-EEEECCCCcEEEECCC----ceEEEEcCCC---------------
Confidence 4679999999999998 58899999987554334 8999999999999864 4799999997
Q ss_pred ccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCCCCCc
Q 046703 166 ETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGL 217 (635)
Q Consensus 166 ~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~w~~~ 217 (635)
+++|.|++.++++|+ +++++. +||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 246789999999997 455654 89999999643
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-14 Score=125.35 Aligned_cols=104 Identities=16% Similarity=0.223 Sum_probs=82.6
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEcc
Q 046703 23 PDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSK 102 (635)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~ 102 (635)
+|+|.+||.|.+|+.| .+|.|.|.|..+|+- .+ |.. .. ||.+|+..+ +..+.|+|+.+|||||+|.
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGnL-----vl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCNL-----VL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSCE-----EE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCeE-----EE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 5789999999999999 479999999887763 22 433 23 999999876 3357899999999999998
Q ss_pred CCc-eEEEeecccC-CCCceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 103 SNI-VVWSAYLSKE-VRTPVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 103 ~~~-~vwss~~~~~-~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
++. ++|+|++... ..+...++|+++|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence 876 5999986421 2223389999999999996 459998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=3.3e-15 Score=166.81 Aligned_cols=136 Identities=20% Similarity=0.164 Sum_probs=104.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCC
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN 456 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~ 456 (635)
+.|+||+....+.......|++||+.+...... .+.. ++.++.||++||.|||+++ |+||||||+|||++. .
T Consensus 396 l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~-~l~~--~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 396 VKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKD-VIED--NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp GGGGTCCCCCEEEEETTTTEEEEECCCSEEHHH-HSTT--CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--S
T ss_pred cCCCCcCceEEEEEeCCccEEEEECCCCCCHHH-HHHH--HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--e
Confidence 479999955554445567799999987322111 1111 7789999999999999999 999999999999998 9
Q ss_pred CccCccccceecCCCCCCC-----ceeeeeeccCCCCcccccC--CCCcccCceeeeehhhHhhhhCCCCC
Q 046703 457 PKISDFGLARTFGGDETEG-----NTTRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 457 ~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
+||+|||+++......... ......||+.|+|||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999999999875432111 1124678999999999976 56888999999988888888776664
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.41 E-value=8.5e-13 Score=115.57 Aligned_cols=95 Identities=19% Similarity=0.243 Sum_probs=72.7
Q ss_pred CCCCCCCCceEEEecCCcEEEEcc-CCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccC
Q 046703 79 LNLINDSSGFLMINKTGNLVLTSK-SNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLP 157 (635)
Q Consensus 79 ~~pv~~~~~~l~~~~~g~l~l~~~-~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLp 157 (635)
+.|+.+...+|.|+.||||||++. .+.++|++++.....+. .++|+++|||||++.+ ++++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~-~l~l~~dGNLVl~d~~----~~~iW~S~t~------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHC-FMRLGHSGELDITDDR----LNTVFVSNTV------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSC-EEEECTTSCEEEECTT----SCEEEECSCC-------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCE-EEEEeCCCcEEEECCC----CCEEEECCCc-------
Confidence 444544567899999999999998 58999999987543334 8999999999999865 4789998210
Q ss_pred CCeeccccccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 158 GMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 158 gq~l~~~~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
-..|.|.+.++++|+.+++ + .+.|.+|+
T Consensus 86 ------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 ------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp ------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0135588999999987654 4 68899875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-12 Score=112.40 Aligned_cols=91 Identities=14% Similarity=0.191 Sum_probs=69.9
Q ss_pred CCCceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecc
Q 046703 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGW 163 (635)
Q Consensus 84 ~~~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~ 163 (635)
....+|.|+.||||||++.++ +|++++....... .++|+++|||||++.++ ..++|||.-+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~-~l~l~~dGNLVl~~~~~---~~~vW~S~t~------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDC-TLRLNNRGQLEIHSANS---NTPVWVYPRS------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSC-EEEECTTSCEEEECSSC---SSCSEEESSS-------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCE-EEEEcCCCcEEEEeCCC---CEEEEEeccc-------------
Confidence 345689999999999999887 9999987543334 89999999999998753 2459999521
Q ss_pred ccccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 164 DLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 164 ~~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
.....|.|.+.++++|+.+++ . .++|.+++
T Consensus 80 ----------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ----------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ----------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347899999999987655 3 68999876
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.4e-11 Score=124.92 Aligned_cols=113 Identities=19% Similarity=0.308 Sum_probs=85.9
Q ss_pred ccccccCCCCc----cCCCCeEEeCCCeEEEeecCCC--CCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecC
Q 046703 21 FAPDIITSSQT----LNDGRTLISKDGSFELGFFSPG--SSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKT 94 (635)
Q Consensus 21 ~~~~~l~~g~~----l~~~~~l~S~~g~f~~gf~~~~--~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~ 94 (635)
..+||+.||+. |..|+.|.|+ ..++.|+|... ...+.+ + |.+ ..+++|.+++..+ +. ..|.|+.+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~--~~-~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGK--GA-VRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTT--TC-CEEEECTT
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCC--cc-EEEEEcCC
Confidence 57899999999 8889998654 45555555421 122333 3 322 3689999999876 22 68999999
Q ss_pred CcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccC
Q 046703 95 GNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDY 150 (635)
Q Consensus 95 g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 150 (635)
|+|+++|.++.++|++++.... .. .|+|+++|||||++. +++||||||
T Consensus 205 GnLvl~d~~~~~vWsS~t~~~~-~~-rl~Ld~dGnLvly~~------~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNAVLWHSHTGGHA-SA-VLRLQANGSIAILDE------KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSCEEEECSCTTCT-TC-EEEECTTSCEEEEEE------EEEEESSSC
T ss_pred CeEEEEeCCCcEEEEecCCCCC-CE-EEEEcCCccEEEEcC------CCeEEccCc
Confidence 9999999988999999976432 34 899999999999964 479999997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.7e-11 Score=104.54 Aligned_cols=86 Identities=16% Similarity=0.301 Sum_probs=66.2
Q ss_pred CceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecccc
Q 046703 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDL 165 (635)
Q Consensus 86 ~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~ 165 (635)
+.+|.|+.||||||++. .++|++++.....+. .++|+++|||||++.+ +.++|||-.+
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~-~l~l~~dGNLvl~d~~----~~~iW~S~t~--------------- 82 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHC-FLRLNHKGELIIKDDD----FKTIWSSRSS--------------- 82 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSC-EEEECTTSCEEEECTT----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCE-EEEEeCCCcEEEEeCC----CCEEEEcCCc---------------
Confidence 46799999999999987 589999987543334 8999999999999865 4789999320
Q ss_pred ccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 166 ETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 166 ~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
-..|.|.+.++++|+.+++ + .+.|.+|+
T Consensus 83 ----------------~~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 83 ----------------SKQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp ----------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ----------------CCCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 0134588999999987654 4 47898874
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=7.5e-11 Score=102.48 Aligned_cols=87 Identities=20% Similarity=0.335 Sum_probs=67.3
Q ss_pred CceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecccc
Q 046703 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDL 165 (635)
Q Consensus 86 ~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~ 165 (635)
..+|.|+.||+|||++. +.++|++++.....+. .++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~-~l~l~~dGNLvl~~~~----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRC-HLSMQSDGNLVVYSPR----NNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSC-EEEECTTSCEEEECTT----SCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCE-EEEEeCCCCEEEECCC----CCEEEECCCCC--------------
Confidence 46799999999999987 7899999987543334 8999999999999865 47899983210
Q ss_pred ccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 166 ETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 166 ~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
..+.|.+.++++|+..++ +. +.|.+++
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 125688999999987654 43 7788765
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.1e-11 Score=102.95 Aligned_cols=91 Identities=21% Similarity=0.398 Sum_probs=68.6
Q ss_pred CCCCCCCceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCC
Q 046703 80 NLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGM 159 (635)
Q Consensus 80 ~pv~~~~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq 159 (635)
.|+.+...+|.|+.||||||+++ +|++++.....+. .++|+++|||||++.+ +.++|+|- |
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~-~l~l~~dGnLvl~d~~----~~~vWss~-----t----- 76 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDC-KLTLTDYGELVIKNGD----GSTVWKSG-----A----- 76 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSC-EEEECTTSCEEEECTT----SCEEEECC-----C-----
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcE-EEEEcCCCeEEEEeCC----CCEEEcCC-----C-----
Confidence 33434456899999999999984 7999987643334 8999999999999865 47899771 1
Q ss_pred eeccccccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCCC
Q 046703 160 KLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 214 (635)
Q Consensus 160 ~l~~~~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~w 214 (635)
....+.|.+.++++|+.+++ . .+.|.+++|
T Consensus 77 ---------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 ---------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp ---------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred ---------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 00235688999999976554 4 689999987
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.12 E-value=3.3e-10 Score=97.56 Aligned_cols=85 Identities=18% Similarity=0.343 Sum_probs=64.5
Q ss_pred ceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeeccccc
Q 046703 87 GFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLE 166 (635)
Q Consensus 87 ~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~ 166 (635)
-+|.++.||||||++. +++||++++..+....+.++|+++|||||++.+ ++++|+|=.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~----~~~vWss~t----------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS----GRSLWASHS----------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT----CCEEEECCC-----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC----cEEEEEecC-----------------
Confidence 4699999999999985 579999998765443348999999999999876 478998710
Q ss_pred cccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEc
Q 046703 167 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRT 211 (635)
Q Consensus 167 tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~ 211 (635)
....+.|.+.++++|+..++ + ...|.|
T Consensus 79 --------------~~~~~~~~l~L~ddGNlVly--~--~~~W~S 105 (105)
T 4h3o_A 79 --------------TRGSGNYILILQDDGNVIIY--G--SDIWST 105 (105)
T ss_dssp --------------CCCSSCEEEEECTTSCEEEE--E--SEEEEC
T ss_pred --------------CCCCCCEEEEEeCCCeEEEE--C--CcEecC
Confidence 11346688999999987654 3 246753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=6e-11 Score=121.18 Aligned_cols=81 Identities=15% Similarity=0.024 Sum_probs=66.2
Q ss_pred ccEEEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCC
Q 046703 393 QDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDE 472 (635)
Q Consensus 393 ~~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~ 472 (635)
...|++|++.+...... +...+...++.||++||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 173 ~~~~lvmE~~~g~~L~~--l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~~---- 242 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR--VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV---- 242 (282)
T ss_dssp ETTEEEEECCCCEEGGG--CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEET----
T ss_pred cceEEEEEecCCCcHHH--cchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeEC----
Confidence 35689999886433332 455677789999999999999999 99999999999999 999999999998642
Q ss_pred CCCceeeeeeccCCCCcccccC
Q 046703 473 TEGNTTRVVGTYGYMAPEYASD 494 (635)
Q Consensus 473 ~~~~~~~~~gt~~y~aPE~~~~ 494 (635)
..+.|||++..
T Consensus 243 -----------~~~~a~e~l~r 253 (282)
T 1zar_A 243 -----------GEEGWREILER 253 (282)
T ss_dssp -----------TSTTHHHHHHH
T ss_pred -----------CCCCHHHHHHH
Confidence 35678998743
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.67 E-value=2.4e-08 Score=99.00 Aligned_cols=88 Identities=20% Similarity=0.280 Sum_probs=68.7
Q ss_pred ceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeeccccc
Q 046703 87 GFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLE 166 (635)
Q Consensus 87 ~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~ 166 (635)
-.|.|..+|+|+|++. +++||.+++..+ ... .++|+++|||||++.+ +++||+|+.+
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~-~l~l~~dGnLvl~d~~----~~~vW~s~~~---------------- 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGC-RAVLQSDGLLVILTAQ----NTIRWSSGTK---------------- 84 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSC-SCC-BCCBCSSSCBCCBCTT----TCCSCCCCCC----------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCC-CCe-EEEEcCCCcEEEEcCC----CcEEEeCCcc----------------
Confidence 4577888999999986 789999998755 334 8999999999999875 5789999864
Q ss_pred cccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCCCCC
Q 046703 167 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNG 216 (635)
Q Consensus 167 tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~w~~ 216 (635)
.+.|.|.+.++++|+.+++ .. .+|.+..+..
T Consensus 85 ---------------~~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p~ 115 (236)
T 1dlp_A 85 ---------------GSIGNYVLVLQPDRTVTIY--GP--GLWDSGTSNK 115 (236)
T ss_dssp ---------------CCSSCCEEEECSSSCEEEE--CS--EEEECSCCCS
T ss_pred ---------------ccCCcEEEEEeCCCCEEEe--cC--CEEECCCCCC
Confidence 1245678999999987653 32 8999877643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=3e-08 Score=99.65 Aligned_cols=70 Identities=17% Similarity=0.091 Sum_probs=55.1
Q ss_pred cEEEEecccch-h----hhh--ccccCcccchhhhhhhccccchhh-ccccceEEeeccCCcceEeccCCCCccCccccc
Q 046703 394 DLYIRMSASEL-D----QER--CKLLDWSKRFRIICGTGRGLLYLH-QDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLA 465 (635)
Q Consensus 394 ~lyl~~~~~~~-~----~~~--~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla 465 (635)
..|++|++... . ... ....++.++..++.||+.+|.||| +.+ |+||||||.|||++. .++|+|||++
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a 216 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQA 216 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTC
T ss_pred CCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECccc
Confidence 45778887731 0 111 112345678899999999999999 998 999999999999998 8999999999
Q ss_pred eec
Q 046703 466 RTF 468 (635)
Q Consensus 466 ~~~ 468 (635)
...
T Consensus 217 ~~~ 219 (258)
T 1zth_A 217 VTL 219 (258)
T ss_dssp EET
T ss_pred ccC
Confidence 764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.13 E-value=7.8e-07 Score=94.09 Aligned_cols=69 Identities=19% Similarity=0.203 Sum_probs=54.5
Q ss_pred EEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCC----------CccCccccc
Q 046703 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN----------PKISDFGLA 465 (635)
Q Consensus 396 yl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~----------~kl~Dfgla 465 (635)
+|+|++.+.... ....+......++.||+.+|.+||+.+ ||||||||.|||+++++. +.|+||+-+
T Consensus 187 ~LVME~i~G~~L-~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 187 TIVMSLVDALPM-RQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp EEEEECCSCEEG-GGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred eEEEEecCCccH-hhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCc
Confidence 588888764322 223345566788999999999999999 999999999999988763 679999877
Q ss_pred eec
Q 046703 466 RTF 468 (635)
Q Consensus 466 ~~~ 468 (635)
...
T Consensus 263 V~~ 265 (397)
T 4gyi_A 263 VSM 265 (397)
T ss_dssp EET
T ss_pred ccC
Confidence 653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00031 Score=69.82 Aligned_cols=77 Identities=17% Similarity=0.076 Sum_probs=55.1
Q ss_pred CCccEEEEecccchhhhhccccCcccchhhhhhhccccchhhcc------------------------------------
Q 046703 391 GGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQD------------------------------------ 434 (635)
Q Consensus 391 ~~~~lyl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------ 434 (635)
.+...|++|++.+.........+......++.+++++|+.||+.
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred cCCceEEEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 34578999998875433222223344557888999999999981
Q ss_pred --------------------ccceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 435 --------------------SRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 435 --------------------~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
....++|+|+++.||+++....+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998765567999987743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0011 Score=65.31 Aligned_cols=30 Identities=17% Similarity=0.204 Sum_probs=25.7
Q ss_pred eEEeeccCCcceEeccCCCCccCcccccee
Q 046703 438 RIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 438 ~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
.++|+|++|.||+++.+..+.|.||+.+..
T Consensus 185 ~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 185 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 399999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0027 Score=66.18 Aligned_cols=75 Identities=15% Similarity=0.117 Sum_probs=55.8
Q ss_pred ccEEEEecccchhhh---hccccCcccchhhhhhhccccchhhccc----------------------------------
Q 046703 393 QDLYIRMSASELDQE---RCKLLDWSKRFRIICGTGRGLLYLHQDS---------------------------------- 435 (635)
Q Consensus 393 ~~lyl~~~~~~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------- 435 (635)
...|++|++.+.... ....++..++..++.++++.|+.||+..
T Consensus 114 g~~~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp SSCEEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred CCeEEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 357888888764322 1223556677788999999999999731
Q ss_pred ---------------------cceEEeeccCCcceEeccCCC--CccCcccccee
Q 046703 436 ---------------------RLRIIHRDLKAGNVLLDQDMN--PKISDFGLART 467 (635)
Q Consensus 436 ---------------------~~~iiH~dik~~NIlld~~~~--~kl~Dfgla~~ 467 (635)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=95.80 E-value=0.00033 Score=71.47 Aligned_cols=82 Identities=21% Similarity=0.311 Sum_probs=49.0
Q ss_pred ceEEeeccCCcceEecc--CCCCccCccccceecCCCCCCCce------------eeeeeccCCCC-cccccCCCCcccC
Q 046703 437 LRIIHRDLKAGNVLLDQ--DMNPKISDFGLARTFGGDETEGNT------------TRVVGTYGYMA-PEYASDGQFSVKS 501 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~--~~~~kl~Dfgla~~~~~~~~~~~~------------~~~~gt~~y~a-PE~~~~~~~s~ks 501 (635)
..++|+|+++.||+++. ...+.|.||+.+............ ......++... |+.... .....
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~ 268 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKE 268 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHH
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHH
Confidence 35899999999999998 455789999988653211000000 00001111222 222211 12235
Q ss_pred ceeeeehhhHhhhhCCCCC
Q 046703 502 DVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 502 DVwS~Gvvl~eiltG~~pf 520 (635)
+.|+++.++|.+.+|..++
T Consensus 269 ~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 269 KYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHcCCHHH
Confidence 7899999999999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=89.43 E-value=0.29 Score=46.94 Aligned_cols=92 Identities=12% Similarity=0.077 Sum_probs=56.8
Q ss_pred hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccC
Q 046703 406 QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYG 485 (635)
Q Consensus 406 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 485 (635)
.....++++++++.++.|.+++|.-+-.... -..+=+.|..|++..+|.+.+.+ ..+. .....
T Consensus 40 ~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~ 102 (229)
T 2yle_A 40 RLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPP 102 (229)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------------
T ss_pred HHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc--------------ccccC
Confidence 4567789999999999999988765511110 01223456888998888776654 1110 11224
Q ss_pred CCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 486 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 486 y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
+.|||... ...+.+.=|||+|++||.-+-
T Consensus 103 ~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 103 PVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred CCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 56888653 345678889999999998885
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=86.59 E-value=0.32 Score=49.12 Aligned_cols=30 Identities=37% Similarity=0.516 Sum_probs=24.8
Q ss_pred eEEeeccCCcceEecc---CCC-CccCcccccee
Q 046703 438 RIIHRDLKAGNVLLDQ---DMN-PKISDFGLART 467 (635)
Q Consensus 438 ~iiH~dik~~NIlld~---~~~-~kl~Dfgla~~ 467 (635)
.++|+|+++.||+++. ++. ..|.||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 5799999999999987 355 47999988754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=85.79 E-value=0.25 Score=50.22 Aligned_cols=31 Identities=23% Similarity=0.334 Sum_probs=27.0
Q ss_pred ceEEeeccCCcceEeccCCCCccCcccccee
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
..++|+|+++.||+++.++.+.|.||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4599999999999998778899999987743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 635 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-32 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-32 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-32 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-30 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-24 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-22 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-22 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-22 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-21 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-21 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-19 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-18 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-18 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-18 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-17 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-17 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-16 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-13 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-12 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-12 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-11 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-11 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
+ K I T +G+ YLH S IIHRDLK+ N+ L +D+ KI DFGLA
Sbjct: 101 FEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157
Query: 472 ETEGNTTRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528
++ G+ +MAPE +S +SDV++FGI+L E+++G+ + +++N+
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNR 215
Query: 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588
+I + + S++ C + + C+++ D+RP P ++
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKA---------MKRLMAECLKKKRDERPLFPQILAS 266
Query: 589 L 589
+
Sbjct: 267 I 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-37
Identities = 42/196 (21%), Positives = 73/196 (37%), Gaps = 18/196 (9%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQD-----SRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR 466
+ ++ T GL +LH + + I HRDLK+ N+L+ ++ I+D GLA
Sbjct: 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 467 TF--GGDETEGNTTRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKK 518
D + VGT YMAPE D + ++D+++ G++ EI
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 519 NRGFYHLDN----KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIH-ISLLCVQ 573
G + L + + K + + + P E +R + I C
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
Query: 574 QHPDDRPCMPSVILML 589
+ R + L
Sbjct: 277 ANGAARLTALRIKKTL 292
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-36
Identities = 50/213 (23%), Positives = 80/213 (37%), Gaps = 17/213 (7%)
Query: 381 DLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440
+ + + ++ ++E +L + +G+ +L +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 186
Query: 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVK 500
HRDL A NVL+ KI DFGLAR D +MAPE +G +++K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 501 SDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTE 560
SDV+S+GILL EI S + + N +KL G + +E
Sbjct: 247 SDVWSYGILLWEIFSLGV-NPYPGIPVDANF----YKLIQNGFKMDQPFYATEE------ 295
Query: 561 VIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593
I C RP P++ LG ++
Sbjct: 296 ---IYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 2e-35
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 22/217 (10%)
Query: 377 MWFGDLID----MRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLH 432
M +GDL + M + + + L +++ I G+ YL
Sbjct: 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157
Query: 433 QDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA 492
+ + +HRDL N L+ ++M KI+DFGL+R + +M PE
Sbjct: 158 ER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214
Query: 493 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCY 552
+++ +SDV+++G++L EI S +Y + ++ G + C
Sbjct: 215 FYNRYTTESDVWAYGVVLWEIFSYGLQP-YYGMAHE-----EVIYYVRDGNILACPENCP 268
Query: 553 QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
E ++ LC + P DRP S+ +L
Sbjct: 269 LE---------LYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 51/230 (22%), Positives = 92/230 (40%), Gaps = 27/230 (11%)
Query: 374 GCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQ 433
I G +++ E K L + + G+ Y+ +
Sbjct: 79 AVVSEEPIYIVTEYMSKGSLLDFLK-------GETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 434 DSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS 493
+ +HRDL+A N+L+ +++ K++DFGLAR +E + APE A
Sbjct: 132 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 187
Query: 494 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQ 553
G+F++KSDV+SFGILL E+ + + Y ++ + ++ Y+
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVL-------------DQVERGYR 232
Query: 554 ESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPK-QPG 602
C + C ++ P++RP + L +P+ QPG
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-34
Identities = 44/204 (21%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453
+ + + +E+ + ++ G G+ YL + +HRDL A N+L++
Sbjct: 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNS 145
Query: 454 DMNPKISDFGLARTFGGDETEGNTT-RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 512
++ K+SDFGL+R D TT + APE S +F+ SDV+SFGI++ E
Sbjct: 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205
Query: 513 IVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCV 572
+++ + + ++++ + I+ ++ + + + C
Sbjct: 206 VMTYGERPYWELSNHEV---------------MKAINDGFRLPTPMDCPSAIYQLMMQCW 250
Query: 573 QQHPDDRPCMPSVILMLGSEIVLP 596
QQ RP ++ +L I P
Sbjct: 251 QQERARRPKFADIVSILDKLIRAP 274
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 5e-34
Identities = 48/232 (20%), Positives = 83/232 (35%), Gaps = 26/232 (11%)
Query: 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453
L + +E + +G+ YL R++HRDL A NVL+
Sbjct: 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKT 146
Query: 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 513
+ KI+DFGLA+ G +E E + +MA E ++ +SDV+S+G+ + E+
Sbjct: 147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206
Query: 514 VSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQ 573
++ + S +++ + I I + C
Sbjct: 207 MTFGS---------------KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 251
Query: 574 QHPDDRPCMPSVILMLGSEIVLPQPKQPGFLADRKSIGPDSLLSIPESSSSN 625
D RP +I+ PQ I D + +P + SN
Sbjct: 252 IDADSRPKFRELIIEFSKMARDPQR--------YLVIQGDERMHLPSPTDSN 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-34
Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 404 LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG 463
L L +K + G+ ++ + + IHRDL+A N+L+ ++ KI+DFG
Sbjct: 98 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154
Query: 464 LARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523
LAR +E + APE + G F++KSDV+SFGILL EIV+ + Y
Sbjct: 155 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI--PY 211
Query: 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP 583
+I + +G D C +E + LC ++ P+DRP
Sbjct: 212 PGMTNPEVI----QNLERGYRMVRPDNCPEE---------LYQLMRLCWKERPEDRPTFD 258
Query: 584 SVILML 589
+ +L
Sbjct: 259 YLRSVL 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 51/217 (23%), Positives = 77/217 (35%), Gaps = 24/217 (11%)
Query: 382 LIDMRSFPDGGQDLYIRMSASELDQERC-------KLLDWSKRFRIICGTGRGLLYLHQD 434
++ + G Y+R +E + L +G+ +L
Sbjct: 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS- 152
Query: 435 SRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD 494
+ IHRDL A N+LL + KI DFGLAR D +MAPE D
Sbjct: 153 --RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210
Query: 495 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQE 554
++++SDV+SFG+LL EI S + + + +G D E
Sbjct: 211 RVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 265
Query: 555 SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591
L C P RP ++ LG+
Sbjct: 266 ---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-33
Identities = 43/192 (22%), Positives = 72/192 (37%), Gaps = 20/192 (10%)
Query: 400 SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKI 459
+ +G+ + + +HRDL A N +LD+ K+
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKV 171
Query: 460 SDFGLARTFGGDETEG--NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+DFGLAR E + N T +MA E +F+ KSDV+SFG+LL E+++
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 518 KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPD 577
Y N ++ + + P DP Y+ + L C +
Sbjct: 232 AP--PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE-------------VMLKCWHPKAE 276
Query: 578 DRPCMPSVILML 589
RP ++ +
Sbjct: 277 MRPSFSELVSRI 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-32
Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 8/121 (6%)
Query: 399 MSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN 456
M LDQ ++ + ++ +GL YL + +I+HRD+K N+L++
Sbjct: 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGE 143
Query: 457 PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516
K+ DFG++ + VGT YM+PE +SV+SD++S G+ L+E+ G
Sbjct: 144 IKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 517 K 517
+
Sbjct: 200 R 200
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-32
Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 387 SFPDGGQDLYI---RMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIH 441
S G + + + M++ L +R K++ +GL +LH + IIH
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIH 137
Query: 442 RDLKAGNVLL-DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVK 500
RDLK N+ + + KI D GLA V+GT +MAPE + ++
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMY-EEKYDES 192
Query: 501 SDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTE 560
DV++FG+ +LE+ + + + N + ++ G+ D + E
Sbjct: 193 VDVYAFGMCMLEMATSE--YPYSECQNAAQI----YRRVTSGVKPASFDKVA--IPEVKE 244
Query: 561 VIRCIHISLLCVQQHPDDRPCMPSVI 586
+I C++Q+ D+R + ++
Sbjct: 245 IIEG------CIRQNKDERYSIKDLL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 2e-32
Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 382 LIDMRSFPDGGQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDS 435
+I + + I S ++ + ++ G G+ YL
Sbjct: 89 VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD-- 146
Query: 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVG---TYGYMAPEYA 492
+ +HRDL A N+L++ ++ K+SDFGL+R D ++ T +G + APE
Sbjct: 147 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 493 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCY 552
+F+ SDV+S+GI++ E++S + R ++ + N+ ++I I+ Y
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGE-RPYWDMTNQ-DVI-------------NAIEQDY 250
Query: 553 QESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
+ + + L C Q+ + RP ++ L
Sbjct: 251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 19/217 (8%)
Query: 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
+GDL++ ++ + ++ LD +G+ +L
Sbjct: 109 CCYGDLLNF--LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--- 163
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ 496
IHRDL A N+LL KI DFGLAR D +MAPE +
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223
Query: 497 FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESC 556
++ +SDV+S+GI L E+ S + + + +K+ +G + E
Sbjct: 224 YTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKMIKEGFRMLSPEHAPAE-- 276
Query: 557 NLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593
I C P RP ++ ++ +I
Sbjct: 277 -------MYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 27/205 (13%)
Query: 392 GQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445
+ + S+ + + L + G+ YL + +IHRDL
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLA 128
Query: 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFS 505
A N L+ ++ K+SDFG+ R D+ ++T + +PE S ++S KSDV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 506 FGILLLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRC 564
FG+L+ E+ S GK + I ++L+ + S
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST----------------HV 231
Query: 565 IHISLLCVQQHPDDRPCMPSVILML 589
I C ++ P+DRP ++ L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-32
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 18/180 (10%)
Query: 407 ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR 466
E + R G++YLH + I HRD+K N+LLD+ N KISDFGLA
Sbjct: 95 EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT 151
Query: 467 TFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHL 525
F + E ++ GT Y+APE +F + DV+S GI+L +++G+ +
Sbjct: 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP--WDQP 209
Query: 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585
+ + P + ID + + + ++P R +P +
Sbjct: 210 SDSCQEYSDWKEKKTYLNPWKKIDS------------APLALLHKILVENPSARITIPDI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-32
Identities = 48/183 (26%), Positives = 74/183 (40%), Gaps = 19/183 (10%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467
+ + + ++ G+ YL + +HRDL A NVLL KISDFGL++
Sbjct: 100 QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 156
Query: 468 FGGDETEGNT-TRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526
DE T + APE + +FS KSDV+SFG+L+ E S + + + +
Sbjct: 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-KPYRGMK 215
Query: 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586
+ KG C +E + LC ++RP +V
Sbjct: 216 GS-----EVTAMLEKGERMGCPAGCPRE---------MYDLMNLCWTYDVENRPGFAAVE 261
Query: 587 LML 589
L L
Sbjct: 262 LRL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-31
Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 25/205 (12%)
Query: 392 GQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445
+ L + M + + + + S ++ G+ YL + +HRDL
Sbjct: 80 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLA 136
Query: 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGN-TTRVVGTYGYMAPEYASDGQFSVKSDVF 504
A NVLL KISDFGL++ G D++ + + APE + +FS +SDV+
Sbjct: 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 505 SFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRC 564
S+G+ + E +S + + + + +G E C E
Sbjct: 197 SYGVTMWEALSYGQ-KPYKKMKGP-----EVMAFIEQGKRMECPPECPPE---------L 241
Query: 565 IHISLLCVQQHPDDRPCMPSVILML 589
+ C +DRP +V +
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (305), Expect = 2e-31
Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 25/202 (12%)
Query: 388 FPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
F G L L + + + + + YL + IHRDL A
Sbjct: 94 FMTYGNLLDY------LRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAAR 144
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG 507
N L+ ++ K++DFGL+R GD + APE + +FS+KSDV++FG
Sbjct: 145 NCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 508 ILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHI 567
+LL EI + + Y + + ++L K E + C ++ +
Sbjct: 204 VLLWEIATYGMS--PYPGID----LSQVYELLEKDYRMERPEGCPEK---------VYEL 248
Query: 568 SLLCVQQHPDDRPCMPSVILML 589
C Q +P DRP +
Sbjct: 249 MRACWQWNPSDRPSFAEIHQAF 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 23/197 (11%)
Query: 392 GQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQ--DSRLRIIHRDLKAGNV 449
G DL ++ +++ LD R++ L H+ D ++HRDLK NV
Sbjct: 89 GGDLASVITKGTKERQY---LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145
Query: 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 509
LD N K+ DFGLAR D + VGT YM+PE + ++ KSD++S G L
Sbjct: 146 FLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 203
Query: 510 LLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569
L E+ + F K +G + E L E+I
Sbjct: 204 LYELCALM--PPFTAFSQK-----ELAGKIREGKFRRIPYRYSDE---LNEIITR----- 248
Query: 570 LCVQQHPDDRPCMPSVI 586
+ RP + ++
Sbjct: 249 -MLNLKDYHRPSVEEIL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-31
Identities = 50/210 (23%), Positives = 69/210 (32%), Gaps = 30/210 (14%)
Query: 387 SFPDGGQDLYIRMS-------ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439
+ LYI L +L + + YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
+HRDL A NVL+ +D K+SDFGL + E + APE + +FS
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 500 KSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLT 559
KSDV+SFGILL EI S + + + K KG + D C
Sbjct: 180 KSDVWSFGILLWEIYSFGR-VPYPRIPLK-----DVVPRVEKGYKMDAPDGCPPA----- 228
Query: 560 EVIRCIHISLLCVQQHPDDRPCMPSVILML 589
+ C RP + L
Sbjct: 229 ----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 49/185 (26%), Positives = 74/185 (40%), Gaps = 21/185 (11%)
Query: 405 DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGL 464
L + RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 465 ARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524
+R G E T +MA E + ++ SDV+S+G+LL EIVS Y
Sbjct: 174 SR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYC 228
Query: 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584
L + +G E C E + C ++ P +RP
Sbjct: 229 GMTCAELY----EKLPQGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQ 275
Query: 585 VILML 589
+++ L
Sbjct: 276 ILVSL 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 382 LIDMRSFPDGGQDLYIRMSASEL-DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440
L+ M G Y+R + + SK ++ G+ YL+ + + +
Sbjct: 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFV 155
Query: 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVK 500
HRDL A N ++ +D KI DFG+ R + + + +M+PE DG F+
Sbjct: 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 215
Query: 501 SDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTE 560
SDV+SFG++L EI + + + + L N+ + +G + D C
Sbjct: 216 SDVWSFGVVLWEIATLAE-QPYQGLSNE-----QVLRFVMEGGLLDKPDNCPDM------ 263
Query: 561 VIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVLPQPKQPGF 603
+ +C Q +P RP +I + E + P ++ F
Sbjct: 264 ---LFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGFREVSF 302
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-30
Identities = 40/180 (22%), Positives = 62/180 (34%), Gaps = 24/180 (13%)
Query: 407 ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLAR 466
++ D + I L Y H R+IHRD+K N+LL KI+DFG +
Sbjct: 98 QKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 154
Query: 467 TFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526
T + GT Y+ PE K D++S G+L E + GK
Sbjct: 155 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
Query: 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586
I + + D +I ++ +P RP + V+
Sbjct: 211 ETYKRISRVEFTFPDFVTEGARD-----------LISR------LLKHNPSQRPMLREVL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-30
Identities = 40/190 (21%), Positives = 70/190 (36%), Gaps = 19/190 (10%)
Query: 400 SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKI 459
+E + + + YL + +HRDL A N L++ K+
Sbjct: 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 141
Query: 460 SDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 519
SDFGL+R DE ++ + PE +FS KSD+++FG+L+ EI S K
Sbjct: 142 SDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK- 199
Query: 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDR 579
++ + +E I + + I C + D+R
Sbjct: 200 --------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 245
Query: 580 PCMPSVILML 589
P ++ +
Sbjct: 246 PTFKILLSNI 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 6e-30
Identities = 54/190 (28%), Positives = 79/190 (41%), Gaps = 27/190 (14%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
Y SAS+L + K L + + G +GL YLH +IHRD+KAGN+LL +
Sbjct: 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPG 152
Query: 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLE 512
K+ DFG A VGT +MAPE +GQ+ K DV+S GI +E
Sbjct: 153 LVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 513 IVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCV 572
+ K +N + + + P+ + N + C+
Sbjct: 207 LAERK------PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD---------SCL 251
Query: 573 QQHPDDRPCM 582
Q+ P DRP
Sbjct: 252 QKIPQDRPTS 261
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 30/202 (14%)
Query: 392 GQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445
+L+I + + + E + L S+ + T L YLH +IIHRDLK
Sbjct: 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLK 137
Query: 446 AGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA-----SDGQFSVK 500
AGN+L D + K++DFG++ +GT +MAPE D + K
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 501 SDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTE 560
+DV+S GI L+E+ + + L I K P + P S N +
Sbjct: 196 ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------KSEPPTLAQPSRW-SSNFKD 247
Query: 561 VIRCIHISLLCVQQHPDDRPCM 582
++ C++++ D R
Sbjct: 248 FLKK------CLEKNVDARWTT 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 45/197 (22%), Positives = 73/197 (37%), Gaps = 18/197 (9%)
Query: 394 DLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453
+L S + ++ R G+ YL R IHRDL A N+LL
Sbjct: 90 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLAT 146
Query: 454 DMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 512
KI DFGL R ++ + + APE FS SD + FG+ L E
Sbjct: 147 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 206
Query: 513 IVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCV 572
+ + + + N ++ K+ +G + C Q+ ++ + C
Sbjct: 207 MFTYGQE--PWIGLNGSQIL---HKIDKEGERLPRPEDCPQD---------IYNVMVQCW 252
Query: 573 QQHPDDRPCMPSVILML 589
P+DRP ++ L
Sbjct: 253 AHKPEDRPTFVALRDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-28
Identities = 45/189 (23%), Positives = 71/189 (37%), Gaps = 23/189 (12%)
Query: 403 ELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDF 462
Q R LD + L YL R +HRD+ A NVL+ + K+ DF
Sbjct: 96 SFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDF 152
Query: 463 GLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI-VSGKKNRG 521
GL+R + D T ++ +MAPE + +F+ SDV+ FG+ + EI + G K
Sbjct: 153 GLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211
Query: 522 FYHLDNKLNLIGHAWKL-WNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
++ + I + +L P + + C P RP
Sbjct: 212 GVKNNDVIGRIENGERLPMPPNCPPTLYS-----------------LMTKCWAYDPSRRP 254
Query: 581 CMPSVILML 589
+ L
Sbjct: 255 RFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 18/178 (10%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
L RG+ YL + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 472 ETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531
+ TT +MAPE D ++ +SDV+SFG+LL EI + + + +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-SPYPGVPVE--- 244
Query: 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILML 589
+KL +G + C E + C P RP ++ L
Sbjct: 245 --ELFKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 44/195 (22%), Positives = 83/195 (42%), Gaps = 23/195 (11%)
Query: 392 GQDLYIRM----SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447
G +L++ M S D +D + + + L +LH ++IHRD+K+
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSD 145
Query: 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFG 507
N+LL D + K++DFG +++ + +VGT +MAPE + + K D++S G
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 508 ILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHI 567
I+ +E++ G+ Y +N L + + + G P S + +
Sbjct: 204 IMAIEMIEGEP---PYLNENPLRAL---YLIATNGTPELQNPEKL--SAIFRDFLNR--- 252
Query: 568 SLLCVQQHPDDRPCM 582
C+ + R
Sbjct: 253 ---CLDMDVEKRGSA 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 103 bits (258), Expect = 4e-25
Identities = 24/204 (11%), Positives = 59/204 (28%), Gaps = 22/204 (10%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
+ S +L + + +H+ +++RD+K N L+ +
Sbjct: 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPN 138
Query: 456 NP-----KISDFGLARTFGGDETEGN-----TTRVVGTYGYMAPEYASDGQFSVKSDVFS 505
+ + DFG+ + + T+ + + GT YM+ + S + D+ +
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 198
Query: 506 FGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCI 565
G + + + G + E+ +E + +
Sbjct: 199 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE---FYKYMHY- 254
Query: 566 HISLLCVQQHPDDRPCMPSVILML 589
D P + +
Sbjct: 255 -----ARNLAFDATPDYDYLQGLF 273
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 6e-24
Identities = 33/202 (16%), Positives = 56/202 (27%), Gaps = 20/202 (9%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL---LD 452
+ S +L + + + Y+H IHRD+K N L
Sbjct: 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGK 140
Query: 453 QDMNPKISDFGLARTFGGDETEGN-----TTRVVGTYGYMAPEYASDGQFSVKSDVFSFG 507
+ I DFGLA+ + T + + GT Y + + S + D+ S G
Sbjct: 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 200
Query: 508 ILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHI 567
+L+ G K + + E
Sbjct: 201 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN------- 253
Query: 568 SLLCVQQHPDDRPCMPSVILML 589
C DD+P + +
Sbjct: 254 --FCRSLRFDDKPDYSYLRQLF 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-24
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 3/110 (2%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467
+ D + L YLH IIHRDLK N+LL++DM+ +I+DFG A+
Sbjct: 101 KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157
Query: 468 FGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+ + VGT Y++PE ++ SD+++ G ++ ++V+G
Sbjct: 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 7e-24
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 404 LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFG 463
LD+ + ++ RGL +LH R++HRDLK N+L+ K++DFG
Sbjct: 105 LDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161
Query: 464 LARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK----KN 519
LAR + + T VV T Y APE ++ D++S G + E+ K +
Sbjct: 162 LARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218
Query: 520 RGFYHLDNKLNLIGHAWKL-WNKGMPSEMIDPCYQESCNLTEVIRCIH---ISLL--CVQ 573
L L++IG + W + + + + + + + I LL C+
Sbjct: 219 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 278
Query: 574 QHPDDRP 580
+P R
Sbjct: 279 FNPAKRI 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 95.5 bits (237), Expect = 6e-22
Identities = 36/207 (17%), Positives = 72/207 (34%), Gaps = 27/207 (13%)
Query: 382 LIDMRSFPDGGQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDS 435
L+++ + ++ + E + + + + +GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 436 RLRIIHRDLKAGNVLLDQDMNP--KISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS 493
+H DLK N++ + K+ DFGL ++ GT + APE A
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAE 198
Query: 494 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQ 553
+D++S G+L ++SG G + D L + K + M +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----KSCDWNMDDSAFSGISE 254
Query: 554 ESCNLTEVIRCIHISLLCVQQHPDDRP 580
+ + IR + P+ R
Sbjct: 255 DGKDF---IRK------LLLADPNTRM 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 94.0 bits (233), Expect = 6e-22
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 27/190 (14%)
Query: 399 MSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN 456
M EL L + +I+ + LH +L I+HRDLK N+LLD DMN
Sbjct: 92 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN 148
Query: 457 PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ------FSVKSDVFSFGILL 510
K++DFG + E V GT Y+APE + + D++S G+++
Sbjct: 149 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 205
Query: 511 LEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLL 570
+++G F+H L L N S D +L +
Sbjct: 206 YTLLAGS--PPFWHRKQMLML--RMIMSGNYQFGSPEWDDYSDTVKDL---VSR------ 252
Query: 571 CVQQHPDDRP 580
+ P R
Sbjct: 253 FLVVQPQKRY 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 7e-22
Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 382 LIDMRSFPDGGQDLYIRM---SASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436
L M ++L+ M + +L + C D S+ GL +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---S 121
Query: 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ 496
I++RDLK N+LLD+D + KI+DFG+ + + + NT GT Y+APE +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 179
Query: 497 FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LNLIGHAWKLWNKGMPSEMIDPCYQE 554
++ D +SFG+LL E++ G+ F+ D + + I + + + E D
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD----- 232
Query: 555 SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587
++ + P+ R + I
Sbjct: 233 ------LLVK------LFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 92.9 bits (230), Expect = 1e-21
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 22/197 (11%)
Query: 390 DGGQDLYIRM---SASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDL 444
G YI M L + + +I + L + H + IIHRD+
Sbjct: 81 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDV 137
Query: 445 KAGNVLLDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDV 503
K N+++ K+ DFG+AR T V+GT Y++PE A +SDV
Sbjct: 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 197
Query: 504 FSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIR 563
+S G +L E+++G+ + D+ +++ + +P S +L V+
Sbjct: 198 YSLGCVLYEVLTGEP---PFTGDSPVSVA--YQHVREDPIPPSARHEGL--SADLDAVVL 250
Query: 564 CIHISLLCVQQHPDDRP 580
+ ++P++R
Sbjct: 251 K------ALAKNPENRY 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 93.2 bits (231), Expect = 4e-21
Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 27/197 (13%)
Query: 392 GQDLYIRM------SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLK 445
++ + + + + ++ + GL ++H I+H D+K
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIK 154
Query: 446 AGNVLLDQDMNP--KISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDV 503
N++ + KI DFGLA DE T + APE +D+
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDM 211
Query: 504 FSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIR 563
++ G+L ++SG F D+ L K + + E+ + I+
Sbjct: 212 WAIGVLGYVLLSGL--SPFAGEDDLETL--QNVKRCDWEFDEDAFSSVSPEAKDF---IK 264
Query: 564 CIHISLLCVQQHPDDRP 580
+Q+ P R
Sbjct: 265 N------LLQKEPRKRL 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (227), Expect = 7e-21
Identities = 40/247 (16%), Positives = 79/247 (31%), Gaps = 35/247 (14%)
Query: 392 GQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451
G D++ R+ L+ + + L +LH I H D++ N++
Sbjct: 85 GLDIFERI------NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIY 135
Query: 452 DQDMNP--KISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 509
+ KI +FG AR + N + Y APE S +D++S G L
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 510 LLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISL 569
+ ++SG + I +A +++ E+ S + +
Sbjct: 193 VYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI-------SIEAMDFVDR----- 240
Query: 570 LCVQQHPDDRPCMPSVI--------LMLGSEIVLPQPKQPGFLADRKSIGPDSLLSIPES 621
+ + R + + S V+ K + + ++S
Sbjct: 241 -LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARI 299
Query: 622 SSSNSIT 628
S +I
Sbjct: 300 SCGGAIR 306
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.5 bits (224), Expect = 1e-20
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 14/154 (9%)
Query: 428 LLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYM 487
L L II+RDLK N+LLD++ + KI+DFG A+ T + GT Y+
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYI 168
Query: 488 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK--LNLIGHAWKLWNKGMPS 545
APE S ++ D +SFGIL+ E+++G FY + I +A +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNE 226
Query: 546 EMIDPCYQESC---NLTEVIRCIHISLLCVQQHP 576
++ D +L++ + + V+ HP
Sbjct: 227 DVKDLL--SRLITRDLSQRLGNLQNGTEDVKNHP 258
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 3e-20
Identities = 47/219 (21%), Positives = 84/219 (38%), Gaps = 24/219 (10%)
Query: 381 DLIDMRSFPDGGQDLYI------RMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQD 434
+++ + LY+ + +D + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 435 SRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE-YAS 493
R++HRDLK N+L++ + K++DFGLAR FG T V T Y APE
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 494 DGQFSVKSDVFSFGILLLEIVSGKK----NRGFYHLDNKLNLIGHAWKLWNKG---MPSE 546
+S D++S G + E+V+ + + L +G ++ G MP
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 547 MIDPCYQESCNLTEVIRCIH---ISLL--CVQQHPDDRP 580
+ ++V+ + SLL + P+ R
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 5e-20
Identities = 54/203 (26%), Positives = 79/203 (38%), Gaps = 29/203 (14%)
Query: 399 MSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPK 458
M A + + L + RGL Y+H ++HRDLK N+LL+ + K
Sbjct: 93 MGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 149
Query: 459 ISDFGLARTFGGDETEGNT-TRVVGTYGYMAPEYASDGQFSVKS-DVFSFGILLLEIVSG 516
I DFGLAR D T V T Y APE + + KS D++S G +L E++S
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 517 KKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIH---------- 566
+ H ++LN I L G PS+ C ++ H
Sbjct: 210 RPIFPGKHYLDQLNHI-----LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264
Query: 567 -------ISLL--CVQQHPDDRP 580
+ LL + +P R
Sbjct: 265 PNADSKALDLLDKMLTFNPHKRI 287
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 1e-19
Identities = 43/215 (20%), Positives = 73/215 (33%), Gaps = 39/215 (18%)
Query: 374 GCAMWFGDLIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQ 433
+ + P+ QDL+ ++ L + + H
Sbjct: 76 DWFERPDSFVLILERPEPVQDLFDFIT-------ERGALQEELARSFFWQVLEAVRHCHN 128
Query: 434 DSRLRIIHRDLKAGNVLLDQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYA 492
++HRD+K N+L+D + K+ DFG + T GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 493 SDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPC 551
++ + V+S GILL ++V G F H + I + + + SE
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEE----IIRGQVFFRQRVSSECQH-- 233
Query: 552 YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586
+IR C+ P DRP +
Sbjct: 234 ---------LIRW------CLALRPSDRPTFEEIQ 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 2e-19
Identities = 38/205 (18%), Positives = 72/205 (35%), Gaps = 25/205 (12%)
Query: 386 RSFPDGGQDLYIRMS-------ASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLR 438
+ G + L I M S + + + I+ G + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 131
Query: 439 IIHRDLKAGNVLLDQDMNP---KISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG 495
I HRD+K N+L K++DFG A+ + T Y+APE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPE 188
Query: 496 QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQES 555
++ D++S G+++ ++ G ++ ++ L + G + S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 556 CNLTEVIRCIHISLLCVQQHPDDRP 580
+ +IR ++ P R
Sbjct: 246 EEVKMLIRN------LLKTEPTQRM 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.9 bits (217), Expect = 2e-19
Identities = 41/185 (22%), Positives = 75/185 (40%), Gaps = 24/185 (12%)
Query: 399 MSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMN 456
M+ +L + + + GL ++H +++RDLK N+LLD+ +
Sbjct: 89 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGH 145
Query: 457 PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVS 515
+ISD GLA F + VGT+GYMAPE G + +D FS G +L +++
Sbjct: 146 VRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201
Query: 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQH 575
G + +K + + + ++ S L ++ +Q+
Sbjct: 202 GHSPFRQHKTKDKHEID--------RMTLTMAVELPDSFSPELRSLLEG------LLQRD 247
Query: 576 PDDRP 580
+ R
Sbjct: 248 VNRRL 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 1e-18
Identities = 41/203 (20%), Positives = 73/203 (35%), Gaps = 21/203 (10%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
+ + L S+ R++ L L+ R +I+HRD+KA NVL+ +D
Sbjct: 98 FCEHDLAGLLSNVLVKFTLSEIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDG 154
Query: 456 NPKISDFGLARTFGGDETEGNT--TRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLE 512
K++DFGLAR F + T V T Y PE + + D++ G ++ E
Sbjct: 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214
Query: 513 IVSGKK----NRGFYHLDNKLNLIG----HAWKLWNKGMPSEMIDPCYQESCNLTEVIRC 564
+ + N + L L G W + E ++ + + + ++
Sbjct: 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 274
Query: 565 IHISLL-------CVQQHPDDRP 580
+ P R
Sbjct: 275 YVRDPYALDLIDKLLVLDPAQRI 297
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 1e-18
Identities = 34/170 (20%), Positives = 62/170 (36%), Gaps = 4/170 (2%)
Query: 382 LIDMRSFPDGGQDLYIRMSASELDQERCKLLDWSKRF--RIICGTGRGLLYLHQDSRLRI 439
L ++ L M + + L R + L +
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 440 IHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSV 499
++RD+K N++LD+D + KI+DFGL + D GT Y+APE D +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 500 KSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMID 549
D + G+++ E++ G+ + LI + + + E
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 2e-18
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 23/200 (11%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
++ + ++ +L S + T +GL YLHQ I+HRDLK N+LLD++
Sbjct: 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENG 137
Query: 456 NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIV 514
K++DFGLA++FG T V T Y APE + + V D+++ G +L E++
Sbjct: 138 VLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 195
Query: 515 SGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLL---- 570
F D+ L+ + ++ + D C + I + +
Sbjct: 196 LR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 252
Query: 571 ----------CVQQHPDDRP 580
+P R
Sbjct: 253 GDDLLDLIQGLFLFNPCARI 272
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 79.2 bits (195), Expect = 2e-18
Identities = 22/127 (17%), Positives = 50/127 (39%), Gaps = 20/127 (15%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
+++T+ + L G S ++ + ++ + ++ + T VW +N L
Sbjct: 2 NLLTNGEGLYAG-------QSLDVEPYHFIMQEDCNLVLYDHS----TSVWASNTGILGK 50
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETY 143
++ GN V+ +W+++ + VL L + GN+V+ G +
Sbjct: 51 KGCK-AVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQEDGNVVIYG-------SD 101
Query: 144 FWQSFDY 150
W + Y
Sbjct: 102 IWSTGTY 108
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.2 bits (205), Expect = 4e-18
Identities = 48/197 (24%), Positives = 75/197 (38%), Gaps = 27/197 (13%)
Query: 392 GQDLYI---RMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446
G LY+ +S EL R+I + YLH I+HRDLK
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKP 135
Query: 447 GNVLL---DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDV 503
N+L D+D ISDFGL++ + GT GY+APE + +S D
Sbjct: 136 ENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDC 192
Query: 504 FSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIR 563
+S G++ ++ G ++ +N L S D S + + IR
Sbjct: 193 WSIGVIAYILLCGYP---PFYDENDAKLF-EQILKAEYEFDSPYWDDI---SDSAKDFIR 245
Query: 564 CIHISLLCVQQHPDDRP 580
+++ P+ R
Sbjct: 246 H------LMEKDPEKRF 256
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 1e-17
Identities = 35/182 (19%), Positives = 71/182 (39%), Gaps = 18/182 (9%)
Query: 414 WSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDET 473
+ + L L ++HRDLK N+L++++ K+++FGLAR FG
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156
Query: 474 EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIG 533
+ VV + +S D++S G + E+ + R + ++ + +
Sbjct: 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLK 213
Query: 534 HAWKLWNK----------GMPSEMIDPCYQESCNLTEVIRCIH---ISLL--CVQQHPDD 578
++L +P P Y + +L V+ ++ LL ++ +P
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 579 RP 580
R
Sbjct: 274 RI 275
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 82.2 bits (202), Expect = 2e-17
Identities = 36/170 (21%), Positives = 64/170 (37%), Gaps = 9/170 (5%)
Query: 408 RCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLART 467
R YLH L +I+RDLK N+L+DQ +++DFG A+
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK- 189
Query: 468 FGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527
+G T + GT +APE ++ D ++ G+L+ E+ +G
Sbjct: 190 ----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 528 KLNLIGHAWKLWNKGMPSEMIDPCYQE-SCNLTEVIRCIHISLLCVQQHP 576
I + S++ D +LT+ + + ++ H
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 2e-17
Identities = 40/187 (21%), Positives = 70/187 (37%), Gaps = 18/187 (9%)
Query: 407 ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD-MNPKISDFGLA 465
+ L + R L Y+H I HRD+K N+LLD D K+ DFG A
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 466 RTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK----NRG 521
+ E N + + Y ++ DV+S G +L E++ G+ + G
Sbjct: 171 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228
Query: 522 FYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQE--SCNLTEVIR------CIHISLLCVQ 573
L + ++G + + M + + + + T+V R I + ++
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288
Query: 574 QHPDDRP 580
P R
Sbjct: 289 YTPTARL 295
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 2e-17
Identities = 35/189 (18%), Positives = 62/189 (32%), Gaps = 23/189 (12%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
+ + L + + L ++ L+I H DLK N++L
Sbjct: 94 LVAGGELFDFLAEKESLTEEEATEFLKQI---LNGVYYLHSLQIAHFDLKPENIMLLDRN 150
Query: 456 NP----KISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLL 511
P KI DFGLA + GT ++APE + +++D++S G++
Sbjct: 151 VPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 512 EIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLC 571
++SG L + N E + + IR
Sbjct: 208 ILLSGASPFLGDTKQETLANVSA----VNYEFEDEYFSNTSALAKDF---IRR------L 254
Query: 572 VQQHPDDRP 580
+ + P R
Sbjct: 255 LVKDPKKRM 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 78.0 bits (191), Expect = 2e-16
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 18/184 (9%)
Query: 412 LDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGD 471
L+ + G+ Y H R++HRDLK N+L++++ KI+DFGLAR FG
Sbjct: 97 LESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153
Query: 472 ETEGNTTRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHLDNKL 529
+ + T Y AP+ ++S D++S G + E+V+G G D +
Sbjct: 154 VRKYTHE--IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211
Query: 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIH---------ISLL--CVQQHPDD 578
+ +K P+ P Y + + E + I LL ++ P+
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
Query: 579 RPCM 582
R
Sbjct: 272 RITA 275
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-14
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 30/220 (13%)
Query: 381 DLIDMRSFPDGGQDLYIRM---SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRL 437
D+ D D Y+ M + + L + ++ +GL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPE-YASDGQ 496
IIHRDLK GN+ +++D KI DFGLAR + + T V T Y APE + +
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 497 FSVKSDVFSFGILLLEIVSGK----------------KNRGFYHLDNKLNLIGHAWKLWN 540
++ D++S G ++ E+++GK K G + L K +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 541 KGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
KG+P N + + +++ + + R
Sbjct: 256 KGLPELEKKDFASILTNASPL--AVNLLEKMLVLDAEQRV 293
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (177), Expect = 3e-14
Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 381 DLIDMRSFPDGGQDLYIRMSASELD--QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLR 438
++ + + QD+Y+ M + + Q LD + ++ G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---G 139
Query: 439 IIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFS 498
IIHRDLK N+++ D KI DFGLART G T V T Y APE +
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYK 196
Query: 499 VKSDVFSFGILLLEIVSGK 517
D++S G ++ E+V K
Sbjct: 197 ENVDIWSVGCIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 3e-14
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 419 RIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTT 478
+ G +L L +L II+RD+K N+LLD + + ++DFGL++ F DETE
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAY 188
Query: 479 RVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAW 536
GT YMAP+ G D +S G+L+ E+++G F K +
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQ----A 242
Query: 537 KLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP 580
++ + + SE P + S ++I+ + + P R
Sbjct: 243 EISRRILKSEPPYPQ-EMSALAKDLIQR------LLMKDPKKRL 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.3 bits (168), Expect = 3e-13
Identities = 26/115 (22%), Positives = 50/115 (43%), Gaps = 3/115 (2%)
Query: 404 LDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ-DMNPKISDF 462
+ + + + +I GL Y+H+ R IIH D+K NVL++ D +
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 463 GLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 517
+A + + T + T Y +PE + +D++S L+ E+++G
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 68.3 bits (166), Expect = 5e-13
Identities = 38/172 (22%), Positives = 73/172 (42%), Gaps = 13/172 (7%)
Query: 382 LIDMRSFPDGGQDLYI--RMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRI 439
L D+ P + ++ ++ Q L D+ RF + + L Y H + I
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-YMYEILKALDYCHS---MGI 150
Query: 440 IHRDLKAGNVLLD-QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-F 497
+HRD+K NV++D + ++ D+GLA + + V + + PE D Q +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMY 207
Query: 498 SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMID 549
D++S G +L ++ K+ F+H + + + K+ + ID
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 61.2 bits (148), Expect = 3e-12
Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 21/127 (16%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
+I+ S +TL+ G L GSF + + ++ + P+ W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYDVDKPI----WATNTGG--L 48
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETY 143
S FL + GNLV+ + SN +W++ + V L N+V+ G T
Sbjct: 49 SRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYV-CILQKDRNVVIYG-------TD 100
Query: 144 FWQSFDY 150
W + +
Sbjct: 101 RWATGTH 107
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 61.4 bits (148), Expect = 3e-12
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 19/130 (14%)
Query: 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIN 83
D + S L+ G +L G + + + + Y N VW + +
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYDN---NRAVWASGTNGKAS 50
Query: 84 DSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETY 143
L + GNLV+ S S + S + L L N+V+ +S
Sbjct: 51 GC--VLKMQNDGNLVIYSGSRAIWASNTNRQ--NGNYYLILQRDRNVVIY----DNSNNA 102
Query: 144 FWQSFDYPSD 153
W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 59.9 bits (145), Expect = 1e-11
Identities = 15/97 (15%), Positives = 27/97 (27%), Gaps = 8/97 (8%)
Query: 62 IWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVV 121
I Y + + S L + NLVL + + V + K T
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK--GTGCR 69
Query: 122 LQLLDSGNLVLRGEQDGDSETYFWQSFD--YPSDTLL 156
L +G + + + W S + +
Sbjct: 70 AVLQPNGRMDVL---TNQNIAV-WTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 41.8 bits (98), Expect = 2e-05
Identities = 19/110 (17%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 25 IITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLIND 84
+ ++ N +TL S +L + + + ++ ++ VW N
Sbjct: 13 LYSTQGNDNHPQTL-HATQSLQLSPYRLSMETDCNLVLFDRDD----RVWSTNTAG--KG 65
Query: 85 SSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRG 134
+ ++ G + + + NI VW++ S+ V L NL + G
Sbjct: 66 TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRYVFVLQPDRNLAIYG 114
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.6 bits (151), Expect = 4e-11
Identities = 48/217 (22%), Positives = 80/217 (36%), Gaps = 24/217 (11%)
Query: 381 DLIDMRSFPDGGQDLYIRM---SASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRL 437
D+ + D+Y+ A + +C+ L +I RGL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 438 RIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF 497
IIHRDLK N+ +++D KI DFGLAR + T V + + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 196
Query: 498 SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLIGHA--------WKLWNKGMPSEMID 549
+ D++S G ++ E+++G+ ++L LI K + I
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 550 PCYQ-ESCNLTEVIRCIH---ISLL--CVQQHPDDRP 580
Q N V + + LL + D R
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.7 bits (126), Expect = 3e-09
Identities = 23/137 (16%), Positives = 47/137 (34%), Gaps = 23/137 (16%)
Query: 14 FFLSEFSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVV 73
F P I+ ++++L ++ + + + + Y N +
Sbjct: 5 FSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCNL------VLYDN---NNPI 51
Query: 74 WVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLR 133
W N L N ++ G LV+ + N+ VW + ++ + V L L N+V+
Sbjct: 52 WATNTGGLGNGC--RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYV-LVLQPDRNVVIY 108
Query: 134 GEQDGDSETYFWQSFDY 150
G W +
Sbjct: 109 G-------DALWATQTV 118
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.1 bits (124), Expect = 2e-08
Identities = 19/118 (16%), Positives = 38/118 (32%), Gaps = 13/118 (11%)
Query: 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDM 455
+ M + + ++ ++ + + I+H DL NVL+ +
Sbjct: 86 AVLMELIDAKELYRVRVENPDE--VLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EE 139
Query: 456 NPKISDFGLARTFGGDETEGNTTR-VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 512
I DF + G + R V Y + Y + D+ S +L+
Sbjct: 140 GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------RTEKDINSAIDRILQ 191
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.9 bits (119), Expect = 3e-08
Identities = 18/87 (20%), Positives = 29/87 (33%), Gaps = 7/87 (8%)
Query: 62 IWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVV 121
I + + + + SS + NLVL S++ VW++ + T
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG--ATGCR 59
Query: 122 LQLLDSGNLVLRGEQDGDSETYFWQSF 148
L G LV+ T W S
Sbjct: 60 AVLQSDGLLVIL----TAQNTIRWSSG 82
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 42.6 bits (100), Expect = 1e-05
Identities = 21/116 (18%), Positives = 43/116 (37%), Gaps = 16/116 (13%)
Query: 19 FSFAPDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANR 78
F + + + QTL+ ++L + SF S + + ++ ++ V
Sbjct: 5 FGLSHEG-SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDSDVRV-------WA 49
Query: 79 LNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRG 134
N + ++ G LV+ + N + WS +K VL L + + G
Sbjct: 50 SNTAGATGCRAVLQSDGLLVILTAQNTIRWS-SGTKGSIGNYVLVLQPDRTVTIYG 104
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 635 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.94 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.92 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.92 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.92 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.92 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.9 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.85 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.84 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.84 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.71 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.64 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.61 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.46 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.24 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.18 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.11 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.1 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.94 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.83 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 87.98 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.53 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 82.84 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.29 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.9 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-35 Score=295.65 Aligned_cols=203 Identities=25% Similarity=0.354 Sum_probs=150.5
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+||+.+..++.. ..+|+++|+++.. ......+++.+++.++.||++||+|||+++ ||||||||+||
T Consensus 60 ~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~Ni 135 (276)
T d1uwha_ 60 KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNI 135 (276)
T ss_dssp TCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred hCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHE
Confidence 3479999999988754 4689999998742 123456899999999999999999999998 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC---CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|++.++.+||+|||+++...............||+.|+|||.+.. .+++.++|||||||++|||++|+.||......
T Consensus 136 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~ 215 (276)
T d1uwha_ 136 FLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215 (276)
T ss_dssp EEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred EEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH
Confidence 999999999999999987654433333445679999999999864 45899999999999999999999998643211
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.........+....... ..+...+..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 216 ------~~~~~~~~~~~~~p~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 216 ------DQIIFMVGRGYLSPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ------HHHHHHHHHTSCCCCGG-----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCcch-----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11222222222211111 111122345778999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.6e-34 Score=296.07 Aligned_cols=195 Identities=26% Similarity=0.376 Sum_probs=154.8
Q ss_pred eccccccccccCCCCccEEEEecccchhh------h----------------------hccccCcccchhhhhhhccccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ------E----------------------RCKLLDWSKRFRIICGTGRGLL 429 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~----------------------~~~~l~~~~~~~i~~~ia~aL~ 429 (635)
.|+|||.+++++.....+|++||+++... . ....+++.+++.++.||++||+
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 69999999999998999999999987421 0 1235889999999999999999
Q ss_pred hhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehh
Q 046703 430 YLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 509 (635)
Q Consensus 430 yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvv 509 (635)
|||+++ ||||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||+
T Consensus 179 yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 179 FLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255 (325)
T ss_dssp HHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHH
Confidence 999999 99999999999999999999999999987655443333344678999999999999999999999999999
Q ss_pred hHhhhh-CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 510 LLEIVS-GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 510 l~eilt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
+|||++ |+.||........ .......+..... +......+.+|+.+||+.||++||||+||+++
T Consensus 256 l~emlt~g~~Pf~~~~~~~~------~~~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHTTTSCCSSTTCCCSHH------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHH------HHHHHhcCCCCCC---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999997 8999865432211 1222223322211 11223457789999999999999999999999
Q ss_pred Hc
Q 046703 589 LG 590 (635)
Q Consensus 589 L~ 590 (635)
|+
T Consensus 321 L~ 322 (325)
T d1rjba_ 321 LG 322 (325)
T ss_dssp HH
T ss_pred Hh
Confidence 85
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=3.6e-34 Score=294.49 Aligned_cols=199 Identities=21% Similarity=0.294 Sum_probs=147.6
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|||||.+.+++..+..+|++||+++.. ......+++.+++.++.||++||.|||+++ |+||||||+||
T Consensus 83 ~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NI 159 (299)
T d1jpaa_ 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNI 159 (299)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred hCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceE
Confidence 347999999999998889999999998742 223457899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCc---eeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGN---TTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHL 525 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~ 525 (635)
|++.++.+||+|||+++.......... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999987654332211 122457889999999999999999999999999999998 8999864321
Q ss_pred CCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 526 DNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
. . ....+..+.... .+...+..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 240 ~---~----~~~~i~~~~~~~---------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 240 Q---D----VINAIEQDYRLP---------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp H---H----HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred H---H----HHHHHHcCCCCC---------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 1 222222332211 11223345778999999999999999999999998653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.2e-34 Score=286.90 Aligned_cols=197 Identities=23% Similarity=0.298 Sum_probs=145.4
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+||+.+.+++.....+|+++|+++.. ......++++.++.++.||++||.|||+.+ |+||||||+||
T Consensus 56 ~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Ni 132 (263)
T d1sm2a_ 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNC 132 (263)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGE
T ss_pred hcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhhe
Confidence 457999999999998888999999998742 234466889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCC-CCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN-RGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~p-f~~~~~~~~ 528 (635)
|++.++.+||+|||+++......... .....||..|+|||.+.+..++.++|||||||++|||+++..| +.... .
T Consensus 133 ll~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~ 208 (263)
T d1sm2a_ 133 LVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---N 208 (263)
T ss_dssp EECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---H
T ss_pred eecCCCCeEecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---H
Confidence 99999999999999998765433222 2235789999999999999999999999999999999996554 43211 1
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
. .....+..+...... ......+.+++.+||+.||++||||+||++.|+.+
T Consensus 209 ~----~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 209 S----EVVEDISTGFRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp H----HHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHHHHhcCCCCCc---------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 122222333222111 11224577899999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-33 Score=288.56 Aligned_cols=201 Identities=23% Similarity=0.321 Sum_probs=151.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+++++.....+|++++++... ....+.+++.+++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 66 l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NIL 142 (283)
T d1mqba_ 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNIL 142 (283)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred cCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEE
Confidence 47999999999998889999999998642 234467999999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||++|..|+..... .
T Consensus 143 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~- 219 (283)
T d1mqba_ 143 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--N- 219 (283)
T ss_dssp ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--H-
T ss_pred ECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--H-
Confidence 9999999999999998765432221 22235678999999999999999999999999999999997666532211 1
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIVL 595 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 595 (635)
......+.++..... +...+..+.+|+.+||+.||++||||.||+++|+.+...
T Consensus 220 ---~~~~~~i~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 220 ---HEVMKAINDGFRLPT---------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---HHHHHHHHTTCCCCC---------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHHHHhccCCCCC---------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 122233334332222 112334678899999999999999999999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-33 Score=284.25 Aligned_cols=194 Identities=24% Similarity=0.283 Sum_probs=150.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||||+.++.+......+|++||+++.. ..+.+.+++.++..++.||++||.|||+++ |+||||||+|||+
T Consensus 60 l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl 136 (271)
T d1nvra_ 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLL 136 (271)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEE
Confidence 46999999999998889999999998742 133557899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++...............||+.|+|||.+.+..+ +.++||||+||++|||++|+.||........
T Consensus 137 ~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-- 214 (271)
T d1nvra_ 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-- 214 (271)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--
T ss_pred CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--
Confidence 9999999999999998754433333344689999999999988876 6889999999999999999999965432211
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ............. ......+.+++.+||+.||++|||++||++
T Consensus 215 ~~----~~~~~~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 215 EY----SDWKEKKTYLNPW--------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HH----HHHHTTCTTSTTG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HH----HHHhcCCCCCCcc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1111111111000 111234667899999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-33 Score=284.06 Aligned_cols=196 Identities=26% Similarity=0.370 Sum_probs=151.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|+||+.+..++.. ..+|+++++++.. ......+++.+++.++.||++||.|||+++ |+||||||+|
T Consensus 64 ~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~N 139 (272)
T d1qpca_ 64 QLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAAN 139 (272)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred hCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhh
Confidence 4579999999988754 4679999998742 223346899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
||+++++.+||+|||+++......... .....|++.|+|||.+....++.++|||||||++|||++|..|+.... ..
T Consensus 140 Ill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~ 216 (272)
T d1qpca_ 140 ILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TN 216 (272)
T ss_dssp EEECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CH
T ss_pred eeeecccceeeccccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CH
Confidence 999999999999999999875433222 223568899999999999999999999999999999999766643221 11
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
......+..+......+ ..+..+.+|+.+||+.||++||||+||+++|+.
T Consensus 217 ----~~~~~~i~~~~~~~~p~---------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 217 ----PEVIQNLERGYRMVRPD---------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----HHHHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCCCCcc---------cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11222333333222211 122357789999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.6e-33 Score=286.27 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=157.1
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|+||+.+.+++..+..+|+++|+++.. ......+++..++.++.||++||.|||+++ |+||||||+|
T Consensus 69 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~N 145 (287)
T d1opja_ 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARN 145 (287)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred hCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCe
Confidence 347999999999998889999999998742 223457899999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
||++.++.+||+|||+++........ ......|+..|+|||.+.+..++.++|||||||++|||++|..|+.... .
T Consensus 146 ILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~- 221 (287)
T d1opja_ 146 CLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--D- 221 (287)
T ss_dssp EEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--C-
T ss_pred EEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--h-
Confidence 99999999999999999876543222 1223568899999999999999999999999999999999877753221 1
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.....+.+..+...+.. ...+..+.+|+..||+.||++||||+||++.|+...
T Consensus 222 ---~~~~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 222 ---LSQVYELLEKDYRMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---HHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HHHHHHHHhcCCCCCCC---------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11222333333222221 122345788999999999999999999999997653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-33 Score=284.15 Aligned_cols=187 Identities=21% Similarity=0.344 Sum_probs=151.5
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||||+.+..+......+|++||+++... .+...+++.++..++.||++||.|||+++ |+||||||+|||+
T Consensus 63 l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill 139 (263)
T d2j4za1 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLL 139 (263)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred cCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeecccccee
Confidence 469999999999988999999999987422 34567999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 140 ~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----- 210 (263)
T d2j4za1 140 GSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----- 210 (263)
T ss_dssp CTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred cCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----
Confidence 99999999999999765432 233467999999999999999999999999999999999999998643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.....+..+... + ... ....+.+++.+||+.||++|||++||++
T Consensus 211 --~~~~~i~~~~~~-~-----p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 211 --ETYKRISRVEFT-F-----PDF----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --HHHHHHHTTCCC-C-----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHcCCCC-C-----Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122222222211 1 111 2235678999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.1e-33 Score=283.40 Aligned_cols=196 Identities=27% Similarity=0.335 Sum_probs=154.1
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.||||+.+.+++.. ...|++||+++.. ..+...+++.+++.++.||++||.|||+++ |+||||||+|||
T Consensus 64 ~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nil 139 (277)
T d1xbba_ 64 QLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVL 139 (277)
T ss_dssp TCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred hCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhc
Confidence 3579999999998854 4689999999742 134567999999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 140 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--- 216 (277)
T d1xbba_ 140 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--- 216 (277)
T ss_dssp EEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---
T ss_pred ccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---
Confidence 999999999999999876543322 12233568999999999999999999999999999999997 8999864321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
..+...+..+....... ..+..+.+|+.+||+.||++||||++|+++|+.
T Consensus 217 ----~~~~~~i~~~~~~~~p~---------~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 217 ----SEVTAMLEKGERMGCPA---------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ----HHHHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCCCCc---------ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 12233333443332221 123457789999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-33 Score=283.81 Aligned_cols=196 Identities=23% Similarity=0.283 Sum_probs=155.8
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.||||+.+.+++.. ..+|++||+++.. ...+..+++.+++.++.||++||.|||+++ |+||||||+||
T Consensus 65 ~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Ni 140 (285)
T d1u59a_ 65 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNV 140 (285)
T ss_dssp HCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred hCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhhe
Confidence 3479999999998764 4689999998742 223457899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDN 527 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~ 527 (635)
+++.++.+||+|||+++.+...... .......||+.|+|||.+....++.++|||||||++|||++ |+.||......
T Consensus 141 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~- 219 (285)
T d1u59a_ 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP- 219 (285)
T ss_dssp EEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-
T ss_pred eeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987543322 12223467899999999999999999999999999999998 89998643221
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.+...+..+...+... ..+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 220 ------~~~~~i~~~~~~~~p~---------~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 220 ------EVMAFIEQGKRMECPP---------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------HHHHHHHTTCCCCCCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------HHHHHHHcCCCCCCCC---------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1223334444433322 223457789999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=280.67 Aligned_cols=198 Identities=23% Similarity=0.342 Sum_probs=149.2
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
.+.|+||+.+.+++.. ..+|+++++++.. ....+.++|.+++.++.||++||+|||+++ |+||||||+|
T Consensus 68 ~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~N 143 (285)
T d1fmka3 68 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAAN 143 (285)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred hcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceE
Confidence 4589999999988754 5689999998742 233456999999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
||++.++.+||+|||+++........ ......||..|+|||.+....++.++|||||||++|||++|..|+.... ..
T Consensus 144 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~ 220 (285)
T d1fmka3 144 ILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VN 220 (285)
T ss_dssp EEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CH
T ss_pred EEECCCCcEEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CH
Confidence 99999999999999999876433322 2233578999999999999999999999999999999999777653321 11
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
......+..+..... +....+.+.+++.+||+.||++||||++|+++|+...
T Consensus 221 ----~~~~~~i~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 221 ----REVLDQVERGYRMPC---------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ----HHHHHHHHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----HHHHHHHHhcCCCCC---------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 112222223322221 1122345778999999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-32 Score=280.00 Aligned_cols=192 Identities=20% Similarity=0.299 Sum_probs=152.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
+.||||+.+..+......+|++||+++.. ....+.+++.++..++.||+.||.|||+++ |+||||||+|||++
T Consensus 74 l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~ 150 (293)
T d1yhwa1 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 150 (293)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEEC
Confidence 46999999999988888999999998742 233457899999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
.++.+||+|||+++.+..... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .
T Consensus 151 ~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~ 222 (293)
T d1yhwa1 151 MDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------L 222 (293)
T ss_dssp TTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------H
T ss_pred CCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------H
Confidence 999999999999988654322 22346799999999999999999999999999999999999999854321 1
Q ss_pred HHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.........+... ... +......+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~-~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 223 RALYLIATNGTPE-LQN-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHHCSCC-CSS-------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhCCCCC-CCC-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122222222211 111 1112235778999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-32 Score=274.35 Aligned_cols=195 Identities=22% Similarity=0.291 Sum_probs=156.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+.+++.....+|+++|+.+.+ ......+++..+++++.||++||+|||+.+ |+||||||+||+
T Consensus 56 l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nil 132 (258)
T d1k2pa_ 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCL 132 (258)
T ss_dssp CCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEE
T ss_pred cCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEE
Confidence 47999999999998888999999998732 234567889999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 133 l~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--- 208 (258)
T d1k2pa_ 133 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--- 208 (258)
T ss_dssp ECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---
T ss_pred EcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---
Confidence 999999999999999876543322 2223568999999999999999999999999999999998 78898644211
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
.....+.++...... ......+.+++.+||+.||++|||++||++.|..
T Consensus 209 ----~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 209 ----ETAEHIAQGLRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----HHHHHHHTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----HHHHHHHhCCCCCCc---------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122223333222111 1122457789999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.1e-33 Score=284.77 Aligned_cols=192 Identities=20% Similarity=0.252 Sum_probs=149.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
.+.|+||+.++.+......+|++||+++.. ....+.+++.++..++.|++.||.|||+.+ |+||||||+|||
T Consensus 64 ~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIl 140 (288)
T d1uu3a_ 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENIL 140 (288)
T ss_dssp HCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred HcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccc
Confidence 347999999999998889999999998742 234568999999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
++.++.+||+|||+++.+.............||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ...
T Consensus 141 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~ 217 (288)
T d1uu3a_ 141 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYL 217 (288)
T ss_dssp ECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH
T ss_pred cCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHH
Confidence 99999999999999998764443334445679999999999999999999999999999999999999986432 111
Q ss_pred HHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
....+..+... + .... ...+.+++.+||+.||++|||++|+++
T Consensus 218 ----~~~~i~~~~~~-~-----p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 218 ----IFQKIIKLEYD-F-----PEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----HHHHHHTTCCC-C-----CTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----HHHHHHcCCCC-C-----CccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11222222211 1 1112 234678999999999999999998743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.5e-33 Score=279.42 Aligned_cols=193 Identities=25% Similarity=0.288 Sum_probs=139.0
Q ss_pred eeccccccccccC--CCCccEEEEecccchhh---------hhccccCcccchhhhhhhccccchhhcccc--ceEEeec
Q 046703 377 MWFGDLIDMRSFP--DGGQDLYIRMSASELDQ---------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR--LRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~--~~~~~lyl~~~~~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~--~~iiH~d 443 (635)
+.||||+.++.+. .....+|++||+++... .....+++.+++.++.||+.||.|||+++. ..|+|||
T Consensus 60 l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrD 139 (269)
T d2java1 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139 (269)
T ss_dssp CCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------
T ss_pred CCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCc
Confidence 4799999998865 34567999999987421 234579999999999999999999998652 3499999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
|||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 140 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 140 LKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 999999999999999999999987654322 223467899999999999999999999999999999999999998643
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ......+..+....+.. .. ...+.+++.+||+.||++|||++||++
T Consensus 218 ~~-------~~~~~~i~~~~~~~~~~-----~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 218 SQ-------KELAGKIREGKFRRIPY-----RY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SH-------HHHHHHHHHTCCCCCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CH-------HHHHHHHHcCCCCCCCc-----cc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 21 11222333444333211 12 235778999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=281.09 Aligned_cols=197 Identities=25% Similarity=0.323 Sum_probs=146.7
Q ss_pred eccccccccccC-CCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhccc
Q 046703 378 WFGDLIDMRSFP-DGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDS 435 (635)
Q Consensus 378 ~h~nLv~l~~~~-~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 435 (635)
.|+|++.+.... ..+..+|+++|+++... .....+++.+++.++.||++||.|||+++
T Consensus 75 ~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ 154 (299)
T d1ywna1 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154 (299)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578888877765 44567899999987311 11345889999999999999999999999
Q ss_pred cceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh
Q 046703 436 RLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 436 ~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt 515 (635)
|+||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 155 ---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 155 ---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp ---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 99999999999999999999999999987655444434445679999999999999999999999999999999998
Q ss_pred CC-CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 516 GK-KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 516 G~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
|. .||......+ .....+..+......+. ....+.+++.+||+.||++||||+||+++|+.+
T Consensus 232 ~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~~---------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 232 LGASPYPGVKIDE------EFCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp TSCCSSTTCCCSH------HHHHHHHHTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH------HHHHHHhcCCCCCCCcc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 75 4664332221 12233334443333221 223577899999999999999999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.1e-32 Score=283.71 Aligned_cols=199 Identities=20% Similarity=0.263 Sum_probs=155.5
Q ss_pred eeeccccccccccCCCCccEEEEecccchh-----------------------------hhhccccCcccchhhhhhhcc
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD-----------------------------QERCKLLDWSKRFRIICGTGR 426 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----------------------------~~~~~~l~~~~~~~i~~~ia~ 426 (635)
.+.|+|++.++.++.....+|+++++++.. ......+++.+++.++.||+.
T Consensus 72 ~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 151 (301)
T d1lufa_ 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 151 (301)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred hcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHH
Confidence 347999999999998888999999987631 111335889999999999999
Q ss_pred ccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeee
Q 046703 427 GLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSF 506 (635)
Q Consensus 427 aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~ 506 (635)
||+|||+++ ||||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||
T Consensus 152 gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 152 GMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp HHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 999999999 99999999999999999999999999987654433333444678899999999999999999999999
Q ss_pred ehhhHhhhhCC-CCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 046703 507 GILLLEIVSGK-KNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 507 Gvvl~eiltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
||++|||++|. +||..... . .....+.++...+..+ ..+.++.+|+.+||+.||++||||.||
T Consensus 229 Gvvl~ell~~~~~p~~~~~~---~----e~~~~v~~~~~~~~p~---------~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 229 GVVLWEIFSYGLQPYYGMAH---E----EVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp HHHHHHHHTTTCCTTTTSCH---H----HHHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhhHHHHHccCCCCCCCCCH---H----HHHHHHHcCCCCCCCc---------cchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999986 45543221 1 1223334454433322 122357789999999999999999999
Q ss_pred HHHHcCCC
Q 046703 586 ILMLGSEI 593 (635)
Q Consensus 586 l~~L~~~~ 593 (635)
+++|+.+.
T Consensus 293 ~~~L~~i~ 300 (301)
T d1lufa_ 293 HRILQRMC 300 (301)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHhc
Confidence 99998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.6e-32 Score=282.46 Aligned_cols=140 Identities=24% Similarity=0.338 Sum_probs=122.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhcc-ccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQD-SRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~dik~~NIl 450 (635)
+.|||||.+..+......+|++||+++.. ..+.+.+++.++..++.||++||.|||++ + |+||||||+|||
T Consensus 61 l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NIL 137 (322)
T d1s9ja_ 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNIL 137 (322)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEE
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHee
Confidence 46999999999998889999999998742 23456799999999999999999999974 7 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++.++.+||+|||+|+..... ......||+.|+|||.+.+.+++.++||||+||++|||++|+.||...
T Consensus 138 l~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 138 VNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999876422 223468999999999999999999999999999999999999999654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-32 Score=279.94 Aligned_cols=193 Identities=24% Similarity=0.276 Sum_probs=150.0
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.||||+.+..+......+|++||+++.. ....+.+++.++..++.||++||.|||+++ |+||||||+||
T Consensus 65 ~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NI 141 (288)
T d2jfla1 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNI 141 (288)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred hCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhhe
Confidence 347999999999988888999999998742 223456999999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCccccc-----CCCCcccCceeeeehhhHhhhhCCCCCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 524 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~ 524 (635)
|++.++.+||+|||+++...... .......||+.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 142 ll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 142 LFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp EECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999997653221 1122367899999999983 4568999999999999999999999986543
Q ss_pred CCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 525 LDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..+ .... +..+....+.. +......+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~---~~~~----i~~~~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 220 PMR---VLLK----IAKSEPPTLAQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GGG---HHHH----HHHSCCCCCSS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHH---HHHH----HHcCCCCCCCc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222 2211 12222222211 1112335778999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.3e-32 Score=274.59 Aligned_cols=195 Identities=23% Similarity=0.285 Sum_probs=144.0
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.||||+.++++.. ...+|+++++++.. ......+++.+++.++.||++||.|||+.+ |+||||||+||+
T Consensus 65 l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIl 140 (273)
T d1mp8a_ 65 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVL 140 (273)
T ss_dssp CCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhhee
Confidence 46999999999886 45789999998742 234557899999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 141 l~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--- 216 (273)
T d1mp8a_ 141 VSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--- 216 (273)
T ss_dssp EEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---
T ss_pred ecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999999999876543222 2334668999999999999999999999999999999998 88888654322
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.+. ..+..+...... ...+..+.+|+.+||+.||++|||++||++.|+.+
T Consensus 217 ~~~----~~i~~~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 217 DVI----GRIENGERLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp GHH----HHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HHHHcCCCCCCC---------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222 222333332221 12234577899999999999999999999988653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=271.91 Aligned_cols=191 Identities=21% Similarity=0.324 Sum_probs=145.8
Q ss_pred eeccccccccccC----CCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFP----DGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~----~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.||||+.++.+. .+...+|++||+++.. ..+...+++.++..++.||++||.|||+++ .+|+||||||+
T Consensus 65 l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~ 143 (270)
T d1t4ha_ 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCD 143 (270)
T ss_dssp CCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGG
T ss_pred CCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChh
Confidence 4799999998764 3456789999998742 134567899999999999999999999976 34999999999
Q ss_pred ceEec-cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLD-QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|||++ .++.+||+|||+++..... ......||+.|+|||.+.+ +++.++|||||||++|||++|+.||.....
T Consensus 144 NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~- 217 (270)
T d1t4ha_ 144 NIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN- 217 (270)
T ss_dssp GEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-
T ss_pred hceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-
Confidence 99996 5789999999999764322 2334679999999998865 699999999999999999999999853221
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.......+..+......+ ...+ ..+.+|+.+||+.||++|||++|+++
T Consensus 218 -----~~~~~~~i~~~~~~~~~~----~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 218 -----AAQIYRRVTSGVKPASFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----HHHHHHHHTTTCCCGGGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHHHcCCCCcccC----ccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 112223333332222111 1112 23678999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.8e-32 Score=277.96 Aligned_cols=197 Identities=26% Similarity=0.320 Sum_probs=159.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+||+.+..++.....+|+++++++... ...+.+++.+++.++.||+.||.|||+.+
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~- 155 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 155 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence 69999999999988889999999987421 12346899999999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS- 515 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt- 515 (635)
||||||||+|||++.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++
T Consensus 156 --ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 156 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp --CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 99999999999999999999999999998765544444445678999999999999999999999999999999998
Q ss_pred CCCCCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 516 GKKNRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 516 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
|+.||..... ..+...+..+....... ..+..+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 234 g~~p~~~~~~-------~~~~~~i~~~~~~~~p~---------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 234 GGSPYPGVPV-------EELFKLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp SCCSSTTCCH-------HHHHHHHHTTCCCCCCS---------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCH-------HHHHHHHHcCCCCCCCc---------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 6778754321 22333444444333221 12235778999999999999999999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.8e-32 Score=280.29 Aligned_cols=197 Identities=21% Similarity=0.281 Sum_probs=150.7
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.||||+.+.+++..+ ..|+++++.... ..+...+++..+++++.||++||.|||+++ |+||||||+||
T Consensus 67 ~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NI 142 (317)
T d1xkka_ 67 SVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNV 142 (317)
T ss_dssp HCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred hCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcc
Confidence 45799999999988654 566666665531 234567899999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCCc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDNK 528 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~~ 528 (635)
|++.++.+||+|||+++...............||..|+|||.+.++.++.++|||||||++|||++ |+.||+.....+
T Consensus 143 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~- 221 (317)
T d1xkka_ 143 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE- 221 (317)
T ss_dssp EEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-
T ss_pred eeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-
Confidence 999999999999999998765544444444678999999999999999999999999999999998 788876543222
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
+ ...+..+..... +......+.+|+.+||+.||++|||+.||++.|+..
T Consensus 222 --~----~~~i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 222 --I----SSILEKGERLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --H----HHHHHHTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --H----HHHHHcCCCCCC---------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1 222223332221 112234577899999999999999999999988654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=5.6e-32 Score=279.08 Aligned_cols=187 Identities=26% Similarity=0.335 Sum_probs=148.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||||+.+.++......+|++||++..+ ....+.+++.++..++.||++||.|||+++ |+||||||+|||+
T Consensus 72 l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl 148 (309)
T d1u5ra_ 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILL 148 (309)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEE
T ss_pred CCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEE
Confidence 47999999999988888999999998642 234567999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC---CCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
+.++.+||+|||++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 149 ~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--- 219 (309)
T d1u5ra_ 149 SEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--- 219 (309)
T ss_dssp ETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred CCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---
Confidence 9999999999999986532 223579999999999853 4689999999999999999999999854321
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
...... ...+......... . ...+.+++.+||+.||++|||++|+++
T Consensus 220 ---~~~~~~-i~~~~~~~~~~~~----~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 220 ---MSALYH-IAQNESPALQSGH----W----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---HHHHHH-HHHSCCCCCSCTT----S----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHH-HHhCCCCCCCCCC----C----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111122 2222222222211 1 235778999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-31 Score=270.27 Aligned_cols=197 Identities=22% Similarity=0.265 Sum_probs=151.9
Q ss_pred eeeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+||+.+++++.. ..+|+++++++.. ..+.+.+++..++.++.||++||.|||+++ |+||||||+||
T Consensus 67 ~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NI 142 (273)
T d1u46a_ 67 SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNL 142 (273)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred hCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHh
Confidence 3479999999998865 4678999998742 234567999999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCC-ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEG-NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDN 527 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~ 527 (635)
+++.++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 143 ll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~- 221 (273)
T d1u46a_ 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS- 221 (273)
T ss_dssp EEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred ccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-
Confidence 99999999999999999875443221 2223567889999999999999999999999999999998 89998643211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGS 591 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~ 591 (635)
+........+...+..+ ..+..+.+++.+||+.||++||||.||+++|+.
T Consensus 222 -----~~~~~i~~~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 222 -----QILHKIDKEGERLPRPE---------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----HHHHHHHTSCCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----HHHHHHHhCCCCCCCcc---------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11222223332222111 122357789999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-31 Score=268.55 Aligned_cols=192 Identities=26% Similarity=0.323 Sum_probs=144.7
Q ss_pred eeccccccccccC-CCCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFP-DGGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~-~~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+||+.+++++ +....+|+++++.+.. ......++|..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 57 l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~N 133 (262)
T d1byga_ 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 133 (262)
T ss_dssp CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHh
Confidence 4799999999976 4456689999998742 223446899999999999999999999998 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhh-CCCCCCCccCCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHLDN 527 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eilt-G~~pf~~~~~~~ 527 (635)
|+++.++.+||+|||+++..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 134 il~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~- 207 (262)
T d1byga_ 134 VLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK- 207 (262)
T ss_dssp EEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-
T ss_pred heecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-
Confidence 99999999999999999865322 223567889999999999999999999999999999998 67776543222
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
.... .+..+...+..+ .....+.+|+.+||+.||++||||.||+++|+.+
T Consensus 208 --~~~~----~i~~~~~~~~~~---------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 208 --DVVP----RVEKGYKMDAPD---------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --GHHH----HHTTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHH----HHHcCCCCCCCc---------cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2222 223333333222 2223577899999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-31 Score=273.01 Aligned_cols=203 Identities=23% Similarity=0.245 Sum_probs=151.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+..+......+|++||++... ......+++.++..++.||++||.|||+++ |+||||||+|||+
T Consensus 57 l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli 133 (299)
T d1ua2a_ 57 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLL 133 (299)
T ss_dssp CCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEe
Confidence 36999999999999999999999998742 233567899999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||+++........ .....||+.|+|||.+... .++.++|||||||++|||++|+.||......+
T Consensus 134 ~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--- 208 (299)
T d1ua2a_ 134 DENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--- 208 (299)
T ss_dssp CTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred cCCCccccccCccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---
Confidence 99999999999999876543222 2235789999999988654 57999999999999999999999986543222
Q ss_pred HHHHHHHHhhcCCCCcCCCC-------ccc--cCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEMIDP-------CYQ--ESCNL-----TEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~-------~l~--~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.+....+...........+. ... ...+. .....+.+++.+||+.||++|||++|+++
T Consensus 209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 22222222111000000000 000 01111 12345788999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.1e-31 Score=272.92 Aligned_cols=213 Identities=19% Similarity=0.195 Sum_probs=154.2
Q ss_pred eeccccccccccCC----CCccEEEEecccchh----hhhccccCcccchhhhhhhccccchhhccc-----cceEEeec
Q 046703 377 MWFGDLIDMRSFPD----GGQDLYIRMSASELD----QERCKLLDWSKRFRIICGTGRGLLYLHQDS-----RLRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~~----~~~~lyl~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiH~d 443 (635)
+.|+||+.+..++. ....+|+++|+++.. ..+...++|.+++.++.|++.||.|||+.+ ...|+|||
T Consensus 54 ~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrD 133 (303)
T d1vjya_ 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred CCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccc
Confidence 47999999888863 224689999999742 234557999999999999999999999742 23499999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCC------CCcccCceeeeehhhHhhhh
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVS 515 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwS~Gvvl~eilt 515 (635)
|||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+. .++.++|||||||+||||++
T Consensus 134 lKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t 213 (303)
T d1vjya_ 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh
Confidence 9999999999999999999999887543322 123346799999999998764 36789999999999999999
Q ss_pred CCCCCCCccCCC--------cccHHHHHHHHhhcCCCCcCCCCcccc-CCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 046703 516 GKKNRGFYHLDN--------KLNLIGHAWKLWNKGMPSEMIDPCYQE-SCNLTEVIRCIHISLLCVQQHPDDRPCMPSVI 586 (635)
Q Consensus 516 G~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl 586 (635)
|..|+....... ..............+.. ++.+.. ..+.+.+..+.+++.+||+.||++||||.||+
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~ 289 (303)
T d1vjya_ 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred CCCCCCcccccccchhhcccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 988764422111 11112222222222221 111111 11334566788999999999999999999999
Q ss_pred HHHcCCC
Q 046703 587 LMLGSEI 593 (635)
Q Consensus 587 ~~L~~~~ 593 (635)
++|+.+.
T Consensus 290 ~~L~~i~ 296 (303)
T d1vjya_ 290 KTLSQLS 296 (303)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.4e-31 Score=275.88 Aligned_cols=198 Identities=20% Similarity=0.229 Sum_probs=142.7
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||||+.+.++...+..+|++||+++... .+...+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 64 l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~ 140 (307)
T d1a06a_ 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLY 140 (307)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceee
Confidence 469999999999988999999999987421 24567999999999999999999999999 9999999999999
Q ss_pred c---cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 452 D---QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 452 d---~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
. .++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 141 ~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-- 215 (307)
T d1a06a_ 141 YSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-- 215 (307)
T ss_dssp SSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred cccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--
Confidence 5 57889999999998764332 223467999999999999999999999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--HcCCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM--LGSEI 593 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 593 (635)
. ....+..+.... .. .........+.+++.+||+.||++|||++|+++. +.+..
T Consensus 216 -~----~~~~i~~~~~~~-~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 216 -K----LFEQILKAEYEF-DS-----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp -H----HHHHHHTTCCCC-CT-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred -H----HHHHHhccCCCC-CC-----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 1 122222222111 00 0111122357789999999999999999999983 55443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=8e-31 Score=275.08 Aligned_cols=186 Identities=20% Similarity=0.189 Sum_probs=150.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.++.+......+|+++++.... ..+.+.+++.++..++.||+.||.|||+++ ||||||||+|||+
T Consensus 98 l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl 174 (350)
T d1rdqe_ 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLI 174 (350)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred cCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHccc
Confidence 47999999999998889999999988642 234567999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...
T Consensus 175 ~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~- 245 (350)
T d1rdqe_ 175 DQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQ- 245 (350)
T ss_dssp CTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-
T ss_pred CCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHH-
Confidence 99999999999999886432 223679999999999999999999999999999999999999986432 111
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
....+..+.+.. .. .....+.+++.+||+.||.+|+ |++||++
T Consensus 246 ---~~~~i~~~~~~~------p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 246 ---IYEKIVSGKVRF------PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---HHHHHHHCCCCC------CT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHhcCCCCC------Cc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 122222222211 01 1123467899999999999994 8999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.9e-31 Score=273.31 Aligned_cols=197 Identities=22% Similarity=0.303 Sum_probs=155.6
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----------------------hhccccCcccchhhhhhhccccchhhcc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----------------------ERCKLLDWSKRFRIICGTGRGLLYLHQD 434 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 434 (635)
.|+||+.+++++.....+|++|++++... .....+++..++.++.||++||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 59999999999998899999999987421 1223688999999999999999999999
Q ss_pred ccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhh
Q 046703 435 SRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 514 (635)
Q Consensus 435 ~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eil 514 (635)
+ ++||||||+||+++.++.+|++|||+++...............||+.|+|||.+.+..++.++|||||||++|||+
T Consensus 165 ~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 165 N---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (311)
T ss_dssp T---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHH
Confidence 9 9999999999999999999999999999876544444444468899999999999999999999999999999999
Q ss_pred hCCCC-CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 515 SGKKN-RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 515 tG~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
+++.| +......+ ........+...... ......+.+|+.+||+.||++||||+||+++|++.
T Consensus 242 t~g~p~~~~~~~~~------~~~~~i~~~~~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 242 SLGSSPYPGMPVDS------KFYKMIKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TTTCCSSTTCCSSH------HHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH------HHHHHHhcCCCCCCc---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 95554 43322211 122233333322211 11234578899999999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4e-31 Score=272.78 Aligned_cols=200 Identities=23% Similarity=0.311 Sum_probs=158.2
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh---------------hhccccCcccchhhhhhhccccchhhccccceEE
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRII 440 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 440 (635)
.+.|+||+.+.+++.....+|+++++++... .....+++..++.++.|+++||.|||+++ |+
T Consensus 79 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---iv 155 (308)
T d1p4oa_ 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FV 155 (308)
T ss_dssp GCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---ee
Confidence 4479999999999988889999999986311 11234688889999999999999999998 99
Q ss_pred eeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCC-CC
Q 046703 441 HRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK-KN 519 (635)
Q Consensus 441 H~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~-~p 519 (635)
||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++|. .|
T Consensus 156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred eceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765444433344457899999999999999999999999999999999985 55
Q ss_pred CCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCCC
Q 046703 520 RGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEIV 594 (635)
Q Consensus 520 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 594 (635)
|..... ......+..+......+ ..+..+.+++.+||+.||++||||++|+++|++..+
T Consensus 236 ~~~~~~-------~~~~~~i~~~~~~~~p~---------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 236 YQGLSN-------EQVLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTTSCH-------HHHHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCH-------HHHHHHHHhCCCCCCcc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 543211 11223333444333222 122458889999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=6.8e-31 Score=275.74 Aligned_cols=197 Identities=17% Similarity=0.176 Sum_probs=153.9
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.++.+......+|++||+++... .....+++.++..++.||+.||.|||+.+ |+||||||+|||
T Consensus 83 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NIL 159 (352)
T d1koba_ 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIM 159 (352)
T ss_dssp CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccccccccc
Confidence 479999999999988999999999987421 22346899999999999999999999999 999999999999
Q ss_pred ec--cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 LD--QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++ .++.+||+|||++....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 160 l~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-- 234 (352)
T d1koba_ 160 CETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-- 234 (352)
T ss_dssp ESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--
T ss_pred ccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 98 56889999999998875432 234467899999999999999999999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--HcCC
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM--LGSE 592 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 592 (635)
.. ...+..+...- .. .........+.+|+.+||+.||++|||+.|+++. +++.
T Consensus 235 -~~----~~~i~~~~~~~-~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 235 -ET----LQNVKRCDWEF-DE-----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -HH----HHHHHHCCCCC-CS-----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -HH----HHHHHhCCCCC-Cc-----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11 12222222210 00 0111122346789999999999999999999873 5544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=5e-31 Score=276.55 Aligned_cols=194 Identities=16% Similarity=0.192 Sum_probs=151.7
Q ss_pred eeeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 376 AMWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.+.|+||+.+..+......+|++||+++... .+...+++.++..++.||+.||.|||+++ ||||||||+||
T Consensus 79 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NI 155 (350)
T d1koaa2 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENI 155 (350)
T ss_dssp HTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHe
Confidence 3479999999999988899999999987421 23456999999999999999999999999 99999999999
Q ss_pred Eecc--CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 450 LLDQ--DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 450 lld~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|++. ++.+||+|||+++.+.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-- 230 (350)
T d1koaa2 156 MFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-- 230 (350)
T ss_dssp EESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred eeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--
Confidence 9964 5789999999998765332 23447899999999999999999999999999999999999999864321
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
... ...+..+... . ..... ......+.+++.+||+.||++|||++|+++.
T Consensus 231 -~~~----~~~i~~~~~~-~-~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 231 -DET----LRNVKSCDWN-M-DDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -HHH----HHHHHHTCCC-S-CCGGG----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -HHH----HHHHHhCCCC-C-Ccccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1222222211 0 01100 1112356789999999999999999999884
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8e-31 Score=270.75 Aligned_cols=199 Identities=20% Similarity=0.258 Sum_probs=153.3
Q ss_pred eeccccccccccCC-CCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 377 MWFGDLIDMRSFPD-GGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 377 l~h~nLv~l~~~~~-~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
+.|+||+.+.+++. ....+|+++++++.. ......+++..++.++.|+++||.|||+.+ |+||||||+||
T Consensus 85 l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NI 161 (311)
T d1r0pa_ 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNC 161 (311)
T ss_dssp CCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhE
Confidence 47999999988753 456899999998742 234456778889999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCC--ceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEG--NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
|+++++.+||+|||+++......... ......||..|+|||.+....++.++||||||+++|||++|+.||......
T Consensus 162 Ll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~- 240 (311)
T d1r0pa_ 162 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT- 240 (311)
T ss_dssp EECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----
T ss_pred eECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-
Confidence 99999999999999998765432221 222356899999999999999999999999999999999988887543211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.... ..+..+......+ .....+.+|+.+||+.||++||+|.||++.|+.+.
T Consensus 241 -~~~~----~~i~~g~~~~~p~---------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 241 -FDIT----VYLLQGRRLLQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ---CH----HHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHH----HHHHcCCCCCCcc---------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 2223333222211 12235778999999999999999999999998773
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=9.7e-31 Score=270.68 Aligned_cols=186 Identities=23% Similarity=0.243 Sum_probs=149.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||||+.+..+......+|++|++++.. ......+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 61 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl 137 (316)
T d1fota_ 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILL 137 (316)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEE
T ss_pred ccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeE
Confidence 47999999999999999999999998742 234566788888899999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ..
T Consensus 138 ~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~- 208 (316)
T d1fota_ 138 DKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MK- 208 (316)
T ss_dssp CTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HH-
T ss_pred cCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HH-
Confidence 99999999999999886432 2236799999999999999999999999999999999999999964321 11
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-----CMPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~evl~ 587 (635)
....+..+... . .... ...+.+++.+||+.||.+|| |++|+++
T Consensus 209 ---~~~~i~~~~~~-~-----p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 209 ---TYEKILNAELR-F-----PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---HHHHHHHCCCC-C-----CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHHcCCCC-C-----CCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 12222222211 0 1111 23467899999999999996 8999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-30 Score=271.44 Aligned_cols=189 Identities=20% Similarity=0.238 Sum_probs=151.5
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||||+.++........+|++|++++.. ..+...++++.+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 62 l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl 138 (337)
T d1o6la_ 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLML 138 (337)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred CCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEe
Confidence 46999999999999999999999999753 234567889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 139 ~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----- 211 (337)
T d1o6la_ 139 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----- 211 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred cCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----
Confidence 9999999999999986543222 233468999999999999999999999999999999999999998653321
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
.....+..+.+. . ....+ ..+.+++.+||+.||++||+ ++||++
T Consensus 212 --~~~~~i~~~~~~-~-----p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 212 --RLFELILMEEIR-F-----PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --HHHHHHHHCCCC-C-----CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --HHHHHHhcCCCC-C-----CccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112222222221 1 11122 34678999999999999995 778775
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=2.1e-30 Score=273.27 Aligned_cols=189 Identities=22% Similarity=0.206 Sum_probs=148.6
Q ss_pred eccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.||||+.+..+......+|++|++++.. ..+...+++.++..++.||+.||.|||+++ |+||||||+|||++
T Consensus 65 ~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~ 141 (364)
T d1omwa3 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD 141 (364)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEc
Confidence 6999999999998889999999998742 134567888999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
.++.+||+|||+++.+.... .....||+.|+|||.+.. ..++.++|||||||++|||++|+.||......+..
T Consensus 142 ~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-- 215 (364)
T d1omwa3 142 EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-- 215 (364)
T ss_dssp SSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--
T ss_pred CCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 99999999999998765432 233579999999999864 56899999999999999999999999754333221
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
......... .... .... ...+.+++.+||+.||++||| ++||++
T Consensus 216 --~~~~~~~~~-~~~~-----~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 216 --EIDRMTLTM-AVEL-----PDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --HHHHHSSSC-CCCC-----CSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --HHHHhcccC-CCCC-----CCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111111 1111 1112 234678999999999999999 688874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.5e-30 Score=266.88 Aligned_cols=194 Identities=24% Similarity=0.325 Sum_probs=152.4
Q ss_pred eccccccccccCCCCccEEEEecccchhh---------------------hhccccCcccchhhhhhhccccchhhcccc
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ---------------------ERCKLLDWSKRFRIICGTGRGLLYLHQDSR 436 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~---------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 436 (635)
.|+||+.+.+++.....+|+++++.+... .....+++.++++++.||++||.|||+.+
T Consensus 69 ~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~- 147 (309)
T d1fvra_ 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 147 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-
Confidence 59999999999988889999999987311 22467899999999999999999999999
Q ss_pred ceEEeeccCCcceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhC
Q 046703 437 LRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 516 (635)
Q Consensus 437 ~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG 516 (635)
|+||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|
T Consensus 148 --iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~ 222 (309)
T d1fvra_ 148 --FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222 (309)
T ss_dssp --EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhc
Confidence 9999999999999999999999999997653221 12235689999999999999999999999999999999997
Q ss_pred CC-CCCCccCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCCC
Q 046703 517 KK-NRGFYHLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSEI 593 (635)
Q Consensus 517 ~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 593 (635)
.. ||.... .......+.++...+.. ......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 223 ~~~p~~~~~-------~~~~~~~i~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 223 GGTPYCGMT-------CAELYEKLPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp SCCTTTTCC-------HHHHHHHGGGTCCCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCC-------HHHHHHHHHhcCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 65 554321 11222333344322221 122345778999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-30 Score=267.28 Aligned_cols=192 Identities=18% Similarity=0.188 Sum_probs=150.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.++......+||+||+++... ...+.+++.++..++.||+.||.|||+.+ |+||||||+||++
T Consensus 70 l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill 146 (293)
T d1jksa_ 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIML 146 (293)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEE
Confidence 469999999999999999999999987421 34567999999999999999999999999 9999999999999
Q ss_pred ccCC----CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 452 DQDM----NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 452 d~~~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
+.++ .+||+|||++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 147 ~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~- 222 (293)
T d1jksa_ 147 LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ- 222 (293)
T ss_dssp SCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred ecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-
Confidence 8776 489999999988653322 22356899999999999999999999999999999999999998643211
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ....+..+...- . ... .......+.+++.+||+.||++|||++||++
T Consensus 223 --~----~~~~i~~~~~~~-~-~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 223 --E----TLANVSAVNYEF-E-DEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --H----HHHHHHTTCCCC-C-HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --H----HHHHHHhcCCCC-C-chh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 112222222110 0 000 0112235678999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3e-30 Score=269.09 Aligned_cols=195 Identities=18% Similarity=0.209 Sum_probs=146.0
Q ss_pred eccccccccccCC----CCccEEEEecccchh-------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFPD----GGQDLYIRMSASELD-------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~~----~~~~lyl~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.+..+.. ....+|++|||++.. ....+.+++.++..++.||+.||.|||+.+ |+||||||
T Consensus 63 ~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp 139 (335)
T d2ozaa1 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 139 (335)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccc
Confidence 5999999887653 356799999998742 111346899999999999999999999999 99999999
Q ss_pred cceEecc---CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 447 GNVLLDQ---DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 447 ~NIlld~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
+|||++. .+.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 140 ~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 140 ENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred cccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 9999986 45699999999987654332 23367999999999999999999999999999999999999999654
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
....... ........+.. . ............+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~---~~~~~i~~~~~-~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 217 HGLAISP---GMKTRIRMGQY-E-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TCC-----------CCCSCSS-S-----CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHH---HHHHHHhcCCC-C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3222111 11111111110 0 000011123446788999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=2.3e-30 Score=262.96 Aligned_cols=198 Identities=21% Similarity=0.295 Sum_probs=144.7
Q ss_pred eeccccccccccCC----CCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPD----GGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~----~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+||+.+..+.. .+..+|++||+++.. ....+.+++.+++.++.||++||.|||+++ |+||||||+
T Consensus 64 ~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~ 140 (277)
T d1o6ya_ 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 140 (277)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred cCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCc
Confidence 47999998877653 234589999998742 234567999999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCC-CCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDET-EGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|||++.++..+|+|||.+........ ........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 141 NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-- 218 (277)
T d1o6ya_ 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-- 218 (277)
T ss_dssp GEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred ccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--
Confidence 99999999999999999876543222 222344679999999999999999999999999999999999999986432
Q ss_pred CcccHHHHHHHHhhcCCCC-cCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHHcC
Q 046703 527 NKLNLIGHAWKLWNKGMPS-EMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRP-CMPSVILMLGS 591 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-t~~evl~~L~~ 591 (635)
..+........+... .... ...+..+.+++.+||+.||++|| |++++++.|..
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~--------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 219 ----PVSVAYQHVREDPIPPSARH--------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----HHHHHHHHHHCCCCCGGGTS--------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----HHHHHHHHHhcCCCCCchhc--------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 112222222222221 1111 11223577899999999999999 89999888754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4e-30 Score=263.97 Aligned_cols=202 Identities=20% Similarity=0.262 Sum_probs=151.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+++..+...+..+|++++++... ....+.+++.++..++.||+.||.|||+++ ||||||||+|||
T Consensus 58 l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl 134 (298)
T d1gz8a_ 58 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLL 134 (298)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchhee
Confidence 36999999999999899999999998642 234567999999999999999999999999 999999999999
Q ss_pred eccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC-CcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 451 LDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 451 ld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
++.++.+||+|||+++........ .....||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..
T Consensus 135 ~~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--- 209 (298)
T d1gz8a_ 135 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--- 209 (298)
T ss_dssp ECTTSCEEECSTTHHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred ecccCcceeccCCcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---
Confidence 999999999999999876543322 22357899999999877665 579999999999999999999998643221
Q ss_pred cHHHHHHHHhhcCCCCcCCCCcc------c------cCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCY------Q------ESCN-----LTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l------~------~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
.......... +...+..-+.. . .... ......+.+++.+||+.||++|||++|+++.
T Consensus 210 ~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 210 DQLFRIFRTL--GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHHHHHH--CCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhc--CCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111111111 11111100000 0 0000 1112456789999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-30 Score=268.73 Aligned_cols=189 Identities=23% Similarity=0.288 Sum_probs=151.1
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.||||+.+..+...+..+|++||+++.. ......+++.++..++.||+.||.|||+++ |+||||||+|||+
T Consensus 60 ~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~ 136 (320)
T d1xjda_ 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILL 136 (320)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred CCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceee
Confidence 46999999999998899999999998742 234567889999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
+.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 137 ~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----- 209 (320)
T d1xjda_ 137 DKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----- 209 (320)
T ss_dssp CTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred cCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----
Confidence 9999999999999986543322 223367999999999999999999999999999999999999999643211
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMP-SVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~-evl~ 587 (635)
.....+..+.+. . .... ...+.+|+.+||+.||++|||+. ||++
T Consensus 210 --~~~~~i~~~~~~-~-----p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 210 --ELFHSIRMDNPF-Y-----PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --HHHHHHHHCCCC-C-----CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --HHHHHHHcCCCC-C-----CccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122222233221 1 1111 23467899999999999999995 6753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.1e-30 Score=265.52 Aligned_cols=201 Identities=21% Similarity=0.205 Sum_probs=147.2
Q ss_pred eccccccccccC-----CCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCC
Q 046703 378 WFGDLIDMRSFP-----DGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKA 446 (635)
Q Consensus 378 ~h~nLv~l~~~~-----~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~ 446 (635)
.|+||+.+..+. .....+|+++++++.. ......+++..+..++.||+.||+|||+++ |+||||||
T Consensus 68 ~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp 144 (305)
T d1blxa_ 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKP 144 (305)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred CCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCc
Confidence 699999887765 3446789999987632 234566889999999999999999999999 99999999
Q ss_pred cceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 447 GNVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 447 ~NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
+|||++.++.+||+|||+++...... ......||+.|+|||.+.+.+++.++||||+||++|||++|+.||......
T Consensus 145 ~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~ 221 (305)
T d1blxa_ 145 QNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221 (305)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999999987653222 233467999999999999999999999999999999999999999654322
Q ss_pred CcccHHHHHHHHhhcCC---CC-------cCCC---CccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGM---PS-------EMID---PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~---~~-------~~~d---~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
+ .+........... .. .... ..............+.+|+.+||+.||++|||++|+++
T Consensus 222 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 222 D---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp H---HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H---HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1 2222211110000 00 0000 00000111112234678999999999999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.8e-30 Score=260.06 Aligned_cols=180 Identities=21% Similarity=0.319 Sum_probs=144.0
Q ss_pred eccccccccccCCCCccEEEEecccchh------hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELD------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
.|+||+.+..+......+|+++++.... ..+...++++++..++.||++||.|||+.+ |+||||||+|||+
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll 143 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILI 143 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEE
Confidence 3899999999998889999999987531 134567999999999999999999999999 9999999999999
Q ss_pred ccC-CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCC-cccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 452 DQD-MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 452 d~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
+.+ +.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 144 ~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----- 214 (273)
T d1xwsa_ 144 DLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214 (273)
T ss_dssp ETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred ecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----
Confidence 855 689999999998754322 233679999999999987765 678999999999999999999986421
Q ss_pred cHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 530 NLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
.. ..+... . ....+ ..+.+++.+||+.||++|||++|+++
T Consensus 215 ----~i----~~~~~~--~----~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 ----EI----IRGQVF--F----RQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----HH----HHCCCC--C----SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH----hhcccC--C----CCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 111111 1 11122 34678999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.95 E-value=1.8e-29 Score=256.09 Aligned_cols=191 Identities=20% Similarity=0.255 Sum_probs=149.9
Q ss_pred eccccccccccCCCCccEEEEecccchhh-----hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec
Q 046703 378 WFGDLIDMRSFPDGGQDLYIRMSASELDQ-----ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD 452 (635)
Q Consensus 378 ~h~nLv~l~~~~~~~~~lyl~~~~~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld 452 (635)
.|+||+.+..+..+...+|++||+++... .....+++.++..++.||++||+|||+++ |+||||||+||+++
T Consensus 68 ~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~ 144 (277)
T d1phka_ 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 144 (277)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEc
Confidence 38999999999999999999999987421 34567999999999999999999999999 99999999999999
Q ss_pred cCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccC------CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 453 QDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
.++.+||+|||+++....... .....||..|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~- 220 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ- 220 (277)
T ss_dssp TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred CCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-
Confidence 999999999999988754322 223578999999999853 3578999999999999999999999964321
Q ss_pred CcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 527 NKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+..+... ...+. .......+.+++.+||+.||++|||++||++
T Consensus 221 ------~~~~~~i~~~~~~-~~~~~-----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 ------MLMLRMIMSGNYQ-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ------HHHHHHHHHTCCC-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ------HHHHHHHHhCCCC-CCCcc-----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122222233221 11111 1112235778999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=6.4e-29 Score=254.99 Aligned_cols=200 Identities=17% Similarity=0.136 Sum_probs=144.6
Q ss_pred ccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEec---
Q 046703 381 DLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLD--- 452 (635)
Q Consensus 381 nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld--- 452 (635)
+++.+..+...+...|+++++.... ....+.+++.+++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 64 ~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~ 140 (299)
T d1ckia_ 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 140 (299)
T ss_dssp TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGG
T ss_pred cccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccC
Confidence 3444455555667788899887532 233567999999999999999999999999 99999999999875
Q ss_pred cCCCCccCccccceecCCCCCC-----CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCC
Q 046703 453 QDMNPKISDFGLARTFGGDETE-----GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDN 527 (635)
Q Consensus 453 ~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~ 527 (635)
.+..+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 4557999999999987543322 12234679999999999999999999999999999999999999997654443
Q ss_pred cccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 528 KLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
..................++ ... .+..+.+++..||+.||++||+++++.+.|+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~-----~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVL-----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----HHHHHHHHHHSCHHHH-----TTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhhcccCCCChhHh-----ccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 33222222111111111111 111 123467899999999999999999998888654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.94 E-value=2.9e-29 Score=255.88 Aligned_cols=203 Identities=20% Similarity=0.259 Sum_probs=147.3
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.........+|+++++.... ....+.+++.++..++.||++||+|||+.+ |+||||||+|||+
T Consensus 57 l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll 133 (286)
T d1ob3a_ 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLI 133 (286)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeE
Confidence 47999999999999899999999887632 234677999999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||++........ ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...... .
T Consensus 134 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~ 208 (286)
T d1ob3a_ 134 NREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---D 208 (286)
T ss_dssp CTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H
T ss_pred cCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---H
Confidence 9999999999999987653322 22335688999999998654 5689999999999999999999998643221 1
Q ss_pred HHHHHHHHhhcCCCCcC---------------CCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGMPSEM---------------IDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~~~~~---------------~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
................. ..+.............+.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222211111000000 0000001111112345778999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.7e-29 Score=261.86 Aligned_cols=192 Identities=16% Similarity=0.152 Sum_probs=149.3
Q ss_pred eeccccccccccCCCCccEEEEecccchhh------hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceE
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELDQ------ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVL 450 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIl 450 (635)
+.|+||+.+.++......+|++||+++... .....+++.++..++.||++||.|||+++ |+||||||+|||
T Consensus 58 l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIl 134 (321)
T d1tkia_ 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENII 134 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCccccccccee
Confidence 469999999999988899999999987421 22336899999999999999999999999 999999999999
Q ss_pred eccC--CCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCc
Q 046703 451 LDQD--MNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNK 528 (635)
Q Consensus 451 ld~~--~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~ 528 (635)
++.+ ..+||+|||+++..... .......+++.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 135 l~~~~~~~ikl~DFG~~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-- 209 (321)
T d1tkia_ 135 YQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-- 209 (321)
T ss_dssp ESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--
T ss_pred ecCCCceEEEEcccchhhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--
Confidence 9854 47899999999876432 2234467899999999999999999999999999999999999998643211
Q ss_pred ccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 529 LNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
. ....+..+... .+...... ....+.+++.+||+.||++|||++|+++
T Consensus 210 -~----~~~~i~~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 210 -Q----IIENIMNAEYT--FDEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -H----HHHHHHHTCCC--CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -H----HHHHHHhCCCC--CChhhccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12222222211 00000001 1234678999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.9e-28 Score=255.76 Aligned_cols=205 Identities=20% Similarity=0.165 Sum_probs=145.5
Q ss_pred eeccccccccccC------CCCccEEEEecccchh--------hhhccccCcccchhhhhhhccccchhhccccceEEee
Q 046703 377 MWFGDLIDMRSFP------DGGQDLYIRMSASELD--------QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHR 442 (635)
Q Consensus 377 l~h~nLv~l~~~~------~~~~~lyl~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 442 (635)
+.|+|++.+..+. .+...+|+++++++.. ......+++.++..++.||++||+|||+++ |+||
T Consensus 70 l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHr 146 (350)
T d1q5ka_ 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHR 146 (350)
T ss_dssp CCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECC
T ss_pred cCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---Cccc
Confidence 3689999887665 2344588999998632 123456899999999999999999999999 9999
Q ss_pred ccCCcceEeccCC-CCccCccccceecCCCCCCCceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCC
Q 046703 443 DLKAGNVLLDQDM-NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 443 dik~~NIlld~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
||||+|||++.++ .+||+|||++......... ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||
T Consensus 147 DiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf 223 (350)
T d1q5ka_ 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223 (350)
T ss_dssp CCCGGGEEECTTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred CCCcceEEEecCCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC
Confidence 9999999999775 7999999999877543322 23578999999998765 57899999999999999999999998
Q ss_pred CCccCCCcccHHHH--------HHHHhhc----CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 521 GFYHLDNKLNLIGH--------AWKLWNK----GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 521 ~~~~~~~~~~~~~~--------~~~~~~~----~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
......+....+.. .+..... ..........+...........+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 65432211111100 0111110 1111111111111111222345778999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=5.6e-28 Score=247.28 Aligned_cols=202 Identities=12% Similarity=0.078 Sum_probs=150.9
Q ss_pred ccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
|++++.+..+...+...|++|++.... ......+++.++..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 60 ~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~ 136 (293)
T d1csna_ 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGR 136 (293)
T ss_dssp CTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECC
T ss_pred CCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecC
Confidence 456666777777778889999987531 233457899999999999999999999999 999999999999974
Q ss_pred -----CCCCccCccccceecCCCCCC-----CceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCc
Q 046703 454 -----DMNPKISDFGLARTFGGDETE-----GNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 523 (635)
Q Consensus 454 -----~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~ 523 (635)
++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 137 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 467999999999987543221 1223467999999999999999999999999999999999999999765
Q ss_pred cCCCcccHHHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHcCC
Q 046703 524 HLDNKLNLIGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILMLGSE 592 (635)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 592 (635)
....................+.++. ... +..+.+++..|++.+|++||+++.+.+.|+..
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~l~-----~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 217 KAATNKQKYERIGEKKQSTPLRELC-----AGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CSCCHHHHHHHHHHHHHHSCHHHHT-----TTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHhccCCCChHHhc-----CCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 4444333322222211111111111 111 23467788899999999999999988877654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.8e-28 Score=251.36 Aligned_cols=209 Identities=20% Similarity=0.248 Sum_probs=142.4
Q ss_pred eeccccccccccCC--------CCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeec
Q 046703 377 MWFGDLIDMRSFPD--------GGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRD 443 (635)
Q Consensus 377 l~h~nLv~l~~~~~--------~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~d 443 (635)
+.|+|++.+..+.. ....+|+++++++.. ......++...+..++.||++||.|||+.+ |+|||
T Consensus 66 l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrD 142 (318)
T d3blha1 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRD 142 (318)
T ss_dssp CCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred hcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecC
Confidence 46888887766542 235689999987632 234557788888999999999999999999 99999
Q ss_pred cCCcceEeccCCCCccCccccceecCCCCCC--CceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCC
Q 046703 444 LKAGNVLLDQDMNPKISDFGLARTFGGDETE--GNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNR 520 (635)
Q Consensus 444 ik~~NIlld~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf 520 (635)
|||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||
T Consensus 143 lKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 143 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 9999999999999999999999876533221 122235689999999998755 6899999999999999999999998
Q ss_pred CCccCCCcccHHHHHHHHhhcCCCCcC--------CCCccccCCCHHH-------HHHHHHHHHHhcccCCCCCCChHHH
Q 046703 521 GFYHLDNKLNLIGHAWKLWNKGMPSEM--------IDPCYQESCNLTE-------VIRCIHISLLCVQQHPDDRPCMPSV 585 (635)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~d~~l~~~~~~~~-------~~~~~~l~~~Cl~~dP~~RPt~~ev 585 (635)
...........+............... ............+ ...+++|+.+||+.||++|||++|+
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 643322211111111100000000000 0000001111111 2245679999999999999999999
Q ss_pred HHH
Q 046703 586 ILM 588 (635)
Q Consensus 586 l~~ 588 (635)
++.
T Consensus 303 L~H 305 (318)
T d3blha1 303 LNH 305 (318)
T ss_dssp HHS
T ss_pred HcC
Confidence 864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.1e-28 Score=254.17 Aligned_cols=208 Identities=23% Similarity=0.258 Sum_probs=148.3
Q ss_pred eeccccccccccCCC------CccEEEEecccchh---hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPDG------GQDLYIRMSASELD---QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~~------~~~lyl~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+|+|.+..+... ...+|++|+++... ..+...+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 74 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~ 150 (346)
T d1cm8a_ 74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPG 150 (346)
T ss_dssp CCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred cCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcc
Confidence 469999988776533 34689999998632 233567999999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|||++.++.+|++|||+++...... ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......
T Consensus 151 NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~ 225 (346)
T d1cm8a_ 151 NLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225 (346)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhcccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence 9999999999999999998764332 235789999999998764 5789999999999999999999998654221
Q ss_pred CcccHHHHHHH-----Hhhc----------CCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--H
Q 046703 527 NKLNLIGHAWK-----LWNK----------GMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM--L 589 (635)
Q Consensus 527 ~~~~~~~~~~~-----~~~~----------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~--L 589 (635)
........... .+.. ....+.....+. .........+.+|+.+||+.||++|||++||++. +
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 11111100000 0000 000111111111 0111112346789999999999999999999984 6
Q ss_pred cCCC
Q 046703 590 GSEI 593 (635)
Q Consensus 590 ~~~~ 593 (635)
+.+.
T Consensus 305 ~~~~ 308 (346)
T d1cm8a_ 305 ESLH 308 (346)
T ss_dssp TTTC
T ss_pred CcCC
Confidence 6554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.2e-27 Score=246.31 Aligned_cols=205 Identities=21% Similarity=0.286 Sum_probs=141.9
Q ss_pred eeccccccccccCCC-----CccEEEEecccch---hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcc
Q 046703 377 MWFGDLIDMRSFPDG-----GQDLYIRMSASEL---DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGN 448 (635)
Q Consensus 377 l~h~nLv~l~~~~~~-----~~~lyl~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~N 448 (635)
+.|+|++.+..+... ...+|++++.... +..+...+++.++..++.||+.||+|||+++ ||||||||+|
T Consensus 63 l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~N 139 (345)
T d1pmea_ 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSN 139 (345)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred cCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcce
Confidence 368888887766532 2346777665442 1223457999999999999999999999999 9999999999
Q ss_pred eEeccCCCCccCccccceecCCCCCC-CceeeeeeccCCCCcccccC-CCCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 449 VLLDQDMNPKISDFGLARTFGGDETE-GNTTRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 449 Illd~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
||++.++.+||+|||++......... .......|++.|+|||.+.. ..++.++||||+||++|||++|+.||......
T Consensus 140 ILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~ 219 (345)
T d1pmea_ 140 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219 (345)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH
Confidence 99999999999999999876433221 22334678999999999844 56789999999999999999999998653321
Q ss_pred CcccHHHHHHHHhhcC------------------CCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 046703 527 NKLNLIGHAWKLWNKG------------------MPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVILM 588 (635)
Q Consensus 527 ~~~~~~~~~~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~~ 588 (635)
+. ........... .........+. ........++.+++.+||+.||++|||++|+++.
T Consensus 220 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 220 DQ---LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HH---HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH---HHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11111100000 00000000000 0000111246789999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-26 Score=240.55 Aligned_cols=192 Identities=22% Similarity=0.231 Sum_probs=146.3
Q ss_pred ccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEecc
Q 046703 379 FGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQ 453 (635)
Q Consensus 379 h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~ 453 (635)
|+||+.+.........+|++++++... ....+.+....+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 88 ~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~ 164 (322)
T d1vzoa_ 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDS 164 (322)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred CCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecC
Confidence 478999988888888999999998642 234556778888899999999999999999 999999999999999
Q ss_pred CCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC--CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccH
Q 046703 454 DMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNL 531 (635)
Q Consensus 454 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~ 531 (635)
++.+||+|||+++.+...... ......|++.|+|||.+... .++.++|||||||+||||++|+.||......+....
T Consensus 165 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~ 243 (322)
T d1vzoa_ 165 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243 (322)
T ss_dssp TSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred CCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999876433222 22335789999999998654 467899999999999999999999976544433322
Q ss_pred HHHHHHHhhcCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 046703 532 IGHAWKLWNKGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPC-----MPSVIL 587 (635)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~evl~ 587 (635)
+. .......+. .+......+.+++.+||+.||++||| ++|+++
T Consensus 244 i~---~~~~~~~~~----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 IS---RRILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HH---HHHHHCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HH---HhcccCCCC----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 22 221122111 11122345778999999999999994 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.5e-26 Score=235.85 Aligned_cols=204 Identities=18% Similarity=0.215 Sum_probs=147.9
Q ss_pred eeccccccccccCCCCccEEEEecccchh-----hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEe
Q 046703 377 MWFGDLIDMRSFPDGGQDLYIRMSASELD-----QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLL 451 (635)
Q Consensus 377 l~h~nLv~l~~~~~~~~~lyl~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIll 451 (635)
+.|+||+.+.........+|+++++.... ....+.+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 58 l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli 134 (292)
T d1unla_ 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLI 134 (292)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred cCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCccccc
Confidence 36999999999998899999999887532 234567888999999999999999999999 9999999999999
Q ss_pred ccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCC-CcccCceeeeehhhHhhhhCCCCCCCccCCCccc
Q 046703 452 DQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLN 530 (635)
Q Consensus 452 d~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~ 530 (635)
+.++.+||+|||.++........ .....++..|+|||.+.... ++.++||||+||++|||++|+.||.... +...
T Consensus 135 ~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~ 210 (292)
T d1unla_ 135 NRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDD 210 (292)
T ss_dssp CTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHH
T ss_pred ccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHH
Confidence 99999999999999886543222 22245678899999887665 6899999999999999999999963221 1112
Q ss_pred HHHHHHHHhhcCC--------------CCcCCC-CccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 531 LIGHAWKLWNKGM--------------PSEMID-PCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 531 ~~~~~~~~~~~~~--------------~~~~~d-~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
....+........ ...... ..............+.+++.+||+.||++|||++||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222221111100 000000 00001111122335678899999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.92 E-value=1.4e-26 Score=240.59 Aligned_cols=201 Identities=15% Similarity=0.125 Sum_probs=143.4
Q ss_pred ccccccccccCC--CCccEEEEecccchhh--hhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccC
Q 046703 379 FGDLIDMRSFPD--GGQDLYIRMSASELDQ--ERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQD 454 (635)
Q Consensus 379 h~nLv~l~~~~~--~~~~lyl~~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~ 454 (635)
|+||+.+..+.. ....+|++|+++.... ...+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~ 165 (328)
T d3bqca1 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE 165 (328)
T ss_dssp STTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred CCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCC
Confidence 889998887653 4457999999987532 23457899999999999999999999999 9999999999999876
Q ss_pred C-CCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCCCcccHH
Q 046703 455 M-NPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKLNLI 532 (635)
Q Consensus 455 ~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~~~~ 532 (635)
+ .+||+|||++........ .....+|..|+|||.+.+. .++.++||||+||+++||++|+.||....... ...
T Consensus 166 ~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~ 240 (328)
T d3bqca1 166 HRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQL 240 (328)
T ss_dssp TTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHH
T ss_pred CCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHH
Confidence 5 589999999987654322 2235689999999998765 47999999999999999999999986433211 111
Q ss_pred HHHHH---------HhhcCCCC----------cCCCCc----cccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 046703 533 GHAWK---------LWNKGMPS----------EMIDPC----YQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL 587 (635)
Q Consensus 533 ~~~~~---------~~~~~~~~----------~~~d~~----l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~ 587 (635)
..... ........ ...... ............+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11100 00000000 000000 000111112235678999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.3e-26 Score=243.55 Aligned_cols=205 Identities=23% Similarity=0.236 Sum_probs=141.4
Q ss_pred eccccccccccC------CCCccEEEEecccchh--hhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcce
Q 046703 378 WFGDLIDMRSFP------DGGQDLYIRMSASELD--QERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNV 449 (635)
Q Consensus 378 ~h~nLv~l~~~~------~~~~~lyl~~~~~~~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NI 449 (635)
.|+||+.+..+. +....+|+++|++... ......+++.++..++.||+.||.|||+.+ |+||||||+||
T Consensus 74 ~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Ni 150 (355)
T d2b1pa1 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNI 150 (355)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccc
Confidence 689998887765 2457899999998742 233457889999999999999999999999 99999999999
Q ss_pred EeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCCCCCCccCCCcc
Q 046703 450 LLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHLDNKL 529 (635)
Q Consensus 450 lld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~~~~ 529 (635)
|++.++.+|++|||+++...... ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...+.....
T Consensus 151 l~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~ 227 (355)
T d2b1pa1 151 VVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_dssp EECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH
Confidence 99999999999999987654332 223357899999999999999999999999999999999999998643211111
Q ss_pred cHHHH--------HH-------HHhhcCCCCc-------CCCCccc---cCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 046703 530 NLIGH--------AW-------KLWNKGMPSE-------MIDPCYQ---ESCNLTEVIRCIHISLLCVQQHPDDRPCMPS 584 (635)
Q Consensus 530 ~~~~~--------~~-------~~~~~~~~~~-------~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~e 584 (635)
..+.. .+ .....+.... ....... ..........+.+|+.+||+.||++|||++|
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 10000 00 0000111000 0000000 0112234556888999999999999999999
Q ss_pred HHHH
Q 046703 585 VILM 588 (635)
Q Consensus 585 vl~~ 588 (635)
|++.
T Consensus 308 lL~H 311 (355)
T d2b1pa1 308 ALQH 311 (355)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.8e-26 Score=238.32 Aligned_cols=207 Identities=23% Similarity=0.274 Sum_probs=137.1
Q ss_pred eeccccccccccCC------CCccEEEEecccch---hhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCc
Q 046703 377 MWFGDLIDMRSFPD------GGQDLYIRMSASEL---DQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAG 447 (635)
Q Consensus 377 l~h~nLv~l~~~~~------~~~~lyl~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~ 447 (635)
+.|+|++.+..+.. .....|+.++.... +....+.+++.++..++.||+.||+|||+++ |+||||||+
T Consensus 74 l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~ 150 (348)
T d2gfsa1 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS 150 (348)
T ss_dssp CCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred cCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCc
Confidence 36888888776542 23345665544322 1233467999999999999999999999999 999999999
Q ss_pred ceEeccCCCCccCccccceecCCCCCCCceeeeeeccCCCCcccccCC-CCcccCceeeeehhhHhhhhCCCCCCCccCC
Q 046703 448 NVLLDQDMNPKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHLD 526 (635)
Q Consensus 448 NIlld~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS~Gvvl~eiltG~~pf~~~~~~ 526 (635)
|||++.++.+|++|||++...... .....|+..|+|||.+.+. .++.++||||+||++|||++|+.||...+..
T Consensus 151 NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~ 225 (348)
T d2gfsa1 151 NLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225 (348)
T ss_dssp GEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999764322 2235789999999987665 4689999999999999999999998654322
Q ss_pred CcccHHHHHHHH-----hh----------cCCCCcCCCCccccCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH--HH
Q 046703 527 NKLNLIGHAWKL-----WN----------KGMPSEMIDPCYQESCNLTEVIRCIHISLLCVQQHPDDRPCMPSVIL--ML 589 (635)
Q Consensus 527 ~~~~~~~~~~~~-----~~----------~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~evl~--~L 589 (635)
.....+...... .. ...........+... .......+.+|+.+||+.||++|||++|+++ .+
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 111111100000 00 000001111000000 0011234678999999999999999999987 45
Q ss_pred cCC
Q 046703 590 GSE 592 (635)
Q Consensus 590 ~~~ 592 (635)
...
T Consensus 305 ~~~ 307 (348)
T d2gfsa1 305 AQY 307 (348)
T ss_dssp TTT
T ss_pred CCC
Confidence 544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=4.8e-24 Score=223.95 Aligned_cols=220 Identities=19% Similarity=0.181 Sum_probs=146.4
Q ss_pred eeeccccccccccCC--CCccEEEEecccch--------hhhhccccCcccchhhhhhhccccchhhc-cccceEEeecc
Q 046703 376 AMWFGDLIDMRSFPD--GGQDLYIRMSASEL--------DQERCKLLDWSKRFRIICGTGRGLLYLHQ-DSRLRIIHRDL 444 (635)
Q Consensus 376 ~l~h~nLv~l~~~~~--~~~~lyl~~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~di 444 (635)
.+.|+|++.+..+.. +....++++.+... .......+++..+..++.||++||+|||+ .+ |+||||
T Consensus 76 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDl 152 (362)
T d1q8ya_ 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDI 152 (362)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCC
T ss_pred hcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccC
Confidence 345888888776653 22334444433221 22345567788889999999999999997 77 999999
Q ss_pred CCcceEeccCCC------CccCccccceecCCCCCCCceeeeeeccCCCCcccccCCCCcccCceeeeehhhHhhhhCCC
Q 046703 445 KAGNVLLDQDMN------PKISDFGLARTFGGDETEGNTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 518 (635)
Q Consensus 445 k~~NIlld~~~~------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvvl~eiltG~~ 518 (635)
||+|||++.++. +|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 999999987654 899999999865422 223568999999999999999999999999999999999999
Q ss_pred CCCCccCCCcccHHHHH---HHHhh--------cC-----------CCCcCCCCc---------cccCCCHHHHHHHHHH
Q 046703 519 NRGFYHLDNKLNLIGHA---WKLWN--------KG-----------MPSEMIDPC---------YQESCNLTEVIRCIHI 567 (635)
Q Consensus 519 pf~~~~~~~~~~~~~~~---~~~~~--------~~-----------~~~~~~d~~---------l~~~~~~~~~~~~~~l 567 (635)
||............... ...+. .+ ....+.... ............+.++
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 98654322211111111 11100 00 000000000 0112345667788999
Q ss_pred HHHhcccCCCCCCChHHHHHH--HcCC---CCCCCCCCCCc
Q 046703 568 SLLCVQQHPDDRPCMPSVILM--LGSE---IVLPQPKQPGF 603 (635)
Q Consensus 568 ~~~Cl~~dP~~RPt~~evl~~--L~~~---~~~p~p~~p~~ 603 (635)
+.+||+.||.+|||++|+++. ++.. .+++.|+.|..
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 999999999999999999873 5433 34555655544
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.85 E-value=2.6e-21 Score=167.78 Aligned_cols=112 Identities=18% Similarity=0.351 Sum_probs=93.6
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEcc
Q 046703 23 PDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSK 102 (635)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~ 102 (635)
+|+|.+||.|.+|++|+ +|.|.|+|+.+|+ |.++. ..++||.||++.|.. +++|+|+.||+|+|+|+
T Consensus 1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEE--ECCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence 58999999999999997 5999999999887 44543 468999999998854 47899999999999997
Q ss_pred CCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCC
Q 046703 103 SNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSD 153 (635)
Q Consensus 103 ~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTD 153 (635)
+.++|++++....... .|+|+|+|||||++.+ ++++|||+.+|++
T Consensus 68 -~~~~w~s~t~~~~~~~-~l~L~ddGNlvly~~~----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SRAIWASNTNRQNGNY-YLILQRDRNVVIYDNS----NNAIWATHTNVGN 112 (112)
T ss_dssp -TEEEEECCCCCSCCCC-EEEECTTSCEEEECTT----SCEEEECCCCCCC
T ss_pred -CCeEEEEeeccCCCce-EEEEcCCCCEEEECCC----CcEEecCCCccCC
Confidence 5678887766544334 8999999999999875 4789999999975
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.84 E-value=4.4e-21 Score=164.95 Aligned_cols=107 Identities=27% Similarity=0.377 Sum_probs=91.1
Q ss_pred ccccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEcc
Q 046703 23 PDIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSK 102 (635)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~ 102 (635)
.|+|.+||.|.+|++|. +|.|.|.|+.+|+ |.|+. ..++||.||++.|. .++.|.|+.+|+|+|+|+
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC--CccEEEEeccceEEEECC
Confidence 47899999999999994 6999999999887 45653 36789999999884 457899999999999999
Q ss_pred CCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccC
Q 046703 103 SNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDY 150 (635)
Q Consensus 103 ~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 150 (635)
+|.+||++++....... .|+|+|+|||||++. .+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~-~l~L~ddGNlVly~~-------~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNY-VCILQKDRNVVIYGT-------DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCE-EEEECTTSCEEEEEC-------CCCCCCCC
T ss_pred CccceEEccccCCCCcE-EEEEcCCCCEEEeCC-------CcccCCCC
Confidence 99999999976554434 789999999999953 48999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.84 E-value=1.1e-20 Score=162.44 Aligned_cols=107 Identities=21% Similarity=0.361 Sum_probs=90.5
Q ss_pred cccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccC
Q 046703 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKS 103 (635)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~ 103 (635)
|+|.+||.|.+|++|. +|.|.|+|+.+|+ |.++ . ..++||+||++.|+.. .++|.|+.||+|||+|++
T Consensus 2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~-~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLY-D---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEE-E---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred CCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEE-e---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCC
Confidence 7899999999999996 5889999998877 3343 2 3689999999999863 678999999999999999
Q ss_pred CceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccC
Q 046703 104 NIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDY 150 (635)
Q Consensus 104 ~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 150 (635)
|.+||+|+++...... .|+|+|+|||||++. .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~-~l~L~ddGNlvly~~-------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNY-VLVLQEDGNVVIYGS-------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCC-EEEECTTSCEEEECC-------EEEECCCC
T ss_pred CcEEEEEeeECCCCCE-EEEEeCCCcEEEECC-------CEecCCCc
Confidence 9999999987554444 899999999999953 49999864
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.71 E-value=4.5e-18 Score=148.39 Aligned_cols=109 Identities=17% Similarity=0.221 Sum_probs=89.5
Q ss_pred EEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCC
Q 046703 61 GIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDS 140 (635)
Q Consensus 61 ~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~ 140 (635)
.|||.++++++.+|++|++.|+....-+|.|+.||||||++. +.++|++++.+..... .|.|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~-~~~l~~~GnLvl~d~~---- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGC-RAVLQPNGRMDVLTNQ---- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSC-EEEEETTTEEEEEETT----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcE-EEEEeCCeeEEEEcCC----
Confidence 589999999999999999999987677899999999999986 6789999987655445 8999999999999876
Q ss_pred ceeeeeeccCCCCcccCCCeeccccccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEE
Q 046703 141 ETYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYR 210 (635)
Q Consensus 141 ~~~~WqSFd~PTDTlLpgq~l~~~~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~ 210 (635)
++++||||. +.++|.|.+.+++||+..+| +.++|.
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY----~~~~W~ 119 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY----GGALWT 119 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE----CCCCCB
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe----CCCccc
Confidence 589999973 23568899999999987654 335664
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=4.2e-16 Score=135.32 Aligned_cols=103 Identities=19% Similarity=0.382 Sum_probs=81.5
Q ss_pred cccCCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccC
Q 046703 24 DIITSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKS 103 (635)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~ 103 (635)
.+|.+||+| .+.+..|.|.|.|+.+|+ |.+ |. ..++||.||+..+.. ...|.|+.||+|+|+|++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCC
Confidence 445555555 346789999999999998 333 32 367999999987743 578999999999999999
Q ss_pred CceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeecc
Q 046703 104 NIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFD 149 (635)
Q Consensus 104 ~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd 149 (635)
|.+||++++....... .|+|+|+|||||++ .++|||-.
T Consensus 80 g~~vWsS~t~~~~~~~-~l~Lq~DGNlvlYg-------~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHY-VLVLQPDRNVVIYG-------DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCE-EEEECTTSCEEEEE-------SEEEECCC
T ss_pred CcEEEECCCcCCCCce-EEEEcCCCCEEEEC-------CCEeccCC
Confidence 9999999987654434 79999999999994 45999953
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.61 E-value=2.2e-16 Score=136.19 Aligned_cols=110 Identities=18% Similarity=0.240 Sum_probs=90.2
Q ss_pred EEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCc
Q 046703 62 IWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSE 141 (635)
Q Consensus 62 iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~ 141 (635)
|||.-..+.+..|+.+.+.++.....+|.|+.||||||+++ +.++|++++.+.. .. .+.|+++|||||++.. +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~~-~~-~l~l~~dGNLvl~d~~----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGAT-GC-RAVLQSDGLLVILTAQ----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCSCS-CC-BCCBCSSSCBCCBCTT----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCCCC-ce-EEEEeccCCEEEEccC----C
Confidence 67766667778899999999987777899999999999984 6789999987533 34 8999999999999876 4
Q ss_pred eeeeeeccCCCCcccCCCeeccccccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 142 TYFWQSFDYPSDTLLPGMKLGWDLETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 142 ~~~WqSFd~PTDTlLpgq~l~~~~~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
++||||+. +.+.|.|.+.|+++|+..+ + +.++|.+|+
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvl--Y--~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTI--Y--GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEE--E--CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEE--e--CCCeecCCC
Confidence 78999863 3467999999999998754 4 347999886
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.46 E-value=3e-14 Score=122.56 Aligned_cols=100 Identities=22% Similarity=0.347 Sum_probs=79.5
Q ss_pred CCCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccCCce
Q 046703 27 TSSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIV 106 (635)
Q Consensus 27 ~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~ 106 (635)
...|+|.+++.| .+|.|.|.|..+|+ |.++. ...+||.+|...+ ..+++.|..+|+|||+|.++.+
T Consensus 12 ~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~ 77 (115)
T d1dlpa1 12 SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTI 77 (115)
T ss_dssp CSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCC
T ss_pred CCcceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCE
Confidence 334667777777 67889999999888 44542 3578999997542 3578999999999999999999
Q ss_pred EEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeec
Q 046703 107 VWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSF 148 (635)
Q Consensus 107 vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSF 148 (635)
||++.+....... .++|+++|||||++ ..+|+|-
T Consensus 78 vWsS~t~~~~g~y-~l~Lq~DGNlvlY~-------~~~Wssg 111 (115)
T d1dlpa1 78 RWSSGTKGSIGNY-VLVLQPDRTVTIYG-------PGLWDSG 111 (115)
T ss_dssp SCCCCCCCCSSCC-EEEECSSSCEEEEC-------SEEEECS
T ss_pred EEEcCCCCCCCCE-EEEECCCCcEEEeC-------CCeecCC
Confidence 9999887655444 79999999999994 3599984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.24 E-value=9e-12 Score=107.85 Aligned_cols=99 Identities=20% Similarity=0.367 Sum_probs=75.2
Q ss_pred CCCccCCCCeEEeCCCeEEEeecCCCCCCCEEEEEEEeeCCCCeEEEeccCCCCCCCCCceEEEecCCcEEEEccCCceE
Q 046703 28 SSQTLNDGRTLISKDGSFELGFFSPGSSKNRYVGIWYKNIPVKTVVWVANRLNLINDSSGFLMINKTGNLVLTSKSNIVV 107 (635)
Q Consensus 28 ~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~v 107 (635)
+.+.|..++.| ..|.|.|.|...|+ |.|+. ...+||.++... .+...++.|..+|||||+|.++.++
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~l 88 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD----RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAV 88 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB----TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec----CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEE
Confidence 34566666666 56779999988776 44432 356789988543 3445789999999999999999999
Q ss_pred EEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeee
Q 046703 108 WSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQS 147 (635)
Q Consensus 108 wss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (635)
|+|++....... .++|+++||||||+ ..+|.|
T Consensus 89 W~S~t~~~~~~~-~l~Lq~DGnlvlY~-------~~~W~t 120 (120)
T d1dlpa2 89 WTSGNSRSAGRY-VFVLQPDRNLAIYG-------GALWTT 120 (120)
T ss_dssp EECCCCCSSSCC-EEEECSSSCEEEEC-------CCCCBC
T ss_pred EEeCCCCCCCcE-EEEECCCCcEEEeC-------CCcccC
Confidence 999987654444 79999999999994 348875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.18 E-value=5.9e-11 Score=102.34 Aligned_cols=85 Identities=19% Similarity=0.276 Sum_probs=67.5
Q ss_pred eEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecccccc
Q 046703 88 FLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLET 167 (635)
Q Consensus 88 ~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~t 167 (635)
+|.+..||||||+++ +.++|++++.+..... .+.|+++|||||++.+ +.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~-~l~l~~dGnLvL~d~~----g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGC-RAVLQPDGVLVVITNE----NVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSC-EEEECTTSCEEEECTT----CCEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcce-EEEEEeCCCEEEECCC----CcEEEECCC------------------
Confidence 588999999999976 5689999987655445 8999999999999876 578998721
Q ss_pred ccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 168 GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 168 g~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
.-+.|.|.+.|+++|+..++ +.+.|.+++
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 11357789999999987654 357899876
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.11 E-value=2.2e-10 Score=97.30 Aligned_cols=88 Identities=18% Similarity=0.365 Sum_probs=67.7
Q ss_pred ceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeeccccc
Q 046703 87 GFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLE 166 (635)
Q Consensus 87 ~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~ 166 (635)
-+|.|..||||||+. ++.+||++++..+......+.|+++|||||++.+ ++++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~s~------------------ 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE----GRSLWASH------------------ 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS----SCEEEECC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC----CcEEEEEe------------------
Confidence 568899999999987 5679999998765443348999999999999876 58899881
Q ss_pred cccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCCC
Q 046703 167 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 214 (635)
Q Consensus 167 tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~w 214 (635)
+..+.|.|.+.|+++|+..++ + .+.|.++++
T Consensus 78 -------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 -------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp -------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred -------------eECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence 111346788999999987654 3 468988764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.10 E-value=1.7e-10 Score=97.77 Aligned_cols=86 Identities=20% Similarity=0.368 Sum_probs=66.9
Q ss_pred ceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeeccccc
Q 046703 87 GFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDLE 166 (635)
Q Consensus 87 ~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~ 166 (635)
-+|.++.||||||++. +.+||++++.++.... .+.|+++|||||++.+ ++++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~-~l~l~~~Gnlvl~~~~----g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSC-FLSMQTDGNLVVYNPS----NKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSC-EEEECTTSCEEEECTT----CCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCcc-EEEEeccceEEEECCC----ccceEEc-------------------
Confidence 4689999999999974 5789999988765555 8999999999999876 5889987
Q ss_pred cccceeEEEeccCCCCCCCceEEEEecCCCceEEEecCCeeeEEcCC
Q 046703 167 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 213 (635)
Q Consensus 167 tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~~g~ 213 (635)
.+....+.|.+.|+++|+..++ . .+.|.++.
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~t 106 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATGT 106 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCCC
Confidence 0112456788999999987654 3 35787764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.94 E-value=5e-11 Score=112.10 Aligned_cols=103 Identities=15% Similarity=0.072 Sum_probs=69.2
Q ss_pred EEEecccchhhhhccccCcccchhhhhhhccccchhhccccceEEeeccCCcceEeccCCCCccCccccceecCCCCCCC
Q 046703 396 YIRMSASELDQERCKLLDWSKRFRIICGTGRGLLYLHQDSRLRIIHRDLKAGNVLLDQDMNPKISDFGLARTFGGDETEG 475 (635)
Q Consensus 396 yl~~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~dik~~NIlld~~~~~kl~Dfgla~~~~~~~~~~ 475 (635)
+++|++.+... ...++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+|||+++.........
T Consensus 86 ~lvme~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~ 159 (191)
T d1zara2 86 AVLMELIDAKE--LYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE 159 (191)
T ss_dssp EEEEECCCCEE--GGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH
T ss_pred EEEEEeecccc--ccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHH
Confidence 46666655322 234677888899999999999999999 9999999999999965 48999999997653221110
Q ss_pred ceeeeeeccCCCCcccccCCCCcccCceeeeehh
Q 046703 476 NTTRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 509 (635)
Q Consensus 476 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS~Gvv 509 (635)
... ..... ..+. ..+.++.++|+||..--
T Consensus 160 ~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 160 ILE---RDVRN-IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp HHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred HHH---HHHHH-HHHH-HcCCCCCcccHHHHHHH
Confidence 000 00000 0111 13567888999987543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.83 E-value=1e-08 Score=87.32 Aligned_cols=88 Identities=23% Similarity=0.432 Sum_probs=66.3
Q ss_pred CceEEEecCCcEEEEccCCceEEEeecccCCCCceEEEEccCCCeEEecccCCCCceeeeeeccCCCCcccCCCeecccc
Q 046703 86 SGFLMINKTGNLVLTSKSNIVVWSAYLSKEVRTPVVLQLLDSGNLVLRGEQDGDSETYFWQSFDYPSDTLLPGMKLGWDL 165 (635)
Q Consensus 86 ~~~l~~~~~g~l~l~~~~~~~vwss~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDTlLpgq~l~~~~ 165 (635)
.-.|.|+.||||||++ .+.+||++++.....++ .++|+.+|||||++.. ..+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~-~l~l~~dGnLvl~~~~-----~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGC-VLKMQNDGNLVIYSGS-----RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSE-EEEECTTSCEEEEETT-----EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCc-EEEEeccccEEEEecC-----CeEEEE------------------
Confidence 3569999999999997 46799999987655545 8999999999999853 556755
Q ss_pred ccccceeEEEeccCCCCCCCceEEEEecCCCceEEEecC-CeeeEEcCC
Q 046703 166 ETGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKG-SRKFYRTGP 213 (635)
Q Consensus 166 ~tg~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~yw~~g~ 213 (635)
.+.-..|.|.+.++++|+..+ ++. ..+.|.+++
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvl--y~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVI--YDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEE--ECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEE--ECCCCcEEecCCC
Confidence 111134678999999998765 443 457899876
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.86 E-value=0.022 Score=35.47 Aligned_cols=31 Identities=32% Similarity=0.737 Sum_probs=25.5
Q ss_pred CCccccccCCCCcccccC-CCCcccccCCCccC
Q 046703 269 DQCDTYGLCGAYGICIIS-QSPVCQCLKGFKHK 300 (635)
Q Consensus 269 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~ 300 (635)
|+|.+-..|| +|-|+.- +.-.|.|-.||+|.
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 6899999998 6889764 45569999999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=87.98 E-value=0.096 Score=48.93 Aligned_cols=30 Identities=20% Similarity=0.313 Sum_probs=25.4
Q ss_pred eEEeeccCCcceEeccCCCCccCcccccee
Q 046703 438 RIIHRDLKAGNVLLDQDMNPKISDFGLART 467 (635)
Q Consensus 438 ~iiH~dik~~NIlld~~~~~kl~Dfgla~~ 467 (635)
.++|+|+.+.||+++++...-|.||+.+..
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEEeeccCcceeecCCceEEEeechhccc
Confidence 489999999999999776667999987753
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.53 E-value=0.097 Score=34.55 Aligned_cols=31 Identities=39% Similarity=0.816 Sum_probs=24.6
Q ss_pred CCCccc-cccCCCCcccccC-CCCcccccCCCc
Q 046703 268 RDQCDT-YGLCGAYGICIIS-QSPVCQCLKGFK 298 (635)
Q Consensus 268 ~~~C~~-~~~CG~~g~C~~~-~~~~C~C~~gf~ 298 (635)
.++|.. ...|..+|.|... ++-.|.|++||+
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 367875 5679999999875 456799999996
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.84 E-value=0.31 Score=31.81 Aligned_cols=31 Identities=29% Similarity=0.735 Sum_probs=23.6
Q ss_pred CCccccccCCCCcccccC-CCCcccccCCCccCC
Q 046703 269 DQCDTYGLCGAYGICIIS-QSPVCQCLKGFKHKS 301 (635)
Q Consensus 269 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~~ 301 (635)
|+|...+.| ..+|... ++-.|+|++||....
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~~ 33 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLDP 33 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEECT
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeECC
Confidence 678877777 4689765 466799999998743
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.29 E-value=0.34 Score=31.19 Aligned_cols=30 Identities=37% Similarity=0.827 Sum_probs=22.3
Q ss_pred CCccccccCCCCcccccC-CCCcccccCCCcc
Q 046703 269 DQCDTYGLCGAYGICIIS-QSPVCQCLKGFKH 299 (635)
Q Consensus 269 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 299 (635)
|+|. ...|...|.|... ..-.|.|++||+=
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 3565 4678888889764 4567999999963
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.90 E-value=0.41 Score=31.52 Aligned_cols=31 Identities=29% Similarity=0.547 Sum_probs=24.0
Q ss_pred CCCccccccCCCCcccccC-CCCcccccCCCcc
Q 046703 268 RDQCDTYGLCGAYGICIIS-QSPVCQCLKGFKH 299 (635)
Q Consensus 268 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 299 (635)
.++|..+. |+.++.|... ++-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47898654 5578999875 4667999999976
|